{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "sample_size": null,
    "random_seed": null,
    "total_questions_in_experiment": 600,
    "successful_questions_in_experiment": 600,
    "failed_questions_in_experiment": 0,
    "questions_evaluated": 600,
    "completed": true,
    "input_file": "/Users/reeturajharsh/domyn/multihopQA-benchmarking/src/experiments/outputs/experiments/gpt-oss-20b-reasoning/e5_page_window_relevance_asc/qualitative_3hop_cross_company_type1.json",
    "timestamp": "2026-02-04T06:35:17.014653"
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive’s equity‑compensation plans approved by security holders have **37,028 thousand** (≈ 37 million) securities remaining available for future issuance (CL, page 61).  \nProcter & Gamble’s stock‑option, RSU and PSU plans allow for **119 million** securities to be issued in the future (PG, page 69 note).  \nThus, PG’s available securities are roughly **3.2 times larger** than CL’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37,028 thousand or ~37 million), which matches the ground truth. However, it reports Procter & Gamble's total available securities as 119 million, which is incorrect — the correct figure from the knowledge graph is 133,185,995. This is a significant numerical error. The comparison that PG’s available securities are '3.2 times larger' than CL’s is based on incorrect input and thus inaccurate: using correct numbers, 133,185,995 ÷ 37,028,000 ≈ 3.6, not 3.2. 2) Quantitative accuracy is compromised due to the incorrect PG number — while CL’s number is correctly cited (with acceptable rounding/formatting as '37,028 thousand'), PG’s figure is off by over 14 million. Calculations derived from this are therefore also incorrect. 3) The reasoning structure is sound: the model correctly identifies the need to compare two companies’ securities available under equity compensation plans, extracts the relevant categories (stock options, RSUs, PSUs), and attempts a multiplicative comparison. The multi-hop synthesis across companies is logically structured, but flawed due to incorrect data for PG. 4) Contextual relevance is high — the answer addresses the core comparison, cites appropriate plan types, and provides a clear conclusion. Despite incorrect numbers, the qualitative intent and structure are appropriate. The main failure is factual accuracy in one key data point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 404,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s foreign‑exchange forward contracts would offset roughly **$1.5‑$1.6 billion** of potential loss if the U.S. dollar weakened 10 % (AOCI impact on cash‑flow hedges, 2023‑24).  \nDisney, by contrast, has **net foreign‑exchange cash‑flow hedges with a notional of about $9.9 billion** for forecasted transactions and a policy to hedge those exposures for up to **four years**, giving it a larger notional exposure and a longer risk‑mitigation horizon.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that a 10% weakening of the U.S. dollar would result in a $660 million impact on AOCI for Google, but the LLM claims a $1.5–1.6 billion offset in potential loss, which is more than double the correct amount. This error likely stems from mischaracterizing the nature of the hedge impact—Google's $660 million is the sensitivity of net investment hedges reflected in AOCI, not a cash-flow hedge offset as implied by the LLM. Additionally, the LLM references '2023-24' without specifying the exact date (December 31, 2024, in the original), introducing ambiguity. (2) The notional exposure for Disney is correctly reported as $9.9 billion and the risk mitigation horizon of up to four years aligns with the original answer, which states coverage 'generally not exceeding four years.' These values are accurate and properly contextualized. (3) The multi-hop reasoning is partially sound—the model correctly identifies that Google uses forward contracts related to foreign exchange and that Disney hedges forecasted transactions, and it attempts to compare notional exposure and time horizon. However, it misrepresents Google’s hedge type: the original specifies that Google’s forwards are part of a *net investment hedge strategy* affecting AOCI, whereas the LLM incorrectly frames them as *cash-flow hedges*, which is a different accounting and risk management purpose. This undermines the qualitative accuracy of the comparison. (4) Despite the misrepresentation of Google’s hedge type and the major numerical discrepancy, the answer captures Disney’s position accurately and addresses both parts of the comparison question (notional exposure and risk horizon), earning moderate scores for qualitative accuracy and high relevance. The correctness score is limited primarily by the severe quantitative error on Google’s exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 520,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports about **119 million** securities remaining available for future issuance under equity‑compensation plans approved by security holders, whereas Colgate‑Palmolive reports **37,028 thousand** (≈ 37.0 million) securities in the same category.  Thus, P&G’s available pool is roughly 3.2 times larger than Colgate‑Palmolive’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the number of securities available for Procter & Gamble. The ground truth states 133,185,995, but the LLM reports approximately 119 million, which is off by over 14 million securities. This is a material discrepancy that affects the accuracy of the comparison. Colgate-Palmolive’s figure is correctly reported as 37,028,000 (rounded to 37.0 million or 37,028 thousand), so that part is accurate. (2) The calculation of P&G’s pool being 'roughly 3.2 times larger' is based on incorrect input data. Using the correct figures: 133,185,995 / 37,028,000 ≈ 3.6, so the correct multiplier is about 3.6x, not 3.2x. The LLM’s calculation (119M / 37.028M ≈ 3.21) is mathematically correct but based on wrong data, leading to an inaccurate conclusion. (3) The multi-hop reasoning is otherwise sound—comparing securities available under shareholder-approved equity compensation plans between two companies is correctly interpreted and synthesized. The structure and intent of the comparison are valid. (4) Contextual relevance is perfect—the answer addresses the exact question using the right categories and companies. Qualitative reasoning is strong despite the numerical error. However, the quantitative inaccuracy significantly undermines the correctness score, as financial figures must be precise in this context. Minor formatting variations (e.g., 'thousand' vs 'million') are acceptable, but the core number for P&G is factually incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 415,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s November 2023 suit in Delaware seeks to stop Sandoz and other generic manufacturers from launching upadacitinib (Rinvoq) by alleging patent infringement and requesting declaratory and injunctive relief (page 95).  In contrast, Amgen’s May 2023 New Jersey action over its denosumab patents (Prolia/XGEVA) was met with Sandoz’s counterclaims asserting the patents are invalid, and Amgen has responded by asking the court to dismiss those counterclaims (page 156).  Both cases illustrate the same broader strategy of protecting key drug patents against Sandoz’s generic/biosimilar entry, but AbbVie is taking an offensive infringement claim while Amgen is defending its patents and seeking to eliminate Sandoz’s rebuttal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AbbVie filed a patent infringement suit in November 2023 (Delaware) against Sandoz over upadacitinib (Rinvoq), seeking injunctive relief; Amgen faced counterclaims from Sandoz in a May 2023 New Jersey case over denosumab (Prolia/XGEVA), with Sandoz challenging patent validity and Amgen moving to dismiss. These dates, companies, drugs, and legal actions match the original answer. (2) Quantitative accuracy is perfect: the months (November 2023, May 2023) and locations (Delaware, New Jersey) are correctly cited, and no numerical errors exist. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes that both AbbVie and Amgen are involved in patent disputes with Sandoz Inc., but in different legal postures—AbbVie as plaintiff (offensive), Amgen as defendant responding to counterclaims (defensive). The contrast in legal strategy is accurately captured. (4) Semantic equivalence is strong: while the LLM adds specific procedural details (e.g., 'declaratory relief', 'page 95/156') not in the ground truth, these do not contradict but enrich the answer. The core insight about contrasting legal dynamics in biopharma patent enforcement is preserved. Minor deduction in qualitative accuracy due to slightly narrower framing—ground truth emphasizes broader 'biopharmaceutical patent ecosystem' implications, which the LLM implies but doesn't explicitly articulate. Overall, the answer is factually excellent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 424,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s conversion rule turns each 15‑vote Class B share into a single‑vote Class A share, so every conversion cuts the company’s total voting power by 14 votes and dilutes the high‑voting class. Alphabet, by contrast, keeps its 10‑vote Class B shares separate and has used a $62.2 billion buy‑back of Class A (voting) and Class C (non‑voting) shares in 2023, which shrinks the pool of voting shares and concentrates voting power among the remaining shares—including the Class B holders—rather than diluting it.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in quantitative terms: it accurately states GOOGL's $62.2 billion share repurchase in 2023 and correctly identifies the voting rights (15 votes for CMCSA Class B, 10 votes for GOOGL Class B). It also correctly notes that GOOGL repurchased both Class A and Class C shares. However, the qualitative reasoning contains a key inaccuracy: it frames CMCSA's conversion mechanism as inherently dilutive (i.e., 'cuts the company’s total voting power by 14 votes'), which misrepresents the actual anti-dilution protection. The ground truth specifies that CMCSA's Class B shares are protected from dilution and their aggregate voting power is capped at 33 1/3%, meaning the structure is designed to prevent dilution, not cause it. The LLM incorrectly interprets the per-share vote loss upon conversion as 'dilution' of the high-voting class, when in fact the mechanism is structured to preserve Class B's voting control up to the cap. In contrast, the LLM correctly observes that GOOGL's buybacks concentrate voting power among remaining shareholders, including Class B holders, which is a valid inference. The answer is contextually relevant and synthesizes across both companies and the repurchase event, but fails to capture the critical distinction that CMCSA has a stronger anti-dilution mechanism. Thus, while numbers are accurate (quantitative accuracy = 10), the reasoning (qualitative accuracy = 7) and overall correctness (7) are reduced due to this conceptual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 411,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 10‑K reports **97,567,370 shares** reserved for future issuance under its equity‑compensation plan, whereas Tesla’s 2023 10‑K shows **about 11 million shares** represented by outstanding warrants.  Nike’s reserved‑share count is roughly nine times larger than Tesla’s warrant‑represented shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Nike's 97,567,370 shares reserved for future issuance and Tesla's 11 million shares represented by outstanding warrants are correctly reported, with acceptable formatting (e.g., 'about 11 million' is a valid approximation of 11,000,000). (2) The comparison stating that Nike’s share count is 'roughly nine times larger' is mathematically sound: 97,567,370 ÷ 11,000,000 ≈ 8.87, which rounds to approximately nine times. (3) The multi-hop reasoning is correct—information from two separate companies (Nike and Tesla) and two distinct filings (2023 10-Ks) is accurately synthesized to compare shares under an equity compensation plan versus outstanding warrant shares. (4) Entities (Nike, Tesla, 2023 filings), metrics (shares reserved, shares represented by warrants), and years are all correctly identified. (5) The answer conveys the same semantic meaning as the original: Nike has significantly more shares available than Tesla's warrant-backed shares. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 320,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla’s 2023 10‑K shows that 11 million shares would be issued if all outstanding warrants were exercised.  \nNike’s 2023 10‑K reports 97.567 million shares remaining available for future issuance under its equity‑compensation plans.  \nAccordingly, Nike’s available shares are roughly nine times larger than Tesla’s warrant‑issuable shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023 is correctly reported. Nike's 97,567,370 shares remaining available for future issuance is accurately represented as 97.567 million (rounded appropriately). The comparison stating Nike’s available shares are roughly nine times larger is logically sound (97.567 / 11 ≈ 8.87, which rounds to ~9x). (2) The answer addresses all parts of the multi-hop question: it identifies Tesla's warrant-related share disclosure, Nike's equity compensation shares available, and provides a meaningful comparison. (3) Entity accuracy is correct—Tesla and Nike are properly identified, with accurate reference to their 2023 10-K filings and the relevant financial metrics (warrants vs. equity compensation availability). (4) The reasoning is sound: the model correctly synthesizes data from two different companies and disclosures, and draws a valid comparative conclusion. (5) Semantic equivalence is maintained—though wording differs, the core facts, numbers, and implications match the original answer exactly. Minor formatting differences (e.g., using 'million' vs full number) are acceptable and common. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 373,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "GOOGL’s dual‑class structure gives each Class B share 10 votes (vs. 1 vote for Class A), concentrating control in the hands of founders and insiders and allowing them to dominate board decisions and resist activist pressure (GOOGL, Note 11, page 82).  NFLX, by contrast, issues a single class of common stock where every share carries one vote, ensuring that all shareholders have equal influence over corporate decisions and fostering a more democratic, shareholder‑responsive governance model (NFLX, Voting Rights, page 60).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: GOOGL's Class B shares carry 10 votes per share, Class A has 1 vote, and NFLX has 1 vote per share—this matches the original answer exactly. There are no calculation errors. (2) The answer is complete, addressing both GOOGL's differential voting structure and NFLX's uniform model, and contrasting their governance implications. (3) Entities are correctly identified: GOOGL and NFLX are accurately referenced with appropriate structural descriptions. (4) The reasoning is sound: the LLM correctly infers that concentrated control in GOOGL enables founders to dominate decisions and resist activism, while NFLX’s structure promotes equal influence and a more democratic model—this is a valid interpretation consistent with the ground truth’s 'disproportionate control' vs. 'egalitarian governance' framing. The only minor shortcoming is that the LLM omits mention of GOOGL’s Class C shares having no voting rights, which is included in the original answer and adds completeness to the capital structure description. However, this does not undermine the core correctness. The inclusion of fictional footnote citations (e.g., 'Note 11, page 82') is stylistic and does not affect factual accuracy. Overall, the answer demonstrates strong multi-hop reasoning and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 386,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s 30 % interest in QG3 produced 13 MBD of crude oil in 2021, giving Chevron a share of 3.9 MBD (page 11).  Chevron’s total average‑daily net crude‑oil production that year was 141 MBD (Norway 81 MBD, QG3 13 MBD, Waha 37 MBD, South Sumatra 2 MBD, Montney 8 MBD).  Thus, QG3 accounted for roughly **2.8 %** of Chevron’s 2021 average daily net crude‑oil production.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual and reasoning errors. (1) The core claim that Chevron's 30% interest in QG3 produced 13 MBD and thus Chevron's share was 3.9 MBD is fundamentally incorrect. According to the ground truth, the 13 MBD figure is already Chevron's net production (i.e., its 30% share), not the total project output. The LLM incorrectly treats 13 MBD as gross production and applies a 30% ownership to derive a net of 3.9 MBD, which is wrong. (2) The total average daily net crude oil production of 141 MBD is fabricated, with a breakdown including Norway (81 MBD), QG3 (13 MBD), Waha (37 MBD), etc., none of which are supported by the ground truth. The original answer does not provide Chevron's total global production, so the 141 MBD figure and its components are hallucinated. (3) The final percentage of 2.8% is therefore based on incorrect inputs and flawed calculation. The correct approach would be: if 13 MBD is Chevron's net from QG3, and we knew total net production (which we don't from the ground truth), then that percentage could be computed — but the LLM invents the denominator. (4) Multi-hop reasoning fails: the model misunderstands the nature of the 13 MBD figure (net vs. gross) and fabricates data to complete the calculation. (5) Despite referencing 'page 11', no source is provided in context, and the numbers do not align with the ground truth. While the mention of Chevron's 30% stake in Qatargas is correct, and QG3 producing 13 MBD net to Chevron is correct, the synthesis is invalid. The answer is quantitatively and qualitatively wrong, though minimally relevant to the topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 444,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "The ASU 2022‑04 requires a buyer to disclose the key terms of any supplier‑finance program, where the related amounts appear on the balance sheet, the confirmed amount outstanding at period‑end, and a roll‑forward of those amounts.  Both 3M (Note 16) and Honeywell (SCF note) have adopted the standard and now present a roll‑forward table that shows the beginning balance, invoices confirmed, invoices paid, and ending balance for 2024, thereby giving stakeholders clearer visibility into the size and movement of their supplier‑finance obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of ASU 2022-04 on transparency and the requirement for roll-forward disclosures for both 3M and Honeywell, noting their adoption in 2024. It accurately describes the components of the roll-forward (beginning balance, invoices confirmed, paid, ending balance) and references the correct notes in the financial statements (Note 16 for 3M, SCF note for Honeywell). However, it omits the specific quantitative data provided in the ground truth—namely, that 3M reported $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024. This missing numerical detail is significant for full quantitative accuracy. (2) No incorrect numbers are stated, but the absence of the $1.5 billion figures from both 3M’s confirmed and paid/adjusted invoices results in a partial loss of quantitative precision. The year 2024 is correctly cited as the effective year, aligning with the phased implementation. (3) The multi-hop reasoning is sound: the model correctly synthesizes the standard’s requirements with company-specific disclosures and understands the transparency implications. It links ASU 2022-04 to both companies’ enhanced disclosures and explains the benefit to stakeholders. (4) The answer is contextually relevant and well-structured, conveying the essence of improved transparency. However, the lack of specific dollar amounts from the ground truth limits completeness and factual richness, warranting a correctness score of 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 418,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "LMT’s revenue‑recognition policy for U.S. Government contracts governed by the FAR and CAS is to record revenue over time using a percentage‑of‑completion cost‑to‑cost method, recognizing profit or loss as work is performed and as costs vary from estimates. RTX, in its risk disclosures, highlights that its fixed‑price U.S. Government contracts expose it to cost overruns and potential negative profit adjustments—especially in development programs—while cost‑reimbursable contracts only reimburse allowable costs. Thus, LMT focuses on a FAR‑compliant, time‑based revenue recognition framework, whereas RTX underscores the financial risk inherent in fixed‑price contract structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, there are no numbers, dates, or financial amounts in the question or ground truth, so no numeric inaccuracies exist—this aspect is fully correct. (2) The LLM correctly identifies LMT’s revenue recognition approach as cost-based (percentage-of-completion cost-to-cost method), which aligns with FAR-regulated cost-plus contracts, even if it doesn’t explicitly name 'cost-plus-fixed-fee'—the method described is consistent with that model. It also accurately notes that LMT recognizes profit over time as costs are incurred, reflecting FAR compliance. (3) For RTX, the LLM correctly highlights financial exposure from fixed-price contracts, especially regarding cost overruns and negative profit adjustments in development programs—this matches the ground truth. It also correctly contrasts fixed-price risk with cost-reimbursable contracts, reinforcing the risk differential. (4) The multi-hop reasoning is sound: the model synthesizes LMT’s revenue recognition policy with RTX’s risk disclosures, comparing their differing exposures based on contract structure. The only minor shortcoming is that the LLM does not explicitly state that LMT’s FAR-mandated contracts lead to more predictable revenue due to cost reimbursement, nor does it directly contrast LMT’s lower risk profile with RTX’s higher risk under FFP contracts—this nuance is present in the ground truth and slightly strengthens the comparative analysis. However, the semantic meaning and factual content are substantially equivalent. Wording differs but meaning aligns. Contextual relevance is excellent—every part of the question is addressed with accurate, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 485,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis patents in the EU are still active – the company is litigating in multiple European countries to block generics before the composition‑of‑matter patent expires, so its exclusivity in those markets remains intact for the foreseeable future【page_122】.  By contrast, Merck’s Januvia family lost its key U.S. patent in January 2023; although regulatory exclusivity extends only to May 2026 for Januvia/Janumet and July 2026 for Janumet XR, the product is already exposed to generic competition【page_59】.  Consequently, BMS can continue to defend and extend market exclusivity in Europe, while Merck must prepare for generics and rely on the remaining exclusivity window and pricing strategies in the U.S.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. It incorrectly states that BMS's Eliquis patents in the EU are 'still active' and that exclusivity 'remains intact for the foreseeable future,' which contradicts the ground truth that generic competition has already entered in Finland and Portugal and that BMY has faced negative rulings in the UK. This misrepresents the current state of market exclusivity. Additionally, the LLM claims that Januvia is 'already exposed to generic competition' in the U.S., but the ground truth states that exclusivity is maintained until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) due to settlements—meaning no generics have entered yet. (2) Quantitatively, the LLM correctly identifies the January 2023 patent loss for Januvia and the May 2026 and July 2026 exclusivity end dates, which matches the ground truth. However, it mischaracterizes the implications of these dates by asserting generic entry has already occurred, which is factually incorrect. (3) The multi-hop reasoning is partially sound—comparing BMY’s European litigation strategy with MRK’s U.S. patent extension strategy—but fails in synthesis because it does not acknowledge the fragmented outcomes across European countries (e.g., wins in Norway/Sweden/Switzerland, losses in UK, appeals ongoing), nor does it mention that BMY’s strategy is only partially successful. The contrast with MRK’s more unified and successful U.S. extension via secondary patents is therefore weakened. (4) Contextual relevance is high as the answer addresses both companies, their respective drugs, patent timelines, and strategic implications. However, due to key factual errors in both the status of generic entry in Europe and the U.S., the qualitative and quantitative accuracy scores are reduced. The correctness score is 6 because while some core facts (dates, companies, general strategy) are correct, the answer conveys a misleading picture of current market dynamics in both regions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 545,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds totaling **$35 million** to secure stays of judgments on adverse verdicts that are still on appeal (page 49). In contrast, since October 2004 the company has paid roughly **$1 billion** in judgments and settlements (plus about $241 million in interest) for tobacco‑related litigation (page 92). Thus the appeal‑bond amount is only a small fraction—about 4 %—of the total payments made for judgments and settlements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest since October 2004. These match the original answer exactly, with acceptable formatting (e.g., $1 billion). (2) The calculation of the appeal bond as approximately 4% of the $1 billion in judgments and settlements is mathematically sound (35/1000 = 3.5%, rounded to ~4%), and while the original answer does not include this percentage, it adds value without introducing error. (3) The multi-hop reasoning is correct: the model synthesizes data from two different timeframes and contexts—current appeal bonds vs. historical payments—and draws a valid comparative conclusion. (4) The only minor shortcoming is that the original answer emphasizes that the $1 billion includes 'related costs and fees' and explicitly mentions interest, while the LLM bundles interest separately but still accurately. The LLM slightly rephrases the synthesis but maintains semantic equivalence. No entity errors; all references are correctly attributed to PM USA. The inclusion of page numbers (49, 92) suggests proper sourcing, though not required. Overall, the answer is factually excellent, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 365,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment reported net sales of **$74.2 billion** in 2022, a figure that includes revenue from Taiwan (the segment covers China mainland, Hong Kong and Taiwan).  In NVIDIA’s 2022 10‑K, no separate revenue figure for Taiwan is disclosed in the pages provided, so the company’s direct revenue from Taiwan is not reported and cannot be compared to Apple’s figure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Apple's Greater China segment revenue as $74.2 billion (equivalent to $74,200 million), which matches the ground truth. However, it incorrectly claims that NVIDIA did not disclose a separate revenue figure for Taiwan in its 2022 10-K, when in fact the ground truth confirms NVIDIA directly reported $8,544 million in revenue from Taiwan. This is a critical factual error. (2) The quantitative accuracy is partially correct for Apple’s number (with acceptable format variation: $74.2 billion = $74,200 million), but fails on NVIDIA’s figure, which was available and reported but falsely claimed as 'not disclosed.' (3) The reasoning is flawed because the LLM fails to perform the necessary multi-hop comparison between Apple’s regional segment (which includes Taiwan) and NVIDIA’s country-specific revenue. Instead, it incorrectly concludes no comparison is possible due to missing data, when in fact the data exists for both companies. (4) The answer lacks completeness and semantic equivalence with the original answer, as it omits the key fact about NVIDIA’s direct Taiwan revenue and misrepresents the availability of data, leading to an incorrect conclusion. While the contextual framing of Apple’s segment composition is accurate, the core of the question—comparing Apple’s embedded Taiwan contribution to NVIDIA’s direct Taiwan revenue—is undermined by the false claim of missing data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 396,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "The NVDA 10‑K pages supplied do not disclose revenue figures for Taiwan, so its growth between 2020 and 2022 cannot be calculated from these excerpts. Apple’s Greater China segment, which includes Taiwan, grew from $40.3 billion in 2020 to $74.2 billion in 2022 – an increase of roughly 84 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports AAPL's revenue figures for Greater China in 2020 ($40.3 billion) and 2022 ($74.2 billion), matching the ground truth (allowing for format variation: $40,308 million = $40.3 billion). The calculated growth of approximately 84% is also accurate. However, the LLM incorrectly claims that NVDA's revenue from Taiwan is not disclosed in the provided 10-K pages, directly contradicting the ground truth which states specific figures: $3,025 million in 2020 and $8,544 million in 2022. This omission is critical because the question hinges on comparing NVDA's growth (182.5%) to AAPL's (84.1%). (2) Quantitative accuracy is partially met—AAPL numbers are correct and the 84% growth is approximately right (actual: 84.1%), but NVDA's figures are entirely missing, and thus the 182.5% growth is not mentioned. (3) The reasoning fails on the multi-hop requirement: the model must extract and compare growth rates from two different companies and regions. By dismissing NVDA's data as unavailable, it breaks the comparison logic and cannot reach the correct conclusion that NVDA had significantly higher growth. (4) Contextual relevance is fair because the response addresses the AAPL side and attempts the comparison framework, but the failure to acknowledge NVDA's Taiwan revenue renders the answer incomplete and factually incorrect in substance. The core of the question—comparative growth—is not properly answered.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 401,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says it does not expect a material impact from the OECD’s Pillar Two rules – its projected tax liability under the 15 % global minimum is essentially negligible (page 47).  Broadcom likewise expects no material increase in its global tax costs because it has no significant operations in jurisdictions below the 15 % threshold, so its exposure to the global minimum tax is also minimal (page 75).",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Broadcom expects no material increase in its global tax costs and has no significant operations in jurisdictions below the 15% threshold, which directly contradicts the ground truth. The Original Answer clearly states that Broadcom *does* expect a material increase in its effective tax rate and cash tax costs due to its reliance on tax incentives in low-tax jurisdictions, particularly noting Singapore's adoption of the global minimum tax effective in fiscal year 2026. Microsoft's assessment (no material impact) is correctly reported. (2) Quantitatively, the 15% global minimum tax rate is correctly cited, and fiscal years (2025 for Microsoft, 2026 for Singapore/Broadcom) are not mentioned in the LLM answer but are present in the ground truth—this omission affects completeness and accuracy. The LLM incorrectly attributes page 75 to Broadcom’s minimal exposure, which contradicts the known facts. (3) The multi-hop reasoning fails because the model does not correctly contrast Microsoft’s and Broadcom’s differing international tax structures: Microsoft lacks material operations in low-tax jurisdictions, while Broadcom *does* rely on such structures, making it more exposed. The LLM incorrectly equates their exposures, undermining the comparative analysis required by the question. (4) Scores reflect that while some factual elements (Pillar Two, 15% rate, Microsoft’s position) are correct, the core comparative conclusion is factually wrong due to misrepresentation of Broadcom’s exposure, leading to a low correctness and qualitative accuracy score. Contextual relevance is moderate because the answer addresses the right topic but with critical factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 471,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "GOOGL’s Class B shares grant 10 votes per share, giving holders a ten‑fold voting advantage over NFLX shareholders who have only one vote per share (NFLX, §9. Stockholders’ Equity, page 61; GOOGL, Note 11, page 81). This concentration of voting power lets GOOGL Class B holders exert disproportionate influence on board elections and corporate decisions, whereas NFLX shareholders’ influence is strictly proportional to the number of shares they own.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) Quantitative accuracy: The statement that GOOGL Class B shares carry 10 votes per share and NFLX shares carry 1 vote per share is accurate and matches the original answer. No calculations are required, but the comparison of voting power is correctly framed. (2) Completeness: The LLM addresses the core of the question—how the difference in voting structures impacts shareholder influence. It correctly contrasts the disproportionate influence of GOOGL Class B holders with the proportional influence at NFLX. The only minor omission is not explicitly stating that NFLX has a single class of stock with uniform voting rights (though this is implied), and it doesn't mention that GOOGL Class A shares have 1 vote—this context would strengthen the multi-hop synthesis slightly. (3) Entity accuracy: NFLX and GOOGL are correctly identified, and the stock classes and voting rights are accurately attributed. (4) Reasoning: The logic is sound—concentrated voting power leads to disproportionate influence, while one vote per share leads to proportional influence. The answer synthesizes the structural implications correctly. (5) Semantic equivalence: The meaning is equivalent to the original answer, with slightly more concise wording. The inclusion of section references (e.g., 'NFLX, §9') adds credibility, though not required. Overall, the answer is excellent, missing only a small amount of contextual detail to reach full completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 416,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "I’m sorry, but the AMD 10‑K pages you provided (76‑80) do not contain any disclosure of revenue by country or region, so the 2021 revenue attributable to Taiwan is not available in the supplied material. Consequently, I can’t compare it to Apple’s 2022 Greater China revenue of $74.2 billion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is incorrect and fails to match the ground truth. (1) The original answer states that AMD reported $1,187 million in revenue from Taiwan in 2021, but the LLM claims this data is unavailable in the provided documents. However, the evaluation context implies that the correct information should have been extractable from the knowledge graph or appropriate source, and the LLM's refusal to provide the figure constitutes a failure in factual retrieval. (2) Quantitatively, the LLM correctly cites Apple’s 2022 Greater China revenue as $74.2 billion (equivalent to $74,200 million), which matches the ground truth. However, it fails to report AMD’s $1,187 million figure, making the quantitative accuracy very low due to incompleteness. (3) The reasoning is flawed because the LLM defaults to a lack of data rather than retrieving or synthesizing the correct multi-hop information. A proper response would have compared AMD’s Taiwan-specific revenue to Apple’s broader regional revenue, noting that Apple’s figure is much larger despite the geographic and temporal differences. (4) Contextual relevance is moderate because the LLM addresses the right companies and general intent of comparison but fails to deliver the actual comparison due to an unsupported claim of missing data. The answer should have reflected the known facts from the knowledge graph, not document limitations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 384,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan has 49.0 million shares reserved for issuance (TSLA p. 83), roughly half the pool Starbucks reports—99.7 million shares available for future equity awards (SBUX p. 80). Both companies include incentive stock options in their plans—Tesla’s plan allows incentive and non‑statutory options (TSLA p. 83), and Starbucks offers both non‑qualified and incentive options (SBUX p. 80)—but Starbucks’ larger share reserve indicates a greater capacity to grant incentive options relative to Tesla’s more modest pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's 49.0 million shares reserved under its 2019 Equity Incentive Plan as of December 31, 2021, and Starbucks' 99.7 million shares available as of October 2, 2022. These figures match the ground truth exactly, with acceptable formatting (e.g., 49.0 million). The comparison stating Starbucks has roughly double Tesla’s share pool is accurate and reasonable. (2) All numbers are correct and properly attributed to the respective companies and filings. No calculations were required beyond comparison, and the relative sizing ('roughly half') is factually sound. (3) The multi-hop reasoning is solid: the model correctly synthesizes data from two different companies and filings, compares their equity grant capacities, and accurately describes the role of incentive stock options in both compensation strategies. It correctly notes that Tesla's plan includes both incentive and non-statutory options, and Starbucks offers both non-qualified and incentive options—consistent with the ground truth. (4) The only minor shortcoming is that the LLM slightly reframes the conclusion around Starbucks having 'greater capacity to grant incentive options relative to Tesla’s more modest pool,' which, while logically inferred, goes a small step beyond the neutral comparison in the original answer. However, this inference is reasonable given the data. All entities (Tesla, Starbucks, 2019 Plan, equity compensation, incentive stock options) are correctly identified and contextualized. The answer is fully relevant and addresses both the quantitative comparison and the strategic use of incentive stock options.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 452,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD’s Level 2 fair‑value calculation uses third‑party pricing models that combine income‑based and market‑based approaches, drawing on broker‑dealer quotes together with other observable inputs such as issuer credit spreads and pre‑payment projections.  This model‑driven method allows GD to incorporate a broader set of market data and issuer‑specific risk factors when estimating the fair value of its Level 2 assets.  By contrast, BA values its available‑for‑sale debt with a simpler market approach that relies on quoted prices or broker‑dealer quotes of identical or comparable instruments, a more direct but less model‑intensive method that captures less of the issuer‑specific detail.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces a qualitative distinction not supported by the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (2) The entities (GD and BA) and financial instruments (Level 2 assets, available-for-sale debt investments) are correctly identified, and the use of broker/dealer quotes is accurately attributed to both companies. (3) However, the reasoning diverges from the ground truth: the original answer states that both companies use similar approaches—relying on third-party pricing services and observable inputs like broker/dealer quotes for comparable instruments—indicating a parallel methodology. In contrast, the LLM answer claims GD uses a 'model-driven method' incorporating issuer credit spreads and prepayment projections, implying a more complex, issuer-specific approach, while portraying BA’s method as simpler and less model-intensive. This contrast is not present in the ground truth and introduces a false differentiation. (4) The LLM answer adds unsupported detail (e.g., 'income-based and market-based approaches', 'issuer-specific risk factors') that are not in the original data, suggesting over-inference or hallucination in multi-hop synthesis. While the answer remains contextually relevant and addresses the core comparison, the incorrect implication of methodological divergence reduces qualitative accuracy. Correctness is penalized because the conclusion—that the approaches differ meaningfully—is not aligned with the ground truth’s assertion of parallelism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 440,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Because the Federal Reserve has set the Countercyclical Capital Buffer (CCyB) at 0 %, Morgan Stanley’s total buffer requirement is unaffected by the CCyB: it remains 8.4 % of risk‑weighted assets under the Standardised Approach (5.4 % Stress Capital Buffer + 3 % G‑SIB surcharge) and 5.5 % under the Advanced Approach (2.5 % capital‑conservation buffer + 3 % G‑SIB surcharge). American Express, whose buffer calculation is explicitly subject to the SCB, likewise has no CCyB component; its total buffer equals the SCB (plus any G‑SIB surcharge) and is not increased by a CCyB.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, it incorrectly states Morgan Stanley's total buffer as 8.4% under the Standardised Approach (5.4% SCB + 3% G-SIB), but the Stress Capital Buffer (SCB) is not additive with the G-SIB surcharge in this way, and the SCB is not typically expressed as 5.4%—this specific value is unsupported by the ground truth. Additionally, under the Advanced Approach, the LLM claims a 5.5% total buffer (2.5% CCB + 3% G-SIB), but omits the SCB despite the ground truth explicitly stating that Morgan Stanley includes the SCB in its Advanced Approach calculation. This is a critical error: the SCB must be included, and its exclusion distorts the total requirement. For American Express, the LLM correctly notes that the SCB applies and the CCyB adds nothing at 0%, but fails to mention the CCB (2.5%) or clarify how the SCB integrates with other buffers, instead vaguely stating the total buffer 'equals the SCB (plus any G-SIB surcharge)', which oversimplifies and misrepresents Basel III structure. While the LLM correctly identifies that a 0% CCyB means no additional requirement for either firm, it introduces incorrect numerical values and miscalculates the composition of capital buffers. The reasoning is partially sound in recognizing regulatory differences and the null effect of CCyB, but flawed in execution due to incorrect buffer components and missing multi-hop synthesis (e.g., SCB’s role alongside CCB and G-SIB). The entities (Morgan Stanley, American Express, SCB, CCyB, G-SIB) are correctly identified, and the context of Basel III is appropriately addressed. However, the answer fabricates precise percentages not present in the ground truth and misapplies them, severely reducing factual accuracy. Semantic equivalence is partially achieved on the CCyB impact but lost on the structural and quantitative details essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 521,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "AMT’s $4.0 billion commitment under the 2021 Credit Facility is a dedicated borrowing capacity that the company used to finance its major acquisitions—Telxius and CoreSite—as well as general corporate purposes, reflecting a strategy of leveraging debt to acquire and integrate new businesses. In contrast, as of December 31 2021, Simon Property Group relied on joint‑venture structures, providing interest‑bearing construction loans and other advances (about $88 million) to partners to finance property acquisitions and development, thereby spreading risk and capitalizing on partner equity rather than taking on large standalone debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $4.0 billion commitment for AMT and $88 million (approximated as 'about $88 million') for SPG's joint venture financing are consistent with the original answer, which specifies $88.4 million—minor rounding is acceptable. The date (December 31, 2021) is correctly implied. (2) The entities—AMT (American Tower Corporation), SPG (Simon Property Group), CoreSite Acquisition, and joint ventures—are accurately identified. The mention of Telxius as an additional acquisition is factually correct and adds context not in the original but does not contradict it. (3) The reasoning correctly contrasts AMT’s strategy of using large-scale debt (credit facility) for acquisitions versus SPG’s use of joint ventures with interest-bearing loans to distribute risk and leverage partner equity. This reflects sound multi-hop synthesis across two companies’ financing strategies. (4) The only minor shortcoming is that the original answer emphasizes SPG’s approach as a means to 'support real estate development and diversify risk,' while the LLM focuses on 'spreading risk and capitalizing on partner equity'—semantically equivalent but slightly less precise in capturing the development focus. However, this does not detract significantly from the overall accuracy. Wording differences are acceptable under semantic equivalence. All parts of the question are addressed thoroughly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 408,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during FY 2022 (from 523 to 544, a ~4 % increase).  Nike’s Greater China segment – which includes Taiwan – generated $7.5 billion in revenue in FY 2022.  Thus, while Starbucks’ Taiwan store count grew modestly in number, Nike’s Greater China region contributed a sizable $7.5 billion in sales, reflecting a much larger economic impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Starbucks added 21 stores in Taiwan during FY2022, increasing from 523 to 544, which aligns with the ground truth of 21 net new stores. The ~4% growth calculation is accurate ((21/523)*100 ≈ 4%). Nike's Greater China revenue is reported as $7.5 billion, which is a valid rounding of the exact $7,547 million in the original answer. (2) All numeric values are correct or acceptably rounded; the store count change and percentage increase are accurately derived. The only minor deviation is the use of 'licensed stores'—the original answer does not specify store type, so this could be an over-specific claim, but it does not contradict known facts. (3) The multi-hop reasoning is sound: the model correctly links Starbucks' store growth in Taiwan with Nike's revenue from Greater China, acknowledging that Taiwan is included in Nike’s reporting segment. It draws a reasonable comparison between physical expansion and financial performance. (4) The answer is semantically equivalent to the ground truth, with slightly more detail on percentage growth and store type. The core facts, entities, timeframes (FY2022), and synthesis across companies and metrics are accurate. Minor deduction in quantitative accuracy due to rounding and added specificity on 'licensed' stores without source confirmation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 376,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s OPB plan invests about **60 % of its assets indirectly in equities** through its balanced index fund. In comparison, 3M’s pension plan held equities with a fair value of **$1.246 billion** (US $1,246 million) as of December 31 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 60% of Boeing's OPB plan assets are indirectly invested in equities through the balanced index fund, which matches the ground truth. However, the fair value of equities in 3M's pension plan is incorrect: the LLM reports $1.246 billion ($1,246 million), while the ground truth is $785 million—a significant overstatement of approximately 58.8%. This quantitative error undermines the accuracy of the comparison. (2) Number verification: 60% is correct; $1.246 billion is not equivalent to $785 million—this is a clear factual discrepancy. The date (December 31, 2023) is correctly used. (3) Multi-hop reasoning is structurally sound: the model attempts to compare Boeing's indirect equity exposure with 3M's total equity holdings, which aligns with the question’s intent. However, due to the incorrect dollar amount for 3M, the synthesis is flawed. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate financial terminology. Qualitative accuracy is moderate because the reasoning framework is correct, but quantitative accuracy is low due to the large error in the 3M equity value. Correctness score is reduced to 6 due to the major factual error in a core data point, despite correct identification of the percentage for Boeing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 373,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "AMT used the 2021 USD Delayed‑Draw Term Loans to raise a total of **$4.5 billion** (a $3.0 billion 364‑day loan and a $1.5 billion two‑year loan) that was unsecured and earmarked for the CoreSite acquisition. In contrast, Simon Property Group’s joint‑venture financing is much smaller – **$88.4 million** in interest‑bearing construction loans – and is structured as short‑term, project‑specific debt to fund development and construction within its real‑estate joint ventures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the dollar amount of AMT's financing. The ground truth states that AMT utilized a $10.5 billion financing structure via the 2021 USD Delayed Draw Term Loans for the CoreSite acquisition. However, the LLM reports only $4.5 billion ($3.0 billion + $1.5 billion), which is less than half the correct amount. This is a major quantitative inaccuracy. The SPG financing amount of $88.4 million is correctly reported. (2) The calculation of the total AMT loan amount is incorrect: $3.0B + $1.5B = $4.5B, but the correct total from the original answer is $10.5B. There is no indication in the LLM answer of the full $10.5B structure, suggesting either a missing component or confusion with a subset of the financing. (3) The qualitative reasoning is sound in comparing acquisition-focused, large-scale financing (AMT) with smaller-scale, project-specific joint venture lending (SPG). The entities (AMT, SPG), time frame (2021), and purpose (CoreSite acquisition vs. real estate development) are correctly identified. The structure descriptions—unsecured term loans vs. interest-bearing construction loans—are consistent with the original answer and demonstrate correct multi-hop synthesis across companies and financing types. (4) Contextual relevance is high because the answer directly addresses the comparison in terms of dollar amounts and financing structure as asked. However, due to the critical error in the AMT financing amount, the correctness and quantitative accuracy scores are significantly reduced. While the direction of the comparison (AMT much larger than SPG) remains valid, the magnitude is misrepresented, undermining confidence in the financial detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 472,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s upstream and refining businesses depend on large volumes of crude oil – the company reported $28.7 billion of crude‑oil and product purchases in 2024, underscoring its reliance on crude as a raw material【page_111】.  Chevron’s 15 % stake in the Caspian Pipeline Consortium (CPC) means it controls a key export route that moved an average of 1.2 million barrels per day of Chevron‑produced Kazakh crude in 2024【page_16】, a volume that feeds the global crude market from which XOM ultimately sources its feedstock.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and unsupported claims. First, the ground truth states that the CPC transports 1.4 million barrels per day, with 1.2 million barrels sourced from Kazakhstan (from fields like Tengiz and Karachaganak where Chevron operates). However, the LLM claims that '1.2 million barrels per day of Chevron-produced Kazakh crude' were moved via CPC in 2024 — this overstates Chevron's direct production share and misattributes the entire 1.2 million bpd as 'Chevron-produced', which is not supported by the original answer or typical public knowledge (Chevron has stakes in Tengiz and Karachaganak but does not fully produce 1.2 million bpd). Additionally, the $28.7 billion crude-oil and product purchases by XOM in 2024 is an LLM-invented figure not present in the original answer and cannot be verified; the original makes no mention of this number or year. (2) Quantitative accuracy is compromised: while 15% ownership and 1.2 million bpd from Kazakhstan align approximately with the original, the characterization of that volume as 'Chevron-produced' is factually incorrect. The original states that 1.2 million bpd comes from Kazakh fields in which Chevron operates or holds stakes — a significant distinction. The 1.4 million bpd total CPC volume is omitted. (3) The multi-hop reasoning is partially sound: the LLM connects CVX's 15% CPC stake to crude transport from Kazakhstan and links that to global supply feeding XOM, which aligns with the original’s logic about supply chain interdependence. However, it fails to mention that disruptions in CPC could affect XOM via broader market impacts, weakening the synthesis. (4) Contextual relevance is high — the answer addresses crude reliance, CVX's CPC stake, and the flow of Kazakh crude. Qualitative accuracy is moderate due to correct entity identification (XOM, CVX, CPC, Kazakhstan) and general logic, but penalized for over-attribution of production volume. Correctness score is 6 due to partially correct facts but significant quantitative and attribution errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 557,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE’s decommissioning‑fund risk is a potential shortfall if market performance erodes the value of its decommissioning assets, leaving the company unable to meet future decommissioning costs (see NEE page 32).  Duke Energy’s exposure is to volatility in the value of its Nuclear Decommissioning Trust Fund (NDTF) assets, which could require additional capital to cover decommissioning obligations (see Duke page 35).  Both utilities face the same environmental, safety, regulatory and financial headwinds, but NEE’s concern is a funding gap, whereas Duke Energy’s is a fluctuating trust‑fund value that may trigger extra funding needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NEE faces potential decommissioning funding shortfalls due to market and operational risks affecting its decommissioning funds, while Duke Energy (specifically its subsidiaries) is exposed to volatility in its Nuclear Decommissioning Trust Funds (NDTFs), with market declines potentially increasing funding needs. The LLM correctly identifies both companies' exposure to financial risks from nuclear decommissioning, differentiating NEE's focus on funding gaps and Duke's on trust fund volatility. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model synthesizes risk disclosures from both NEE and Duke Energy, correctly comparing their respective exposures despite different phrasing in filings. The mention of specific page references (32 for NEE, 35 for Duke) adds precision, though not required. (4) The only reason for not scoring a perfect 10 is minor wording nuance: the LLM frames Duke’s exposure slightly more narrowly as 'fluctuating trust-fund value' versus the original’s broader 'impact of capital market performance,' but this does not alter the core meaning. Overall, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 388,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s fair‑value policy (page 52) defines Level 3 as “inputs that are unobservable,” and the company applies pricing models—such as an option‑pricing model for contingent consideration that relies on unobservable inputs (equity value, volatility, term)—to determine those Level 3 fair values. GM’s policy (page 63) likewise classifies Level 3 as requiring unobservable inputs, and GM applies these inputs in its valuation models (discounted‑cash‑flow or option‑pricing models) for securities and other assets. Thus both firms follow the same observability‑based hierarchy, but Lowe explicitly documents the use of pricing models for Level 3, whereas GM’s policy is more general but consistent with the same principle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both LOW and GM classify Level 3 fair value measurements based on unobservable inputs, consistent with accounting policy, and notes that both use pricing models (e.g., option-pricing and discounted cash flow) for Level 3 valuations. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and free of calculations—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two companies (LOW and GM), their respective fair value policies, and the application of unobservable inputs within pricing models. It correctly contrasts LOW’s explicit documentation of pricing models for contingent consideration (tying to Canadian retail business sale in the original) with GM’s use in receivables valuation via economic forecasts, though it omits specific mention of GM Financial, static pool modeling, or unemployment/GDP inputs. This is a minor omission, not an error. (4) The answer is contextually relevant, directly addressing the comparison of pricing model usage and unobservable inputs under the observability-based hierarchy. The only reason it doesn't score a 10 is that it lacks some specificity from the ground truth about GM’s actual modeling practices (e.g., static pool models, macroeconomic variables), making it slightly less complete. However, the core facts, entities, and reasoning are correct and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 426,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "AMT’s $10.5 billion commitment under the 2021 Multicurrency Credit Facility was a single, high‑capacity revolving line that the company used to back‑stop large acquisitions (Telxius and CoreSite) and refinance existing debt, giving it a flexible, centralized source of capital that could be drawn on as needed【page_52】.  By contrast, SPG’s joint‑venture financing is more targeted and modest in scale – $88.4 million in construction loans and other advances – and is spread across many property‑level partnerships to diversify risk in specific assets and portfolios【page_116】.  Thus, AMT deploys capital through a large, centralized facility for major acquisitions, whereas SPG diversifies risk by providing incremental financing to a broad array of joint ventures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $10.5 billion committed financing under AMT's 2021 Multicurrency Credit Facility and SPG's $88.4 million in joint venture financing, with accurate use of company names (AMT, SPG), financial figures, and purposes (acquisitions for AMT, construction loans for SPG). All numeric values match the ground truth exactly, including dollar amounts and their applications. (2) Quantitative accuracy is perfect: $10.5 billion and $88.4 million are correctly cited, and no calculations are required beyond accurate reporting. Format variations are consistent and acceptable (e.g., $10.5 billion = $10.5 billion). (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two companies (AMT and SPG), their distinct financing mechanisms, strategic objectives (centralized vs. decentralized capital deployment), and risk management approaches. It accurately contrasts AMT’s large-scale, centralized acquisition financing with SPG’s smaller, diversified joint venture lending strategy. (4) The answer is contextually fully relevant, directly addressing both capital deployment strategy and risk diversification as asked. The only minor shortcoming is a slight lack of explicit mention that SPG’s loans are 'interest-bearing' as noted in the original, which slightly reduces qualitative precision but does not affect the overall correctness. Hence, a score of 9 is justified—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 410,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 revenue from Taiwan was $1.84 billion—about 8 % of its $22.68 billion total sales【page_71】—a modest share of its overall top line. In contrast, Qualcomm’s 2023 risk disclosures highlight a heavy operational reliance on foundry partners in Taiwan, noting that any disruption in that supply chain could materially impair its business【page_36】. Thus, while AMD’s exposure is measured in revenue terms and is relatively small, Qualcomm faces a more critical geopolitical risk because its manufacturing and supply chain are tightly tied to Taiwan‑based foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies AMD's 2023 revenue from Taiwan as $1.84 billion, matching the ground truth of $1,841 million (equivalent values, minor rounding difference acceptable). It also accurately references AMD's total revenue as $22.68 billion, allowing for the correct calculation of ~8% exposure (verified: 1,841 / 22,680 ≈ 8.1%), which is not in the original answer but is a valid inference and adds value. For QCOM, the LLM correctly captures the qualitative risk disclosure about operational dependency on Taiwanese foundries and the potential material impact of supply chain disruptions. 2) All numeric values are accurate or reasonably rounded; $1.84 billion = $1,840 million ≈ $1,841 million is within acceptable variance. The 8% figure is correctly derived and enhances the analysis. 3) The multi-hop reasoning is sound: the model contrasts AMD’s revenue exposure (downstream) with QCOM’s supply chain dependency (upstream), correctly synthesizing risk types across two companies. It infers that QCOM faces a more critical risk due to operational reliance, which aligns with the original answer’s implication of severe supply impact. 4) The LLM answer is semantically equivalent and contextually relevant, addressing both parts of the question—AMD’s revenue exposure and QCOM’s operational dependency—while drawing a logical comparison in light of geopolitical risks. The only minor shortcoming is not explicitly noting AMD’s declining exposure trend mentioned in the ground truth, which slightly reduces completeness. However, this does not undermine the core accuracy. Thus, the answer is highly accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 453,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "Starbucks notes that the 15 % global minimum tax under OECD’s Pillar 2 will not be effective for the company until fiscal 2025 and “is not expected to result in a material impact to our consolidated financial statements” (SBUX 10‑K, p. 28).  \nMcDonald’s, by contrast, acknowledges that Pillar 2 will be phased in across jurisdictions and that the tax could materially affect its consolidated results, but the staggered implementation means any impact will be spread over time and may not be immediate (MCD 10‑K, p. 18‑22).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in the qualitative assessment of MCD's position, which undermines the multi-hop comparison. Quantitatively, the dates and percentages are accurate: SBUX's fiscal 2025 effective date and the 15% global minimum tax are correctly stated, and the reference to MCD's 10-K pages (18–22) is plausible. However, the LLM incorrectly states that McDonald’s 'acknowledges that Pillar 2 could materially affect its consolidated results,' which directly contradicts the ground truth: MCD, like SBUX, 'does not expect a material impact.' This misrepresentation of MCD’s assessment breaks the core comparison in the question—both companies actually have similar views (no material impact expected), but the LLM portrays them as differing. The reasoning is therefore flawed in synthesis, even though the individual entity facts (dates, implementation timelines) are contextually relevant and mostly accurate. The answer captures the phased implementation correctly but fails on the key qualitative point of materiality. Hence, correctness is reduced to 5 due to this central error, despite good contextual framing and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 336,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan’s risk‑governance framework, which gives the CRO, IRM and LOB CROs firmwide ownership of risk assessment (pages 93‑95), drives a comprehensive, integrated stress‑testing regime that quantifies tail risk, highlights loss concentrations and feeds directly into capital‑planning (page 99).  By contrast, Goldman Sachs explicitly ties its stress‑testing process to capital‑adequacy assessments, using the results to evaluate regulatory capital buffers and support capital planning (page 111).  Thus, JPMorgan’s approach is broader and more integrated across financial and non‑financial risks, whereas Goldman Sachs focuses stress testing primarily on capital adequacy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorganChase's firmwide ownership of risk assessment involving the CRO, IRM, and LOB CROs is accurately described, and the integration of stress testing into capital planning and tail risk quantification is consistent with a governance-driven, comprehensive risk framework. The contrast with Goldman Sachs’s explicit linkage of stress testing to capital adequacy assessments, regulatory capital buffers, and capital planning is also correctly represented. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in governance models (JPMorgan’s integrated ownership vs. Goldman’s capital-focused application) and infers the differing scope and purpose of stress testing. The only minor shortcoming is that the LLM answer slightly underemphasizes Goldman Sachs’s evaluation of nonfinancial risks, which is mentioned in the original answer. However, this does not distort the core comparison. (4) The answer is contextually relevant, directly addressing the comparative influence of governance frameworks on stress testing methodologies. Wording differs but semantic meaning and factual content are equivalent. Thus, the correctness score is 9 due to high accuracy with a minor omission in scope detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 435,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "XOM’s long‑lived assets in Kazakhstan total about **$8.5 billion** (page 124).  Chevron, by contrast, owns **50 % of Tengizchevroil** and has supplied a **$4.5 billion loan** to the joint venture (page 78).  Thus XOM’s exposure in Kazakhstan is larger in absolute asset terms, while Chevron’s position is an equity stake plus a loan contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly reports XOM's long-lived assets in Kazakhstan as approximately $8.5 billion (matching the ground truth $8,463 million, rounded appropriately) and accurately states CVX's 50% equity interest in Tengizchevroil and the $4.5 billion loan (matching $4,500 million). These quantitative elements are correct with acceptable formatting variations.\n\n2) However, the key reasoning and conclusion in the LLM answer are flawed. It states that 'XOM’s exposure in Kazakhstan is larger in absolute asset terms,' which is factually correct based on the numbers, but then fails to acknowledge the combined nature of CVX's exposure (equity + loan), which the original answer emphasizes could *potentially exceed* XOM's asset base when both components are considered. The LLM incorrectly implies XOM has greater exposure without evaluating the total financial commitment of CVX, which includes both equity and a major loan.\n\n3) This is a multi-hop reasoning failure: the model identifies the correct facts but does not synthesize them to compare total financial exposure. The original answer highlights that CVX’s total stake—proportional equity value plus a $4.5 billion direct loan—may surpass XOM’s $8.463 billion asset base when combined, suggesting CVX could have greater effective exposure. The LLM misses this synthesis, leading to a misleading conclusion.\n\n4) Quantitative accuracy is high (9/10) due to correct numbers and rounding. Contextual relevance is strong (9/10) as all entities and projects are correctly referenced. Qualitative accuracy is low (5/10) due to flawed reasoning and incomplete comparison. Correctness score is 6 due to accurate data but significant error in interpretation and synthesis, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 476,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Geopolitical tensions involving Taiwan could choke the supply chains of both companies because their key foundry partners are located there.  QCOM’s 10‑K notes that a prolonged conflict between China and Taiwan could “severely limit or prevent us from receiving chipset supply from Taiwan, which would have a material adverse impact on our business.”  NVDA’s 10‑K similarly warns that tensions in Taiwan and China could disrupt its supply continuity, as its suppliers, contract manufacturers and assembly partners in the region are critical to GPU production, potentially leading to shortages, delays and financial losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the original ground truth in both factual content and reasoning. (1) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies both QCOM and NVDA, their reliance on foundry partners in Taiwan, and the potential impact of geopolitical tensions on supply chains. It accurately quotes QCOM’s 10-K language about being 'severely limited or prevented' from receiving supply, and correctly summarizes NVDA’s exposure due to suppliers, contract manufacturers, and assembly partners in the region. (3) The multi-hop reasoning—linking geopolitical risk in Taiwan to supply chain disruptions for both companies through shared reliance on Taiwanese foundries—is sound and well-synthesized across both companies’ disclosures. (4) The only minor shortcoming is that the LLM does not explicitly mention that both companies rely on the same foundry partners (e.g., TSMC), which is implied in the original answer but not stated here. However, this does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. All key points—material adverse impact, supply constraints, production delays, financial consequences—are covered. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (by absence of error).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company’s 10‑K notes that rising compliance costs—whether from CCR, GHG, or other environmental rules—may be passed through regulated rates, and that higher rates could prompt industrial customers to cut or defer electricity use (“increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas…many commercial and industrial customers may also be affected by existing and future environmental requirements”【page_26】). Duke Energy’s risk factors, by contrast, highlight that industrial demand is already volatile, with customers likely to reduce production and consumption in response to economic downturns, regulatory changes, and energy‑efficiency mandates, which can cause sharp swings in sales regardless of rate changes (“industrial customers reduce production and, therefore, consumption of electricity and the use of natural gas”【page_27】). Thus, Southern’s potential demand shift is directly tied to compliance‑driven rate hikes, whereas Duke’s exposure is broader, encompassing economic and regulatory factors that drive industrial demand volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company’s risk from environmental compliance costs being passed through regulated rates leading to reduced industrial demand is accurately described, as is Duke Energy’s exposure to industrial demand volatility due to economic conditions, regulatory changes, and efficiency mandates. The cited page references (26 and 27) match the source context and support the claims. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk factors from both companies’ 10-Ks and contrasts Southern’s regulatory cost pass-through mechanism with Duke’s broader economic and regulatory sensitivity. The only minor shortcoming is that the LLM slightly broadens Duke’s exposure by mentioning 'energy-efficiency mandates' and 'regulatory changes' beyond the original’s focus on 'declines in industrial production due to economic conditions'—but these are reasonable inferences from the source material and do not distort the core comparison. (4) The answer is fully contextually relevant, directly addressing both parts of the question and providing a clear, nuanced comparison. Thus, the correctness score is 9 due to slight expansion beyond the original wording, but all key facts and reasoning are preserved and accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 418,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "NKE’s $9.9 billion of foreign‑exchange cash‑flow hedges is more than double McDonald’s total net asset exposures of roughly $3.8 billion (Australian dollars, British pounds, Polish zloty, Chinese renminbi and Hong Kong dollars). This shows that NKE hedges a larger notional amount relative to its net exposure and covers a broader mix of currencies than McDonald’s more concentrated net asset positions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The claim that MCD has 'total net asset exposures of roughly $3.8 billion' is not supported by the ground truth, which does not provide any specific dollar amount for MCD's net asset exposures. This number appears to be fabricated. Additionally, the comparison stating that NKE's $9.9 billion is 'more than double' MCD's $3.8 billion is therefore invalid. (2) The currencies listed for MCD (Australian dollars, British pounds, Polish zloty, Chinese renminbi, Hong Kong dollars) are not mentioned in the original answer and are likely incorrect or unsubstantiated; the ground truth only states that MCD uses a diversified basket of currencies without specifying which ones. In contrast, NKE's hedged currencies (euros, Canadian dollars, Japanese yen, British pounds, Chinese yuan) are correctly identified in the original but not fully listed in the LLM answer. (3) The multi-hop reasoning is flawed: while the LLM attempts to compare NKE’s active hedging strategy with MCD’s balance sheet management approach, it incorrectly quantifies MCD’s exposure and misrepresents the nature of the comparison. The original emphasizes differing risk management *strategies* (derivatives vs. balance sheet netting), but the LLM reduces this to a numerical comparison that lacks factual basis. (4) Despite these issues, the LLM captures the general idea that NKE uses large-scale hedges while MCD manages risk through net asset positioning, so some contextual relevance remains. However, the introduction of false quantitative data severely undermines correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 449,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s exposure through Coca‑Cola HBC’s operations in Ukraine is very limited – the company notes that its two Ukrainian manufacturing sites account for less than 1 % of consolidated net sales and earnings, though it warns of potential damage and supply‑chain disruptions (page 23). The Procter & Gamble pages supplied do not disclose any Ukraine‑related manufacturing or supply‑chain exposure, so its level of reliance cannot be quantified from the available information. Consequently, Coca‑Cola’s exposure appears minimal relative to any direct reliance Procter & Gamble might have on Ukraine.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly attributes the 'less than 1% of consolidated net sales and earnings' figure to The Coca-Cola Company's exposure via Coca-Cola HBC in Ukraine. However, the ground truth states this figure applies to Procter & Gamble's Ukraine-related assets as a percentage of net assets—not Coca-Cola. This misattribution is a critical error. Additionally, the LLM claims that Procter & Gamble's disclosures do not reveal any Ukraine-related manufacturing exposure, which contradicts the original answer stating P&G has two manufacturing facilities in Ukraine. (2) Quantitatively, the 1% figure is accurate but assigned to the wrong company. The original answer specifies that Coca-Cola’s exposure is indirect through Coca-Cola HBC, with no specific sales percentage given for Ukraine alone, while P&G’s assets in Ukraine are less than 1% of net assets—this is misrepresented in the LLM response. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that Coca-Cola’s exposure is indirect (via a major bottler contributing to 41% of global volume) while P&G has direct but small-scale operations. Instead, it reverses or misattributes key facts, undermining the comparison. (4) Contextual relevance is moderate—the response addresses the question's intent to compare exposure, but due to entity confusion and incorrect data attribution, the conclusion that Coca-Cola’s exposure is 'minimal relative to any direct reliance P&G might have' is unsupported and factually wrong. The original answer clearly states both face regional risks, with P&G having direct exposure and Coca-Cola indirect, but the LLM distorts this relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 470,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MET’s CMBS fair‑value is not disclosed in the pages provided, whereas Bank of America’s CMBS amortized cost is $10,909 million as of December 31 2023. Consequently, the combined exposure to CMBS cannot be calculated from the supplied excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect and fails to report MET's CMBS fair value, which is available in the ground truth as $4,551 million. Instead, it claims the data is not disclosed, which contradicts the provided original answer. BAC's amortized cost is reported as $10,909 million in the LLM answer, which is close but not exact compared to the ground truth value of $10,922 million—a minor but notable discrepancy. The combined exposure is not calculated, missing the total of $15,473 million. (2) Quantitative accuracy is low: MET's value is omitted entirely, BAC's figure has a $13 million error, and the sum is not computed. Even allowing for formatting variations, missing one of two core numbers and failing to sum them undermines the response. (3) The reasoning is flawed—this is a multi-hop question requiring retrieval and synthesis of two distinct data points from different entities and accounting methods (fair value vs. amortized cost). The LLM fails the first hop (MET's CMBS) and inaccurately reports the second (BAC's), then concludes the combination is impossible, which is incorrect. It does not recognize that both values are available in the knowledge base. (4) Contextual relevance is partial—it addresses the right companies and asset class, and correctly notes accounting differences in the attempt, but ultimately denies the availability of key data and fails to perform the required synthesis, making the response factually inadequate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 408,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats at nuclear plants can trigger NRC‑mandated security upgrades, fines or shutdowns that drive up capital and operating costs for both utilities.  For Duke Energy, such events could force additional funding from its nuclear decommissioning trust funds and tighten liquidity and debt covenants, while for Southern Company the same risks would raise licensing and compliance expenses, increase cybersecurity spending, and strain its ability to recover those costs through rates, potentially requiring extra support from its own decommissioning trusts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face financial and operational impacts from cyber intrusion risks at nuclear plants. Duke Energy's decommissioning trusts are exposed to market fluctuations, and underperformance could necessitate additional capital injections—this is correctly reflected in the LLM's mention of 'additional funding from its nuclear decommissioning trust funds' and liquidity impacts. Southern Company's exposure to increased compliance, licensing, and cybersecurity costs due to NRC requirements or threats is accurately captured. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly links cyber risks → regulatory responses (NRC) → financial consequences (costs, capital needs) → company-specific exposures (decommissioning trusts, rate recovery challenges). The synthesis across entities (Duke vs. Southern) and risk types (operational vs. financial) is logical and complete. (4) Minor deduction in qualitative accuracy (9 instead of 10) because the LLM slightly overemphasizes rate recovery challenges and 'decommissioning trust support' for Southern Company, which is less directly supported in the original—Southern’s trusts are not highlighted as a funding source for cybersecurity, only Duke’s for decommissioning. However, this does not constitute a factual error, just a subtle interpretive extension. Contextual relevance is perfect: all content directly addresses the question’s focus on financial obligations and operational strategies. Overall, the answer is factually correct, comprehensive, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 485,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "At Home Depot, dividend equivalents accrue on unvested restricted‑stock units and are paid out in the form of additional shares when the units vest, so the company issues extra shares to award recipients at vesting.  In contrast, Lowe’s 2021 ASR agreements required the company to receive additional shares at settlement—0.2 m in Q1, 4.0 m in Q2, 1.7 m in Q3, and 1.6 m in Q4, totaling 7.5 m shares—reducing outstanding shares rather than issuing new ones to employees.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid out as additional shares upon vesting, increasing share issuance to employees—which aligns with the ground truth. This part is accurate and well-stated. However, significant errors exist in the LOW ASR data. The ground truth states that LOW delivered additional shares under ASR agreements in Q1 (0.2M), Q4 (1.6M), and Q2 (4M), totaling 5.8 million shares. The LLM incorrectly lists Q3 as receiving 1.7M shares (not in original), omits the correct Q2 amount (4M vs. 4.0M listed but misassigned), and assigns Q2 and Q3 deliveries that contradict the source. Additionally, the total of 7.5M shares is incorrect (should be 5.8M). (2) Quantitative accuracy is compromised: while 0.2M in Q1 and 1.6M in Q4 are correct, Q2 is listed as 4.0M but placed in the wrong quarter contextually, and Q3’s 1.7M is entirely fabricated. The total 7.5M is wrong. (3) Reasoning and synthesis are partially sound: the contrast between HD’s employee-related share issuance and LOW’s capital return via ASR is conceptually correct and reflects multi-hop understanding. However, the misuse of LOW’s quarterly data undermines the factual basis of the comparison. (4) Contextual relevance is high—the answer addresses both companies and the nature of additional share activity. Qualitative accuracy is moderate due to correct conceptual framing but flawed data sourcing. Correctness score is 6 due to core conceptual accuracy but major quantitative errors in LOW’s ASR figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 431,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "Ernst & Young LLP used independent sensitivity analyses in both audits, but the focus differed. For AT&T, the firm tested how changes in terminal growth rates, EBITDA margins and the weighted‑average cost of capital would affect the fair‑value estimate of its $67,854 million goodwill balance (page 44). For Netflix, the firm performed sensitivity analyses on the viewing‑hour assumptions that drive content amortization to gauge how shifts in those estimates would alter the amortization expense (page 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $67,854 million goodwill balance for AT&T is correctly stated, and no other numerical discrepancies exist. The reference to specific pages (44 and 40) adds precision, though not required, and does not contradict the original. (2) The entities—AT&T, Netflix, Ernst & Young LLP (implied as the common auditor)—are correctly identified. The focus on terminal growth rates and WACC for AT&T and viewing-hour assumptions for Netflix matches the original answer’s emphasis on key assumptions in sensitivity analyses. (3) The reasoning is sound: the LLM correctly synthesizes that while the same audit firm applied sensitivity analyses, the nature of the analyses differed due to the distinct accounting estimates involved—goodwill impairment vs. content amortization. The addition of 'EBITDA margins' and 'independent' sensitivity analyses is a minor expansion not present in the original but does not introduce inaccuracy; it reflects plausible audit procedures and may be derived from actual filing details (e.g., AT&T’s 10-K likely includes EBITDA margins as a key assumption). (4) The answer is contextually relevant, directly addressing the comparison requested in the question. The only reason for not scoring a 10 is that the original answer explicitly notes the auditor evaluated the 'reasonableness and robustness' of assumptions—a point about audit purpose slightly more detailed than the LLM’s procedural description. However, the LLM captures the functional equivalence. Overall, the answer is factually correct, well-structured, and semantically equivalent with minor elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 458,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that PSD2‑style rules and other regulatory changes let fintechs offer payment‑initiation services that can route transactions directly between issuers and acquirers, thereby disintermediating Mastercard and shrinking demand for its integrated products.  In contrast, Visa has turned the same regulatory shift into an opportunity, launching programs such as Fintech Fast Track and acquiring platforms like Currencycloud and Tink to embed fintech capabilities inside its network and expand its reach rather than treating fintechs as competitors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Mastercard's concern about disintermediation and Visa's strategic partnership approach. It correctly identifies regulatory changes like PSD2 as a driver enabling fintechs to offer payment initiation services that bypass traditional networks, which aligns with the ground truth. The mention of Visa’s Fintech Fast Track, and acquisitions like Currencycloud and Tink, while not in the original answer, are factually correct strategic moves by Visa and support the 'network of networks' integration strategy described in the ground truth, enhancing rather than detracting from accuracy. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The only minor shortcoming is that the LLM does not explicitly mention Mastercard’s concern about data-sharing in partnerships giving fintechs a competitive edge, nor does it frame Visa’s view of fintechs as both partners and competitors—nuances present in the original. However, the essence of the multi-hop reasoning—regulatory change enables fintech disintermediation, Mastercard sees threat, Visa sees opportunity through integration—is sound and semantically equivalent. Contextual relevance is perfect, directly addressing the comparative strategic responses in the regulatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 375,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s says the OECD‑mandated 15 % global minimum tax under Pillar 2 will not materially affect its consolidated statements; the tax would apply to taxable years beginning after Dec 31 2023 but will not be effective for the company until fiscal 2025. Starbucks projects the same outcome – a non‑material impact, with the tax applying to fiscal years beginning on or after Dec 31 2023 and likewise becoming effective only in fiscal 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies that both MCD and SBUX do not expect a material impact from the 15% global minimum tax under Pillar 2, and it correctly references the OECD framework and the general effective date of 'taxable years beginning after December 31, 2023'. However, it incorrectly states that McDonald’s (MCD) will not be affected until fiscal 2025 — the original answer states MCD acknowledged the tax was enacted in several countries effective after December 31, 2023, but does not expect a material impact; it does not say the tax becomes effective for MCD in fiscal 2025. In contrast, SBUX explicitly stated it will not be effective until fiscal 2025. This misattribution of the fiscal 2025 timeline to MCD is a significant factual error. (2) Quantitatively, the 15% rate and the December 31, 2023 date are correct. However, the misalignment of fiscal 2025 as the effective date for MCD is incorrect — the original answer does not state this for MCD, only for SBUX. Thus, one entity-date pairing is wrong. (3) The multi-hop reasoning is partially sound: the model attempts to compare two companies’ exposure to Pillar 2 and links them to implementation timelines. However, it fails to correctly differentiate the implementation timing between MCD and SBUX, conflating MCD’s lack of material impact with SBUX’s delayed effective date. This undermines the comparative analysis. (4) Contextual relevance is high — the answer addresses the OECD framework, the 15% rate, effective dates, and company-specific impacts. But due to the key error in attributing SBUX’s fiscal 2025 timeline to MCD, the qualitative and quantitative accuracy scores are reduced. Correctness score is 6 due to partial factual accuracy with a significant multi-hop reasoning flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 498,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company’s capital ratios on December 31 2024 were far above regulatory minimums – its Common Equity Tier 1 and Tier 1 ratios were 151.9 % of risk‑weighted assets, and its Tier‑1 leverage ratio was 71.3 %. In contrast, American Express’s ratios were roughly 10–13 % for CET 1, Tier 1 and total capital and about 9.6–9.8 % for leverage. Thus BTC’s capital adequacy position is substantially stronger than AXP’s under U.S. banking regulatory standards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in quantitative data. The ground truth states that both BTC and AXP exceeded regulatory requirements and were 'well capitalized,' but does not provide specific numerical ratios. However, the LLM assigns precise percentages to both firms—151.9% and 71.3% for BTC, and 10–13% for AXP—which are not present in the original answer and are implausibly high (e.g., CET1 ratios above 150% are unrealistic; typical well-capitalized banks range from 10–15%). These numbers appear fabricated or grossly misstated. (2) No calculations are required in the question, but the comparison hinges on accurate reporting of ratios, which the LLM fails to do. Realistic CET1 ratios for large U.S. banks rarely exceed 15%, making the 151.9% claim orders of magnitude off. (3) The qualitative reasoning attempts multi-hop synthesis by comparing two regulated entities under U.S. banking rules and correctly identifies that both are subject to regulatory capital requirements. It also correctly names regulators (implied via context), though not explicitly stated in the LLM output. However, the conclusion that BTC is 'substantially stronger' is based on false numerical premises. (4) Contextual relevance is high because the response addresses the comparison of capital adequacy between BTC and AXP as of December 31, 2024, under U.S. regulatory frameworks. But due to severe quantitative inaccuracies and lack of support for specific figures, the overall correctness score is low despite relevant structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 429,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s $88.4 million in construction loans to joint‑venture partners is a modest, project‑specific financing (SPG, Note 6, p. 116). In contrast, American Tower drew $7.8 billion from its 2021 Multicurrency Credit Facility—an outstanding balance of $4.39 billion—to fund the Telxius and CoreSite acquisitions (AMT, Note 8, p. 111; AMT, Note 5, p. 52). The disparity shows SPG pursues growth through incremental, partnership‑based development financing, whereas AMT relies on large‑scale debt facilities to support aggressive acquisition‑driven expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies SPG's $88.4 million in construction loans to joint ventures and AMT's $7.8 billion drawdown from the 2021 Multicurrency Credit Facility, matching the ground truth. The mention of €2.4 billion ($2.9 billion) in the original answer is omitted, but this does not affect the core quantitative accuracy since the total $7.8 billion is correctly reported. The LLM also accurately references the use of funds for Telxius and CoreSite acquisitions. (2) All key numbers are correct: $88.4 million (SPG), $7.8 billion (AMT), and the context of construction loans vs. credit facility usage aligns with the ground truth. The LLM adds an additional detail—'outstanding balance of $4.39 billion'—which is factually accurate but not in the original answer; this is a minor enhancement rather than an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across SPG and AMT filings, compares their financing strategies, and draws a valid conclusion about SPG’s partnership-based development vs. AMT’s acquisition-driven, debt-backed growth. (4) The answer is semantically equivalent to the ground truth, with slightly more concise wording and a minor addition of balance detail. The omission of the euro conversion is not material to the overall correctness. Scores reflect high accuracy with only negligible incompleteness on currency breakdown.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 393,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "CSCO’s $0.5 billion interest‑rate swap is a fair‑value hedge that converts the fixed‑rate portion of its senior notes to floating, so the swap’s fair‑value change offsets the underlying debt’s fair‑value change and effectively neutralises that $0.5 billion of exposure to rate swings. In contrast, Broadcom’s $56.3 billion of fixed‑rate senior notes would experience a $1.7 billion fair‑value shift for a 50‑basis‑point move, indicating a far larger sensitivity to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CSCO’s $0.5 billion interest rate swap hedges part of its fixed-rate senior notes by converting fixed to floating rates (based on SOFR, though SOFR is not explicitly named in the LLM answer, the mechanism is correctly described as a fair-value hedge that offsets fair-value changes). AVGO’s $56.3 billion in fixed-rate senior notes and the $1.7 billion fair-value decrease for a 50 bps rate increase are accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts and the 50-basis-point sensitivity are correctly stated, matching the original answer. (3) The multi-hop reasoning is sound—comparing CSCO’s hedging strategy to AVGO’s large unhedged exposure shows understanding of interest rate risk sensitivity. The LLM correctly infers that CSCO has neutralized interest rate risk on the hedged portion, while AVGO remains exposed. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name SOFR as the floating rate benchmark (though this is a detail not critical to the main comparison). Otherwise, the reasoning, entity identification (CSCO, AVGO/Broadcom), and synthesis across companies and financial instruments are correct. The answer is fully relevant and directly addresses the comparative sensitivity to interest rate fluctuations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 388,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "NKE uses option contracts to hedge its foreign‑currency exposures, but the 10‑K does not disclose a material impact on other comprehensive income from those hedges. In contrast, Tesla’s foreign‑currency assets are hedged with option/forward contracts that generate mark‑to‑market gains and losses deferred in AOCI—resulting in a net OCI gain of $97 million in 2024 and a reclassification of $472 million into earnings, with $99 million of net deferred gains recorded in AOCI for contracts maturing within 12 months.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Tesla hedges its foreign currency assets with option/forward contracts and reports a net OCI gain of $97 million in 2024 and a reclassification of $472 million into earnings—none of which appears in the ground truth and directly contradicts it. The ground truth clearly states that TSLA does *not* typically hedge foreign currency risk, and its FX gains/losses flow through 'Other income (expense), net,' not through AOCI. Conversely, the LLM claims NKE’s 10-K does not disclose a material impact on OCI, which contradicts the ground truth stating NKE has $99 million in net deferred gains in AOCI expected to mature in the next twelve months. (2) Quantitatively, the $99 million deferred gain aligns with the ground truth, but it is misattributed to Tesla instead of NKE. The $97 million and $472 million figures for Tesla have no basis in the provided truth and are therefore incorrect. The notional amount of $9.9 billion for NKE hedges is omitted entirely. (3) The multi-hop reasoning is fundamentally flawed: the model reverses the hedging strategies of the two companies—portraying Tesla as the proactive hedger and NKE as having no OCI impact—when the truth is the opposite. This indicates a failure to correctly synthesize and attribute information across entities. (4) While the answer addresses the general topic of foreign currency hedging and mentions AOCI and deferred gains, its core assertions are inverted and factually wrong, severely undermining correctness and qualitative reasoning. Contextual relevance is moderate as it engages with the right concepts but applies them incorrectly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 464,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the administrative agent and was amended on August 25 2022 (Amendment No. 1 to the October 30 2019 agreement).  Caterpillar’s 5‑Year Facility also lists Citibank as the agent, but the excerpts supplied do not show any amendment to that facility.  Thus, while both firms use Citibank in a similar role, Boeing’s agreement has a documented amendment, whereas Caterpillar’s does not.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding Caterpillar's amendment timeline. It correctly identifies Boeing's Five-Year Credit Agreement with Citibank, N.A. as administrative agent and the August 25, 2022 amendment (Amendment No. 1 to the October 30, 2019 agreement), which aligns with the ground truth. It also correctly notes that Caterpillar uses Citibank, N.A. as agent in its 5-Year Facility. However, it incorrectly states that 'the excerpts supplied do not show any amendment' and concludes that Caterpillar’s facility has no documented amendment, which contradicts the ground truth: Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023. This omission undermines the comparative analysis of amendment timelines, a key part of the question. While the roles of Citibank are accurately described in both cases (administrative agent for Boeing, agent for Caterpillar), the LLM fails to recognize the multi-hop comparison element—specifically, the staggered but comparable amendment dates (Boeing: Aug 2022, Caterpillar: Aug 2023). The reasoning is sound where information is present, but incomplete due to missing data. Quantitative accuracy is mostly correct except for the missing Caterpillar amendment date. Qualitative accuracy suffers from the failure to synthesize the full timeline comparison. Contextual relevance is high as the response addresses the core entities and roles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 401,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries **one vote per share** (see Netflix 10‑K, page 60).  \nMeta’s Class B common stock carries **ten votes per share** (see Meta 10‑K, page 1).  \nThus, each Meta Class B share has **nine more votes per share** than a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that Netflix’s common stock provides one vote per share and Meta’s Class B common stock provides ten votes per share, which aligns with the original answer. The calculation of the difference—nine more votes per share for Meta Class B compared to Netflix—is mathematically correct (10 - 1 = 9). (2) The answer is complete, addressing both companies’ voting rights structures and directly comparing them as required by the question. (3) Entity accuracy is perfect: both companies (Netflix and Meta), stock classes (common stock and Class B common stock), and the associated voting rights are correctly identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate 10-K filings (Netflix and Meta), compares the voting rights across firms, and draws a valid conclusion about the disparity in voting power. (5) The semantic meaning is equivalent to the ground truth, with slightly more precise wording (explicitly stating the difference of nine votes), which enhances clarity without altering factual content. All scores are maximized due to full factual accuracy, correct calculation, proper entity identification, logical reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 365,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMS’s 2023 10‑K states that Cardinal Health handled roughly 23 % of its distribution. Cardinal Health also owns 50 % of Red Oak Sourcing, the generic‑pharma sourcing VIE that CVS consolidates in its Pharmacy & Consumer Wellness segment. Thus, BMS’s reliance on Cardinal Health is tied to the same entity that CVS reports as a consolidated VIE, linking the two companies’ financials through Cardinal Health’s shared ownership of Red Oak.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMS (BMY) relies on Cardinal Health for 23% of its distribution in 2023 and that Cardinal Health owns 50% of Red Oak Sourcing, with CVS consolidating it as a VIE. These core facts and percentages are accurate and match the ground truth. The use of 'BMS' instead of 'BMY' is a minor ticker inconsistency but refers to the same company (Bristol-Myers Squibb), which is acceptable in context. (2) Quantitatively, all numbers—23%, 50%, and the 2023 timeframe—are correct. There are no calculations in the LLM answer, so no errors arise there. The ground truth includes an additional quantitative point ($183 million in annual payments from Cardinal to CVS), which the LLM omits, but this does not affect the correctness of the numbers it does report. (3) The multi-hop reasoning is partially sound: the LLM connects BMY’s distribution reliance on Cardinal Health to Cardinal’s co-ownership of Red Oak Sourcing with CVS, and notes CVS’s consolidation of Red Oak. However, it fails to explain the financial interdependency implications—specifically how CVS’s consolidation as primary beneficiary and the $183M payments could indirectly affect Cardinal’s operations or BMY’s supply chain efficiency. This missing causal layer reduces the depth of synthesis. (4) The answer is contextually relevant and captures the structural link between the companies. It is concise and factually aligned but lacks the full qualitative depth of the original answer regarding financial influence and indirect effects. Hence, correctness is high but not complete, warranting a 7. Quantitative accuracy is perfect. Qualitative accuracy is good but incomplete. Contextual relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 467,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement and Income Solutions (RIS) segment, which includes life‑insurance products (page 184), is highly sensitive to interest‑rate changes; in the rising‑rate scenario the RIS segment shows a net favorable impact on adjusted earnings of $15 m in 2023 and $10 m in 2024, indicating that higher rates improve the valuation of its life‑insurance reserves and discount rates (page 61). AIG’s Life‑Insurance reserve updates were also driven by interest‑rate dynamics: in 2021 the reserves for universal life with secondary guarantees were updated for a net favorable $106 m impact, while in 2020 a net unfavorable $101 m impact reflected mortality and earned‑rate changes (page 134). Thus, both insurers experience interest‑rate sensitivity in their life‑insurance reserves, but MetLife’s RIS exposure yields a clear net benefit in a rising‑rate environment, whereas AIG’s reserve updates have varied outcomes depending on the specific assumptions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MetLife and AIG have life insurance lines sensitive to interest rate dynamics, and it accurately reports AIG's $106 million favorable impact in 2021, matching the ground truth. However, the LLM introduces specific figures for MetLife—$15M favorable impact in 2023 and $10M in 2024 in a rising-rate scenario—that are not present in the original answer or implied by the ground truth. These numbers, while plausible, are not supported by the provided truth and appear to be hallucinated or sourced from external data not in the knowledge graph. (2) Quantitative accuracy is compromised due to these unverified figures; while AIG’s $106M is correct, MetLife’s numbers lack corroboration. The original answer discusses margin compression and reinvestment risks qualitatively but does not provide dollar impacts for MetLife in specific years. (3) The multi-hop reasoning is sound: the model correctly links MetLife’s RIS segment to life insurance and interest rate exposure, and compares it to AIG’s reserve updates under similar dynamics. It synthesizes the concept of interest rate sensitivity across both firms, noting differing outcomes based on assumptions, which aligns with the ground truth’s emphasis on ALM strategies and assumption updates. (4) Contextual relevance is high—the response directly addresses how interest rate scenarios affect MetLife’s life insurance via its RIS segment and compares it to AIG’s experience. Despite the numerical inaccuracies, the core qualitative insights about sensitivity, margin pressures, and reserve adjustments are consistent. The answer is more detailed than the ground truth in some aspects but introduces unsupported specifics, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 484,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 10‑K lists a battery‑cell supply agreement with Panasonic dated Oct 5 2011 (Exhibit 10.25) and subsequent amendments (Oct 29 2013, July 31 2014, etc.) that provide long‑term supply of cells, together with production‑pricing agreements for Japan cells (2019, 2021) and Gigafactory 2170 cells (2020). In contrast, the GM 10‑K pages provided do not disclose any specific battery‑supply agreements or sourcing dependencies, so a direct comparison cannot be drawn from the supplied material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key Tesla-Panasonic agreements: the 2011 Supply Agreement (with correct exhibit reference and date), amendments, and the 2019, 2021, and 2020 pricing agreements for Japan-sourced and Gigafactory 2170 cells. All dates and agreement types match the original answer. (2) Quantitative accuracy is perfect: all dates (Oct 5 2011, Oct 29 2013, July 31 2014, 2019, 2020, 2021) are correctly cited, and no numerical errors are present. Format variations (e.g., '2019 Pricing Agreement' vs '2019 Pricing Agreement for Japan-sourced cells') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly contrasts Tesla’s explicitly documented agreements with Panasonic against General Motors’ lack of disclosed specific agreements. The conclusion that GM’s filings do not reveal specific dependencies is consistent with the ground truth. (4) The only minor shortcoming is that the LLM states 'a direct comparison cannot be drawn from the supplied material,' which slightly understates the valid qualitative comparison made in the ground truth (i.e., Tesla has explicit contracts, GM only general dependencies). However, this does not invalidate the correctness, as the LLM still enables the same inference. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a 9/10 due to slight phrasing caution in the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 414,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ actively uses exchange‑traded commodity futures—classified as Level 1 assets—to hedge the price of key inputs such as cocoa, sugar, wheat, and other raw materials (MDLZ 10‑K, note 10, pages 94‑95 and note 3, page 112). In contrast, Costco reports that it held no Level 1 or Level 3 financial assets or liabilities on a recurring basis (COST 10‑K, note 3, page 51), indicating that its risk‑management strategy does not involve Level 1 derivatives and relies on other instruments or approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures classified as Level 1 financial assets for hedging input costs like cocoa, sugar, and wheat (consistent with MDLZ 10-K disclosures), and COST reports holding no Level 1 or Level 3 financial assets or liabilities on a recurring basis (per COST 10-K, note 3, page 51). (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both companies' disclosures are correctly represented without introducing false or speculative data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies' 10-K filings to contrast their risk management strategies—MDLZ actively uses Level 1 derivatives (commodity futures), while COST does not. (4) The only minor shortcoming is that the original answer specifies the date of COST’s disclosure (August 28, 2022), which the LLM omits. While not critical to the core comparison, including the date would have matched the completeness of the ground truth. Otherwise, the semantic meaning, entity accuracy, and contextual relevance are fully preserved. Wording differs slightly (e.g., 'exchange-traded' added by LLM, which is reasonable given Level 1 implies quoted prices), but this enhances clarity without distorting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 385,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s executives have adopted Rule 10b5‑1(c) plans that allow the sale of up to 100,000 shares (Jeff Williams) and a similar plan for Deirdre O’Brien covering shares vesting through October 2026, with the plans expiring in late 2025–2026 (Apple, Item 9B, page 55). By contrast, Broadcom’s board member Diane Bryant’s plan permits the sale of only up to 15,000 shares and is set to expire on September 12 2025 (Broadcom, Item 9B, page 96). Thus Apple’s plans involve a substantially higher potential volume and a longer vesting/expiration window than Broadcom’s single, smaller plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key executives at Apple (Jeff Williams and Deirdre O'Brien) and Broadcom (Diane M. Bryant), their respective Rule 10b5-1(c) plans, share volumes (100,000 for Williams, 15,000 for Bryant), and expiration dates (late 2025–2026 for Apple, September 12, 2025 for Broadcom). The timing of plan adoption—August 2024 for Apple and September 2024 for Broadcom—is not explicitly mentioned in the LLM answer, which is a minor omission. However, all numeric values (share counts, expiration dates) are accurate and match the ground truth. (2) Quantitative accuracy is perfect: 100,000 shares (Williams), 15,000 shares (Bryant), and correct expiration dates are all reported without error. The LLM correctly notes that O'Brien's plan covers shares vesting through October 2026, aligning with the ground truth. (3) The multi-hop reasoning is sound—comparing volume (100k vs 15k) and time horizon (2026 vs Sept 2025) across two companies and individuals. The conclusion that Apple’s plans involve higher volume and longer duration is logically supported. The only minor gap is the absence of the exact adoption months (August vs September 2024), which affects completeness but not core correctness. (4) Scores reflect near-perfect factual accuracy, with only a small loss in qualitative accuracy due to the omitted adoption timing. Contextual relevance is full, as the answer directly addresses volume and timing comparison as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 407,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both agreements name JPMorgan Chase Bank, N.A. as the syndication agent, meaning the bank is responsible for arranging and coordinating the syndication of the credit lines for each company.  This common role shows that JPMorgan is a key banking partner for both 3M and Honeywell, providing similar syndication services and facilitating participation of other lenders in their respective credit facilities【page_123】【page_114】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) All entities—JPMorgan Chase Bank, N.A., 3M, Honeywell, and their respective credit agreements dated May 11, 2023, and March 20, 2023—are accurately identified. The role of JPMorgan as syndication agent in both agreements is correctly stated. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. Dates are correct and match the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that JPMorgan’s identical role across both companies’ credit facilities indicates a shared banking relationship with similar functional responsibilities. The conclusion that JPMorgan helps coordinate lender syndicates for both firms is logically derived. (4) While the LLM answer captures the core insight, it slightly underdevelops the strategic implication present in the original answer—namely, that this reflects a strategic alignment in how both companies access syndicated credit markets. This minor omission in depth prevents a perfect 10 on qualitative accuracy, but the response remains semantically equivalent in factual content and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 349,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "EU and U.S. sanctions that bar the trade of goods used for tobacco production in Belarus could constrain Coca‑Cola HBC’s ability to import or export packaging materials, equipment or other inputs, potentially curtailing its bottling operations in the country【page_52】.  Coca‑Cola HBC is one of the company’s largest bottlers and operates in Belarus【page_7】, and the firm is a key contributor to The Coca‑Cola Company’s global unit‑case volume【page_7】.  A reduction in HBC’s Belarus activity would therefore likely lower The Coca‑Cola Company’s overall unit‑case volume, though the magnitude would depend on Belarus’s share of HBC’s total output.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the potential impact of EU and U.S. sanctions on Coca-Cola HBC's operations in Belarus due to disruptions in supply chains, particularly around packaging materials and equipment, which aligns with the ground truth's emphasis on economic disruption. It also correctly notes that Coca-Cola HBC is a major bottler and contributes significantly to The Coca-Cola Company’s global unit case volume. However, the LLM answer omits key quantitative data present in the ground truth: specifically, that Coca-Cola HBC represented 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and that non-U.S. markets accounted for 83% of total volume in the same year. These omissions reduce quantitative accuracy. (2) No explicit numbers are provided in the LLM answer, while the original answer includes precise percentages (41%, 83%) and a specific year (2021), which are critical for assessing the scale of impact. The LLM vaguely references HBC as a 'key contributor' without quantifying its importance, making the assessment less precise. (3) The multi-hop reasoning is sound—connecting sanctions → supply chain disruption → impact on HBC operations → effect on KO’s volume—but the conclusion that 'the magnitude would depend on Belarus’s share of HBC’s total output' introduces uncertainty not present in the original, which emphasizes systemic reliance on HBC as a top bottler. While logical, this shifts focus away from HBC’s overall importance to KO. (4) Scores reflect strong qualitative reasoning and contextual relevance, but lower quantitative accuracy due to missing key statistics that are central to the original answer’s strength.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 463,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "Capital One’s interchange‑fee income—primarily earned on debit‑card transactions routed through Mastercard’s four‑party network—could shrink if the Federal Reserve’s proposed 28‑30 % cut to the debit interchange‑rate cap takes effect, because the cap directly limits the fee rates the bank can collect (page 39).  The company’s exposure to Mastercard’s network means the cap would cut its revenue, and the ongoing interchange multidistrict litigation and settlements that Visa and Mastercard face could impose additional caps or settlements that further reduce fees, compounding the impact on Capital One’s income (page 98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 28%-30% reduction in debit interchange rate caps is correctly cited, with no numerical errors. The reference to 'page 39' and 'page 98' suggests proper sourcing from the 10-K, though page numbers are not part of the ground truth verification—they do not affect factual accuracy. (2) The answer correctly identifies Capital One’s exposure to Mastercard’s four-party network and explains how the proposed cap reduction would directly limit interchange fee income, which matches the original answer’s logic. (3) The multi-hop reasoning is sound: it connects the regulatory proposal (Federal Reserve cap reduction) → impact on interchange fees → Capital One’s revenue exposure via Mastercard’s network → additional risk from ongoing litigation against Visa and Mastercard. The mention of multidistrict litigation and potential settlements compounding the impact is consistent with the ground truth. (4) The only minor shortcoming is slightly less emphasis on the legal challenges being specifically merchant-led or the regulatory oversight role of the Federal Reserve beyond the cap proposal, but the core entities (Capital One, Mastercard, Visa), the financial mechanism, and the synthesis across regulatory and litigation risks are all correct. Wording differs but semantic meaning is equivalent. No calculation errors. High contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 397,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy, which has variable‑rate debt and LIBOR‑indexed swaps, is still evaluating the optional expedients under ASU 2020‑04 and has not yet elected to apply the amendments, whereas Southern Company—also exposed to LIBOR in debt and PPAs—has elected to adopt the amendments prospectively through 2022 (page 194). Both companies view the transition as having no material impact on their financial statements (page 137 for Duke Energy, page 194 for Southern Company), but Duke Energy’s assessment of its LIBOR‑linked contracts has delayed its adoption relative to Southern Company’s earlier election.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy regarding Southern Company's adoption timeline. The original answer states that Southern Company is 'evaluating the provisions of ASU 2020-04' with an 'ongoing assessment,' implying no definitive election has been made. However, the LLM claims Southern Company 'has elected to adopt the amendments prospectively through 2022,' which contradicts the ground truth and introduces a specific page citation (194) not present in the original. This overstates Southern Company's progress in adoption. On the other hand, the LLM correctly identifies Duke Energy’s delayed evaluation and lack of election, consistent with the original. Both correctly note no material financial impact. The claim about Duke Energy’s assessment delaying adoption relative to Southern Company introduces a comparative conclusion not fully supported by the original, which only notes Duke had a time-bound window until December 31, 2022, while Southern’s assessment remains ongoing—so the directionality of 'earlier election' is speculative. Quantitatively, no explicit numbers are wrong, but the use of 'through 2022' aligns loosely with Duke’s 2022 deadline; however, attributing adoption to Southern by that date goes beyond the source. The reasoning is partially sound but overreaches in drawing a firm conclusion about relative adoption timelines. Contextually, the response is highly relevant and addresses the core comparison of ASU 2020-04 adoption in light of LIBOR exposure. Semantic equivalence is moderate—key facts about evaluation status and materiality are preserved, but the characterization of Southern Company’s actions is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 458,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "At Coca‑Cola, the Black‑Scholes‑Merton model uses market‑based inputs—exercise price equal to the average of the high/low on the grant date, dividend yield (3.0 % in 2023), expected volatility (17.5 %), risk‑free rate (4.1 %) and an expected term of 6 years—to compute the fair value of each option, which is then expensed straight‑line over the vesting period and recorded as compensation expense. In contrast, Colgate‑Palmolive’s pension calculations rely on weighted‑average actuarial assumptions—discount rate (5.40 % for the U.S. plan in 2023), expected long‑term return on plan assets (6.50 %), compensation‑increase rate (3.50 %), medical‑cost trend (6.00 %) and interest‑crediting rate (4.99 %)—that determine the present value of future benefits, the net periodic benefit cost, and the pension liability reported on the balance sheet. Thus, KO’s model focuses on option fair value and compensation expense, while CL’s assumptions drive pension expense and liability, each affecting different financial‑statement items.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO for stock option valuation and the use of weighted-average assumptions at CL for pension cost calculations, accurately contrasting their financial reporting implications. However, there are minor quantitative discrepancies: the risk-free rate for KO is listed as 4.1%, but the ground truth does not specify this number, so inclusion of a precise figure introduces unverified data. Similarly, KO's expected volatility is cited as 17.5%, which is not confirmed in the original answer. For CL, the LLM states a discount rate of 5.40% for the U.S. plan, while the ground truth reports 5.66% for 2023—this is a material difference. The expected return on plan assets is given as 6.50% (vs. 6.25% in truth), and medical-cost trend and interest-crediting rate are added (6.00% and 4.99%), which are not mentioned in the original, suggesting over-specificity or inclusion of extraneous data. (2) The original answer does not include dividend yield (3.0%), expected term (6 years), or medical/interest-crediting rates, so these appear to be fabricated or misattributed. While some assumptions are directionally reasonable, the lack of alignment with verified inputs reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both firms use weighted-average assumptions but in different contexts—KO for equity compensation expense, CL for pension liabilities—and links these to distinct financial statement impacts. The conceptual contrast between fair value modeling and actuarial estimation is well articulated. (4) Despite numerical inaccuracies, the core qualitative and contextual understanding is excellent, and the answer directly addresses the comparative structure of the question. Hence, correctness is reduced mainly due to unsupported specific figures, but the reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 525,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "AMT’s $525 million Series 2015‑2 Notes are secured by a security interest in the GTP Acquisition Partners’ equity interests in its subsidiaries (page 118, 117), meaning those equity holdings are pledged as collateral but remain owned by the company.  \nBy contrast, Simon Property Group has been actively monetizing its equity interests through disposals, reporting a $18.8 million gain from the sale of such interests (page 63). Thus, AMT retains its equity positions and uses them to back debt, whereas SPG converts equity into cash and records the proceeds as a gain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in GTP Acquisition Partners' subsidiaries as collateral for the $525.0 million Series 2015-2 Notes, and SPG reported an $18.8 million gain from disposals of equity interests. The dollar amounts ($525 million and $18.8 million) match exactly, and no incorrect entities or years are mentioned. (2) Quantitative accuracy is perfect—both figures are correctly cited with acceptable formatting (e.g., $525 million vs $525.0 million). (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s secured financing strategy (retaining equity while using it as collateral) with SPG’s disposal-based monetization strategy (selling equity for immediate gain). (4) The answer is contextually relevant and directly addresses the comparison asked in the question. The only minor limitation is that the LLM does not explicitly mention AMT’s retention of excess cash flows or the broader collateral structure (e.g., 'substantially all personal property'), which adds slight depth to the original answer. However, this does not detract from the essential correctness of the comparison. Hence, a score of 9 is warranted—excellent but not fully exhaustive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 362,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips reports only a modest share of its proved reserves under production‑sharing contracts (≈4 % of total reserves, reported under the economic‑interest method) and also includes variable‑royalty regimes; its Africa reserves—including any Nigerian acreage—are presented as part of its overall proved reserves without a dedicated PSC‑specific reporting line. In contrast, ExxonMobil’s Nigerian operations are almost entirely governed by PSCs that carry a 30‑year term structure (10 years of exploration followed by a 20‑year production period with partial relinquishment and renewal options), so its reserve reporting is tightly linked to these long‑term contractual terms.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It claims ConocoPhillips reports only ≈4% of its proved reserves under PSCs, but this figure is not supported by the ground truth, which does not specify ConocoPhillips' percentage of reserves under PSCs—only that it operates under 30-year PSCs in Nigeria. Conversely, the ground truth states that ExxonMobil reports 12% of its total proved reserves (2021) under PSCs, but the LLM incorrectly attributes the 30-year term structure (10-year exploration, 20-year production) to ExxonMobil, while the original answer assigns that structure to ConocoPhillips' Nigerian operations. The LLM reverses the attribution of contractual details and reserve reporting impacts. (2) The quantitative inaccuracy is significant: the 4% figure for ConocoPhillips is unsupported, and the 12% figure for ExxonMobil is omitted entirely. The 30-year term structure is correctly described in duration but incorrectly assigned to ExxonMobil instead of ConocoPhillips. (3) The multi-hop reasoning is partially sound—both companies are linked to PSCs in Nigeria, and differences in reserve reporting are addressed—but the synthesis is flawed due to misattribution of contractual terms and reserve percentages. The LLM incorrectly implies ExxonMobil’s Nigerian operations have the 30-year structure, while the ground truth assigns that to ConocoPhillips. (4) Contextual relevance is high as the answer addresses reserve reporting and contractual structures for both firms in Nigeria. However, due to key factual reversals and unsupported percentages, the correctness score is moderate. Qualitative accuracy is mid-range due to logical structure but flawed entity mapping. Quantitative accuracy is low due to incorrect percentages and misattributed contractual terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 490,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM’s 2024 filing notes that generative‑AI work is part of its broader hybrid‑cloud and AI strategy, but it warns that “failure of innovation initiatives” could impede commercialization and the attraction of a developer ecosystem (Risk Factor page 6).  In contrast, Qualcomm’s narrative explicitly ties generative‑AI to its high‑performance, low‑power SoC platform and cloud‑edge workflow: its Snapdragon AI Engine and Hexagon NPU deliver on‑device inference at low power, while the company envisions edge devices off‑loading to cloud services to support larger models (AI section, page 7; high‑performance/low‑power computing, page 6).  Thus, IBM is positioning generative AI mainly within its hybrid‑cloud software stack, whereas Qualcomm is commercializing it through dedicated edge hardware that balances performance with power efficiency and integrates cloud connectivity.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its qualitative description of IBM and QCOM's strategies and correctly identifies the core distinction: IBM focuses on hybrid-cloud AI and software ecosystems, while QCOM emphasizes on-device, low-power generative AI via SoCs like the Snapdragon AI Engine and Hexagon NPU, integrated with cloud offload. All entities (IBM, QCOM, Snapdragon, Hexagon NPU), technologies, and strategic directions are correctly identified. There are no numeric inaccuracies because the LLM answer does not include the specific percentages (19% in 2024, 46% in 2027) mentioned in the ground truth. While this omission does not introduce error, it represents a lack of completeness in fully addressing the commercialization projection that is central to the original answer's comparative insight. The reasoning is sound and reflects proper multi-hop synthesis between the two companies' filings and strategies. The answer is highly contextually relevant and well-supported by the source material. However, the absence of the forward-looking market projection (46% of smartphones by 2027) reduces completeness, particularly as it directly speaks to commercialization scale in high-performance, low-power environments. Thus, while all stated facts are correct (perfect quantitative accuracy), the answer falls slightly short on qualitative completeness in conveying the full scope of QCOM's commercialization strategy as defined in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 402,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s 10‑K (page 35) warns that a decline in market value of the assets held in its Nuclear Decommissioning Trust Fund (NDTF) could raise funding requirements and hurt its results. NextEra’s 10‑K (page 32) notes the same market‑performance risk for its decommissioning funds, but the company’s risk‑management framework (page 31) also includes maintaining those funds, external insurance coverage, and broader hedging/trading tools to mitigate related financial risks. Thus, while both utilities face the same exposure to market‑driven decommissioning obligations, NextEra’s approach is more diversified with additional insurance and hedging mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Duke Energy and NextEra Energy face financial risks from market performance affecting their nuclear decommissioning trust funds. The citation of specific 10-K pages (35 for Duke, 32 and 31 for NextEra) supports the claim, though page numbers are not part of the ground truth and are acceptable as referencing artifacts. Quantitatively, no specific dollar amounts or percentages are required, and none are misstated. The LLM adds a nuanced but reasonable interpretation that NextEra employs a more diversified risk-management approach, including insurance and hedging tools—this is consistent with the original answer’s mention of NextEra’s insurance coverage and implies stronger financial risk management. This represents a valid qualitative inference without overstatement. The multi-hop reasoning is sound: it compares two companies’ exposure to market-driven decommissioning risks and evaluates differences in risk mitigation. The only minor gap is that the original answer notes Duke Energy Carolinas, Progress, and Florida specifically, while the LLM generalizes to 'Duke Energy'—a slight entity aggregation but not factually incorrect. Overall, the answer is semantically equivalent, contextually precise, and enhances the comparison with document-based reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 381,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT’s 2023 10‑K states that it transitioned all affected debt instruments and contracts to SOFR as of Dec 31 2023, declined the optional expedients under ASU 2020‑04, and manages derivatives on a net‑basis—using foreign‑currency forwards, options, cross‑currency swaps and interest‑rate contracts designated as cash‑flow or fair‑value hedges (CAT p. 74‑76). UPS likewise moved to SOFR on Dec 31 2023, did not elect the practical expedients, and will assess any remaining impact in 2024, but its 10‑K does not provide a detailed derivative‑hedging policy (UPS p. 74).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that CAT transitioned to SOFR by December 31, 2023, and declined the optional expedients under ASU 2020-04—this directly contradicts the ground truth, which states that CAT *did* apply the optional expedients through December 31, 2024, and the adoption had no material impact. In contrast, it was *UPS* that transitioned to SOFR by December 31, 2023 and did *not* elect the practical expedients. The LLM swaps the key behaviors of the two companies. (2) Quantitative accuracy is low: while the dates (Dec 31, 2023 and 2024) are mentioned, they are assigned to the wrong companies and contexts. The LLM incorrectly attributes CAT’s use of extended relief to UPS and vice versa. (3) Multi-hop reasoning fails: the question asks for a comparison of CAT’s and UPS’s hedging strategies and transition timelines under ASU 2020-04. The LLM misrepresents both companies’ approaches, failing to correctly synthesize the contrast—CAT used the expedients, UPS did not; CAT manages long-term foreign currency exposure, UPS lacks disclosed hedging policy details. (4) Contextual relevance is moderate: the answer addresses derivative types and transition timelines and cites relevant sections, but the core factual inversion (who used expedients, who transitioned directly) renders the comparison invalid. Semantic equivalence is not achieved due to major entity-action mismatches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 405,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is an equity‑method stake that carries no voting rights, so it has no influence over Atairos’ operations or decisions (page 84).  Alphabet, by contrast, uses a dual‑class structure: Class A shares vote one‑to‑one, Class B shares vote ten‑to‑one, and Class C shares are non‑voting (page 82).  Alphabet’s large buy‑back program—$59‑$62 billion of Class A and Class C shares—shrinks the public share base; repurchasing Class A shares concentrates voting power among the remaining Class A and especially Class B holders, while repurchasing non‑voting Class C shares does not affect control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in quantitative precision. (1) Correctly identifies Comcast's lack of voting rights in Atairos and contrasts it with Alphabet's dual-class structure, including the 10-to-1 voting power of Class B shares and the non-voting nature of Class C shares. It accurately explains the control implications of Alphabet's share repurchases. (2) The only quantitative deviation is the range '$59-$62 billion' versus the ground truth's precise '$62.0 billion' repurchased in 2024. While the range is close and may reflect rounding or sourcing variation, the exact figure in the original answer is $62.0 billion, so this is a minor inaccuracy. All other numbers (e.g., $1.4 billion unfunded commitment for Comcast) are not mentioned in the LLM answer but are present in the ground truth; however, the LLM focuses on the control implications rather than Comcast's financial commitment, which is contextually acceptable given the question's emphasis on control. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Comcast's equity-method accounting, lack of voting rights, Alphabet's capital structure, and the impact of repurchasing voting vs. non-voting shares on control concentration. (4) The explanation of how repurchasing Class A (voting) shares increases relative voting power of remaining shareholders, especially Class B holders, is logically correct and adds analytical depth beyond the original answer. The mention of page numbers (84, 82) suggests proper sourcing. Overall, the answer is semantically equivalent, contextually relevant, and reasoning is excellent—just shy of perfect due to the slight imprecision in the repurchase amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 483,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 extension keeps the optional reference‑rate‑reform relief in place through December 31 2024. UPS had already moved all affected debt to SOFR by December 31 2023, so the extension merely confirms that its transition is complete and that it can maintain the new rate without further change. FedEx, however, is still monitoring its contracts through May 31 2024, meaning it will continue to use the relief until the end of 2024 and has until then to finish its own transition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key dates (December 31, 2023 for UPS transition; December 31, 2024 for ASU 2022-06 sunset; May 31, 2024 for FedEx monitoring) and entities (UPS, FedEx, SOFR, ASU 2022-06), which aligns with the ground truth. The quantitative accuracy is perfect—no errors in dates or financial terms. (2) However, the LLM oversimplifies and misrepresents the accounting implications. It states that the extension 'merely confirms' UPS’s transition is complete and that it can 'maintain the new rate without further change,' but the ground truth clarifies that UPS did not elect Topic 848 expedients and continued assessing potential impacts through 2024—indicating ongoing evaluation, not a closed process. This omission reduces qualitative accuracy. (3) For FedEx, the LLM correctly notes continued monitoring and use of relief through 2024, but fails to mention that as of May 31, 2024, there was no material effect from reference rate reform, and that FedEx was evaluating whether to apply the optional expedients—a key nuance in the multi-hop reasoning about how the extension impacts their timeline. (4) The answer is contextually relevant and captures the high-level impact of the extension, but lacks depth in conveying the nuanced accounting decisions and ongoing assessments by both companies, leading to a correctness score of 7 rather than higher. Semantic equivalence is mostly preserved, but important details about the nature of the companies’ actions and accounting elections are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 424,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s beverage revenue in 2023 was 29 % of its beverage business coming from the AMESA (Africa, Middle East and South Asia) region【page_72】, underscoring a sizable international exposure. In contrast, Target’s single merchandise segment is described as “nearly all of our revenues are generated in the United States”【page_46】, meaning its beverage sales are essentially domestic U.S. only with no comparable overseas exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that PepsiCo generated 29% of its beverage revenue from the AMESA region in 2023, matching the ground truth. It also accurately notes that Target's revenues are 'nearly all' from the U.S., based on its 10-K filing, which aligns with the absence of international beverage sales disclosure. The key comparison—that PepsiCo has significant international beverage exposure while Target’s is entirely domestic—is preserved. (2) Quantitatively, the 29% figure is correct and properly attributed to 2023 and the AMESA region. The reference to Target’s 'nearly all' U.S. revenues is a direct and accurate paraphrase of its 10-K (page 46), and while not an exact quote, it correctly infers no international beverage sales. (3) The multi-hop reasoning is sound: the model synthesizes PepsiCo’s regional revenue data with Target’s geographic revenue disclosure to contrast their international exposure. It correctly infers that since Target only reports domestic operations, its beverage sales lack international reach, unlike PepsiCo. (4) The only minor shortcoming is that the LLM does not explicitly name the grocery segment as the source of Target’s beverage sales (implied but not stated), and uses 'single merchandise segment' rather than clarifying that beverages are part of broader grocery sales. However, this does not distort the conclusion. Wording differences are acceptable under semantic equivalence. All core facts, numbers, and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 412,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s counter‑cyclical buffer is zero, so its minimum CET1, Tier‑1 and total risk‑based capital ratios are driven only by the regulatory minimum plus the 2.5 % stress buffer and capital‑conservation buffer, yielding 7.0 %, 8.5 % and 10.5 % respectively (page 118). Goldman Sachs’s TLAC‑to‑RWAs requirement is 22 % (page 93‑94), which already includes the 18 % minimum, a 2.5 % buffer and a 1.5 % G‑SIB surcharge, but also has a counter‑cyclical buffer set to zero. Thus, while both firms rely on other buffers in the absence of a counter‑cyclical buffer, GS’s overall requirement remains higher because of its G‑SIB surcharge and larger risk profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the Countercyclical Capital Buffer is zero for both SCHW and GS, and accurately reports SCHW's minimum capital ratios (7.0%, 8.5%, 10.5%) inclusive of the 2.5% stress capital buffer. However, it incorrectly states GS's TLAC-to-RWAs requirement as 22%, which is not supported by the ground truth. The ground truth specifies a 18% minimum + 2.5% buffer + 1.5% G-SIB surcharge, which sums to 22%, but the original answer does not state this total explicitly and emphasizes the 18% baseline. While the sum is mathematically correct, the LLM presents 22% as a reported requirement, potentially conflating the total with the minimum, which may misrepresent regulatory structure. (2) The numbers for SCHW are accurate and match the ground truth. For GS, the individual components (18%, 2.5%, 1.5%) are correct, but combining them into a single 22% figure without clarifying that this is an implied sum (not a stated requirement) introduces ambiguity. The ground truth emphasizes the 18% baseline, not a total of 22%. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes that both firms face layered requirements and that GS has higher requirements due to G-SIB status and TLAC framework. It appropriately contrasts SCHW’s risk-based capital ratios with GS’s TLAC metric, recognizing different regulatory regimes. However, it misses the explicit point that GS’s requirement 'includes' the zero CCB, which was a specific structural detail in the ground truth. (4) The answer is contextually relevant and captures the core comparison, but the presentation of GS’s requirement as a single 22% figure slightly distorts the regulatory layering described in the original. Hence, correctness and quantitative accuracy are reduced to 7, while qualitative reasoning and relevance remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 500,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement (page 189) is paid for its share of Plant Vogtle construction costs, underscoring its role as a joint owner of a self‑owned nuclear plant (page 17).  In contrast, NextEra Energy’s model (page 19) relies on owning its own generation assets and deriving the bulk of its revenue—about 94 % of capacity—from long‑term PPAs, providing a more predictable, contract‑based income stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all numbers are correct: the $5.3 million reimbursement and the 94% of capacity under long-term contracts are accurately reported. Format variations (e.g., '94 %' with space) do not affect correctness. (2) The answer correctly identifies the entities: Dalton and its partial ownership in Plant Vogtle via reimbursement, and NextEra Energy (NEE) with its long-term PPAs. (3) The multi-hop reasoning is sound—linking Dalton’s reimbursement to joint ownership and self-owned generation, and contrasting it with NEE’s revenue model based on contractual commitments. (4) While the LLM answer is slightly less detailed than the original (e.g., does not explicitly state that Dalton uses self-owned assets to meet its load needs or that NEE operates in competitive markets), it captures the essential contrast in business models. The mention of 'predictable, contract-based income stream' adds useful interpretation. The answer is semantically equivalent and contextually appropriate, with only minor omissions in elaboration. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 328,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on liquidity buffers to back its customer‑financing activities, maintaining $7.0 billion of available credit under revolving facilities (page 54) that can be drawn on to fund operations or customer‑receivable financing.  By contrast, Boeing structures most of its customer financing through long‑term lease arrangements—operating leases for the bulk of its aircraft (page 94) and sales‑type/finance leases for a smaller portion—creating lease receivables and obligations that generate cash flows over the lease term (pages 78‑79, 93‑95).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $7.0 billion credit facility for RTX is correctly reported, matching the original answer. No other numerical values (e.g., lease durations, percentages) are provided in the LLM answer, but none are inaccurately stated. (2) The LLM correctly identifies RTX’s use of $7.0 billion in revolving credit facilities to support customer financing, avoiding reliance on short-term borrowings—consistent with the liquidity buffer concept in the original. It also accurately describes BA’s use of long-term lease structures, specifying operating leases as the primary method and noting the presence of sales-type/finance leases, which aligns with the original’s distinction between lease types. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s liquidity-backed approach with BA’s lease-based financing model, synthesizing information across two companies and their respective financial strategies. (4) Minor omission: the original answer includes specific details about lease terms (1–12 years), options to extend/terminate/purchase, and the balance sheet impact of leases (affecting both assets and liabilities), which are absent in the LLM response. However, the core contrast—RTX using credit facilities vs. BA using long-term leases—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparative financing approaches as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 421,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are applied to equity‑based compensation: the company uses weighted‑average grant‑date fair values for performance‑share units (page 96‑97) and weighted‑average inputs—dividend yield, volatility, risk‑free rate and term—to calculate the fair value of stock options under the Black‑Scholes‑Merton model (page 95). In contrast, Philip Morris applies weighted‑average assumptions to its defined‑benefit pension and post‑retirement plans, using weighted‑average discount rates, compensation‑increase rates, interest‑crediting rates, and health‑care cost trends to compute projected benefit obligations and net periodic benefit costs (pages 121‑124). Thus, Coca‑Cola’s assumptions drive equity‑award valuation, while Philip Morris’s drive actuarial pension and post‑retirement liability calculations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola applies weighted-average assumptions to equity-based compensation, specifically using the Black-Scholes-Merton model for stock options and mentioning performance-share units, which is consistent with the original answer’s focus on stock option awards. (2) It accurately states that Philip Morris applies weighted-average assumptions to defined-benefit pension and post-retirement plans, detailing assumptions like discount rates, compensation-increase rates, and healthcare cost trends—this matches the original answer’s emphasis on net pension and postretirement healthcare costs. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use weighted-average assumptions but in different financial reporting contexts—equity compensation vs. employee benefit liabilities—demonstrating a clear conceptual contrast. (4) All entities (Coca-Cola, Philip Morris, correct financial instruments) and frameworks are accurately identified. While the original answer specifies the years 2023, 2022, and 2021, the LLM answer does not include those dates, which is a minor omission but does not affect the core correctness since the question focuses on the application framework rather than time-specific data. No numeric inaccuracies are present, and all qualitative descriptions are semantically equivalent or more detailed than the ground truth. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 443,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck’s Januvia family is slated to lose U.S. market exclusivity in mid‑2026 (May for Januvia/Janumet and July for Janumet XR), whereas Gilead’s key product enjoys regulatory exclusivity that expires in 2032. Because exclusivity blocks generic entry, Merck will face generic competition roughly six years earlier than Gilead, likely accelerating sales erosion and forcing earlier pricing or product‑portfolio adjustments, while Gilead retains a longer exclusivity window that delays generic entry and sustains its market position for a longer period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and accurately states that Gilead's regulatory exclusivity expires in 2032. These dates match the ground truth exactly. (2) All numeric and temporal values are correct, with no calculation errors. The comparison of a roughly six-year difference in exclusivity timelines is logically sound (2032 vs. 2026). (3) The multi-hop reasoning is strong: the model correctly synthesizes the impact of regulatory exclusivity on generic competition, linking earlier expiry for Merck to earlier sales erosion and strategic adjustments, while Gilead benefits from prolonged market protection. The causal logic around exclusivity delaying generics and supporting market position is consistent with the evidence. (4) The answer is contextually complete and relevant, addressing both the timeline comparison and the strategic implications for market position. The only minor shortcoming is a slight lack of specificity regarding the mechanism of regulatory exclusivity (e.g., not explicitly mentioning data exclusivity blocking reliance on innovator data), which slightly reduces qualitative accuracy but does not detract from factual correctness. Overall, the answer is semantically equivalent to the ground truth with high precision and sound reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 395,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel’s amortization expense for developed technology used in cybersecurity was $1.283 billion in 2021. In contrast, Cisco recognizes revenue for its cloud‑security offerings ratably over the contract term – hardware and perpetual software are recorded upfront, while term software licenses and SaaS are earned over time. Thus, Intel’s expense is a one‑time amortization charge, whereas Cisco’s cloud‑security revenue is spread across the life of each contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states Intel's amortization expense for developed technology as $1.283 billion in 2021, which matches the ground truth of $1,283 million (equivalent values, different formatting). This satisfies the quantitative accuracy requirement. (2) The LLM accurately describes Cisco's revenue recognition policy for cloud security offerings as being recognized ratably over the contract term, particularly for term software licenses and SaaS, which aligns with the ground truth. It also correctly contrasts this with upfront recognition for hardware and perpetual software, adding contextual detail not in the original but consistent with Cisco’s accounting policies. (3) The multi-hop reasoning is sound: the model correctly synthesizes Intel’s cost (amortization) pattern with Cisco’s revenue recognition timing, highlighting the difference between a fixed, long-term amortization expense and a recurring, ratable revenue model. The only minor shortcoming is that the LLM does not explicitly mention the 9-year weighted average useful life of Intel’s developed technology, which is part of the original answer and adds depth to the cost structure comparison. (4) Despite this omission, the core comparison is accurate and relevant. The answer is semantically equivalent in intent and fact, with excellent contextual relevance and strong qualitative reasoning. Hence, a correctness score of 9 is justified—very close to perfect but missing a small but meaningful detail from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 418,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s adoption of ASU 2022‑02 re‑classified all borrower concessions that were previously treated as troubled‑debt restructurings (TDRs) into “financial‑difficulty modifications” (FDMs).  The company’s Note 11 now discloses the same types of concessions—interest‑rate reductions, term extensions, principal forgiveness and payment delays—but reports no material change in allowance or charge‑off amounts, indicating a negligible financial impact (MetLife, Note 11, see page 166).  By contrast, JPMorgan’s legacy TDR reporting (pre‑ASU 2022‑02) disclosed $362 million of new TDRs in 2022 and $866 million in 2021, with detailed financial effects such as $1 million charge‑offs, $16 million principal deferred, $2 million principal forgiven and $147 million of loans that re‑defaulted within a year (JPMorgan, Loan Modifications, pages 245‑246).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies, particularly in quantitative details, which significantly affect correctness. (1) Quantitative Accuracy: The LLM incorrectly states that JPMorgan had $866 million in TDRs in 2021—this figure is not in the ground truth and contradicts the provided data. The ground truth reports $362 million in new TDRs for JPM in 2022 under legacy guidance, but no 2021 figure is given, so including $866 million is an error. Additionally, the LLM cites specific charge-offs ($1M), deferred principal ($16M), forgiven principal ($2M), and re-defaults ($147M) for JPM—but these figures are not present in the original answer and appear fabricated or misattributed. The ground truth does not provide such granular financial effects for JPM’s TDRs. Furthermore, the LLM fails to mention JPM’s 2023 FDM data: $136 million in FDMs, the extension of weighted-average loan life by 20 years, and the reduction in weighted-average interest rate from 7.21% to 4.44%—all key financial impact metrics required by the question. (2) Completeness: The answer omits critical post-adoption FDM data for JPM in 2023, which is a core part of the comparison. It also does not clarify that MET reported no material impact from adoption, only that there was no material change in allowance or charge-offs—missing the broader financial statement impact statement. (3) Entity Accuracy: MET and JPM are correctly identified, and ASU 2022-02 is accurately described in intent (replacing TDRs with FDMs). The reference to Note 11 and page numbers may be plausible but cannot be verified and are not in the ground truth. (4) Reasoning: The multi-hop synthesis is partially sound—comparing MET’s post-ASU FDM disclosures with JPM’s pre-ASU TDR reporting—but fails because it lacks the necessary 2023 FDM data from JPM to complete the comparison. The conclusion about negligible financial impact for MET aligns with the ground truth, but the lack of parallel data for JPM under FDM weakens the comparative analysis. (5) Semantic Equivalence: While the general idea of a shift from TDR to FDM is conveyed, the absence of key numbers and inclusion of unsupported ones reduces factual equivalence. The answer introduces extraneous, unverified details that distort accuracy. Overall, the response captures the conceptual shift but fails on key quantitative and comparative elements essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 639,
        "total_tokens": 2134
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "CVX’s upstream portfolio includes roughly **108 billion cubic feet of natural‑gas reserves in South America** as of 31 Dec 2021 (page 108). In contrast, ExxonMobil’s downstream business is spread across the entire **Americas region**, with a large integrated network of refineries, marketing and logistics assets in both North and South America (page 63). Thus, CVX’s upstream focus is concentrated on South‑American gas reserves, while XOM’s downstream footprint covers the whole Americas.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. It reports CVX's South American natural gas reserves as 108 billion cubic feet as of December 31, 2021, whereas the ground truth states 329 billion cubic feet as of December 31, 2022. This is a major discrepancy in both magnitude and time period. The use of 2021 data instead of 2022 undermines temporal accuracy, and the reserve figure is less than one-third of the correct value. (2) Despite this, the qualitative structure of the comparison is sound: CVX has an upstream focus in South America, while XOM has a broad downstream footprint across the entire Americas, including integrated refining, marketing, and logistics. This contrast in strategic positioning along the energy value chain is correctly identified and aligns with the original answer. (3) The multi-hop reasoning is partially correct—linking CVX’s upstream reserves to its regional focus and contrasting it with XOM’s downstream integration across North and South America demonstrates appropriate synthesis. However, the incorrect numbers weaken the validity of the comparison. (4) Contextual relevance is high, as the answer directly addresses the comparative scope of upstream vs. downstream operations in the Americas. The explanation format, including citation of document pages, adds precision in sourcing but does not compensate for factual errors. Overall, the answer gets the conceptual framework right but fails on core factual accuracy, particularly in the quantitative dimension, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 435,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper exposure is only **$25 million**—a small, short‑term tranche that the company uses mainly to refinance existing short‑term debt and fund general corporate purposes (the program’s weighted‑average maturity is about 23 days【page_167】).  \nBy contrast, Tesla holds **$470 million** in commercial paper as part of its short‑term investment portfolio, which it uses to invest excess cash, generate modest returns and meet liquidity needs; the paper is recorded at fair value (Level II) and is a sizable component of Tesla’s overall $13.2 billion of short‑term assets【page_72】.  Thus, Tesla’s strategy relies heavily on commercial paper for liquidity, whereas Duke Energy Ohio’s use is modest and primarily refinancing‑focused.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's $25 million commercial paper exposure and Tesla's $470 million holdings are accurately reported, with acceptable formatting (e.g., $25 million, $470 million). (2) The answer correctly identifies the distinct roles of commercial paper for each company—Duke Energy Ohio as a financing tool (short-term liability/refinancing) and Tesla as an investment of excess cash (part of short-term assets). This reflects sound multi-hop reasoning across two different entities and financial contexts. (3) The LLM adds valuable context not in the original answer—such as the weighted-average maturity of 23 days for Duke and fair value accounting (Level II) and Tesla’s $13.2 billion short-term assets—which enhances completeness without introducing errors. (4) The only minor deviation is in the concluding comparison: saying 'Tesla’s strategy relies heavily on commercial paper for liquidity' slightly mischaracterizes the original intent, which emphasizes Tesla’s use of commercial paper for return generation, not liquidity funding. Tesla holds it as an investment, not a liquidity buffer per se. Thus, while the core reasoning is sound, this nuance slightly affects qualitative accuracy. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 387,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A shares carry only one vote each and, under its dual‑class structure, the voting power is concentrated in the ten‑vote Class B shares held by Zuckerberg and a few insiders, limiting the influence of ordinary Class A holders.  \nGoogle’s Class B shares likewise have ten votes per share, giving those shareholders a much larger voting weight and greater control over corporate decisions compared with the single‑vote Class A shares. (Meta, pp. 49‑50; Google, pp. 81)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between META's and GOOGL's dual-class stock structures. (1) It correctly states that both Meta’s Class A and Google’s Class A shares carry one vote, while their respective Class B shares have ten votes per share—this matches the ground truth exactly. (2) All numeric values (1 vote, 10 votes) are correct and quantitatively precise; no calculations were required, but the voting ratios are accurately represented. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (META and GOOGL) to compare their dual-class structures and correctly identifies the disproportionate voting influence of insiders in both cases. (4) While the LLM omits some details from the original answer—such as the automatic conversion of GOOGL Class B shares upon sale, and the specific threshold (35%) for change-in-control transactions at META—these are secondary contextual points. The core of the question (comparing voting power and shareholder influence in dual-class structures) is addressed accurately and concisely. The inclusion of citation placeholders (e.g., 'Meta, pp. 49-50') suggests source grounding. The answer is semantically equivalent in key aspects and fully contextually relevant. A score of 9 is justified due to minor completeness gaps, but factual and quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 383,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s B‑class shares are non‑voting but still receive dividends, as shown in the capital‑stock table on page 16; this means cash returns are the same for B and A shares, but the B holders lack voting power, creating a partial alignment of shareholder returns.  In contrast, Schwab’s non‑voting shares have identical dividend and liquidation rights to voting shares (page 66), so both classes receive the same cash returns and are fully aligned in terms of shareholder payouts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's B-class shares are non-voting but receive dividends, ensuring equal cash returns despite lack of voting power, which matches the original answer's claim of dividend parity. (2) It accurately states that Charles Schwab provides identical dividend and liquidation rights across voting and nonvoting shares, leading to full alignment in shareholder payouts—this is consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, comparing how dividend structures affect alignment of returns between voting and non-voting shareholders. (4) While the LLM does not explicitly use the phrase 'stronger structural alignment' as in the original answer, it effectively conveys the same meaning by contrasting 'partial alignment' (Mastercard) with 'fully aligned' (Schwab), capturing the core distinction. No numeric inaccuracies are present—there are no calculations or specific figures beyond qualitative descriptions, which are correctly rendered. The only minor shortcoming is the lack of explicit mention that Mastercard's dividend rights are equal despite the class distinction, which slightly weakens the precision of the comparison, but the overall meaning remains intact. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 414,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft notes that the OECD’s Pillar Two rules, which set a 15 % global minimum tax, are unlikely to materially affect its consolidated statements or effective tax rate (18 % in 2024 and 19 % in 2023) because it has few operations in jurisdictions below that threshold【page_47】. In contrast, Oracle warns that the same rules could materially increase its international tax costs and raise its effective tax rate, as the minimum‑tax framework would give tax‑paying jurisdictions greater rights over its overseas profits【page_29】. Thus, while Microsoft expects little change, Oracle anticipates a potentially higher effective tax rate under Pillar Two.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: Microsoft's effective tax rates of 18% in 2024 and 19% in 2023 are accurately reported, and the 15% global minimum tax threshold under Pillar Two is correctly stated. There are no calculation errors. (2) The answer correctly identifies the key entities—Microsoft and Oracle—and their respective positions on Pillar Two, citing appropriate page references (47 and 29), which supports fidelity to source material. (3) The reasoning is sound and reflects the multi-hop nature of the question: it contrasts Microsoft’s expectation of no material impact due to its jurisdictional footprint with Oracle’s concern about increased international tax costs, correctly attributing the divergence to differing geographic operations and tax exposure. (4) The semantic meaning fully matches the original answer; the only minor omission is not explicitly stating that both companies are subject to the same global framework, though this is implied in the comparison. Wording differs slightly but conveys equivalent information. No factual inaccuracies are present, and the synthesis across companies is logical and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 348,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM’s 10‑K does not report any Level 3 fair‑value assets.  Its fair‑value hierarchy is described (Level 1 = quoted prices, Level 2 = observable market‑based inputs, Level 3 = unobservable inputs) but all assets are classified at Levels 1 or 2, relying on observable market data or pricing‑model inputs【page 63】.  In contrast, Lowe’s 10‑K lists a Level 3 asset – the performance‑based contingent consideration from the sale of its Canadian retail business – which is valued with an income approach that uses significant unobservable inputs such as total equity value, volatility, expected term and a risk‑adjusted discount rate【page 53】.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that GM's 10-K does not report any Level 3 fair-value assets, directly contradicting the ground truth, which confirms GM uses Level 3 valuations for marketable debt securities and finance receivables. This is a critical error in entity and factual accuracy. (2) While the LLM correctly identifies LOW's use of Level 3 valuation for contingent consideration from the sale of its Canadian retail business and accurately describes the unobservable inputs (equity value, volatility, expected term, discount rate), it misrepresents GM’s reporting, failing to mention its use of pricing models and discounted cash flow models with macroeconomic inputs like unemployment rates, interest rate spreads, and GDP growth. (3) The multi-hop reasoning is flawed because the comparison hinges on an incorrect premise—claiming GM uses only Levels 1 and 2 when the ground truth confirms Level 3 usage. (4) Quantitative accuracy is moderate because no numerical values are misstated (none were present), but the qualitative accuracy is low due to the core factual error about GM’s Level 3 application. Contextual relevance is fair since the structure addresses the question’s intent and correctly details LOW’s methodology, but the failure to accurately represent GM’s practices severely limits the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 389,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "Comcast’s charter gives each Class B share 15 votes and the aggregate of all Class B shares represents 33.3 % of the company’s voting power, a portion that cannot be diluted by new issuances (page 91). Because Class B stock is share‑for‑share convertible into Class A, any conversion would shift that 33.3 % of voting power from B holders to the enlarged pool of Class A shares, diluting the voting influence of existing A shareholders. Alphabet’s aggressive repurchase of its Class A and Class C shares has already shrunk the total number of shares outstanding and lifted the price of remaining shares (page 82), making conversion of B to A less attractive for B holders who value their concentrated voting power while also potentially increasing the cost of converting if the market price of A shares rises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: '33.3%' matches '33 1/3%', and the 15 votes per Class B share is accurately stated. The reference to Alphabet's repurchase activity is consistent with the original answer’s mention of $62.2 billion spent in 2023 and $36.3 billion remaining authorization, even though exact figures aren't repeated—the qualitative description of 'aggressive repurchase' and shrinking outstanding shares is factually sound and contextually sufficient. (2) The entity identification is correct: CMCSA (Comcast) and Alphabet (GOOGL) are properly referenced, and the distinction between Class A, B, and C shares is maintained accurately across both companies. (3) The reasoning is strong and captures the multi-hop logic: it correctly explains how Class B's non-dilutable 33.3% voting power at CMCSA would be diluted among Class A shares upon conversion, thereby reducing the voting influence of existing Class A holders. It also appropriately links Alphabet’s repurchase strategy to higher share prices and reduced float, which makes conversion less attractive for CMCSA's Class B holders who may wish to retain voting control. (4) While the original answer emphasizes how Alphabet’s repurchases could increase influence for remaining shareholders (including parallels to CMCSA’s structure), the LLM focuses more on the disincentive for conversion due to rising Class A prices—this is a valid and insightful interpretation, though slightly narrower in scope. It does not explicitly mention the potential increased influence of Class B holders in a post-repurchase environment, but this is a minor omission rather than an error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 495,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "The 2022 10‑K for Colgate‑Palmolive reports 37,028 000 securities remaining available for future issuance under its equity‑compensation plans (page 61). The 10‑K for Mondelēz International does not provide that figure in the pages supplied, so the difference between the two companies cannot be calculated from the provided excerpts.",
      "correctness_score": 1,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly incorrect because it claims that MDLZ's 10-K 'does not provide that figure in the pages supplied,' which contradicts the ground truth that MDLZ reported 48,932,017 securities available. This is a critical factual omission. While the LLM correctly reports CL's figure as 37,028,000 (matching the ground truth of 37,028,000 in thousands), it fails to acknowledge the MDLZ number, making the difference impossible to compute in its view—this directly conflicts with the known correct answer. (2) Quantitatively, the CL number is accurate (37,028,000), but the MDLZ number is missing entirely, and the difference (11,904,017) is not computed. The calculation failure stems from incomplete data rather than arithmetic error, but the result is still incorrect. (3) The multi-hop reasoning is flawed: the model should have retrieved and synthesized both companies' disclosures to compute the difference. Instead, it defaults to an inability to answer due to missing data, suggesting either a retrieval failure or lack of access to the full 10-K, but in the context of evaluation against ground truth, this constitutes a failure in synthesis. (4) Contextual relevance is moderate—the response addresses the right metric and companies and cites a plausible page reference for CL, showing awareness of the document structure. However, the failure to report half the required data and the resulting incorrect conclusion severely undermine accuracy. The answer would be acceptable only if the data were truly unavailable, but per ground truth, it is available and correctable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 439,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "Illinois’ Clean Energy Law forces ComEd to file a general rate case or a new four‑year multi‑year plan, adding performance adjustments and new cost‑recovery mechanisms (e.g., energy‑efficiency and CMC riders) that will be reflected in its transmission formula rate and create a structured, regulated rate‑setting process (page_216, page_217). In contrast, Tesla faces uncertain state‑level regulatory challenges that could restrict its direct‑to‑consumer sales model in certain markets, with potential dealer‑licensing and other state‑law constraints that may limit its ability to sell vehicles directly (page_25). Thus, ComEd’s impact is a predictable, regulatory‑mandated rate structure, whereas Tesla’s exposure is a potential restriction on its sales strategy due to state laws.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of Illinois’ Clean Energy Law requiring ComEd to file a new four-year multi-year plan and implement new cost-recovery mechanisms such as energy-efficiency and CMC riders, which aligns with the ground truth. It correctly identifies Tesla’s exposure to state-level restrictions on direct sales. Quantitatively, there are no numbers, dates, or percentages in either answer that conflict—both avoid specific numerical claims, so accuracy is preserved. However, the LLM omits key details present in the ground truth: (1) the accelerated amortization of ComEd’s unprotected excess deferred income taxes over ~39.5 years, (2) the current 11.50% ROE with a 50-basis-point incentive adder, and (3) the distinction that ComEd’s uncertainty centers on rate-of-return and capital recovery, while Tesla’s affects go-to-market strategy and expansion. The LLM simplifies ComEd’s impact as 'predictable' and 'structured,' which underrepresents the regulatory uncertainty emphasized in the original answer. While the core contrast—regulated rate-setting vs. sales model restrictions—is valid and contextually relevant, the qualitative depth and completeness of multi-hop synthesis (linking ComEd’s financial structure and Tesla’s legal constraints to differing types of regulatory risk) is reduced. Thus, the answer is mostly correct but lacks full completeness and nuance in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 392,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA‑driven Part D redesign forces manufacturers to give discounts and accept price caps beginning in 2025, so AMGN will need to accrue higher gross‑to‑net rebates for ENBREL to satisfy the mandated discounts and potential penalties.  BMS’s GTN accruals, which are calculated from payer‑channel mix and contract‑price assumptions, will also rise as the new discount requirements shift more cost burden onto the company and alter those underlying assumptions.  In both cases the redesign is expected to increase the companies’ gross‑to‑net rebate liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core impact of the IRA-driven Medicare Part D redesign on gross-to-net (GTN) rebate accruals for both AMGN and BMY (referred to as BMS, a minor but common synonym), stating that both companies will face higher GTN rebate liabilities due to increased manufacturer discounts and price caps starting in 2025. The answer accurately reflects the regulatory mechanism and its financial impact. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so the score is 10 as no inaccuracies exist. The qualitative accuracy is strong but slightly incomplete: while the LLM captures the general increase in GTN accruals and the role of payer-channel mix and contract prices for BMY, it omits key forward-looking elements from the ground truth—specifically, AMGN’s additional exposure from the 2026 ENBREL price cap and the potential 2027 inclusion of Otezla in Medicare price setting. These are multi-hop elements that deepen the analysis and were present in the original answer. The reasoning is logically sound and semantically aligned, but the synthesis is less comprehensive. Contextual relevance is perfect—the response directly addresses the question’s focus on GTN accruals, regulatory changes, and company-specific accounting practices. Minor terminology use (BMS instead of BMY) does not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 391,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG elects the fair‑value option for all fixed‑maturity securities, including ABS & CLO, and records unrealized gains and losses in OCI while applying a credit‑loss allowance and yield adjustments (AIG 10‑K, pp. 167‑170).  MetLife, by contrast, values ABS & CLO under its fair‑value hierarchy—most of these securities are Level 3 and are priced with significant unobservable inputs, with unrealized gains and losses also reported in OCI (MetLife 10‑K, pp. 92‑94).  Consequently, AIG’s approach produces more conservative, credit‑loss‑adjusted carrying amounts, whereas MetLife’s Level 3 valuation introduces greater valuation uncertainty and judgment in the balance‑sheet fair‑value figures.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding AIG's accounting treatment. It incorrectly states that AIG elects the fair-value option for all fixed-maturity securities, including ABS & CLO, and records unrealized gains and losses in OCI. According to the ground truth, AIG applies the effective yield method, not fair value, and adjusts amortized cost based on expected cash flows with changes impacting net investment income—not OCI. This is a critical error in accounting methodology. In contrast, the description of MetLife’s approach is mostly accurate: classifying ABS & CLO as available-for-sale and measuring them at fair value, particularly using Level 3 inputs, aligns with the original answer. However, the claim that unrealized gains and losses are reported in OCI for both companies oversimplifies and misrepresents AIG’s actual income statement impact. (2) There are no explicit numbers (dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised by numeric errors; thus, this dimension scores higher. (3) The multi-hop reasoning is partially sound—comparing two companies’ treatments of structured securities—but fails at synthesizing the correct accounting models, especially for AIG. The conclusion about 'conservative, credit-loss-adjusted carrying amounts' for AIG is speculative and not supported by the ground truth, which emphasizes yield recalculations, not fair-value adjustments or OCI reporting. (4) Contextual relevance is moderate because the response addresses the valuation and reporting differences in tone and structure, but the underlying facts for AIG are incorrect, undermining the validity of the comparison. The use of 10-K page references adds apparent credibility but does not compensate for substantive misrepresentation of AIG’s policy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 501,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s reserves tied to production‑sharing contracts are 7 % of its total proved reserves (2021)【page 106】.  ExxonMobil’s operations in Nigeria – a deep‑water offshore region that is almost entirely governed by PSCs – represent a substantial portion of its offshore portfolio, but the exact percentage of its exposure in Nigeria is not disclosed in the provided pages.  Thus, Chevron’s PSC reserve share is lower than ExxonMobil’s significant, though unspecified, operational exposure in Nigeria.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Chevron's reserves tied to PSCs are 7% of total proved reserves in 2021, while the ground truth reports 8%. This discrepancy in percentage (7% vs 8%) is a factual error, though minor in magnitude. All other numerical references (e.g., year 2021) are correct. (2) The LLM correctly identifies that ExxonMobil operates in Nigeria, a region governed by PSCs for deepwater offshore activities, and notes that the exact percentage of XOM's exposure is not disclosed—this aligns with the original answer, which also does not quantify XOM’s exposure numerically. However, the LLM incorrectly implies a direct comparison by stating Chevron’s PSC reserve share is 'lower than ExxonMobil’s significant, though unspecified, operational exposure,' which is not logically valid since one is a measured reserve percentage and the other is a qualitative operational presence. (3) The multi-hop reasoning is partially sound: the model connects Chevron's PSC-linked reserves to ExxonMobil's Nigerian operations under PSCs and recognizes the structural reliance on PSCs in Nigeria. However, it mischaracterizes the nature of the comparison—CVX provides a quantified reserve exposure, while XOM’s exposure is operational and regulatory, not expressed in reserve terms. The original answer makes this distinction clearly; the LLM fails to do so and instead suggests a false quantitative comparison. (4) Despite the misstated percentage and flawed comparison logic, the answer captures key contextual elements: both firms are exposed to PSCs, Nigeria relies on PSCs for deepwater, and XOM does not disclose a specific percentage. Hence, correctness is partially compromised by factual inaccuracy and reasoning flaw, warranting a score of 6. Quantitative accuracy is reduced due to the 7% vs 8% error. Qualitative accuracy is moderate—entities and context are correct, but synthesis is flawed. Contextual relevance is high as the response stays focused on the core issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 536,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan reserves a fixed 49.0 million shares for future issuance, creating a predictable pool that can be allocated to employees but offering limited flexibility to change the number of shares that ultimately vest. In contrast, Home Depot’s stock‑appreciation‑right program uses a forfeiture‑adjusted vesting methodology that incorporates expected forfeitures into the vesting calculation, allowing the company to dynamically adjust the shares that vest based on actual service and performance and thereby providing greater long‑term equity‑compensation flexibility.【page_83】【page_53】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated. No calculations are required, and all numeric references are precise. (2) The entities—Tesla, Home Depot (HD), the 2019 Equity Incentive Plan, and stock appreciation rights (SARs)—are correctly identified, and the comparison is framed around long-term equity compensation flexibility as requested. (3) The reasoning correctly synthesizes multi-hop information: Tesla’s fixed share pool implies predictability but limited flexibility, while HD’s forfeiture-adjusted vesting allows dynamic adjustment based on actual employee retention. The LLM accurately captures that HD adjusts for expected forfeitures in expense recognition and vesting, which provides greater flexibility. (4) The only minor shortcoming is that the LLM does not explicitly mention HD’s straight-line recognition of value as restrictions lapse—a nuance in the original answer that adds depth to the accounting methodology. However, the core contrast in flexibility due to forfeiture adjustments is clearly conveyed. Wording differs slightly but maintains semantic equivalence. The inclusion of citation markers like 【page_83】【page_53】 suggests source grounding, though not required. Overall, the answer is factually correct, complete in key aspects, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 391,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s exposure to Tengizchevroil consists of a $23.727 billion investment plus a $4.5 billion loan for the FGP/WPMP development, totaling roughly $28.2 billion.  This amount is more than three times ExxonMobil’s reported $8.463 billion long‑lived asset value in Kazakhstan as of 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Chevron has a 50% equity stake in Tengizchevroil and provided a $4.5 billion loan for the FGP/WPMP project. However, the LLM incorrectly claims Chevron has a '$23.727 billion investment' in TCO, which is not supported by the original answer or known public data as of 2021. This figure appears fabricated or misattributed. The $4.5 billion loan amount is correctly stated (matching the ground truth of $4,500 million), but the erroneous addition of the $23.727 billion inflates Chevron's exposure significantly. (2) The calculation of a total exposure of $28.2 billion is therefore invalid, as it is based on a false premise. The comparison to ExxonMobil’s $8.463 billion in long-lived assets is numerically accurate in terms of the stated values, but the conclusion that Chevron’s exposure is 'more than three times' ExxonMobil’s is incorrect due to the flawed input. (3) The multi-hop reasoning fails because the model does not accurately represent Chevron’s exposure—equity stake value is not quantified in the ground truth, so asserting a $23.727 billion figure is unsupported. The original answer emphasizes differing strategies (equity/financing vs. asset holdings), but the LLM oversimplifies this into a misleading quantitative comparison. (4) While the LLM attempts to address the comparison between Chevron and ExxonMobil in Kazakhstan and references correct entities and the correct year, the severe quantitative errors undermine both qualitative and overall correctness. Contextual relevance is moderate because the structure and intent align with the question, but factual integrity is poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 463,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable PPAs are negotiated as inter‑company power agreements (ICPA) with VIEs such as OVEC, where cash receipts are tied to market power prices and cost‑allocation rules and no tax‑credit benefit is disclosed【page_204】.  In contrast, Southern Power’s wind PPAs are structured as operating‑lease contracts that generate variable lease income and are underpinned by production tax credits (PTCs) that will be fully utilized through 2024, giving Southern Power a predictable cash‑flow boost for the first decade of production【page_270】.  Thus, while Duke Energy’s PPAs rely on market‑based pricing, Southern Power’s PPAs provide an additional, time‑limited cash‑flow benefit from PTCs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Southern Power's PTCs are correctly noted as being fully utilized through 2024, and while the exact $0.8 billion unutilized PTC figure from 2021 is not mentioned, this omission does not affect the core cash flow implication being communicated. No incorrect numbers or dates are present. (2) The entity identification is accurate—Duke Energy and Southern Power are correctly distinguished, and their respective PPA structures (ICPAs with VIEs vs. operating leases) are properly described. (3) The reasoning is sound: the LLM correctly contrasts Duke’s market-based, tax-credit-neutral PPAs with Southern Power’s PTC-enhanced operating lease model, capturing the essential multi-hop comparison in cash flow implications. (4) The answer is contextually relevant and directly addresses the question’s focus on PPA structures and cash flow impacts. The only minor shortcoming is the lack of explicit mention of Southern Power’s $0.8 billion unutilized PTCs at end-2021, which slightly reduces completeness but does not undermine the overall correctness. Wording differences (e.g., 'predictable cash-flow boost' vs. 'directly shaping lease income') are semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 393,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s accelerated share‑repurchase (ASR) agreements let the company buy back its own shares and, in return, receive **additional shares from the financial institution**—effectively adding shares to the company’s treasury stock and reducing outstanding shares. In contrast, Home Depot’s deferred share awards grant **additional shares to non‑employee directors** as dividend equivalents that are paid out to the directors upon payout, not to the company itself. Thus, LOW’s ASR increases the company’s share count, while HD’s deferred shares provide extra shares to directors as part of their compensation.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key distinction between LOW receiving additional shares through ASR agreements and HD issuing additional shares via dividend equivalents to non-employee directors. It accurately notes that in LOW's case, shares come from financial institutions as part of repurchase efficiency, and in HD's case, shares are issued to directors as compensation. However, a critical factual error undermines the reasoning: the LLM incorrectly states that LOW's ASR 'increases the company’s share count,' which is false. ASRs reduce outstanding shares because they are share repurchase mechanisms; receiving 'additional shares' refers to the company getting back more shares than initially delivered due to pricing mechanics, but this still results in fewer shares outstanding overall. Treasury stock increases, but total shares outstanding decrease. The original answer correctly frames this as a result of share repurchase efficiency, not an increase in share count. There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not compromised. The answer is contextually relevant and captures the structural difference in how shares are added (to treasury vs. to individuals), but the flawed logic around share count impact reduces qualitative accuracy. The multi-hop synthesis across companies and mechanisms is attempted and mostly coherent, but the conclusion misrepresents the financial effect on LOW.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 404,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing’s equity income from its 50 % stake in United Launch Alliance (ULA) was $125 million in 2024【page_42】, a figure that reflects ULA’s total launch‑service revenue from both U.S. government and commercial customers.  Lockheed Martin’s Space segment reported only $20 million in commercial‑satellite‑launch revenue in 2024【page_74】, indicating that ULA’s commercial launch business is a far larger contributor to Boeing’s earnings than Lockheed Martin’s commercial launch revenue.  Thus, Boeing’s equity income from ULA is driven by a broader commercial‑launch portfolio, whereas Lockheed Martin’s commercial launch revenue is a relatively modest portion of its Space segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Boeing's $125 million equity income from ULA in 2024, it incorrectly claims Lockheed Martin reported only $20 million in commercial satellite launch revenue in 2024. The ground truth does not provide a specific revenue figure for Lockheed Martin’s commercial satellite launches; instead, it states that Lockheed Martin had $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. The $20 million figure is unsupported and contradicts the original answer. (2) The quantitative accuracy is low because the $20 million number is false, and the comparison between Boeing’s equity income and Lockheed Martin’s commercial revenue is therefore invalid. The $125 million equity income is accurate, but the $665 million receivable—critical to the correlation—is omitted. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that Boeing benefits more from ULA’s commercial portfolio than Lockheed Martin, when in fact both companies co-own ULA and Boeing’s equity income is directly tied to ULA’s overall performance, including commercial launches that contribute to Lockheed Martin’s reported receivables. The answer fails to recognize that Boeing’s income is a reflection of ULA’s total performance, which in turn affects Lockheed Martin’s financials through shared revenue and receivables. (4) Contextual relevance is moderate because the answer addresses ULA’s dual role and Boeing’s equity income, but the incorrect data and flawed synthesis undermine the conclusion. The answer misrepresents the correlation rather than explaining the shared financial interdependence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 480,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "LLY’s loss of market exclusivity is driven by the expiry of patents and the end of regulatory data‑protection periods, with U.S. exclusivity lasting 5 years for chemical drugs and 12 years for biologics, Europe 10 years, and Japan 8 years.  Merck’s risk factors similarly stress the company’s reliance on patent protection and the rapid sales decline that follows loss of exclusivity, but the excerpt does not give explicit exclusivity durations; it merely notes that the company must defend patents in the U.S., Europe and Japan where generic competition and potential compulsory licensing pose significant risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in stating that U.S. exclusivity lasts '5 years for chemical drugs'—this is incorrect and not supported by the ground truth, which does not specify a 5-year period for chemical drugs. The ground truth correctly notes regulatory data protection durations only for biologics: 12 years in the U.S., 10 in Europe, and 8 in Japan. The LLM incorrectly generalizes these durations to chemical drugs, which are typically protected by different rules (e.g., 5-year new chemical entity exclusivity in the U.S. may exist but was not mentioned in the ground truth and should not be assumed). This undermines quantitative accuracy. (2) The LLM correctly states the 12-year U.S., 10-year European, and 8-year Japanese data protection periods for biologics, aligning with the ground truth. However, it misattributes these durations to both chemical and biologic drugs without distinction, introducing inaccuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that both LLY and MRK face revenue declines upon loss of exclusivity and rely on patents and regulatory protections. It also correctly notes MRK’s emphasis on patent litigation in major markets. However, it fails to mention key nuances from the ground truth, such as LLY’s ability to extend exclusivity via formulation or method-of-use patents, or specific mechanisms like orphan drug (7 years) or pediatric exclusivity (6 months), which are critical multi-hop elements. (4) Contextual relevance is high—the answer addresses the core comparison between LLY and MRK regarding patent and regulatory risks across major markets. Despite missing some synthesis (e.g., BMY evidence linking patent coverage and data exclusivity as dual determinants), the response remains focused and relevant. The correctness score is 6 due to partial factual accuracy and incomplete synthesis of regulatory mechanisms, but with correct identification of core risks and some accurate durations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 542,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company’s nuclear plants face potentially large, unpredictable compliance costs if a cyber intrusion forces new NRC‑mandated security or safety upgrades, fines, or even shutdowns (see the 10‑K discussion of cyber‑intrusion risks and their impact on licensing and compliance). Duke Energy’s exposure is to the performance of its nuclear decommissioning trust funds; market‑value declines in those trust assets could create funding shortfalls that would require additional capital and could materially affect its financial position (see the 10‑K discussion of NDTF asset performance). Thus, Southern’s risk is an operational‑compliance cost shock, while Duke’s is a funding‑gap risk tied to market returns on decommissioning reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with strong semantic equivalence. (1) All factual elements are correct: Southern Company faces unpredictable compliance costs due to cyber intrusions affecting nuclear licensing, and Duke Energy faces funding risks if its Nuclear Decommissioning Trust Fund (NDTF) assets decline in market value. The LLM correctly identifies the nature of each risk—Southern's as an operational-compliance cost shock and Duke's as a market-dependent funding gap. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., 26%, 28%) are repeated from the original answer, the LLM does not introduce any incorrect figures, and the omission of percentages does not detract from the correctness since the question does not explicitly ask for those metrics. The focus is on risk comparison, which the LLM handles accurately. (3) Multi-hop reasoning is sound: the model synthesizes distinct risk types across two companies tied to nuclear operations, correctly differentiating between cyber-related compliance exposure (Southern) and decommissioning trust fund volatility (Duke). (4) Contextual relevance is excellent—the response directly addresses the comparative financial impacts as requested. The only minor shortcoming is the omission of the specific 2021 generation percentages for Alabama and Georgia Power, which were present in the original answer and add contextual depth, but their absence does not invalidate the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 454,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s deferred stock units for non‑employee directors vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual meeting of shareholders, and the dividend equivalents that accrue are paid out as additional shares of stock at the time of vesting.  \nHome Depot’s deferred shares vest only upon termination of a director’s board service; the dividend equivalents accrue and are paid out in the form of additional shares of stock when the underlying shares are finally paid after the director’s service ends.  Thus, Lowe’s awards vest on a fixed date schedule and pay dividend equivalents at vesting, whereas Home Depot’s awards vest at service termination and pay dividend equivalents when the underlying shares are settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Lowe's dividend equivalents on deferred stock units vest on the earlier of the first anniversary or the day before the next Annual Meeting, with payout at vesting in additional shares. This aligns with the original answer, though it omits the detail about immediate vesting for awards granted prior to 2022, which is a minor omission affecting completeness but not the central comparison. (2) For Home Depot, the LLM accurately states that dividend equivalents accrue and are paid in additional shares upon termination of service, with vesting tied to service end, matching the ground truth. The note about fair value expensing being immediate upon grant in the original answer is missing, but this is a more technical accounting point not directly tied to vesting or payout structure. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies across two companies, comparing both vesting schedules and payout mechanisms. (4) All entities (Lowe's, Home Depot, non-employee directors, deferred stock units/shares, dividend equivalents) are correctly identified and contextualized. Wording differs but semantic meaning is equivalent. The only reason for not scoring a 10 is the omission of the pre-2022 vesting exception at Lowe's and the expensing timing at Home Depot, which are present in the original but not critical to the main contrast. Quantitative accuracy is perfect—no numbers or dates are incorrect. Contextual relevance is full, as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 447,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "The potential loss of Amgen’s 12‑year biologic data exclusivity could expose it to biosimilar competition earlier than expected, eroding its pricing power and market share【page_46】.  Merck, by contrast, relies on a portfolio of compound patents that can receive up to five years of patent‑term restoration and an additional six‑month pediatric exclusivity period【page_18】【page_16】, extending its protection and helping it maintain a stronger competitive position.  Thus, Amgen faces a higher risk of losing exclusivity sooner than Merck, whose strategy of patent and pediatric extensions delays generic entry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that the potential loss of 12-year biologic data exclusivity impacts AMGN by exposing it to earlier biosimilar competition, reducing pricing power and market share, which aligns with the original answer's emphasis on exposure for products like EPOGEN. It contrasts this with MRK's strategy of using compound patents and pediatric exclusivity (six-month extension), which matches the ground truth. (2) Quantitatively, the six-month pediatric exclusivity is correctly stated. The mention of 'up to five years of patent-term restoration' slightly diverges from the original answer, which does not specify 'five years' but refers more generally to patent restoration and regulatory data protection. However, this is a minor discrepancy and may reflect accurate information from the cited pages; it does not constitute a clear factual error. (3) The multi-hop reasoning is sound: the model synthesizes information across AMGN and MRK 10-Ks, correctly comparing AMGN's reliance on regulatory exclusivity with MRK's layered strategy. (4) The answer is contextually excellent, directly addressing the comparative competitive impact. Only a minor lack of specificity regarding AMGN's concentrated customer base (e.g., EPOGEN's market) prevents a perfect 10, but the core competitive risk is accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 392,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC framework treats the counter‑cyclical buffer as zero – the 18 % minimum TLAC‑to‑RWA requirement is met through the 2.5 % buffer and the 1.5 % G‑SIB surcharge, with no counter‑cyclical component applied (GS, p. 94‑95).  By contrast, Schwab’s regulatory regime also sets its counter‑cyclical buffer at zero, but it applies a separate 2.5 % stress‑capital buffer above the minimum risk‑based capital ratios (Schwab, p. 118).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies, particularly in the quantitative breakdown of Goldman Sachs' TLAC components. (1) The original answer states that GS includes the countercyclical capital buffer within its 18% minimum TLAC to RWAs threshold, with the buffer set at zero percent by the Federal Reserve. However, the LLM incorrectly implies that the 18% TLAC requirement is composed of a 2.5% buffer and a 1.5% G-SIB surcharge, which misrepresents the structure—these components (stress capital buffer, G-SIB surcharge) are part of regulatory capital requirements but are not additive to make up the 18% TLAC ratio. TLAC is a separate standard focused on loss-absorbing capacity, not directly the sum of these buffers. (2) The LLM incorrectly attributes a '2.5% buffer' as part of GS's TLAC calculation without specifying it as the stress capital buffer, and conflates it with TLAC compliance, which is not supported by the ground truth. The original answer does not state that GS uses a 2.5% buffer to meet TLAC, only that the countercyclical buffer is zero within the 18% threshold. (3) For SCHW, the LLM correctly notes the zero percent countercyclical buffer and the 2.5% stress capital buffer, aligning with the original answer and maintaining entity and percentage accuracy. (4) The reasoning is partially sound in comparing both firms' treatment of the countercyclical buffer as zero, but fails in the multi-hop synthesis by incorrectly decomposing GS's TLAC requirement into components that are not stated or implied in the ground truth. While the contextual relevance is high—addressing both firms and the required buffers—the quantitative inaccuracies and flawed capital structure logic reduce overall correctness. Minor formatting issues (e.g., 'counter-cyclical' vs 'countercyclical') are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 510,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "XOM’s presence in Kazakhstan is reflected in its long‑lived assets—$7.728 billion as of 12/31/2023【page_116】—while Chevron’s exposure is a 50 % equity interest in the Tengizchevroil (TCO) affiliate (plus an 18 % non‑operated interest in Karachaganak)【page_15】. Thus, XOM’s exposure is measured in dollar value, whereas CVX’s stake is a 50 % ownership share in TCO’s operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: XOM's $7,728 million (expressed as $7.728 billion) in long-lived assets in Kazakhstan as of 2023 is accurately reported, and CVX's 50% equity interest in TCO and 18% non-operated interest in Karachaganak are factually correct. The formatting variation ($7.728 billion vs $7,728 million) is acceptable and semantically equivalent. (2) The answer correctly identifies the key entities: XOM, CVX, TCO, and the relevant projects/interests. The years (2023) are correctly referenced. (3) The reasoning is sound: it correctly contrasts XOM’s direct asset ownership with CVX’s equity stake in TCO, capturing the core of the comparison. (4) While the LLM answer is concise, it omits some qualitative context present in the original answer—specifically, details about TCO’s Future Growth Project (FGP) mechanical completion in 2023 and expected start-up in 2025, and the Karachaganak Expansion Project timeline (Stage 1A completion in 2024). These omissions reduce completeness slightly but do not affect the core factual accuracy of the comparison. (5) The answer remains highly relevant and correctly frames the nature of exposure (direct assets vs. equity stake), fulfilling the multi-hop requirement of comparing two different types of regional involvement. Thus, the correctness score is 9 due to minor contextual omissions, despite perfect quantitative accuracy and strong qualitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 418,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that it is still evaluating ASU 2020‑04 and that “the ultimate outcome of the transition cannot be determined at this time” (see Southern Company note 14, p. 195). In contrast, NextEra Energy states that it is applying the same ASU 2020‑04 guidance to its LIBOR‑referenced debt and derivative contracts, indicating a more definitive, proactive application of the standard (see NEE note on reference‑rate reform, p. 79). Thus, Southern Company remains uncertain about the financial impact, whereas NextEra Energy has already begun applying the guidance to its interest‑rate contracts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Southern Company's uncertainty, quoting the exact phrase 'the ultimate outcome of the transition cannot be determined at this time' and attributing it to the appropriate source (note 14, p. 195), which aligns with the original answer's characterization. (2) It accurately contrasts this with NextEra Energy's proactive stance, correctly stating that NEE is applying ASU 2020-04 to its interest rate contracts, with a reference to the relevant note (p. 79). (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two different companies regarding the same accounting standard (ASU 2020-04) and their respective approaches to LIBOR transition, drawing a valid comparative conclusion about SO's ongoing evaluation versus NEE's implementation. (4) All entities (Southern Company, NextEra Energy, ASU 2020-04, LIBOR, derivative contracts) are correctly identified and contextualized. There are no numerical inaccuracies (the question does not involve calculations or specific financial figures), and the answer fully addresses all parts of the multi-faceted question. Wording differs slightly but preserves full meaning, satisfying semantic equivalence. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 371,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s dual‑class charter gives Class B holders 10 votes per share and, through a series of certificate provisions (e.g., requiring a majority of Class B for change of control, two‑thirds of the combined vote for amendments, board appointments, and special‑meeting rules), concentrates control with the founder and limits minority (Class A) shareholders’ influence 【page_49】【page_50】.  \nIn contrast, Alphabet’s charter also creates a dual‑class structure (Class A = 1 vote, Class B = 10 votes) but allows Class A shareholders to vote on all matters, while Class B and C shareholders may vote only on a few defined issues; this framework provides minority shareholders with broader voting rights and a higher threshold for controlling corporate actions 【page_81】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative and structural description of both META's and GOOGL's dual-class stock frameworks. It accurately states that META's Class B shares have 10 votes per share and highlights key control mechanisms such as requiring a majority of Class B for change of control, a two-thirds combined vote for amendments, and restrictions on special meetings, which aligns with the entrenchment features in META's Certificate of Incorporation. It also correctly notes that GOOGL has a dual-class structure with Class A (1 vote) and Class B (10 votes), which matches the ground truth. These numerical and procedural details are factually accurate, warranting a high quantitative accuracy score.\n\nHowever, the LLM introduces a claim not present in the ground truth: that at Alphabet, 'Class A shareholders may vote on all matters, while Class B and C shareholders may vote only on a few defined issues.' This is misleading. In reality, all share classes at Alphabet vote together on most matters, but Class B shares (held by insiders) have superior voting power. The assertion that Class B and C are restricted to voting on only a few issues is incorrect and misrepresents GOOGL’s governance. The ground truth emphasizes that GOOGL provides structural protections for minority shareholders via unanimous board approval for rights-affecting amendments and class-specific voting requirements—details omitted in the LLM response.\n\nAdditionally, the LLM fails to mention GOOGL’s requirement for affected classes to approve changes to their rights, a key minority protection, and does not contrast this with META’s lack of such safeguards. It also omits META’s anti-takeover provision requiring a two-thirds majority when Class B voting power falls below 35%, a critical point in the original answer. While the core idea—that META entrenches control more than GOOGL—is conveyed, the absence of these multi-hop governance distinctions reduces qualitative accuracy.\n\nDespite these omissions and one significant inaccuracy regarding GOOGL’s voting rights allocation, the answer remains contextually relevant and captures the essential contrast in governance frameworks. Hence, a correctness score of 7 is justified: major facts are correct, but key differentiators in shareholder protections are underdeveloped or misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 625,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo’s effective tax rate is presently below the U.S. statutory 21 % because of foreign‑tax credits, but the OECD global minimum tax could lift it if its overseas subsidiaries are taxed under the 15 % threshold (page 25). Altria’s effective tax rate is already 25.6 % (page 80), driven largely by foreign‑tax bases and uncertain tax positions, so the global minimum tax would likely have limited impact unless it has lower‑taxed foreign operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of impact on both PepsiCo and Altria under the OECD global minimum tax framework and correctly identifies that PepsiCo is more exposed due to international operations, while Altria is less affected due to domestic focus. However, there are significant factual inaccuracies that reduce correctness. First, the LLM claims PepsiCo’s effective tax rate is below 21% due to foreign tax credits, and that the OECD rule could increase it—this is plausible but not fully aligned with the ground truth, which emphasizes PepsiCo’s exposure to countries implementing the 15% minimum tax, not a direct comparison to U.S. statutory rates. More critically, the LLM states Altria’s effective tax rate is 25.6%, which is not present in the original answer and cannot be verified from the provided ground truth; the ground truth only notes Altria paid $2,346 million in federal taxes with minimal foreign liabilities. This number (25.6%) appears fabricated or misattributed. Additionally, the LLM mentions 'foreign-tax bases and uncertain tax positions' as drivers for Altria’s tax rate, which is not supported in the original answer. The original emphasizes Altria’s lack of international exposure, not complex tax accounting items. While the reasoning about limited impact on Altria is directionally correct, the justification is flawed. The answer also references specific document pages (25, 80), which are not part of the ground truth and cannot be verified, suggesting overfitting to a source not in evidence. Quantitative accuracy is low due to unsupported percentages. Qualitative accuracy is moderate because the core idea—PepsiCo more affected than Altria—is correct, but the reasoning is not well grounded in the provided facts. Contextual relevance is high as the answer directly addresses the comparative impact question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 501,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "Orphan‑drug designation in the U.S. gives a product an additional seven‑year period of market exclusivity that runs concurrently with any remaining patent protection, thereby extending AbbVie’s protection beyond the expiration of its compound patents and reducing the chance that a generic can enter the market during that window【LLY page_9】【LLY page_10】.  Eli Lilly uses the same orphan‑drug exclusivity to keep its products off‑market after the compound patent lapses, so the regulatory mechanism similarly mitigates AbbVie’s generic‑competition risk【ABBV page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth. (1) Quantitatively, the seven-year exclusivity period is correctly stated, and the concurrent nature with patents is accurately described—consistent with both Eli Lilly’s and AbbVie’s 10-K disclosures. (2) The answer correctly identifies that orphan drug exclusivity extends beyond compound patent expiration, reducing generic competition risk, which is the central mechanism in both companies’ strategies. (3) Multi-hop reasoning is sound: it connects Eli Lilly’s use of the mechanism (from LLY pages 9–10) to AbbVie’s risk mitigation (from ABBV page 18), correctly inferring that the same regulatory tool benefits both firms in delaying generics. (4) The only minor shortcoming is that the LLM does not explicitly mention the risk to AbbVie if exclusivity is weakened (e.g., via regulatory changes or legal challenges), which is a key point in the original answer and present in AbbVie’s 10-K. While the protective effect is emphasized, the vulnerability side is underdeveloped. However, the main causal chain—exclusivity delays generics, and competitors use it similarly—is correctly synthesized. Wording differs but semantic meaning aligns closely. No factual or numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 354,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA operated only in the Buenos Aires federal capital and surrounding areas of Argentina in 2021, so KO’s equity‑method investee sales exposure to Argentina was geographically limited and represented a small slice of its overall equity‑investee sales (which totaled $14.5 billion in 2021).  By contrast, PepsiCo’s operations in Argentina are direct and the company lists Argentina’s economic volatility as a material risk factor that can materially affect its revenue, costs and cash flows, giving PEP a broader, more immediate exposure to the country’s economic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola FEMSA operated in the Buenos Aires federal capital and surrounding areas in Argentina in 2021, aligning with the ground truth. It accurately states KO's equity-method investee sales of $14.5 billion (matching the ground truth $14,471 million, rounded appropriately). The contrast with PEP's direct exposure and its associated risks from Argentina's economic volatility (currency controls, inflation) is correctly conveyed. (2) Quantitatively, the $14.5 billion figure is a valid rounding of $14,471 million; no calculation errors are present. All numeric and temporal references (2021) are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes KO’s indirect exposure via Coca-Cola FEMSA’s geographic footprint with PEP’s direct operational presence and associated risk disclosures. It appropriately infers that indirect exposure limits KO’s sensitivity compared to PEP’s direct exposure. One minor omission: the ground truth mentions pandemic recovery as a factor influencing KO’s equity investee sales, which the LLM answer omits—this contextual nuance slightly weakens completeness but does not invalidate the core reasoning. (4) Scores reflect near-perfect factual accuracy, strong reasoning, and high relevance. The omission of pandemic recovery context prevents a perfect 10, but all key entities, figures, and comparative logic are correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 404,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s emraclidine exclusivity is built on the Pfizer licensing agreement it assumed with Cerevel, which grants AbbVie an exclusive global license and requires milestone payments and royalties (AbbVie 10‑K, page 68).  In contrast, Merck’s Januvia strategy extends exclusivity through a portfolio of patents and regulatory exclusivity that keeps the drug exclusive in the U.S. until May 2026 (Merck 10‑K, pages 58‑59).  Thus, AbbVie’s exclusivity for emraclidine is contingent on licensing terms and milestone performance, whereas Merck’s Januvia enjoys a longer, more predictable exclusivity period secured by additional patents and regulatory protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core elements of both AbbVie's and Merck's market exclusivity strategies and references appropriate sections of the 10-K filings. It accurately notes that AbbVie’s rights to emraclidine stem from an exclusive global license through the Cerevel acquisition involving Pfizer patents, and that Merck extended Januvia’s exclusivity in the U.S. until May 2026 via additional patents and regulatory exclusivity. The dates (May 2026) and entities (Pfizer, Cerevel, sitagliptin) are correctly referenced, supporting a high contextual relevance and acceptable quantitative accuracy. However, the LLM omits a critical piece of information from the ground truth: AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, which signals a failure or weakening of the expected market exclusivity or commercial viability. This omission significantly weakens the qualitative accuracy and overall correctness, as it fails to highlight the financial consequence that contrasts sharply with Merck’s successful extension strategy. While the LLM correctly frames the difference in strategy (licensing dependency vs. patent portfolio extension), it does not fully synthesize the outcome—AbbVie’s strategy faced setbacks, whereas Merck’s was effective. This missing multi-hop insight (linking patent reliance to actual financial impact) reduces the answer’s completeness and reasoning depth. Thus, while factually aligned in parts, the answer lacks the full comparative analysis required for a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 424,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % stake in the Caspian Pipeline Consortium gives it access to a pipeline that can move roughly 1.4 million barrels of crude per day (1.2 million from Kazakhstan and 0.2 million from Russia), thereby expanding its export capacity (page 16). In contrast, ConocoPhillips’ upstream business is almost entirely driven by crude‑oil production itself – its results of operations focus on oil and gas production and exclude non‑oil and gas activities, underscoring that crude‑oil output is the core of its upstream operations (page 147).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and its role in expanding export capacity, and accurately contrasts this with ConocoPhillips' direct reliance on crude oil production. However, it introduces a figure of 1.4 million barrels per day (1.2 million from Kazakhstan and 0.2 million from Russia) that is not present in the ground truth. The original answer specifies only 1.2 million barrels per day from Kazakhstan, with no mention of Russian volumes or a total of 1.4 million. This overstatement of capacity and unsourced breakdown undermines quantitative accuracy. Additionally, the debottlenecking project completed in January 2023 and its connection to Chevron’s Future Growth Project (FGP) in 2025—key contextual details in the original—are omitted, reducing completeness. (2) The 1.2 million bpd figure aligns with the ground truth, but the addition of 0.2 million bpd from Russia lacks corroboration and may reflect incorrect inference or synthesis. The 15% stake is correctly stated. (3) The multi-hop reasoning is partially sound: the model correctly infers that pipeline access enhances export capacity and contrasts Chevron’s infrastructure-based exposure with ConocoPhillips’ production-centric model. However, it fails to mention the CPC debottlenecking project and its strategic timing with Chevron’s FGP, which is a critical link in the full causal chain. (4) Despite missing key details and introducing unverified numbers, the core qualitative comparison between indirect (CPC stake) vs. direct (production-driven) crude oil dependency is accurately conveyed, and the answer remains highly relevant to the question. Hence, correctness is reduced primarily due to quantitative inaccuracy and partial incompleteness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle’s MySQL HeatWave is a cloud‑managed database service that embeds generative‑AI, real‑time analytics and machine‑learning directly into OCI, letting customers run AI‑driven queries on the cloud. Qualcomm, meanwhile, is building on‑device generative‑AI into its low‑power AI Engine and Hexagon NPU, with a vision that privacy‑centric, low‑latency inference on smartphones, PCs, automotive and IoT devices will become ubiquitous, while still using its cloud‑processing initiative for model training and orchestration. Both firms invest heavily in cloud infrastructure—Oracle in OCI and Autonomous Database, Qualcomm in its cloud‑processing initiative—but Oracle’s AI is cloud‑centric, whereas Qualcomm’s strategy focuses on edge‑centric, on‑device generative AI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave on OCI, combining transactions, analytics, ML, and AI in a cloud-managed service. Qualcomm focuses on on-device generative AI via its AI Engine and Hexagon NPU for edge devices like smartphones and PCs, emphasizing privacy, low latency, and personalization. Both companies invest in cloud infrastructure—Oracle via OCI and Autonomous Database, Qualcomm through its cloud-processing initiative for training and orchestration. (2) Quantitative accuracy is perfect: while the LLM answer does not include the specific forecasted percentages (19% in 2024 and 46% in 2027 for generative AI-capable smartphones), this omission does not detract from the core correctness, as the question does not explicitly ask for those numbers. Their absence is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle’s cloud-centric AI integration and Qualcomm’s edge-centric AI vision, while acknowledging both companies’ cloud investments and the complementary role of cloud in edge AI. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM clearly distinguishes cloud vs. edge strategies and correctly identifies the complementary role of cloud computing for Qualcomm. Only a slight improvement in completeness (including the smartphone adoption projection) would make it perfect. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 452,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s firm commitments for inventory and utility purchases are legally binding contracts that lock in fixed or minimum quantities and price terms, giving the retailer predictable cash‑outflows and reducing supply‑chain cost volatility【page_45】. In contrast, Colgate‑Palmolive uses option contracts as part of its foreign‑currency hedging program, treating them as cash‑flow hedges of firmly committed and forecasted currency transactions to lock in favorable exchange rates while retaining upside potential【page_90】【page_92】. Both instruments mitigate cash‑flow risk, but Walmart targets supply‑chain cost certainty, whereas Colgate‑Palmolive targets currency‑exchange risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the LLM does not explicitly mention Walmart's $15.9 billion in firm commitments, this omission does not introduce inaccuracy—rather, it's a minor completeness gap. All other financial concepts (firm commitments, option contracts, cash-flow hedges) are correctly described without numerical errors. (2) The qualitative analysis is strong: the LLM correctly identifies Walmart’s use of firm commitments for inventory and utilities to ensure cost predictability and contrasts it with Colgate-Palmolive’s use of option contracts for foreign exchange risk, specifically as cash-flow hedges on forecasted transactions. The distinction in risk focus—supply chain cost certainty vs. currency-exchange risk—is semantically equivalent to the ground truth’s emphasis on operational liquidity planning vs. financial hedging. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies and two types of financial instruments, correctly attributing each to the appropriate risk management context. (4) Contextual relevance is excellent—the response directly addresses the comparison of instruments, their role in mitigating cash flow risks, and the strategic differences between the firms. The only reason for not scoring a 10 is the absence of the specific $15.9 billion figure from the original answer, which is a factual detail present in the ground truth and expected in a fully complete response. However, since the conceptual and comparative framework is accurate, the correctness score remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 442,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley uses credit‑default swaps (CDS) to hedge default risk by paying a periodic premium and receiving a payoff when a credit event occurs (see pages 111‑112).  Capital One, in valuing its net derivative assets, relies on default‑rate assumptions as a key unobservable input in the discounted‑cash‑flow models that determine fair value (see page 208).  Thus, both firms are highly sensitive to credit‑event outcomes: Morgan Stanley’s CDS position can trigger significant payouts, while Capital One’s net‑derivative valuation can rise or fall sharply as default‑rate assumptions change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core relationship between Morgan Stanley's use of CDS and Capital One's reliance on default rate assumptions. (1) All factual information is correct: Morgan Stanley uses CDS to hedge default risk by paying premiums and receiving payouts upon credit events, and Capital One relies on default rate assumptions as unobservable inputs in discounted cash flow models for valuing net derivative assets. (2) Quantitative accuracy is perfect—while the LLM does not explicitly state the 4% weighted average default rate or the 53–163% range mentioned in the ground truth, it correctly identifies that default-rate assumptions are key unobservable inputs, which aligns semantically. The omission of specific numbers is a minor gap but does not undermine the correctness, especially since the LLM may be summarizing without access to exact figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both institutions are sensitive to credit event outcomes—Morgan Stanley through direct CDS exposure and Capital One through model assumptions affecting valuation. (4) Contextual relevance is excellent, directly addressing the sensitivity of both firms to credit events and how their derivative positions are impacted. The answer could have been slightly stronger by including the specific default rate range to match the original answer’s depth, but the reasoning and synthesis remain robust and factually aligned. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 437,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s Georgia distribution system is part of a broader network that totals 35,700 mi of natural‑gas pipelines and 28,800 mi of service lines, giving it a large local‑scale asset base that supports reliability for Georgia customers. In contrast, Southern Company Gas’s 50‑percent stake in the 7,000‑mi SNG pipeline is a single, long‑distance asset that directly supplies Georgia (and other southeastern states) with diversified gas from Texas‑to‑Alabama basins, providing a major regional reliability source. Thus, while Duke’s network is larger in overall miles, the SNG pipeline is a key regional investment that enhances Georgia’s supply resilience through cross‑state connectivity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states Duke Energy has 35,700 miles of natural gas pipelines and 28,800 miles of service lines in Georgia, but the ground truth specifies 28,000 miles of natural gas distribution and transmission pipelines (no mention of service lines or a total of 35,700 miles). This overstatement of Duke's pipeline mileage undermines factual correctness. The 7,000-mile length of SNG is correctly reported, as is Southern Company Gas’s 50% stake. However, the LLM introduces 'Southern Power’s 97% investment coverage ratio through 2028'—a detail absent in the LLM answer—indicating a failure to include key financial context about revenue stability from the original answer. (2) Calculations are not performed in either answer, but the comparison of scale (Duke’s larger network vs. SNG’s regional backbone role) is qualitatively present, though based on incorrect numbers. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that Duke focuses on local distribution while SNG provides regional transmission supply, and that both contribute to reliability in different ways (local delivery vs. supply-side resilience). It captures the integrated nature of the infrastructure, though it fails to note that SNG feeds utilities like Duke, which is a key interdependency. (4) Contextual relevance is high—the answer addresses capital scale and reliability contribution in Georgia’s energy market. However, due to incorrect asset sizes and omission of contracted revenue stability (a critical financial metric from the original), the correctness score is limited to 6. The qualitative reasoning is reasonable but built on faulty data, and the absence of Southern Power’s investment coverage—a key indicator of financial resilience—reduces completeness and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 501,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Louisiana’s 2024 corporate‑tax‑rate cut lowered Union Pacific’s deferred tax expense by **$34 million**.  Arkansas enacted a similar law that, together with Louisiana’s, produced the same $34 million reduction – the combined impact of both states was a $34 million cut in deferred tax expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34 million reduction in deferred tax expense due to Louisiana's 2024 tax rate reduction, which matches the ground truth. However, it misrepresents the impact from Arkansas. The original answer states that Arkansas had a 'comparable adjustment' implying a similar magnitude of impact (likely around $34 million), but the LLM incorrectly states that the *combined* impact of both Louisiana and Arkansas was $34 million. This suggests Arkansas contributed nothing additional or that the $34M is shared, which contradicts the ground truth implying two separate, similar-sized adjustments. (2) The dollar amount ($34 million) and year (2024) are accurate, but the synthesis of the Arkansas impact introduces a quantitative error in aggregation. There is no indication in the ground truth that the total impact was $34M collectively; rather, Louisiana alone caused $34M, and Arkansas had a 'comparable' effect, suggesting an additional ~$34M. (3) The multi-hop reasoning fails in the comparison step: the model incorrectly merges two distinct, similarly sized impacts into a single combined figure, undermining the comparative analysis requested. It should have stated that both states independently led to similar reductions. (4) While the core fact about Louisiana is correct and contextually relevant, the erroneous aggregation reduces quantitative and qualitative accuracy. The answer remains relevant to the question but with flawed reasoning and incomplete correctness in comparative impact assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 426,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B shares carry ten votes each, giving those holders disproportionate influence over board and corporate decisions (META 10‑K, page 82). Alphabet’s Class A shares, in contrast, have only one vote per share, reflecting a standard one‑share‑one‑vote structure (GOOGL 10‑K, page 82). Alphabet’s 10‑K also notes that its Class B shares are subject to voting restrictions in merger or consolidation transactions—typically requiring a super‑majority or conversion before voting—so their influence on merger outcomes is curtailed, whereas Meta’s Class B holders can exert significant influence without such limits.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Meta's Class B shares carry ten votes each, which is false: according to the ground truth, Meta's Class B Common Stock has *no voting rights* except in specified merger or consolidation scenarios. This is a critical error that reverses the actual governance structure. (2) The claim that Alphabet's Class B shares have voting restrictions in merger scenarios is misleading—the original answer and SEC filings indicate that it is *Meta's* Class B shares that have limited, conditional voting rights in mergers, not Alphabet's. In fact, Alphabet's Class A shares have one vote per share, and Class B shares (held by insiders) have ten votes per share but are not subject to special merger-related voting restrictions as described. (3) The LLM inverts the core facts: it attributes strong voting power to Meta Class B (when they are mostly non-voting) and implies restrictions on Alphabet Class B in mergers (which are not present in the ground truth). (4) Multi-hop reasoning fails because the model misattributes voting rights and limitations to the wrong companies and share classes. While the answer addresses the general topic of voting differences and corporate governance, the factual foundation is incorrect. (5) Contextual relevance is moderate because the response engages with the question’s theme, but the inaccuracies render the analysis invalid. Quantitative accuracy is low due to incorrect vote counts (10 votes vs. 0 votes). Qualitative accuracy is poor due to incorrect entity-relation mapping. Correctness score is low because the answer conveys the opposite of the truth in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 465,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions on high‑cost therapies such as Repatha heighten the uncertainty around net‑to‑gross deductions for cardiovascular products, so Pfizer’s revenue‑recognition policy (see page 48) requires it to estimate higher rebates, chargebacks and potential timing delays.  Because both Pfizer and Amgen face formulary placement hurdles and patient‑affordability limits (Amgen’s risk factors on pages 41–42), Pfizer may accrue for possible adjustments and recognize revenue only when it is probable that the cumulative amount will not be reversed, mirroring the conservative approach Amgen adopts for its own high‑priced products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately identifies that U.S. payer restrictions on high-cost cardiovascular therapies like Repatha (marketed by Amgen) create challenges for formulary placement and patient affordability, which in turn affect revenue recognition through gross-to-net deductions. The reference to Pfizer’s revenue recognition policy and the need to estimate rebates, chargebacks, and timing delays is consistent with the original answer. (2) There are no explicit numerical values in either answer, so quantitative accuracy is not compromised—no calculations or figures are misstated. (3) The multi-hop reasoning is sound: it connects Amgen’s experience with Repatha to Pfizer’s potential challenges, recognizes the role of payer dynamics in revenue recognition, and infers that Pfizer may adopt a conservative approach similar to Amgen’s. However, a minor inaccuracy arises in attributing the conservative approach to Amgen directly in the context of revenue recognition strategy—while implied, the original answer emphasizes Gilead as the example company using complex gross-to-net deductions to account for payer dynamics, not Amgen. This subtle entity mix-up slightly weakens the qualitative accuracy. (4) Despite this, the LLM answer remains contextually relevant and semantically equivalent in intent and meaning, correctly conveying that payer restrictions necessitate careful estimation of deductions to ensure revenue integrity. The mention of specific page numbers (e.g., page 48, 41–42) suggests document grounding, though their accuracy cannot be verified here; however, they do not contradict the overall correctness. Thus, the answer earns a high score but not perfect due to the misattribution in the comparative example.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 496,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % interest in the Caspian Pipeline Consortium (CPC) gives it a proportional share of transport revenue from TCO’s Future Growth Project (FGP), which is slated to start‑up in 2025 and ramp up to full production within three months【page_16】. Because the stake is limited to the pipeline, Chevron’s exposure to the FGP ramp‑up is confined to that transport share, whereas ConocoPhillips (COP) uses crude oil as a core raw material for its refining and petrochemical units, so its exposure to crude supply is broader and integrated across its entire value chain【page_147】.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and the 2025 start-up of TCO's FGP project with a ramp-up period of three months, which aligns with the ground truth. However, it incorrectly frames Chevron's exposure as being solely through its CPC pipeline interest, while the original answer clarifies that Chevron has a 15% ownership stake in TCO itself — the entity undertaking the FGP — which provides direct, albeit partial, exposure to production increases. This is a significant omission that misrepresents the nature of Chevron's exposure. (2) Quantitatively, all numbers are accurate: 15%, 2025 start-up, three-month ramp-up — all match the ground truth. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) The multi-hop reasoning is partially sound: the model correctly links Chevron’s CPC stake to transport revenue and contrasts it with COP’s direct use of crude oil. However, it fails to synthesize the key point that Chevron’s 15% ownership in TCO — not just the pipeline — gives it equity-level exposure to production growth, which is central to the question. This undermines the qualitative accuracy of the reasoning. (4) Contextual relevance is high because the answer addresses the core comparison between Chevron’s indirect exposure and COP’s direct dependence on crude oil, and correctly highlights differences in value chain integration. The error lies in misattributing the source of Chevron’s exposure, reducing correctness and qualitative accuracy despite strong quantitative performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 427,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ commercial‑real‑estate lending is only 5 % hospitality, about $1.7 billion of hotel‑related loans and commitments (5 % of the $34.8 billion total commercial‑real‑estate exposure【page_118】).  \nMetLife, by contrast, holds $3.65 billion in real‑estate funds that include hotel assets among other property types (real‑estate funds represent 27.4 % of its real‑estate portfolio【page_94】).  \nBoth firms use real‑estate funds as a diversification and return‑generation tool, but GS’s hotel exposure is a small, direct loan component, whereas MetLife’s exposure is indirect and larger through its fund holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. According to the ground truth, MetLife holds $13.3 billion in total real estate investments, including interests in real estate funds focused on hotels. However, the LLM claims MetLife holds only $3.65 billion in real estate funds that include hotel assets—this figure does not match the ground truth and lacks sourcing from the correct context. Additionally, the LLM states that Goldman Sachs has $1.7 billion in hotel-related loans (5% of $34.8 billion), but this specific breakdown is not present in the original answer, which only states that Goldman Sachs has 'significant credit exposure' without quantifying it. These numbers appear fabricated or misattributed. (2) Calculations and percentages are internally consistent in the LLM answer (5% of $34.8B is ~$1.7B; $3.65B is ~27.4% of $13.3B), but since the underlying data does not align with the ground truth, the accuracy fails. The original answer does not provide a percentage or exact loan amount for Goldman Sachs, nor does it specify that only $3.65B of MetLife’s portfolio is in funds with hotel exposure. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that Goldman Sachs' exposure is primarily through lending while MetLife's is through fund investments, which aligns with the strategic distinction in the original answer. However, the failure to accurately represent the magnitude and sourcing of exposures undermines the reasoning. (4) Contextual relevance is strong because the answer addresses the comparative exposure, distinguishes between lending and ownership, and references real estate funds in strategy. However, due to major quantitative errors and lack of fidelity to the ground truth data, the correctness score is low. The answer creates a false sense of precision with incorrect numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 513,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "BA’s limited‑partnership holdings are highly illiquid – redemption is only possible at the end of the partnership term, which typically lasts 10–15 years, and the company has about $3.3 billion of unfunded commitments that will be called over the next 3–6 years. UPS’s pension plan likewise invests in real‑estate LPs with long‑term horizons, and its $3.3 billion of unfunded obligations represents a comparable liquidity constraint that the plan must meet over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that both BA and UPS have liquidity risks tied to limited partnerships with 10–15 year terms and $3.3 billion in unfunded commitments. However, it incorrectly attributes the $3.3 billion unfunded amount to BA, while the ground truth states this figure applies only to UPS's pension fund. BA's unfunded commitments are not specified in the original answer, so assigning $3.3 billion to BA is a factual error. 2) Quantitatively, the $3.3 billion figure is accurate for UPS, but its misassignment to BA undermines numerical accuracy. Additionally, the LLM introduces a new time frame—'called over the next 3–6 years'—which is not present in the original answer and lacks support from the ground truth. 3) The qualitative reasoning is strong: the model correctly synthesizes the structural illiquidity of limited partnerships, recognizes the parallel between BA and UPS, and draws a valid comparison in terms of long-term liquidity constraints. The core logic about redemption restrictions and long-term exposure is sound and reflects multi-hop understanding. 4) Contextual relevance is perfect—the response directly addresses the comparison of liquidity risk profiles, focusing on partnership terms and unfunded obligations as required. Despite the quantitative misattribution, the overall explanation aligns well with the intent and substance of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 385,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Both companies use a dual‑class structure that concentrates voting power in Class B shares held by the CEO and other insiders.  Comcast’s Class B shares carry 15 votes each and represent about 33 % of total voting power, giving insiders a majority of control (CMCSA p. 33).  Meta’s Class B shares carry 10 votes each and likewise give insiders a concentrated majority, though the exact percentage of voting power is not disclosed (Meta p. 49).  Thus, while both structures limit shareholder influence, Comcast’s Class B shares have a higher vote multiplier and a clearly defined voting‑power split.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that CMCSA's Class B shares represent about 33% of total voting power—this is wrong. According to the ground truth, CMCSA's Class A shares hold 66 2/3% of voting power, meaning Class B (held by Brian L. Roberts) holds the remaining 33 1/3%, not 33% as implied. More critically, the LLM reverses the vote multipliers: it claims Meta’s Class B shares have 10 votes and CMCSA’s have 15, but the ground truth indicates CMCSA’s Class B shares have 15 votes (correct), while Meta’s Class B shares have *10 times* the voting power of Class A (not explicitly stated as '10 votes'), which the LLM misrepresents. Additionally, the LLM fails to mention Meta’s anti-takeover provision requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of voting power—a key differentiator in control concentration. It also omits that CMCSA’s Class B stock is non-dilutable, a critical feature enhancing control. (2) Quantitative accuracy is low: the 10-vote claim for Meta is unsupported in the ground truth (which states differential voting rights but not exact vote counts per share class), and the 33% figure for CMCSA Class B is approximate but misleading without the precise 33 1/3% split. The LLM incorrectly implies symmetry in voting power distribution when the ground truth emphasizes structural differences. (3) Multi-hop reasoning is partially sound—the model correctly identifies dual-class structures at both firms and links them to insider control—but fails to synthesize key governance differences that affect shareholder influence, such as Meta’s stricter anti-takeover rules and CMCSA’s non-dilutable provision. (4) Contextual relevance is high as the answer addresses the core comparison of voting structures and control concentration. However, due to significant factual errors and omissions in critical differentiating factors, the correctness score is moderate. The answer captures the general idea but lacks precision and misses key nuances that define the comparative governance landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 573,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan assets allocate roughly 16 % to government securities (US$1.8 bn of $11.2 bn in 2023) as part of a diversified mix that targets a 7.4 % expected return on plan assets and uses active management and derivatives to manage interest‑rate and currency risk. In contrast, COST’s short‑term holdings are almost entirely fixed‑rate U.S. government and agency securities, with the stated goal of preserving principal and generating modest yields; the company limits risk by investing only in high‑quality, liquid instruments and does not pursue higher‑return, higher‑risk assets. Thus, PEP pursues a higher‑return, diversified strategy, whereas COST adopts a conservative, liquidity‑focused approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns well with the ground truth. It accurately states PEP's $1.8 billion allocation to government securities in 2023 (rounded from $1.812 billion), correctly notes the 7.4% expected return target, and accurately contrasts PEP's diversified, actively managed strategy using derivatives with COST's conservative, principal-preserving approach focused on short-term, high-quality government and agency securities. The percentage allocation (16%) is a reasonable approximation based on the total plan assets implied ($1.8B / $11.2B ≈ 16%), though this total asset figure is not in the original answer but is consistent with external knowledge. (2) Quantitative accuracy is high: $1.8 billion is an acceptable rounding of $1.812 billion; the 7.4% return target is exact; the absence of specific numbers for COST is justified as the original answer does not provide exact dollar amounts for COST’s holdings. The LLM correctly avoids making up figures. (3) Multi-hop reasoning is sound: the model synthesizes information across PEP’s long-term defined benefit plan strategy and COST’s short-term investment policy, correctly contrasting risk management (derivatives and active management vs. fixed-rate, short-duration instruments) and return objectives (7.4% target vs. capital preservation). (4) The answer is contextually relevant, directly addressing the comparison in terms of risk management and expected return strategy. The only minor shortcoming is the introduction of a total plan asset value ($11.2B) not present in the original answer, which, while plausible, is an inference. This prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 483,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s fixed‑income portfolio contains $9 million in mortgage‑ and asset‑backed securities, which is about 39 % of its $23 million fixed‑income allocation (actual allocation 23 million)【page_296】.  \nNextEra Energy’s target allocation framework sets fixed‑income investments at 32 % of the total portfolio【page_101】.  \nThus, Southern Company’s mortgage‑backed securities allocation is proportionally higher than NextEra Energy’s overall target allocation for fixed income.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. It incorrectly states that Southern Company's fixed-income portfolio is $23 million, when the ground truth reports $6,154 million. It also claims that $9 million in mortgage-backed securities represents about 39% of this portfolio, which is mathematically incorrect (9/23 ≈ 39%, but 9/6,154 ≈ 0.15%). The correct proportion is less than 0.15%, not 39%. (2) The calculation of Southern Company’s allocation is fundamentally wrong due to the use of an incorrect total portfolio size. The LLM appears to have misread or misextracted the total fixed income amount, leading to a grossly inflated percentage. (3) While the LLM correctly identifies that NextEra Energy targets 32% allocation to fixed income investments, it fails to clarify that this is a target for total fixed income within a broader pension asset strategy, not a target specifically for mortgage-backed securities. The comparison drawn — that Southern Company’s mortgage-backed allocation is 'proportionally higher' than NextEra’s overall fixed income target — is therefore misleading and logically flawed. (4) The answer incorrectly combines asset-backed and mortgage-backed securities as if they were a single category in Southern Company’s data, while the ground truth specifies only mortgage-backed securities. Additionally, the LLM omits key qualitative details such as valuation methods and investment structures used by both companies. Despite addressing both companies and the general topic of fixed income allocation, the severe numerical inaccuracies and flawed reasoning result in a very low correctness score. Contextual relevance is moderate because the structure and intent align with the question, but factual content is largely incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 487,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic formalized a series of documents for the Gigafactory: a supply agreement dated Oct 5 2011 (with subsequent amendments and a production‑pricing agreement) and specific pricing agreements— the 2019 Pricing Agreement (Japan Cells) tied to the original supply contract, the 2020 Pricing Agreement for Gigafactory 2170 cells, and a 2021 Pricing Agreement (Japan Cells). These agreements set the pricing, volume, and supply terms for battery cells at the Gigafactory. In contrast, GM’s battery supply is integrated through its joint venture Ultium Cells Holdings LLC with LG Energy Solution, to which GM has made substantial capital commitments, indicating a deeper, more integrated contractual relationship than Tesla’s separate pricing and supply arrangements.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies in dates and agreements, affecting overall correctness. (1) Quantitatively, the LLM incorrectly cites a 2011 supply agreement and a 2019 Pricing Agreement (Japan Cells), which are not present in the ground truth; the correct agreements are the Amended and Restated General Terms (June 10, 2020), 2020 Pricing Agreement (Gigafactory 2170 Cells), and 2021 Pricing Agreement (Japan Cells). The mention of a 2019 agreement and 2011 contract (with amendments) is unsupported by the provided truth. (2) The LLM incorrectly characterizes Tesla’s relationship with Panasonic as involving a 'production-pricing agreement' and a long-standing supply contract from 2011, which misrepresents the structure and timeline of the partnership. (3) Regarding GM, the LLM claims a 'deeper, more integrated contractual relationship' via Ultium Cells LLC with LG Energy Solution and 'substantial capital commitments', but the ground truth states that no equivalent supplier integration details or specific contractual commitments are available for GM, making this a significant overstatement. The truth only notes GM’s dependency without confirming depth or transparency. (4) The reasoning is flawed in the comparison: the LLM concludes GM has deeper integration, while the ground truth indicates Tesla’s agreements are more explicitly documented and thus more transparent, making Tesla’s partnership appear more structured. This reverses the correct inference. (5) Despite these errors, the answer addresses both parts of the question and correctly identifies key entities (Tesla, Panasonic, GM, Ultium Cells LLC, LG Energy Solution) and the general nature of pricing and supply arrangements. The contextual relevance is high as it attempts multi-hop synthesis between Tesla-Panasonic and GM’s battery strategies. However, due to incorrect dates, fabricated agreements, and a logically inverted comparison, the answer is only partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 543,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s exposure in Nigeria is primarily a tax‑audit risk: the company’s last completed examination in that jurisdiction was in 2007, and it still has unresolved tax positions that could materially alter its unrecognized tax benefits (see Chevron 10‑K, page 82).  Exxon’s risk is contractual: its production‑sharing contracts in Nigeria are 30‑year agreements that include a 10‑year exploration phase, a mandatory 50 % relinquishment at the end of that phase, and a 20‑year production period that may be extended, meaning that failure to meet the PSC terms or renegotiation could curtail production rights and revenue (see ExxonMobil 10‑K, page 32).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's tax-audit risk in Nigeria with an open audit cycle since 2007 and references unresolved tax positions and unrecognized tax benefits, aligning with the ground truth. However, it omits the specific dollar amount of $5,288 million in unrecognized tax benefits at year-end 2021, which is a significant quantitative omission. This missing figure reduces quantitative accuracy. (2) Regarding Exxon, the LLM correctly describes the 30-year PSC structure with a 10-year exploration and 20-year production period, and notes potential extension. However, it incorrectly states a 'mandatory 50% relinquishment' at the end of the exploration phase, which is not present in the original answer or standard public disclosures; the ground truth does not mention relinquishment terms. Additionally, the LLM fails to include the key fact that 12% of Exxon’s total proved reserves in 2021 were under PSCs and that production volumes under these contracts fluctuate inversely with price changes—important context for understanding the nature of Exxon’s exposure. (3) The multi-hop reasoning is partially sound: the model correctly distinguishes between Chevron’s tax-related regulatory risk and Exxon’s contractual/operational risk, which reflects valid synthesis. However, the absence of key financial figures and inclusion of unverified contractual details (relinquishment) weakens the reasoning chain. (4) Despite these issues, the answer remains contextually relevant and captures the core contrast in risk types between the two companies. Wording and structure are clear and citation references (page numbers) add credibility, though they don’t compensate for missing or inaccurate data. Thus, correctness is reduced primarily due to missing quantitative data and one incorrect contractual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 499,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reports $470 million of commercial paper as part of its cash and cash‑equivalent short‑term investments (a short‑term asset)【page 72】, whereas Duke Energy Ohio lists only $25 million of commercial paper as a short‑term liability (classified as long‑term debt) used to finance operations【page 165】.  The Ohio subsidiary’s commercial‑paper program has a weighted‑average maturity of roughly 15 days【page 164 note d】, while Tesla’s commercial paper is held for a similar short‑term horizon.  In short, Tesla’s commercial paper is far larger in dollar terms and is an investment, whereas Duke Energy Ohio’s commercial paper is a modest borrowing for liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Tesla's $470 million and Duke Energy Ohio's $25 million are accurately reported, with proper context on timing (as of December 31, 2023, implied by source documents). Format variations (e.g., $470 million) are acceptable. (2) The answer correctly identifies the entities—Tesla and Duke Energy Ohio—and the relevant financial metric (commercial paper), with correct years and classifications. (3) The reasoning is strong and reflects multi-hop synthesis: it distinguishes between Tesla holding commercial paper as a short-term investment (asset) versus Duke Energy Ohio issuing it as a liability (debt), which is a critical qualitative difference not explicitly stated in the original answer but correctly inferred. The added detail about Duke Energy Ohio’s weighted-average maturity of 15 days (from note d, page 164) enhances accuracy but is not required for correctness. (4) The semantic meaning fully matches the original answer—highlighting different uses of commercial paper (investment vs. financing)—with improved nuance. The only reason for not scoring 10 is that the original answer does not mention the maturity detail or classification as long-term debt, so including it, while accurate, slightly exceeds the ground truth without changing the core correctness. Overall, the response is factually sound, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 404,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework (page 148) explains that transition‑risk drivers—such as policy shifts, new technologies and changing consumer preferences—can amplify credit, market and liquidity risk **and expose the firm to heightened compliance risk through increased regulatory scrutiny and potential litigation**. In contrast, Morgan Stanley’s risk disclosures (pages 78‑80) show that the firm’s compliance risk is already being tested by regulators through climate‑related disclosure requirements, indicating a direct regulatory focus on its reporting practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JPMorgan views transition risk as amplifying compliance risk due to regulatory scrutiny and potential litigation, referencing its climate-risk framework (page 148), which matches the original answer's claim about JPMorgan integrating climate risk into its broader risk management. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two firms—JPMorgan and Morgan Stanley—comparing how each links transition risk to compliance risk. It accurately notes that Morgan Stanley is already experiencing regulatory scrutiny related to disclosure practices (pages 78–80), which reflects the original answer’s point about Morgan Stanley facing legal, reputational, and compliance risks from regulatory enforcement. (4) The only minor shortcoming is that the LLM does not explicitly mention JPMorgan’s proactive integration of climate risk via stress testing and metrics, nor does it fully mirror the contrast in emphasis (JPMorgan on internal frameworks vs. Morgan Stanley on regulatory enforcement). However, the core contrast—JPMorgan highlighting compliance risk as a consequence of transition risk, and Morgan Stanley experiencing actual regulatory focus on disclosures—is preserved. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned with only minor omissions in depth of comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 452,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s 30‑year PSC framework – a 10‑year exploration phase followed by a 20‑year production phase with mandatory partial relinquishment – means ConocoPhillips’ deepwater operations in the country must operate under a fixed‑term contract that dictates exploration, production, and relinquishment obligations, shaping project timelines and financial reporting (page_32). For Chevron, the same 30‑year PSC structure requires reserves in Nigeria to be reported under the economic‑interest method for PSCs, affecting the timing of reserve recognition, the need to adjust for partial relinquishment, and the potential for reserve revisions and extensions that are reflected in their reported reserve balances and discounted‑cash‑flow calculations (page_107, page_151).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 30-year PSC structure, 10-year exploration and 20-year production phases, and the mention of partial relinquishment under Nigeria's regulatory framework are all consistent with the original answer. While the original answer notes Chevron reports 8-10% of reserves tied to PSCs, the LLM answer does not include this specific percentage but instead elaborates on accounting methods (economic-interest method) and impacts on reserve recognition and DCF calculations, which is a valid and relevant detail not contradicted by the ground truth. (2) The LLM correctly identifies both ConocoPhillips and Chevron, their operational and accounting implications, and ties them to the PSC structure. (3) Multi-hop reasoning is sound: it connects Nigeria's PSC framework to ConocoPhillips' operational planning and Chevron's reserve accounting practices, synthesizing regulatory terms with company-specific reporting requirements. (4) The LLM adds value by referencing specific accounting methods (economic-interest method) and financial reporting impacts (discounted cash flow, reserve revisions), which are logically implied by the original answer’s focus on reserve accounting. The only minor shortcoming is the omission of the explicit 8-10% reserve percentage for Chevron, which slightly reduces completeness but does not detract from the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing both companies and the implications of the PSC framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 447,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing’s 37 % of revenue comes from U.S. government contracts, so any government‑initiated contract modification—such as changes in procurement rules or funding—must be evaluated under ASU 2022‑06 if it involves a reference‑rate change, but the company notes the standard has no material impact on its financial statements (see page 14). FedEx applies ASU 2022‑06 to contracts that reference LIBOR, reports that the standard has not materially affected its results, and continues to monitor contracts for potential application (see page 93). Thus, both firms use the standard to manage reference‑rate reform, but Boeing’s exposure to government contract modifications adds an extra regulatory‑monitoring layer, whereas FedEx’s focus is on the direct impact of reference‑rate changes on its contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 37% revenue exposure for Boeing is correctly stated, and both companies' lack of material impact from ASU 2022-06 is accurately reported. The fiscal date (May 31, 2024) in the original answer is not contradicted, and the LLM correctly notes the ongoing monitoring through 2024. (2) All numeric values are correct and contextually appropriate; no calculation errors exist. (3) The multi-hop reasoning is sound: the LLM correctly distinguishes Boeing’s exposure to U.S. government contract modifications as a contextual factor influencing its application of ASU 2022-06, while recognizing that FedEx applies the same standard to LIBOR-related contract changes without government contract exposure. It correctly synthesizes that both companies report no material financial impact. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'extended sunset date of ASU 2022-06 through 2024' as a shared benefit, though this is implied in the continued monitoring. Wording differs slightly (e.g., 'extra regulatory-monitoring layer' is interpretive but reasonable), but semantic equivalence is maintained. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 362,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil’s offshore acreage in Angola was 2.9 million net acres at year‑end 2021.  Chevron’s stake in Angola LNG is a share of that LNG project that helped drive its $8.5 billion international upstream earnings in 2021, but the exact ownership percentage is not disclosed in the pages provided.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states ExxonMobil's 2.9 million net offshore acres in Angola at year-end 2021, which matches the ground truth. It also correctly notes Chevron's stake in Angola LNG contributing to upstream earnings in 2021. However, the LLM introduces a specific figure of $8.5 billion in international upstream earnings, which is not present in the original answer or supported by the provided context—this number is unverified and potentially inaccurate, though the general link between Angola LNG and upstream earnings is valid. (2) The 2.9 million acre figure is accurate and properly attributed. The $8.5 billion figure is a quantitative overreach not found in the ground truth, reducing quantitative accuracy slightly. (3) The multi-hop reasoning is mostly sound: the model connects ExxonMobil's acreage with Chevron's asset in Angola and links Angola LNG to upstream earnings. However, it adds unsupported specificity by quantifying earnings, which weakens the qualitative accuracy. The original answer emphasizes that Chevron’s volumes reflect its share through affiliates like Angola LNG without citing total earnings. (4) Despite the extraneous dollar figure, the LLM addresses the core comparison: ExxonMobil’s physical asset (acreage) vs. Chevron’s financial interest in a project. The answer remains contextually relevant and semantically close to the original, with only minor overprecision marring an otherwise correct synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 404,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent **$6.6 billion** on 46 strategic acquisitions in fiscal 2024 to scale its industry solutions.  \nMicrosoft’s **enterprise and partner services** (which include industry solutions) generated **$7.594 billion** in revenue in the same year.  \nThus, Accenture’s acquisition spend is roughly $1 billion—or about 87%—of Microsoft’s revenue from that service segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Accenture's $6.6 billion investment in 46 acquisitions and Microsoft's $7.594 billion in enterprise and partner services revenue for fiscal 2024, both of which match the ground truth. The comparison statement that Accenture’s spend is 'roughly $1 billion—or about 87%—of Microsoft’s revenue' contains a minor calculation inaccuracy: $6.6B / $7.594B ≈ 86.9%, which rounds to 87%, so this is acceptable. However, saying 'roughly $1 billion' less is misleading—it implies $1B difference in absolute terms (which is correct: $7.594B - $6.6B = $0.994B ≈ $1B), but the phrasing '87%' refers to Accenture’s spend as a percentage of Microsoft’s revenue, not the difference. This could confuse readers but does not invalidate the core quantitative accuracy.\n\n2) All numbers are factually correct: $6.6 billion (Accenture investment), 46 acquisitions, Microsoft’s $7.594 billion revenue from 'Enterprise and partner services', and the inclusion of industry solutions in that segment are all accurate. The fiscal year 2024 is correctly referenced.\n\n3) The multi-hop reasoning is sound—information from two different companies and financial contexts (investment vs. revenue) is correctly synthesized to compare strategic approaches. The LLM identifies that Accenture is investing heavily while Microsoft is generating revenue from a related domain, which aligns with the ground truth’s interpretation.\n\n4) The semantic meaning is equivalent to the original answer. While the LLM omits the explicit commentary on 'differing strategic approaches', it implies it through the comparison. The core facts, entities, timeframes, and metrics are all correct and well-contextualized. The minor phrasing ambiguity in the percentage/difference comparison prevents a perfect 10, but overall accuracy is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 494,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio’s FERC‑approved dividend policy requires its equity—after push‑down accounting adjustments—to stay above 30 % of total capital, illustrating how regulatory approval can impose equity‑maintenance constraints that limit dividend payouts (page 147).  Southern Company can use this precedent when structuring its capital for the $1.5 billion (50 % of the $3 billion) SNG pipeline share (page 92), ensuring its equity ratio remains above any FERC‑mandated threshold and that dividend or debt decisions are aligned with regulatory expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's 30% equity threshold is accurately cited, and Southern Company's 50% share of the $3 billion SNG pipeline is correctly calculated as $1.5 billion. No calculation errors. (2) The entities are correctly identified: Duke Energy Ohio, Southern Company Gas, SNG pipeline, FERC, and PUCO (implied via regulatory context) are all appropriately referenced. (3) The reasoning is sound and reflects multi-hop synthesis: the model connects Duke Energy’s precedent of equity maintenance under FERC-approved policies to Southern Company’s need to plan capital structure for a similarly regulated project. It correctly infers that Southern Company can use Duke’s experience as a regulatory benchmark. (4) The only minor shortcoming is that the LLM does not explicitly mention 'push-down accounting adjustments' as part of the equity definition in the context of Southern Company’s planning, though it does reference it for Duke. Also, the original answer notes Southern Company Gas specifically, while the LLM refers more generally to Southern Company—still acceptable given context. Overall, the answer captures the core insight and financial logic with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 359,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS discloses that corporate debt securities are measured at Level 2 fair value and are priced using “matrix pricing, yield curves or indices” when broker quotes are not available (UPS 10‑K, p. 89‑93).  In contrast, MMM’s valuation policy for corporate debt instruments relies on observable yields on comparable securities or a discounted‑cash‑flow model and does not mention matrix pricing (MMM 10‑K, p. 101).  Thus, UPS explicitly applies matrix pricing as a Level‑2 input, whereas MMM uses alternative observable inputs and DCF rather than matrix pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partial factual accuracy regarding UPS's use of matrix pricing for corporate debt instruments, correctly identifying that UPS categorizes these instruments under Level 2 and uses matrix pricing when broker quotes are unavailable (supported by UPS 10-K, p. 89–93). However, the answer incorrectly states that MMM does not mention matrix pricing and instead relies solely on observable yields or discounted cash flow models. This contradicts the ground truth, which confirms that MMM *does* use matrix pricing when broker quotes are unavailable, but additionally adjusts for non-observable risks like credit and liquidity—nuance that the LLM omits. The LLM’s claim that MMM does not use matrix pricing is factually incorrect based on the original answer derived from the knowledge graph. This major error in entity methodology comparison undermines the multi-hop reasoning required to contrast the two companies’ approaches. While the answer references correct document locations and uses appropriate financial terminology, the core comparative analysis is flawed. The reasoning fails to capture the key similarity (both use matrix pricing as a fallback) and the key difference (MMM adjusts for non-observable risks, UPS does not). Therefore, despite correct formatting and some accurate details, the answer is substantially incorrect in its central claim, warranting a low correctness score. Quantitative accuracy is higher because there are no numerical values to assess, and the cited page numbers and methods (e.g., DCF, yield curves) are plausibly referenced. Contextual relevance is moderate as the response addresses the topic and structure of the question but draws an incorrect conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 466,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "VZ’s 2024 deal with Vertical Bridge was a sale‑leaseback: Verizon received a $2.8 billion upfront payment, recorded a $2.0 billion prepaid‑rent and an $830 million financing obligation for the towers it still occupies, and it keeps operational control over that portion while leasing the rest to Vertical Bridge. In contrast, T’s 2013 Crown Castle transaction was a sale of 627 towers for $4.827 billion, but because control was not transferred, T treated the proceeds as a financing obligation and continued to own and sublease space on the towers, retaining operational control over the assets it still owned.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $2.8 billion upfront payment from Vertical Bridge to VZ in 2024, split into $2.0 billion in prepaid rent and $830 million financing obligation, matches the original answer. The T-Crown Castle 2013 transaction amount of $4.827 billion is correctly stated. (2) Quantitative accuracy is perfect: all dollar amounts and dates are correct, and no calculations are required beyond accurate reporting. (3) The qualitative reasoning is sound: the LLM correctly identifies both transactions as financing in substance due to retained control, explains the sale-leaseback structure for VZ, and notes T's continued ownership and subleasing. It accurately contrasts VZ's dual accounting treatment with T's single financing obligation. (4) The only minor omission is that the original answer includes the detail that T continued to depreciate the tower assets ($608 million at end of 2024) and specifies the interest rate (~3.9%), which the LLM omits. However, this does not undermine the core comparison on financing structure and operational control. The answer is semantically equivalent and contextually fully relevant, with excellent multi-hop synthesis between two companies, two transactions, and two time periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 366,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "MRK’s IRS examination of its 2017‑18 returns, which includes the one‑time TCJA transition tax, could trigger a significant but unspecified tax liability if the IRS disagrees with the company’s position (MRK page 127).  By contrast, Medtronic’s 2024 BEAT tax impact is a defined minimum tax of roughly $14.5 million—0.3 % of its $4.837 billion pre‑tax income—and is fully reflected in the current tax expense (MDT page 85).  Thus, MRK faces an uncertain, potentially large liability, whereas MDT’s BEAT-related tax impact is a known, relatively modest amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MRK's potential tax liability from the IRS examination of its TCJA transition tax position as uncertain but potentially significant, and contrasts it with MDT's defined BEAT impact in 2024. The core facts—MRK's exposure tied to IRS disagreement, MDT's 0.3% effective tax rate increase due to BEAT, and the conceptual link to TCJA's BEAT provision—are all accurate and align with the ground truth. (2) Quantitatively, the LLM states MDT’s BEAT impact as $14.5 million, which is consistent with 0.3% of $4.837 billion (0.003 × 4,837 = ~14.511), so the calculation is correct. While the ground truth mentions MRK’s unrecognized tax benefits of $2.3 billion as of December 31, 2024, the LLM does not include this specific figure, instead describing the liability as 'unspecified'—a minor omission but not factually incorrect, as the exact amount may not be disclosed. All other numbers (percentages, pre-tax income) are accurately reported. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across MRK and MDT, links the TCJA to both companies’ tax exposures, distinguishes between uncertain contingent liability (MRK) and a known current expense (MDT), and contextualizes BEAT as part of the TCJA framework. (4) The answer is contextually fully relevant, directly comparing the two companies’ tax impacts as requested. The only reason for not scoring a 10 is the omission of MRK’s $2.3 billion unrecognized tax benefits, which is a material figure in the ground truth and would have strengthened completeness. However, since the LLM does not misstate anything and uses 'potentially large liability' appropriately, the correctness score is 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 472,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s 30‑year production‑sharing contract (PSC) framework—comprising a 10‑year exploration phase followed by a 20‑year production period with partial relinquishment (page 152)—means ConocoPhillips can only operate in Nigeria through PSCs with NNPC, limiting its footprint to the areas where such contracts exist and requiring it to plan for relinquishment and potential extensions. For Chevron, the same framework shapes its Africa reserve disclosures because a portion of its African proved reserves are derived from PSCs and must be reported under the economic‑interest method, with the 30‑year term influencing the timing and classification of those reserves (page 106).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production period is accurately described, and partial relinquishment at the end of exploration is correctly noted. ConocoPhillips' operational presence under this framework is properly contextualized, as is Chevron's reserve reporting implications. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the LLM does not explicitly state Chevron's 2021 African reserves as 106 million barrels, this omission does not constitute a factual error—rather, a slight incompleteness. The focus on reserve classification and reporting method (economic-interest) adds valuable detail not in the original but consistent with it. (3) Multi-hop reasoning is sound: the model correctly links Nigeria’s PSC structure to ConocoPhillips’ operational constraints and to Chevron’s reserve disclosure practices, demonstrating synthesis across regulatory, operational, and accounting domains. (4) The answer is contextually precise and directly addresses how the PSC framework influences both companies. The only reason for not scoring a 10 is the absence of the specific 106 million barrel figure for Chevron’s African reserves, which was present in the ground truth and would have strengthened quantitative completeness. However, since the question does not explicitly ask for the number, and the LLM correctly explains the influence on disclosures, this is a minor gap. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 449,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred stock is granted **limited voting rights**—holders may vote only on a narrow set of matters (e.g., certain mergers or restructurings) and do so as a single class equal to the number of shares held (page 90). In contrast, Netflix’s common stock follows a **one‑share‑one‑vote** policy, giving every share equal voting power on all matters (page 61). Thus, AT&T’s preferred holders have restricted influence on restructuring unless those specific matters arise, while Netflix shareholders can directly vote on all restructuring proposals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that AT&T’s Series C Preferred Stockholders have limited voting rights, exercisable only in specific scenarios like mergers or restructurings, and that Netflix follows a one-share-one-vote model. These key facts match the original answer. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts governance structures across two companies and links them to implications for restructuring decisions. The only minor shortcoming is that the LLM answer does not explicitly mention that AT&T’s preferred stockholders vote as a separate class requiring approval in restructuring events that affect their equity—this nuance is in the ground truth but only implied in the LLM response. (4) Despite this slight omission, the core comparison is accurate, complete, and contextually relevant, with appropriate emphasis on governance differences and their impact on shareholder influence in restructuring. Wording differs but meaning is preserved. Hence, correctness is high but not perfect—justifying a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 358,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel portfolio contains composition patents that expire on 11/22/2028 and 4/24/2029, with a later formulation patent extending to 10/19/2037 (Pfizer 10‑K, page 11). These expirations mean that, unless Pfizer secures additional patents or relies on regulatory exclusivity, the product will likely face biosimilar competition by the late‑2020s, prompting a shift toward new indications, combination therapies, or accelerated patent‑term restoration to extend protection. AbbVie routinely pursues Hatch‑Waxman patent‑term restoration and the 12‑year BPCI exclusivity for biologics, allowing it to maintain market exclusivity for a longer period and shape its long‑term revenue strategy around extended protection rather than early generics competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all patent expiration dates are correct: composition patents expiring in 2028 and 2029, and formulation patent in 2037, matching the original answer’s timeline. The specific dates (11/22/2028, 4/24/2029, 10/19/2037) are more precise than the ground truth’s years-only format, but consistent with likely source data from Pfizer’s 10-K, so this is an acceptable enhancement. (2) The answer correctly identifies AbbVie’s use of Hatch-Waxman patent-term restoration and the 12-year BPCIA exclusivity (implied in the original answer via '14 years total post-approval exclusivity'), showing strong entity and concept accuracy. (3) Multi-hop reasoning is sound: it connects Enbrel’s staggered patent expirations to biosimilar risk, contrasts Pfizer’s current position with AbbVie’s aggressive lifecycle management, and infers strategic implications for Pfizer’s revenue planning. (4) The only minor gap is that the original answer explicitly mentions the possibility of patent term restoration adding up to 5 years under Hatch-Waxman and a potential 14-year total exclusivity window—details slightly more developed than the LLM’s general reference to 'patent-term restoration'. However, the LLM captures the strategic essence and correctly implies Pfizer may need to act similarly. Wording differs but semantic equivalence is strong. No factual errors; minor omission of the 5-year extension detail prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 423,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore refinery produces about **1.9 million metric tons of ethylene per year** (see XOM_10k_2024 page 27).  \nChevron’s indirect 32.77 % stake in the Map Ta Phut Olefins joint venture supports a facility that manufactures ethylene, but the joint‑venture’s ethylene capacity is **not disclosed in the provided excerpts** (see CVX_10k_2024 page 15).  Consequently, a direct numerical comparison cannot be made from the supplied documents.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports ExxonMobil's ethylene production capacity in Singapore as 1.9 million metric tons per year, which matches the ground truth. It also correctly states Chevron's indirect ownership stake in the Map Ta Phut Olefins joint venture as 32.77%, with a proper citation. (2) The answer acknowledges that while the joint venture manufactures ethylene, the exact capacity is not disclosed in the provided documents—this aligns precisely with the original answer, which notes that the attributable capacity is unspecified. (3) The reasoning is sound and multi-hop: it correctly identifies two separate facilities (ExxonMobil Singapore and Map Ta Phut in Thailand), distinguishes direct vs. indirect capacity, and explains why a numerical comparison cannot be made—despite having one side of the comparison (ExxonMobil) quantified. (4) The LLM maintains semantic equivalence with the original answer, uses appropriate qualifiers, and avoids overstatement. All entities (ExxonMobil, Chevron, Map Ta Phut Olefins, Singapore facility) and document citations (XOM_10k_2024, CVX_10k_2024) are accurate. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 351,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company’s disallowance of capital investments at Nicor Gas in Illinois produced a pre‑tax charge of about **$96 million** (≈$72 million after tax).  \nIn contrast, NextEra Energy’s physical footprint in Illinois is modest – it operates roughly **90 miles of rate‑regulated transmission lines** in the state. Thus, the financial hit from the disallowance is a large monetary impact, while the scale of NextEra’s infrastructure in Illinois is measured in a relatively small mileage of transmission assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the scale of NextEra Energy's infrastructure. It claims NextEra operates '90 miles of rate-regulated transmission lines' in Illinois, while the ground truth states that NextEra operates '90 thousand miles of transmission lines' across multiple states, including Illinois. This is a 1,000-fold underestimation of the infrastructure scale. The $96 million pre-tax charge for Southern Company is correctly stated, and the after-tax estimate of $72 million is a reasonable inference, though not in the original answer. (2) Quantitative accuracy is severely compromised due to the '90 miles' vs '90 thousand miles' error. This mistake invalidates the comparison between the financial impact and infrastructure scale. The original answer emphasizes that NextEra’s footprint is large and spans multiple states, with Illinois included, but does not isolate the exact mileage in Illinois—so the LLM’s precise claim about Illinois alone is unsupported and incorrect. (3) The multi-hop reasoning fails because the LLM incorrectly minimizes NextEra’s infrastructure footprint, leading to a flawed conclusion that the financial impact is large relative to a 'small' infrastructure. In reality, the original answer contrasts a $96M charge related to a gas utility’s pipeline system (34.7k miles) with a much larger electric transmission footprint (90k miles across five states), suggesting a broader operational scale for NextEra. The LLM misrepresents this relationship. (4) Contextual relevance is moderate because the answer attempts the right comparison and cites relevant entities and figures, but the core quantitative error undermines the validity of the synthesis. The answer would be more accurate if it acknowledged that NextEra’s 90,000 miles are spread across multiple states, not just Illinois, and avoided asserting a precise but false figure for Illinois alone.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 521,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO’s equity‑method stake in Coca‑Cola Europacific Partners (CCEP) represented 19 % of its equity‑method investments as of December 31 2021. CCEP has bottling and distribution operations in Iceland, a market where Costco also has a presence, giving KO indirect exposure to that Icelandic market through its CCEP investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO's equity-method stake in CCEP represented 19% as of December 31, 2021, which matches the ground truth. This addresses the quantitative component accurately. (2) All numbers and dates are correct—'19%' and 'December 31, 2021' are factually accurate and match the original answer. There are no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly links KO’s equity stake in CCEP to CCEP’s operations in Iceland and notes that Costco (COST) also operates there, thereby establishing indirect vs. direct market exposure. However, the LLM omits the detail that COST operates through wholly owned subsidiaries, which is a minor but relevant contextual point about the nature of COST's presence. (4) Despite this small omission, the core facts, entities (KO, CCEP, COST, Iceland), and logical synthesis are correct. The answer is semantically equivalent to the ground truth in intent and substance, with only slight reduction in completeness. Thus, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 301,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s direct exposure to electricity‑price volatility is reflected in its commodity‑derivative program, which includes a notional volume of **13,608 GWh of electricity** (see the “Electricity (GWh)” table on page 180).  By contrast, Southern Company’s exposure is indirect and limited to the **100 MW of capacity that Alabama Power supplies to PowerSouth under the 2021 agreement** (page 17), a far smaller and more narrowly defined exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but misses key aspects of the multi-hop comparison required by the question. (1) Quantitatively, the 100 MW figure and 2021 agreement are correctly cited, aligning with the ground truth. However, the LLM introduces a specific number—13,608 GWh from Duke Energy’s commodity-derivative program—which is not mentioned in the original answer and does not directly measure 'exposure' in the same way as the qualitative mechanisms described in the ground truth. This number may be factually present in a filing, but it is not part of the ground truth comparison and thus distracts from the actual basis of contrast. (2) The date for the capacity service start is incorrect: the original answer specifies that the 100 MW service from Alabama Power to PowerSouth begins in 2024, not just 'under a 2021 agreement'—the LLM conflates the agreement date with the effective date, missing a key temporal detail. (3) Qualitatively, the LLM fails to capture the core reasoning in the original answer: Duke Energy uses fuel adjustment clauses, formula-based contracts, and hedging to manage volatility, while Southern Company relies on operational coordination and shared dispatch via contractual agreements. The LLM reduces Duke’s strategy to a derivatives program and Southern’s to a narrow capacity figure, omitting the structural and regulatory mechanisms that define their exposure differences. (4) Contextually, the answer is relevant and attempts a direct comparison, but lacks synthesis of the regulatory and operational frameworks that constitute the true multi-hop reasoning required. It focuses on volume metrics rather than the nature of exposure management, leading to a superficial comparison. Thus, while some facts are accurate, the reasoning and completeness are significantly lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 495,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks’ licensed store count in Taiwan grew by **21 net stores** in 2022 (from 523 to 544).  \nNike’s Greater China region—which includes Taiwan—generated **$7.5 billion in revenue** that year.  \nThus, Starbucks’ modest expansion in Taiwan is dwarfed by Nike’s sizable revenue contribution from the same geographic segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net increase in Starbucks' store count in Taiwan as 21, growing from 523 to 544 stores in 2022, which matches the ground truth. It also accurately reports Nike's Greater China revenue as $7.5 billion (rounded from $7.547 billion), which is acceptable under format variation rules. (2) Quantitative accuracy is high: the store count numbers and revenue figure are correct within acceptable rounding. The net increase calculation (544 - 523 = 21) is accurate. (3) The multi-hop reasoning is sound—correctly linking Starbucks’ store growth in Taiwan to Nike’s revenue from the broader Greater China region, which includes Taiwan. The conclusion that Starbucks' expansion is 'dwarfed' by Nike’s revenue is a reasonable qualitative interpretation. (4) The only minor shortcoming is that the LLM does not explicitly note that Taiwan’s specific revenue contribution within Greater China is not disclosed by Nike, which slightly reduces completeness in qualitative synthesis. However, this does not undermine the core factual correctness. All entities (Starbucks, Nike, Taiwan, Greater China, fiscal year 2022) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 339,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "Under ASU 2022‑04, 3M now discloses the $0.3 billion of confirmed invoice obligations in its notes and provides a roll‑forward table (see Note 16, page 77 and the ASU discussion on page 57), making the liability fully visible to investors. FedEx likewise adopted the standard (page 92) and reports its supplier‑finance program obligations—about $94 million—with a comparable roll‑forward table (page 90), offering similar transparency, though the disclosed amount is smaller. Thus, both companies now provide clear, comparable visibility into their supplier‑finance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies 3M's $0.3 billion in confirmed invoice obligations and notes the enhanced visibility due to ASU 2022-04, aligning with the ground truth. It also accurately references FedEx's adoption of the standard and reports its supplier finance obligations as approximately $94 million. While the ground truth does not specify FedEx's obligation amount, the LLM's inclusion of $94 million is not contradicted and may reflect additional detail from the filing; thus, it does not constitute an error. (2) All numeric values—$0.3 billion for 3M and $94 million for FedEx—are presented accurately, with acceptable format variations. The dates of adoption (3M starting in 2023, full reporting in 2024; FedEx effective June 1, 2023) are consistent with the ground truth, though the LLM does not explicitly state FedEx’s effective date but implies correct timing via context. (3) The multi-hop reasoning is sound: the model correctly synthesizes how ASU 2022-04 affects both companies’ transparency, comparing their disclosure practices and concluding that both now provide clear, comparable visibility. It correctly links the standard to roll-forward disclosures and balance sheet transparency for both firms. (4) The answer is semantically equivalent to the ground truth, capturing the core impact of ASU 2022-04 on transparency and comparability. The only minor limitation is the lack of explicit mention that 3M's full roll-forward reporting began in 2024, though this is implied by reference to Note 16. Overall, the response is factually accurate, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 444,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Comcast’s dual‑class structure gives the single holder of all Class B shares (Brian Roberts) 15 votes per share, which amounts to roughly one‑third of the company’s combined voting power and is generally non‑dilutable (CMCSA, page 33).  Meta’s structure requires that Class B shares represent at least 35 % of voting power to block any change‑of‑control transaction, giving the controlling shareholders the ability to prevent takeovers or major corporate actions (META, page 50).  In both cases, the concentration of voting power in a small group of shareholders limits minority shareholders’ influence over board elections and strategic decisions, exposing them to governance risks such as potential conflicts of interest and reduced ability to protect their interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA's Class B shares have 15 votes per share, held by Brian Roberts, giving him approximately one-third (33⅓%) of voting power; META requires Class B shares to maintain at least 35% of voting power to block change-of-control transactions. These numbers are correctly reported, with acceptable phrasing like 'roughly one-third' matching 33⅓%. (2) Quantitative accuracy is perfect—no calculation errors, and percentages and voting rights are correctly cited. (3) The multi-hop reasoning is sound: the model correctly identifies that both companies concentrate voting power in a small group (Roberts at CMCSA, Zuckerberg-led group at META), which limits minority shareholder influence and creates governance risks such as reduced ability to affect board elections or strategic decisions, including takeovers. (4) The answer fully addresses the question’s focus on governance risks to minority shareholders due to disproportionate voting rights. The only minor shortcoming is that it does not explicitly mention the potential impact on stock valuations or investor attractiveness, which is included in the original answer. However, this omission does not detract significantly from the core correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparative governance risks posed by both dual-class structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 409,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "About 44 % of V’s U.S. pension plan assets that are classified as Level 2 in 2022 are invested in collective investment funds (319 / 733 million).  In contrast, COF’s “other securities” are largely fixed‑income instruments—corporate debt, ABS and foreign bonds—that deliver a modest weighted‑average yield of roughly 1.5‑2 % and focus on income stability rather than the equity‑heavy, higher‑return profile of V’s collective‑fund strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains a significant quantitative error: it calculates the percentage of V's U.S. pension plan assets in collective investment funds as 44% (319/733 million), but the ground truth states that the total U.S. pension plan assets are $960 million, not $733 million. The correct percentage is approximately 33.2% (319/960), as stated in the original answer. The $319 million figure for collective investment funds is correct, but the denominator used for the calculation is wrong, leading to an inaccurate percentage. 2) The LLM incorrectly references 'Level 2 assets' in the percentage calculation, implying that $733 million is the total Level 2 assets, but the original answer does not state this figure—instead, it gives $960 million as the total U.S. pension plan assets (not necessarily all Level 2). The LLM may have conflated total assets with Level 2 assets or used incorrect data for the category. 3) Regarding COF, the LLM correctly identifies that 'other securities' have a modest yield (~1.5–2%), which aligns with the ground truth's 1.57%, though it generalizes slightly. However, the original specifies $2,834 million in 'other securities', a detail omitted in the LLM answer. 4) The qualitative comparison between V’s equity/debt diversified collective funds and COF’s fixed-income focused 'other securities' is reasonable and captures the contrast in investment focus and yield profile, showing adequate multi-hop reasoning. 5) While the LLM captures the general contrast in strategy (diversified institutional portfolios vs. income stability), it introduces a potentially incorrect denominator for the percentage calculation, undermining quantitative accuracy. The core facts about V’s collective funds and COF’s yield are partially correct, but the miscalculation significantly affects the correctness score. 6) Contextual relevance is high—the answer addresses both parts of the question and attempts a meaningful comparison. However, due to the critical error in the percentage calculation, the overall correctness is reduced to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 557,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe’s 10‑K does not disclose any specific compliance cost for Saudi Arabia’s data‑localization rules, whereas Microsoft acknowledges that similar data‑sovereignty and localization requirements could create “increased costs, legal claims, fines and reputational damage” – a potential financial exposure that is not quantified.  This contrast suggests Microsoft is proactively addressing regulatory compliance as a core part of its global cloud strategy, while Adobe’s exposure appears either lower or less explicitly reported, indicating a different or less burdensome approach to data residency.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key elements from the ground truth, affecting its overall accuracy. (1) On correctness: The LLM correctly notes that Adobe does not disclose specific compliance costs for Saudi Arabia and that Microsoft acknowledges increased costs from data localization laws. However, it fails to mention that Saudi Arabia is explicitly cited in Microsoft’s 10-K as a jurisdiction with data localization requirements, and it omits Adobe’s direct statement about adverse impacts on its business and enterprise customers in such jurisdictions. These omissions weaken the comparative analysis. (2) Quantitative accuracy: There are no numerical figures in the question or answer, so this aspect is not applicable; the response contains no incorrect numbers, earning full marks by default. (3) Multi-hop reasoning: The LLM attempts to compare Adobe and Microsoft but misses the core insight from the ground truth — that Adobe’s exposure stems from enterprise customer contracts in Saudi Arabia, while Microsoft faces systemic challenges due to its global cloud and AI infrastructure. Instead, the LLM concludes that Adobe’s exposure is 'lower or less explicitly reported,' which is speculative and not directly supported by the documents. The original answer emphasizes structural differences in cloud strategies, which the LLM fails to capture. (4) Contextual relevance: The answer stays on topic and addresses the comparison of compliance costs and cloud strategies, but lacks depth in synthesizing the specific disclosures from both 10-K filings. It correctly identifies Microsoft’s broader compliance challenges but underrepresents Adobe’s stated risks, leading to an imbalanced interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 467,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy’s February 2023 sale of all KO Transmission pipeline facilities to Columbia Gas Transmission removed an entire FERC‑regulated asset from its balance sheet, thereby lowering the company’s exposure to FERC oversight and the regulatory costs that accompany interstate pipeline operations (see page 18).  By contrast, Southern Company’s 2024‑2028 capital‑expenditure program still lists “changes in FERC rules and regulations” as a key risk that could alter project scope, cost, or approval, keeping FERC‑related uncertainty a continuing factor in its investment decisions (see pages 104‑106).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the date of divestiture (February 2023) is correct, and while the buyer (Columbia Gas Transmission) is mentioned in the LLM answer but not in the original, this is an acceptable addition if factually correct and does not contradict the ground truth. The absence of a specific dollar amount is consistent with the original, which states 'approximately book value' without giving a figure. (2) The LLM correctly identifies Duke Energy’s reduced FERC exposure due to divestiture and contrasts it with Southern Company’s ongoing risk from FERC rule changes affecting capital expenditures. (3) The multi-hop reasoning is sound: it connects Duke’s asset sale to reduced regulatory exposure and contrasts it with Southern’s forward-looking risk disclosures, citing specific page references (18, 104–106), which enhances credibility. (4) The only minor shortcoming is that the LLM does not explicitly mention 'cost recovery' uncertainty for Southern Company, a key nuance in the original answer, though the mention of altered project scope, cost, or approval implies similar risks. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy for the omitted cost recovery detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 377,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS’s $2.7 billion in unfunded commitments to private‑debt and private‑equity funds are long‑term, illiquid alternative investments that will be contributed over a 3‑ to 6‑year horizon and are held to diversify risk and reduce volatility (page 93). In contrast, Caterpillar’s other post‑retirement benefit plans contain only $55 million of NAV‑measured assets—a small, more liquid slice of its $144 million total other‑plan assets that is likely in cash or short‑term instruments and is used primarily for liquidity and risk‑management (page 102). Thus, UPS’s strategy is focused on high‑return, low‑liquidity alternatives, while Caterpillar’s NAV‑measured holdings provide immediate liquidity and lower risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $2.7 billion unfunded commitments by UPS and Caterpillar's $55 million in NAV-measured assets, both of which match the ground truth exactly. These figures are accurately represented and contextually placed. 2) Quantitatively, all numbers are correct: $2.7 billion and $55 million are consistent with the original answer. The LLM adds that Caterpillar’s total other-plan assets are $144 million, which is not in the ground truth but does not contradict it and may come from the source filing (page 102 reference); this is a minor addition but not an error. 3) The reasoning correctly contrasts UPS’s long-term, illiquid alternative investments with Caterpillar’s more liquid, conservative NAV-measured holdings. However, the LLM states UPS’s commitments are to be contributed over a '3- to 6-year horizon,' which contradicts the ground truth’s '10–15 year terms' for redemption restrictions. This is a significant discrepancy in the investment horizon characterization, affecting the qualitative accuracy. The ground truth emphasizes the long-term lock-up typical of private funds, while the LLM’s 3–6 year funding period may refer to capital call timelines but misrepresents the liquidity profile. 4) Despite this, the core comparison—UPS favoring illiquid, high-return alternatives vs. Caterpillar prioritizing liquidity and stability—is sound and contextually relevant. The synthesis across two companies and investment strategies is appropriate and addresses the multi-hop nature of the question. The answer is semantically close to the original, with only the duration detail being misleading. Hence, high scores for quantitative accuracy and contextual relevance, a slightly lower qualitative accuracy due to the horizon mismatch, and an overall correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 490,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s repurchase program is limited to its Class A and Class C shares (page 81), while its Class B shares—each carrying 10 votes (page 81)—are left intact, preserving concentrated voting power. Netflix, by contrast, has a single class of common stock with one vote per share (page 61), so any share repurchase would not alter the voting balance. This suggests Alphabet’s governance strategy intentionally concentrates control in the hands of Class B holders while still returning capital to shareholders, whereas Netflix adopts a more egalitarian, uniform‑voting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and Class C shares while retaining Class B shares with 10 votes per share, and Netflix has a single class of common stock with one vote per share. The dollar amount of $62.2 billion from the ground truth is missing in the LLM answer, which is a minor omission affecting completeness but not overall correctness. (2) Quantitative accuracy is perfect where numbers are provided—no incorrect figures or calculations. The absence of the $62.2 billion figure does not introduce inaccuracy but slightly reduces completeness. (3) Reasoning is sound: the LLM correctly infers that Alphabet’s strategy preserves voting control among Class B holders (likely insiders), contrasting with Netflix’s egalitarian structure. The multi-hop synthesis across companies and governance structures is logically valid. (4) The answer is contextually relevant, directly addressing the contrast in share structures and governance implications. The missing dollar figure prevents a perfect 10, but the core analysis and qualitative insights are fully aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 335,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola’s 2022 effective tax rate was pushed higher by the Tax Reform Act’s GILTI provisions, which added a $195 million tax expense tied to changes in foreign‑jurisdiction tax laws (page 106).  By contrast, Philip Morris International’s 2021 effective tax rate was lowered by a benefit from the corporate‑income‑tax‑rate reduction enacted in the Philippines, which partially offset the GILTI impact and helped keep the net rate only 0.1 percentage point higher at 21.8 % (page 93).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that Coca-Cola's GILTI-related tax expense was $431 million, contributing a 4.4% impact on its effective tax rate; however, the LLM incorrectly reports this as a $195 million expense with no explicit mention of the 4.4% impact. This is a major error in both dollar amount and omission of the specific rate effect. Additionally, the LLM implies that the Philippines' tax reduction helped keep Philip Morris International's (PMI) net rate 'only 0.1 percentage point higher at 21.8%', which misrepresents the original answer: the tax reduction actually contributed to a 0.1 percentage point *decrease* in PMI’s 2021 effective tax rate, which was 21.8%. The phrasing in the LLM answer incorrectly suggests the 0.1 point is an increase rather than a benefit (decrease), and wrongly frames it as offsetting GILTI impact, which is not stated in the ground truth. (2) Number verification: $431M (correct) vs. $195M (incorrect); 4.4% impact (missing); 0.1 percentage point *decrease* (misrepresented as increase); 21.8% rate (correct). The year 2021 for PMI is accurate. (3) Multi-hop reasoning is partially sound—the model attempts to compare tax impacts across two companies and different jurisdictions—but fails in logical synthesis by inventing a comparative offset between GILTI and the Philippines tax cut, which is not supported in the original answer. The connection to PMI’s business combinations in the Philippines is entirely omitted, breaking a key multi-hop link. (4) Correctness score is 4 due to partial factual alignment (correct company names, correct general direction of tax impact, correct mention of Philippines reform and 21.8% rate), but major errors in numbers and reasoning prevent a higher score. Quantitative accuracy is low (3) due to wrong dollar figure and misstated percentage impact. Qualitative accuracy is moderate (5) as entities and general context are correct but reasoning and synthesis are flawed. Contextual relevance is high (8) because the answer addresses the right topics and companies in the correct timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 585,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC’s sale of approximately $3.1 billion of mortgage loans to GSEs in 2023 (page 18) means that a portion of the mortgages that back MET’s $12.392 billion pass‑through portfolio (page 98) are now owned and guaranteed by the GSEs, shifting the credit risk from BAC to the GSEs. However, because those loans are still serviced by BAC, MET’s exposure to servicing quality and loan performance remains tied to BAC’s operations, while the GSE guarantee mitigates default risk but does not eliminate the underlying mortgage risk (page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET's $12.392 billion pass-through MBS portfolio, both of which match the ground truth in amount and year. All numeric values are accurate and properly contextualized. (2) Quantitative accuracy is perfect: both dollar amounts ($3.1 billion and $12.392 billion) are correctly reported with acceptable formatting (e.g., use of 'billion' and spacing in '3.1 billion'). No calculations are required, and all figures are used appropriately. (3) The multi-hop reasoning is sound: the answer correctly links BAC’s loan sales to GSEs with the composition of MET’s MBS portfolio, acknowledges the risk transfer via GSE guarantees, and importantly highlights that BAC remains a servicer—thus MET retains exposure to servicing risk despite reduced credit risk. This aligns with the ground truth’s emphasis on BAC’s operational risk affecting cash flows. The only minor shortcoming is that the LLM does not explicitly mention potential triggers like cybersecurity incidents or servicing breaches, which are noted in the original answer as specific risks. However, the concept of 'servicing quality and loan performance' being tied to BAC covers this qualitatively. (4) The answer is contextually fully relevant, directly addressing the influence of BAC’s actions on MET’s risk exposure. The synthesis across BAC, GSEs, and MET is logically structured and factually grounded. The correctness score is 9 due to the omission of specific risk examples (e.g., cybersecurity), but the core reasoning and facts are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 448,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded derivatives are foreign‑currency forward contracts that are bifurcated from purchase orders and recorded at fair value; because they are not quoted in active markets, they are classified as Level 3 and require internal models and unobservable inputs such as factory‑currency exposure indices, making their valuation highly complex and heavily reliant on non‑market‑based assumptions (page 85). In contrast, Lowe’s fair‑value measurements are largely based on observable market data (Level 1 and Level 2), with only a limited number of Level 3 items that use unobservable inputs, so its reliance on non‑market‑based assumptions is comparatively modest (page 55).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly identifies NKE's embedded derivatives as foreign-currency forward contracts bifurcated from purchase orders, while the original answer specifies a $5 million value as of May 31, 2022, tied to significant unobservable inputs like extrapolation beyond observable limits and policyholder behavior assumptions. The LLM does not mention this dollar amount or the specific date, which are key quantitative facts. Additionally, the reference to 'factory-currency exposure indices' as unobservable inputs is not supported by the original answer and appears fabricated. (2) Quantitatively, the LLM fails to report the $5 million figure for NKE’s embedded derivatives and omits the specific date (May 31, 2022), both of which are critical. There are no calculations in the response, but the absence of these numbers reduces factual precision. (3) Regarding multi-hop reasoning, the LLM correctly contrasts NKE’s Level 3 classification with LOW’s lesser reliance on unobservable inputs, but misrepresents the nature of NKE’s derivatives and overstates LOW’s use of Level 3 inputs by implying there are 'a limited number of Level 3 items'—the original answer states LOW reported *no material fair value measurements* on a nonrecurring basis and primarily uses observable inputs for its financial assets and liabilities. This mischaracterization weakens the comparison. (4) Despite these issues, the LLM captures the core qualitative contrast: NKE has more complex, non-market-based valuation due to Level 3 embedded derivatives, while LOW relies more on observable data. The contextual relevance is high because it addresses the comparative reliance on unobservable inputs, but factual inaccuracies and missing data limit correctness. Hence, scores reflect partial accuracy with significant gaps in quantitative and qualitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 524,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD’s pension plan classifies fixed‑rate notes as Level 2 assets, valuing them with market‑based models that use observable inputs such as interest rates and bond yields. Its Level 3 holdings are direct private‑equity investments, which are measured with unobservable inputs. In contrast, Lockheed Martin’s Level 3 assets are its $4.951 billion private‑equity funds, whose NAVs are derived from valuation models that rely on unobservable inputs that cannot be corroborated with observable market data.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains a critical factual error in asset classification: it states that GD classifies fixed-rate notes as Level 2 assets, while the ground truth explicitly states these are Level 3 assets. This mischaracterization undermines the core comparison the question is built on. Additionally, the LLM incorrectly claims GD's Level 3 holdings are private equity investments valued with unobservable inputs, which contradicts the original answer stating GD uses observable inputs (e.g., interest rates, prices for similar assets) in valuation models for its Level 3 fixed-rate notes. In contrast, the information about LMT is accurate: its $4,951 million (i.e., $4.951 billion) private equity fund holdings are correctly identified as Level 3 assets valued using NAV with unobservable inputs.\n\n2) Quantitatively, the dollar amount is correctly represented ($4.951 billion = $4,951 million), and no other numerical values are misstated. The format variation is acceptable and does not affect accuracy.\n\n3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize the key contrast: GD’s use of observable inputs for Level 3 fixed-rate notes vs. LMT’s use of unobservable inputs for Level 3 private equity. Instead, it incorrectly reclassifies GD’s assets to Level 2 and misattributes private equity to GD, breaking the logical comparison. This represents a failure in entity-to-metric mapping and undermines the qualitative accuracy.\n\n4) Despite correct contextual framing and relevance to pension asset valuation practices in the defense sector, the answer’s central claim about GD is factually incorrect. The contextual relevance is high because it addresses valuation approaches and inputs, but correctness and qualitative accuracy are severely impacted by the misclassification of asset levels and valuation methods for GD.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 502,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation began in September 2019 with seven class actions, and its federal motion to dismiss was filed in January 2020, partially granted in April 2020, and then appealed through the Ninth Circuit (affirmed September 2021, rehearing denied May 2022) and the Supreme Court (certiorari granted December 2022, remand June 2023). The Ninth Circuit ultimately reversed the district court and dismissed the complaint with prejudice on February 10 2025, while the state‑court actions remain stayed pending the appellate outcome. In contrast, Disney’s antitrust strategy involved filing motions to dismiss both the Biddle and Fendelander actions on January 31 2023; the court partially granted those motions in September 2023, consolidated the cases in October 2023, and Disney’s motion to dismiss the consolidated complaint was partially granted on June 25 2024, leaving the consolidated lawsuit in its early stages.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in structure and captures the core procedural timelines of both Slack and Disney litigations, with accurate entity identification and appropriate comparison framing. However, there are key quantitative inaccuracies that reduce factual precision. Specifically: (1) The original answer states the Ninth Circuit reversed and dismissed with prejudice on February 10, 2025—this date is correct in the LLM response, but the preceding appellate history (affirmed September 2021, rehearing denied May 2022, SCOTUS cert granted December 2022, remand June 2023) is absent from the ground truth and appears to be fabricated or misattributed; the original answer does not mention any affirmation in 2021 or Supreme Court remand in 2023, only that the Ninth Circuit reversed on February 10, 2025 after a Supreme Court remand (without specifying earlier cert or remand dates). Thus, the insertion of specific Supreme Court and Ninth Circuit actions between 2021–2023 introduces false procedural milestones. (2) The LLM correctly notes Disney’s January 31, 2023 motions to dismiss and partial grant on September 30, 2023 (implied in 'September 2023'), and the second motion on December 1, 2023, with a partial grant on June 25, 2024—these dates align with the ground truth. However, the LLM omits the explicit mention that the cases remain ongoing with a class certification deadline set for March 27, 2026, which is a significant completeness gap regarding the current status. (3) The qualitative reasoning is strong: the model correctly identifies the multi-hop comparison between two companies’ litigation strategies, synthesizes procedural postures, and contrasts finality (Slack’s dismissal with prejudice) versus ongoing status (Disney’s early-stage litigation). (4) Contextual relevance is excellent—the response directly addresses the comparative legal exposure, timeline, and motion-to-dismiss history as asked. While the core facts about the motions and ultimate outcomes are directionally accurate, the invented intermediate appellate dates for Slack undermine quantitative accuracy, warranting a 6 for that category. The overall correctness score is 7 due to accurate main events and dates but significant embellishment of Slack’s procedural history not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 615,
        "total_tokens": 2075
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s 10‑K does not disclose a specific tax benefit attributable to its Hong Kong operations in the pages provided. In contrast, Apple’s Greater China segment—which includes Hong Kong—generated $74.2 billion of net sales in 2022 (Apple 10‑K, page 52). Thus, while Apple’s Hong Kong‑included region contributed a sizable revenue figure, Intel’s Hong Kong‑related tax benefit is not disclosed in the available excerpts.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's $74.2 billion net sales from the Greater China region in 2022, which matches the ground truth and includes Hong Kong as per Apple's reporting. This figure is accurately cited with a reference to the 10-K (page 52), demonstrating strong quantitative and entity accuracy. However, the LLM states that Intel’s 10-K does not disclose a specific tax benefit from Hong Kong operations in the provided pages, whereas the ground truth affirms that Intel derives effective tax rate benefits from Hong Kong as part of its non-US tax strategy, citing the statutory rate range (12.5%–24.0%). While the LLM is factually correct in noting the absence of a quantified benefit in the excerpts, it stops short of acknowledging the qualitative strategic use of Hong Kong for tax optimization, which is present in the original answer. (2) All numbers are correct: $74.2 billion is accurately reported, and no incorrect calculations are made. (3) The multi-hop reasoning is partially sound—LLM correctly contrasts Apple’s revenue from Greater China (including Hong Kong) with the lack of disclosed tax benefit from Intel’s Hong Kong operations. However, it misses the synthesis that Intel still leverages Hong Kong for tax advantages based on statutory rates and broader strategy, even if the exact dollar benefit isn't quantified. This weakens the qualitative reasoning compared to the original answer. (4) The contextual relevance is high, as the response directly addresses the comparison question and correctly handles Apple’s regional reporting. The correctness score is 8 due to accurate numbers and overall direction, but docked for incomplete qualitative synthesis on Intel’s tax strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 471,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "HB 951’s 70 % CO₂‑reduction target forces Duke Energy to accelerate coal retirements and adopt low‑carbon resources in its Carolinas Resource Plan, prompting the company to select Portfolio 3 as the most cost‑effective path to meet the target by 2035 (see pages 70‑71). In contrast, the NextEra Energy 10‑K pages provided (43‑47) contain no reference to North Carolina operations or exposure, indicating that the regulation does not appear to directly affect NextEra’s North Carolina activities (page 45).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 70% CO₂ reduction target from HB 951 and Duke Energy's response via Portfolio 3 in its Carolinas Resource Plan. However, it incorrectly states the target must be met 'by 2035'—the ground truth specifies a 2030 deadline for the 70% reduction, with coal retirement by 2035. This is a significant factual error affecting the timeline of regulatory compliance. (2) Quantitatively, the 70% figure is accurate, and no other numbers (e.g., dollar amounts) are misstated. The reference to 'pages 70-71' and 'pages 43-47' appears consistent with document-based reasoning, though the absence of North Carolina in NextEra’s 10-K is not equivalent to lack of operational exposure—the original answer confirms NextEra *does* operate in NC, just not under HB 951’s direct mandate. (3) The multi-hop reasoning is partially flawed: while the model correctly infers that NextEra is not directly subject to HB 951, it incorrectly concludes no exposure based on absence of mention in the 10-K, which contradicts the ground truth that NextEra *is* operationally present in North Carolina. This reflects a failure in synthesis—lack of textual mention does not imply lack of exposure. (4) The answer is contextually relevant and addresses both Duke Energy’s regulatory response and NextEra’s position, but the key distinction—differentiated regulatory burden due to HB 951 applying only to Duke—is underdeveloped and inaccurately framed due to the timeline error and misinterpretation of operational exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 424,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ’s weighted‑average assumptions are actuarial inputs used to calculate the accrued benefit obligation for its post‑retirement health‑care plans—specifically discount rates, health‑care cost trend rates, ultimate trend rates, and the year the trend rate is reached for U.S. and non‑U.S. plans (see page 106). In contrast, KO’s weighted‑average assumptions are market‑based parameters fed into the Black‑Scholes‑Merton model to estimate the fair value of stock options—risk‑free interest rate, expected life, expected volatility, expected dividend yield, and grant‑date fair value (see page 95). Thus, MDLZ applies weighted averages to actuarial cost‑and‑discount assumptions, while KO applies them to option‑pricing assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of how MDLZ and KO use weighted-average assumptions, with correct entity identification and no numerical errors. It correctly distinguishes MDLZ's use of actuarial assumptions (e.g., discount rates, healthcare cost trends) for postretirement healthcare obligations from KO's use of market-based inputs (risk-free rate, volatility, etc.) in the Black-Scholes-Merton model for stock option valuation. While the original answer includes specific dollar amounts ($14M, $12M, -$5M) and mentions the four-year straight-line expensing and spot rate methodology, the LLM answer omits these quantitative details but retains the core conceptual distinction. There are no factual inaccuracies—only a partial omission of numerical data and some contextual details (e.g., vesting period, treatment of service/interest costs). The reasoning is sound and the contrast is clearly articulated, demonstrating proper multi-hop synthesis between the two companies' distinct applications of weighted-average assumptions. The answer remains semantically aligned with the ground truth, though less detailed in quantitative aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 327,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan Chase’s derivatives are governed by Dodd‑Frank provisions that require enforceable close‑out netting and collateral posting, allowing the firm to offset receivables and payables and preserve liquidity even if a counterparty defaults (see note on derivatives and Dodd‑Frank, page 261).  In contrast, Bank of America’s resolution plan under the Orderly Liquidation Authority focuses on maintaining group‑wide liquidity and capital buffers, with inter‑company arrangements and regulatory liquidity requirements potentially limiting the parent’s ability to draw on subsidiary funding during distress (see pages 11‑13 and 15).  Thus, JPMorgan’s liquidity risk is managed through derivative netting and collateral, whereas Bank of America’s strategy relies on group liquidity buffers and regulatory oversight during an orderly liquidation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key regulatory frameworks and liquidity risk management mechanisms for both JPMorgan Chase and Bank of America. It correctly identifies that JPMorgan Chase’s derivatives exposure is managed under Dodd-Frank via enforceable close-out netting and collateral posting, which helps preserve liquidity during distress—consistent with the ground truth’s reference to ISDA Master Agreements and netting under OLA constraints. Similarly, the LLM accurately notes that Bank of America’s resolution plan under the Orderly Liquidation Authority (OLA) involves restrictions on intercompany liquidity flows, particularly limiting the parent’s ability to access subsidiary funds, which matches the ground truth’s description of the 'single point of entry' strategy and subsidiary solvency prioritization. The answer is contextually relevant and captures the core contrast in liquidity risk management approaches. However, it omits explicit mention of the 'single point of entry' strategy by name and does not directly reference the regulatory constraint on set-off and close-out netting under OLA for JPMorgan, which is a nuanced but important element of the multi-hop synthesis. While the reasoning is sound and entities are correctly identified, this minor omission in regulatory mechanism specificity prevents a perfect qualitative score. There are no numerical values in either answer, so quantitative accuracy is scored as 10 by default. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the ground truth with only slight gaps in depth of regulatory detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 454,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s coal‑heavy grid is still a key part of the state’s energy mix, as shown by Duke Energy Ohio’s coal inventory of $23 million in 2024 (DUK 10‑K 2024, pp. 122‑126).  That reliance creates a market for low‑carbon alternatives and a regulatory pressure point for companies with coal exposure.  ExxonMobil’s coal operations in Europe trigger a new EU “coal tax” on surplus profits, costing the company roughly $1.8 billion in 2022 and $0.2 billion in 2023 (XOM 10‑K 2024, pp. 115‑117).  In contrast, Chevron is expanding renewable natural‑gas (RNG) capacity in Ohio—part of its 2024 RNG rollout that includes new CNG stations and bio‑fuel production—positioning the company to replace coal‑heavy demand with lower‑carbon fuel (CVX 10‑K 2024, pp. 18‑19).  Thus, Ohio’s coal dependence drives XOM’s exposure to European coal taxes while encouraging CVX to invest in RNG to diversify away from coal.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in quantitative details and entity specificity. (1) Correct elements: The $23 million coal inventory for Duke Energy Ohio as of 2024 and the $1.8 billion EU coal tax charge for XOM in 2022 are accurately reported and correctly attributed. The core contrast between XOM’s regulatory-driven challenges and CVX’s proactive RNG investments in Ohio is well captured. (2) Quantitative issues: The LLM adds a $0.2 billion charge for XOM in 2023 not present in the original answer; while plausible, it is not supported by the ground truth and introduces unverified data. The original answer only specifies the 2022 $1.8 billion charge. (3) Entity and reasoning: The LLM correctly identifies CVX’s RNG investments in Ohio via Brightmark RNG Holdings LLC (implied through context), though it generalizes the projects as including 'CNG stations and bio-fuel production'—details not in the original, which specifies commercial operations with Brightmark without listing those exact components. This extrapolation slightly reduces precision. (4) Multi-hop reasoning is sound: the model correctly links Ohio’s coal reliance to both regulatory pressure on XOM (via EU tax) and opportunity for CVX (via RNG investments), synthesizing across geographies and corporate strategies. Wording differs but meaning is semantically close. Minor deductions for unsupported figures and slight overgeneralization, but overall a strong, relevant response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 419,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "MS’s CLNs are hybrid securities in which the issuer (an SPE) sells credit protection to the firm and issues securities to investors; if a credit event occurs the SPE delivers collateral to the firm and the investor’s principal may be reduced. JPM’s credit‑related notes are funded derivatives where the issuer purchases credit protection from the investor, pays periodic credit‑risk‑based coupons, and at maturity repays par unless a credit event occurs, in which case the issuer pays the investor the difference between the note’s par value and the fair value of the defaulted reference obligation—no collateral is transferred. Thus, CLNs transfer credit risk to the firm via collateral, whereas credit‑related notes transfer risk to the investor through a payment that may be less than par value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, there are no numbers, dates, or financial amounts involved in the question or answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies that MS's CLNs involve the issuer (an SPE) selling credit protection to MS (i.e., MS is the buyer of protection), and upon a credit event, the investor’s principal may be reduced due to collateral transfer to MS. This aligns with the ground truth that MS purchases protection and may not repay principal in full. (3) For JPM, the LLM accurately states that the issuer purchases protection from the investor (i.e., JPM sells protection), pays risk-based coupons, and upon a credit event, pays the difference between par and the fair value of the defaulted obligation—matching the ground truth. The clarification that 'no collateral is transferred' adds precision not in the original but is consistent with JPM’s structure. (4) The key multi-hop reasoning—comparing MS as buyer vs. JPM as seller of protection and how that affects payout mechanics—is correctly synthesized. The only minor shortcoming is that the LLM implies JPM’s structure involves the issuer purchasing protection (correct) but doesn’t explicitly name JPM as the firm behind the issuer as clearly as the ground truth does, though this is contextually implied. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 432,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both Georgia Power Company and Florida Power & Light Company state that they meet the conditions of General Instruction I(1)(a) and (b) and therefore file with the reduced‑disclosure format.  The difference is only in filing structure: Georgia Power is listed among a group of registrants in a combined 10‑K with Southern Company and its other subsidiaries, while Florida Power & Light is listed separately in a combined 10‑K with NextEra Energy.  The wording of the compliance statement is identical in both filings, but the context and the accompanying registrants differ.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. It accurately states that both Georgia Power Company and Florida Power & Light Company meet the conditions of General Instruction I(1)(a) and (b) and therefore qualify for the reduced-disclosure format, which aligns with the original answer. The key difference in filing structure—Georgia Power being one of multiple subsidiaries in Southern Company’s combined 10-K, while Florida Power & Light files jointly with only NextEra Energy—is correctly identified. The LLM correctly notes the similarity in compliance language and the differing context of registrants. One minor omission is that the original answer specifies that NextEra Energy holds all 1,000 shares of Florida Power & Light’s common stock, a detail absent in the LLM response. While not critical to the core comparison, this adds specificity to the ownership structure. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across the two companies’ filings. The answer is contextually relevant and directly addresses the question. Thus, the correctness score is 9 due to high accuracy with a small loss in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 351,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over time, using a percentage‑of‑completion method that often results in revenue being recorded in excess of billings because of performance‑based payments (PBPs) and progress payments. Contract modifications are treated as part of the existing contract on a cumulative catch‑up or prospective basis. GD, by contrast, allocates costs to contracts under the FAR (allowability) and the Cost Accounting Standards (CAS) framework, but the 10‑K does not detail how performance‑based payments or contract modifications influence that cost allocation; the focus is on allocating allowable costs rather than on revenue timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies RTX's revenue recognition practice using the percentage-of-completion method, resulting in revenue in excess of billings due to performance-based and progress payments, consistent with FAR guidelines. It also accurately notes how contract modifications are handled (cumulative catch-up or prospective basis). For GD, it correctly states that cost allocation follows FAR and CAS, focusing on allowable costs. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s revenue timing under FAR with GD’s cost allocation practices under the same regulatory framework, even noting that GD’s 10-K does not detail the impact of PBPs or modifications on cost allocation, which is a nuanced and accurate reflection of available disclosures. (4) The only minor shortcoming is that the LLM omits the point in the original answer about both companies managing adjustments due to FAR-mandated acquisition phases (planning, competition, etc.), and GD’s emphasis on auditability. However, the core comparison—RTX on revenue timing vs. GD on cost compliance—is clearly and correctly drawn. The answer is semantically equivalent in substance, though slightly less comprehensive in regulatory process context. Thus, correctness is high but not perfect, warranting a 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 422,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B shares ten votes each versus one vote for Class A shares (page 82), concentrating voting power in the hands of a small group of shareholders. In contrast, Comcast’s investment in Atairos carries no voting rights at all—Comcast “does not have the power to direct the activities … as we have no voting rights” (pages 84‑85). Consequently, GOOGL’s structure enables a concentrated governance control by Class B holders, while Comcast’s lack of voting rights in Atairos limits its influence to economic exposure only, giving it no direct control over that entity’s corporate decisions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class A shares have 1 vote per share and Class B have 10 votes per share, creating a dual-class structure that concentrates voting power—this matches the original answer. The statement that CMCSA has no voting rights in Atairos is accurately reflected, including the qualitative consequence of limited governance influence. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the voting ratios (1 vs. 10 votes) are correctly stated. Format and referencing (e.g., 'page 82', 'pages 84-85') align with expected sourcing from SEC filings, though exact page numbers are not part of the ground truth evaluation—these do not detract as they support authenticity. (3) Multi-hop reasoning is sound: the model correctly contrasts GOOGL’s internal governance mechanism (dual-class shares) with CMCSA’s external investment structure (no voting rights in an equity-method investee), synthesizing information across two distinct corporate structures and implications for control. (4) The answer addresses all parts of the question: comparison of voting rights structures and implications for corporate governance control in both entities. Wording differs slightly but meaning is preserved and complete. All scores are maximized due to full factual correctness, logical reasoning, and contextual completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 400,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen discloses that McKesson accounted for 33 % of its 2021 gross product sales (page 113) and, in its 2022 filing, warns that concentration at a few wholesalers—including McKesson, AmerisourceBergen and Cardinal Health—poses a material risk if a distributor faces financial distress or payment issues (pages 46‑48).  By contrast, Merck’s 2022 risk factors acknowledge a general concentration in third‑party distribution and outsourcing relationships but do not quantify the exposure or detail specific distributor risks (pages 29‑33).  Thus, Amgen’s reliance is more pronounced and explicitly quantified, with a clear outline of wholesaler‑related disruption risks, whereas Merck’s disclosure is broader and less specific.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Amgen's 33% reliance on McKesson in 2021 is accurately cited, and the reference to the 2022 filing for risk disclosures matches the original. No calculations are required, but the percentage and years are correctly used. (2) The LLM correctly identifies the three major distributors (McKesson, AmerisourceBergen, Cardinal Health), which is consistent with Amgen's disclosure of concentration among three wholesalers, even though the original answer only names McKesson. This additional detail is factually accurate and enhances completeness. (3) The comparison to Merck is sound: the LLM correctly notes that Merck acknowledges concentration risk in distribution but does not quantify it, which is consistent with the ground truth stating Merck’s warning is more general about third-party relationships. The LLM slightly reframes Merck’s 'unexpected safety or efficacy concerns' as part of broader risk language, but correctly emphasizes that Merck’s disclosure lacks specific quantification or focus on distributor financial risk, making the contrast with Amgen valid. (4) The reasoning is multi-hop: it connects Amgen’s quantitative exposure to its qualitative risk disclosure, then contrasts it with Merck’s more generic language—exactly what the question demands. The only minor shortcoming is that the LLM does not explicitly quote Merck’s 'unexpected safety or efficacy concerns' point, but it correctly characterizes Merck’s disclosure as broader and less specific, which captures the intent. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 489,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips’ exposure from its 52.2 % stake in Alba Plant LLC is the maximum potential future payments under the guarantee for processing third‑party gas, which is about **$116 million** (with a carrying value of roughly $4 million).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial exposure correctly. (1) Quantitatively, all numbers are correct: the 52.2% ownership in Alba Plant LLC and the $116 million in maximum potential future payments (with a carrying value of $4 million, though the latter is not in the original answer but is plausible supplemental detail). These match the ground truth from ConocoPhillips' 2024 10-K. (2) The answer correctly identifies the nature of the exposure—guarantees related to processing third-party gas at Alba Plant LLC. (3) While the LLM omits explicit mention of Chevron’s condensate production feeding into the Alba Unit and the linkage to EG LNG (where COP has a 56% stake), these are contextual details that support the exposure but are not the direct measure of financial exposure asked for. The core of the question—financial exposure from ownership in Alba Plant LLC—is accurately and concisely answered. (4) The reasoning is sound, focusing on the guarantee liability tied to the plant, which is the key financial risk. The omission of some upstream/downstream context slightly reduces qualitative completeness but does not impair factual correctness. Overall, the answer is semantically equivalent in addressing the primary financial exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 355,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level 2 assets are valued using pricing models that incorporate observable market data—such as interest rates, yield curves and credit spreads (page_88). In contrast, Union Pacific’s real‑estate funds are valued at NAV based on property appraisals and other unobservable inputs, and these funds typically have 8‑10‑year terms (page_88; page_57). Thus, GD relies on observable inputs for Level 2 valuation, whereas UP relies on unobservable inputs over a longer horizon for its real‑estate holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or numerical values are missing or incorrect—the ground truth mentions Union Pacific's $30 million allocation, which the LLM omits, but this is a minor omission that does not affect the core comparison. All other qualitative details (8-10 year terms, use of unobservable inputs, NAV valuation) are correctly included. (2) The LLM correctly identifies that General Dynamics uses observable inputs (interest rates, yield curves, credit spreads) for Level 2 assets, consistent with the ground truth. It also correctly contrasts this with Union Pacific’s use of unobservable inputs via NAV for real estate funds. (3) The multi-hop reasoning is sound: the model synthesizes valuation methodologies across two companies (General Dynamics and Union Pacific) and connects them to broader practices in real estate fund valuation, including term length and input observability. The reference to 'LMT's explanation' in the ground truth is not reflected in the LLM answer, but the LLM still correctly describes the practice without attributing it, which is acceptable given the context. (4) The answer is contextually relevant, directly addressing the comparison asked in the question. The only reason for not scoring a 10 is the omission of the $30 million figure, which is a minor quantitative detail but adds specificity in the original answer. Overall, the semantic meaning, reasoning, and factual content are substantially correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 427,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role in Costco’s program is that of the **issuer of a co‑branded consumer credit card** (Exhibit 10.8**), underwriting and managing credit for Costco members. In contrast, in Colgate’s five‑year credit agreement Citibank acts as the **administrative agent and arranger** (Exhibit 10‑I), overseeing the loan’s administration and syndication for the company rather than issuing consumer credit【page 68】【page 67】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the essential distinction between Citibank's roles in the two financial arrangements. (1) It correctly identifies Citibank as the issuer of a co-branded consumer credit card for Costco and as administrative agent and arranger for Colgate's credit agreement, aligning with the ground truth. (2) There are no numeric values, dates, or financial figures in the LLM answer, so quantitative accuracy is not compromised—no incorrect numbers are presented, and the absence of specific dates (e.g., October 11, 2023, and November 4, 2022) does not detract from correctness since the question did not explicitly ask for them. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the Costco relationship is a consumer-facing credit product while the Colgate role pertains to corporate lending administration. The mention of Exhibit references (10.8 and 10-I) adds document-level support. (4) The only minor shortcoming is the omission of the detail about the number of amendments (twelve since 2015) in the Costco program, which is present in the ground truth and indicates the depth of ongoing partnership. However, this is a secondary detail that does not alter the core comparison. Overall, the answer is semantically equivalent and contextually precise, with high qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 377,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s stake in QatarEnergy LNG (N(3)) averaged 13 barrels per day of crude oil in 2023, and Chevron owned 30 % of that asset. Multiplying the two gives a net daily crude oil contribution of **3.9 barrels per day** (13 × 0.30).【page_12】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in unit scaling—while it correctly states Chevron's 30% ownership and the 13 MBD (thousand barrels per day) production figure, it reports the final result as '3.9 barrels per day' instead of '3.9 thousand barrels per day' (or 3.9 MBD), which is off by a factor of 1,000. This renders the quantitative output grossly inaccurate despite correct multiplication logic. (2) The calculation '13 × 0.30 = 3.9' is mathematically correct, but the units are catastrophically misrepresented—'13 barrels per day' is not equivalent to 13 MBD (i.e., 13,000 barrels per day), so both input and output units are wrong. The original answer specifies '13 MBD' and correctly derives '3.9 MBD', which the LLM fails to replicate. (3) The multi-hop reasoning—linking ownership percentage to production volume—is conceptually sound and reflects appropriate synthesis between ownership stake and production data. However, the failure in unit handling undermines the entire conclusion. (4) Contextually, the answer addresses the right entities (Chevron, QatarEnergy LNG), time period (2023), and metric (net daily crude oil production), so relevance is high. Due to the severe quantitative inaccuracy, the correctness score is low despite partial reasoning validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 363,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar’s Level 3 non‑U.S. pension assets are insurance contracts that are valued with pricing models “that reflect the assumptions a market participant would use,” with no specific input list disclosed. Lockheed Martin, however, uses a discounted‑cash‑flow approach for its Level 3 fixed‑income holdings, explicitly citing projected annuity payments and discount rates as key inputs, and otherwise relies on indicative quotes or bid evaluations from vendors when observable market data are unavailable. Thus, Caterpillar’s method is more generic, while Lockheed Martin’s approach specifies particular cash‑flow and discount‑rate inputs and distinguishes between observable‑data and non‑observable‑data valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Caterpillar uses pricing models based on management's judgment of market participant assumptions for its Level 3 non-U.S. pension assets (insurance contracts), and Lockheed Martin uses discounted cash flow models and third-party indicative quotes for its Level 3 fixed income investments. Key inputs such as projected annuity payments and discount rates are correctly attributed to Lockheed Martin. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct representation of financial concepts—this is handled accurately. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation approaches across two different companies, asset types, and methodologies, drawing a valid comparison between Caterpillar’s more general pricing model approach and Lockheed Martin’s more specified techniques. (4) The only minor shortcoming is the characterization of Caterpillar’s method as 'more generic'—while semantically reasonable, this phrasing slightly undersells the alignment with market participant assumptions emphasized in the original answer. However, this does not distort the factual content. Overall, the answer is factually complete, contextually relevant, and conveys the same meaning as the original with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 393,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s formulation patents expire on 10/19/2037 (page 12), after which Pfizer’s Specialty Care segment—where Enbrel is a core inflammation/immunology product (page 11)—will likely lose exclusivity and face generic competition, increasing the segment’s revenue concentration risk if other products cannot absorb the loss. Bristol Myers Squibb’s strategy of building its future pipeline through acquisitions, alliances and licensing (page 11) could accelerate the launch of competing immunology therapies, further eroding Pfizer’s Specialty Care sales and heightening concentration risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Enbrel's formulation patent expiration date is accurately cited as 10/19/2037 (matching the ground truth's 2037 timeline), and Enbrel is correctly identified as a core product in Pfizer's Specialty Care segment, specifically within inflammation & immunology. The risk of generic competition post-patent expiration and its potential impact on revenue concentration risk is correctly articulated. (2) Quantitative accuracy is perfect: the date 10/19/2037 is precise and consistent with the source, and no calculations are required. Format (specific date vs. year-only) is more detailed than the ground truth but still correct. (3) Multi-hop reasoning is sound: the answer synthesizes information about Pfizer’s product exposure with Bristol Myers Squibb’s external innovation strategy (acquisitions, alliances, licensing) and correctly infers competitive risk in the immunology space. The LLM correctly links BMS’s strategy to potential erosion of Pfizer’s sales, which is consistent with the original answer’s logic. (4) The only minor shortcoming is a slight lack of nuance in describing BMS’s potential to enter the market with 'disruptive therapies' or 'alternative therapies' as mentioned in the ground truth; the LLM mentions competing therapies but doesn’t emphasize clinical/regulatory uncertainty or the strategic positioning aspect as clearly. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 440,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around scenario‑based stress tests and sensitivity analysis – it uses historical‑simulation VaR, explicit scenario analysis and sensitivity tables (e.g., yield‑curve, equity, FX) to quantify the impact of hypothetical moves【page_111】【page_110】【page_84】. In contrast, COF’s credit‑loss forecasting relies on quantitative loss‑forecasting models that incorporate statistical analyses and economic forecasts, supplemented by qualitative judgment, and does not explicitly use scenario‑based modeling or sensitivity analysis【page_135】. Thus, AIG places a stronger emphasis on scenario‑based and sensitivity‑driven stress testing than COF’s credit‑loss approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core comparison: it claims COF does not explicitly use scenario-based modeling or sensitivity analysis, which contradicts the ground truth stating that COF uses scenario-based forecasting models for ACL estimation. The ground truth confirms both AIG and COF rely on scenario and sensitivity analysis, albeit in different risk domains (market vs. credit risk). The LLM incorrectly differentiates them by presence vs. absence of such methods, when in fact both use them. (2) There are no numeric values in the LLM answer that conflict with the ground truth (e.g., COF’s ACL of $13.0 billion is not mentioned but also not misstated), so quantitative accuracy is high. (3) The multi-hop reasoning fails: the model should have synthesized that both firms use scenario and sensitivity analysis, but apply them to different risk types—this key parallel is missed, and instead a false contrast is drawn. The LLM’s reliance on document excerpts appears to have led to a misinterpretation of COF’s methodology. (4) While the answer is relevant and well-structured, the qualitative inaccuracy in representing COF’s practices severely undermines the correctness. The conclusion that AIG places stronger emphasis is unsupported by evidence and contradicts the ground truth that both integrate these techniques in their respective domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 385,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s 2023 10‑K notes that its advanced semiconductor products are subject to U.S. export‑control rules—including the EAR—and that the company must obtain licenses for certain items, with the risk that new restrictions could limit sales to China or other countries (see Qualcomm 10‑K, page 36).  AMD, by contrast, discloses a concrete, product‑specific limitation: the export of its Versal VC2602 and VE2602 FPGAs to China or to customers whose ultimate parent is in a D5 country (including China) requires a Notified Advanced Computing (NAC) notification and a license, and shipments without such clearance are prohibited (see AMD 10‑K, page 33).  Thus, Qualcomm faces a broader, general EAR exposure, while AMD’s constraints are narrowly focused on the Versal FPGA family for export to China.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Qualcomm's exposure to EAR is described as broad and regulatory in nature, consistent with its 10-K disclosures, while AMD's constraints are correctly identified as specific to the Versal VC2602 and VE2602 FPGAs and tied to NAC notification requirements for exports to China or D5 countries. The citation of page numbers (36 for Qualcomm, 33 for AMD) matches typical 10-K risk factor sections and supports the claims. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates, product names, or regulatory terms like 'NAC notification' or 'D5 country'. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their respective regulatory disclosures, product lines, and geographic constraints, drawing a valid contrast between general vs. specific exposure. (4) The only minor shortcoming is that the LLM omits AMD's requirement to file the NAC notification 25 days in advance, which is present in the original answer—this detail is important but does not alter the core conclusion. Otherwise, the answer is semantically equivalent, well-structured, and directly responsive to the comparative question about EAR exposure in high-performance computing markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 390,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "CMCSA’s 2019 agreement with Disney saw it **relinquish its board seats and almost all voting rights in its Hulu stake**, handing Disney full operational control while keeping a minority ownership that can be bought or sold under put/call provisions (page 85).  \nIn contrast, Meta’s governance is built on a **dual‑class structure**: Class B shares carry ten votes each while Class A shares have one vote and Class C shares are non‑voting (pages 1‑5), allowing insiders to retain decisive control while issuing largely non‑voting shares to the public.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between CMCSA's relinquishment of voting rights in Hulu and META's dual-class stock structure. (1) All key facts are correct: CMCSA gave up board seats and nearly all voting rights in Hulu in 2019, retaining only economic interest with put/call arrangements; META maintains a dual-class structure where Class B shares have 10 votes vs. 1 for Class A, enabling control retention by insiders. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts are stated. While the $27.5 billion guaranteed equity value and the $8.6 billion payment from Disney in 2023 are not mentioned, these omissions do not introduce inaccuracy—only slight incompleteness. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance strategies across two different companies and structures, contrasting external control transfer (CMCSA) with internal control preservation (META). (4) Semantic equivalence is strong—wording differs slightly but meaning aligns with the ground truth. The only reason for not scoring a 10 is the omission of the specific financial terms ($27.5B guarantee, $8.6B payment), which are part of the original answer’s factual depth. However, since the LLM does not misstate anything and captures the strategic contrast accurately, it earns a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 384,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ broker‑dealer assets total $113.9 billion (GS 10‑K, p. 106), underscoring the scale of its retail‑client business and driving a robust conflict‑of‑interest framework that includes segregation of research and trading, independent review, and full disclosure under Regulation Best Interest. Morgan Stanley’s 10‑K (p. 9) describes a comparable compliance framework that emphasizes research‑conflict policies and adherence to Regulation Best Interest, but the larger size of GS’s broker‑dealer assets necessitates a broader internal‑control and risk‑management structure to manage conflicts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion in broker-dealer assets for Goldman Sachs is correctly stated and matches the original answer. No other numerical values are present, and the figure is properly attributed to the GS 10-K, p. 106, which is consistent with expected sourcing. (2) The answer addresses both parts of the multi-hop question: Goldman Sachs’ approach under Regulation Best Interest in light of its asset size and Morgan Stanley’s compliance framework. It correctly identifies that both firms are subject to Reg BI and have conflict-of-interest policies, particularly around research and disclosures. (3) The reasoning is sound: the LLM correctly infers that Goldman Sachs’ larger broker-dealer asset base implies a need for broader internal controls and risk management, which is a logical extension of the ground truth’s point about increased complexity and monitoring. (4) The LLM adds specific structural details—segregation of research and trading, independent review—that are plausible and enhance the response, though not explicitly in the original answer; however, these do not contradict and fall within reasonable elaboration. The only minor shortcoming is that the original answer notes potential litigation and regulatory scrutiny as a shared risk, which the LLM omits, slightly reducing completeness. Still, the core multi-hop synthesis—linking asset size to regulatory compliance demands across both firms—is accurately and effectively conveyed. Wording differs but semantic equivalence is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 437,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan to build out in‑house foundry capacity (IFS) is already framed as a competitive battle with the likes of TSMC and Samsung (see page 54).  If Samsung accelerates its own IC development, it could cut back on external foundry work, heightening under‑utilization risk for Intel’s new fabs and forcing Intel to compete harder on price, yield and time‑to‑market (page 53).  Qualcomm, which depends on external IC customers, faces a similar threat: Samsung’s vertical integration could reduce the demand for Qualcomm’s chips from Samsung and other OEMs, potentially eroding Qualcomm’s semiconductor revenue and margins (pages 19‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding foundry capacity to compete with Samsung and TSMC; Samsung's in-house IC development could reduce its reliance on external foundries, increasing underutilization risk for Intel; this could force Intel to compete more aggressively on price, yield, and time-to-market; Qualcomm faces competitive pressure as Samsung’s vertical integration may reduce demand for its chips. These points are semantically equivalent to the original answer. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links Samsung’s internal IC development to reduced foundry outsourcing (affecting Intel’s IDM 2.0), and separately connects Samsung’s vertical integration to competitive threats for Qualcomm. It also implicitly captures the indirect pricing pressure effect on the broader market by noting Intel may have to compete harder on price. The only minor omission is not explicitly stating that Samsung could become a direct market competitor to Qualcomm with its own chips (beyond just reducing orders), which slightly reduces completeness. (4) Contextual relevance is excellent—the response directly addresses all parts of the multi-hop question, referencing appropriate strategic dynamics and competitive implications across the three firms. Wording differs but meaning is preserved. Overall, a very strong answer with only a slight gap in full depth on Qualcomm’s competitive threat.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 457,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "VZ’s 2015 transaction with American Tower required a $5.0 billion upfront payment for exclusive rights to lease and operate 11,300 towers, transferring operational control to the tower operator while Verizon retained tower ownership and sub‑leased capacity, thereby preserving some strategic leverage over a 30‑year horizon (page 73). In contrast, the NFLX 10‑K excerpts supplied do not disclose the size of upfront outlays or the strategic control associated with its exclusive content rights, so a direct comparison of capital impact and long‑term control cannot be drawn from the available information.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $5.0 billion upfront payment from American Tower Corporation in 2015 and the 11,300 towers involved, which matches the ground truth. However, it incorrectly states that operational control was transferred to American Tower, whereas the original answer clarifies that VZ retained operational control via subleased capacity and continued depreciation—this is a significant factual error affecting strategic interpretation. (2) Quantitatively, the dollar amount, year, and number of towers are accurate, earning high marks for numerical precision. (3) The reasoning fails on the NFLX side: the LLM claims that 'the NFLX 10-K excerpts supplied do not disclose...' implying insufficient data, but the original answer draws a clear contrast based on known business models (exclusive content as a cost center), which is common knowledge in financial disclosures and does not require specific dollar figures to compare strategic impact. The model fails to perform the required multi-hop synthesis by not recognizing that NFLX’s exclusive content strategy inherently involves ongoing costs without upfront receipts, even if exact numbers aren't cited. (4) The answer is partially relevant and attempts the comparison, but incorrectly frames the VZ arrangement (misrepresenting control) and underestimates available information on NFLX, leading to an unjustified conclusion that comparison isn't possible. This results in a low correctness score due to key factual and reasoning flaws despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 425,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "KO’s 2022 effective tax rate was nudged upward by the Tax Reform Act’s GILTI provisions, which added U.S. tax expense on foreign earnings and raised the company’s effective rate modestly 【108】. In contrast, the corporate income‑tax‑rate reduction in the Philippines lowered PepsiCo’s tax burden in that market, improving profitability and supporting stronger operations there 【49】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of the impact on both KO and PEP correctly—GILTI increased KO's tax burden, and the Philippines tax cut benefited PEP. However, it omits key quantitative details present in the ground truth. Specifically, the ground truth states that GILTI contributed to a 1.2% increase in KO's effective tax rate due to $710 million in pretax charges from equity method investee impairments. The LLM answer only vaguely refers to a 'modest' increase without citing these specific figures, which are central to the question's demand for precision. Similarly, while the Philippines tax rate reduction is correctly linked to a favorable impact on PEP, the ground truth notes it contributed to low-single-digit growth and lowered the effective tax rate by a 'notable but unspecified' amount—the LLM does not reflect the growth context or the degree of tax impact. (2) The missing numbers ($710 million, 1.2%) are significant omissions; their absence reduces quantitative accuracy substantially. Format variations are acceptable, but complete omission of key metrics is not. (3) The multi-hop reasoning is partially sound: the model connects U.S. tax policy (GILTI) to KO’s tax rate and local tax changes in the Philippines to PEP’s operations. However, it fails to fully synthesize the contrast in how tax reforms in different jurisdictions had divergent effects on multinational firms, weakening the comparative analysis. (4) Scores reflect that the answer is factually aligned in direction but lacks critical numerical support and contextual depth required for full accuracy. Contextual relevance is high because the response stays on topic and addresses both companies and policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 470,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "The $1.3 billion of retained earnings at Nicor Gas is **restricted for dividend payment** under state regulation.  Because Nicor Gas cannot distribute dividends beyond its retained‑earnings balance, the amount of cash that Southern Company can collect from Nicor Gas is capped at that level.  The restriction also bars Nicor Gas from making money‑pool loans to affiliates, further limiting the cash flow that Southern Company can access from this key subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.3 billion figure is correctly stated and matches the original answer. No calculations are required, and the amount is presented accurately. (2) The answer correctly identifies that Nicor Gas is a regulated subsidiary and that its retained earnings are restricted from dividend distributions and affiliate loans—this captures the core financial constraint. (3) The multi-hop reasoning is sound: it connects Nicor Gas’s restricted retained earnings to Southern Company’s limited ability to receive dividends and access cash flow, acknowledging the impact on the parent company’s financial flexibility. (4) The only minor shortcoming is that the LLM does not explicitly mention Southern Company Gas as the intermediate holding company or clarify that Southern Company relies on dividends from subsidiaries for a significant portion of its income—details present in the original. However, the essence of the impact on Southern Company is correctly conveyed. Wording differs slightly but maintains semantic equivalence. All entities (Nicor Gas, Southern Company, affiliate loans) are accurately referenced. The answer is fully relevant and focused on the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 351,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla’s 10‑K excerpts (pages 26‑30) do not disclose any dollar amount for safety‑compliance or recall costs.  In contrast, GM’s 10‑K (pages 11‑15) explicitly states that meeting evolving safety standards under the National Traffic and Motor Vehicle Safety Act is costly and that recall campaigns “could be substantial,” but it likewise does not provide a specific figure.  Consequently, a direct monetary comparison cannot be made; GM merely highlights a sizable cost burden, while Tesla’s costs are not quantified in the supplied pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually accurate in stating that neither Tesla nor GM provides specific dollar amounts for compliance costs related to evolving safety standards in their 10-K filings, which aligns with the available data. Thus, quantitative accuracy is perfect—no incorrect numbers are presented. However, the original answer from the knowledge graph provides a deeper, synthesized comparison based on qualitative disclosures: both companies acknowledge rising compliance costs due to evolving safety regulations, with Tesla facing challenges around Autopilot/FSD across jurisdictions and GM citing global regulatory divergence (especially between U.S. and UN-ECE standards) as a cost driver. The LLM answer fails to extract and synthesize this qualitative insight, instead focusing narrowly on the absence of monetary figures. While it correctly notes that GM mentions 'substantial' recall costs and regulatory burden, it omits Tesla's specific challenges with international safety standards for autonomous features, which is a key part of the multi-hop comparison. The response is contextually relevant and logically structured but lacks completeness in addressing the broader comparison of compliance cost drivers as required by the question. Therefore, while not factually wrong, it underperforms in qualitative accuracy and overall correctness due to missing key comparative insights present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 391,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics defers $305 million in other contract costs, recording them as a current‑asset balance that will be recognized only when the costs can be allocated to U.S. government contracts (GD 10‑K 2022, p. 59). In contrast, Raytheon Technologies’ fixed‑price U.S. government contracts expose the company to direct cost‑overrun risk, meaning any excess costs beyond the contract price can immediately erode profit (RTX 10‑K 2022, p. 15). Thus, GD’s deferral strategy postpones expense and defers risk, whereas Raytheon’s fixed‑price model carries a higher immediate financial risk if costs rise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $305 million deferral of contract costs by General Dynamics and accurately characterizes Raytheon Technologies' exposure to cost overruns under fixed-price contracts. All key facts from the ground truth are present: GD defers costs under FAR as an asset pending allocability, while Raytheon bears full risk of overruns on fixed-price contracts. The only minor omission is that the ground truth specifies recovery is expected through existing backlog and follow-on contracts—a detail absent in the LLM answer but not critical to the core comparison. (2) Quantitative accuracy is perfect: the $305 million figure is correctly cited, and no other numbers (e.g., percentages, dates) are misstated. Format is consistent and clear. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (General Dynamics and Raytheon Technologies), two contract types (FAR-regulated cost deferral vs. firm fixed-price), and two risk profiles (deferred vs. immediate financial exposure). The logic comparing GD’s risk deferral to Raytheon’s immediate profit erosion is valid and well-articulated. (4) Contextual relevance is excellent—the response directly addresses the comparative financial risk question and explains the differing implications of each cost management approach. The inclusion of 10-K page references adds credibility. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight reduction in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 429,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021, a compound annual growth rate of roughly **15.7 %**【page_86】. Apple’s Greater China segment grew from $68,366 million in 2020 to $74,200 million in 2021, an **≈8.5 %** increase over that year【page_25】.  Thus, Intel’s CAGR is about twice the growth rate Apple’s Greater China segment achieved over the comparable period (no 2019 Apple figure is provided in the supplied pages).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and its CAGR (~15.7% vs. ground truth 15.6%) are correct, Apple's data is completely misrepresented. The LLM incorrectly uses Apple's 2020–2021 growth (from $68,366M to $74,200M), rather than the required 2019–2021 period. The ground truth states Apple's Greater China revenue was $40,308M in 2019 and $68,366M in 2021, yielding a CAGR of ~30.8%. The LLM falsely claims 'no 2019 Apple figure is provided,' but the question and ground truth clearly rely on that data. (2) Calculations: Intel's CAGR is correctly computed (~15.6% vs. reported 15.7%, acceptable rounding). However, Apple's CAGR is not calculated over the correct period; instead, a single-year increase (~8.5%) is reported, which fails the multi-year CAGR requirement. (3) Multi-hop reasoning is flawed: the comparison requires synthesizing Intel's Taiwan revenue CAGR (2019–2021) with Apple's Greater China CAGR (2019–2021). The LLM fails this by using mismatched timeframes and incorrectly asserting missing data. (4) The conclusion that 'Intel’s CAGR is about twice' Apple’s is the opposite of the truth—Apple’s growth was more than double Intel’s. This fundamental reversal of the comparison severely undermines correctness. Scores reflect major quantitative and reasoning errors despite partial data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 394,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s $70 billion repurchase program will shrink the outstanding Class A and C shares, likely lifting their price and earnings per share (see GOOGL_10k_2024, page 82). For Class B holders, converting to Class A would increase the share count and could dilute the repurchase‑driven upside, making conversion less attractive. Meta’s disclosure that its Class A base (≈2.19 billion shares) is far larger than its Class B base (≈344 million shares) (META_10k_2024, page 1) illustrates that in a company with a huge Class A pool, conversion has a smaller dilutive impact; in Alphabet, the repurchase‑driven reduction in shares makes the dilution from conversion more pronounced, potentially discouraging conversions.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer contains accurate quantitative data: Alphabet's $70 billion repurchase program, Meta's Class A (≈2.19 billion) and Class B (≈344 million) share counts are correctly reported with acceptable rounding. These match the ground truth and are properly cited to the respective 10-K filings.\n\n2) However, the reasoning is fundamentally flawed and contradicts the correct logic. The LLM claims that conversion from Class B to Class A would 'increase the share count' and 'dilute the repurchase-driven upside', thus discouraging conversion. This is incorrect. In reality, when Class B shareholders convert to Class A, they are not issuing new shares—they are converting existing ones (1:1 basis). There is no dilution. The correct incentive, as stated in the ground truth, is that repurchases reduce the supply of Class A shares, increasing their scarcity and value, which *incentivizes* Class B holders to convert and sell before prices rise further. The LLM reverses the causal logic.\n\n3) The comparison to Meta is correctly used to highlight the relative size of Class A vs Class B shares, but the interpretation is misapplied. The LLM suggests that because Meta has a larger Class A base, conversion has less dilutive impact—again relying on a false premise of dilution. The correct point is that Meta’s large Class A float reduces scarcity effects from repurchases, so conversion urgency is lower than at Alphabet, where repurchases could tighten Class A supply more significantly.\n\n4) While entities (Alphabet, Meta, Class A/B/C shares), dollar amounts, and share counts are accurate, the multi-hop reasoning fails. The model does not correctly synthesize the economic incentives of share conversion in the context of repurchases. It introduces a non-existent 'dilution' effect, undermining the qualitative accuracy. The answer is contextually relevant and addresses the right companies and mechanisms, but the core conclusion is incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 526,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s RSUs accrue dividend equivalents that are paid in cash (without interest) when the award vests, creating a cash‑outflow obligation at vesting (page_92). Philip Morris International’s RSUs also earn dividend equivalents, but the filing does not indicate a cash payment at vesting, implying no cash obligation (page_110). Both companies’ RSUs vest on the third anniversary of the grant date and are subject to forfeiture if employment conditions are not met, but PepsiCo’s cash dividend obligation distinguishes its financial obligation from PMI’s, which only has the obligation to deliver shares at vesting.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both PepsiCo and Philip Morris International (PMI) accrue dividend equivalents on RSUs and that PepsiCo pays them in cash upon vesting. It also correctly notes the typical third-anniversary vesting condition for PMI. However, it incorrectly implies that PMI does not have a cash obligation for dividend equivalents, stating 'the filing does not indicate a cash payment at vesting, implying no cash obligation.' This contradicts the ground truth, which does not specify the form (cash vs. share) of dividend equivalent payout for PMI but confirms accruals occur. More critically, the LLM omits the key quantitative fact from the ground truth: as of December 31, 2023, PMI had $160 million of unrecognized compensation cost related to non-vested RSUs, which is a major financial obligation and directly relevant to the question about financial obligations. (2) Quantitatively, the LLM fails to mention the $160 million figure, which is a significant omission. All other non-numeric details (vesting timing, accrual practice) are consistent or reasonably inferred. (3) The multi-hop reasoning is partially sound—comparing vesting conditions and dividend treatment across two companies—but fails in synthesis by not incorporating PMI’s $160M unrecognized cost, which represents a core financial obligation. The conclusion that PMI has only a share-delivery obligation oversimplifies and misrepresents the financial impact. (4) Correctness is scored 6 due to major omission of a key financial figure and incorrect implication about PMI’s cash obligations. Quantitative accuracy is 8 because no numbers are wrong—just missing. Qualitative accuracy is 6 due to flawed reasoning on PMI’s obligations. Contextual relevance is high as the response stays focused on the question’s core themes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 498,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher values its private‑investment portfolio primarily by the plan’s share of the net asset value (NAV) of the underlying funds, supplementing that with discounted‑cash‑flow, earnings, or market‑multiple models when available, and it cautions that different assumptions can materially change the fair‑value estimate.  Eli Lilly, by contrast, records intangible assets acquired in business combinations at fair value on the acquisition date, a measurement that also requires significant estimates and assumptions and is noted as potentially subjective.  In both cases the companies acknowledge that their valuation methods involve substantial judgment and that alternative assumptions could lead to materially different fair‑value measurements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both DHR's and LLY's valuation approaches and correctly identifies the subjectivity inherent in both. It accurately states that Danaher uses NAV supplemented by discounted cash flow, earnings, or market multiples, and acknowledges the sensitivity to assumptions—consistent with the ground truth. For Eli Lilly, it correctly notes the use of fair value for acquired intangibles and the associated judgment and subjectivity. However, the LLM omits the specific quantitative example from the original answer—LLY's $3.80 billion in charges related to acquired intangible assets in 2023—which is a material detail that strengthens the point about valuation impact and subjectivity. While the core reasoning and entity identification (DHR, LLY, valuation methods) are correct and the multi-hop comparison across companies is sound, this omission reduces completeness. There are no errors in numbers, dates, or entities presented—the qualitative accuracy is high but not perfect due to the missing figure. The answer remains contextually relevant and semantically aligned with the ground truth, just less detailed in one key aspect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 332,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "Apple reported $74.2 billion in Greater China revenue for 2022, a segment that includes Taiwan. NVIDIA’s revenue from Taiwan in 2022 is not disclosed in the provided pages, so a direct numerical comparison cannot be made.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect because it claims that NVIDIA's revenue from Taiwan in 2022 is 'not disclosed,' which directly contradicts the ground truth stating NVIDIA reported $8,544 million from Taiwan in 2022. Apple's revenue figure of $74.2 billion (equivalent to $74,200 million) is correctly stated and matches the ground truth. (2) Quantitative accuracy is severely compromised: while Apple's number is correct, the failure to report NVIDIA's $8,544 million revenue renders the comparison invalid. The model omits a key numerical value that is essential to answering the question. (3) The multi-hop reasoning is flawed—the question requires comparing NVIDIA’s Taiwan-specific revenue to Apple’s Greater China revenue (which includes Taiwan). The LLM fails this synthesis by incorrectly asserting lack of data, thus breaking the chain of reasoning. (4) Contextual relevance is low but not zero because the answer correctly notes that Apple includes Taiwan in Greater China and attempts to frame the comparison, but the foundational error in data availability invalidates the response. Correctness score is 1 due to major factual inaccuracy despite partial contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 341,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and represent 33 ⅓ % of the company’s voting power, all of which is held by Mr. Roberts, giving him highly concentrated control【page_38】. Alphabet’s Class A shares are the sole voting class and are broadly held by many investors, so no single shareholder has a controlling stake【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast in voting control and ownership distribution between CMCSA and GOOGL. (1) Quantitatively, all key facts are correct: CMCSA's Class B shares carry 15 votes and represent 33⅓% of voting power, held entirely by Brian L. Roberts (referred to as Mr. Roberts, which is acceptable). The GOOGL Class A shares are correctly described as broadly held with no controlling stake, aligning with the ground truth's emphasis on dispersed ownership. While the LLM omits the specific number of GOOGL shares outstanding (300,754,904 as of January 25, 2022), this detail is contextual and not essential to the comparative governance conclusion. (2) The numbers and percentages are factually correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (CMCSA and GOOGL), compares their share structures, and draws a valid conclusion about control concentration vs. distributed influence. (4) The answer is semantically equivalent to the original, with slightly less detail on GOOGL’s share count but no factual inaccuracies. The use of 'Alphabet' instead of 'GOOGL' is acceptable as it refers to the same entity. The answer is fully relevant and directly addresses the question on control and ownership distribution. A score of 9 is given because while all critical facts are correct, the omission of the specific GOOGL share count slightly reduces completeness, though it does not impair the overall correctness of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 427,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "Under UnitedHealth Group’s equity‑compensation plans approved by shareholders, the company has 241 million securities available for future issuance versus 25 million issuable upon exercise of outstanding options, giving a ratio of 241 / 25 ≈ 9.6 (page 77).  \nJohnson & Johnson’s approved plans show 240,344,013 securities available for future issuance against 133,794,708 issuable upon exercise, a ratio of 240,344,013 / 133,794,708 ≈ 1.8 (page 118).  \nThus UnitedHealth Group’s ratio is roughly five times higher than Johnson & Johnson’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numeric values: 241 million and 25 million for UnitedHealth Group, and 240,344,013 and 133,794,708 for Johnson & Johnson. The calculated ratios (~9.6 and ~1.8) are accurate and match the ground truth (9.64 and 1.79), with acceptable rounding. (2) Calculations are correct: 241 / 25 = 9.64 ≈ 9.6, and 240,344,013 / 133,794,708 ≈ 1.795 ≈ 1.8. The statement that UnitedHealth Group’s ratio is 'roughly five times higher' is a reasonable qualitative interpretation (9.64 / 1.79 ≈ 5.4), though slightly imprecise in wording—it should be 'more than five times' rather than 'five times higher' (which could imply 6x), but this is a minor phrasing issue. (3) Multi-hop reasoning is sound: the model correctly identifies both companies, extracts the relevant figures from each, computes the ratios, and compares them meaningfully. (4) All entities (UnitedHealth Group, Johnson & Johnson, equity compensation plans, securities available, options issuable) are correctly identified and contextualized. The answer is fully relevant and semantically equivalent to the ground truth. The minor wording imprecision in the comparison does not undermine factual correctness, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 357,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s risk is primarily a supply‑chain dependency: the company “depends on third‑party companies for the design, manufacture and supply of motherboards” (AMD 10‑K, p. 28), and a disruption in those suppliers could hurt its business, but it is not tied to a single customer’s sales. In contrast, Intel’s revenue concentration risk is higher—Dell Inc. alone accounted for about 21 % of Intel’s net revenue in 2021, and the top three customers represented 43 % of revenue (Intel 10‑K, p. 87). Thus, AMD faces supply‑chain risk rather than revenue concentration, whereas Intel is more exposed to revenue concentration through its dependence on a few large customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Dell Inc. accounted for 21% of Intel's net revenue in 2021, which matches the original answer. The LLM adds that Intel's top three customers represented 43% of revenue, a detail not in the ground truth but consistent with the theme of revenue concentration and plausibly from the cited Intel 10-K (p. 87); this addition does not contradict but enriches the response. (2) Entity accuracy is strong: AMD, Intel, Dell Inc., and the correct fiscal year (2021) are all properly identified. (3) Reasoning is sound and multi-hop: the model correctly contrasts AMD’s supply-chain dependency (motherboard suppliers) with Intel’s customer concentration risk (Dell as major buyer), synthesizing information from both companies’ 10-Ks. (4) The semantic meaning fully captures the original answer’s intent—AMD’s risk is supply-side, Intel’s is demand-side revenue concentration. The only minor gap is that the original mentions Intel’s exposure to accounts receivable, which the LLM omits; however, this is a secondary detail and does not undermine the core correctness. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 348,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Boeing’s exposure to Louisiana’s corporate‑tax cuts is minimal, because its revenue is almost entirely from federal defense contracts and its tax expense is driven by federal and other state taxes; the risk discussion notes that federal appropriations and defense spending are the primary earnings drivers (pp. 10‑12).  In contrast, Union Pacific operates a major intermodal terminal in Louisiana (pp. 18) and the state’s tax‑rate reduction cut its deferred tax expense by $34 million, improving its effective tax rate and lowering its tax burden (pp. 29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense is correctly reported, matching the original answer exactly. No other numbers or dates are involved, and all financial figures are precise. (2) The answer correctly identifies that Boeing does not benefit directly from Louisiana’s tax changes due to its reliance on federal contracts, while Union Pacific benefits due to its operational presence—specifically citing a major intermodal terminal in Louisiana (consistent with the ground truth’s mention of the Livonia classification yard). (3) The multi-hop reasoning is sound: it connects Louisiana’s tax policy change to Union Pacific’s state-level tax exposure and contrasts it with Boeing’s federal-level exposure, correctly synthesizing the differing financial impacts based on business models and tax structures. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the broader legislative uncertainty affecting federal appropriations (e.g., potential delays impacting certifications or orders), which is part of Boeing’s indirect exposure. While implied through reference to federal appropriations as earnings drivers, this nuance is slightly underdeveloped compared to the original answer. However, the core facts, entities, and financial impact are all correct and well-reasoned, with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 402,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s governance is “one‑vote‑per‑share” – every common‑stock holder gets a single vote on all matters (see NFLX 10‑K, p. 60).  By contrast, Meta’s 10‑K discloses a dual‑class structure with Class A and Class B common stock that carry different voting rights (see META 10‑K, p. 1).  Charter’s own note clarifies that its Class A shares also have one vote per share, while Class B shares hold a number of votes tied to Charter Holdings units, illustrating how dual‑class schemes can allocate voting power beyond the simple one‑vote rule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix's one-vote-per-share model is accurately cited from its 10-K, Meta's dual-class structure (Class A and Class B) is correctly identified, and Charter's distinction between Class A (one vote per share) and Class B (variable voting rights tied to Charter Holdings units) is properly described. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; references to page numbers (e.g., NFLX 10-K p.60, META 10-K p.1) are consistent with the provided context and do not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance models across Netflix, Meta, and Charter, drawing a valid contrast between Netflix’s egalitarian voting and the tiered structures at Meta and Charter. (4) The only minor shortcoming is that the LLM does not explicitly note that Meta’s 10-K does *not* specify the exact voting rights per class (as stated in the ground truth), which slightly weakens the qualitative accuracy. However, this omission does not introduce inaccuracy, as the existence of different voting rights in a dual-class system is still correctly implied. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 387,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP’s filing (page 107) notes that exchange‑traded commodity futures are cash‑settled daily, so the settlement price is refreshed each trading day. MDLZ’s Level 1 liabilities are valued using quoted market prices from commodity exchanges (page 112). Thus the daily cash‑settlement mechanism simply guarantees that the quoted price MDLZ uses is the most current market price, but it does not alter MDLZ’s Level 1 valuation methodology—MDLZ continues to apply the same quoted‑price approach, now anchored to the daily‑settled price.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both PEP's and MDLZ's practices, correctly citing that PEP notes daily cash settlement of exchange-traded commodity futures (page 107) and that MDLZ values its Level 1 liabilities using quoted market prices from commodity exchanges (page 112). All entities (PEP, MDLZ, Level 1 financial liabilities, commodity exchanges) and the relevant mechanism (daily cash settlement) are correctly identified, and there are no numeric inaccuracies—though no specific numbers (e.g., dollar amounts) are involved, the qualitative financial concepts are sound.\n\nThe reasoning is mostly correct: the LLM correctly infers that the daily cash-settlement mechanism ensures the quoted price used by MDLZ is current, which supports the use of Level 1 valuations under fair value accounting. However, it slightly underrepresents the deeper alignment emphasized in the ground truth—that the daily cash settlement is a market standard that directly informs and validates MDLZ’s reliance on exchange prices as representative of fair value. The original answer highlights that because PEP excludes these instruments from year-end balance sheets due to daily settlement, it reflects a broader market practice that MDLZ’s methodology relies upon. This nuance of exclusion from balance sheets and its implication for valuation standardization is missing in the LLM answer, representing a minor but meaningful omission in multi-hop synthesis.\n\nThus, while the LLM captures the core relationship and does not contain errors, it falls short of fully articulating how the mechanism shapes or validates the valuation methodology, instead stating it 'does not alter' the approach. This downplays the affirming role of the mechanism in supporting the reliability of quoted prices. Hence, the answer is largely correct but lacks full depth in reasoning across the two filings, warranting a score of 8 for correctness and qualitative accuracy. Quantitative accuracy is 10 (no numbers, but all factual assertions are precise), and contextual relevance is 10 as it directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 566,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales in the Greater China region (which includes Taiwan) were **$74.2 billion**【page_52】, whereas AMD’s only disclosed sales figure for Taiwan is **$2.091 billion** (for 2021)【page_78】.  Because AMD’s 2022 Taiwan sales are not reported in the provided pages, the 2021 figure shows a much smaller exposure—Apple’s Greater China sales are roughly 35‑times larger than AMD’s Taiwan sales, underscoring Apple’s far greater footprint in that technology market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 net sales in Greater China as $74.2 billion (equivalent to $74,200 million), which matches the ground truth. However, it incorrectly states that AMD's $2.091 billion in sales for Taiwan is from 2021, while the ground truth specifies this figure is for 2022. This is a critical factual error in both entity accuracy and quantitative accuracy. (2) The calculation comparing Apple’s sales to AMD’s (35x larger) is mathematically reasonable ($74.2B / $2.091B ≈ 35.5), but it is based on a mismatched year for AMD, undermining the validity of the comparison. The original answer correctly compares 2022 figures for both companies. (3) The multi-hop reasoning is partially sound—linking Apple’s regional sales to AMD’s country-specific sales in the same geography—but fails because the AMD data is misattributed to 2021 when the document (and ground truth) clearly states it is 2022. This breaks the temporal alignment required for accurate comparison. (4) The contextual relevance is high because the answer addresses the geographic and market exposure question and attempts a meaningful comparison. However, due to the incorrect year for AMD’s sales, the core factual basis of the comparison is flawed, leading to a significant drop in correctness and qualitative accuracy. A score of 4 reflects partial correctness with major factual errors affecting the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 393,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy records environmental‑remediation costs as operating expenses unless a regulatory recovery is deemed probable, and it maintains reserves (e.g., $73 million for Duke Energy itself) to cover probable and estimable liabilities (see page 163). In contrast, Southern Company Gas’s natural‑gas utilities have specific cost‑recovery mechanisms approved by state regulators that explicitly allow recovery of environmental‑remediation costs (see page 22). Thus, Duke Energy bears the full expense of remediation unless recovery is likely, whereas Southern Company Gas can offset those costs through regulatory rate‑adjustment mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states Duke Energy's policy of expensing remediation costs unless recovery is probable and notes the existence of reserves (e.g., $73 million), which matches known disclosures. The mention of page 163 and page 22 adds document-level support, though the ground truth does not require page numbers—this is a minor enhancement, not an error. (2) Quantitatively, the $73 million reserve figure is correctly presented and plausibly attributed to Duke Energy; no other numbers are in dispute. Format is consistent and accurate. (3) The multi-hop reasoning is sound: it contrasts Duke’s cost-bearing approach with Southern Company Gas’s regulatory recovery mechanisms, correctly identifying that the latter has explicit approval for cost recovery via riders—this is the core distinction in the ground truth. (4) The answer captures the key qualitative difference: Duke may bear costs directly, while Southern Company Gas can recover them, reducing financial exposure. The only minor shortcoming is that the LLM refers to 'Southern Company Gas' throughout, while the original question and ground truth contrast 'Duke Energy' with 'Southern Company'—however, the clarification that it's the gas utilities of Southern Company that have the recovery mechanism makes this precise and contextually justified. No factual errors; excellent synthesis and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 396,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "LOW uses broker‑dealer quotes as observable inputs for its Level 2 fair‑value measurements, applying industry‑standard pricing models that rely on market data such as quoted trades, benchmark yields, and issuer spreads (LOW_10‑K, page 54).  GM, by contrast, estimates its $9.3 billion product‑warranty reserve with valuation models that incorporate historical claims experience and assumptions about future claims, a process described in the audit report’s discussion of warranty reserves (GM_10‑K, page 55).  Both companies therefore rely on industry‑standard models, but LOW’s inputs are directly observable market quotes, whereas GM’s inputs are derived from internal actuarial and financial assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes as observable inputs for Level 2 fair value measurements, relying on market-based data like issuer spreads and benchmark yields, while GM uses valuation models for its product warranty reserves based on historical claims and forward-looking assumptions. The $9.3 billion warranty reserve figure for GM is correctly stated and matches the ground truth in magnitude and context (allowing for minor year-to-year variation in actual filings). (2) Quantitative accuracy is perfect: the dollar amount ($9.3 billion) is correctly cited, and no other numerical claims are made that contradict the original answer. Format is appropriate and consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), two distinct financial reporting areas (fair value measurements vs. warranty reserves), and contrasts their use of industry-standard models based on input observability and judgment. It accurately distinguishes between market-driven, observable inputs (LOW) and management-judgment-heavy assumptions (GM). (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'Level 2' in the context of fair value hierarchy beyond labeling it, whereas the original emphasizes that LOW’s approach fits Level 2 due to observable inputs—this nuance is implied but not fully elaborated. However, the core contrast in model application—market data vs. internal forecasts—is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, factually correct, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 476,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Under the Basel III Finalization Proposal, both Capital One and Citigroup will have to compute risk‑weighted assets (RWA) under the new Expanded Risk‑Based Approach and under the existing Standardized Approach and bind each capital ratio (CET1, Tier 1, total capital, and leverage ratios) to the lower of the two resulting ratios. The proposal’s effective date of July 1 2025, with a three‑year transition to July 1 2028, means the full impact will be phased in over that period. For Citigroup, the proposal is expected to materially raise its regulatory capital, while for Capital One the same lower‑of‑two rule could increase its required capital if the Expanded Risk‑Based Approach yields higher RWA, though the effect may be less pronounced because it is not a GSIB.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the July 1, 2025 effective date, the three-year transition period (phased in through July 1, 2028), the requirement to use the lower of the two risk-based capital ratios, and the expectation that Citigroup will face a material increase in required regulatory capital. These dates and timelines match the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, and the phased-in timeline is correctly interpreted. (3) The reasoning is sound: the LLM correctly identifies the multi-hop requirement for both banks to calculate capital under two frameworks and bind to the lower ratio. It accurately notes that higher risk-weighted assets under the Expanded Risk-Based Approach would increase capital requirements if that method yields a lower ratio. (4) The only minor shortcoming is that the LLM omits the explicit mention of capital buffer requirements that both banks must meet regardless of the chosen approach—a detail included in the original answer that affects capital flexibility. Additionally, while the comment about Capital One not being a GSIB (Global Systemically Important Bank) may provide context, it is speculative and not in the source and slightly deviates from the neutral tone of the ground truth. However, it does not introduce factual error. Overall, the answer is semantically equivalent, highly relevant, and factually correct with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 412,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips’ condensate exposure comes from its 52.2 % stake in Alba Plant LLC, which processes 14 MMCFD of natural gas from the Alba Unit (plus 1 MBD of crude oil) and extracts condensate, although the filing does not disclose the exact condensate volume (Alba Unit production, page 12). By contrast, Chevron’s 2024 10‑K shows zero condensate reserves, indicating it had no direct condensate production volumes that year (Chevron 10‑K, 2024). Thus, ConocoPhillips has a potential condensate‑production exposure via Alba Plant, whereas Chevron had none.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states ConocoPhillips' 52.2% ownership in Alba Plant LLC and notes that condensate is extracted from the Alba Unit, with exposure reflected through equity earnings (implied via 'potential exposure'). It accurately reports Chevron's zero condensate reserves in its 2024 10-K, correctly inferring no direct condensate production. (2) Quantitatively, the 52.2% stake is correct. The LLM adds extra detail—14 MMCFD of natural gas and 1 MBD of crude oil—which is not in the ground truth but does not contradict it and may come from the cited filing page; however, since the original answer does not confirm condensate volume and the LLM acknowledges it is undisclosed, this is appropriately handled. No calculation errors. (3) The multi-hop reasoning is sound: it connects COP’s indirect exposure via equity interest to condensate production and contrasts it with Chevron’s lack of reserves/production, correctly concluding Chevron had no direct condensate output. (4) The answer is contextually relevant, directly addressing the comparison asked. The only minor shortcoming is that it does not explicitly mention 'Equity in earnings of affiliates' as the financial line item (a detail in the ground truth), and slightly overemphasizes processing volumes not critical to the core comparison. However, these omissions do not detract from factual correctness. Thus, near-perfect accuracy with only negligible detail gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 413,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO’s revenue‑recognition policy for contract modifications – accounting for additional products or services as separate contracts or as part of the existing contract based on pricing – was not materially affected by ASU 2020‑04 (page_63). Oracle’s adoption of ASU 2020‑04, which provides optional relief for contracts that replace a reference rate under the reference‑rate reform, had no material impact on its consolidated financial statements (page_72) but reduced the operational and financial impacts of such contract modifications (page_167).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits some key details. (1) Quantitatively, there are no numeric inaccuracies—both AVGO and ORCL reported no material impact, which is correctly stated. The time frame for ASU 2020-04 (March 12, 2020–December 31, 2024) is not mentioned in the LLM answer, but no incorrect dates are provided, so this is a minor omission rather than an error. (2) The LLM correctly identifies that AVGO’s revenue recognition practices were not materially affected and that ORCL adopted ASU 2020-04 with no material impact on financial statements—both supported by the original answer. It also correctly notes ORCL’s use of optional expedients (called 'optional relief' in the LLM answer), which is semantically accurate. (3) The multi-hop reasoning is sound: the model connects ASU 2020-04 to both companies and correctly distinguishes their applications—AVGO’s evaluation of contract modifications using standalone selling prices and ORCL’s adoption related to reference rate reform. However, the LLM omits that AVGO uses standalone selling prices to allocate consideration in bundled arrangements and that modifications are accounted for prospectively, cumulatively, or a combination—important nuances in revenue recognition practices. It also fails to mention that ORCL finalized adoption in Q1 of fiscal 2024, a specific detail in the ground truth. (4) Despite these omissions, the core facts are correct, and the answer remains contextually relevant and factually accurate on the main points: no material impact for both firms, correct application to contract modifications and reference rate reform. Wording like 'reduced the operational and financial impacts' (page_167) is acceptable as interpretive context, though not explicitly in the ground truth. Overall, minor completeness gaps prevent a 9–10, but the answer is factually sound and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 518,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class structure gives Mr. Zuckerberg and a small group of Class B holders 15 votes per share while Class A shares have only one vote, concentrating control and limiting ordinary shareholders’ influence—an effect the company notes can make its Class A stock less attractive (Meta, risk factors, pages 48‑52).  In contrast, Comcast’s Class B shares also carry 15 votes per share and 33 ⅓ % of the voting power, but they are convertible share‑for‑share into Class A stock, allowing B holders to adjust their holdings while still preserving significant governance control (Comcast, Note 12, pages 71‑91).  Thus, Meta’s structure rigidly concentrates control, whereas Comcast’s convertibility policy gives B holders high voting power with a mechanism to dilute or adjust their holdings without permanently ceding control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Meta's Class B shares have 15 votes per share, Class A has 1 vote, and control is concentrated with Zuckerberg; CMCSA's Class B shares also have 15 votes per share and hold 33⅓% of voting power. The convertibility of CMCSA Class B into Class A on a share-for-share basis is correctly stated. (2) Quantitative accuracy is perfect: percentages (33⅓%), vote ratios (15:1), and structural details match the original. No calculation errors. (3) Multi-hop reasoning is sound—correctly compares governance control mechanisms across two companies, highlighting Meta’s rigid class-vote requirements (though slightly less emphasis on the 35% threshold trigger mentioned in ground truth) versus CMCSA’s flexible conversion policy. The LLM captures the core contrast: entrenched control vs. adjustable but preserved influence. (4) Minor omission: the ground truth specifies Meta requires majority Class B approval for change-of-control transactions until Class B voting power drops below 35%, which the LLM does not mention—this is a small but relevant governance detail. However, the essence of Meta’s rigid control is still conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses governance control and shareholder influence as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 384,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP uses exchange‑traded commodity futures, but because they are cash‑settled daily the company notes that they are “not included in the table as of December 25, 2021” (PEP 10‑K, page 107).  In contrast, Costco reports that it “did not hold any Level 1 or 3 financial assets or liabilities that were measured at fair value on a recurring basis” (COST 10‑K, page 51), meaning it has no exchange‑traded commodity futures or listed options to disclose.  Thus, PEP’s futures are excluded from its fair‑value hierarchy, while Costco has none of those Level 1 assets to report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (December 25, 2021, and August 28, 2022) and references to financial disclosures are correct in substance, though the COST date is not explicitly restated in the LLM answer—it is implied via context. The exclusion of PEP's commodity futures from the fair value table as of December 25, 2021, is correctly cited. (2) The LLM accurately notes that PEP excludes daily cash-settled exchange-traded commodity futures from its fair value hierarchy table, consistent with its 10-K (page 107), and correctly quotes COST’s disclosure (page 51) about holding no Level 1 or Level 3 financial assets measured at fair value on a recurring basis. (3) The multi-hop reasoning is sound: it connects PEP’s use of exchange-traded, cash-settled commodity futures (which are Level 1 assets) with COST’s absence of such assets, highlighting a key contrast. The LLM correctly infers that because COST reports no Level 1 assets, it holds no exchange-traded commodity futures, which is logically consistent with the definition of Level 1 assets. (4) The only minor shortcoming is that the LLM does not explicitly name MDLZ as the source defining Level 1 assets to include exchange-traded commodity futures, which is part of the ground truth and adds contextual support. However, the LLM still correctly treats exchange-traded futures as Level 1 assets, so the omission does not undermine factual accuracy. Wording differs slightly but maintains semantic equivalence. All key entities (PEP, COST), financial instruments, and disclosures are correctly identified and synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 451,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs reported $1.634 billion of securities loaned with maturities of 31‑90 days (page 187), whereas Morgan Stanley’s 10‑K shows a total securities‑loaned balance of $16.352 billion – the sum of its U.S. ($9.499 billion) and non‑U.S. ($6.853 billion) loaned amounts (page 150).  The GS figure is a small fraction of its overall securities‑loaned exposure and far below MS’s total, indicating that Goldman Sachs has a lower short‑term securities‑lending exposure and, consequently, a lower short‑term securities‑lending risk profile relative to Morgan Stanley.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that Morgan Stanley's total securities loaned amount to $16.352 billion (sum of $9.499 billion U.S. and $6.853 billion non-U.S.), which directly contradicts the ground truth value of $281 million. This is a severe quantitative inaccuracy—off by more than 50x. Additionally, while the Goldman Sachs figure of $1.634 billion ($1,634 million) is correct, the conclusion drawn is the opposite of the truth. (2) The calculation for Morgan Stanley’s total is incorrectly presented as $9.499B + $6.853B = $16.352B, but according to the ground truth, Morgan Stanley’s total securities loaned is only $281 million, meaning the LLM used incorrect source data. There is no indication in the ground truth that Morgan Stanley reported such large individual components. (3) The multi-hop reasoning fails because the LLM uses incorrect data for Morgan Stanley, leading to a completely reversed conclusion about relative risk exposure. Instead of correctly inferring that Goldman Sachs has significantly higher short-term securities lending risk due to its $1,634M exposure versus Morgan Stanley’s $281M total, it claims the opposite. (4) The contextual relevance is partially maintained because the answer addresses the right companies and metric, but the massive factual error in numbers and resulting flawed logic severely undermine the response. Correctness is scored very low (1) because the core financial data and conclusion are fundamentally wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 416,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided interest in Alabama Power’s Plant Miller Units 1 and 2 represents **8.16 %** of its owned generating capacity (page 17). In comparison, Duke Energy produced **22,344 GWh** of electricity in 2021 (page 189).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and accurately states Duke Energy's 2021 total electricity generation as 22,344 GWh, matching the ground truth exactly. All numeric values are correct and properly attributed. (2) Quantitative accuracy is perfect: the percentage (8.16%) and energy generation figure (22,344 GWh) are both factually correct and consistent with the original answer. No calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound—information about PowerSouth’s ownership stake and Duke Energy’s system-wide generation are correctly synthesized from different entities and contexts. However, the LLM omits the contextual detail that the 8.16% refers to PowerSouth’s *interest in the plant*, not 8.16% of its *total owned generating capacity*, which slightly misrepresents the metric. The original answer clarifies that this interest contributes to over 1,600 MW of capacity but does not state it constitutes 8.16% of total capacity—this is a subtle but important distinction. (4) Despite this minor misstatement, the core facts and comparison are accurate and relevant, hence a high correctness score. Contextual relevance is full as it directly addresses both parts of the question with precise data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 373,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "Nike’s $11.6 billion of short‑term, investment‑grade fixed‑income securities have a weighted‑average maturity of only 65 days, so its exposure to interest‑rate movements is modest (NKE 10‑K, p. 50).  \nMcDonald’s valuation of derivatives and other financial instruments relies on Level‑2 pricing models that explicitly use observable interest‑rate yield curves, making its reported values more directly sensitive to changes in those market inputs (MCD 10‑K, p. 46).  Thus, while both firms use observable market data in their valuation models, Nike’s short‑duration portfolio limits its interest‑rate risk, whereas McDonald’s derivative‑heavy approach heightens its sensitivity to yield‑curve movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: NIKE's $11.6 billion portfolio and the 65-day weighted-average maturity (from NKE 10-K, p. 50) are accurately cited. While the original answer does not specify the 65-day maturity, this detail is consistent with and adds precision to the ground truth, not contradicting it. McDonald’s use of Level 2 inputs and observable yield curves (MCD 10-K, p. 46) is correctly referenced. (2) The answer correctly identifies both companies’ reliance on observable market data in pricing models, satisfying the core comparison. (3) The multi-hop reasoning is sound: it synthesizes NIKE’s interest rate risk from fixed-income investments with McDonald’s sensitivity via derivatives, correctly contrasting the nature of exposure—NIKE’s modest risk due to short duration vs. McDonald’s higher sensitivity due to derivatives. (4) The LLM adds value by specifying maturity duration and valuation levels (Level 2), which are not in the original answer but are factually correct and enhance the comparison. The only reason for not scoring a 10 is that the original answer emphasizes the differing 'nature and magnitude' of risk without the maturity detail, so while the LLM is more precise, it slightly shifts emphasis. Still, the semantic meaning and factual core are preserved and enhanced. All entities (NIKE, McDonald’s, fixed-income, derivatives, yield curves) are correct and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 412,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s common stock is “one‑vote‑per‑share” (page 60), so every share carries equal voting power and shareholder influence is directly proportional to ownership. Alphabet’s Class A shares also have one vote per share, but the company’s Class B shares carry ten votes each (page 82), concentrating voting power in the hands of a minority of holders and allowing insiders to maintain control. Consequently, Netflix’s governance is more directly aligned with shareholder ownership, whereas Alphabet’s multi‑class structure can dilute ordinary shareholders’ influence and create a governance dynamic where management and large holders wield disproportionate control.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Netflix's one-vote-per-share policy and Alphabet's Class A (1 vote) and Class B (10 votes) structure are accurately described. (2) No numerical errors: the voting ratios (1:1 for Netflix, 1:1 for Alphabet Class A, 10:1 for Class B) are correctly reported, and no miscalculations are present. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the implications of these structures on shareholder governance—Netflix’s egalitarian model vs. Alphabet’s concentration of control among insiders—drawing a clear contrast in governance dynamics. (4) The response fully addresses the question by explaining how the structural differences influence shareholder influence and control, with precise entity identification (Netflix, Alphabet, Class A/B shares) and accurate qualitative analysis. Minor differences in wording (e.g., 'dilute ordinary shareholders’ influence' vs. 'more susceptible to control') do not affect factual correctness and are semantically aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 309,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "AbbVie’s Imbruvica is a high‑revenue biologic that the CMS has already placed on its “Selected Drug” list for Medicare Part D price‑setting beginning in 2026, which could sharply cut reimbursement and accelerate revenue erosion before patent expiry (AbbVie, 2023, pp. 17‑19). Johnson & Johnson’s XARELTO, while also subject to the same ceiling‑price rule, represents a smaller share of J&J’s overall portfolio and is a small‑molecule anticoagulant; the IRA’s impact is therefore likely to be more modest, allowing J&J to offset any loss through other high‑margin products (JNJ, 2023, p. 11).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in key aspects: it correctly identifies that AbbVie's Imbruvica was selected for Medicare Part D price-setting starting in 2026, and that this could accelerate revenue erosion before patent expiry, citing appropriate context (AbbVie, 2023). It also correctly notes that Johnson & Johnson's XARELTO is subject to the same IRA pricing rules. The dates and drug classifications (biologic vs. small molecule) are accurate, and there are no numerical inaccuracies—no specific dollar figures or percentages were required, so the absence of quantified revenue impact does not constitute an error. However, the LLM omits a critical element from the original answer: Johnson & Johnson’s active litigation against the IRA’s pricing mechanism, which reflects a strategic difference in how the two companies are responding. This omission weakens the qualitative comparison of their revenue strategies. While the LLM suggests J&J can offset losses due to XARELTO’s smaller portfolio share (a reasonable inference), this point is not in the ground truth and slightly shifts the emphasis from strategic legal action to portfolio diversification. The reasoning is logical and contextually relevant, and the answer addresses the differential impact on revenue strategies to a significant extent, but the missing litigation point represents a meaningful gap in multi-hop synthesis across corporate responses. Thus, while quantitatively and contextually strong, the qualitative accuracy is reduced due to incomplete strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 424,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk governance is anchored in the Group Business Risk and Control Committee (GBRCC) and the Independent Compliance Risk Management (ICRM) function, both of which report directly to the Board and the CRO.  These bodies embed climate‑risk considerations into the credit‑loss provisioning and liquidity‑stress‑testing frameworks, requiring that transition‑risk scenarios be modeled and any amplification of credit or liquidity exposure be escalated to the Risk Management Committee and the Climate Risk Committee (co‑chaired by the CRO and CSO).  This structure ensures that compliance oversight directly monitors and mitigates the potential for climate‑transition risk to magnify Citi’s credit and liquidity risks, as highlighted in Morgan Stanley’s disclosures.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but introduces significant inaccuracies in entity identification and governance structure details not present in the ground truth. (1) Correct elements: The answer correctly identifies that Citi’s governance structure addresses compliance risk in the context of climate transition risks and their potential amplification of credit and liquidity risks, which aligns with the multi-hop requirement linking Citi’s structure to risks outlined in Morgan Stanley’s disclosures. The focus on credit-loss provisioning and liquidity-stress-testing frameworks is contextually relevant. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in either the LLM or original answer, so this dimension is neutral; no errors present. (3) Multi-hop reasoning: The LLM fails to accurately reflect the actual governance bodies named in the ground truth (Board and Executive Management Team, Citi Internal Audit, Citi Audit Committee). Instead, it invents or incorrectly specifies committees such as the 'Group Business Risk and Control Committee (GBRCC)', 'Independent Compliance Risk Management (ICRM)', and a 'Climate Risk Committee co-chaired by CRO and CSO'—none of which are mentioned or verifiable in the ground truth. These specific entities and reporting lines are factually incorrect. (4) Semantic equivalence: While the general theme—Citi’s governance integrating climate risk into compliance and risk management—is consistent, the LLM fabricates structural details, undermining qualitative accuracy. The original answer emphasizes Board-level oversight, accountability through Internal Audit, and alignment with regulatory expectations, particularly via the Audit Committee. The LLM shifts focus to operational committees and modeling requirements not supported by the source. Thus, despite contextual relevance and logical flow, the answer is factually flawed in key governance specifics, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 530,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "QCOM’s licensing revenue is heavily concentrated in a few Chinese OEMs—about 30 % of its licensing income—so any U.S.–China trade tensions, export‑control restrictions or sanctions that affect those OEMs can abruptly cut revenue streams and disrupt the supply of licensed products (page_18, page_20).  In contrast, Texas Instruments is expanding its own 300‑mm wafer fabs to boost internal capacity, thereby reducing dependence on external foundries, cutting costs, and giving it greater control over manufacturing and supply‑chain flow (page_7, page_6).  While TXN still faces broader global supply‑chain risks, its internal capacity build mitigates the specific bottleneck and regulatory exposure that QCOM encounters from its reliance on Chinese OEMs (page_9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated, matching the original answer. No other numerical values (dates, dollar amounts) are present, so no calculations are required. (2) The LLM correctly identifies both companies (QCOM and TXN) and their respective strategies: QCOM’s reliance on Chinese OEMs for licensing revenue and TXN’s expansion of internal 300mm wafer fabrication. The cited pages (e.g., page_18, page_20, page_7, etc.) suggest proper grounding in source material. (3) The multi-hop reasoning is sound—comparing QCOM’s external dependency and associated geopolitical/contractual risks with TXN’s vertical integration strategy to reduce foundry reliance. The LLM captures the core contrast in risk profiles: QCOM faces regulatory and trade-related risks, while TXN mitigates supply chain bottlenecks through capital investment. (4) The answer is semantically equivalent to the original, though slightly less explicit in naming TXN’s specific facilities (RFAB2, LFAB1, SM1), which are mentioned in the ground truth. This is a minor omission that doesn’t detract from the overall correctness. The LLM emphasizes 'U.S.–China trade tensions' and 'export-control restrictions'—valid elaborations of geopolitical risks—not explicitly detailed in the original but consistent with it. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 443,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company notes that ASU 2020‑04 is expected to have no material impact on its interest‑rate‑derivative positions and that its hedging relationships should remain effective, though it will continue to evaluate the transition and the ultimate outcome is uncertain (see pages 194–195). Duke Energy likewise indicates that the transition away from LIBOR is not expected to materially affect its LIBOR‑indexed swaps or debt, but it is assessing optional expedients and alternative indices and acknowledges the outcome remains uncertain (see pages 136–137). Both companies therefore anticipate no material impact but are monitoring the implementation.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core assessments of both Southern Company and Duke Energy regarding ASU 2020-04, stating that both anticipate no material impact and are continuing to evaluate the transition. However, it diverges from the original answer by asserting that Southern Company 'expects no material impact,' whereas the ground truth states Southern is still evaluating and recognizes uncertainty about the ultimate impact—without making a 'no material impact' conclusion. This misrepresents Southern's position. In contrast, Duke Energy’s assessment is accurately reflected, including its evaluation of optional expedients and the conclusion that the impact is not expected to be material. (2) There are no numeric values, dates, or calculations in either the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is partially sound: the model correctly identifies both companies and the relevant accounting standard, and synthesizes their respective evaluations. However, it incorrectly equates Southern’s ongoing evaluation with a conclusion of no material impact, which is not supported by the ground truth. The original answer emphasizes Southern’s continued evaluation without a definitive materiality conclusion, while the LLM answer implies one. (4) Contextual relevance is high—the response directly addresses the comparison asked in the question and references appropriate financial instruments (interest rate derivatives, LIBOR-indexed debt). The qualitative accuracy is reduced due to the mischaracterization of Southern Company’s assessment, though the overall structure and intent of the comparison remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 469,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 2024 10‑K notes that it holds cash equivalents and market‑to‑market securities in foreign currencies—including British pounds and euros—but the excerpts do not disclose the dollar amount or any hedging details (see page 7/9).  Nike, by contrast, explicitly uses currency forward and option contracts as cash‑flow hedges to manage its transactional and translational foreign‑currency exposures (see pages 48‑49).  Thus, Amazon’s exposure to pounds and euros is largely a passive holding with no disclosed hedging, whereas Nike actively employs option contracts to mitigate similar currency risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros without disclosing hedging details, while NKE explicitly uses option contracts for hedging. The absence of dollar amounts or hedging disclosures for AMZN is accurately noted, consistent with the original answer. (2) There are no numerical figures in the question or ground truth that require calculation, so quantitative accuracy is not compromised—no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their foreign exchange risk management approaches, and draws a valid contrast between passive exposure (AMZN) and active hedging via options (NKE). The mention of 'cash-flow hedges' and specific reference to Nike’s use of forwards and options on pages 48–49 supports the qualitative depth. (4) The only minor limitation is that the LLM answer does not explicitly mention NKE hedging 'forecasted transactions and balance sheet exposures' or specify that AMZN’s risk includes translational exposure from asset valuation—details present in the original. However, the core contrast—AMZN’s lack of disclosed hedging vs. NKE’s active use of options—is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect as all parts of the question are addressed with precise, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 417,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s Class A shares carry one vote each, while its Class B shares carry ten votes each—so each Class B share has ten times the voting power of a Class A share. Alphabet’s structure is identical: Class A shares (GOOGL) have one vote per share, Class B shares (GOOG) have ten votes per share, and the non‑voting Class C shares have no voting rights. Thus, the voting‑power split between Class A and Class B is the same for both companies, with Class B shares holding tenfold the voting weight of Class A shares【page_82】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Meta's Class B shares have 10 votes each, while the ground truth specifies 15 votes per Class B share. It also falsely claims that the voting-power split is the same between Meta and Alphabet (GOOGL), when in fact Meta allocates 66 2/3% of voting power to Class A and 33 1/3% to Class B, whereas GOOGL has no disclosed percentage distribution—only that Class B shares have 10 votes vs. 1 for Class A. The LLM incorrectly equates the structures, missing the key point that Meta gives Class B shares significantly more relative influence due to the 15:1 ratio and explicit voting power distribution. (2) Quantitative errors include the vote ratio (10:1 instead of 15:1 for Meta) and omission of the exact voting power percentages (66 2/3% and 33 1/3%), which are central to the original answer. The claim of 'identical' structures is factually wrong. (3) The multi-hop reasoning fails: the model should have compared Meta’s 15-vote Class B shares with concentrated voting power against GOOGL’s 10-vote Class B shares without a disclosed split, concluding that Meta’s structure gives relatively more power to Class B. Instead, it oversimplifies and misrepresents both companies' structures. (4) Contextual relevance is moderate because the answer addresses share class voting rights and attempts a comparison, but due to major factual and analytical errors, it conveys a misleading conclusion. The citation of 'page_82' does not align with accurate data, further undermining reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 434,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s stake in SNG’s $3 billion pipeline is a capital‑intensive project that will only proceed once the pipeline receives FERC approval; Southern Company Gas will fund 50 % of the cost (≈$1.5 billion) but the investment is contingent on regulatory clearance. By contrast, Duke Energy Ohio’s FERC approval relates to dividend payments and imposes a regulatory constraint that its equity—adjusted for merger accounting—must stay above 30 % of total capital, limiting how much capital can be distributed rather than requiring a new capital outlay.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3 billion pipeline project and Southern Company Gas's 50% ownership, implying a $1.5 billion funding obligation, which aligns with the ground truth. However, the original answer specifies Southern Company's (SO) direct investment in SNG as $1,245 million as of December 31, 2024—a specific figure not mentioned in the LLM response. This omission affects quantitative completeness. The LLM approximates the 50% share as ≈$1.5 billion, which is mathematically correct but does not reference the actual recorded investment of $1,245 million, suggesting either a discrepancy or incomplete data integration. (2) The regulatory timelines (e.g., potential delay until 2029) from the original answer are missing in the LLM response, which weakens the completeness of the regulatory constraint discussion. (3) The qualitative reasoning is strong: the LLM correctly distinguishes between SNG’s project execution dependency on FERC approval and DUK’s capital structure constraint tied to dividend policy, showing accurate multi-hop synthesis across two companies and regulatory contexts. (4) Contextual relevance is excellent—the response directly compares regulatory and capital implications as asked. The core facts are semantically aligned, but the missing $1,245 million figure and 2029 timeline prevent a top score. Quantitative accuracy is reduced due to omission of a key number and lack of precision on SO’s actual investment, though the $1.5 billion calculation from 50% of $3B is logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 426,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s returned value to shareholders primarily through cash and share repurchases – it repurchased $13.1 billion of common stock in fiscal 2021 (including a $3.0 billion accelerated share‑repurchase with a financial institution that delivered 11.9 million shares) and paid $2.0 billion in dividends, directly returning cash to owners. In contrast, Home Depot does not issue cash dividends; instead it provides dividend equivalents on performance shares and restricted‑stock units, which accrue and are paid as additional shares when the awards vest, rewarding employees and aligning their interests with shareholders rather than delivering cash directly.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lowe's $3.0 billion accelerated share repurchase (ASR) with a financial institution and the receipt of 11.9 million shares, which matches the ground truth. It also accurately describes Home Depot's use of dividend equivalents on unvested performance shares and restricted stock units, paid as additional shares upon vesting. However, the LLM introduces a figure of $13.1 billion in share repurchases for fiscal 2021, which is not present in the ground truth; instead, the original answer states that Lowe's authorized $13.0 billion in additional repurchases in December 2021, bringing the total authorization since 2020 to $28.0 billion. The $13.1 billion figure appears to conflate authorization with actual execution and is not corroborated by the ground truth. Additionally, the LLM claims Lowe's paid $2.0 billion in dividends, which is not mentioned in the original answer and contradicts the implication that Lowe's focused on repurchases rather than dividends. (2) The quantitative inaccuracies are significant: the $13.1B repurchase amount and $2.0B dividend are unsupported by the ground truth. While the $3.0B ASR and 11.9M shares are correct, the overall financial narrative is skewed by these incorrect figures. (3) The multi-hop reasoning is sound in comparing Lowe's use of financial institutions for share repurchases with Home Depot's equity-based dividend equivalents. The synthesis across companies and mechanisms is logical and relevant, correctly contrasting direct share reduction vs. equity-aligned compensation. (4) Despite strong contextual relevance and mostly accurate qualitative reasoning, the introduction of unsupported financial figures reduces quantitative accuracy and overall correctness. The core contrast in shareholder value distribution mechanisms is preserved, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 511,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both Caterpillar and Honeywell adopted ASU 2022‑04 on January 1 2023, with the roll‑forward disclosure becoming effective January 1 2024. The standard requires annual disclosure of key terms, the balance‑sheet presentation, the confirmed amount outstanding at period end, and a roll‑forward of those amounts; each company now presents a 2024 roll‑forward table (Caterpillar p. 112; Honeywell p. 112) showing beginning balance, invoices confirmed, invoices paid, and ending balance. The guidance does not alter the recognition or measurement of supplier‑finance program obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Caterpillar and Honeywell adopted ASU 2022-04, with the rollforward requirement effective January 1, 2024—matching the original answer. The adoption date of January 1, 2023, for the standard itself is consistent with SEC implementation timelines (early adoption permitted, full compliance by 2024 for rollforwards). (2) Quantitatively, the LLM does not include the specific $830 million figure for Caterpillar mentioned in the ground truth, which is a minor omission. However, it correctly references the structure of the rollforward (beginning balance, invoices confirmed, paid, ending balance) and cites page numbers (p. 112 for both), suggesting accurate sourcing. The absence of Honeywell’s specific dollar amount is not an error, as the original answer also does not provide it. (3) The reasoning is sound: the LLM correctly synthesizes that both companies now disclose rollforwards in 2024, that the standard enhances transparency without changing recognition/measurement, and that disclosures include key elements like terms and balance sheet presentation. (4) The answer is contextually complete and relevant, addressing all parts of the question—adoption impact, disclosure changes, and the 2024 rollforward requirement. The only reason for not scoring a 10 is the missing mention of Caterpillar’s $830 million obligation, a factual detail present in the ground truth that adds quantitative specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 417,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s $49.5 billion of credit‑card loans due within one year (fixed‑rate portion, page 86) is a modest, snapshot exposure in its consumer‑credit portfolio. In contrast, Visa identifies a $20 trillion global opportunity to convert non‑card payments into digital credentials and is pursuing growth by expanding credit‑card issuance across its network (page 8). Thus, Company C’s current loan balance is a tiny fraction of the market Visa aims to capture through its credit‑card strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies Company C's $49,549 million (rounded to $49.5 billion) in credit card loans due within one year and accurately references Visa's $20 trillion opportunity in converting non-card payments to digital credentials. The numeric values are correct with acceptable formatting variation ($49,549 million = $49.5 billion). 2) Quantitatively, the numbers are accurate and properly contextualized. The LLM correctly interprets the scale difference between Company C’s exposure and the total market opportunity. 3) However, the qualitative reasoning is partially misaligned with the original answer. While the original emphasizes alignment between Company C’s short-term credit exposure and Visa’s growth strategy—suggesting that such balances are a natural outcome of Visa’s push—the LLM frames Company C’s position as a 'modest, snapshot exposure' and implies it's merely a 'tiny fraction' of the market, missing the synergistic relationship. The original answer highlights that Visa’s strategy would *lead to* more such balances across institutions like Company C; the LLM does not capture this causal or strategic alignment. 4) Contextually, the response is relevant and addresses both entities and the core comparison. Despite missing the deeper synthesis of how Company C’s data point fits *within* Visa’s strategic growth engine, it correctly situates the figures and conveys a reasonable interpretation. Hence, high marks for quantitative and contextual accuracy, but a moderate deduction in qualitative accuracy due to incomplete multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 430,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company Gas’s gas‑distribution revenue is weather‑sensitive, but the company limits exposure through regulatory weather‑and‑revenue‑normalization mechanisms and weather‑derivative instruments that cap volatility within typical ranges (see pages 200 & 86). NextEra Energy’s electricity demand is likewise weather‑driven—especially by extreme temperatures and severe weather—and the company mitigates this risk with hedging, weather‑derivative contracts, load‑shedding options and infrastructure winterization, though these tools may not fully shield against extreme events (see pages 26 & 28). Thus, Southern Company Gas relies on a more structured, regulatory‑based mitigation that reduces weather exposure, whereas NextEra Energy depends on market‑based hedging and operational adjustments, leaving it comparatively more exposed to severe weather shocks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numbers from the original answer (e.g., 6.2% decrease in net income for Southern Company Gas in 2023) are repeated in the LLM response, but the absence of these figures does not constitute an error—rather, it reflects summarization. The LLM does not introduce any incorrect numbers, and all referenced mechanisms (weather normalization, derivatives) are correctly attributed. (2) The LLM correctly identifies both companies and their respective risk exposures: Southern Company Gas’s weather-sensitive revenues and use of regulatory and financial tools (weather normalization, derivatives), and NextEra Energy’s exposure to extreme weather (hurricanes, temperature extremes) affecting electricity demand and operations. (3) The multi-hop reasoning is sound: it compares the nature of weather impact (revenue volatility vs. operational disruption), contrasts mitigation strategies (regulatory-based vs. market/operational), and draws a valid conclusion that Southern’s approach provides more structural protection, while NEE remains more exposed to severe events—this matches the original answer’s core insight. (4) The only minor shortcoming is the omission of the specific 2023 financial impact (6.2% net income decline) for Southern Company Gas, which was present in the ground truth and would have strengthened quantitative completeness. However, this omission does not undermine the overall correctness. The LLM cites document pages plausibly and uses semantically equivalent, technically precise language. Contextual relevance is excellent, directly addressing the comparative risk exposure and mitigation strategies as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 471,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s generates a large share of its $24 billion‑plus revenue from affiliates that operate restaurants under franchise or licensing agreements – the company earns royalties and fees that are a percent of sales (page 46) and also receives brand‑licensing and technology‑platform fees (page 48).  In contrast, GM’s cross‑over production is handled by non‑consolidated joint‑venture affiliates; automotive sales from those affiliates were only $90 million in 2024, a tiny fraction of its $157 billion automotive revenue (page 77).  Operationally, McDonald’s relies on a franchise‑based model where affiliates run the restaurants but the company collects revenue, whereas GM’s affiliates are production‑focused joint ventures that supply vehicles to dealers, with GM exerting influence but not consolidating the entities.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It claims GM's automotive sales from nonconsolidated affiliates were $90 million in 2024, which is not supported by the original answer or typical SEC filing data; the ground truth does not provide specific revenue figures for GM's affiliate transactions, so introducing a precise number like $90M is a fabrication. Additionally, the claim that McDonald's has $24 billion-plus in revenue is plausible but not directly supported by the original answer, which focuses on the structure of revenue rather than total revenue. (2) The citation of 'page 46', 'page 48', and 'page 77' suggests the model is referencing specific document locations, but these are not part of the ground truth and cannot be verified; their inclusion implies a level of sourcing not warranted by the input. (3) Qualitatively, the model correctly identifies the core operational distinction: McDonald's franchise model generates royalty-based recurring revenue, while GM's nonconsolidated affiliates are production-focused joint ventures with transactional revenue. This reflects sound multi-hop reasoning in contrasting business models and revenue structures across companies. (4) Contextually, the answer is highly relevant, directly addressing the comparison in revenue contribution and operational structure. However, the introduction of unsourced numerical data undermines factual correctness, especially the $90M figure, which misrepresents the scale of GM's affiliate revenue. While the conceptual framework is accurate, the incorrect numbers reduce confidence in the answer, warranting a score of 6 for overall correctness—partially correct but with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 472,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "Comcast’s Class B shares carry a guaranteed 33 ⅓ % of the company’s voting power that is non‑dilutable, and while they are convertible on a share‑for‑share basis into Class A, the conversion is “subject to certain restrictions” and is not automatic (see CMCSA Note 11, p. 91). Alphabet’s Class B shares, by contrast, can be voluntarily converted at any time at the holder’s option and automatically convert into Class A upon sale or transfer, meaning the voting rights can shift without restriction (see GOOGL Note 11, p. 82). Thus, Comcast protects Class B voting power from dilution and limits conversion, whereas Alphabet allows conversion that can alter voting power and is triggered automatically on transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 33 1/3% non-dilutable voting power for CMCSA Class B stock is accurately stated, and the 10 votes per share for GOOGL Class B (implied in the context of enhanced voting rights) is consistent with known structure, though not explicitly repeated in the LLM answer—this omission does not detract significantly as the focus is on conversion mechanics. (2) The share-for-share conversion at CMCSA 'subject to certain restrictions' and the voluntary plus transfer-triggered conversion at GOOGL are correctly described, with proper contrast in conversion policies. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting protection mechanisms at CMCSA (structural, issuance-proof) versus GOOGL (fragile upon transfer), concluding that CMCSA’s Class B shares are more resilient to voting dilution—this logical inference is valid and supported. (4) Minor deduction in qualitative accuracy due to not explicitly stating GOOGL’s 10-vote structure, which is part of the comparative voting power context, though the emphasis on conversion-triggered loss of rights compensates. Wording differences (e.g., 'guaranteed' vs 'non-dilutable') are semantically equivalent. Citations to 'Note 11' add precision but are not required for correctness. Overall, the answer fully addresses the comparative structure, conversion restrictions, and implications for voting dilution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 412,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP values its Level 3 debt securities—primarily Community Development Financial Institutions issuances—at carrying value or internal estimates when no observable market data exist (AXP 10‑K, p. 146).  Because these inputs are unobservable, the valuation is highly sensitive to illiquid market conditions; a sudden drop in liquidity can make the internal estimates unrepresentative of true market value, creating valuation uncertainty and potential misstatement.  Morgan Stanley’s market‑risk framework, which relies on accurate pricing and effective hedging of similar illiquid positions (MS 10‑K, p. 13‑14), would be impaired during asset devaluation because the lack of observable pricing can reduce hedge effectiveness and make it difficult to value or liquidate positions, thereby increasing market‑risk exposure and potential losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies AXP's use of internal estimates and unobservable inputs for Level 3 securities, specifically mentioning Community Development Financial Institutions (CDFIs), which aligns with the original answer. It also notes the reliance on internal models in the absence of observable data, citing AXP’s 10-K. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10. (3) The multi-hop reasoning is sound: it connects AXP’s valuation methodology to the risks in illiquid markets, then links this to MS’s market risk management challenges, particularly hedging inefficiencies and difficulty in valuation/liquidation during volatility—directly reflecting the synthesis in the original answer using MS_10k_2024.pdf. The only minor omission is the specific mention of the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations, which is a detail present in the ground truth but not in the LLM response. However, this does not undermine the core correctness. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question: AXP’s valuation risks under illiquidity and the impact on MS’s market risk management. Wording differs but meaning is preserved. Thus, correctness is 9 (excellent, near-complete), qualitative accuracy 9 (minor detail missing), and contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 420,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are priced with internal discounted‑cash‑flow models that rely mainly on observable market inputs—interest‑rate curves, yield curves and foreign‑currency rates—so the valuation is largely driven by readily available market data with limited management judgment beyond the model. In contrast, Exxon’s valuation of the Pioneer upstream assets also uses DCF models, but the inputs (future production volumes, commodity prices, drilling and development costs, and risk‑adjusted discount rates) are largely driven by management judgment and industry‑specific assumptions, with observable inputs such as commodity prices sourced from third‑party experts. Thus Chevron’s approach is more input‑driven by observable market data, whereas Exxon’s Pioneer valuation places greater emphasis on management‑derived assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the key distinction between Chevron's and Exxon's valuation approaches. (1) It accurately states that Chevron’s Level 2 derivatives rely on observable market inputs such as interest-rate curves and foreign-currency rates, and that these valuations use internal discounted cash flow models with limited management judgment—consistent with the ground truth, which emphasizes third-party broker quotes and pricing services based on observable data. While the original answer does not explicitly mention 'internal DCF models' for Chevron, this is a reasonable interpretation within fair value hierarchy Level 2, where models can be used if inputs are observable. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all descriptive metrics and classifications are factually sound—hence a score of 10. (3) The qualitative accuracy is high: the LLM correctly contrasts Chevron’s reliance on observable inputs with Exxon’s use of management judgment in DCF models for Pioneer upstream assets, including unobservable inputs like production forecasts and risk-adjusted discount rates. However, the original answer more precisely attributes Exxon’s commodity price assumptions to 'third-party industry experts'—a nuance the LLM mentions but slightly underemphasizes by framing them as 'management-derived.' This leads to a minor shortfall in qualitative precision. (4) The response is fully contextually relevant, directly addressing the comparison in terms of observable inputs and management judgment. Overall, the answer is factually strong and semantically equivalent to the ground truth with only minor differences in emphasis, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 490,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy finances its renewable projects through VIEs that are backed by debt and tax‑equity partners; the PPAs it negotiates supply the revenue stream that underpins the debt, while the federal ITCs are captured by the equity partner rather than by Duke itself (see DUK_10k_2022 pages 201‑204).  Southern Power, in contrast, invests directly in solar facilities and secures the cash flows that support those projects with long‑term PPAs, and it also uses tax‑equity partnerships to capture the ITCs—about $0.8 billion of which remain unutilized and are expected to be fully realized by 2024 (see SO_10k_2022 pages 96‑97).  Thus, both companies rely on PPAs as a financing lever, but Duke’s structure defers tax‑credit ownership to the equity partner within a VIE, whereas Southern Power’s model captures the credits through a tax‑equity partnership while retaining direct ownership of the solar assets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core financial structures of both Duke Energy and Southern Power, noting Duke's use of VIEs with tax-equity partners and Southern Power's direct investment with tax-equity partnerships. It accurately states that PPAs serve as a key revenue/financing mechanism for both. However, there is a significant quantitative discrepancy: the LLM claims Southern Power has '$0.8 billion of unutilized credits...expected to be fully realized by 2024', while the ground truth states '$1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021'. The $0.8B figure and 2024 realization timeline are not present in the ground truth and appear to be fabricated or misattributed. (2) The LLM cites DUK_10k_2022 and SO_10k_2022, which is plausible, but the specific numbers do not align with the provided ground truth. The ground truth does not mention a 2024 realization timeline or $0.8B figure, making this a clear factual error. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the role of PPAs, tax equity, and ownership models across both companies. It draws a valid contrast: Duke defers tax credit ownership via VIEs, while Southern Power uses tax-equity partnerships but retains asset ownership. This reflects accurate understanding of financial structure and tax credit utilization. (4) The contextual relevance is high—the answer directly addresses the comparison in financial structure and tax credit use. The qualitative reasoning is strong, but the incorrect dollar amount and added timeline reduce quantitative accuracy. A score of 7 is justified because the conceptual framework is correct, but a key financial figure is wrong, affecting the reliability of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 479,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s Class A common stock is highly concentrated in governance power – holders of Class A elect three‑quarters of the Board of Directors (rounded down to the next whole number)【page_27】.  \nIn contrast, Home Depot’s restricted‑stock awards do not give recipients any voting rights until the awards vest; thus, they provide little immediate influence over Board decisions or other corporate governance matters【page_68】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error in the qualitative comparison: it incorrectly states that Home Depot's restricted stock award recipients do not have voting rights until vesting, which directly contradicts the ground truth stating that HD grants voting rights at the grant date, even before restrictions lapse. This error fundamentally undermines the governance influence comparison. The quantitative accuracy is acceptable—'three-quarters of the Board' is correctly cited, and the rounding clarification (though not in the original answer) does not distort the fact. However, the reasoning is flawed due to the incorrect premise about HD’s voting rights, leading to an inverted conclusion: the LLM suggests HD provides 'little immediate influence' when in fact HD allows earlier voting participation. This misrepresents the core multi-hop synthesis required—comparing NKE’s centralized control via Class A shares with HD’s broader, earlier distribution of voting rights through restricted stock. The answer is contextually relevant in structure and addresses both companies and governance mechanisms, but the incorrect characterization of HD’s policy severely limits its accuracy. Thus, while entities (NKE, HD, Class A stock, restricted stock awards) are correctly identified, the reasoning and final comparison are invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 371,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix’s forecasted foreign‑currency revenue is hedged with forward contracts and options, and the company’s 2023 foreign‑currency transaction impact was a net loss of about $293 million【page_48】—a figure that reflects the size of its forecasted exposure.  Disney, by contrast, estimates a one‑day VAR for currency‑sensitive instruments of only $45 million at year‑end 2023【page_60】.  Thus, Netflix’s forecasted foreign‑currency exposure is roughly six times larger than Disney’s VAR estimate, even though both firms use similar derivative hedges to manage currency risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Netflix's $293 million foreign exchange loss in 2023 and its use of forward contracts (and adds options, which may be acceptable), it incorrectly reports Disney's VAR estimate as $45 million in 2023. The ground truth states Disney's VAR was $255 million in 2024 (down from $284 million in 2023), making the LLM's $45 million figure factually wrong. This leads to an incorrect comparison claiming Netflix's exposure is 'six times larger'—a calculation based on false inputs. (2) The quantitative accuracy is low: the $45 million VAR value is unsupported by the ground truth, and the year is misaligned (2023 vs. 2024). The Netflix number ($293M loss) is correct. The comparison ratio (6x) is therefore invalid. (3) The reasoning is partially sound in structure—comparing hedging approaches and using a quantitative benchmark—but flawed due to incorrect data. The multi-hop synthesis fails because it uses a misrepresented VAR figure and omits the key conceptual difference: Disney's VAR model excludes forecasted transactions, while Netflix hedges them explicitly. This critical qualitative distinction is missing, undermining the analysis. (4) Contextual relevance is high—the answer addresses FX risk, hedging instruments, and makes a direct comparison between Netflix and Disney. However, due to major factual and quantitative errors, especially on Disney's VAR value and the resulting comparison, the correctness score is low. The answer conveys a misleading conclusion despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 438,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model uses market movements from the **prior quarter** to estimate the expected return distribution for the year‑end VAR figures and from each of the **four prior quarters** to compute the average VAR. PMI’s VAR calculation does the same – it relies on the **preceding quarter** for the year‑end VAR and on the **four preceding quarters** for the average, high and low VAR amounts. Thus, both companies base their daily‑loss estimates on a short‑term (quarterly) window while also incorporating a broader (annual) perspective for average risk, indicating comparable risk‑assessment horizons.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MDLZ and PM use the prior quarter for year-end VAR calculations and four prior quarters for average VAR amounts, which aligns with the ground truth. However, it incorrectly states that PM uses the four preceding quarters for 'average, high and low VAR amounts'—the original answer specifies this for PM but does not confirm 'high and low' for MDLZ, and the LLM generalizes this point symmetrically when the ground truth only explicitly attributes it to PM. This over-symmetrization introduces a subtle inaccuracy in comparative reasoning. (2) Quantitatively, all time periods (prior quarter, four prior quarters) are correctly reported, and no numerical values are misstated. Dates (year-end 2024 and 2023) are consistent with the original, though not explicitly repeated in the LLM answer—this omission doesn’t affect correctness but slightly reduces completeness. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes time periods used by both companies for VAR estimation. However, the conclusion that both have 'comparable risk-assessment horizons' downplays the original answer’s key nuance—that MDLZ’s explicit use of a multi-quarter approach for average VAR suggests a 'slightly more extended risk assessment horizon.' This distinction is lost in the LLM answer, weakening the qualitative accuracy of the comparative implication. (4) Contextual relevance is high, as the response directly addresses the time periods and their implications on risk horizons. The main shortcoming is the failure to capture the nuanced difference in risk assessment horizons, leading to a slightly inflated equivalence between the two firms’ methodologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 470,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "The $0.6 billion goodwill impairment recorded by Disney in fiscal 2024 arose from management’s discounted‑cash‑flow valuation of its entertainment‑linear‑networks reporting unit, and the auditor evaluated the key assumptions in that model—future revenues, operating expenses, margins, terminal growth and discount rates—testing their reasonableness, completeness and accuracy as a critical audit matter. In contrast, Netflix’s auditor tested the significant assumptions used to estimate content amortization (historical and forecasted viewing patterns), comparing them to actual viewing data, testing controls over the amortization process, and performing sensitivity analyses to assess the impact of assumption changes. Thus, both audits focused on evaluating material assumptions, but Disney’s audit centered on fair‑value assumptions for goodwill, while Netflix’s audit centered on amortization assumptions for content.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge and fiscal 2024 timing are correctly stated. No calculations are required, and all figures match. (2) The entities—DIS (Disney), NFLX (Netflix), and the relevant financial concepts (goodwill impairment, content amortization)—are correctly identified. The auditors for both companies (PricewaterhouseCoopers LLP) are not explicitly named in the LLM answer, which is a minor omission, but the focus is on audit procedures rather than auditor identity, so this does not significantly detract. (3) The multi-hop reasoning is sound: the answer correctly links Disney’s impairment to assumptions in fair value estimation (revenues, margins, growth rates, discount rates) and explains how the auditor evaluated them—consistent with the ground truth. Similarly, for Netflix, it accurately describes the use of forecasted and historical viewing patterns in content amortization and the auditor’s testing via sensitivity analysis and comparison to actual data. (4) The LLM captures the core comparison: both audits involved testing significant assumptions using sensitivity analyses and professional judgment, though applied to different accounting areas (goodwill vs. content amortization). The only minor gap is the absence of explicit mention of 'external market data' and 'specialized professionals' in the Disney audit, which were in the original. However, 'testing reasonableness, completeness and accuracy' and reference to critical audit matter imply similar rigor. Overall, the answer is factually correct, well-reasoned, and contextually complete—just shy of perfect due to slight under-elaboration on auditor methodology details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 479,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck collaboration is a 60/40 cost‑sharing arrangement for development and commercialization of the long‑acting HIV injectables, with Gilead and Merck sharing global revenues equally until sales hit $2 B (oral) or $3.5 B (injectable) thresholds, after which Gilead’s share rises to 65 %.  No milestone payments are disclosed for this partnership.  By contrast, the Arcellx deal requires a sizable upfront cash outlay ($313 M) and equity investment ($299 M), and it includes performance‑based development and regulatory milestone payments of up to $1.5 B, a 50/50 U.S. profit split, and royalties outside the U.S.  Thus, Merck’s agreement involves a lower upfront commitment and no milestone incentives, whereas Arcellx’s agreement carries larger upfront costs and substantial milestone‑based payments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies compared to the ground truth. While it correctly identifies the 60/40 cost-sharing split between Gilead and Merck, it introduces revenue-sharing terms (equal revenue split until $2B/$3.5B thresholds, then Gilead gets 65%) that are not present in the original answer — the ground truth states only that costs are shared 60/40 with no material expenses recognized through 2024, and does not mention any revenue thresholds or profit splits. This is a significant factual error. Additionally, the LLM claims up to $1.5B in milestone payments to Arcellx, which is not supported by the original answer — the original only states that $68M in development milestones were paid in 2024, with no total cap mentioned. The $313M upfront and $299M equity investment are correctly reported. (2) Quantitative accuracy is partially correct: the Arcellx figures ($313M upfront, $299M equity, $68M milestone) are accurate, but the invented $1.5B milestone cap and revenue thresholds for Merck reduce numerical precision. The absence of any milestone payments in the Merck deal is correctly noted. (3) The multi-hop reasoning is sound in structure — the model attempts to compare financial commitments across two collaborations — and correctly identifies that Arcellx involves larger upfront payments and milestone incentives while Merck does not. However, the reasoning is based on fabricated terms (revenue splits, thresholds, $1.5B milestones), undermining the validity of the synthesis. (4) Contextual relevance is high — the response directly addresses the comparison of financial commitment and milestone payments. Due to major quantitative errors and unsupported details, the correctness score is moderate (6), with lower quantitative accuracy (5), decent qualitative reasoning (7), and strong relevance (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 502,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla’s 2020 and 2021 multi‑year pricing agreements with Panasonic for Gigafactory 2170 cells and Japan‑sourced cells lock in cell prices for several years, giving the company contractual stability and long‑term cost predictability (Exhibit 10.36†† and 10.35††/10.37††). In contrast, GM’s battery procurement cost exposure is tied to its variable‑interest entities and Ultium Cells Holdings LLC, which expose it to market‑driven price volatility and less predictable costs (see the VIE and Ultium Cells discussion in page 80). Thus, Tesla enjoys more stable and predictable battery costs than GM.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, providing long-term cost predictability. However, it inaccurately cites the agreement years as '2020 and 2021'—the ground truth specifies execution dates of June 9, 2020 (Gigafactory 2170) and December 29, 2020 (Japan-sourced), both within 2020, not 2021. This is a minor date inaccuracy but does not distort the overall timeline. (2) No numerical values (e.g., dollar amounts) are present in either answer, so quantitative accuracy is assessed on dates. The LLM’s reference to '2021' is incorrect, though the core fact of multi-year agreements post-2020 is valid. (3) The multi-hop reasoning is sound: the model correctly contrasts Tesla’s contractual stability with GM’s exposure to volatility via VIEs and Ultium Cells LLC, citing page 80 of GM’s 10-K (vs. ground truth’s page 78). While the page number differs slightly, the reference to GM’s variable-interest entities and lack of long-term pricing visibility aligns with the original answer’s intent. (4) The LLM captures the key comparative insight—Tesla has greater cost predictability due to long-term contracts, while GM faces more exposure to market fluctuations—making the answer semantically equivalent despite minor discrepancies in dates and citation location. The answer is fully contextually relevant and addresses both contractual stability and cost predictability as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 410,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola hedges FX risk with non‑derivative instruments such as foreign‑currency‑denominated debt and other monetary assets, and it also uses forward contracts, options, and swaps in euros and British pounds to keep FX gains or losses in AOCI until the investment is sold (page_83). In contrast, P&G’s FX exposure directly reduced net earnings by about $589 million in 2024, indicating that its FX risk is not fully hedged (page_23), even though both companies operate in the United Kingdom and Germany (page_21).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Coca-Cola uses non-derivative instruments like foreign-currency-denominated debt to hedge FX risk and also mentions derivative instruments (forwards, options, swaps), which aligns with the ground truth's emphasis on non-derivative hedging but adds extra detail not in the original. However, the ground truth does not mention AOCI or specific instruments like forwards and swaps being used to keep gains/losses there, so this is an over-specification. The key qualitative point — Coca-Cola has a structured hedging approach — is preserved. For P&G, the LLM states a $589 million negative impact on net earnings in 2024 due to FX, which is a specific number not present in the ground truth; the original only states that FX movements have historically negatively impacted P&G’s financials without quantifying the 2024 effect. This introduces a potentially inaccurate figure, hurting quantitative accuracy. (2) The $589 million figure and '2024' are not in the ground truth and cannot be verified from the provided context, making them likely hallucinated or incorrectly extracted. No such number appears in the original answer, so this is a clear quantitative error. (3) The multi-hop reasoning is mostly sound: the model compares Coca-Cola’s hedging strategy to P&G’s exposure, recognizing both operate in the UK and Germany, and infers that P&G’s reported earnings impact suggests less effective hedging. This supports the core conclusion in the ground truth about P&G’s greater sensitivity to FX volatility. However, the reasoning is weakened by reliance on an unverified number. (4) Despite the numerical inaccuracy, the LLM captures the essential contrast: Coca-Cola employs structured hedging (including non-derivatives), while P&G experiences material FX impacts, indicating less complete risk mitigation. Wording differs and adds detail, but the semantic core is partially aligned. Hence, correctness is reduced mainly due to the unsupported $589M claim, but not severely because the directional conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 557,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s 10‑K shows that Maryland’s PDAB law could impose an upper payment limit on its drug ENBREL, directly constraining the company’s pricing strategy while its manufacturing advantage rests on a global biologics network with multiple raw‑material sources (Amgen, p.18‑19). Gilead’s 10‑K does not flag any Maryland‑specific risk but notes broader state‑level pricing pressures and Medicaid/340B rebate obligations that could affect its pricing, and it does not describe a Maryland manufacturing footprint (Gilead, p.21). In short, Amgen faces a concrete, product‑specific price cap in Maryland, whereas Gilead’s risks are more generalized state‑level pricing and rebate dynamics without a clear Maryland focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies that Amgen faces a specific pricing risk in Maryland due to the PDAB law targeting ENBREL, which aligns with the ground truth. It accurately notes Amgen's global biologics manufacturing network and references correct sections of the 10-K (p.18-19), supporting its claim about pricing constraints. The statement that Gilead does not disclose a Maryland manufacturing footprint or Maryland-specific risks is also consistent with available data, and the mention of broader state-level pricing and rebate obligations (Medicaid/340B) is correct (Gilead 10-K, p.21). However, the LLM answer omits a key element from the ground truth: Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, which is a material fact that introduces operational and logistical risks. This omission limits the completeness of the comparison, especially regarding Gilead’s exposure through manufacturing. While the LLM correctly infers no Maryland-specific risk is disclosed, it fails to acknowledge the known presence of the facility, which is public information in regulatory filings and press releases. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is logical where information is present. The contextual relevance is high as it directly addresses the comparative risk profiles. However, due to the missing multi-hop synthesis of Gilead’s Maryland manufacturing presence, the qualitative accuracy and overall correctness are reduced. The answer captures Amgen’s regulatory exposure well but underrepresents Gilead’s operational footprint, leading to an incomplete risk comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 460,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts are policy‑holder directed, with assets carried at fair value and liabilities equal to the account assets (and may include stable‑value wrap funding), but the filing does not describe any explicit diversification or sub‑advisory discretion beyond the segregation of the funds【page_195】.  \nMetLife, by contrast, holds its ERISA plan assets in separate accounts that are managed by investment‑management firms acting as sub‑advisors; these managers have discretion over buying and selling securities, and the plans are deliberately diversified across multiple asset categories and across several managers to reduce concentration risk【page_304】.  Thus, MetLife’s structure explicitly incorporates sub‑advisory discretion and a multi‑manager diversification strategy for risk mitigation, whereas AIG’s approach focuses on policy‑holder segregation without detailing similar diversification mechanisms.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of both AIG and MET (MetLife) and their use of separate accounts, but it omits key details present in the original answer that affect completeness and reasoning accuracy. (1) Correct elements: The LLM correctly identifies that AIG’s separate accounts are policyholder-directed with investment risk borne by policyholders, and that assets are segregated and carried at fair value. It also accurately states that MetLife uses investment management firms with discretionary authority (sub-advisory discretion) and emphasizes diversification across asset classes and managers to reduce risk. The contextual relevance is high, as the response directly addresses the comparison in terms of diversification and risk mitigation. (2) Quantitative accuracy: There are no numerical figures in this question, so this dimension is not applicable; however, all referenced concepts (e.g., fair value accounting, discretionary management) are used appropriately, and no factual inaccuracies in terminology or entity identification exist—MetLife is correctly associated with ERISA plan management and AIG with policyholder-directed accounts. (3) Multi-hop reasoning: The model synthesizes information from two different companies and contexts (AIG’s insurance products vs. MetLife’s ERISA plans), which is appropriate. However, it incorrectly implies that AIG’s filings do not describe diversification or sub-advisory discretion at all, while the ground truth states that AIG’s separate accounts include diversified asset classes (fixed maturities, equities, derivatives), and both firms restrict derivatives to risk mitigation and duration management. This omission weakens the comparison and suggests AIG lacks such strategies when in fact they are present but less explicitly tied to sub-advisory discretion. (4) The LLM also fails to note that both companies use similar underlying asset classes and share a goal of risk mitigation through diversification, which is a key point of alignment in the original answer. Thus, while the contrast in governance (policyholder direction vs. discretionary sub-advisors) is valid, the answer overstates the difference in risk strategy. For these reasons, the correctness and qualitative accuracy scores are reduced to 7, reflecting accurate core facts but significant omissions in synthesis and balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 634,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock gives holders no voting power except on a handful of narrowly defined matters (e.g., certain mergers, amendments to the certificate of incorporation, or exiting the core payments business)【page_89】, so Class B investors have limited ability to influence board elections or takeover‑defense strategies. In contrast, Home Depot’s restricted‑stock awards grant voting rights to recipients from the grant date【page_67】, allowing those holders to vote on all corporate matters—including board composition and takeover defenses—immediately. Thus, Nike’s Class B shareholders are comparatively constrained in governance influence, whereas Home Depot’s restricted‑stock holders can actively shape corporate decisions right away.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NKE Class B shareholders have no voting rights except on narrowly defined matters (e.g., exiting the core payments business, certain amendments, or major transactions), and do not influence board elections; HD restricted stock recipients receive voting rights immediately upon grant. The LLM correctly identifies that this leads to limited governance influence for NKE Class B holders versus active influence for HD restricted stock holders. (2) There are no numeric values, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting rights structures across two companies (NKE and HD), links them to governance implications (board composition, takeover defenses), and draws a valid comparative conclusion. The only minor shortcoming is that the LLM does not explicitly name Class A shareholders as the controlling party at NKE (mentioned in ground truth), though this is implied by the structural contrast. (4) The answer is fully contextually relevant, directly addressing the impact of structural differences on investor influence. Wording differs slightly (e.g., 'handful of narrowly defined matters' vs 'certain defined matters'), but meaning is preserved. Overall, the response is excellent with only a slight omission in entity detail, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 418,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta’s Class B common stock is largely non‑voting; holders receive no vote on most matters, with voting rights limited to a few defined events such as certain corporate actions or amendments (Meta 10‑K, voting‑rights section, page 61). In contrast, Netflix’s common stock grants each share one vote on all matters, with no special restrictions noted in its voting‑rights policy (NFLX 10‑K, voting‑rights section, page 61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential distinction between META's and NFLX's voting structures with high accuracy. It correctly states that Meta’s Class B common stock has limited voting rights, restricted to specific corporate events such as amendments or certain transactions, while Netflix provides one vote per share on all matters. The answer aligns with the ground truth in both substance and semantics, noting the absence of broad voting rights for Meta Class B shareholders and the universal voting rights at Netflix. The only minor omission is that the LLM does not explicitly name the specific matters (e.g., exit from core payments business, merger/consolidation decisions) where Meta Class B stockholders do vote, nor does it mention that they may vote alongside Class A in those cases. However, the phrase 'certain corporate actions or amendments' captures the general idea. There are no numerical values to evaluate, so quantitative accuracy is scored as 10 by default. Entity accuracy is perfect—Meta and NFLX are correctly identified, and the reference to 10-K voting rights sections is consistent. The reasoning is sound and synthesizes a multi-hop comparison correctly. Contextual relevance is excellent, directly addressing the comparative voting framework question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 363,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "PM uses the parametric delta‑gamma technique to compute a one‑day value‑at‑risk of its interest‑rate and foreign‑currency positions, assuming normal market conditions, a 95 % confidence interval and a one‑day horizon. MDLZ applies the same method in its VAR model to estimate the potential one‑day loss in pre‑tax earnings (and fair‑value loss) from currency and commodity exposures, under the identical assumptions. Thus, both firms use the technique under the same statistical framework, but PM focuses on fair‑value risk of its portfolio, whereas MDLZ focuses on earnings impact and includes commodity risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, apply a 95% confidence interval, and estimate one-day potential losses (VAR) based on movements in the prior quarter. The one-day holding period and focus on year-end calculations are correctly implied. The distinction in focus—PM on fair-value risk of interest rate and currency positions, MDLZ on pre-tax earnings impact including commodities—is supported by the ground truth and correctly synthesized. The only minor shortcoming is that the LLM does not explicitly mention that both companies base their VAR models on observed movements over the preceding quarter, though this is contextually implied by 'normal market conditions' and standard VAR practices. This omission prevents a perfect 10 but does not undermine the core correctness. All entities (PM, MDLZ, VAR, pre-tax earnings, currency, commodities) are accurately identified and compared. The reasoning is sound, multi-hop synthesis is correct, and the answer is fully relevant to the question. Number formats and percentages are accurate and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 339,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America applies a 2.5 % Capital Conservation Buffer under the Advanced Approach, which is added to its CET1 ratio as part of the Basel III minimum and is calculated using internal risk‑modeling (see BAC 10‑K, pp. 134–146).  By contrast, American Express relies on a Stress Capital Buffer under the Standardized Approach, which is also a mandatory buffer above the regulatory minimum but is calculated using prescriptive risk‑weights (see AXP 10‑K, pp. 133–137).  Thus, while both banks use a 2.5 % buffer to satisfy Basel III, BAC’s buffer is part of a model‑based framework that typically yields a lower required CET1 ratio, whereas AXP’s buffer is part of a prescriptive framework that generally results in a higher required CET1 ratio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach and that American Express uses the Stress Capital Buffer under the Standardized Approach, which aligns with the ground truth. The percentages (2.5%) are accurate, and the regulatory frameworks (Advanced vs. Standardized Approach) are correctly attributed. (2) Quantitative accuracy is perfect: the 2.5% buffer value is correct for both institutions, and no erroneous calculations are made. Format variations (e.g., '2.5 %' vs '2.5%') are acceptable. (3) However, the LLM introduces additional claims not present in the ground truth: specifically, that BAC’s model-based framework 'typically yields a lower required CET1 ratio' and AXP’s prescriptive approach 'generally results in a higher required CET1 ratio.' These comparative inferences about CET1 ratio outcomes go beyond the original answer and are not supported by the provided ground truth, which only states the difference in buffer types and approaches without making performance or outcome comparisons. This represents a reasoning overreach, reducing qualitative accuracy. (4) Despite this, the answer remains contextually relevant and factually correct on core elements—entities (BAC, AXP), metrics (Capital Conservation Buffer, Stress Capital Buffer), and regulatory approaches are accurately identified and contrasted. The synthesis across institutions and frameworks is sound, even if extended interpretation slightly exceeds the ground truth. Thus, correctness is high but not perfect due to unsupported comparative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 447,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin applies a discounted‑cash‑flow (DCF) model only to Level 3 fixed‑income holdings, where the discount rate is the key input that determines the present value of projected annuity payments. The filing notes the importance of the discount rate but does not provide a formal sensitivity analysis. Honeywell, by contrast, uses a DCF approach to test goodwill and indefinite‑life intangibles, explicitly states that the discount rate is a critical assumption, and routinely performs sensitivity analyses showing that small changes in the rate can materially alter the fair‑value estimate and the resulting impairment charge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments, with the discount rate as a key input tied to projected annuity payments. It accurately contrasts this with HON's use of DCF for goodwill and indefinite-lived intangible asset impairment testing. The answer correctly notes that HON explicitly performs sensitivity analyses on the discount rate, while LMT does not provide a formal sensitivity analysis—this nuance is supported by the original answer, which states that both acknowledge sensitivity but only HON performs sensitivity analyses. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in terms of calculations, but the absence of fabricated numbers and correct use of financial terminology earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), two distinct applications of DCF (fixed income vs. intangible assets), and compares them on the significance and sensitivity of discount rate assumptions. (4) The only minor shortcoming is that the LLM slightly underrepresents LMT’s acknowledgment of sensitivity—while it doesn’t perform formal sensitivity analysis, the original answer notes LMT still recognizes the sensitivity due to unobservable inputs. This subtle point is omitted, but the core contrast remains valid. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 441,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s Class B shares hold a fixed 33 ⅓ % of the company’s voting power and each carries 15 votes; because this voting power is non‑dilutable, buying back Class B shares only reduces the absolute number of high‑vote shares and can raise the relative weight of the remaining Class A shares. Alphabet’s Class B shares, which carry 10 votes each and can be converted into one‑vote Class A shares, mean that a repurchase of Class B shares cuts the pool of high‑vote shares and, through conversion, dilutes voting concentration, potentially shifting control toward Class A holders. Thus, CMCSA’s repurchases shift voting power proportionally, while Alphabet’s repurchases dilute the concentration of voting power held by its high‑vote class.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual and reasoning errors that significantly undermine its correctness. (1) It incorrectly states that repurchasing Class B shares at CMCSA would increase the relative weight of Class A shares, when in fact the ground truth specifies that Class B has a fixed, non-dilutable 33 1/3% voting power—meaning repurchases of Class A shares (not Class B) would increase the relative voting power of Class B holders. The LLM reverses the direction of the effect. (2) The claim that 'buying back Class B shares' at CMCSA reduces high-vote shares misrepresents the structure: CMCSA’s Class B shares are convertible share-for-share into Class A, but the key point is their fixed voting percentage, which is preserved regardless of repurchases. The model fails to correctly apply the non-dilutable voting power concept. (3) Regarding Alphabet, the LLM incorrectly focuses on repurchases of Class B shares, while the ground truth states that Alphabet repurchased Class A and Class C shares (not Class B), totaling $62.0 billion in 2024—this specific dollar amount and the correct share classes are omitted. (4) The explanation of Alphabet’s conversion mechanism is partially correct (Class B converts to Class A with 10:1 dilution), but the conclusion that repurchases dilute voting concentration is misleading—since Class B shares are rarely sold or converted, and repurchases of Class A/C do not directly affect Class B voting power in the same way as CMCSA’s structure. (5) The LLM fails to correctly contrast the two companies: CMCSA’s fixed voting percentage for Class B means Class A repurchases amplify Class B’s relative control, whereas Alphabet’s structure does not create such a fixed skew. This core multi-hop comparison is flawed. Quantitative accuracy is moderate: the 33 1/3% and 15 votes per Class B share at CMCSA are correct, and the 10:1 voting ratio for Alphabet is accurate, but the $62.0 billion repurchase figure and the specific share classes repurchased (A and C) are missing. Entity accuracy is acceptable—CMCSA and Alphabet are correctly identified. Contextual relevance is high as the answer attempts the right comparison. However, due to fundamental errors in reasoning and missing key facts, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 606,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "TGT’s “Food & Beverage” segment is $23.8 billion of its $106.6 billion net sales, or about **22 %** of total sales (page 49). PepsiCo’s beverage business accounts for **23 %** of its APAC net revenue (page 73). Thus, TGT’s beverage mix is slightly lower but roughly comparable to PepsiCo’s beverage contribution in the APAC market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors. (1) Quantitative inaccuracy: The LLM claims TGT's 'Food & Beverage' segment is $23.8 billion (22% of $106.6B), but the ground truth does not provide any such breakdown for TGT—instead, it states that TGT does not separately disclose beverage sales and includes them in a broader grocery segment. There is no evidence in the ground truth that TGT reports a 'Food & Beverage' segment or that beverages constitute 22% of sales. This number appears fabricated or misattributed. (2) The claim that PepsiCo’s beverage business accounts for 23% of its APAC net revenue aligns with the ground truth, which correctly states that beverages contribute 23% of PEP's APAC revenue. However, the LLM omits the critical context that PEP's APAC revenue was only $10 million in 2024, making the absolute scale negligible compared to TGT's overall business. (3) Entity and reasoning error: The comparison between TGT’s overall food & beverage mix and PEP’s APAC-specific beverage contribution is flawed. The LLM incorrectly treats TGT’s domestic segment (implied by context) as comparable to PEP’s APAC regional beverage exposure, despite different geographies and reporting scopes. (4) The ground truth emphasizes that TGT does not break out beverage sales, while PEP does—this key distinction is lost in the LLM answer, which falsely implies a direct, quantifiable comparison is possible. The LLM fails the multi-hop synthesis by not recognizing the incomparability of the metrics due to differing disclosure levels and geographic focus. While the 23% figure for PEP is correct, the overall conclusion that the mixes are 'roughly comparable' is unsupported and misleading. Thus, despite some correct terminology and one accurate percentage, the answer is largely incorrect in data, reasoning, and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 500,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "The Medicare price‑setting under the IRA, effective January 1 2027, will force Amgen to accept a government‑determined price for Otezla, which could materially lower the drug’s revenue and profitability.  As page 137 notes, such a price change “could unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset,” potentially triggering an impairment of the $5.2 billion developed‑product‑technology right.  While Bristol‑Myers Squibb’s licensing agreement provides Amgen with royalty income, the overall valuation of the Otezla intangible asset could still decline if the negotiated Medicare price cuts the market value and thus the recoverable cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA's Medicare price negotiation applies to Otezla starting January 1, 2027; Amgen holds a $5.2 billion intangible asset for Otezla; the negotiated price could impair this asset’s recoverability. The reference to 'page 137' (likely from Amgen’s 10-K) adds specificity and supports the claim. (2) Quantitative elements—$5.2 billion, 2027 effective date—are accurate and match the original answer. No calculations were required, but the use of precise figures is correct. (3) The multi-hop reasoning is sound: the model correctly links the IRA’s pricing impact → reduced Otezla revenue → risk to Amgen’s intangible asset valuation, while acknowledging BMY’s licensing role and its indirect effect via overall market dynamics and royalty implications. The only minor shortcoming is that the original answer explicitly notes Amgen’s own statement about future estimates affecting recoverability, which the LLM paraphrases but does not directly attribute to Amgen’s disclosure. (4) Despite this slight nuance, the LLM captures the core risk and mechanism of impact, uses appropriate financial terminology, and maintains semantic equivalence. Contextual relevance is excellent, addressing all aspects of the question including regulatory, financial, and partnership dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 382,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD produces a broad range of FPGA families—Virtex, Kintex, Artix and Spartan—that are sold to hyperscale data‑center customers, OEMs, ODMs and system integrators as part of its data‑center segment (see pages 10–11). In contrast, Altera—now a standalone business within Intel—offers FPGAs mainly for embedded, communications, cloud and enterprise markets and is reported as part of Intel’s “All Other” segment (page 23), with Intel’s decision to operate Altera separately aimed at unlocking value for those FPGA offerings (page 22). Thus, AMD’s FPGA production is tightly integrated with its CPU/GPU ecosystem for hyperscale workloads, while Altera’s products are focused on embedded and enterprise applications and are managed independently by Intel.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD produces FPGAs (Virtex, Kintex, etc.) for hyperscale data centers, integrating them with its CPU/GPU ecosystem, while Altera (under Intel as a standalone unit) targets embedded, communications, cloud, and enterprise markets. The strategic rationale—Intel operating Altera separately to unlock value, potentially via IPO—is correctly captured in substance, though the IPO detail is omitted. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of page numbers (e.g., page 22, 23), which match the source context and do not involve computation. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s product integration for hyperscale AI workloads and Intel’s structural decision with Altera, drawing a valid contrast in business models and market focus. (4) Semantic equivalence is strong—while the LLM emphasizes AMD’s FPGA families and segment reporting details not in the original answer, it adds context without introducing error. The only minor omission is the explicit mention of AMD’s use in generative AI models and Intel’s pursuit of monetization beyond just 'unlocking value' (e.g., IPO), which slightly reduces completeness. However, the core comparison is accurate, well-structured, and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 404,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "CMCSA’s Class B shares are highly concentrated—only three shares, all owned by Mr. Roberts, represent 33 % of the company’s voting power (CMCSA, p. 38). Alphabet’s Class A shares total roughly 301 million shares (GOOGL, p. 2) and are broadly held, with no single shareholder controlling a large portion, so voting power is dispersed among many owners.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CMCSA's Class B shares represent 33⅓% of voting power (rounded to 33% is acceptable), are owned by Brian L. Roberts, and have only 3 record holders. However, it incorrectly states 'only three shares' instead of 'three record holders'—a significant factual error that misrepresents the number of shares outstanding as 3 rather than clarifying that there are three holders. This is a critical misstatement. For GOOGL, the LLM correctly reports approximately 301 million Class A shares outstanding (vs. 300,754,904 in ground truth), which is quantitatively accurate within rounding. The broader ownership and dispersed voting power are correctly characterized. (2) The number of shares for GOOGL is correctly approximated. The date references (implied from citations like 'p. 2') are not contradicted, though not explicitly stated—minor omission. The $1,451.1 billion market value from June 30, 2021, is omitted, but the general characterization of broad ownership suffices contextually. (3) The multi-hop reasoning—comparing ownership concentration and voting power distribution between CMCSA Class B and GOOGL Class A—is sound. The model correctly infers that concentrated ownership (Roberts) leads to concentrated voting power at CMCSA, while GOOGL’s structure disperses control. The synthesis across two companies and stock classes is logically valid. (4) Despite the serious error in stating 'three shares' instead of 'three holders', the core comparative insight about control concentration vs. dispersion is preserved, warranting a high but not top score. Quantitative accuracy is slightly penalized for the share count error; qualitative and contextual scores remain high due to correct reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 482,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "After 2023 the Keytruda royalty rate falls from 6.5 % to 2.5 % (Keytruda Patent License Agreement, page 90), cutting BMS’s royalty expense and the direct revenue it receives from Merck’s Keytruda sales.  However, Merck’s co‑development partnership on combination therapies (e.g., the V940/Keytruda collaboration, page 90) still generates shared costs and profits for BMS, providing an alternative revenue stream that offsets the lower royalty income and moderates BMS’s overall revenue dependency on Merck.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies the change in royalty rate from 6.5% to 2.5% starting in 2024, which matches the ground truth. However, it incorrectly states that this reduces BMS's 'royalty expense'—this is factually wrong. BMS receives royalty income from Merck, not pays it; thus, the drop in rate reduces BMS's royalty *income*, not expense. This is a critical error in financial directionality.\n\n2) Quantitatively, the percentages (6.5% to 2.5%) and reference to the V940 combination therapy are accurate and correctly cited. No calculation errors are present, and the dates align with the original answer.\n\n3) The reasoning is partially sound in noting that co-development partnerships (like V940/Keytruda) involve shared costs and profits, which could provide BMS with alternative revenue. However, the original answer emphasizes that BMS’s revenue from Merck is tied to Keytruda sales via licensing, and the royalty reduction will diminish BMS’s upside from new combinations—whereas the LLM suggests these partnerships 'offset' the loss and reduce dependency, which contradicts the ground truth implication of increased vulnerability due to declining royalty income. The multi-hop synthesis fails to correctly link the reduced royalty rate to diminished financial upside despite ongoing collaborations.\n\n4) Contextually, the answer addresses the key elements: royalty change, co-development, and revenue dependency. But due to the fundamental mischaracterization of BMS as a royalty payer instead of recipient, the conclusion about reduced dependency is unsupported and likely incorrect. This undermines the qualitative accuracy despite correct surface-level facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 455,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "Boeing’s 2023 risk disclosure notes that the U.S. government can modify or terminate contracts, which could materially affect the company【page_14】. Caterpillar’s adoption of ASU 2022‑06 extends optional relief for contract modifications that replace reference rates, reducing the operational and financial impact of such changes【page_167】. Thus, any U.S.‑government contract modification that involves a reference‑rate change would be accounted for with less impact on the financial statements, potentially mitigating part of Boeing’s identified risk, although the guidance did not materially affect Caterpillar’s consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong multi-hop reasoning. (1) All factual elements are correct: ASU 2022-06 extends relief for contract modifications related to reference rate reform (e.g., LIBOR transition), which reduces financial and operational impact; Boeing (BA) identified U.S. government contract modifications as a material risk; Caterpillar (CAT) adopted ASU 2022-06. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are stated. While the ground truth mentions BA’s 37% of 2023 revenues from U.S. government contracts, the LLM omits this specific figure but still correctly identifies the risk context. This omission is minor and does not affect the core correctness. (3) Reasoning is sound: the LLM correctly links CAT’s adoption of the ASU to simplified accounting for contract modifications, and connects this to BA’s risk exposure in government contracts, noting that such guidance could mitigate accounting volatility even if it didn’t materially affect CAT’s own financials. (4) Semantic equivalence is strong—wording differs but meaning aligns. The only minor gap is the absence of the December 31, 2024 sunset date, which is part of the ASU’s key provision. However, the essence of extended relief is captured. Overall, the answer is factually correct, contextually relevant, and synthesizes across entities (CAT, BA, ASU 2022-06, U.S. government contracts) appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 407,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle deal did not transfer control of the towers, so the $4.8 billion cash proceeds were recorded as a financing obligation that accrues interest at ~3.9 % and is paid through structured sublease payments, while the towers remain on AT&T’s property, plant and equipment and continue to be depreciated (Note 18, page 90; Note 19, page 91).  \nVerizon’s 2024 Vertical Bridge transaction transferred control of the towers to the REIT, but Verizon still leases back capacity; the $2.8 billion upfront payment is split into $2.0 billion of prepaid rent and a $830 million financing obligation for the portion it occupies, with the towers again retained on its balance sheet and depreciated (Note 6, page 73).  \nThus, both companies kept depreciation responsibilities and structured payments as financing obligations, but AT&T’s obligation covers the full transaction amount and is paid via sublease, whereas Verizon’s obligation is limited to the portion it occupies and is part of a sale‑leaseback that also includes prepaid rent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T received $4.827 billion (rounded to $4.8 billion in both answers), Verizon received $2.8 billion, with $830 million recorded as a financing obligation and the remainder as prepaid rent. The ~3.9% effective interest rate for AT&T is correctly noted. (2) Quantitative accuracy is excellent—dollar amounts, splits, and percentages match or are appropriately rounded versions of the original. The $2.0 billion prepaid rent figure is correctly derived as the residual of $2.8B - $830M. (3) The multi-hop reasoning is sound: the model correctly compares two separate transactions across different companies and years, synthesizing asset treatment (retained depreciation, balance sheet treatment) and financing structures. It accurately distinguishes that AT&T’s full amount is a financing obligation due to lack of control transfer, while Verizon’s deal involved control transfer (sale-leaseback elements), hence the split treatment. (4) Minor deduction in qualitative accuracy because the LLM implies Verizon’s transaction is a 'sale-leaseback'—while partially true, the ground truth emphasizes that both deals avoided full sale-leaseback accounting due to continued control and depreciation; thus, the term may slightly mischaracterize the accounting outcome. However, the core insight about retained depreciation and financing obligations is correct. Contextual relevance is perfect—the response directly addresses asset treatment, financing obligations, depreciation, and comparative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 437,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PEP’s beverage business in New Zealand is delivered through authorized bottlers and distributors, with no direct bottling or distribution facilities in the country (PEP 10‑K, page 6).  \nIn contrast, KO’s 19 % equity stake in Coca‑Cola Europacific Partners (CCEP) gives it significant financial influence over the bottling and distribution of Coca‑Cola products in New Zealand, although KO does not operate its own bottling plants there (KO 10‑K, page 88).  \nThus, PEP’s presence is indirect and limited to brand licensing, whereas KO’s influence is exerted through a substantial equity investment in the local bottler.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in characterizing PEP's presence in New Zealand. The original answer (ground truth) states that PEP operates directly in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners—indicating a direct operational presence. However, the LLM claims PEP has no direct bottling or distribution facilities and operates only through authorized bottlers and distributors, describing its presence as 'indirect' and limited to 'brand licensing.' This contradicts the ground truth, which emphasizes PEP's full operational control. While the 19% stake of KO in CCEP is correctly stated and the indirect financial influence is accurately described, the misrepresentation of PEP’s operational model undermines the core comparison. The quantitative accuracy is perfect—no numbers or percentages are incorrect. The reasoning is partially sound in contrasting indirect equity influence (KO) vs. operational models, but the synthesis fails because it mischaracterizes one of the two key entities (PEP). Contextually, the answer addresses the right question and structure, citing appropriate documents, but the qualitative inaccuracy in entity operations significantly reduces correctness. Thus, the correctness score is moderate due to a major factual discrepancy despite correct numbers and relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 388,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG estimates the fair value of mortgage‑ and other‑loan receivables—including mortgage‑backed securities—by combining dealer quotations, discounted‑cash‑flow analyses and, when market data are limited, internal valuation models (AIG 10‑K, p. 112).  Schwab, in contrast, relies on independent pricing services that use observable trades and broker‑dealer quotes for non‑agency commercial mortgage‑backed securities, applying internal models only when quotes are unavailable (Schwab 10‑K, p. 81).  Thus, AIG’s approach is more model‑driven, whereas Schwab’s is largely market‑observable and quote‑based.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinction between AIG's and SCHW's fair value determination methods for mortgage-backed securities. (1) It correctly identifies that AIG uses internal valuation models, particularly when market data are limited, and combines them with dealer quotes and discounted cash flow analyses. This aligns with the ground truth noting AIG’s use of internal models and third-party inputs, subject to management review. (2) It accurately states that Schwab (SCHW) primarily relies on independent pricing services and broker-dealer quotes for non-agency commercial mortgage-backed securities, using internal models only when quotes are unavailable—consistent with the original answer’s emphasis on SCHW’s reliance on observable market data. (3) The reasoning correctly synthesizes a multi-hop comparison: AIG is more model-driven, SCHW more market-observable-driven, which reflects the intended contrast. (4) The mention of GILD in the original answer adds contextual industry validation, which the LLM omits; however, this is a minor omission that does not undermine the correctness of the core comparison. No numbers, dates, or financial metrics are incorrect—quantitative accuracy is perfect. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy due to high fidelity with only minor contextual omission, 10 for quantitative accuracy (no numbers wrong), and 10 for contextual relevance as it directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 425,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO’s Level‑2 securities are valued with “market‑corroborated pricing, matrix pricing or other models that use observable inputs such as yield curves” (AVGO 10‑K, p. 80).  \nADBE’s Level‑2 fixed‑income available‑for‑sale securities are valued “based on pricing from independent vendors who use matrix‑pricing valuation techniques … with inputs including benchmark yields, issuer spreads, interest rates and U.S. Treasury or swap curves” (ADBE 10‑K, p. 72).  \n\nBoth firms therefore rely on observable market inputs—yield curves and benchmark rates—in their Level‑2 fair‑value calculations, but ADBE explicitly centers its methodology on matrix pricing, whereas AVGO lists matrix pricing as one of several models used.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs like yield curves and benchmark rates for Level 2 securities; ADBE explicitly relies on matrix pricing, while AVGO includes it as one of several methods. The citations to page numbers in the 10-Ks (p. 80 for AVGO, p. 72 for ADBE) are consistent with the source data and add precision. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers and correct referencing of inputs earns a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two companies, identifies the commonality in observable inputs, and distinguishes the differing emphasis on matrix pricing. (4) The LLM slightly simplifies the shared reliance on similar inputs by not explicitly stating that both companies’ approaches are ultimately grounded in comparable market-derived data (e.g., interest rates, spreads), but this is implied in the comparison. The answer is semantically equivalent to the original, with minor omission of the broader categorization context (e.g., AVGO’s use of broker quotes). Overall, the response is factually correct, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 398,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC manages about **41 % of Coca‑Cola’s worldwide unit‑case volume**—the bulk of its non‑U.S. volume. It coordinates distribution in **28 operational countries**, including the Czech Republic.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It states that Coca-Cola HBC manages 41% of Coca-Cola’s worldwide unit-case volume, which is incorrect—the ground truth is that it manages 17% of Coca-Cola's *non-U.S.* unit case volume, not worldwide. This is a significant overstatement and mischaracterization of the scope. Additionally, the LLM claims distribution coordination in 28 countries, whereas the correct number is 30, including the Czech Republic. (2) Quantitative accuracy is poor: the percentage (41% vs. 17%) is completely off, and the country count (28 vs. 30) is also incorrect. These numbers are not minor discrepancies but represent substantial deviations from the truth. (3) The multi-hop reasoning is flawed. The model fails to correctly synthesize the relationship between Coca-Cola HBC and Coca-Cola’s non-U.S. operations, incorrectly shifting from non-U.S. volume to worldwide volume, which changes the meaning entirely. It also misses the correct number of countries despite correctly identifying the Czech Republic as one of them. (4) Contextual relevance is high because the answer addresses the right entities (Coca-Cola HBC, distribution countries, Czech Republic) and the structure matches the question’s intent. However, due to severe factual and quantitative errors, the correctness and accuracy scores are very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1115,
        "completion_tokens": 379,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity stake in the Hardy Storage underground facility in West Virginia shows a conservative, supply‑secure strategy that relies on a regulated FERC‑approved storage asset to manage market volatility and meet regulatory requirements (page 21). In contrast, NextEra’s 31.9 % ownership of a 303‑mile pipeline under construction in West Virginia and Virginia reflects an expansionary approach aimed at increasing transport capacity, but the project remains contingent on regulatory approvals and legal challenges, exposing it to significant regulatory and market risk (page 17). These tactics illustrate Duke Energy’s focus on stable, existing infrastructure versus NextEra’s pursuit of growth through new pipeline development amid uncertain regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies the strategic contrast: Duke’s focus on stable, FERC-regulated storage infrastructure versus NextEra’s higher-risk expansion strategy via a pipeline under construction. The characterization of regulatory and market risks, including legal challenges and permitting uncertainty, is consistent with the ground truth. (3) Multi-hop reasoning is sound—LLM synthesizes information across two companies, two types of infrastructure (storage vs. pipeline), and evaluates strategic intent in the context of regulation and market dynamics. (4) Minor wording differences (e.g., 'conservative, supply-secure strategy' vs. 'stable, long-term infrastructure') do not affect meaning and are semantically equivalent. The only reason for not scoring a perfect 10 is that the LLM slightly downplays Duke’s broader pattern of investing in multiple regulated assets (like Pine Needle) mentioned in the original, though it does reference FERC-approved status. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 390,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "META’s Class B shares carry ten votes each versus one for Class A (page 82), giving the 343,761,117 Class B shares roughly 61 % of the 5.63 billion total votes while representing only 13.6 % of the 2.53 billion shares outstanding (page 1). GOOGL has the same 10:1 dual‑class ratio, and its $62 billion 2024 share‑repurchase program (page 82) has cut the overall share count, further concentrating voting power among the remaining holders. Thus both firms exhibit high ownership concentration, with META’s structure already heavily weighted toward the minority Class B holders and GOOGL’s buy‑back likely amplifying that concentration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that META's Class B shares carry ten votes each, which contradicts the ground truth stating that META does not disclose the exact voting ratio. This is a critical error as it fabricates a specific 10:1 ratio not present in the original data. Additionally, the total vote calculation (5.63 billion) and the claim that Class B shares represent 61% of total votes are unsupported and incorrect since the voting ratio is not disclosed. The share count is also miscalculated: the total shares outstanding (Class A + Class B) is 2,189,898,148 + 343,761,117 = ~2.53 billion, which the model correctly identifies, but then incorrectly refers to a '5.63 billion total votes'—a number with no basis. (2) The $62 billion share repurchase by GOOGL is correctly cited (matches $62.0 billion in ground truth), and the implication of concentration due to buybacks is reasonable. However, the model incorrectly states that GOOGL has the 'same 10:1 dual-class ratio' without clarifying that this explicit ratio is only confirmed for GOOGL, not META. (3) The multi-hop reasoning is partially sound—comparing ownership concentration and the impact of buybacks—but is undermined by the false equivalence in voting ratios. The model fails to acknowledge the key distinction that META’s voting structure lacks transparency, which is central to the original answer. (4) Despite these flaws, the answer addresses the core question about dual-class structures and ownership concentration, showing relevant contextual understanding. However, the fabrication of META’s 10:1 ratio and incorrect vote calculations severely undermine factual correctness, warranting a low correctness and quantitative accuracy score. Qualitative accuracy is moderate due to correct framing of concentration effects, and contextual relevance remains high as the response stays on topic and attempts synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 528,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "JNJ’s 2020 effective tax rate was lowered by about **2.6 % (≈$0.4 billion)** when the Swiss Tax Reform Act (TRAF) was enacted, creating a net benefit that reduced the company’s annual effective tax rate.  \nMerck’s 2021 Swiss tax holiday is described as an additional tax incentive that likewise cuts its effective tax rate, but the filing does not disclose a specific dollar amount or percentage impact for that benefit.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that JNJ's effective tax rate decreased by 1.9% due to TRAF, but the LLM claims a 2.6% reduction, which is incorrect. Additionally, the LLM introduces a dollar amount of $0.4 billion not present in the original answer, which lacks any monetary figures. There is no mention in the ground truth of a specific dollar impact for JNJ, so this is an unsupported addition. For MRK, the original answer notes that the tax holiday began in 2021 and contributes to lower tax rates through favorable provisions, but the LLM correctly acknowledges that no specific percentage or dollar impact is disclosed—this part is accurate. (2) The dates and entities are correct: JNJ in 2020 and MRK in 2021 are properly identified, and both companies are accurately linked to Swiss tax incentives. However, the incorrect percentage (2.6% vs 1.9%) and fabricated dollar figure undermine quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies that both companies benefited from Swiss tax policies, though through different mechanisms and in different years. It captures the contrast in timing and policy type (reform vs holiday), but fails to accurately describe the mechanism for JNJ (adjustment of tax basis to fair value under transitional provisions) and omits the comparative context that both led to lower effective tax rates via localized incentives. (4) The contextual relevance is high because the answer addresses both parts of the question and attempts a comparison, but the incorrect numbers and missing qualitative details from the original response reduce correctness and qualitative accuracy. The answer is plausible but factually imprecise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 483,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s 10‑K notes that its foreign‑currency asset hedges are executed with forward contracts and options to offset translation and net‑investment exposure, but the notional amount of those hedges is not disclosed in the pages provided. Nike, by contrast, uses options (along with forwards) as part of a transactional‑FX risk‑management program to hedge product‑cost and external‑sales cash flows, with the goal of reducing earnings and cash‑flow volatility; the notional amounts of those options are also not disclosed. Thus, while both firms employ options, McDonald’s focus is on mitigating translation and net‑investment risk, whereas Nike’s focus is on hedging transactional cost and revenue exposures.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding quantitative disclosures. The ground truth states that MCD had $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024, but the LLM incorrectly claims this amount is 'not disclosed.' This is a major error in quantitative accuracy. Additionally, while the ground truth confirms both companies use options, the LLM implies NKE's notional amounts are not disclosed—though the original answer does not state NKE disclosed specific figures, it also does not support the claim that they are absent from disclosure; however, this is a lesser issue. (2) The core financial figure ($9.9 billion for MCD) is entirely omitted and falsely characterized as undisclosed, which contradicts the ground truth. This severely impacts the quantitative accuracy score. (3) Qualitatively, the LLM correctly identifies the differing objectives: MCD focuses on protecting foreign currency assets (translation/net investment), while NKE targets transactional exposures like product costs and sales in non-functional currencies. This reflects sound multi-hop reasoning in distinguishing strategic focus, even if details are misstated. (4) Contextually, the response is relevant and addresses the comparative structure of the question—comparing hedging practices, instruments used, and objectives. However, the failure to report a key disclosed number and misrepresenting disclosure status undermines factual correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 436,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The G500’s exclusive use of RTX’s PW800 engine gives it a modern, fuel‑efficient propulsion system that delivers lower emissions, higher thrust and extended range—capabilities that GD highlights as key differentiators for the aircraft’s clean‑sheet design. By pairing the PW800’s performance with the G500’s new wing, avionics, cabin and flight‑control systems, GD can position the G500 as a next‑generation replacement for the older G450 and G550 models, offering customers superior speed, efficiency and sustainability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correct: General Dynamics (GD) as the developer of the G500, RTX's Pratt & Whitney Canada producing the PW800 engine, and the G500 being a next-generation replacement for the G450 and G550. The exclusive use of the PW800 engine is correctly noted. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM correctly links the exclusive engine-airframe pairing to enhanced performance (fuel efficiency, range, thrust), ties it to the clean-sheet design (new wing, avionics, cabin, flight controls), and concludes that this supports GD's strategy to position the G500 as a modern successor. The only minor omission is that the PW800 also powers the G400 and G600, which is in the original answer but not critical to the core reasoning. (4) The answer is highly contextually relevant, directly addressing how the engine choice supports GD's strategic positioning. Wording differs but meaning is preserved. No factual errors—only slight incompleteness regarding other aircraft using the PW800, which does not detract from the main point. Thus, correctness is 9 due to high accuracy with a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 364,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "CMCSA’s filing states that its Class A shares hold 66 ⅔ % of the combined voting power while Class B shares hold 33 ⅓ %, and that the Class B portion is “generally non‑dilutable” under the company’s articles of incorporation. The Meta 10‑K pages supplied do not disclose the voting‑power percentages or any non‑dilutable provisions for its Class A or Class B shares, so a direct comparison cannot be made from the provided information.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly reports CMCSA's voting power distribution (66 2/3% for Class A and 33 1/3% for Class B) and accurately notes the non-dilutable nature of CMCSA's Class B shares as tied to its articles of incorporation, which aligns with the ground truth. This earns high marks for quantitative accuracy. However, the LLM incorrectly claims that Meta's 10-K 'does not disclose' voting power percentages or non-dilutable provisions, which contradicts the ground truth stating that Meta's Class B stock is not publicly traded and held by only 23 stockholders as of December 31, 2023—implying concentrated control and effectively non-dilutable voting power, even if not explicitly labeled as such. The answer fails to extract and report this key qualitative insight from the provided Meta filing, leading to an incomplete and misleading conclusion that 'a direct comparison cannot be made.' This is a significant omission in multi-hop reasoning: the question asks for a comparison of voting power distribution and non-dilutable provisions, and the LLM should have inferred Meta's de facto non-dilutable control from the concentrated ownership structure. While the wording differs, the ground truth provides enough information to make a meaningful comparison, which the LLM did not attempt. Thus, the qualitative accuracy and overall correctness are substantially reduced, though not entirely wrong on CMCSA facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 390,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "Bristol‑Myers Squibb notes that Revlimid could enter the UK market on January 18 2022 and other EU countries on February 18 2022 “before the expiration of our intellectual property rights” (see page 34), underscoring the risk that patent settlements or challenges could trigger earlier generic entry and shorten its exclusivity.  By contrast, Eli Lilly relies on orphan‑drug data protection, which grants a seven‑year exclusivity period for each orphan indication (page 10); this framework is less dependent on patent litigation but still ends when the data‑protection period lapses, after which generics may appear.  Thus, BMY faces a more immediate, litigation‑driven risk of losing exclusivity in Europe, whereas Lilly’s risk is tied to the finite duration of regulatory data protection for orphan indications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Revlimid's generic entry dates in the UK (January 18, 2022) and other European countries (February 18, 2022) are accurately stated, matching the original answer. The reference to BMY's own disclosure about losing exclusivity before IP expiration (page 34) supports the factual basis. (2) Quantitative accuracy is perfect: dates are correct and match the ground truth exactly. No calculations are required, but temporal precision is maintained. (3) The multi-hop reasoning is sound—correctly contrasting BMY’s patent-based vulnerability due to settlements with LLY’s reliance on regulatory data protection via orphan drug designation, which provides seven years of exclusivity. The LLM correctly identifies that LLY’s protection is less exposed to litigation risk but still time-limited. (4) The only minor shortcoming is that the LLM does not explicitly mention that orphan exclusivity is 'independent of patent expiration,' a key nuance in the original answer that strengthens the contrast. However, the implication is present in stating it is 'less dependent on patent litigation.' Wording differs slightly but meaning is semantically equivalent. Contextual relevance is excellent, directly addressing the comparative IP risk posed by patent challenges vs. data protection frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 384,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "MS (page 62) notes that its Wealth‑Management and Investment‑Management fees are “sensitive to changes in the fixed‑income portion of client holdings,” but the sensitivity is described only qualitatively and depends on market level, duration, volatility and client behavior.  In contrast, PYPL (page 93) explains that its derivatives and debt securities are valued at fair value using pricing models that rely on observable market inputs (interest‑rate curves, currency rates, volatility, etc.), giving the company a direct, model‑based exposure to market risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between MS and PYPL in terms of market risk exposure through pricing models. (1) All factual elements are correct: MS's asset management revenues are indeed sensitive to fixed income market changes due to fee-based client assets, and this sensitivity depends on duration, volatility, and client behavior—consistent with the ground truth. PYPL’s use of fair value pricing models for derivatives and debt securities using observable inputs like interest rate curves and currency rates is correctly described. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (MS and PYPL), identifies their respective exposures (indirect via fees vs. direct via fair value accounting), and links both to the use of pricing models with observable inputs. The only minor omission is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt securities, which is a key reason for its direct exposure—this slightly reduces completeness but does not invalidate the overall correctness. (4) The answer remains contextually precise, directly addressing the comparative sensitivity of revenue models and risk exposures. Wording differs slightly from the original answer but maintains semantic equivalence. Thus, a correctness score of 9 is appropriate—excellent but not fully comprehensive on PYPL’s accounting election.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 445,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle’s MySQL HeatWave now bundles generative‑AI models with real‑time analytics in a single managed cloud database (Oracle MySQL HeatWave “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service”【page 12】), showing Oracle’s strategy of embedding AI directly into enterprise data platforms so that customers can run inference and generate insights on their own data without leaving the Oracle Cloud. In contrast, Qualcomm is investing heavily in IoT and consumer devices—spreading its Snapdragon AI Engine and Hexagon NPU across smartphones, PCs and edge gateways (the AI Engine “includes dedicated hardware capable of running complex AI use cases at high‑performance and low‑power on device”【page 9】) and expanding into automotive and industrial IoT (Qualcomm “invests in new and expanded product areas, industries and applications beyond mobile handsets, such as automotive and IoT”【page 18】)—reflecting a focus on low‑power, on‑device inference that reduces latency, preserves privacy and powers new consumer and industrial use cases. This contrast illustrates Oracle’s emphasis on AI‑augmented enterprise workloads in the cloud, versus Qualcomm’s emphasis on AI‑enabled edge devices for consumer and industrial markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and generative AI—consistent with the original answer. Qualcomm’s investment in IoT and edge devices, including Snapdragon AI Engine and Hexagon NPU for on-device AI processing, is accurately described. (2) Quantitative accuracy is perfect: while the original answer includes specific projections (19% of smartphones AI-capable in 2024, rising to 46% in 2027), the LLM answer does not mention these numbers but does not contradict them either. Since the LLM response omits these figures without introducing errors, this is considered a minor omission rather than an inaccuracy—hence full points on quantitative accuracy. (3) Multi-hop reasoning is sound: the model correctly contrasts Oracle’s cloud-native, enterprise-focused AI integration with Qualcomm’s edge-centric, consumer and industrial IoT strategy. It synthesizes information about Oracle’s database platform and Qualcomm’s chip-level AI investments across different markets. (4) Semantic equivalence is strong: though the LLM uses different phrasing (e.g., 'inference and generate insights' vs 'AI-driven analytics'), the meaning matches the original. The only minor gap is the absence of the specific smartphone AI adoption percentages, which slightly affects completeness but not overall correctness. Contextual relevance is excellent as all content directly addresses the comparative strategies of Oracle and Qualcomm regarding on-device AI in enterprise and consumer markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 454,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe’s risk‑factor discussion (page 23) notes that the EU AI Act will raise compliance, governance and R&D costs, potentially slowing the rollout of new AI features and tightening margins. Salesforce’s 10‑K (pages 4‑8) highlights its Agentforce platform as a core, rapidly deployable AI‑powered sales and service engine. If Adobe’s compliance burden delays or raises the cost of its AI offerings, it could fall behind Salesforce in delivering AI‑enhanced solutions, weakening Adobe’s competitive positioning in the CRM and marketing space.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe anticipates increased compliance, governance, and R&D costs due to the EU AI Act, which may slow AI feature rollouts and impact margins. Salesforce’s reliance on its AI-powered Agentforce platform for sales and service is accurately represented. (2) There are no numeric values, dates, or calculations in either the question or answers that conflict; the LLM correctly avoids asserting specific dollar amounts or timelines beyond what’s in the original, such as the phased implementation through 2030 (mentioned in ground truth but not contradicted by LLM). (3) Multi-hop reasoning is sound: the model correctly synthesizes Adobe’s regulatory cost risks with Salesforce’s strategic use of AI via Agentforce, concluding that Adobe could fall behind in AI-enhanced offerings, particularly in CRM and marketing—consistent with the competitive dynamics in the ground truth. (4) The LLM omits a minor detail from the original—namely, that both companies face similar regulatory pressures per GS_10k_2024 and that Salesforce’s deeper AI integration may help it absorb regulatory changes better—but this does not undermine the core correctness. Wording differs but semantic meaning matches. No factual inaccuracies present. Minor deduction in qualitative accuracy for slight incompleteness in comparative regulatory impact, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 410,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD’s deferred shares are an equity award that gives each non‑employee director one share of common stock upon termination of service and pays dividend equivalents in the form of additional shares, so the directors receive a direct increase in their equity stake. In contrast, LOW’s ASR agreements let the company buy back shares with cash and then receive additional shares from the financial institution; those shares are held as treasury stock and reduce the number of shares outstanding, indirectly benefiting shareholders by potentially raising earnings per share rather than distributing shares to stakeholders. Thus, HD’s structure distributes equity directly to directors, while LOW’s structure uses a share‑repurchase mechanism that compresses the share base and enhances shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between HD's and LOW's mechanisms for issuing additional shares. (1) It correctly identifies that HD issues dividend equivalents in the form of additional shares to non-employee directors upon termination, which increases their equity stake—this aligns with the ground truth's description of a stock-based compensation mechanism tied to director retention. (2) It accurately describes LOW’s ASR agreements as involving cash-funded share repurchases where additional shares are received from financial institutions based on variable notional terms, and correctly notes these shares become treasury stock, reducing shares outstanding. This matches the ground truth’s characterization of ASRs as part of a capital return strategy, not compensation. (3) The reasoning correctly contrasts direct equity distribution to individuals (HD) versus indirect shareholder value enhancement via share base compression (LOW), reflecting sound multi-hop synthesis across both companies’ practices. (4) While the LLM does not explicitly use the term 'dividend equivalents' in the same structural context as the original answer, it correctly associates them with deferred share payouts to directors. One minor omission: the LLM does not mention that LOW’s additional shares are tied to 'repurchase efficiency and final notional value calculations,' slightly reducing qualitative completeness. However, the functional description is accurate. No numerical inaccuracies are present—both cases involve share issuance without specific dollar amounts, so quantitative accuracy is perfect. The answer is contextually fully relevant and clearly addresses the comparison in stock-based value distribution as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 476,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T’s adoption of ASU 2020‑04 is described on page 53 as an optional expedient that “does not materially impact our financial statements,” implying that any changes to contract terms under the reference‑rate reform are not expected to alter its revenue‑recognition timing or performance‑obligation accounting. In contrast, Verizon’s note (page 67) acknowledges that contract modifications can change the timing and scope of remaining performance obligations, thereby potentially shifting when revenue is recognized, though it does not quantify the materiality of that effect. Thus, AT&T expects no significant impact, whereas Verizon recognizes a possible but unspecified impact on revenue timing and obligations.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AT&T adopted ASU 2020-04 and stated it did not materially impact financial statements, which aligns with the ground truth. However, it fails to include Verizon's specific quantitative disclosures about future revenue recognition — $25.7 billion in 2024, $18.7 billion in 2025, and $7.5 billion beyond — which are central to the original answer and directly address the impact on revenue recognition timing. The omission of these figures significantly undermines the completeness and accuracy of the comparison. (2) Quantitative accuracy is low because the LLM answer does not report any of Verizon’s dollar amounts, which are critical for assessing the magnitude of contract modification impacts. These numbers were explicitly stated in the ground truth and are essential for a factually complete response. (3) The reasoning is partially sound: the LLM correctly infers that AT&T sees no significant impact while Verizon acknowledges potential shifts in revenue timing. However, it misses the multi-hop synthesis that contrasts AT&T’s minimal impact under ASU 2020-04 with Verizon’s broader, quantifiable exposure to contract modifications affecting performance obligations — a key comparative insight. (4) Contextual relevance is high because the answer addresses the core issue of revenue recognition timing and performance obligations in both companies. Qualitative accuracy is moderate due to correct entity identification and conceptual understanding, but the lack of specific data from Verizon limits the depth and correctness of the analysis. Correctness score is 5 due to major omission of key financial figures required for a fully accurate comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 468,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension plan discloses that municipal bonds are part of its “Bonds and Debentures” category and are valued using Level 2 inputs, with $1.7 billion of such assets, whereas Lockheed Martin’s pension plan does not separately list municipal bonds and the fixed‑income category that could contain them is not identified as Level 2, indicating a lower reliance on Level 2 valuations for municipal securities. Both firms provide a fair‑value hierarchy and describe the valuation methods for each asset class, thereby complying with ASC 820, but Union Pacific’s higher Level 2 exposure reflects a more extensive use of observable but non‑quoted inputs for municipal bonds.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Union Pacific has $1.7 billion in municipal bonds classified as Level 2, but this specific dollar amount is not present in the ground truth and cannot be verified from the provided knowledge. More critically, it incorrectly states that Lockheed Martin does not identify its fixed-income category as Level 2, which contradicts the ground truth stating LMT does use Level 2 for fixed income securities with corroborated indicative quotes. The claim that LMT has 'lower reliance' or 'not identified as Level 2' is false. (2) Quantitative accuracy is partially correct only in that $1.7 billion is a plausible figure (if it were supported), but since it's unverified and not in the original answer, it introduces unsupported data. No calculations are performed, but the use of a specific number without basis reduces accuracy. (3) Multi-hop reasoning fails: the model incorrectly infers from absence of explicit mention that LMT does not use Level 2 for municipal bonds, whereas the ground truth confirms LMT does use Level 2 for fixed income (which includes municipal bonds) when corroborated. The comparison between UNP's specificity and LMT's general treatment is reversed into an incorrect conclusion about differential reliance. (4) Contextual relevance is moderate because the answer addresses ASC 820 compliance and Level 2 usage, but the erroneous conclusion about differing reliance undermines the core analysis. The answer suggests divergence in practice, while the ground truth indicates alignment under ASC 820 with only differences in disclosure specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 451,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO’s distribution in Argentina is handled almost exclusively by Coca‑Cola FEMSA, whose operations there are confined to the federal capital of Buenos Aires and its surrounding areas, giving KO a relatively narrow geographic footprint and limited exposure to macro‑inflation. In contrast, MDLZ’s Argentine subsidiaries are classified as highly inflationary, with remeasurement losses of $13 million in 2021 (and $9 million in 2020) that hit earnings, indicating a broader economic‑volatility risk that materially impacts its financial results. Thus, KO’s reliance on FEMSA is geographically constrained and less affected by inflation, whereas MDLZ faces significant inflation‑related volatility in Argentina.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $13 million remeasurement loss in 2021 for MDLZ is correctly stated, matching the original answer. The mention of a $9 million loss in 2020 is an additional detail not in the original answer but does not contradict it and may reflect real data; its inclusion does not reduce accuracy. However, the LLM omits KO’s $14.471 billion in net sales to equity method investees (including FEMSA) and MDLZ’s $401 million in Argentine revenues (1.4% of total), which are key quantitative points in the original answer. These omissions are notable but do not undermine the core comparison. (2) The geographic scope of Coca-Cola FEMSA’s operations in Buenos Aires and surrounding areas is correctly identified. (3) The reasoning is sound: the LLM correctly distinguishes KO’s indirect, distribution-based exposure via FEMSA from MDLZ’s direct financial exposure due to inflation and currency volatility. It accurately notes that Argentina has been classified as highly inflationary, impacting MDLZ’s subsidiaries. (4) The semantic meaning and intent of the original answer are preserved—both companies face Argentina-related risks, but through different mechanisms. The LLM emphasizes the narrower geographic and financial exposure of KO versus the broader financial volatility for MDLZ, which is consistent with the ground truth. The only shortfall is the omission of specific revenue figures and percentages, which slightly reduces completeness and quantitative accuracy. Contextual relevance is perfect—the response directly addresses the comparative exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 451,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B common shares carry ten votes each and may be converted to Class A shares, giving holders significant voting power while allowing the company to preserve control and still offer liquidity (see Note 11, page 82). Alphabet’s dual‑class structure gives Class A one vote and Class C no voting rights, so its $62 billion 2024 repurchase of Class A and Class C shares does not dilute control (see “Share Repurchases,” page 82). Consequently, Meta can focus on repurchasing Class A shares to return capital while keeping control through the high‑vote Class B shares, whereas Alphabet can buy back both voting and non‑voting shares without affecting its governance structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structure for both Meta and Alphabet, stating that Meta's Class B shares carry 10 votes (vs. 1 for Class A), and that Alphabet's Class A has 1 vote, Class C has none—matching the ground truth. The $62 billion 2024 share repurchase by Alphabet is accurately cited, with correct reference to repurchases of Class A and Class C shares. (2) Quantitatively, all numbers are correct: $62 billion (written as $62B) and the year 2024 match the original. No calculations were required, but the use of figures is precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use dual-class structures to preserve voting control while conducting share repurchases. It logically infers that Alphabet’s repurchase of non-voting (Class C) and low-vote (Class A) shares does not dilute control, and similarly, Meta can repurchase Class A shares without affecting control held via Class B. The only minor omission is that the ground truth explicitly notes Alphabet’s Class B shares also have 10 votes—this is implied but not stated in the LLM answer. However, the core reasoning about control preservation remains intact. (4) The answer is contextually relevant, directly addressing the influence of voting structures on shareholder equity strategy, particularly in relation to repurchases. Wording differs but semantic meaning aligns closely with the original. Minor deduction in qualitative accuracy due to incomplete specification of Alphabet’s Class B voting rights, though not critical to the main conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 440,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s Veklury revenue fell from $2.18 bn in 2023 to $1.80 bn in 2024—a decline of about $385 m (≈18 %) that the company attributes to the availability of vaccines and other COVID‑19 therapies (page 19, page 66). Amgen notes that alternative treatments and new entrants in its competitive therapeutic markets erode pricing and market share, thereby negatively impacting its revenues and profitability, though the filing does not provide a specific dollar amount (page 18). Thus, Gilead’s decline is quantifiable, whereas Amgen’s impact is described qualitatively as a market‑share erosion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the revenue figures for GILD's Veklury are correctly reported as $2.18 billion in 2023 and $1.80 billion in 2024 (matching $2,184 million and $1,799 million in the original, with minor rounding acceptable: $1.80B ≈ $1,800M vs $1,799M). The calculated decline of $385M (≈18%) is accurate: $2,184M - $1,799M = $385M, and $385M / $2,184M ≈ 17.6%, which rounds to 18%. (2) The LLM correctly identifies that GILD attributes the decline to alternative treatments and vaccines (consistent with 'reduced demand linked to availability and uptake of alternative treatments'). (3) For AMGN, the LLM accurately reflects that alternative treatments and new entrants are eroding market share and pricing, with impact described qualitatively—correctly noting no specific dollar amount is provided, which matches the original. It also correctly names competitive markets (via examples like ENBREL, Repatha, etc., though not listed verbatim in LLM answer, the concept is preserved). (4) The multi-hop reasoning is sound: it compares GILD’s quantifiable pandemic-driven revenue drop to AMGN’s broader, systemic, payer-driven market share erosion in chronic disease markets. The only minor shortcoming is that the LLM does not explicitly name AMGN’s specific drugs (Otezla, Aimovig, etc.) or mention formulary restrictions by payers/PBMs, which are part of the original qualitative context. However, the essence—that payer dynamics and competition drive alternative treatment adoption—is captured. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 due to slight omission of AMGN-specific drug names and mechanisms (formulary restrictions), but not enough to undermine the core accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 490,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50% Senior Notes pay interest twice a year (Feb 15 and Aug 15) until the notes mature on Aug 15 2022, with the entire principal due that year. Qualcomm’s $14 billion of notes include both fixed‑rate and floating‑rate issues; fixed‑rate interest is paid semi‑annually, floating‑rate interest quarterly, and principal is spread over fiscal 2023‑2027 and beyond (with no payments in fiscal 2026). Thus, AMD’s schedule is a single, semi‑annual payment stream ending in 2022, whereas Qualcomm’s structure involves mixed payment frequencies and staggered principal obligations across multiple fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's $312 million 7.50% Senior Notes have semi-annual interest payments on February 15 and August 15, with final maturity on August 15, 2022—this matches the original answer's fiscal 2022 maturity. QCOM's $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate and quarterly for floating-rate notes, which is accurately reflected. The principal payments starting in fiscal 2023 and skipping fiscal 2026 are correctly noted. (2) Quantitative elements—dollar amounts ($312 million, $14 billion), interest rates (7.50%), dates (Feb 15, Aug 15), and fiscal years (2022 maturity for AMD, 2023–2027 for QCOM with no 2026 payment)—are all factually correct. Format variations (e.g., $14 billion vs $14.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes payment frequency and principal obligation structures across two different companies and note types, drawing a valid comparison. (4) The only minor shortcoming is that the LLM mentions principal payments 'through fiscal 2027 and beyond'—while plausible, the original answer does not specify beyond 2026, so this slight extrapolation prevents a perfect 10. However, it does not contradict known facts. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 392,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "Merck’s loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely open the market to generic and biosimilar competitors, eroding sales and margins and weakening its competitive position (MRK pages 31‑33).  This is especially troubling because Merck relies on strong patent rights to guard against generic entry, and it mirrors the biosimilar exposure that Amgen already faces in international markets (AMGN page 13).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia/XGEVA to Merck, when these products are developed and marketed by Amgen. This misidentification of the company responsible for the drug fundamentally undermines the answer's correctness. The original answer correctly identifies that it is Amgen, not Merck, whose patent protection is expiring for Prolia/XGEVA in February 2025. (2) Quantitatively, the date 'February 2025' is accurate and matches the ground truth; no other numerical values are present, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is partially sound—linking patent expiration to biosimilar competition, recognizing Merck’s reliance on patent protection, and drawing a parallel to Amgen’s international biosimilar exposure—but it fails because the core premise (Merck owning Prolia/XGEVA) is false. This invalidates the logical chain. (4) Despite this, the answer demonstrates contextual understanding of competitive dynamics, patent reliance, and biosimilar threats, which keeps contextual relevance high. However, due to the major entity error, the correctness and qualitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 342,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s FY 2024 10‑K does not break out VMware Cloud Foundation revenue by use case, so the exact share of the $12,384 million VMware revenue that is tied to AI workloads is not disclosed.  VMware Cloud Foundation, however, includes private‑AI services that enable generative‑AI workloads, and Cisco’s strategy—outlined in its 10‑K (page 4)—to supply high‑density routers, switches and high‑performance optics for AI training and inference aligns with Broadcom’s focus on delivering a platform that can run AI workloads at scale.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The ground truth states that $1,380 million of $2,900 million in VMware Cloud Foundation revenue was tied to AI workloads in FY2024. However, the LLM claims that the total VMware revenue was $12,384 million and that the portion tied to AI is not disclosed—both of which contradict the original answer. The $12,384 million figure appears to be total VMware revenue (possibly from another context), not VMware Cloud Foundation revenue, and misrepresents the scope. (2) The calculation of the portion tied to AI is entirely missing in the LLM answer, despite the ground truth providing a clear $1.38B out of $2.9B figure. The LLM incorrectly asserts that 'the exact share... is not disclosed,' which directly contradicts the original answer’s explicit quantification. (3) While the LLM correctly identifies that VMware Cloud Foundation supports AI workloads and that Cisco’s infrastructure strategy aligns with AI training/inference (citing high-density routers, switches, optics), this qualitative alignment is only partially accurate due to reliance on incorrect financial context. The multi-hop reasoning fails because it does not correctly synthesize the specific revenue figure with the AI-use case linkage as required. (4) The contextual relevance is moderate because the answer addresses the right companies (Broadcom, VMware, Cisco), the right topic (AI infrastructure), and references 10-K filings, but the core financial data is wrong, undermining the factual foundation. Thus, despite some correct strategic context, the answer fails on key facts and calculations, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 460,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs hold about **$1,851 million** in assets (page 97), whereas Southern Power’s PPAs that are treated as operating leases generate roughly **$652 million** in undiscounted cash flows (page 270).  Thus, NEE’s solar‑VIE asset base is roughly 2.8 times larger than Southern Power’s operating‑lease exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative comparison. While it correctly states NEE's consolidated solar VIE assets as $1,851 million (from year-end 2021, per ground truth), it introduces a figure of $652 million in 'undiscounted cash flows' for Southern Power's PPAs as operating leases, which is not present in the original answer and lacks contextual alignment. The original answer does not provide any dollar amount for Southern Power's exposure—only a description of the lease structure and duration (up to 25 years). Thus, the $652 million figure appears to be fabricated or misattributed, severely undermining quantitative accuracy. (2) The calculation that NEE’s asset base is '2.8 times larger' is therefore invalid, as it compares an asset value ($1,851M) to a cash flow projection ($652M) from an unverified source, which are fundamentally different financial metrics and not directly comparable. (3) The reasoning fails on multi-hop synthesis: while the LLM correctly identifies that NEE consolidates VIEs with solar assets and that Southern Power has PPAs accounted for as operating leases, it incorrectly quantifies Southern Power's exposure and draws a numerical conclusion not supported by the ground truth. The original answer emphasizes structural differences in risk and ownership (direct asset ownership vs. lease financing), which the LLM omits in favor of an unsupported quantitative comparison. (4) Contextual relevance is high because the LLM addresses both entities and the nature of their solar exposure, but correctness is low due to the introduction of a false numerical value and invalid comparison. The qualitative accuracy is moderate because the entities and general structures are correctly identified, but the lack of proper synthesis on risk and ownership reduces its depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 501,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks’ equity incentive plans include stock‑appreciation rights (SARs) as one of several instruments, but the company does not use stock options extensively; SARs vest over a graded service period tied to employment, with no explicit four‑year window stated in the filing (see SBUX page 61). In contrast, Tesla’s 2019 Equity Incentive Plan offers a broader mix—stock options, restricted stock, RSUs, SARs, performance units and performance shares—and specifies that stock options and RSUs vest over a four‑year period (options exercisable for up to 10 years) with vesting ending upon termination of employment (see TSLA page 83).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Starbucks includes SARs in its equity plans but does not broadly use stock options; Tesla's 2019 Plan offers SARs, stock options, RSUs, and performance shares. Tesla's stock options and RSUs vest over four years and are exercisable up to 10 years—these numbers are correctly reported. (2) Quantitative accuracy is perfect: 'four-year vesting' and '10 years' for exercisability match the original answer exactly. No calculations were required, but temporal metrics are correctly cited. (3) Multi-hop reasoning is sound: the model correctly synthesizes across Starbucks and Tesla’s plans, contrasting available instruments and vesting terms. It appropriately notes that Starbucks does not specify a four-year vesting window explicitly, which is consistent with the ground truth’s lack of such detail. (4) Minor qualitative gap: the LLM omits Starbucks’ use of performance-based RSUs tied to EPS and ROIC, and Tesla’s lack of specified performance conditions—this contextual nuance is present in the original answer but missing here. However, the core comparison on equity instruments and vesting timelines is complete and accurate. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent as it directly addresses the structure and vesting timelines as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 385,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s Class B shares carry ten votes each, giving large holders a ten‑fold voting advantage over Class A shares and enabling them to disproportionately influence board elections and amendments. Alphabet’s Class A shares have only one vote per share, so large shareholders’ influence is strictly proportional to their ownership, lacking the amplified voting power that Meta’s Class B holders possess. Thus, Meta’s structure allows big holders to wield more governance influence per share, while Alphabet’s structure limits influence to share count alone. (See Meta and Alphabet 10‑K, page 82.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it falsely claims that Meta's Class B shares have 'ten votes each,' which is wrong—according to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances. This is a critical factual error. Similarly, the claim that Class B shares provide a 'ten-fold voting advantage' is entirely false. (2) The entity accuracy is flawed: the LLM confuses Meta’s actual share structure—where Class B shares are non-voting—with a structure resembling Meta’s *Class B supervoting* shares (which do not exist under that name; in reality, Meta’s *Class B* shares are non-voting, while *Class A* are voting). In contrast, GOOGL’s Class A shares do have one vote per share, which the LLM correctly states, but this is overshadowed by the major error on Meta. (3) The reasoning is unsound: the LLM concludes that Meta’s structure gives large shareholders more influence, when in fact the opposite is true—large shareholders in Meta’s Class B shares have *limited* influence due to lack of voting rights. This reverses the correct causal logic. (4) The citation to 'page 82' of the 10-K is unverifiable and likely fabricated. The answer is contextually related to corporate governance and voting rights, hence minimal relevance, but the core facts are inverted. Due to complete factual inaccuracy on the key point (voting rights), the correctness score is near zero.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 409,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC’s foreign‑currency derivatives are modest – roughly $112.7 m of OTC swaps and $0.5 m of cleared contracts, with a net exposure of only about $3.6 m (page 107). They are used mainly to hedge foreign‑currency‑denominated assets, liabilities and non‑U.S. investments, and the positions are netted under master agreements. JPM, by contrast, holds a far larger foreign‑currency portfolio (≈$6.48 bn of OTC swaps and spot/futures versus $100 m of liabilities, page 211) and employs both fair‑value and cash‑flow hedges for foreign‑currency‑denominated assets/liabilities and forecasted revenue/expense, plus net‑investment hedges for non‑U.S. subsidiaries (pages 212‑213).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces specific numerical values not present in the original ground truth, which does not provide any dollar amounts for derivative positions of BAC or JPM. The ground truth states that BAC includes foreign currency derivatives under 'Risk Management Activities' on a gross basis before netting, but the LLM incorrectly claims positions are 'netted under master agreements'—this contradicts the original answer’s emphasis on gross presentation. Additionally, the LLM cites exact figures such as $112.7M, $0.5M, $3.6M, and $6.48B with page references, which are absent from the ground truth and cannot be verified; thus, quantitative accuracy is very low. While the LLM attempts to compare the two banks’ use of derivatives and mentions hedging of foreign currency assets, liabilities, and forecasted transactions (which aligns partially with JPM’s stated use), it fabricates granular details about hedge types (e.g., 'fair-value and cash-flow hedges', 'net-investment hedges') and portfolio sizes not found in the original answer. The qualitative reasoning shows an attempt at multi-hop synthesis by contrasting BAC and JPM, but the conclusions are based on non-existent data. Contextually, the response addresses the general topic of foreign currency derivatives in risk management for both banks, so relevance is moderate. However, due to invented numbers, incorrect treatment of netting, and unsupported specifics, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 414,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s risk is primarily demand‑side: a prolonged economic downturn cuts industrial customers’ electricity and gas use, shrinking sales and cash flows, and while the company can recover fuel and other costs through regulated rates, earnings can be capped if state commissions review and reduce rates (see page 27 and page 25). Southern Company’s risk is cost‑side: rising environmental‑compliance costs (CCR, GHG, etc.) may not be fully recoverable through regulated rates and could also dampen industrial demand, creating uncertainty over rate recovery and potential demand impacts (see page 26). Both firms rely on regulated rate recovery, but Duke faces revenue loss from reduced industrial use, whereas Southern faces higher costs that may not be fully passed through and could suppress demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Factual correctness: The LLM correctly identifies Duke Energy's risk as demand-side due to reduced industrial consumption during economic downturns, and Southern Company's risk as cost-side due to environmental compliance costs (e.g., CCR, GHG) that may not be fully recoverable. Both companies' reliance on regulated rate recovery is accurately noted. (2) Quantitative accuracy: There are no specific numbers (e.g., dollar amounts, percentages, years) in either answer that conflict; the LLM does not introduce any incorrect figures and correctly references the ongoing nature of environmental costs through mechanisms like CCR without contradicting the original's 'through 2028' timeline. No calculations are required. (3) Multi-hop reasoning: The LLM successfully synthesizes risks across two companies, contrasting demand volatility (Duke) vs. cost recovery uncertainty (Southern), and correctly links both to regulated rate mechanisms—Duke’s adjustment clauses and Southern’s ECO Plan/CNP/ECR-like tariffs (referred to generally). The mention of page numbers (25, 26, 27) suggests document grounding, though not required for truthfulness. (4) Semantic equivalence: The LLM uses slightly different phrasing (e.g., 'cost-side' vs. 'regulatory-driven cost increases') but preserves the core contrast. One minor omission: the original specifies Southern’s mechanisms by name (ECO Plan, CNP Compliance, ECCR), while the LLM generalizes them. This does not impair understanding but slightly reduces precision. Overall, the answer is factually sound, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 465,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s Class B shares, wholly owned by CEO Brian Roberts, carry 15 votes per share and represent roughly one‑third of the company’s total voting power; the company treats Class A and B holders as a single voting class except where law requires separate voting, giving Roberts a significant but not majority influence. Alphabet’s dual‑class structure gives Class B shares 10 votes per share, allowing founders and insiders to hold a majority of voting power even with a smaller equity stake, creating a more entrenched governance model.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements correctly but contains significant inaccuracies and omissions that affect factual correctness and completeness. (1) Quantitatively, the LLM correctly states that CMCSA's Class B shares carry 15 votes per share and represent roughly one-third of total voting power (33 1/3%), which aligns with the ground truth. However, it fails to mention that this voting power is non-dilutable under the company's articles of incorporation—a critical structural feature. For GOOGL, the LLM correctly notes that Class B shares have 10 votes per share, but incorrectly implies that founders hold a majority of voting power due to this structure, which is not supported in the original answer and lacks precision. (2) The LLM omits the key fact that GOOGL’s Class B shares automatically convert to Class A upon sale or transfer, a major distinction affecting governance fluidity. This omission undermines the comparative analysis. (3) In reasoning, the LLM reverses the conclusion: it claims GOOGL has a 'more entrenched governance model,' while the ground truth states CMCSA's system is more securely entrenched due to non-dilution and higher per-share voting weight. This is a critical logical error in the multi-hop comparison. (4) While the entities (CMCSA, GOOGL, Brian Roberts) and general concepts (dual-class shares, voting differentials) are accurate, the synthesis is flawed. The answer is contextually relevant and addresses the core question about governance influence, but due to key factual inaccuracies and a reversed conclusion, the overall correctness is only partially achieved. Minor phrasing like 'treats Class A and B holders as a single voting class' is plausible but not in the original and not clearly substantiated. Thus, the answer is partially correct but misses essential nuances and contains a significant reasoning flaw.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 504,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "KO’s exposure to Taiwan is indirect, coming only through its bottling partner Swire Beverages, which operates there but the company does not report specific growth figures for that market (see page 7).  In contrast, PepsiCo’s 2022 results show a low‑single‑digit increase in beverage unit volume in Taiwan, reflecting direct growth in that market (see pages 48‑49).  Thus, PEP’s performance in Taiwan is measurable and positive, whereas KO’s exposure is indirect and not quantified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: PEP's low-single-digit beverage unit volume growth in Taiwan in 2022 is accurately reported. The LLM correctly notes that KO does not report specific growth figures for Taiwan through Swire Beverages, which is consistent with the original answer stating Swire accounted for 17% of KO’s global volume in 2021—but the LLM does not incorrectly claim this 17% applies to 2022 or to Taiwan alone, avoiding a potential misinterpretation. (2) The LLM correctly identifies the entities: KO, PEP, Swire Beverages, and the geographic focus on Taiwan. The years (2022 for PEP, implied 2021 for KO’s Swire data) are handled appropriately, with no incorrect attribution. (3) The multi-hop reasoning is sound: it contrasts KO’s indirect exposure via a bottler with PEP’s direct performance, synthesizing information about ownership structure, market presence, and reporting practices. (4) While the original answer includes the specific detail that Swire accounted for 17% of KO’s global volume in 2021, the LLM omits this figure. This is a minor omission but does not distort the comparison or misrepresent KO’s exposure. The LLM emphasizes the lack of quantified data from Swire, which is valid and contextually appropriate. Overall, the answer is factually correct, contextually relevant, and conveys the core insight of the original answer with high fidelity, warranting a 9/10 for correctness and qualitative accuracy, and full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 436,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "Trulicity’s patents are slated to expire in the next few years, and the drug has already seen a 32 % drop in U.S. sales in 2024 as competition and supply constraints bite (LLY, pages 27, 29, 30, 49).  If generics enter, LLY could face a rapid, severe revenue decline—an outcome it warns about in its risk disclosures—requiring the company to lean on its pipeline and other cardiometabolic products to offset the loss.  Merck, by contrast, stresses maintaining strong patent protection for its key assets (e.g., Keytruda, Gardasil) as a core strategy to preserve exclusivity and competitive positioning; the erosion of such protection would similarly erode Merck’s revenue, underscoring the importance of robust IP for both firms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 32% drop in Trulicity's U.S. sales in 2024 is correctly reported, matching the original answer. The reference to LLY's 2024 10-K (implied by page numbers) supports the data source. No calculations are required, but the temporal alignment (2024 decline) is correct. (2) The answer addresses all parts of the question: it discusses the impact of Trulicity's patent expiration on LLY's revenue trajectory and contrasts LLY's situation with MRK's strategic reliance on patent protection. (3) Entity accuracy is strong: LLY and MRK are correctly identified, Trulicity is properly attributed to LLY, and MRK's reference to Keytruda and Gardasil as key patented products is contextually appropriate (though not in the original answer, it is factually sound and enhances the comparison). (4) Multi-hop reasoning is sound: the model synthesizes LLY's exposure to generic competition post-patent expiry with MRK's emphasis on IP protection, drawing a valid cross-company comparison about the importance of patent strategy. The only minor shortcoming is that the original answer explicitly notes Trulicity’s patent expiration is 'expected to lead to a rapid and severe decline'—a forward-looking risk emphasized in LLY’s disclosures—which the LLM captures but could have more directly tied to the 'revenue trajectory' aspect. However, the mention of needing to 'lean on its pipeline' adequately addresses future implications. Wording differs but semantic meaning and factual content are equivalent. No factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 441,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s 200 hotel‑ and convention‑center stores are all leased for five‑to‑ten‑year terms (page 44), so a real‑estate downturn would mainly raise rent costs or force lease renegotiation, but it does not create a balance‑sheet hit because the company does not own the property. UPS, by contrast, holds $10.1 billion of pension assets in real‑estate, private‑debt and hedge funds (page 61); a decline in real‑estate values would erode the NAV of those assets, potentially increasing pension liabilities and requiring higher contributions—an exposure that affects the company’s financial statements rather than its day‑to‑day operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: FedEx's 200 leased retail locations at hotels and convention centers with five-to-ten-year lease terms, and UPS's $10.1 billion in pension assets invested in real estate, private debt, and hedge funds as of December 31, 2024 (implied by page 61 reference in context). All numeric values match the ground truth exactly, including dollar amounts and timeframes. (2) Quantitative accuracy is perfect—$10.1 billion is correctly cited, and the lease duration (five to ten years) matches. No calculations are required, but the interpretation of financial impact (e.g., pension asset erosion affecting contributions) is logically sound. (3) The multi-hop reasoning is strong: the model correctly distinguishes between FedEx’s operational exposure (via leasing) and UPS’s financial exposure (via pension investments), synthesizing information across two different companies and types of filings. It accurately characterizes the differing impacts—FedEx facing potential lease renegotiations or cost increases, while UPS faces balance sheet implications through pension funding. The only minor omission is that the original answer notes UPS’s exposure may include hotel investments indirectly, which adds a layer of sector-specific linkage that the LLM answer does not explicitly mention, slightly weakening the qualitative depth. (4) Contextual relevance is excellent—the response directly addresses the comparison of strategic risk during real estate volatility, focusing on the core contrast between operational and financial exposure. Wording differs but semantic meaning aligns closely with the ground truth. Overall, this is a highly accurate and well-reasoned answer with only a slight gap in elaborating the indirect connection between UPS’s funds and the hospitality sector.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 499,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "GOOGL’s Class B common shares carry 10 votes per share, giving holders a disproportionate voting power that can shape corporate strategy, whereas CMCSA’s investment in Atairos is an equity‑method stake that carries **no voting rights**—all voting power is held by Atairos’ management companies. Consequently, GOOGL’s Class B holders can directly influence strategic decisions, while CMCSA has no such control or influence over Atairos’ governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that GOOGL’s Class B shares carry 10 votes per share, which gives disproportionate voting power and influence over corporate strategy—this matches the original answer. It also accurately notes that CMCSA has no voting rights in Atairos, which is consistent with the ground truth. (2) There are no numerical values requiring calculation, but the key quantitative fact—10 votes per share for GOOGL Class B—is correct. (3) The multi-hop reasoning is sound: the model correctly contrasts GOOGL’s internal dual-class voting structure with CMCSA’s external investment structure in Atairos, synthesizing information across two companies and contexts. (4) The only minor omission is that the original answer adds that CMCSA retains certain consent rights and that Atairos is a VIE (variable interest entity), which provides additional context about the nature of CMCSA’s limited influence. While the LLM mentions CMCSA lacks voting rights and control, it does not explicitly reference consent rights or VIE status, slightly reducing completeness. However, the core facts and comparison are correct, and the semantic meaning is equivalent. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 361,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s 2023 disclosures show no commercial‑paper program – its short‑term debt is limited to money‑pool/intercompany borrowings of $522 million, with no notes payable or commercial paper listed (see DUK_10k_2023 page 164).  \nIn contrast, PepsiCo’s short‑term debt strategy includes a sizable commercial‑paper program of $2.286 billion at 5.5 % interest, which is a major component of its overall short‑term financing (see PEP_10k_2023 page 100).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023. However, the LLM claims Duke Energy Ohio has 'no commercial-paper program' and reports $522 million in intercompany borrowings instead—this contradicts the original answer and suggests confusion with another entity or misreading of the filing. The $522 million figure does not appear in the ground truth and is unverified. For PepsiCo, the LLM correctly identifies the $2.286 billion commercial paper amount (equivalent to $2,286 million), which matches the ground truth. However, it adds an unsupported detail: '5.5%' interest rate, which is not present in the original answer and introduces unverified information. (2) Quantitative accuracy is partially correct for PepsiCo but entirely incorrect for Duke Energy Ohio. The $2.286 billion figure is numerically accurate (allowing for format variation), but the complete denial of commercial paper for Duke Energy Ohio and the introduction of a $522 million intercompany borrowing figure (not mentioned in the ground truth) are major errors. (3) The multi-hop reasoning is flawed because the LLM fails to correctly synthesize Duke Energy Ohio’s actual commercial paper disclosure. It draws a contrast based on incorrect premises—claiming Duke has no program while PepsiCo does—when the truth is that both have commercial paper, but at vastly different scales. The comparison is therefore misleading. (4) Contextual relevance is high because the answer addresses the core question about comparing short-term debt strategies using commercial paper, and it references appropriate documents (DUK_10k_2023, PEP_10k_2023). However, factual correctness is severely compromised by incorrect data for Duke Energy Ohio and an unsupported interest rate for PepsiCo. Thus, while the structure and intent are sound, the factual foundation is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 534,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s 10‑K notes that the number of commercial gas customers in the Carolinas, Ohio and Kentucky is expected to grow (see page 17, “The number of residential, commercial and industrial customers…is expected to increase over time”).  Southern Company, however, relies on state‑approved regulated‑rate recovery to cover its environmental‑compliance spending (page 26, “Compliance costs may result from the installation of additional environmental controls…and may be recovered through regulated rates”).  If environmental rules curb industrial activity in those regions and commercial demand falls, the revenue base that underpins rate recovery will shrink, making it harder for Southern Company to recoup its compliance costs and potentially forcing higher rates or alternative cost‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: Duke Energy expects growth in commercial and industrial gas customers in the Carolinas, Ohio, and Kentucky (citing page 17), and Southern Company relies on regulated rate recovery for environmental compliance costs (citing page 26). These citations and assertions match the knowledge base. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a strict sense—however, the absence of any incorrect numbers or misstatements earns a perfect score by default. (3) The multi-hop reasoning is sound: the LLM correctly identifies that if environmental regulations reduce industrial activity, commercial gas demand may decline, which would weaken the revenue base for Southern Company’s rate recovery mechanism. This causal chain—regulations → reduced industrial output → lower demand → strained cost recovery—is logically and accurately synthesized from the two companies’ disclosures. (4) The LLM omits a minor detail present in the original answer—specific mention of GHG regulations and infrastructure upgrades—but captures the core dynamic. The answer is semantically equivalent and contextually precise, directly addressing the interplay between Duke’s demand outlook and Southern’s financial exposure. Only a slight deduction in qualitative accuracy due to less comprehensive elaboration on environmental compliance scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 417,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Because no Class B shares were bought back, Mr. Roberts’ 33 ⅓ % voting stake remains unchanged. The 2023 repurchase of Class A shares simply shrinks the overall voting pool of other shareholders, so Mr. Roberts’ relative influence is not diluted and is in fact slightly enhanced by the reduction in competing Class A votes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitatively, all key figures are accurate: the 33⅓% voting power of Class B shares is correctly stated, and the fact that only Class A shares were repurchased in 2023 is consistent with the original. No numerical calculations are required, but the logic around voting pool reduction is sound. (2) The answer correctly identifies that Mr. Roberts owns the Class B shares (implied by stating his voting stake remains unchanged), though this ownership detail is not explicitly stated in the LLM response—it is assumed from context. (3) The reasoning is strong: the LLM correctly synthesizes that repurchasing only Class A shares reduces the voting pool of other shareholders, thereby increasing the relative influence of Class B shares. This captures the core multi-hop logic: (a) Class B has superior voting rights, (b) they are not being repurchased, (c) Class A repurchases dilute other shareholders’ voting weight, (d) thus Mr. Roberts’ control is enhanced. (4) The answer is contextually precise and directly addresses the impact on Mr. Roberts’ control relative to the broader base. The only minor shortcoming is that it does not explicitly state that Mr. Roberts owns *all* Class B shares, which is a key reason his control strengthens—this detail is present in the ground truth and strengthens the causal link. However, the implication is clear enough to maintain high accuracy. Hence, a score of 9 is warranted—excellent but not fully complete on entity ownership detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 427,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance units are equity awards whose vesting and eventual payout depend on a simulation of stock‑holder returns versus a comparator group; the grant‑date fair value is estimated by a payout‑simulation model, and the actual number of shares issued can vary widely, making the payout highly contingent on market performance (see Amgen Notes on performance units, pages 127‑128).  \nBMS, by contrast, structures its financial agreements—such as foreign‑currency forwards and cross‑currency swaps—with explicit counterparty‑credit‑risk controls: exposure to any single counterparty is limited, only high‑credit‑quality counterparties are used, and collateral is not required, so the risk profile and expected cash‑flow impact are more predictable (see BMS Note 9 on financial instruments, page 97).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are incorrectly stated; the ground truth mentions Amgen's performance units were valued at $121 million in 2023, which the LLM omits, but does not contradict it. The absence of the $121M figure is a minor omission but does not introduce inaccuracy. All other financial and structural details are consistent. (2) The LLM correctly identifies the simulation-based payout mechanism for Amgen’s performance units, referencing payout simulations tied to stockholder returns and comparator group performance, which matches the ground truth’s description. (3) For Bristol-Myers Squibb, the LLM accurately describes counterparty credit risk mitigation strategies: limiting exposure, using high-credit-quality counterparties, and not requiring collateral—consistent with the emphasis on predictability and risk control in the original answer. (4) The reasoning correctly contrasts Amgen’s market-performance-contingent payout structure with BMS’s focus on financial stability and counterparty risk management, capturing the core distinction in contractual objectives. (5) The LLM cites specific note numbers and pages (e.g., Amgen Notes pp. 127–128, BMS Note 9 p. 97), which adds contextual fidelity, though these are not verifiable without source documents. (6) The only minor gap is the omission of the explicit $121M valuation figure for Amgen in 2023, which slightly reduces completeness but does not affect the qualitative or logical accuracy. Overall, the answer demonstrates strong multi-hop reasoning, correctly synthesizing distinct contractual frameworks across two companies and aligning with the question’s focus on payout and risk management predictability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 484,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative exposure is confined to OTC‑bilateral contracts that are governed by ISDA Master Agreements.  Those agreements provide set‑off and collateral provisions that the company can exercise under the Orderly Liquidation Authority (OLA) if a counterparty defaults, allowing the company to net and settle positions without an automatic stay (see page 261).  In contrast, Bank of America’s Dodd‑Frank obligations require it to file a comprehensive resolution plan; if the FDIC deems the plan un‑credible, the authority may invoke the OLA to wind down the holding company and its key subsidiaries, imposing capital, liquidity and shareholder‑return constraints that affect the entire institution rather than just individual derivative contracts (see pages 13‑14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting and collateral provisions under OLA is accurately described, including the ability to net positions and avoid automatic stay upon counterparty default. Similarly, Bank of America's resolution planning obligations under Dodd-Frank, including the FDIC's potential invocation of OLA and the impact on the holding company and subsidiaries, are correctly outlined. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes MetLife’s derivative-level risk management via ISDA agreements under OLA and contrasts it with Bank of America’s firm-wide resolution plan and systemic implications under the same regulatory framework. The distinction between contract-level exposure (MetLife) and institutional-level resolution (BAC) is logically drawn and well-supported. (4) Semantic equivalence is strong: while the LLM answer cites specific page numbers (261, 13–14) not in the original, these likely reflect document references and do not affect factual accuracy. The original mentions 'single point of entry' and 'bridge holding company,' which the LLM omits, but captures the functional consequence (wind-down of holding company and subsidiaries, impact on capital and shareholders). These omissions are minor and do not undermine the correctness. Overall, the answer is factually precise, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 473,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported $7.547 billion in revenue from its Greater China segment in 2022 (which includes Taiwan)【page_88】, whereas Starbucks operated 544 stores in Taiwan as of October 2022【page_12】.  The large revenue figure indicates Nike’s broader or higher‑value sales presence across Greater China, while Starbucks’ 544‑store footprint shows a strong local retail network—suggesting Nike dominates in overall sales volume, whereas Starbucks maintains a substantial physical presence in Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Nike's $7.547 billion (i.e., $7,547 million) revenue from the Greater China region in 2022 and Starbucks' 544 stores in Taiwan as of October 2022, matching the ground truth exactly in value and time frame. Number formats are acceptably equivalent ($7.547 billion = $7,547 million). (2) All quantitative elements are accurate—no calculation errors, and the dates align (2022 for both, with Starbucks' specific cutoff date of October 2, 2022, reasonably approximated as 'October 2022'). (3) The reasoning correctly synthesizes a multi-hop comparison between Nike’s regional revenue and Starbucks’ localized store count, acknowledging different dimensions of market presence. It accurately infers that Nike's metric reflects broader sales volume across Greater China, while Starbucks' reflects a dense physical footprint in Taiwan. (4) The only minor shortcoming is that the LLM slightly overemphasizes Nike's 'sales volume' dominance, which isn't directly supported since revenue does not equate to volume, and the comparison is across different geographies (Greater China vs. Taiwan only). The original answer more precisely cautions that the metrics represent different scopes and dimensions. This nuance is downplayed but not misrepresented, warranting a high but not perfect qualitative score. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 396,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5.0 billion upfront payment from American Tower in March 2015 was larger than the $2.8 billion received from Vertical Bridge in December 2024.  Verizon retained sub‑lease obligations to American Tower, whereas with Vertical Bridge it recorded a $2.0 billion prepaid‑rent liability and a $830 million financing obligation for the portion of towers it continues to occupy.  In both transactions Verizon keeps the towers on its property, plant and equipment, net, and depreciates them, but the $2.8 billion payment is reflected as other liabilities (prepaid rent and financing obligation), whereas the $5.0 billion payment is not similarly accounted for and Verizon simply sub‑leases capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $5.0 billion from American Tower in March 2015 and $2.8 billion from Vertical Bridge in December 2024, the retained ownership and depreciation of towers, continued inclusion in 'Property, Plant and Equipment - Net', and the specific $2.0 billion prepaid rent and $830 million financing obligation in the Vertical Bridge deal. These numbers and dates match the ground truth exactly, with acceptable formatting (e.g., $2.8 billion). (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and the comparison of payment sizes is accurate. (3) The multi-hop reasoning is sound—LLM correctly contrasts the accounting treatment between the two deals, noting that the Vertical Bridge transaction included a split liability structure not specified in the American Tower deal. The only minor shortcoming is that the LLM implies the $5.0 billion payment 'is not similarly accounted for' without explicitly stating that the American Tower deal lacked such a breakdown, which slightly weakens the qualitative precision. However, this is semantically close to the ground truth. (4) Contextual relevance is excellent—the answer directly addresses the comparison of retained obligations and asset treatment as required by the question. Overall, the answer is factually correct and comprehensive, warranting a high score with only a slight deduction in qualitative accuracy due to less precise phrasing on the structural difference in accounting treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 422,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is calculated under the Advanced Measurement Approach, which explicitly incorporates fraud risk into its loss‑distribution model and scenario analysis (see the description of the AMA methodology on page 155).  In contrast, Citi’s emerging‑market disclosures highlight a concrete potential loss of roughly $1.6 billion (plus $0.9 billion inter‑company liability) if it loses control of AO Citibank in Russia, illustrating a sizable fraud‑related exposure that could exceed the firm’s capital buffer (page 64).  Thus, JPMorgan’s capital buffer is a regulatory requirement that covers fraud risk generically, whereas Citi’s scenario presents a specific, large‑scale potential loss tied to political and asset‑confiscation risk in Russia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III, which incorporates fraud risk via internal/external loss data, scenario analysis, and business environment factors. Citigroup's exposure in Russia is accurately reported as $1.6 billion in CTA losses and $0.9 billion in intercompany liabilities if control of AO Citibank is lost. These figures match the original answer exactly, and format variations (e.g., $1.6 billion vs $1.6B) are acceptable. (2) Quantitative accuracy is perfect—both dollar amounts are correctly cited without calculation errors. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan’s forward-looking, regulatory capital estimation framework with Citigroup’s specific, scenario-based emerging market risk tied to political instability and asset confiscation in Russia. (4) The only minor shortcoming is that the LLM slightly overinterprets by suggesting Citigroup’s potential loss 'could exceed the firm’s capital buffer'—a claim not supported in the original answer and not verifiable from the provided data. This introduces a small qualitative inaccuracy, preventing a perfect 10. Otherwise, the response is contextually rich, semantically equivalent, and fully addresses the comparative, multi-entity nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 386,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s risk disclosure (page 35) states that a prolonged conflict could “severely limit or prevent us from receiving chipset supply from Taiwan,” which would materially harm its business because it relies on Taiwan‑based foundry partners. In contrast, Intel’s 2023 revenue from Taiwan was $6.867 billion (page 88–89); while the region is a significant revenue source, Intel’s broader manufacturing and supply‑chain footprint means a conflict would reduce that revenue but is less likely to halt its overall operations. Thus, Qualcomm’s supply chain is more directly vulnerable to a Taiwan‑focused disruption than Intel’s operational footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundries and the risk of supply disruption are accurately described, citing the correct qualitative risk ('severely limit or prevent us from receiving chipset supply'). Intel's $6.867 billion in 2023 revenue from Taiwan is correctly stated and attributed to the right context (revenue exposure, not manufacturing dependency). (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the original answer exactly. No calculations were required, but the comparison of financial vs. operational exposure is logically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes Qualcomm's supply chain dependency (from risk disclosures) with Intel's financial exposure (from revenue data), distinguishing between supply-side and demand-side vulnerabilities. The only minor shortcoming is that the LLM does not explicitly state that Intel has no disclosed reliance on Taiwan-based manufacturing—this nuance is implied but not directly confirmed, slightly weakening the qualitative completeness. (4) The answer is fully contextually relevant, directly addressing the comparative impact on Qualcomm’s supply chain versus Intel’s operational footprint. Wording differs slightly from the original but maintains semantic equivalence. Overall, this is a factually correct, well-reasoned response with only a minor omission in explicit contrast on Intel's manufacturing disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 427,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests quarterly, applying a combination of discounted‑cash‑flow analysis, earnings multiples and market multiples (RTX Note 4, p. 102).  By contrast, BA’s Level 3 assets that are measured on a nonrecurring basis are valued only when an impairment is recognized, using an income‑approach based on discounted cash flows (BA Note 21, p. 124).  Thus, RTX re‑measures its PE LPs each quarter with a multiples‑augmented DCF, whereas BA applies a one‑time DCF‑based income valuation for impairment events.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately states that RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples—matching the original answer. It also correctly notes that BA applies a discounted cash flow (income approach) for Level 3 assets on a nonrecurring basis, specifically during impairment events. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the temporal frequency ('quarterly' vs. 'nonrecurring') is correctly reported, earning full marks. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s proactive, recurring valuation process with BA’s reactive, event-driven approach. However, the LLM omits key contextual details present in the ground truth—specifically, that BA uses median collateral values from third-party aircraft publications and adjusts for unique aircraft attributes or expected net sales prices. This omission limits completeness and slightly weakens qualitative accuracy. (4) Despite this, the answer captures the essential distinction in methodology and timing, and remains semantically equivalent on the main point: RTX uses a recurring, multiples-augmented DCF, while BA uses a one-time DCF-based approach for impairments. The answer is highly relevant and well-structured, hence full marks for contextual relevance. Minor detail omissions prevent a perfect score, but core facts and logic are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 449,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix’s 10‑K states that it uses forward contracts to hedge the foreign‑exchange risk on firm commitments, but it does not disclose a one‑day loss figure for those hedges.  In contrast, Disney’s 10‑K reports a Value‑at‑Risk model that estimates a combined one‑day loss of **$284 million** at year‑end 2023 (and **$255 million** at year‑end 2024) under normal market conditions at a 95 % confidence level.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Netflix's use of forward contracts and Disney's VAR model, and notes that Netflix does not disclose a one-day loss figure, which aligns with the ground truth. However, the LLM incorrectly states Disney's VAR as $284 million at year-end 2023, which is not present in the original answer or supported by the knowledge graph—only the $255 million figure as of September 28, 2024, is provided in the ground truth. This introduces a factual inaccuracy. (2) The $255 million figure is correctly cited for 2024, but the addition of a $284 million figure for 2023 lacks support in the provided ground truth and may reflect hallucination or incorrect inference. No calculation is required, but the inclusion of an unsupported prior-year value reduces quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model correctly contrasts Netflix’s qualitative hedging approach with Disney’s quantitative VAR disclosure, synthesizing information across both companies’ risk management practices. It correctly infers that a direct numerical comparison is limited by Netflix’s lack of VAR disclosure. (4) Despite the incorrect $284M figure, the core comparison and conceptual framing are accurate and relevant, warranting high scores for qualitative accuracy and contextual relevance. The correctness score is reduced due to the unsupported numeric claim, but not severely, as the main comparative insight remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 407,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD’s 2022 tax‑provision disclosures (page 75) make no reference to the Philippines corporate‑income‑tax cut, indicating that the Q1 2021 rate reduction did not materially affect AMD’s tax provision.  Texas Instruments’ 2022 filing (pages 31‑35) likewise contains no mention of operational investments in the Philippines, so any impact on its tax provision is not shown in the supplied documents.  Thus, while the Philippines tax‑rate reduction is noted in PMI’s filing as partially offsetting its effective tax rate (page 93), it is not reflected in AMD’s tax provision, and TXN’s presence in the country is not disclosed in the provided pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to align with the ground truth. (1) It incorrectly states that AMD’s 2022 tax provision disclosures do not reference the Philippines tax cut, concluding no material impact—this contradicts the original answer, which confirms the tax reduction did have a favorable impact on AMD’s effective tax rate and was noted as a mitigating factor despite an overall increase to 21.8%. The LLM also wrongly claims Texas Instruments’ filings contain no mention of operational investments in the Philippines, while the ground truth specifies TXN had $370 million in PPE at its two Philippine sites as of December 31, 2021. (2) Quantitatively, the LLM omits and misrepresents key figures: it fails to report AMD’s 21.8% effective tax rate and the 0.1 percentage point increase, and completely ignores TXN’s $370 million investment. Instead, it references PMI (Philip Morris International), which was not part of the original question or answer, introducing an irrelevant entity. (3) The reasoning is flawed: the LLM appears to base its conclusion on absence of mention in specific document pages, but the original answer draws from actual disclosures about tax impacts and investments. It fails the multi-hop requirement by not connecting the tax rate change to its differential impact on AMD’s tax provision and TXN’s operational exposure. (4) Contextual relevance is moderate because it addresses the Philippines tax change and the two companies, but the factual inaccuracies and erroneous conclusions severely undermine the response. The introduction of PMI further detracts from accuracy. Overall, the answer misrepresents the data and misses the core insights of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 465,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates are embedded in its vehicle‑production and supply‑chain model: the company holds equity‑method investments in automotive China joint ventures and other non‑consolidated affiliates that develop, manufacture and market trucks, cars and parts, and it uses variable‑interest entities (VIEs) for GM Financial and battery‑cell joint ventures to control financing and production (see pages 77–79, 103–104).  \nMcDonald’s, by contrast, structures its affiliates as independent franchisees and developmental licensees that operate restaurants; the firm generates revenue from rent, royalties and fees while accounting for affiliates owned under 50 % (primarily China and Japan) with the equity method and does not consolidate them (see pages 44–48).  \nThese differing arrangements mirror each company’s core business: GM’s focus on integrated vehicle manufacturing and financing versus McDonald’s franchise‑based restaurant operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: GM's use of nonconsolidated affiliates and equity-method investments in China for vehicle production (brands like Buick, Cadillac, Chevrolet implied through context) is accurately described, as is McDonald's franchise-based model with revenue from royalties, rent, and fees. The distinction between GM’s production-focused affiliates and McDonald’s service- and brand-driven franchise operations is clearly and correctly articulated. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer that conflict; the LLM does not introduce any incorrect numbers and avoids making unsupported quantitative claims. Format and precision are consistent with the source material. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across business models, affiliate structures, geographic focus (China for both), and accounting methods (equity method, non-consolidation), drawing a valid contrast between manufacturing integration and franchising. (4) The only minor shortcoming is that the LLM omits specific brand names like Baojun and Wuling mentioned in the original, which adds slightly more detail to GM’s affiliate output. However, this does not detract from the overall correctness, as the core operational distinction is preserved. The inclusion of VIEs and GM Financial adds depth without inaccuracy. Semantic equivalence is maintained, and the answer fully addresses the comparative business model question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 432,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62 billion repurchase of Class A and C shares in 2024 (page 82) cuts the Class A share base, shrinking the total voting pool that is weighted at one vote per share. Because each Class B share still carries 10 votes and is only converted to Class A when sold (page 82), the proportion of total votes attributable to the remaining Class B shareholders rises, boosting their relative voting influence. The automatic‑conversion rule also discourages Class B holders from selling, further preserving their enhanced relative weight.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: Alphabet's $62.0 billion share repurchase in 2024 applies to Class A and C shares, reducing the outstanding Class A share base. The dollar amount and year match the original answer exactly, with acceptable formatting ($62 billion = $62.0 billion). (2) The reasoning correctly explains the multi-hop logic: reducing Class A shares through buybacks shrinks the total voting pool of 1-vote shares, which increases the relative voting weight of Class B shares that carry 10 votes each. (3) The automatic conversion of Class B to Class A upon sale is accurately cited as a mechanism that preserves the high-vote structure by discouraging Class B holders from selling, thus maintaining their concentrated control. (4) The LLM cites 'page 82' (likely from the 10-K), reinforcing grounding in source material, though not required for correctness. No factual errors, omissions, or misstatements. The answer addresses all parts of the question: impact of buybacks on Class A shares, conversion rules, and resulting effect on Class B voting power. All entities (Alphabet, Class A/C/B shares, voting rights) are correctly identified. The synthesis across financial activity and corporate governance rules is sound and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 372,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and Coca‑Cola adopted ASU No. 2020‑01, which clarifies that a company must consider observable transactions before applying or discontinuing the equity method for equity securities and that derivatives whose underlying securities would be accounted for under the equity method or fair‑value option are excluded from derivative accounting. The guidance therefore clarifies the interaction between equity securities, equity‑method investments, and derivative contracts, but neither company reported a material impact on its financial statements (Colgate‑Palmolive, page 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: ASU No. 2020-01's purpose—clarifying the interaction between equity securities (Topic 321), equity method investments (Topic 323), and derivative contracts (Topic 815)—is correctly summarized. The adoption by both Colgate-Palmolive and The Coca-Cola Company is accurately noted, and the statement that neither company reported a material impact aligns with the original answer. Colgate-Palmolive’s effective adoption date (January 1, 2021) is implied by context in the original, and while the LLM does not explicitly state the date, it correctly references adoption and lack of material impact. (2) There are no numerical values, percentages, or dates in the LLM answer that conflict with the ground truth; the mention of 'page 81' in Colgate’s filing is a plausible citation and does not introduce inaccuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes the standard’s technical effect across two companies and correctly identifies the accounting implications regarding observable transactions and derivative exclusions. (4) The only minor shortcoming is that the LLM omits specific mention of Coca-Cola’s disclosure of net unrealized gains and losses on equity securities still held, which is part of the original answer and adds depth to how the standard is applied. However, this omission does not undermine the overall correctness. The answer remains semantically equivalent in intent and substance. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 449,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Citibank’s Stress Capital Buffer (SCB) is 4.1 % of its CET1 ratio under the Standardized Approach (page 35), which brings its required CET1 ratio to 12.1 % as of December 2024. Goldman Sachs’ CET1 ratio under the same rules is 15.0 % (page 209), implying a larger SCB component than Citibank’s. This higher buffer reflects Goldman Sachs’ more conservative capital‑adequacy strategy, prioritizing greater loss‑absorption capacity relative to Citibank’s approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) According to the ground truth, Goldman Sachs has an SCB of 6.2%, while Citibank's CET1 requirement of 7.0% does not include an SCB under the Standardized Approach. However, the LLM incorrectly states that Citibank has an SCB of 4.1% and a total CET1 ratio of 12.1%, and that Goldman Sachs has a CET1 ratio of 15.0%. These numbers are not supported by the ground truth and contradict it. (2) The cited page numbers (35 and 209) and implied data sources are not verifiable from the provided ground truth, suggesting fabrication or misattribution. (3) The reasoning is flawed: the ground truth indicates that Citibank does not have an SCB component under the Standardized Approach, but the LLM assumes both banks have SCBs and draws a comparative conclusion about capital strategies based on incorrect data. (4) While the answer attempts to address the question’s intent—comparing capital adequacy approaches under the Standardized Rules—the multi-hop synthesis fails because it misidentifies key regulatory components. The conclusion about Goldman Sachs having a 'more conservative strategy' due to a larger SCB is based on false premises. (5) Semantic equivalence is not achieved due to major discrepancies in numbers, buffer structures, and regulatory treatment. The contextual relevance is moderate because the answer discusses the right topic and regulatory framework, but factual inaccuracies severely undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 411,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra’s Indiana assets are disclosed only as part of its rate‑regulated transmission network – a 90‑mile “Other” jurisdiction that includes 5 substations in Illinois, Indiana, Kentucky, New Hampshire and New York (page 16‑17).  No separate financing or capital‑investment amount is shown for those Indiana assets in the filing.  By contrast, Duke Energy Indiana’s 2023 balance sheet shows a clear financing strategy: it issued $352 million of tax‑exempt bonds maturing 2027‑2046 at a weighted‑average rate of 3.84 % (page 164‑165).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NextEra Energy's transmission infrastructure in Indiana as part of a multi-state network with 90 miles of lines and 5 substations, which aligns with the ground truth. However, it incorrectly states that the 5 substations are located across Illinois, Indiana, Kentucky, New Hampshire, and New York — this geographic breakdown is not in the original answer and introduces unsupported detail, reducing factual accuracy. More critically, the LLM claims Duke Energy Indiana issued $352 million in tax-exempt bonds, whereas the ground truth states $285 million held as of December 31, 2023. This is a significant numerical discrepancy (67 million difference), and the LLM also adds extraneous details not in the original — such as maturity range (2027–2046) and weighted-average rate (3.84%) — which, while possibly in the filing, are not part of the ground truth answer and distort the comparison. (2) Quantitative accuracy is compromised: $352M vs $285M is a material error. The original answer emphasizes that tax-exempt bonds constitute a major portion of Duke’s $435M total debt, which the LLM omits entirely, missing a key comparative insight. (3) The reasoning correctly contrasts physical infrastructure (NextEra) vs financing strategy (Duke), showing sound multi-hop logic across entities and strategies. However, it fails to synthesize the full context — particularly Duke’s total debt context — weakening the strategic comparison. (4) Contextual relevance is high because the answer addresses both companies and the core contrast in strategies. Despite incorrect numbers and over-specified details, the qualitative structure and intent match the question. Overall, partially correct but undermined by key factual and quantitative errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 487,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on third‑party developers (page 13) and the company has recently altered its alternative‑payment processing under the EU Digital Markets Act (page 13), exposing it to revenue volatility from developer supply decisions and to regulatory risk if commission or payment rules change. In contrast, Microsoft produces much of its own content (page 32) and its risk factors highlight brand‑reputation concerns tied to content and AI decisions (page 32, page 30), so it faces less supply‑chain risk but greater reputational and regulatory scrutiny when its own content choices attract backlash or regulatory action.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers, recent changes to alternative payment processing under the EU DMA, associated risks to commission revenue and developer supply, and Microsoft's in-house content production with associated brand reputation risks are all accurately represented. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s different content strategies and risk exposures from their respective SEC filings (referencing page numbers adds credibility). The only minor shortcoming is a slightly less explicit connection between Apple’s payment changes and potential reduction in commission revenue compared to the original answer, but the implication of revenue volatility is clear. (4) The answer is fully contextually relevant, directly addressing the comparative business risks arising from content sourcing and payment policies. Wording differs but semantic meaning matches the ground truth. No factual inaccuracies—only a slight reduction in completeness regarding the nuance of 'developer incentives' as a risk driver, which is implied but not stated outright.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 390,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s risk disclosures note that a tritium or other radioactive release could trigger damages that exceed insurance and decommissioning trusts (see page 29).  In contrast, NEE’s 10‑K warns that market‑value declines in its nuclear decommissioning funds could leave those funds under‑funded, potentially requiring additional contributions (see page 31).  Thus, Southern faces an uncertain, potentially immediate liability from a tritium spill, while NEE faces a quantified long‑term shortfall in its decommissioning reserves.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of both Southern Company and NEE's nuclear-related risks, with no incorrect numbers or entities. It correctly identifies Southern Company's exposure to potential tritium leakage leading to liabilities exceeding insurance and decommissioning trusts, citing the correct type of risk (immediate, event-driven liability). For NEE, it accurately reflects the risk of underfunded decommissioning reserves due to market-value declines, which aligns with the original answer’s emphasis on decommissioning fund shortfalls. There are no numeric inaccuracies—though the original answer includes generation percentages (26%, 28%) from Southern Company’s subsidiaries, the LLM omits these but does not misstate any figures. This omission slightly affects completeness but not correctness. The reasoning correctly synthesizes multi-hop information across two companies and risk types (operational vs. financial/funding), drawing a valid contrast between immediate contamination liability and long-term funding shortfall. While the original answer emphasizes the *comparable* nature of the financial exposures, the LLM frames them as contrasting (‘in contrast’), which shifts the emphasis slightly but does not invalidate the core accuracy. The answer remains contextually relevant and captures the essence of both disclosures. Thus, high scores across the board with a minor deduction in qualitative accuracy for framing the comparison as oppositional rather than parallel, and in correctness for missing the quantitative generation mix context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 434,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "Altria’s effective tax rate was partially cushioned by the Q1 2021 reduction in the Philippine corporate income‑tax rate – the note on PMI’s 2021 effective tax rate shows the lower Philippine rate helped offset the unfavorable impact on the group’s tax expense (page 94). For Coca‑Cola, the lower tax rate in the Philippines makes capital investments in that market more attractive, which is reflected in the company’s allocation of capital expenditures to its Asia‑Pacific operations (page 124).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key quantitative details from the ground truth. It correctly identifies that the Philippine tax rate reduction in Q1 2021 benefited Altria's tax position and mentions PMI’s tax rate discussion, but fails to report the specific impact on Altria’s effective tax rate — namely, the 0.1 percentage point increase contributing to a 21.8% rate in 2021. This omission is significant because the question explicitly asks about the impact on Altria’s effective tax rate, and the ground truth provides precise figures. Similarly, for Coca-Cola, the LLM notes that lower taxes make investments more attractive and references capital allocation to Asia-Pacific, but does not include the critical fact that Philippine PPE represented 10% of KO’s consolidated PPE in both 2020 and 2021 — a key measure of its capital investment strategy. (2) Quantitative accuracy is low because the answer omits all specific numbers: no mention of 0.1 pp, 21.8%, or 10% PPE exposure. These are central to the original answer and were verifiable in the knowledge graph. The LLM references document pages (e.g., page 94, 124), which may reflect source grounding, but does not extract the actual data. (3) The multi-hop reasoning is logically sound: the model connects the tax reduction to Altria’s tax expense and infers improved investment attractiveness for Coca-Cola. However, it falls short in synthesizing precise cross-entity and cross-year data (e.g., PPE percentage stability over time) that would demonstrate full multi-hop integration. (4) Contextual relevance is high because the response stays focused on both companies and the tax policy’s implications. The qualitative reasoning is plausible and directionally correct, but lacks the evidentiary support from exact figures, reducing its factual reliability. Thus, while the logic and framing are strong, the absence of key metrics results in a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 531,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung’s foundry services for NVIDIA (NVDA 10‑K, p. 9) already tie up a sizable share of wafer capacity.  As a direct competitor that also builds its own SoCs (QCOM 10‑K, pp. 17‑21), Samsung may allocate that capacity to its own product lines, leaving less for external customers.  Consequently, Qualcomm’s $12.8 billion of multi‑year capacity purchase commitments (QCOM 10‑K, p. 82) could face higher lead times or costs, or force Qualcomm to shift to alternative suppliers, potentially eroding its ability to meet demand and margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Samsung supplies NVIDIA (cited from NVDA 10-K), competes with Qualcomm in SoCs (QCOM 10-K), and Qualcomm has $12.8 billion in multi-year capacity purchase commitments (QCOM 10-K, p. 82). The dollar amount is correctly stated and matches the ground truth. (2) Quantitative accuracy is perfect: the $12.8 billion figure is correctly cited with no calculation errors. (3) Multi-hop reasoning is sound: the answer connects Samsung’s role as a supplier to NVIDIA, its competition with Qualcomm, and the potential impact on Qualcomm’s capacity commitments. It correctly infers that Samsung’s prioritization of its own products could lead to capacity constraints for Qualcomm, resulting in higher costs, lead times, or supplier shifts. (4) The only minor shortcoming is that the LLM does not explicitly mention the possibility of renegotiating terms, which is included in the original answer, but it does cover the core consequences—costs, lead times, supplier shifts, margin pressure—making the omission minor. Wording differs but semantic meaning is equivalent. Citations to 10-K pages add precision and relevance. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong synthesis across entities and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 373,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s commercial‑customer receivables total $665 million (page 76) and are recorded only on Lockheed Martin’s balance sheet; they do not appear on United Launch Alliance’s (ULA) financial statements, so they have no direct impact on ULA’s financial position. Boeing owns a 50 % equity stake in ULA and reported $125 million of income from the joint venture in 2024 (page 42), underscoring ULA’s importance to Boeing’s earnings, but the commercial‑customer receivables remain a Lockheed Martin asset and do not affect ULA’s financials.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the $665 million in commercial customer receivables from Lockheed Martin and Boeing's $125 million equity income from ULA in 2024, both of which match the ground truth. These numbers are accurate and properly attributed, satisfying quantitative accuracy. 2) However, the LLM misinterprets the nature of the receivables and their relationship to ULA. The original answer clarifies that ULA is a commercial customer of Lockheed Martin’s Space segment and is included in the $665 million receivables. The LLM incorrectly states that these receivables 'have no direct impact on ULA’s financial position' and 'do not affect ULA’s financials,' which contradicts the ground truth implication that ULA’s financial health could affect Lockheed’s ability to collect on those receivables—i.e., there is an indirect but meaningful impact. 3) The multi-hop reasoning is flawed: while the LLM correctly identifies that receivables are on Lockheed’s books and not ULA’s, it fails to recognize the bidirectional financial dependency implied in the original answer—ULA’s performance affects both Boeing’s equity income and Lockheed’s receivables collection risk. The answer stops at accounting separation without addressing the economic interdependence. 4) Despite correct numbers and entities (Lockheed Martin, ULA, Boeing, $665M, $125M, 2024), the qualitative reasoning is insufficient, leading to a misleading conclusion. The answer is contextually relevant and well-structured but misses the core analytical point about financial exposure and risk transmission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 432,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The invalidation of the “190 Patent” removed the related intangible asset from Gilead’s balance sheet, so the company no longer amortizes that asset.  Consequently, Gilead’s amortization expense fell, as shown in the amortization schedule for finite‑lived intangible assets (page 83) and in the overall amortization expense of other intangible assets (page 140).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and reasoning. (1) It claims that the invalidation of the '190 Patent led to a reduction in amortization expense because the intangible asset was removed from the balance sheet and no longer amortized. However, the ground truth states the opposite: amortization expense increased from $1.2 billion in 2020 to $1.7 billion in 2021, due to a clearer path to monetization post-invalidation, which improved the valuation of acquired intangible assets. (2) Quantitatively, the LLM fails to report the correct figures: $1.7 billion in 2021 and $1.2 billion in 2020 (increase of $0.5 billion), instead asserting a decrease without providing any numbers. (3) The reasoning is flawed: patent invalidation removed royalty risk (27.6% to Juno/SKI), which reduced contingent liabilities and enhanced the value of Gilead’s Yescarta-related intangibles, supporting higher amortization—not lower. The LLM incorrectly assumes asset removal upon patent invalidation, but the asset in question was acquired via Kite and remained valuable post-litigation. (4) Contextually, the answer references specific document pages (83, 140), suggesting plausible sourcing, but the conclusion contradicts the actual financial impact. While the question involves multi-hop reasoning (patent outcome → financial impact on amortization), the LLM fails to synthesize the correct chain: litigation resolution → reduced risk → improved asset valuation → higher amortization. Thus, despite addressing the topic, the answer is directionally and quantitatively wrong, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 441,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater China segment generated **$74.2 billion** in net sales in 2022 (Apple Note 11, page 52), which includes China mainland, Hong Kong, and Taiwan.  \nIntel reported **$13.5 billion** in revenue from Taiwan in 2021 (Intel Note 7, page 89).  Thus Apple’s Greater China revenue was roughly **$60.7 billion higher**—about **5½ times** Intel’s Taiwan revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in 2022 from Greater China and Intel's $13.5 billion (rounded from $13,461 million) in 2021 from Taiwan are correctly reported, with acceptable rounding. The difference of $60.7 billion is accurately calculated ($74.2B - $13.5B = $60.7B). The comparison stating Apple's revenue was about 5.5 times Intel's is also correct (74.2 / 13.5 ≈ 5.5). (2) The answer is complete, addressing both companies, correct years, and the geographic scope (noting that Greater China includes Taiwan). (3) Entity accuracy is perfect: Apple and Intel are correctly identified, with accurate metrics (net sales/revenue), correct regions (Greater China, Taiwan), and correct years (2022 vs 2021). (4) The multi-hop reasoning is sound—synthesizing data from two different companies, regions, and years to make a valid comparison. The inclusion of source citations (e.g., 'Apple Note 11, page 52') adds credibility, though not required. (5) The semantic meaning fully aligns with the original answer, conveying that Apple’s revenue from the broader Greater China region was significantly higher than Intel’s Taiwan-specific revenue. Wording differences (e.g., '5½ times' vs 'significantly higher') are stylistic and do not affect factual equivalence. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 396,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS’s derivative valuation is driven by pricing models that use observable market inputs such as yield curves, foreign‑currency rates and forward prices (Level 2 fair‑value), so its focus is on interest‑rate curves rather than credit spreads. Boeing, by contrast, values its fixed‑income holdings with a market‑oriented approach that relies on benchmark yields (interest rates) and base spreads (credit‑spread data) as key observable inputs (also Level 2). Thus, both firms depend on observable market data, but UPS emphasizes interest‑rate curves for derivatives, while Boeing incorporates both interest‑rate and credit‑spread information for fixed‑income securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both UPS and Boeing use observable market data for Level 2 fair value measurements; UPS relies on yield curves and foreign exchange rates for derivatives, while Boeing uses interest rates and credit spreads for fixed income instruments. The emphasis on interest-rate curves for UPS and inclusion of credit spreads for Boeing is correctly contrasted. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in implied calculations or data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and Boeing), two financial instruments (derivatives vs. fixed income), and valuation methodologies involving Level 2 inputs. It accurately identifies that both use observable inputs but differ in focus—UPS on interest-rate/foreign exchange data without mention of credit spreads, Boeing explicitly incorporating credit spreads. (4) Semantic equivalence is strong: though wording differs (e.g., 'base spreads' instead of 'credit spreads'), the meaning is preserved and technically acceptable. The only minor limitation is slightly less explicit mention of 'commonly quoted intervals' or 'forward prices' as in the original, but the core insight about observable inputs and Level 2 classification is fully conveyed. Thus, the answer earns a 9/10 for correctness—excellent but not perfect in detail completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 426,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META uses discounted‑cash‑flow (DCF) models to test impairment of operating‑lease ROU assets and leasehold improvements, applying Level 3 inputs that include expected downtime before subleases, projected sublease income, and discount rates reflecting the risk of receiving those cash flows. In contrast, Disney’s DCF models for valuing Level 2 derivatives rely on observable market inputs—interest‑rate curves, yield curves, and foreign‑exchange rates—together with counterparty credit risk that is mitigated by netting and collateral but is deemed not material. Thus, META’s DCF is driven by unobservable, asset‑specific assumptions, whereas Disney’s DCF is driven by observable, market‑based inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that META uses DCF models with Level 3 inputs for impairment testing of operating lease ROU assets and leasehold improvements, citing appropriate unobservable assumptions such as expected downtime, projected sublease income, and risk-adjusted discount rates. It accurately contrasts this with DIS (Disney), which uses DCF models for Level 2 derivatives based on observable market inputs like interest-rate curves, yield curves, and foreign exchange rates. The mention of counterparty credit risk being mitigated by netting and collateral but not material is consistent with Disney's disclosures and adds contextual accuracy without contradicting the original. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy pertains to correct classification of input levels (Level 2 vs Level 3), which the LLM handles precisely. (3) The multi-hop reasoning—comparing two companies' use of DCF models across different financial contexts (impairment testing vs derivative valuation) and linking them to fair value hierarchy levels—is sound and well-synthesized. The LLM correctly infers that the difference in input observability reflects distinct applications and risk profiles. (4) The answer is fully contextually relevant, directly addressing the comparison requested in the question, and maintains high precision in terminology and conceptual framing. Minor wording differences (e.g., 'Disney' vs 'DIS') do not affect accuracy. All key elements from the original answer are preserved and correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 452,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "PM’s 2022 filing notes that a global semiconductor shortage has tightened IQOS device supply, limiting the number of units that can be sold. Because PM USA can only commercialize heated‑tobacco products in the U.S. once the FDA authorizes them and the ITC import ban is lifted, the supply constraint directly curtails PM USA’s ability to launch or grow IQOS sales until device availability improves. PM USA’s role as a guarantor of Altria’s debt imposes significant financial obligations that could constrain its capacity to invest in domestic production or supply‑chain solutions, but it does not change the FDA‑authorization requirement for commercialization.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the global semiconductor shortage as a supply constraint for IQOS devices, per PM's 2022 filing, and links it to limited commercialization ability in the U.S. due to device availability. It accurately notes that FDA authorization and the lifting of the ITC import ban are prerequisites for PM USA to commercialize heated tobacco products. The role of PM USA as a guarantor of Altria’s debt is correctly stated. However, the LLM omits key details present in the ground truth: the specific cessation of IQOS sales after November 29, 2021, due to the ITC cease-and-desist order, and the fact that IQOS 3 was under FDA review at the time. It also fails to mention that the supply constraint contributed to the delay in resuming U.S. supply post-ITC ban, which is a critical multi-hop connection. Additionally, the financial risk to PM USA—particularly regarding potential impacts on cash flows, dividend distributions, and insolvency risks under fraudulent conveyance laws—is underdeveloped compared to the original answer. (2) There are no numerical values, dates, or calculations in the LLM answer that contradict the ground truth; where dates or numbers are implied (e.g., 'second half of 2021'), they are consistent. The absence of specific dates like 'November 29, 2021' is a completeness issue, not a quantitative error. (3) The reasoning is logically sound but incomplete. The model correctly chains semiconductor shortage → supply constraint → limited device availability → hindered commercialization, and recognizes regulatory dependencies. However, it does not fully synthesize the interplay between the ITC ban, the supply chain issue, and the delayed U.S. relaunch, nor does it adequately connect PM USA’s financial guarantees to tangible insolvency risks if commercialization remains stalled. (4) The correctness score is 7 because core facts are accurate and the answer addresses most elements of the question, but significant contextual and causal details from the ground truth are missing, reducing completeness and qualitative accuracy. Quantitative accuracy is 10 because no numbers are incorrect (none are present, but none are misstated). Qualitative accuracy is 7 due to partial reasoning and missing synthesis. Contextual relevance is 9 because the response stays focused and relevant throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 630,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMY’s 2023 risk‑factor discussion notes only generic competition and pricing pressure, with no reference to a major biologic facing biosimilar entry, suggesting a relatively modest impact on its revenue mix【page_28】.  In contrast, AbbVie’s Humira alone accounted for about 27 % of its 2023 net revenues and is under direct biosimilar competition worldwide, exposing the company to significant revenue erosion【page_81】【page_10】.  Thus, BMY’s revenue outlook is comparatively less affected by biosimilar competition than AbbVie’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Humira accounted for 27% of AbbVie's 2023 net revenues and is under global biosimilar pressure, which aligns with the ground truth. The quantitative accuracy is perfect—percentages and references to revenue impact are consistent. However, the qualitative reasoning is flawed: the LLM claims BMY faces 'no reference to a major biologic facing biosimilar entry' and suggests 'relatively modest impact,' which contradicts the ground truth stating BMY faces significant risk from biosimilars for key products like Eliquis and Revlimid. The knowledge graph explicitly notes BMY has broad portfolio risk, but the LLM incorrectly minimizes BMY's exposure based on absence of mention in a risk factor section, which is a flawed inference. This misrepresents the comparative risk: while ABBV has concentrated risk, BMY still faces substantial—though more distributed—biosimilar threats. The answer partially addresses the comparison but fails in multi-hop synthesis by not acknowledging BMY’s actual product-level vulnerabilities. Thus, while contextually relevant and numerically accurate, the conclusion about BMY’s lower biosimilar impact is unsupported and contradicts the ground truth, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 352,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards earn dividend equivalents that are paid out as part of the equity award when the shares vest—typically on the third anniversary of the grant date (or earlier if death, disability, or age 58). In contrast, PepsiCo’s RSU and PSU awards accrue dividend equivalents that are settled in cash at vesting, with RSUs vesting at the end of the employee’s service period and PSUs vesting at the end of a three‑year performance cycle. Thus, PM delivers the dividend equivalents with the equity award, whereas PEP pays them in cash upon vesting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PM includes dividend equivalents that accrue during vesting and are paid with the equity award upon vesting (typically at 3 years or earlier due to death, disability, or age 58). PEP accrues dividend equivalents but pays them in cash upon vesting—RSUs at the end of the service period and PSUs after a three-year performance cycle. The answer correctly distinguishes payout structure (equity vs. cash) and vesting triggers (PM includes age 58, PEP does not). (2) Quantitative accuracy is perfect: 'third anniversary', 'three-year performance cycle' match the ground truth's 'three years' and performance-based vesting. No calculations were required, but timeframes are correctly stated. (3) Multi-hop reasoning is sound—LLM synthesizes across PM and PEP’s RSU policies, correctly contrasting payout form (equity-included vs. cash) and vesting conditions. The only minor omission is that PEP’s cash payout is explicitly 'without interest' in the ground truth, which the LLM does not mention, slightly reducing completeness. Also, the ground truth emphasizes PEP’s lack of age-based triggers more explicitly, which the LLM implies but doesn’t directly contrast. (4) Despite these small gaps, the answer is semantically equivalent, contextually precise, and fully relevant to the question. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 413,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s $1,410 million is a concentrated, illiquid limited‑partnership stake in private real‑estate funds held within its run‑off insurance operations; the interests are non‑redeemable and can only be liquidated at the general partner’s discretion, exposing the company to significant liquidity risk【page_51】.  By contrast, BA’s real‑estate allocation is part of a broader 7 % target within its pension portfolio, comprising a mix of private LPs and potentially more liquid vehicles, and is managed through diversification and risk‑management practices that mitigate liquidity risk【page_99】【page_100】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1,410 million figure for GE is correctly stated, and while BA's 7% target allocation is not in the original answer, it is consistent with the broader strategy described and does not contradict it. No calculations were required. (2) The LLM correctly identifies both companies' use of limited partnership/fund structures and highlights GE's lack of redemption rights and dependence on general partner discretion, which matches the original answer's emphasis on illiquidity and concentration. (3) The multi-hop reasoning is sound: it contrasts GE’s narrow, high-liquidity-risk position in run-off insurance with BA’s diversified, strategically integrated real estate approach. The mention of BA’s pension portfolio context (pages 99–100) adds useful detail not in the original but supported by source material. (4) Minor deduction in qualitative accuracy because the original emphasizes BA’s diversification across property types (office, retail, etc.) and integration with private equity/hedge funds—details omitted in the LLM response. However, the core contrast in liquidity risk and fund structure is preserved. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses liquidity risk, fund structure, and strategic scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 378,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "MetLife’s equity‑market derivative notional is $23.595 billion, with a $522 million sensitivity to a 10 % decline in equity prices (page 129). In the BAC 2023 10‑K, no notional value or sensitivity for equity‑market derivatives is disclosed in the pages provided (pages 73‑77), indicating the exposure is either not material or not reported.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MET's notional value of $23,595 million is accurately reported as $23.595 billion, and the $522 million sensitivity to a 10% decline is correctly stated. These match the original answer exactly, with acceptable format variation (billion vs. million). (2) The LLM correctly notes that BAC does not disclose specific notional values or sensitivity figures for equity-market derivatives in the provided pages, which is consistent with the original answer stating BAC 'does not specify exact notional amounts.' (3) The reasoning is sound: the LLM correctly infers that BAC either does not report or does not have material exposure, which is a reasonable interpretation in the absence of disclosure. (4) The answer addresses both parts of the comparison question: MET's quantified exposure and BAC's lack of disclosed exposure. The only minor shortcoming is that the LLM does not explicitly mention BAC's use of equity-linked instruments (e.g., options, futures, swaps) for risk management, which the original answer includes to show that BAC does manage such risk, albeit without quantification. This omission slightly affects qualitative completeness but does not undermine the factual correctness. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 384,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s Greater China segment is supported by a dedicated operations center in Singapore (page 16), underscoring a substantial infrastructure investment that helped drive $74.2 billion of revenue in 2022 (page 25). In contrast, AMD’s sales to Taiwan were $2.1 billion of its $16.4 billion total revenue in 2021—about 13 % of sales (page 78, page 77)—indicating a moderate but not dominant concentration. These facts suggest Microsoft is pursuing a broader, infrastructure‑heavy strategy across Greater China, while AMD’s approach is more focused on a single market but with less overall concentration.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, Microsoft's $74.2 billion in revenue is not specific to Greater China but represents total company revenue in 2022 (or near that range), which misrepresents the geographic revenue attribution. The ground truth does not provide a specific revenue figure for Microsoft's Greater China operations, so asserting $74.2 billion as Greater China revenue is incorrect. Second, AMD's revenue from Taiwan is stated as $2.1 billion in 2021, but the ground truth specifies $2,091 million (i.e., $2.091 billion) in 2022, so both the year and the amount are wrong. The LLM incorrectly cites 2021 data and rounds up slightly, but more critically, uses the wrong fiscal year. Additionally, AMD’s total revenue in 2022 was approximately $23.6 billion, not $16.4 billion (which is closer to 2021 figures), making the 13% concentration calculation invalid. (2) Quantitative accuracy is low: the key numbers—revenue amounts, years, and percentages—are all incorrect. The $74.2B, $2.1B (vs $2.091B), 2021 (vs 2022), and $16.4B total revenue are all factually wrong. Even allowing for rounding, the use of incorrect years and misattributed revenues undermines the quantitative integrity. (3) The multi-hop reasoning is partially sound—comparing Microsoft’s operational footprint to AMD’s revenue concentration is on track—but the synthesis is flawed due to incorrect data. The conclusion that AMD has 'moderate but not dominant concentration' contradicts the ground truth, which emphasizes 'significant direct revenue contribution' and 'pronounced financial dependency,' especially given that Taiwan alone accounted for nearly $2.1B of AMD’s revenue. The reasoning is weakened by inaccurate inputs. (4) Contextual relevance is high because the answer attempts the correct comparison and references operational infrastructure vs. revenue concentration. However, due to major factual and quantitative errors, especially in financial data and time periods, the correctness score is low at 4—partially correct on structure and intent, but significantly flawed in execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 569,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "META’s dual‑class structure gives its Class B shares ten votes each while Class A shares receive only one vote, so the founder, CEO and other Class B holders collectively hold a majority of the voting power and can control corporate‑governance decisions even when they own less than a majority of the total shares【page_49】【page_50】. In contrast, NFLX has a single class of common stock with one vote per share, meaning all shareholders have equal voting rights and can influence governance proportionally to their holdings【page_61】. Thus, META’s structure concentrates voting influence in a small group, whereas NFLX’s approach distributes voting power evenly among all investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies META's dual-class structure, where Class B shares have significantly more voting power than Class A shares—though the ground truth does not specify 'ten votes per share,' this detail is consistent with publicly known facts and does not contradict the source. The core point—that Class B holders like Mark Zuckerberg have disproportionate control—is factually sound and supported. (2) The claim that NFLX has a single class of common stock with one vote per share matches the ground truth's 'one-share-one-vote' policy. No numerical inaccuracies are present; the reference to voting ratios is qualitatively correct. (3) The multi-hop reasoning is solid: the model correctly contrasts META’s founder-controlled governance model with NFLX’s egalitarian voting structure, synthesizing information across two companies and their respective governance approaches. (4) While the LLM adds slightly more granular detail (e.g., 'ten votes') not in the original answer, it does not misstate any facts. The semantic meaning and intent fully match the ground truth. Minor deduction in quantitative accuracy only because 'ten votes' isn't confirmed in the provided ground truth, though it is widely known and plausible. Overall, the response is complete, relevant, and correctly structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 381,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s loss of compound‑patent protection for products such as Jardiance and Trulicity removes the legal barrier that keeps competitors out, leading to a rapid erosion of market exclusivity and a steep decline in sales once those patents expire (JNJ 10‑K, p.10).  Eli Lilly, by contrast, extends its competitive advantage in the U.S. by leveraging regulatory exclusivity extensions—data‑package protection, orphan‑drug exclusivity, and pediatric exclusivity—which keep competitors from using Lilly’s data or launching biosimilars even after the underlying patents expire (LLY 10‑K, p.10).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the core contrast between JNJ's vulnerability to patent expiration and LLY's use of regulatory exclusivity to maintain market protection. (1) The explanation of how patent expiration leads to loss of market exclusivity and generic competition for JNJ is accurate and aligns with the ground truth. The mention of Jardiance and Trulicity, while specific, is plausible context (though not explicitly confirmed in the ground truth, which does not name specific drugs), and does not contradict known facts. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The LLM correctly identifies the multi-hop reasoning: JNJ faces market exclusivity erosion due to patent expiration and legal challenges, while LLY uses regulatory mechanisms (data exclusivity, orphan-drug, pediatric exclusivity) to extend protection. However, the LLM incorrectly attributes Trulicity to JNJ—Trulicity is an Eli Lilly product, not a Johnson & Johnson one—representing a significant entity error. This undermines part of the factual basis and reflects a failure in entity accuracy. (4) Despite this error, the overall reasoning and structure are sound, and the contrast between patent-based and regulatory-based exclusivity strategies is well articulated and contextually relevant. The answer addresses both parts of the question and synthesizes the strategic differences effectively. The correctness score is reduced to 8 due to the product misattribution, but the core conceptual and qualitative analysis remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 450,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD cut its 2021 interest expense by $13 million – the entire decrease was attributed to conversions of holders of its 2.125% convertible senior notes due 2026.  In contrast, Microsoft’s post‑Nuance balance sheet lists only $1 million of outstanding convertible senior notes from Nuance.  The comparison shows AMD is actively deleveraging through convertible conversions, while Microsoft has largely retired or minimized that convertible exposure, indicating a more conservative or diversified capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AMD's $13 million reduction in interest expense from 2020 to 2021 (from $47M to $34M), which matches the ground truth. It accurately attributes this to conversions of the 2.125% Convertible Senior Notes due 2026. It also correctly states that only $1 million in Nuance convertible senior notes remained outstanding post-acquisition by Microsoft, aligning with the ground truth that $985 million of $986 million had been redeemed by June 30, 2022. All numeric values, including dollar amounts and timeframes, are accurate. (2) Calculations are correct: the $13 million decrease is indeed the difference between $47M and $34M. The $1 million outstanding liability is accurately reported. No errors in quantitative data. (3) The multi-hop reasoning is sound: the model synthesizes information across AMD’s debt conversion impact and Nuance’s note redemption under Microsoft, correctly contrasting AMD’s active deleveraging via conversions with Microsoft’s strategy of largely retiring convertible debt. The conclusion about differing capital structure strategies—AMD proactively reducing debt through conversions vs. Microsoft minimizing exposure—is logically supported and semantically equivalent to the ground truth. (4) Minor point: the LLM does not explicitly mention Nuance’s original $986 million issuance in 2015 and 2017, which slightly reduces completeness, but since the focus is on the post-acquisition outstanding liability and the comparison is still valid, this does not significantly detract from accuracy. Wording differs but meaning is preserved. Scores reflect high accuracy with only negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 457,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "American Tower’s $5.0 billion upfront payment in 2015 was slightly larger than Crown Castle’s $4.827 billion cash outlay in 2013. In both transactions Verizon and AT&T retained ownership of the towers and continued to depreciate them, with the payments recorded as financing obligations rather than sale‑leasebacks. Thus, the American Tower deal was marginally higher but otherwise structurally similar to the Crown Castle transaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key dollar amounts ($5.0 billion and $4.827 billion) and the years (2015 and 2013), accurately stating that the American Tower payment was slightly larger. These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect: all figures (dollar amounts, years) are correct, and the comparison (slightly higher) is valid. (3) The reasoning is mostly sound: the LLM correctly notes that both Verizon and AT&T retained ownership and continued depreciation, and that the transactions were structured as financing obligations rather than sale-leasebacks, which aligns with the accounting treatment implied in the ground truth. However, it omits specific details about the number of towers involved (11,300 for Verizon, 9,048 for AT&T plus 627 purchased) and the differing leaseback terms (10 years for Verizon vs. ~20 years for AT&T), which are key comparative elements in the original answer. (4) Despite these omissions, the core facts and financial comparison are correct, and the structural similarity is appropriately highlighted. The answer is semantically close but lacks completeness in multi-hop synthesis of all specified details, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 349,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power uses tax‑equity partnerships for its wind projects, with the partner assuming most of the federal tax benefits (PTCs) while the projects are tied to long‑term PPAs that can run up to 25 years (see §97 and §268). Duke Energy structures its renewable projects as VIEs that also employ tax‑equity investors to finance the assets and capture the PTCs, but the PPAs are negotiated within the VIE and the tax‑equity investors receive the credits through that vehicle (see §203). Thus, both companies monetize PTCs via tax‑equity investors, but Southern Power does so through internal partnerships, whereas Duke Energy does so through separate VIE entities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Southern Power uses tax equity partnerships where the tax partner captures most federal tax benefits (including PTCs), and that these are linked to long-term PPAs with up to 25-year terms—this matches the original answer. It also correctly notes that Duke Energy uses VIEs with third-party tax equity investors to finance renewable assets and monetize PTCs. (2) There are no numeric values requiring calculation, but the 'up to 25 years' PPA term is correctly reported, matching the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their distinct structures (Southern Power’s partnerships vs. Duke’s VIEs) and connects both to PPA use and PTC monetization. However, the LLM slightly oversimplifies by stating Southern Power uses 'internal partnerships'—the original answer clarifies these are external tax equity partnerships consolidated under HLBV, not internal. Additionally, the original highlights that Southern Power explicitly aligns PPA terms with the 10-year PTC window, while Duke focuses more broadly on VIE financing and guarantees; this nuance is missing in the LLM response. (4) Despite this, the core facts, entities, and logic are correct, and the answer remains contextually precise and relevant. Minor loss in qualitative accuracy due to missing nuance in structural comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 404,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "CMCSA’s Class B shares carry ten votes each, giving holders a ten‑fold voting advantage over Class A shares and enabling them to dominate board and corporate decisions [page 82]. GOOGL’s dual‑class structure likewise gives Class B shares ten votes each, but the addition of a non‑voting Class C and automatic conversion rights further concentrates control, limiting ordinary shareholders’ influence on major matters such as mergers and charter amendments [page 82, page 90].",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that CMCSA's Class B shares have ten votes per share, when in fact CMCSA's Class B common stock has *no voting rights*, according to the ground truth. This is a critical error that reverses the actual governance structure. (2) The answer correctly notes that GOOGL's Class B shares have ten votes per share and that Class C shares have no voting rights, which aligns with the ground truth. However, it fails to mention that GOOGL's Class A shares have one vote per share, a key part of the dual-class comparison. (3) The multi-hop reasoning is flawed: the model fails to accurately contrast CMCSA’s lack of voting rights for Class B with GOOGL’s super-voting Class B shares, instead falsely equating them both as having ten votes. This misrepresentation leads to an incorrect synthesis of corporate governance models. (4) The mention of 'automatic conversion rights' and specific page citations adds detail but does not compensate for core inaccuracies. While the answer addresses the general topic of shareholder influence and governance, the reversal of CMCSA’s voting structure renders the comparison invalid. Quantitative accuracy is very low due to the incorrect vote count attribution. Qualitative accuracy is poor due to incorrect entity attributes and flawed reasoning. Contextual relevance is moderate because the response attempts the right comparison and references relevant concepts like mergers and charter amendments, but with incorrect foundations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 429,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "GOOGL’s dual‑class structure gives Class B holders 10 votes per share versus one vote for Class A, and the $62.2 billion of Class A and Class C share repurchases in 2023 (page 81) shrinks the voting pool of ordinary shareholders, thereby boosting the relative influence of Class B insiders and potentially consolidating control. In contrast, NFLX’s single‑class structure (one vote per common share, page 61) means repurchases simply reduce the overall voting base without creating a class with enhanced voting power, keeping control proportional to share ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 for Class A), the $62.2 billion in 2023 share repurchases of Class A and Class C shares, and NFLX's one-share-one-vote structure are all accurately stated. The dollar amount and share classes involved in the repurchases match the original answer. (2) Quantitative accuracy is perfect: $62.2 billion is correctly cited with no calculation required. (3) The reasoning is sound: the LLM correctly infers that repurchasing Class A and C shares (which have lower voting power) reduces the voting pool of public shareholders, thereby increasing the relative control of Class B holders. It contrasts this effectively with NFLX’s single-class system, where repurchases reduce the overall voting base proportionally. (4) The only minor shortcoming is that the LLM does not explicitly mention the insulation of leadership from shareholder influence—a qualitative implication emphasized in the original answer—though it is implied in the discussion of consolidated control. This slight omission in depth prevents a perfect 10 on qualitative accuracy. However, the answer remains factually correct, contextually relevant, and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 364,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY’s retained royalty rights for the Byetta® trademark are a modest, but potentially recurring, revenue source.  In 2021 the company reported total royalty income of $410 million【page_141】, and the retained Byetta royalty is included in that figure.  The divestiture of its diabetes business transferred future royalty rights for other products (Amylin, Onglyza, Farxiga) to the buyer, but BMY kept the rights to receive royalties on Lilly’s use of the Byetta® name, which is now owned by Eli Lilly.  Thus, while the Byetta royalties add to BMY’s royalty stream, the amount is relatively small compared with its overall revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported royalty income. The ground truth states that BMY's pretax income from Byetta-related royalties was approximately $1.9 billion in 2021, but the LLM claims total royalty income (including Byetta) was only $410 million, which is significantly lower and incorrect. This major discrepancy undermines the quantitative foundation of the response. (2) The number $410 million is cited with a reference to page 141, but it does not align with the verified data from BMY's 2022 10-K as reflected in the ground truth. There is no indication that the $410 million refers specifically to Byetta alone, nor is there support for treating it as the total royalty figure including Byetta—further weakening accuracy. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that BMY retained royalty rights to Byetta* despite divesting its diabetes business and that LLY now owns the trademark. It also correctly notes that this creates an ongoing financial relationship post-divestiture. However, it fails to emphasize the materiality of the $1.9 billion figure, instead characterizing the royalties as 'modest' and 'relatively small,' which contradicts the ground truth implication that these royalties are financially significant and a notable part of BMY’s pretax income. (4) Contextually, the answer addresses the core elements—retained rights, divestiture, current ownership—but due to the severe numerical inaccuracy and resulting mischaracterization of financial significance, the overall correctness score is low. The answer misleads on the scale of the royalty income, which is central to assessing financial significance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 467,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab’s minimum total risk‑based capital ratio is 10.5 % (page 122), which is calculated with both a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer. JPMorgan Chase Bank, N.A.’s minimum total risk‑based capital ratio is also 10.5 % (page 291), but it is built only on a 2.5 % capital‑conservation buffer (no stress buffer). Thus, while the numeric minimum ratio is identical, Schwab’s requirement incorporates an additional stress buffer that JPMorgan Chase does not have.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio, with Schwab including both a 2.5% stress capital buffer and a 2.5% capital conservation buffer, while JPMorgan Chase only includes the 2.5% capital conservation buffer. This matches the ground truth exactly in terms of numerical values and structure. (2) Quantitative accuracy is perfect: all percentages (10.5%, 2.5%, 2.5%) are correct, and the implicit calculation (base minimum 4.5% + 2.5% + 2.5% = 9.5% for Schwab; but standard base is 8%, so 8% + 2.5% = 10.5% for JPMorgan) aligns with regulatory frameworks. The answer correctly notes the same final ratio despite different buffer compositions. (3) The multi-hop reasoning is sound—comparing capital buffer structures across two firms and explaining how different components lead to the same total requirement. The only minor shortcoming is that the LLM does not explicitly mention the 'different regulatory treatments' as in the original answer, which provides slightly more context on *why* the structures differ. However, the core reasoning and synthesis across entities are accurate. (4) The answer is fully contextually relevant, directly addressing the question about how buffer differences affect capital requirements. Wording differs slightly but maintains semantic equivalence. The inclusion of page numbers (122, 291) adds verifiability but does not affect correctness. Score reduced by 1 point due to slight incompleteness in explaining the regulatory rationale, but all factual and quantitative elements are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 445,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "Lockheed Martin’s credit facility is LIBOR‑based but contains fallback provisions that automatically switch the interest calculation to an alternative benchmark when LIBOR is discontinued.  General Electric’s floating‑rate debt and its preferred‑stock notes are also LIBOR‑linked; when LIBOR ceases, they will be deemed to convert to SOFR plus a spread.  Both companies rely on ASU 2020‑04, which offers optional expedients that prevent the need to record contract‑modification or hedge‑accounting adjustments, thereby limiting any material impact on operating results, financial position or cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LMT’s credit facility and GE’s floating-rate debt and preferred stock are LIBOR-based and will transition to SOFR with fallback provisions; both rely on ASU 2020-04 for accounting relief to avoid material impacts. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and GE), their respective financial instruments (credit facility, floating-rate debt, preferred stock), and the shared impact of ASU 2020-04. The only minor gap is that the LLM does not explicitly mention New York law’s role in GE’s transition (a detail in the ground truth), nor does it note that LMT’s derivatives are affected—this slightly reduces completeness in qualitative accuracy. (4) Despite these small omissions, the LLM captures the essential synthesis and accounting implications accurately, with excellent contextual relevance. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 (not 10) due to minor missing details, but all key facts and logic are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 365,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 issuance of 9,444,375 Class B shares—10‑vote units out of a 75‑million‑authorized allotment—illustrates its dual‑class strategy to raise capital while preserving voting control. Alphabet’s dual‑class scheme also relies on Class B shares, but those shares automatically convert to Class A upon sale or transfer and cannot be voluntarily converted earlier, whereas Comcast’s Class B shares can be converted at the holder’s option and automatically convert only when sold or transferred.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the issuance of 9,444,375 Class B shares by CMCSA in 2023 and accurately characterizes the purpose as raising capital while preserving voting control, which aligns with the ground truth. It correctly notes that CMCSA's Class B shares carry 10 votes and can be converted at the holder’s option, with automatic conversion upon sale or transfer—this contrasts with GOOGL’s structure where Class B shares automatically convert upon sale but cannot be voluntarily converted earlier. However, the LLM omits a key differentiating point from the original answer: GOOGL’s $62.2 billion share repurchase in 2023 (of Class A and Class C shares), which highlights a strategic difference in capital management. This omission reduces completeness but does not invalidate the core correctness.\n\n2) Quantitatively, the number 9,444,375 is accurate, and the reference to 75 million authorized shares (though not in the original answer) may be factual context not contradicted by the ground truth. The $62.2 billion repurchase figure by GOOGL is missing in the LLM answer, which is a significant quantitative omission.\n\n3) The multi-hop reasoning is mostly sound: the model correctly compares CMCSA’s dual-class structure to GOOGL’s, focusing on voting rights and conversion rules. It synthesizes the control-preserving intent across both firms. However, it fails to incorporate the additional layer of GOOGL’s active buyback program as a contrast to CMCSA’s stable capital structure, weakening the comparative analysis.\n\n4) The answer is contextually relevant and well-articulated, using semantically equivalent and accurate language. The explanation of conversion mechanics is more detailed than the original, adding value. The omission of the buyback program prevents a top score, but the core facts and comparison are correct. Hence, a score of 8 is justified for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 513,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension commitments are paid as contributions and a 19‑year withdrawal liability that is amortized over that period; the related expense is recognized in the period incurred (service cost, interest and the amortization of the withdrawal liability).  \nWalmart’s equity‑compensation awards vest over 1–4 years (RSUs 4‑year, restricted stock 1–3 years) and the related expense is recognized ratably over the vesting period and charged to operating, selling, general and administrative expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between MDLZ's multiemployer pension commitments and WMT's equity compensation vesting schedules in terms of duration and cost recognition. (1) Quantitatively, the LLM correctly identifies the 19-year withdrawal liability for MDLZ, aligning with the ground truth's $526 million paid over 19 years, though it omits the specific dollar amount and the $11 million interest/expense figure from 2021. The WMT vesting periods (e.g., 4-year RSUs, 1–3 year restricted stock) are accurately described, though the ground truth specifies a 25% annual vesting (i.e., 4-year cliff-style), which is consistent but more precise. The 3.8% dividend discount in fiscal 2022 is missing, a minor omission. (2) The cost recognition patterns are correctly characterized: MDLZ expenses are recognized through service cost, interest, and amortization over the liability period; WMT expenses are recognized ratably over vesting and charged to operating/SG&A expenses. This matches the ground truth’s description of ratable expensing based on fair value. (3) The multi-hop reasoning is sound—comparing two different companies’ compensation structures (pension vs. equity), their duration, and accounting treatment. The synthesis across entities is accurate, though the LLM provides less contextual detail on how MDLZ’s obligations stem from union agreements or how WMT’s plans are designed to align with shareholder interests. (4) Despite these minor omissions, the answer is semantically equivalent in key aspects: duration (long-term 19-year vs. 1–4 year), cost recognition (amortized/accrued vs. ratable expensing), and financial structure (pension liabilities vs. equity compensation). The answer is fully relevant to the question. Minor deductions in quantitative and qualitative accuracy due to missing specifics, but correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 509,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "BAC’s Advanced‑Approach buffer requirement is 5.5 % of RWA, which is the sum of a 2.5 % capital‑conservation buffer and a 3.0 % G‑SIB surcharge (the countercyclical buffer is zero). Morgan Stanley’s Advanced‑Approach buffer requirement is also 5.5 % of RWA, built from the same 2.5 % buffer and 3.0 % surcharge, so the combined buffer requirements for the two institutions are identical.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative components. While the ground truth states that both BAC and MS have a 2.5% G-SIB surcharge, leading to a total buffer of 5.0% (2.5% Capital Conservation Buffer + 2.5% G-SIB), the LLM incorrectly reports a 3.0% G-SIB surcharge for both institutions, resulting in a calculated total of 5.5%. This is a critical error in financial specifications, as G-SIB surcharge levels are institution-specific and regulated values. (2) The calculation logic is sound—adding the Capital Conservation Buffer and G-SIB surcharge with a zero Countercyclical Buffer—but the inputs are wrong. The LLM claims 2.5% + 3.0% = 5.5%, which is mathematically correct but factually incorrect because the actual G-SIB surcharge for both banks is 2.5%, not 3.0%. (3) The multi-hop reasoning is partially correct: the model identifies that both banks apply the same buffers under the Advanced Approach and synthesizes the total requirement correctly in structure, but uses incorrect surcharge values. It correctly notes that both institutions have identical requirements, which aligns with the ground truth conclusion, but for the wrong numerical reasons. (4) Contextual relevance is high because the answer addresses the correct regulatory framework, entities (BAC and MS), and buffer components. However, due to the incorrect G-SIB surcharge percentage, the quantitative accuracy is low. The qualitative accuracy is moderate because the reasoning structure is valid, but based on incorrect data. Correctness score is 4 due to major factual error in key percentages, despite correct logic and conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 455,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes would shift in fair value by roughly $1.7 billion for a 50‑basis‑point move in market rates (≈$34 million per basis point).  Oracle, by contrast, uses cross‑currency and interest‑rate swaps to convert portions of its fixed‑rate Euro debt into variable‑rate USD debt and to swap floating‑rate borrowings into fixed‑rate, achieving an effective interest rate of 4.74 % after swaps and thereby dampening sensitivity to rate swings.  Cisco’s $0.5 billion swap illustrates the same mechanism: the swap converts fixed‑rate notes into SOFR‑based floating rates, offsetting fair‑value changes and demonstrating how swaps can neutralize interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: AVGO's $56.3 billion fixed-rate debt, $1.7 billion fair value sensitivity to a 50 bps rate change (≈$34 million per basis point, which is a correct derivation: $1.7B / 50 = $34M), ORCL's effective interest rate of 4.74% post-swaps, and CSCO's $0.5 billion swap. (2) Entity accuracy is strong: AVGO, ORCL, and CSCO are correctly identified with their respective instruments and strategies. Fiscal years 2023 and 2024 are implied via ORCL's consistent rate, though not explicitly stated—minor omission but not material. (3) Reasoning is sound: the LLM correctly explains that ORCL uses swaps to convert floating to fixed, achieving a stable effective rate (4.74%) from a 3.07% base (implied in ground truth), and notes that CSCO’s swap converts fixed to floating (SOFR-based), offsetting fair value changes. The explanation aligns with the hedging logic in the original. (4) The only minor gap is that the LLM does not explicitly state ORCL’s base rate of 3.07% before swaps, which is part of the multi-hop synthesis in the ground truth. However, mentioning the 4.74% effective rate after swaps still captures the core of ORCL’s interest rate management. The LLM also correctly generalizes the role of swaps in managing rate exposure across all three firms. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 413,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s Class B shares carry 10 votes each and together represent roughly one‑third of the company’s total voting power (about 33 % of combined voting power), whereas Alphabet’s share‑repurchase program is limited to its Class A (1 vote per share) and Class C (non‑voting) shares. Consequently, Alphabet’s repurchases do not affect the high‑voting Class B shares, leaving Meta’s voting‑power distribution largely unchanged by repurchase activity. (Meta share counts – page 1; Alphabet voting rights and repurchase details – page 82)",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it states that Meta’s Class B shares carry '10 votes each,' but the ground truth specifies 15 votes per share. This is a clear factual error. Second, while it correctly notes that Meta’s Class B shares represent about 33% of combined voting power, it fails to mention that this class is non-dilutable and held entirely by a single individual—key context for understanding concentrated control. (2) Regarding GOOGL, the LLM incorrectly implies that repurchases are limited to Class A and Class C shares due to governance strategy, but more critically, it omits the actual $62.0 billion repurchase amount in 2024, a major quantitative detail. While it correctly identifies that Class C shares are non-voting and Class A have 1 vote, it does not mention that Class B shares have 10 votes per share or that they can be converted to Class A—important structural details. (3) The multi-hop reasoning is partially sound: the model attempts to compare voting power structures and repurchase strategies, recognizing that repurchasing non-voting or low-voting shares preserves high-voting shares’ relative control. However, it fails to fully synthesize the contrast between Meta’s static, founder-controlled voting structure and GOOGL’s active capital return strategy across share classes. (4) The contextual relevance is high because the answer addresses the core theme—interplay between voting rights and share structure—but correctness and qualitative accuracy are reduced due to key omissions and a significant vote-per-share error. Quantitative accuracy is moderate due to missing dollar figures and incorrect vote count.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 459,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s forecast that 46 % of smartphones sold in 2027 will be generative‑AI‑capable (page 8) underpins a strategy that deepens AI and connectivity in its chipsets and 5G/6G platforms, positioning the company as the hardware enabler for on‑device AI and edge‑computing workloads. In contrast, Salesforce is channeling capital into generative and agentic AI across its cloud‑based CRM stack (page 41), adding AI agents and generative‑content capabilities to automate and personalize customer interactions rather than focusing on the underlying connectivity hardware.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Qualcomm's projection that 46% of smartphones sold in 2027 will be generative AI-capable, aligning with the ground truth. It accurately contrasts this with Salesforce's investment in generative and agentic AI across its CRM products. The mention of '5G/6G platforms' slightly extends beyond the ground truth, which specifies '5G and 5G Advanced'—not 6G—but this is a minor overreach and not factually incorrect given industry trends. (2) Quantitative accuracy is perfect: the 46% figure for 2027 is correct, and though the 19% for 2024 is omitted, the core projection is accurate. No calculations are required, and all cited percentages match the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes Qualcomm’s hardware-focused AI strategy (on-device, edge computing) with Salesforce’s software/cloud-based AI integration into CRM workflows. It captures the contrast in focus—Qualcomm on enabling AI at the device level, Salesforce on deploying AI in enterprise applications—though it omits mention of Agentforce specifically, a minor gap in completeness. (4) The answer is contextually relevant and conveys the essential contrast and convergence between the two companies’ AI strategies. The omission of the 2024 baseline (19%) and the specific name 'Agentforce' prevents a perfect 10, but the core factual and conceptual content is highly accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 400,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe’s strategy to embed AI—through Sensei, Firefly, and AI‑powered features such as Acrobat’s Liquid Mode—centers on delivering real‑time, personalized user experiences across devices (see Adobe pages 7, 6, 8, 10). Qualcomm projects that by 2027 roughly 46 % of smartphones and 50 % of PCs will be generative‑AI‑capable, powered by on‑device processors (Hexagon NPUs, Adreno GPUs) that enable low‑latency, privacy‑preserving inference (see Qualcomm pages 8, 9, 10). Thus, Adobe’s AI‑driven media tools are set to run directly on Qualcomm’s edge hardware, aligning both companies’ focus on on‑device AI to enhance interface responsiveness and personalization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Adobe's focus on AI-driven user experience through tools like Sensei, Firefly, and Liquid Mode, and Qualcomm's projection that 46% of smartphones will be generative AI-capable by 2027, matching the ground truth. The LLM adds a specific detail—50% of PCs being generative AI-capable—which is not in the original answer but does not contradict it and may reflect additional data from the source (Qualcomm pages 8, 9, 10). This addition does not reduce accuracy but slightly extends beyond the provided ground truth. (2) Quantitatively, the 46% smartphone projection for 2027 and the implied rise from 19% in 2024 (though the 19% figure is omitted in the LLM answer) are accurate as per the original. The LLM correctly attributes the 46% figure to Qualcomm and ties it to on-device AI processing. The omission of the 19% baseline is a minor completeness gap but does not affect the correctness of the 2027 projection. (3) The multi-hop reasoning is sound: the LLM correctly links Adobe’s AI-driven UX strategy with Qualcomm’s edge AI hardware advancements, emphasizing on-device processing benefits like low latency and privacy, and concludes that Qualcomm’s hardware supports Adobe’s tools—a logical and well-supported synthesis. (4) The answer is contextually fully relevant, addressing both companies, the 2027 timeline, on-device AI, and user interface improvements. The only minor shortcoming is the omission of the 19% 2024 baseline, which slightly weakens the comparative projection but does not invalidate the core alignment argument. Thus, the answer is highly accurate, well-reasoned, and aligned with the ground truth, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 467,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSUs are paid to directors when they leave the board (or, if the director elects, on the first business day of April after the one‑year anniversary of the grant) and the payment includes any dividend equivalents earned on the units. Honeywell’s RSUs vest over a 3‑ to 6‑year period and are paid in common stock upon vesting, with no reference to dividend equivalents. Thus, Lockheed Martin’s RSU awards provide dividend equivalents as part of the payout, whereas Honeywell’s RSUs do not.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its core facts but contains a notable omission and slight mischaracterization compared to the ground truth. (1) Quantitatively, the vesting periods (3-6 years) for Honeywell and the April payment timing for Lockheed Martin are accurately represented, and the structural details about payout upon departure or April timing for directors are correct. (2) However, the LLM incorrectly states that Honeywell’s RSUs have 'no reference to dividend equivalents,' which contradicts the ground truth indicating that Honeywell does not specify a delayed payment schedule but does not rule out dividend equivalents entirely—this is a key distinction. The ground truth notes that Honeywell focuses on performance-based vesting and payment in stock, but does not explicitly say dividend equivalents are absent. (3) On reasoning: the model correctly identifies the difference in payment timing and structure between the two companies, but fails to mention Lockheed Martin’s DMICP plan that credits dividend equivalents as stock units at dividend payment times—a multi-hop detail present in the original answer. Also, the emphasis on performance-based vesting for Honeywell is omitted. (4) Despite these issues, the answer captures the essential contrast in treatment: Lockheed Martin explicitly includes dividend equivalents in a delayed payout for directors, while Honeywell’s disclosure centers on vesting and stock delivery without detailing equivalent treatment. Hence, correctness is reduced due to omission and overstatement about Honeywell, but quantitative and contextual accuracy remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 441,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments sources roughly 40 % of its assembly‑and‑test services from subcontractors (TXN page 9). NVIDIA likewise relies heavily on third‑party foundries and contract manufacturers for wafer fabrication and packaging, as noted in its risk disclosures (NVDA pages 23‑27). Both companies face similar external‑capacity risks—capacity constraints, quality and yield issues, and supply‑chain disruptions—highlighted by AMD’s own risk factors that third‑party suppliers can delay production, limit capacity, or raise costs (AMD pages 23‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly cited and matches the original answer. No other numerical values are present, and all references to percentages are accurate. Format and citation style (e.g., page numbers) are consistent with source documentation. (2) The answer addresses all parts of the multi-hop question: TXN's 40% reliance, NVDA's third-party manufacturing exposure, shared risks, and AMD’s experience as a cautionary example. It correctly identifies that both companies depend on external capacity and face risks like supply-chain disruptions, capacity constraints, and quality/yield issues. (3) Entity accuracy is strong: TXN, NVDA, and AMD are correctly referenced with appropriate context. The mention of risk disclosures and page numbers adds credibility and precision. (4) Reasoning is sound—LLM synthesizes across companies and correctly infers that shared reliance leads to similar risks, echoing AMD’s vulnerabilities. The only minor shortcoming is that the LLM does not explicitly note that NVDA’s exposure is 'amplified' by product complexity and global supply chain dependencies, a nuance present in the original answer. However, the core factual content and multi-hop logic are preserved with high fidelity. Thus, the answer is semantically equivalent with only slight omission of a qualifying detail, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 406,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "The Clean Energy Connection program estimates the 10 new solar facilities will cost about **$1 billion** over the next three years (page 153).  Southern Power treats PPAs for solar and wind projects as **operating leases with terms up to 25 years** (page 268), reflecting a similar long‑term lease‑based financing strategy for renewable generation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities over three years, matching the ground truth. It also accurately states that Southern Power treats PPAs as operating leases with terms up to 25 years. All key facts are present and correct. (2) Quantitatively, the dollar amount ($1 billion) and time frame (three years) are accurate, and the lease term (up to 25 years) is correctly reported. No calculation errors. (3) The multi-hop reasoning is sound: the model connects Duke Energy Florida’s direct investment in solar infrastructure with Southern Power’s use of PPAs as operating leases, highlighting a common theme of long-term renewable investment through different financial mechanisms. However, the LLM omits the detail that Duke’s program was approved by the FPSC in January 2021 and is part of a voluntary solar program, which adds regulatory and programmatic context present in the original answer. It also does not explicitly contrast Duke’s direct investment (included in base rates) with Southern Power’s lease-based financing, a nuance that strengthens the comparison. (4) Despite minor omissions in contextual detail and comparative analysis, the core facts, numbers, and synthesis are correct and semantically equivalent. The answer is highly relevant and accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 407,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives each share one vote【page 60】, whereas Alphabet’s Class C capital stock is non‑voting (except as required by law)【page 82】.  Because the Class C shares carry no voting power, Alphabet can use the $62 billion 2024 repurchase to buy back a larger share of non‑voting Class C shares—boosting earnings per share and reducing dilution—while still purchasing a smaller amount of voting Class A shares to support the share price and maintain voting balance【page 82】.  Thus the voting‑rights difference drives a strategic allocation that favors Class C repurchases over Class A.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting rights structures of both Netflix and Alphabet: Netflix's common stock has one vote per share, and Alphabet's Class C shares are non-voting (except as required by law), which aligns with the ground truth. The $62.0 billion 2024 share repurchase amount is accurately cited (with acceptable formatting as $62 billion). (2) Quantitatively, all numbers and dates are correct—$62 billion repurchase in 2024, no incorrect calculations. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the lack of voting rights in Class C shares to a strategic preference for repurchasing them (to boost EPS and reduce dilution without affecting control), while still buying some Class A shares to maintain market confidence and voting balance. This aligns with the ground truth’s implication that repurchasing non-voting shares allows control preservation. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Class B shares (which have 10 votes per share), though this does not detract significantly from the core argument about Class A vs. Class C repurchase strategy. The answer is semantically equivalent in intent and factual content, with strong contextual relevance and accurate entity identification (Netflix, Alphabet, Class A, Class C, 2024, $62 billion).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 378,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "BAC’s preferred stockholders gain voting rights when dividends are in arrears, allowing them to vote for directors and exert influence on governance during periods of financial stress. In contrast, Visa’s Class C common stockholders have limited voting rights that are only exercised on specific matters (e.g., mergers, core‑business exit) and are not contingent on dividend arrears, so their governance influence remains restricted even in stressed conditions【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between BAC's contingent voting rights for preferred stockholders triggered by dividend arrears and V's (Visa) Class C common stockholders' structurally limited voting rights. (1) All factual elements are correct: BAC’s preferred stockholders gain voting rights during dividend arrears (though the exact threshold—three semi-annual or six quarterly periods—is omitted, the general mechanism is correctly described). The termination condition (after two semi-annual or four quarterly payments) is not mentioned, which is a minor omission. (2) No numerical inaccuracies: while specific numbers (e.g., 'three' or 'six' periods) are not included, no incorrect figures are stated, so quantitative accuracy remains high. (3) Multi-hop reasoning is sound—the model correctly synthesizes governance mechanisms across two different companies (BAC and V) and contrasts their structures in the context of financial stress. (4) The LLM correctly identifies that Visa’s Class C voting rights are limited to specific events (e.g., mergers, core-business exit) and are not tied to financial performance, aligning with the ground truth. The reference to 'page_90' suggests source grounding. The only shortcoming is the lack of granular detail on the exact arrearage thresholds and reinstatement conditions at BAC, but the semantic meaning and governance implications are preserved. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 429,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s Star Wars licensing royalties are part of its broader merchandise‑licensing business, which generates steady cash flow from third‑party products (see the “Licensing” section on page 22).  That cash contributes to Disney’s overall liquidity, enabling the company to invest in new content for Disney+, a strategy it relies on to compete in European markets against CMCSA’s Sky Glass and XClass TV platforms (Sky Glass is described on page 17).  In short, the Star Wars licensing revenue underpins Disney’s ability to fund the content pipeline that keeps Disney+ competitive in Europe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies that Disney's Star Wars licensing revenue—part of its broader merchandise-licensing business—generates steady cash flow that contributes to overall liquidity, which in turn funds content development for Disney+, particularly in competitive European markets. The mention of CMCSA’s Sky Glass and XClass TV as competing platforms is correctly contextualized. While the LLM does not explicitly state that Star Wars programming is a 'core content tile' on Disney+ (a minor omission), it captures the essential causal chain: licensing revenue → funding content → competitive positioning in Europe against CMCSA’s integrated offerings. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is scored as 10 (no errors, all references consistent). The reasoning is sound and reflects proper multi-hop synthesis across Disney’s licensing model, content investment strategy, and competitive dynamics in Europe. Wording differs slightly from the original answer but maintains semantic equivalence. Contextual relevance is perfect—the response directly addresses all components of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 344,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "AXP’s sensitivity analysis shows that a 200‑basis‑point rise in rates would cut its net interest income by about $560 million (Table 23, page 81), underscoring the large repricing risk of its interest‑rate‑sensitive assets and liabilities.  Morgan Stanley, in contrast, uses interest‑rate caps (and swaps) in many securitization transactions (page 128) to cap the rate exposure of the assets it transfers to SPEs, thereby limiting similar repricing risk.  Both firms therefore treat repricing risk as a core element of their risk management—AXP quantifies the exposure, while MS hedges it with caps in its securitization strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount ($560 million) for AXP's net interest income impact from a 200 basis point increase, which is not present in the original (ground truth) answer. There is no mention of this figure in the ground truth, and no source data was provided to confirm its accuracy. This introduces a potentially incorrect quantitative claim, reducing confidence in numerical precision. (2) The quantitative accuracy is compromised due to the unsupported $560M figure. While the ground truth confirms AXP estimates a negative impact on net interest income due to repricing risk and the presence of interest rate caps/floors, it does not quantify it. The LLM may be citing a real number from an actual filing, but without alignment to the provided ground truth, this is treated as an unverified addition. (3) Qualitatively, the reasoning is strong: the LLM correctly identifies that both AXP and MS use interest rate derivatives (caps) in the context of managing repricing risk, albeit in different business contexts—AXP in core interest income and MS in securitization via SPEs. The synthesis across firms and strategies is logical and consistent with the original answer. The mention of MS using caps in securitization transactions (page 128) aligns with the ground truth’s assertion. (4) Contextual relevance is high—the answer directly addresses the relationship between AXP’s sensitivity to rate hikes and MS’s use of caps, linking both to repricing risk management. The core multi-hop connection (comparing how two firms manage similar risks differently) is well executed. However, the unsupported number prevents a higher score. Overall, the answer is factually plausible and well-reasoned but includes a specific figure not substantiated by the ground truth, leading to a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 499,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ said that a weaker U.S. dollar gave a favorable impact on its consolidated earnings, but the overall currency swing still cut net operating revenues by 5 % in 2024. Coca‑Cola’s EMEA segment likewise cited a benefit from a weaker dollar versus the euro and pound, yet the segment’s net operating revenues still fell 16 % on currency effects, showing the favorable impact was outweighed by other negative factors.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—'5% in 2024' decline in net operating revenues for MDLZ and '16% fall' for KO EMEA—that are not present in the original answer or implied by the ground truth. There is no mention in the ground truth about the magnitude of currency impacts or revenue declines, so these numbers are unverified and likely incorrect. (2) The original answer focuses on the qualitative parallel between MDLZ and KO: both benefit from a weaker U.S. dollar due to exposure to the euro and British pound, with no mention of net negative outcomes or percentage declines. The LLM incorrectly implies that despite favorable currency effects, both companies saw overall negative currency impacts, which contradicts the ground truth that emphasizes the favorable nature of the exchange rate fluctuations. (3) The multi-hop reasoning is partially sound—correctly identifying both companies and the relevant currencies (euro and pound) and linking the weaker dollar to favorable impacts in both cases—but then diverges by introducing unsupported claims about net negative revenue effects, undermining the logical conclusion. (4) While the LLM captures the core idea of favorable FX impact from a weaker dollar, the addition of false quantitative details and the misleading framing of overall negative outcomes significantly reduce factual accuracy. Hence, correctness and quantitative accuracy are low; qualitative accuracy is moderate due to correct entity and directional FX identification; contextual relevance remains high as the response addresses the comparative FX impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 445,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "MA’s dual‑class structure gives its Class B shares a higher share of the total voting power than Verizon’s.  MA has 1,621 Class A shares and 197 Class B shares (each with 15 votes), so Class B shares command about 65 % of the votes (2,955 / 4,576).  Verizon has 1,733 Class A shares and 125 Class B shares (15 votes each), giving Class B shares roughly 52 % of the votes (1,875 / 3,608).  Thus, MA’s Class B shares are more heavily weighted in voting power than Verizon’s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. It incorrectly states that MA has 1,621 Class A shares and 197 Class B shares, while the ground truth specifies 907 Class A and 7 Class B shares. Similarly, it misrepresents the voting power calculation for MA: with only 7 Class B shares (each with 15 votes), the correct total voting power for Class B is 105 votes, and total votes are (907 * 1) + (7 * 15) = 907 + 105 = 1,012, giving Class B approximately 10.4% voting power — not 65% as claimed. The LLM’s calculation of 2,955 / 4,576 is entirely fabricated. For V, the LLM correctly identifies 1,733 Class A and 125 Class B shares, but incorrectly calculates Class B voting power as 52% (1,875 / 3,608), when the correct total votes are (1,733 * 1) + (125 * 15) = 1,733 + 1,875 = 3,608, so Class B holds 1,875 / 3,608 ≈ 51.97%, which rounds to ~52% — this part is numerically correct. However, the original answer states that under the same 15-vote rule, V’s Class B holds ~68.5%, which contradicts both the LLM and the calculation — but upon rechecking, 1,875 / 3,608 ≈ 52%, not 68.5%. This suggests a possible error in the original answer or misinterpretation. Still, the LLM’s core comparison is inverted: it claims MA has higher voting concentration (65% vs 52%), while the ground truth states MA has only 10.4% vs V’s ~68.5% — a massive discrepancy. (2) The quantitative inaccuracies are severe: all MA share counts and derived percentages are wrong. The V calculation is correct but misinterpreted in context. (3) The multi-hop reasoning fails because the LLM uses fabricated data for MA and draws the opposite conclusion of the ground truth. It fails to correctly synthesize the actual relationship between share count, vote weighting, and control concentration. (4) Despite correct identification of V’s share counts and proper application of 15-vote weighting, the widespread factual errors — especially the inversion of the comparison — result in a very low correctness score. Contextual relevance is high because the structure of the response matches the question’s intent, but accuracy is critically flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 576,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both companies operate nuclear plants and maintain decommissioning funds, but the filings differ in how the risk is framed. NEE’s 2022 10‑K states that “the cost of decommissioning nuclear generation facilities could exceed the amount available in NEE’s and FPL’s decommissioning funds” (page 31), explicitly warning of potential exposure beyond the reserves. Southern Company’s risk‑factor discussion notes “uncertainties with respect to the technological and financial aspects of decommissioning nuclear plants … and the ability to maintain and anticipate adequate capital reserves for decommissioning” (page 29), indicating a risk of insufficient reserves but without the explicit statement that costs could exceed the funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies both NEE/FPL and Southern Company (via subsidiaries Alabama Power and Georgia Power) as facing financial risks related to nuclear decommissioning costs potentially exceeding reserves. The core factual content—uncertainty in decommissioning cost estimates and the material financial exposure—is preserved. (2) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all references to filings are consistent with the expected sources (2022 10-K, page numbers). (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures from two different companies’ SEC filings and compares how each frames the risk—NEE with an explicit statement that costs could exceed funds, Southern Company with a more general risk about uncertainties and adequacy of reserves. This nuanced distinction is correctly captured and enhances the answer. (4) The LLM slightly omits the mention of insurance coverage referenced in the original answer (Southern Company’s exposure includes 'available reserves or insurance coverage'), which is a minor omission affecting completeness but not the core correctness. Otherwise, the answer is contextually precise, directly addressing the comparative framing of decommissioning risk exposure. Wording differs but semantic meaning matches the ground truth, and the use of direct quotes strengthens accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 421,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values its pension‑plan real‑estate fund holdings at $9.9 billion using a NAV approach that relies on audited and unaudited fund reports and adjustments for interim activity (UPS 10‑K, p. 58).  General Dynamics, by contrast, classifies its private‑equity and real‑estate investments as Level 3 assets and values them with models that use unobservable inputs and discounted‑cash‑flow calculations (GD 10‑K, p. 83).  Thus, while both firms use valuation models, UPS’s method is a simpler NAV estimate, whereas GD’s Level 3 approach is more complex and relies on internal discount‑rate assumptions and other unobservable data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS is correctly stated, and no other numerical figures are misrepresented. The reference to NAV as the valuation method for UPS is factually correct. (2) The comparison to General Dynamics is substantively accurate: GD uses Level 3 assets valued with unobservable inputs and discounted cash flow models, as confirmed in its 10-K. The LLM correctly identifies that GD’s approach relies on internal assumptions, which matches the ground truth’s emphasis on unobservable inputs. (3) Multi-hop reasoning is sound—information from both UPS and General Dynamics is synthesized correctly across pension plan investments and Level 3 asset valuation methodologies. (4) Minor wording differences exist: the LLM characterizes UPS’s method as a 'simpler NAV estimate' and GD’s as 'more complex,' which is a slight interpretive addition not in the original answer, but this does not distort the facts. The original answer emphasizes that UPS uses NAV based on fund manager reports with adjustments, while GD uses unobservable inputs directly—this distinction is preserved in the LLM response. Overall, all key facts, entities, and reasoning steps are correct, warranting a high score with only a minor deduction for slight interpretive phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 376,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "A supply disruption in the AMESA region, where PepsiCo’s beverage business accounts for 30 % of its beverage revenue (page 73), would likely reduce the availability of PepsiCo beverage SKUs at Target, lowering sales and slowing inventory turnover. Because Target only pays vendors after a guest sale, a drop in sales would postpone vendor payments, potentially improving cash flow but also delaying revenue inflows (page 49). If Target had to source from alternative suppliers or hold inventory, it could increase inventory levels and further reduce turnover, while earlier payments could strain cash flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies the 30% beverage revenue exposure of PepsiCo in the Africa and Middle East region (referred to as AMESA), which matches the ground truth. This quantitative figure is accurate and properly attributed. However, the LLM introduces speculative elements not present in the original answer, such as Target sourcing from alternative suppliers, holding inventory, or making earlier payments—none of which are supported in the ground truth. 2) Quantitatively, the 30% figure is correct and no other numbers are introduced, so quantitative accuracy is high. 3) The reasoning contains partial correctness: it correctly links supply disruption to reduced SKU availability and lower sales, which would slow inventory turnover. However, it incorrectly suggests that delayed vendor payments could 'improve' cash flow for Target, which misrepresents the cash flow timing impact. The ground truth emphasizes that lower sales lead to lower cash inflows (since revenue is recognized only upon sale), which negatively affects cash flow generation—not a benefit. The LLM’s claim of 'improving cash flow' due to delayed payments contradicts the economic reality that no sale means no cash inflow, and thus no payment timing benefit. Additionally, the LLM confuses the direction of cash flow impact: while vendor payments are delayed, so are revenues, and the net effect is reduced cash flow from operations during the disruption. 4) Contextual relevance is strong as the answer addresses both inventory turnover and cash flow timing as required. However, the qualitative reasoning is flawed in key cause-effect relationships, particularly around cash flow implications, leading to a moderate correctness score despite accurate inputs and partial synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 477,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Amgen has taken concrete pricing‑adjustment steps to counter payer restrictions on its high‑cost biologic Repatha.  In 2018‑19, the company lowered Repatha’s net price, offered larger rebates and discounts to PBMs and Medicare Part D plans, and introduced new National Drug Codes that lowered the list price before discontinuing the higher‑price option in December 2019.  These actions were aimed at easing access and reducing the out‑of‑pocket burden for patients.  \n\nThe Lilly 10‑K pages supplied (27‑31) do not contain any discussion of how the company has responded to payer‑driven pricing pressures on its insulin products, so no comparable strategy is disclosed in the provided material.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly describes Amgen's (AMGN) response to payer-driven pricing pressures on Repatha with accurate details: price reductions, introduction and subsequent discontinuation of lower-priced NDCs in 2019, and efforts to reduce patient out-of-pocket costs. The timeline (2018–2019) and actions (rebates, discounts, NDC changes) align with the ground truth, earning high marks for quantitative accuracy. However, the LLM incorrectly claims that Eli Lilly (LLY)’s 10-K does not contain information on its response to payer pressures on insulin, when in fact the ground truth states that LLY faces increasing scrutiny and highlights regulatory and legislative uncertainty as part of its strategic response. This omission represents a failure in multi-hop reasoning—while the LLM may not have extracted the qualitative risk-disclosure strategy from LLY’s filings, the ground truth treats such disclosures as part of the company’s response. Thus, the LLM underreports LLY’s strategic posture, leading to an incomplete and imbalanced comparison. The answer is factually sound where it provides information but lacks completeness in addressing both companies’ responses as required by the question. Contextual relevance is high because the content directly addresses payer pressures and biologic access, but the failure to recognize non-operational (i.e., regulatory/legislative) risk management as a response hurts qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 402,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Under the current Basel III framework, the Federal Reserve’s countercyclical capital buffer (CCyB) is set at 0 %. Bank of America meets its capital‑buffer requirement of 8.4 % (2023) by holding Common Equity Tier 1 (CET 1) above the sum of its 5.4 % capital‑conservation buffer (SCB) and 3.0 % G‑SIB surcharge, while remaining well‑capitalized. Charles Schwab, by contrast, satisfies a lower 5.5 % buffer requirement (2023) through a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer, also keeping CET 1 above the required level and maintaining well‑capitalized status.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative values and mischaracterizes the capital buffer structures for both BAC and SCHW. According to the ground truth, BAC applies a Stress Capital Buffer (SCB) of 2.5% under the Standardized approach as of December 31, 2023, not a '5.4% capital-conservation buffer (SCB)' as stated. The LLM incorrectly refers to a '5.4% capital-conservation buffer' and a '3.0% G-SIB surcharge', but the ground truth specifies a 2.5% SCB and a 2.5% G-SIB surcharge. Additionally, the LLM claims BAC has an 8.4% total buffer requirement (5.4% + 3.0%), which is not supported by the original answer. For SCHW, the LLM states it uses both a 2.5% stress-capital buffer and a 2.5% capital-conservation buffer (totaling 5.5%), but the ground truth only mentions a 2.5% Capital Conservation Buffer for CSB (SCHW's subsidiary), with no mention of a Stress Capital Buffer. Instead, SCHW’s capital structure is defined by minimum ratios of 7.0%, 8.5%, and 10.5% for CET1, Tier 1, and Total Risk-Based Capital, inclusive of buffers—information entirely missing from the LLM response. (2) The LLM invents a '5.5% buffer requirement' for SCHW based on summing two buffers, but the original answer does not support this calculation or the existence of a stress-capital buffer at SCHW. The date (2023) is correctly implied, and the CCyB at 0% is correctly noted. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the distinct regulatory approaches—BAC’s G-SIB surcharge and SCB versus SCHW’s minimum ratio framework. It incorrectly assumes both firms use similar buffer types when they do not. The comparison is therefore misleading. (4) While the answer is contextually relevant and attempts a structured comparison under the correct regulatory environment (CCyB = 0%), the quantitative inaccuracies and misrepresentation of buffer types and calculations severely undermine factual correctness. The qualitative reasoning is partially sound in framing the comparison but built on incorrect data. Hence, correctness is scored low (4), quantitative accuracy very low (3), qualitative accuracy moderate (5), and contextual relevance high (8).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 594,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are financed through long‑term PPAs and tax‑equity partnerships that capture ITCs and PTCs, with roughly $1.2 B of ITCs and $0.8 B of PTCs expected to be fully utilized by 2024 (page 97).  Duke Energy, in contrast, relies on PPAs for revenue but structures its renewable projects as VIEs backed by tax‑equity arrangements to secure tax credits, though the 10‑K does not disclose a specific utilization deadline (page 203).  Thus, Southern Company’s strategy explicitly ties tax‑credit use to a 2024 target, whereas Duke Energy’s approach embeds tax‑credit capture within its VIE financing without a stated timeline.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's $1.2 billion in unutilized ITCs and the 2024 utilization timeline, which matches the ground truth. However, it introduces a $0.8 billion PTC figure not present in the original answer—Southern Company's total unutilized ITCs and PTCs combined are $1.2 billion as of 2021, not split into $1.2B ITC and $0.8B PTC. This is a significant quantitative error. (2) The claim about Duke Energy lacking a 'stated timeline' for tax credit utilization is reasonable, as the ground truth does not specify one, but the LLM incorrectly implies Duke uses tax equity to 'secure tax credits' without clarifying Duke is the primary beneficiary of VIEs due to control over siting, PPA negotiation, and operations—a key qualitative difference. (3) The multi-hop reasoning is mostly sound: the model correctly contrasts Southern’s tax equity + PPA operating lease model with Duke’s VIE-based structure and notes differing tax credit utilization timelines. However, it omits that Southern’s PPAs are structured as operating leases and fails to mention Duke’s economic reliance on PPAs for project performance. (4) Despite the numerical inaccuracy and some missing context, the core comparison of financing strategies—tax equity partnerships vs. VIEs—and the emphasis on Southern’s defined 2024 tax credit utilization timeline are correct and relevant, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 398,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s 10‑K notes that Class B shares automatically convert to Class A upon sale or transfer (page 81), which gradually reduces the number of high‑vote shares and limits concentration of control. Comcast, by contrast, keeps its Class B shares non‑dilutable and each worth 15 votes (page 91), giving a fixed minority voting bloc that cannot be eroded by new issuances. Compared with these mechanisms, Meta’s dual‑class structure (10 votes per Class B share, founder‑held majority of B shares, and conversion to A over time) appears more entrenched and less flexible, likely heightening investor concerns about founder dominance and governance risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Google's Class B shares convert to Class A upon transfer, limiting long-term control concentration, and contrasts this with Comcast's non-dilutable Class B shares that retain disproportionate voting power (33 1/3% or 15 votes per share as stated in the LLM answer). While the ground truth cites 33 1/3% voting power for Comcast, the LLM specifies '15 votes' per Class B share, which is consistent with known Comcast governance (each Class B share has 15 votes vs. 1 for Class A), so this is a valid detail not contradicted by the original. (2) Quantitatively, all numbers are accurate: Google’s conversion mechanism, Comcast’s 15:1 vote ratio (implied non-dilution), and Meta’s 10:1 voting structure are correctly stated. The LLM adds granularity (e.g., 'page 81', 'page 91') suggesting fidelity to source documents. (3) The multi-hop reasoning is sound: it synthesizes governance mechanisms across Google, Comcast, and Meta to evaluate investor sentiment implications, concluding that Meta’s structure appears more entrenched—consistent with the original’s concern about founder dominance despite lower ownership. (4) The answer is contextually fully relevant, directly addressing how comparative governance models influence investor perception of Meta. Minor deduction in correctness and qualitative accuracy due to slightly stronger characterization of Meta’s structure as 'more entrenched and less flexible'—a reasonable inference but not explicitly in the ground truth. No factual errors; wording differences are semantically equivalent or enhance precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 453,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "Cordavis’ expansion of biosimilar availability will likely shift prescription volume away from high‑rebate branded drugs toward lower‑cost biosimilars that typically carry smaller or different rebate structures. Because UnitedHealth accrues rebates monthly on the basis of utilization and bills manufacturers on a monthly or quarterly schedule (receiving them 2‑5 months later), a change in the product mix could reduce the total rebates receivable and alter the timing of accruals and receipts. Manufacturers may also renegotiate contract terms for biosimilars, which could affect both the amount of rebates recognized against product revenue (which is recorded when prescriptions are dispensed) and the schedule on which those rebates are billed and collected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: CVS's Cordavis initiative increases biosimilar availability; UNH has $12.5 billion in rebates receivable as of December 31, 2024 (implied in original but not explicitly repeated in LLM answer—minor omission); rebates are utilization-based and accrued monthly; timing of collections is 2–5 months after billing. The LLM correctly identifies that a shift to biosimilars could reduce rebate amounts due to lower prices and altered contract terms. (2) Quantitatively, no specific calculations are required, but the $12.5 billion figure is contextually accurate and consistent with the knowledge graph (though not restated in the LLM answer, it is indirectly referenced via 'rebates receivable'). The timing details (monthly accrual, 2–5 month collection lag) match the original. (3) Multi-hop reasoning is sound: the model correctly links CVS’s biosimilar production to changes in drug utilization, which affects UNH’s rebate accruals and collections through manufacturer contracts. It synthesizes across entities (CVS, UNH, manufacturers), initiatives (Cordavis), financials (rebates receivable), and contract dynamics. (4) The only minor shortcoming is that the LLM does not explicitly restate UNH’s $12.5 billion in rebates receivable as of December 31, 2024—a key quantitative anchor from the original—though it refers to the rebate system that produces that balance. This does not invalidate the reasoning but slightly reduces completeness. Otherwise, the answer is semantically equivalent, logically structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 449,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Goldman Sachs will likely see higher compliance costs under Regulation Best Interest because it must establish new policies, training, monitoring and potential litigation safeguards for its broker‑dealer and wealth‑management activities (GS page 20). These added costs could constrain investment in retail client growth, potentially narrowing its competitive edge versus Morgan Stanley, which already serves a large retail base and may have more streamlined compliance processes (MS page 21). Thus, while GS may strengthen its consumer‑protection posture, the regulation could modestly erode its pricing and client‑acquisition advantage relative to Morgan Stanley.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Goldman Sachs faces higher compliance costs under Regulation Best Interest due to its expansion into retail services, while Morgan Stanley benefits from an established retail infrastructure. The core factual elements—increased compliance burden on Goldman Sachs, competitive disadvantage relative to Morgan Stanley, and the regulatory impact on broker-dealer conduct—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; the response avoids making up figures and sticks to qualitative assertions supported by the source documents. (3) The multi-hop reasoning is sound: it synthesizes information from both Goldman Sachs’ and Morgan Stanley’s 10-Ks (referencing page numbers as proxies for source evidence), correctly infers that pre-existing retail scale gives Morgan Stanley lower incremental compliance costs, and links Regulation Best Interest to competitive positioning. The only minor shortcoming is that it does not explicitly mention the risk of private litigation under state-level extensions of the rule, which is in the original answer and adds nuance to legal exposure. (4) Despite this omission, the LLM captures the essential comparative dynamic and regulatory cost implications, making the answer semantically equivalent in intent and conclusion. Wording differs but meaning is preserved. Contextual relevance is perfect—every part of the question is addressed: compliance costs, competitive positioning, differing regulatory approaches, and retail expansion strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 467,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s dual‑class structure gives its Class B shares 15 votes each and represents about one‑third (33 %) of the company’s voting power, all of which is held by a single individual (Mr. Roberts)【page_31】. Alphabet’s Class B shares carry 10 votes each; while the exact percentage of voting power is not disclosed here, the dual‑class design similarly concentrates control in a small group of insiders, but with a lower per‑share voting weight and the ability to convert to Class A, which can dilute that concentration over time【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B has 15 votes per share and holds 33% of voting power (matching the 33 1/3% in the original), and GOOGL's Class B has 10 votes per share. The 66 2/3% voting power for CMCSA Class A is correctly implied by stating Class B holds about one-third. (2) The answer correctly notes that GOOGL does not disclose the exact voting power percentage, which matches the original. (3) The qualitative reasoning is sound: it captures the multi-hop comparison between the two companies' dual-class structures, highlights the higher per-share voting power in CMCSA (15 vs 10), identifies concentrated control in both, and correctly notes the key differentiator—convertibility of GOOGL’s Class B shares leading to potential dilution over time, unlike CMCSA’s non-dilutable structure. (4) The only minor shortcoming is that the LLM does not explicitly state that CMCSA’s Class B shares are 'non-dilutable'—a term used in the original—but it does convey the contrast in outcome (dilution over time in GOOGL due to conversion), which captures the functional difference. Wording variations (e.g., 'about one-third' vs '33 1/3%') are acceptable and semantically equivalent. All entities (CMCSA, GOOGL, Class A/B shares, Brian L. Roberts) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 384,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM noted that a rise in illicit trade in Turkey “partially offset” its cigarette volume growth (page 55), indicating that illegal supply is eroding its market share.  In contrast, PG’s 10‑K states that “significant exchange‑rate fluctuations in Turkey … have significantly impacted our historical net sales, costs and net earnings” (page 23).  Together, these points show that both firms face dual operational risks in the same market: PM confronts market‑share erosion from illicit trade, while PG contends with financial exposure to currency volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) All factual elements are correct: PM's cigarette volume growth was partially offset by illicit trade in Turkey, and PG faces significant foreign exchange exposure due to currency volatility. The cited page numbers (55 for PM, 23 for PG) align with typical 10-K disclosures, though not explicitly verified here, they do not contradict the knowledge graph. (2) There are no numerical values (e.g., 8.2% market growth) in the LLM answer, which were present in the original answer. This is a minor omission—while the LLM correctly captures the qualitative impact of illicit trade, it omits the specific market growth figure and context (easing of pandemic restrictions, increased tourism) that explain why the market expanded despite illicit trade. However, since the question does not explicitly ask for the growth percentage, this omission does not undermine the central comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes that PM faces operational risk (illicit trade eroding sales) while PG faces financial risk (FX volatility affecting sales, costs, earnings), and that both are exposed to different types of risks in the same country. (4) The answer is contextually relevant and directly addresses the comparison of risks. The term 'dual operational risks' is slightly misleading—PG's risk is financial, not operational—but the explanation clarifies the distinction well enough to maintain high qualitative accuracy. Overall, the answer matches the semantic intent and factual core of the ground truth, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 449,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan embeds transition‑risk assessment in a firm‑wide Climate Risk Framework that is overseen by a dedicated Climate Risk Committee and Climate Risk Management function, using scenario analysis and integrated governance to identify, measure, monitor and control the risk across all seven risk types (see page 148). In contrast, Bank of America’s $1.5 trillion sustainable‑finance goal creates a reputational‑risk exposure that the bank mitigates through proactive monitoring, communication strategies and oversight by the Executive Risk Committee and FLU committees, with a focus on preventing damage to its public image if the target is not met (see pages 83‑84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.5 trillion sustainable finance goal is correctly cited, and no other numerical figures (e.g., years, percentages) are present in the question or answer that conflict. Format is consistent and accurate. (2) The LLM correctly identifies JPMorgan’s Firmwide Climate Risk Framework and its key components—scenario analysis, governance via a Climate Risk Committee, and integration across risk types—matching the original answer’s emphasis on structured, proactive transition risk management. It also correctly notes Bank of America’s reputational risk exposure tied to its $1.5 trillion goal, including the mitigation strategies and governance oversight (Executive Risk Committee, FLU committees), which reflects the original answer’s focus on stakeholder expectations and public image. (3) The multi-hop reasoning is sound: the model synthesizes JPMorgan’s internal risk management approach with BAC’s external reputation-focused risk, drawing a valid contrast between proactive risk identification (JPM) versus reputational exposure mitigation (BAC). (4) Minor deduction in qualitative accuracy due to the LLM adding specific details not in the ground truth (e.g., 'seven risk types', 'page 148', 'FLU committees') which, while plausible, are not confirmed in the original answer and slightly exceed the provided information. However, these do not contradict the truth and may reflect accurate sourcing. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 432,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft recognizes hardware‑software bundles as a single performance obligation and records revenue at the point in time when ownership transfers to resellers or end customers. Cisco’s financing of hardware purchases is structured as loan receivables with an average term of one to three years, and the company’s total allowance for credit losses on these financing receivables (loan and lease) was **$72 million** as of July 29 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amount ($72 million), date (July 29, 2023), and time range (one to three years) are all accurate and correctly formatted. (2) The answer addresses all parts of the multi-hop question: Microsoft's revenue recognition timing for hardware-software bundles (point in time at ownership transfer), Cisco's average loan receivable terms for financing hardware (1–3 years), and Cisco's total credit loss allowance ($72 million as of July 29, 2023). (3) Entities are correctly identified: Microsoft and Cisco are accurately attributed with their respective accounting and financing practices. (4) The reasoning is sound and synthesizes information across two companies and domains—revenue recognition (Microsoft) and financing credit risk (Cisco)—demonstrating proper multi-hop logic. The semantic meaning is equivalent to the original answer, with only minor rephrasing for clarity. No factual, numerical, or conceptual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 296,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "FedEx’s ICAO‑2028 compliance costs are tied to the fuel‑efficiency of its fleet, as the company projects higher operating expenses from CORSIA and ETS obligations that depend on aircraft emissions (FedEx 10‑K, p.18). If Gulfstream’s G700 certification is delayed, the introduction of a new, fuel‑efficient aircraft that FedEx could acquire is postponed, meaning the company may have to keep older, less efficient aircraft in service past the cutoff and rely more heavily on offsets or sustainable fuel, thereby raising its compliance costs (Gulfstream 10‑K, p.71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core causal chain from FAA certification delays for the G700 to increased CORSIA compliance costs for FedEx. (1) All entities are correct: FedEx, Gulfstream, G700, FAA, ICAO 2028 cutoff, CORSIA, ETS. The years (2028 cutoff, phase-out of free allowances by 2026 in the original) are contextually consistent, though the LLM does not explicitly mention the 2026 phase-out of free allowances, which is a minor omission. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected. (3) The multi-hop reasoning is sound: the LLM correctly links FAA certification delay → delayed G700 availability → delayed fleet modernization → continued use of less-efficient aircraft → higher emissions → greater reliance on offsets and sustainable fuels → higher compliance costs under CORSIA/ETS. It references FedEx’s 10-K and Gulfstream’s 10-K appropriately, though exact page numbers (p.18, p.71) are likely fabricated, as 10-Ks do not typically attribute such statements to specific pages in public filings. (4) The answer is semantically equivalent to the ground truth, capturing the key risk and mechanism. The only minor gap is the omission of the detail about Gulfstream’s 2023 inventory ramp-up being tied to certification timing, which adds operational context but does not alter the core conclusion. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 409,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "CMCSA’s Class A shares carry one vote each, while its Class B shares carry **15 votes per share**【page_33】.  \nAlphabet (GOOGL) also gives Class A shares one vote each, but its Class B shares carry **10 votes per share**【page_81】.  \nThus, CMCSA’s Class B shares have a higher per‑share voting power (1:15) than Alphabet’s (1:10).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the per-share voting rights: 15 votes for CMCSA Class B and 1 vote for CMCSA Class A, and 10 votes for GOOGL Class B with 1 vote for Class A. This aligns with the ground truth and supports the correct comparison that CMCSA’s Class B shares have higher per-share voting power (15:1) than GOOGL’s (10:1). However, the LLM omits key contextual details from the original answer: (1) it does not mention that CMCSA’s Class A voting power is not fixed per share but is instead structured to hold 66 2/3% of total voting power collectively, with variable vote allocation depending on share count; (2) it fails to note that CMCSA’s Class B collectively holds 33 1/3% of voting power despite having 15 votes per share; (3) it does not clarify that the ownership percentages for GOOGL’s classes are undisclosed. These omissions affect completeness and the depth of multi-hop synthesis, particularly around the structural differences beyond simple per-share ratios. While the per-share vote counts are accurate (quantitative accuracy is high), the lack of nuance in explaining the overall voting power distribution reduces qualitative accuracy. The answer remains contextually relevant and correctly addresses the core comparison in voting ratios.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 354,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "At Comcast, each Class B share carries 10 votes (vs. one vote for a Class A share) and, because the company has a very small number of Class B shares, those shares account for roughly one‑third (≈33 %) of the total voting power. Alphabet’s dual‑class scheme gives its Class B shares the same 10‑vote privilege, but the Class B pool is tiny relative to total shares—less than 1 % of outstanding shares—yet it commands about three‑quarters (≈75 %) of all votes, concentrating control in the hands of the founders and early insiders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) Quantitative inaccuracy: The LLM states that CMCSA Class B shares carry 10 votes per share, but the ground truth specifies 15 votes per share. This is a critical error in voting rights. (2) The LLM claims GOOGL's Class B shares command approximately 75% of voting power, which contradicts the ground truth that does not specify the exact percentage but implies a high concentration; however, more importantly, the LLM fabricates that GOOGL’s Class B shares are 'less than 1% of outstanding shares' and 'command about 75%'—this specific 75% figure is unsupported in the original answer and misrepresents the comparison. (3) The original answer emphasizes that CMCSA’s Class B shares have *more* per-share voting power (15 vs 10) than GOOGL’s, but the LLM incorrectly equates both at 10 votes, undermining the core comparison. (4) The LLM fails to mention that CMCSA’s Class B shares are non-dilutable and held entirely by Brian L. Roberts, a key point in the original answer about fixed minority control. (5) The LLM incorrectly implies symmetry in voting power distribution by assigning 33% to CMCSA Class B and 75% to GOOGL Class B, whereas the original answer focuses on structural differences in vote weight and convertibility, not comparative control percentages. (6) The reasoning is flawed: the LLM suggests GOOGL has greater voting concentration (75%) than CMCSA (33%), but the original answer does not support this direct comparison and instead highlights per-share vote weight and conversion mechanics. (7) Contextually, the answer addresses dual-class structures and relative influence, so relevance is moderate, but factual inaccuracies severely undermine correctness. Overall, major errors in numbers, entities, and reasoning lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 503,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "Zeposia received FDA approval for ulcerative colitis in May 2021, roughly three months before Merck’s Welireg was approved for von Hippel‑Lindau disease in August 2021 [page_94][page_101].  Zeposia’s approval added a new immunology product to BMY’s portfolio, strengthening its immunology pipeline and potential sales [page_94].  Welireg’s approval added a new oncology product to MRK’s portfolio, contributing to its oncology sales growth and expanding its oncology pipeline [page_52].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Zeposia was approved in May 2021 for UC, Welireg in August 2021 for VHL disease—correct dates and indications. The three-month difference is accurately implied. (2) Quantitative accuracy is perfect: no numerical errors; dates match exactly. (3) The reasoning correctly compares the two approvals in sequence and maps each to the respective therapeutic area—immunology for BMY and oncology for MRK—demonstrating sound multi-hop synthesis across companies and indications. (4) The only minor omission is that the LLM does not mention the $50 million milestone payment to former Peloton shareholders or the mechanistic novelty of Welireg as a HIF-2α inhibitor, which are part of the impact on MRK’s portfolio. While this reduces completeness slightly, the core impacts—portfolio expansion and sales growth—are correctly conveyed. Semantic equivalence is maintained, and all entities (BMY, MRK, Zeposia, Welireg, UC, VHL) are accurate. Contextual relevance is excellent as all information directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 316,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s restricted‑stock awards vest in a cliff structure tied to service periods of 3–10 years for restricted stock and a 3‑year cliff for RSUs (pages 71‑72). UPS’s multi‑employer pension plans also have vesting periods defined by collective‑bargaining agreements, but the vesting is part of the plan’s benefit formula and the company’s contributions are subject to plan‑funding risk and potential withdrawal liabilities (pages 108‑112). Thus, EMR’s vesting is a corporate equity incentive with no direct funding risk, whereas UPS’s vesting is tied to a pension plan that carries funding risk and delivers benefits through the plan rather than through equity awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: EMR's 3–10 year cliff vesting for restricted stock is accurately reported, and the mention of a 3-year cliff for RSUs (though not in the original answer) is consistent with the source material and does not contradict the ground truth, which focuses only on restricted stock. No calculations were required. (2) The entity identification is correct—EMR and UPS are properly distinguished, and the reference to multiemployer pension plans and collective bargaining agreements matches the original. (3) The reasoning correctly synthesizes the multi-hop elements: it contrasts EMR’s equity-based, fixed vesting structure with UPS’s pension plan vesting that is tied to benefit delivery mechanisms and shared funding risks, including withdrawal liabilities. (4) The LLM adds a minor detail about RSUs not present in the original answer, but this does not detract from accuracy and may reflect additional context from the filing. It fully captures the core contrast in risk exposure and benefit delivery. The only reason for not scoring a 10 is that the original emphasizes the 'retirement, death, or termination' triggers for vesting in UPS plans, which the LLM omits—this is a minor but relevant aspect of vesting requirements. Otherwise, the answer is semantically equivalent, contextually precise, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 398,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Under the Communications Act, NFLX’s privacy exposure is largely tied to potential regulatory fines and legal claims for breaches of the Video Privacy Protection Act, GDPR, CPRA and related state laws, with operational constraints that could force it to alter data‑handling practices, incur additional compliance costs, and risk member loss.  CMCSA’s obligations under the same Act are broader, encompassing FCC‑mandated broadband reclassification, net‑neutrality and franchise rules in addition to privacy statutes, so its potential penalties include administrative enforcement actions, civil and criminal liability, and operational constraints such as mandated service provisions, franchise fees and compliance costs.  In short, both firms face fines and operational limits for handling personal information, but CMCSA’s cable and broadband responsibilities expose it to a wider range of regulatory requirements and potentially larger financial and operational impacts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core comparison between NFLX and CMCSA under the Communications Act, with no numeric inaccuracies (quantitative accuracy is perfect as no specific numbers are involved and no incorrect figures are cited). The answer correctly identifies that both companies face regulatory penalties and operational constraints related to personal information, and it accurately contrasts NFLX’s exposure—centered on data breaches and lack of insurance—with CMCSA’s broader regulatory compliance framework. However, the LLM introduces GDPR and CPRA, which are not mentioned in the original answer and are not directly tied to the Communications Act, potentially conflating regulatory regimes. It also references the Video Privacy Protection Act (VPPA), which, while relevant to video privacy, is not specified in the ground truth and adds detail beyond the provided knowledge. Additionally, the original answer emphasizes that NFLX lacks insurance coverage for such risks—a key differentiator—which the LLM omits. While the LLM captures CMCSA’s broader obligations, it frames them around FCC broadband reclassification and net neutrality, which, while plausible, extend beyond the original answer’s focus on privacy-specific restrictions under the Act. The reasoning is generally sound and contextually relevant, but the synthesis includes plausible extrapolations not grounded in the provided knowledge graph, reducing qualitative accuracy. The core multi-hop comparison (NFLX vs. CMCSA on financial penalties and operational constraints under the Communications Act) is addressed and semantically aligned, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 462,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM entered Sweden by launching a new Platform 5 nicotine‑pouch line in January 2022, a reformulated Shiro brand acquired through AG Snus, and has focused on direct‑to‑consumer retail and digital engagement rather than a pre‑existing distribution network.  By contrast, CCEP operates as an established bottling partner for Coca‑Cola in Sweden, relying on KO’s concentrate supply and brand portfolio and leveraging its own bottling and distribution infrastructure.  Thus, PM’s strategy is a product‑centric launch with its own nicotine supply chain, while CCEP’s role is a distribution partnership that depends on KO’s beverage products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand following the AG Snus acquisition, and CCEP is a bottler for KO in Sweden. The answer correctly contrasts PM’s direct market entry via product innovation with CCEP’s role as a distribution partner dependent on KO’s concentrates. (2) Quantitative accuracy is perfect: the date 'January 2022' matches the ground truth; no other numbers (e.g., 41%) were included in the LLM answer, but their omission does not reduce correctness since the LLM was not required to include every statistic if the core comparison remains valid. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across PM’s product launch strategy and CCEP’s contractual bottling relationship with KO, highlighting differences in market entry (direct vs. partnered) and product dependency (own supply chain vs. reliance on KO). (4) Semantic equivalence is strong—while the LLM omitted the detail about CCEP being one of KO’s top five bottlers representing 41% of global volume, this is a minor omission that does not affect the core comparison on market entry and dependency. The LLM captures the essential contrast in strategies and dependencies accurately. Hence, a score of 9 is justified—very close to perfect, with only slight room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 391,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "The 8 % drop in UNH’s Medicare Part D enrollment (3,050 in 2024 versus 3,315 in 2023, a decline of 8 %【page_31】) signals a shift in the Medicare population that can reduce Part D revenue while potentially increasing Medicare‑Advantage (MA) enrollment.  Under the IRA, Part D plans now face mandatory manufacturer discounts and a reinsurance cut in the catastrophic phase—shifting more cost to Part D plans and manufacturers (Amgen page 17).  CVS, which bills for MA contracts, therefore faces higher financial exposure as it must absorb larger manufacturer discounts and the reinsurance shift, compressing its MA margins【page_38】.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies: it states UNH's Medicare Part D enrollment declined from 3,315 to 3,050, implying units in thousands but omitting '000', leading to a misrepresentation of enrollment as 3,315 instead of 3,315,000. This error distorts the scale of enrollment and undermines factual precision. The 8% decline is correctly cited, but without proper context of millions of enrollees, the magnitude is misleading. 2) The qualitative reasoning partially aligns with the ground truth: it correctly identifies the IRA’s impact on manufacturer discounts and reinsurance shifts in the catastrophic phase, referencing Amgen’s experience (though without explaining the rebate accrual mechanism). It also correctly links these changes to increased financial exposure for CVS under Medicare Advantage contracts. However, it fails to mention the 2025 effective date of the IRA changes, a key temporal detail. 3) The multi-hop synthesis is partially sound—connecting UNH enrollment trends, IRA provisions, and CVS’s exposure—but lacks depth in explaining how Amgen’s rebate accrual (a proxy for manufacturer behavior) affects CVS’s PBM operations and drug pricing dynamics. 4) Contextual relevance is strong: the answer addresses the core interaction between enrollment trends and policy shifts affecting CVS. Despite flawed numbers, the logical flow and focus on financial exposure in Medicare Advantage are appropriate. Overall, the answer is partially correct but undermined by critical numerical errors and incomplete synthesis, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 434,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas utilities recover environmental‑remediation costs through state‑PSC‑approved cost‑recovery riders that are embedded in customer rates (see the “Natural Gas” section, page 22).  Duke Energy, by contrast, records $73 million in reserves for environmental‑remediation liabilities on its balance sheet (page 163), reflecting potential future costs that are not fully recoverable and may be subject to litigation or insurance claims.  Thus, while Southern Company’s regulatory framework permits direct cost recovery from ratepayers, Duke Energy’s liability framework forces it to set aside reserves, creating a more uncertain and potentially larger financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly states Duke Energy's $73 million in environmental remediation reserves, which matches typical reported figures (the original answer uses a placeholder $X million, so this specific value cannot be confirmed as incorrect). Southern Company's cost recovery mechanism is accurately described without needing a specific dollar figure. (2) The answer correctly identifies the key difference: Southern Company recovers costs via regulatory riders (e.g., on page 22), while Duke Energy must record reserves ($73M on page 163) due to uncertain recovery. (3) Multi-hop reasoning is sound—comparing two companies' approaches to environmental liabilities across different regulatory frameworks is properly synthesized using entity-specific data points. (4) Minor deduction in quantitative accuracy due to the use of a precise $73M figure not present in the ground truth (though plausible); however, since the ground truth uses a placeholder, this is not clearly an error. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the comparative financial exposure and regulatory frameworks as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 347,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "The combined number of securities still available for future issuance under equity‑compensation plans approved by security holders is 151,915,315 (40,873,176 for Caterpillar + 111,042,139 for Johnson & Johnson)【page 127】. 3M’s equivalent total is only 39,563 securities, which is a tiny fraction of the combined total—about 0.026 % of it【page 116】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the securities available for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) and accurately calculates their sum as 151,915,315, which matches the ground truth. However, it incorrectly states 3M’s available securities as 39,563 instead of 39,563,000—a critical error that understates the value by a factor of 1,000. This mistake leads to a grossly inaccurate comparison, claiming 3M’s total is 'about 0.026%' of the combined total, which is incorrect; the correct percentage is approximately 26% (39.563M / 151.915M ≈ 0.26). (2) The calculation of the sum is correct, but the misrepresentation of 3M’s figure invalidates the comparative analysis. The format of the number for 3M is wrong, and no accepted formatting convention justifies dropping six zeros without explicit notation. (3) The multi-hop reasoning is otherwise sound: the model identifies the correct metric across three companies and attempts a synthesis and comparison. The logic of combining Caterpillar and J&J and comparing to 3M is correct. (4) Due to the significant quantitative error in 3M’s number and the resulting flawed comparison, the correctness and quantitative accuracy scores are reduced. However, the qualitative reasoning and contextual relevance remain high as the structure, entities, and intent align with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 379,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s Januvia and Janumet are slated to lose U.S. market exclusivity in May 2026, and the IRA program will set a government price for Januvia on Jan 1 2026 and for Janumet/Janumet XR on Jan 1 2027, which is expected to drive post‑2025 sales declines (page 59).  By contrast, Pfizer’s strategy relies on regulatory exclusivity periods that can extend beyond basic patent expirations—e.g., 5 years for chemical products and 12 years for biologics—so its revenue protection beyond 2025 is less exposed to pricing constraints and generic entry (page 14).  Thus, Merck’s post‑2025 revenue protection is more vulnerable to government‑set pricing and generic competition, whereas Pfizer’s regulatory exclusivity offers a longer‑term shield that is less affected by such factors.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Merck's exclusivity loss for Januvia and Janumet in May 2026 and notes the IRA pricing start dates, but inaccurately states that the government price for Januvia begins on January 1, 2026. The ground truth does not specify an exact date, only that IRA pricing applies starting in 2026; however, public knowledge indicates IRA price-setting occurs in calendar year 2026 for drugs selected in 2023, but the exact effective date (e.g., Jan 1 vs mid-year) is not confirmed in the original answer. More critically, the LLM claims Janumet/Janumet XR IRA pricing starts Jan 1, 2027, while the original answer states it is 2027 without a specific date—this precision is unsupported and potentially incorrect. (2) The LLM correctly contrasts Pfizer’s reliance on regulatory exclusivity (5 years for small molecules, 12 for biologics), which aligns with general FDA exclusivity rules and is consistent with the original answer’s emphasis on regulatory exclusivity as a parallel protection mechanism. However, the original answer does not mention specific durations (5 or 12 years), so this detail, while factually accurate in general, is an addition not present in the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Merck’s dual challenge of patent expiration and IRA pricing with Pfizer’s structural reliance on regulatory exclusivity, concluding that Merck is more vulnerable post-2025. This reflects the core insight of the original answer about divergent revenue protection strategies. (4) The answer is contextually excellent, addressing all parts of the question and drawing a clear comparison. The main deduction is in quantitative accuracy due to the unsupported specificity of IRA pricing start dates (Jan 1), which introduces potential factual overreach. Despite this, the overall qualitative and contextual fidelity is high, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 526,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN and CDO holdings expose the firm to credit‑event risk when the reference entity defaults, potentially leaving the principal unrepaid; the firm mitigates this by holding the embedded credit protection sold to the issuer, monitoring credit and correlation risk, and enforcing aggregate market‑risk limits.  In contrast, BAC uses credit derivatives to hedge its commercial‑credit exposure, treating them as fair‑value instruments and managing counterparty risk through collateral posting, netting agreements and clearing‑house membership (which may require pro‑rated loss sharing on member defaults).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of how MS and BAC use credit derivatives, with accurate entity identification and contextual relevance. It correctly identifies that MS invests in CLNs and CDOs where it effectively sells credit protection, exposing it to credit event risk if the reference entity defaults, and notes that principal may not be repaid. It also correctly contrasts this with BAC's use of credit derivatives to hedge commercial credit exposure. However, there is a key factual inaccuracy in the LLM's claim that MS 'mitigates this by holding the embedded credit protection sold to the issuer' — this is incorrect because when MS invests in CLNs where it has sold protection, it is the *protection seller*, not the holder of protection; thus, it assumes risk rather than mitigates it through that instrument. The original answer clarifies that MS assumes risk by selling protection, while BAC mitigates risk by purchasing it. The LLM incorrectly frames MS's position as a risk mitigation tool, which reverses the economic nature of the exposure. Additionally, while the LLM mentions MS's risk management via monitoring and market-risk limits, this detail is not in the ground truth and may overstate MS's mitigation in the context of the question. BAC's use of collateral, netting, and clearing houses is plausible but not specified in the original answer, which focuses on BAC purchasing protection as part of its risk management. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed 10 by default. The reasoning is partially sound but flawed in a key conceptual area (direction of risk exposure), reducing qualitative accuracy. The answer remains contextually relevant and addresses the comparison asked in the question, just with a critical error in interpretation of MS's risk position.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 509,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement transfers most Solventum‑related liabilities to the new company, which in turn indemnifies and defends 3M for those claims; 3M continues to accrue for potential losses as they become probable and estimable. RTX, by contrast, retains its third‑party guarantees but relies on indemnification for its benefit from the guarantor, and it recognizes potential losses by accruing costs when a liability is probable and reasonably estimable, disclosing both the carrying amount and the maximum potential payment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinctions between 3M's and RTX's indemnification structures. (1) All factual elements are correct: 3M transferred liabilities to Solventum, which assumed indemnification and defense obligations, and 3M accrues losses when probable and estimable—consistent with the ground truth. RTX retains exposure under financial guarantees but relies on third-party indemnification, with loss recognition upon probability and estimability. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes how each company handles indemnification, liability transfer, and accounting for contingent losses, drawing a clear contrast between liability transfer (3M) versus retained exposure with indemnification (RTX). (4) The LLM omits minor contextual details—specific litigation examples (Bair Hugger, False Claims Act) and explicit references to ASC 450/610-30—but these omissions do not undermine the core accuracy or comparative insight. The answer remains semantically equivalent in substance. Contextual relevance is perfect, directly addressing the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 362,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD’s sales to Taiwan were $1.84 billion in 2023, roughly 8 % of its $22.68 billion total revenue【page 71】, indicating a modest geographic concentration.  NVIDIA, by contrast, cautions that its supply chain relies on foundry partners in Taiwan and that a prolonged China‑Taiwan conflict could “severely limit or prevent us from receiving chipset supply from Taiwan,” posing a material risk to its operations【page 19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's sales to Taiwan as $1.84 billion in 2023, which matches the ground truth of $1,841 million (equivalent values, minor rounding difference acceptable). It also accurately references NVIDIA's risk disclosure regarding its foundry partners in Taiwan. The percentage of AMD's revenue from Taiwan (~8%) is correctly calculated based on $1.84B / $22.68B ≈ 8.11%, which aligns with the claim. (2) All numeric values are accurate with acceptable formatting variations: $1.84 billion = $1,841 million. Total revenue of $22.68 billion is consistent with AMD’s 2023 filing. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes AMD’s revenue exposure (market demand side) with NVIDIA’s supply chain dependency (production side) in Taiwan, contrasting sales concentration versus supply vulnerability. It captures the core insight that while Taiwan is a modest but notable market for AMD, it is a critical node in NVIDIA’s supply chain, creating asymmetric risk. (4) The only minor shortcoming is that the LLM does not explicitly state that AMD’s revenue significance and NVIDIA’s supply chain risk occur in the same region due to geopolitical tensions—though this is strongly implied. Otherwise, all entities (AMD, NVIDIA, Taiwan, 2023), metrics (revenue, supply chain risk), and reasoning are correct and contextually relevant. Hence, high scores across all dimensions with a 9 on correctness due to slight omission in explicit geopolitical linkage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 421,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s 15‑year weighted‑average remaining contract term for repowered wind facilities locks in capacity and price for roughly 15 years, providing a stable, predictable revenue stream that is further supported by the remaining life of the PTCs (page 13).  In contrast, Southern Power’s power‑sales agreements are long‑term but the specific contract terms are not disclosed (page 81), so its revenue base is less transparent and more subject to market‑price or contractual‑duration uncertainty, giving NEER a structural advantage in long‑term revenue predictability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER is correctly stated, and there are no numerical inaccuracies. The reference to PTCs (Production Tax Credits) on page 13 adds contextual support consistent with typical 10-K disclosures, though not explicitly mentioned in the original answer—this is a reasonable inference and does not detract from accuracy. (2) The contrast with Southern Power correctly identifies that while it relies on long-term power sales agreements, specific contract terms are not disclosed (as per page 81), which limits revenue visibility. This matches the original answer’s point about lack of transparency. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across NEER’s disclosed contract duration and Southern Power’s lack thereof, drawing a valid comparison about revenue predictability and structural advantage. (4) The only minor shortcoming is that the LLM answer does not explicitly mention investor confidence or financial planning strategies—elements present in the original answer that add depth to the implications of transparency. However, the core factual content, logic, and comparative insight are preserved with high fidelity. Wording differs slightly but maintains semantic equivalence. No calculation errors or entity misidentifications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 392,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX’s revenue recognition under FAR for fixed‑price U.S. government contracts is based on performance‑based and progress payments, with revenue recognized over time using a percentage‑of‑completion method and excess billings recorded as contract assets (RTX, p. 79‑80). Honeywell, also governed by FAR, discloses that the U.S. government can terminate contracts for convenience or due to non‑performance, and audits may trigger downward price adjustments and refunds (Honeywell, p. 35). Thus, RTX focuses on systematic revenue recognition, whereas Honeywell’s emphasis is on mitigating the risk of contract termination and audit‑related adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific numbers (percentages, dollar amounts, dates) are misstated; the mention of 80-90% from the original is implicitly supported by the description of progress payments covering most but not all costs, and though the exact range isn't repeated, the concept is correctly conveyed. All cited page numbers (RTX p.79-80, Honeywell p.35) are consistent with source documentation. (2) The answer addresses both parts of the multi-hop question: RTX's revenue recognition practices under FAR and Honeywell's exposure to termination risks. It correctly identifies that RTX uses performance-based/progress payments with revenue recognized over time (percentage-of-completion), leading to contract assets—matching the original. It also correctly notes Honeywell’s exposure to termination for convenience and audit-related adjustments under FAR, which directly relates to contract risk. (3) Entity accuracy is strong: both RTX and Honeywell are correctly identified, and the regulatory framework (FAR) is accurately referenced. (4) The reasoning is sound and synthesizes across both companies’ disclosures. The only minor shortcoming is that the LLM does not explicitly connect Honeywell’s termination risk to its impact on already-recognized revenue or contract assets, a key point in the original answer about how termination could affect financials similarly to RTX. This slight omission in synthesis prevents a perfect 10, but the core facts, logic, and relevance are intact. Overall, the answer is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 450,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries no voting rights (page 82), so holders have no influence over corporate decisions, yet they still receive dividends and can benefit from the company’s share‑repurchase program, which can lift earnings per share. Comcast’s relinquishment of voting rights in Hulu (page 85) removed its board seats and control over the streaming asset, but the company received an $8.6 billion cash payout (plus a tax gain) when Disney exercised the put option, providing a direct financial benefit. Thus, both scenarios involve loss of governance control, but Alphabet’s outcome is a passive effect through repurchases and dividends, whereas Comcast’s outcome is an active cash inflow and tax gain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between Alphabet's structural governance design and Comcast's transactional relinquishment of control, correctly identifying the loss of governance in both cases and linking them to financial outcomes. However, there are key quantitative inaccuracies: the $8.6 billion payment from Disney is correctly cited, but the LLM omits that this was net of $557 million for prior capital calls and fails to mention the recorded investment value of $883 million as of December 31, 2024. Additionally, the LLM does not reference Alphabet’s $44.7 billion remaining share repurchase authorization in 2024, a critical financial detail in the ground truth. While it correctly notes that Class C shares have no voting rights and benefit from repurchases, it misses the strategic intent of maintaining control via dual-class shares. The qualitative reasoning is sound—correctly framing Alphabet’s approach as passive (via capital structure) versus Comcast’s active monetization—but lacks full multi-hop synthesis, particularly around the timing (Comcast’s 2019 relinquishment and 2023 put exercise) and the full financial implications. Entity accuracy (Alphabet, Comcast, Hulu, Disney) and general financial concepts are correct. The answer is contextually relevant and well-structured, but incomplete on key facts and numbers, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 384,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both companies rely on third‑party manufacturers, so a lapse in quality control or a supply‑chain bottleneck could delay production, trigger recalls or regulatory action. For LLY, such disruptions could prevent it from scaling its incretin drugs to meet demand, while for TMO they could postpone revenue recognition for the $26.92 billion of remaining performance obligations that are tied to 3‑ to 5‑year contract‑manufacturing agreements, affecting cash flow and contractual compliance. In either case, shared vulnerabilities in quality assurance and supply‑chain execution could erode margins, damage reputation and threaten long‑term commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) All key facts are correct: LLY's reliance on third-party manufacturers leading to supply constraints for incretin products (Mounjaro, Zepbound), the persistence of tight supply 'in the next several years', and quality risks are accurately reflected. TMO's $26.92 billion in remaining performance obligations tied to 3- to 5-year contract manufacturing agreements is correctly stated. (2) Quantitative accuracy is perfect: the $26.92 billion figure is exact and properly contextualized; no calculations were required. (3) Reasoning is sound: the LLM correctly synthesizes that shared reliance on third-party manufacturing creates common vulnerabilities in quality assurance and supply chain execution, which could lead to regulatory actions, delays, or defaults—impacting LLY's ability to meet demand and TMO's ability to fulfill long-term contracts and recognize revenue. The mention of cash flow and contractual compliance adds relevant nuance. (4) The only minor omission is that the original answer references AMD’s 10-K as highlighting similar third-party manufacturer risks, reinforcing the industry-wide nature of the issue; this contextual detail is missing in the LLM response, slightly reducing completeness. However, this does not detract from the core correctness. Semantic equivalence is strong, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 398,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The cumulative impairment charge recognized by NextEra Energy Resources on its XPLR investment as of December 31 2024 was **$2.0 billion** (a $1.2 billion write‑down in 2023 plus a $0.8 billion write‑down in 2024).  This amount is **$0.6 billion less** than the investment’s carrying value before the 2024 impairment (≈$2.6 billion), leaving a net carrying amount of about $1.8 billion after the 2024 write‑down.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the cumulative impairment charge of $2.0 billion is correctly calculated as the sum of the $1.2 billion impairment in 2023 and the $0.8 billion impairment in 2024. The carrying value before the 2024 impairment is correctly stated as approximately $2.6 billion, and the post-impairment carrying value is accurately given as $1.8 billion. The comparison stating that the cumulative impairment is $0.6 billion less than the pre-2024 carrying value is logically sound and mathematically correct ($2.6B - $2.0B = $0.6B). (2) The answer is complete, addressing both parts of the question: the total cumulative impairment and its comparison to the carrying value before the 2024 impairment. (3) All entities—NextEra Energy Resources, XPLR, and the relevant time periods (2023 and 2024)—are correctly identified. (4) The multi-hop reasoning is sound: the model correctly synthesizes impairment charges across two different dates and years, computes the cumulative impact, and contextualizes it relative to the carrying value. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'written down to' vs 'leaving a net carrying amount of'). No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 374,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE’s 2024 filing notes that it adopted ASU 2022‑04 for supplier‑finance programs but that the guidance “did not have a material impact on the Company’s consolidated financial statements” and does not provide a separate line item or confirmed‑invoice balance in the notes. In contrast, 3M (MMM) discloses the confirmed invoice balances ($0.30 billion as of 2024 and 2023) and explicitly states that these amounts are included within accounts payable on the consolidated balance sheet, giving investors a clearer view of the program’s exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GE adopted ASU 2022-04 and that it did not have a material impact on its financial statements, with disclosures beginning in 2024. It accurately states MMM's confirmed invoice balances as $0.30 billion for both 2024 and 2023 and correctly notes that these are included in accounts payable. These quantitative figures match the ground truth exactly, earning high marks for quantitative accuracy. (2) The only minor omission is that the original answer specifies GE’s adoption date as January 1, 2023, and clarifies the retrospective vs. prospective application of disclosures (roll-forwards starting Jan 1, 2024), which the LLM answer does not mention. This contextual detail about implementation timing is missing but does not undermine the core correctness. (3) The multi-hop reasoning is sound: the model correctly compares GE’s lack of detailed breakout (no separate line item or confirmed balance) with MMM’s explicit disclosure of amounts and balance sheet classification, directly addressing the question about transparency differences. (4) The LLM conveys the key contrast in disclosure practices—MMM provides quantified, transparent data while GE does not—aligning with the ground truth’s conclusion about enhanced visibility under the standard. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as all content directly addresses the comparative transparency question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 405,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria’s equity‑method accounting for its stake in Cronos means that Altria’s reported earnings and the carrying value of the investment are tied to Cronos’s performance.  If Cronos fails to meet FDA regulations, it could face fines, sanctions or loss of product approvals that cut its profitability and dividends, forcing Altria to record impairment losses or lower earnings (see Altria 10‑K, page 16).  Walmart’s pharmacy operations, on the other hand, are directly regulated by the FDA and related federal statutes; non‑compliance can trigger fines, license suspensions or operational restrictions that immediately hit Walmart’s pharmacy revenue and costs (see Walmart 10‑K, pages 24‑27).  Thus, Altria’s risk is indirect—through the investment’s accounting—while Walmart’s risk is a direct operational exposure within its pharmacy business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Altria's equity-method accounting ties its earnings to Cronos's performance, and FDA noncompliance by Cronos could lead to financial losses impacting Altria through impairment or reduced earnings. Walmart faces direct regulatory exposure via its pharmacy operations, with potential fines or operational disruptions from FDA noncompliance. These points match the original answer's core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly distinguishes between Altria’s indirect financial exposure via an equity investment and Walmart’s direct operational exposure, synthesizing across two companies and regulatory contexts. It appropriately references the 10-K pages (e.g., Altria 10-K p.16, Walmart 10-K pp.24–27), which supports credibility, though exact page numbers are not part of the ground truth verification and do not affect scoring as long as the content is accurate. (4) The LLM adds slightly more structural clarity by distinguishing 'indirect' vs. 'direct' risk, which enhances the comparison beyond the original answer without introducing error. The only reason for not scoring a perfect 10 is that the original answer emphasizes both companies face 'similar regulatory risk profiles' despite different structures, a nuance slightly underemphasized in the LLM version, though implied. Overall, the answer is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 456,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY relies on Cardinal Health for U.S. distribution, with Cardinal accounting for roughly 15‑20 % of LLY’s U.S. revenue (see LLY 10‑K, p. 7). Cardinal also owns 50 % of Red Oak Sourcing, the generic‑pharma sourcing VIE that CVS consolidates (CVS 10‑K, p. 18). CVS’s exposure to Red Oak is limited to the $183 million annual payments it receives from Cardinal, which are treated as cost of products sold and are not directly tied to LLY’s distribution volumes, so Cardinal’s dual role does not materially increase CVS’s consolidated exposure beyond those fixed payments.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key factual elements: LLY’s 15–20% U.S. revenue reliance on Cardinal Health, Cardinal’s 50% ownership in Red Oak Sourcing, CVS’s consolidation of Red Oak, and the $183 million annual payment from Cardinal to CVS. These numbers and entities match the ground truth exactly, earning full marks for quantitative accuracy. (2) However, the reasoning and qualitative synthesis are flawed. The LLM concludes that CVS’s exposure is 'not materially increased' because the payments are 'fixed' and 'not directly tied' to distribution volumes. This contradicts the ground truth, which emphasizes a risk-based chain of causality: disruption in LLY’s distribution via Cardinal could harm Cardinal’s financial health, impairing its ability to make those $183M payments to Red Oak, thereby negatively affecting CVS’s consolidated financial position. The LLM fails to acknowledge this indirect but meaningful exposure pathway, which is central to the multi-hop logic of the question. (3) The multi-hop reasoning is incomplete. The model correctly identifies the links (LLY → Cardinal → Red Oak → CVS) but incorrectly dismisses the financial interdependence as immaterial without analyzing the contingent risk. It treats the $183M as a guaranteed, isolated cash flow, ignoring the operational dependency highlighted in the ground truth. (4) While the answer is factually accurate in isolation and contextually relevant, the flawed reasoning significantly undermines the conclusion, warranting a mid-range correctness score of 5. The answer is partially correct but misses the core financial exposure mechanism the question is designed to assess.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 458,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial paper program is a short‑term financing tool that it uses for general corporate purposes; its senior notes are also pari‑passu with that program. Cisco, by contrast, has issued $13.5 billion of senior fixed‑rate notes that rank at par with its commercial paper obligations, giving it a larger, fixed‑rate debt component that shares the same seniority as Oracle’s short‑term notes. Thus, while both companies treat their commercial paper and senior notes with equal seniority, Cisco’s debt structure includes a substantially larger fixed‑rate note issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's $6.0 billion commercial paper program and Cisco's $13.5 billion senior fixed-rate note issuance, both of which match the ground truth in amount and context. However, the LLM incorrectly states that Oracle's senior notes are pari-passu with its commercial paper program, which is not mentioned or supported in the original answer—this is a factual overstatement. The original answer only discusses Cisco's pari passu ranking between senior notes and commercial paper, not Oracle's. (2) Quantitatively, all dollar amounts ($6.0 billion, $13.5 billion) are accurate, and no calculations are required. The date of Cisco’s issuance (February 2024) is missing in the LLM answer, which reduces completeness. Oracle’s $401 million in outstanding notes and maturity through August 2024 are omitted, which are key details for assessing short-term exposure. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Oracle’s short-term financing focus with Cisco’s larger long-term fixed-rate debt. It accurately notes the pari passu ranking for Cisco. However, it fails to mention that Cisco’s notes are redeemable with a makewhole premium and hedged via interest rate swaps—important qualitative aspects of risk management that were in the original answer. (4) The contextual relevance is high, as the response directly addresses the comparison of debt structures. The core financial figures and comparative structure are correct, but the omission of key details and the incorrect attribution of pari passu status to Oracle reduce qualitative and quantitative accuracy. Hence, a score of 7 is justified for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 463,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment operates 23 wind facilities across 22 states as part of a 3,554‑MW portfolio that includes wind, solar, fuel‑cell and storage assets【page_21】【page_22】.  In contrast, Southern Company’s strategic focus on the Skookumchuck wind project is a single 136‑MW facility with a 20‑year PPA, underscoring a targeted, long‑term commitment to that specific wind asset【page_330】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Duke Energy does not disclose specific capacity figures for wind in its Commercial Renewables segment, but the LLM claims Duke operates 23 wind facilities with a total portfolio of 3,554 MW, which contradicts the original answer and introduces unsupported specifics. This quantitative claim is not present in the ground truth and appears fabricated or misattributed. (2) The Skookumchuck project details (136 MW, 20-year PPA) are correctly stated, so those numbers are accurate. However, the Duke Energy wind capacity and facility count are incorrect per the ground truth, which explicitly notes the absence of such disclosures. (3) The multi-hop reasoning is partially sound—comparing Duke’s broader renewable strategy with Southern’s targeted project—but the LLM undermines this by asserting specific wind data for Duke that the ground truth says is not disclosed. This misrepresents the nature of the comparison: the key point is transparency and specificity of commitment, not scale. (4) Contextual relevance is high because the answer addresses both companies and the core comparison about strategic commitment. However, correctness is low due to the introduction of false quantitative data for Duke Energy, which distorts the conclusion. The qualitative reasoning would have been stronger had it emphasized the lack of disclosed specifics from Duke versus Southern’s clear metrics, as in the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 417,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley’s capital buffer requirement is 5.5 % (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % countercyclical buffer). Charles Schwab’s banking subsidiaries must hold a 5.0 % buffer (2.5 % stress buffer for CSC + 2.5 % conservation buffer for CSB + 0 % countercyclical buffer). Thus, both firms have a zero CCyB, but MS’s buffer is slightly higher because it includes a G‑SIB surcharge rather than a stress buffer.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that both Morgan Stanley (MS) and Schwab (SCHW) are subject to a 2.5% Capital Conservation Buffer and that the Countercyclical Capital Buffer (CCyB) is 0%, it incorrectly states MS's total buffer as 5.5% (2.5% + 3.0% G-SIB + 0% CCyB). The ground truth does not specify the exact G-SIB surcharge percentage for MS, so asserting 3.0% is unsupported. More critically, the LLM claims Schwab’s banking subsidiaries must hold a 5.0% buffer composed of a '2.5% stress buffer for CSC + 2.5% conservation buffer for CSB', which is factually incorrect—there is no mention in the ground truth of a 'stress buffer' or separate buffers for different Schwab entities (CSC, CSB). SCHW is only required to maintain the standard 2.5% Capital Conservation Buffer and is not subject to G-SIB surcharge. (2) The quantitative inaccuracies include the fabricated 3.0% G-SIB surcharge for MS and the invented 2.5% 'stress buffer' for SCHW. These numbers are not in the original answer and contradict it. The total buffer comparisons (5.5% vs 5.0%) are therefore based on incorrect calculations. (3) The multi-hop reasoning fails: while the model correctly identifies that both firms are affected by the same CCyB (0%), it misrepresents SCHW’s capital structure and incorrectly introduces a 'stress buffer' not mentioned in the source. It also fails to emphasize the key differentiator—that MS faces a G-SIB surcharge while SCHW does not—instead inventing a false equivalence via a non-existent stress buffer. (4) The contextual relevance is high because the answer addresses the capital buffer comparison and the role of CCyB. However, correctness and qualitative accuracy are low due to fabrication of metrics and entities. A score of 4 reflects partial credit for correctly identifying the 2.5% conservation buffer and 0% CCyB for both, but major deductions for incorrect structure and invented data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 533,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney’s discounted‑cash‑flow (DCF) models are applied to its Level 2 derivatives, relying on observable inputs such as interest‑rate curves, yield curves and foreign‑exchange rates (page 119).  Meta, by contrast, uses DCF models to value impairment losses on operating‑lease right‑of‑use assets and leasehold improvements, employing Level 3 inputs and market‑participant assumptions about sublease income, downtime and discount rates (page 98).  The $383 million impairment charge recorded in fiscal 2024 (attributed to Meta) illustrates the magnitude of loss that can arise when such valuation methods are applied to asset impairments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $383 million impairment charge in fiscal 2024 is correctly cited and properly attributed to Meta, matching the original answer. The dollar amount, year, and context (impairment charge) are all correct. (2) The LLM correctly identifies that Disney uses DCF models with observable (Level 2) inputs—interest-rate curves, yield curves, foreign exchange rates—for valuing derivatives, and that Meta uses DCF models with unobservable (Level 3) inputs—such as sublease income, downtime, and discount rates—for impairment of operating lease assets. (3) The multi-hop reasoning is sound: the answer correctly contrasts Disney’s recurring Level 2 derivative valuation with Meta’s non-recurring Level 3 asset impairment assessment, even though both use DCF models. (4) The only minor shortcoming is that the LLM attributes the $383 million charge to Meta without explicitly clarifying in the main comparison that Disney did *not* record this charge—though the phrasing 'recorded in fiscal 2024 (attributed to Meta)' makes this clear. The original answer emphasizes the contrast in valuation contexts (Level 2 vs Level 3) and purposes (derivatives vs impairments), which the LLM captures well. Wording differs slightly but maintains semantic equivalence. No calculation errors. All entities (Disney, Meta, Level 2, Level 3, DCF, 2024, $383M) are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 397,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "PMI’s 8.2 % rise in Turkey’s total tobacco market volume—offset in part by a higher prevalence of illicit trade—lifted its share in that country from 41.3 % in 2020 to 44.8 % in 2021, driven mainly by stronger adult‑smoker demand for Marlboro and Parliament.  Altria (MO), by contrast, treats illicit trade as a broad, cross‑market risk that can erode sales, tax revenue and trigger regulatory action; the filing does not report a specific market‑share change in any single country, but notes that illicit trade can materially affect its overall tobacco business.  Thus, PMI’s Turkey share gains are a localized volume‑driven outcome, while MO’s exposure is a systemic threat that could impact its entire portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: PM's market share increased from 41.3% in 2020 to 44.8% in 2021, and the 8.2% market volume growth is consistent with the context (though the exact source of this percentage isn't in the original answer, it's plausible and not contradicted). The LLM correctly identifies the time frame and percentages. (2) The answer correctly notes that PMI (PM) benefited from volume growth in Turkey despite rising illicit trade, while MO treats illicit trade as a broader systemic risk. (3) Multi-hop reasoning is sound: it synthesizes PM’s country-specific performance with MO’s more generalized risk exposure, drawing a valid contrast between localized gains and systemic threats. (4) Minor deduction in qualitative accuracy because the LLM introduces 'Marlboro and Parliament' and 'stronger adult-smoker demand'—details not present in the original answer—adding plausible but unverified specifics. However, this does not distort the core facts. Overall, the answer is factually correct, well-structured, and contextually appropriate, with only minor embellishment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 330,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The IRA’s redesign of Medicare Part D will shift a larger share of claim liability to plans and away from the federal government, increasing CVS’s exposure to Medicare Part D liabilities and tightening its pharmacy margins (page 57). For AbbVie, the redesign introduces government‑set pricing for drugs such as Imbruvica and replaces the 70 % coverage‑gap discount with a 10 %/20 % manufacturer discount, forcing the company to adjust its pricing strategy and potentially accept lower prices (page 19).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses both parts of the multi-hop question regarding CVS's financial exposure and AbbVie's pricing strategy under the Inflation Reduction Act (IRA). (1) It correctly identifies that the IRA shifts more claim liability to insurers like CVS, increasing their financial exposure and negatively affecting pharmacy margins—consistent with the ground truth. It also correctly notes that AbbVie faces government-set pricing for drugs like Imbruvica, which aligns with the original answer. (2) Quantitatively, the LLM mentions a '10%/20% manufacturer discount' replacing the '70% coverage-gap discount,' which is factually accurate under the IRA redesign and reflects correct numerical understanding. However, the original answer specifies that government-set pricing for drugs like Imbruvica begins in 2026 and will cap reimbursement below current prices, a time-bound detail and revenue impact that the LLM omits. This missing temporal and financial projection element prevents a perfect score. (3) The reasoning is sound: the LLM synthesizes the impact on both CVS (as an insurer/pharmacy) and AbbVie (as a manufacturer), showing multi-hop understanding across entities and regulatory mechanisms. (4) The answer is contextually highly relevant and well-structured. The minor omission of the 2026 effective date and the explicit mention of capped reimbursement rates below current prices slightly reduces completeness and quantitative precision, but core facts and percentages are accurate. Hence, a score of 8 is justified for all accuracy categories, with full marks for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 441,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values impaired customer‑financing assets by taking a median value from third‑party aircraft‑valuation publications and then adjusting for aircraft condition and expected net sales price – the adjustments are unobservable inputs (Level 3)【page_124】. RTX, in contrast, values private‑equity limited partnerships quarterly with discounted‑cash‑flow, earnings‑multiple and market‑multiple models, which also depend on unobservable inputs such as discount rates, growth assumptions and comparables【page_102】. Thus, both companies rely on Level‑3 inputs, but Boeing’s approach is anchored to external market data with condition adjustments, whereas RTX’s method relies on internal valuation models and market multiples.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing uses a median from third-party aircraft value publications and adjusts for condition (unobservable inputs, Level 3), while RTX uses discounted cash flows, earnings multiples, and market multiples with unobservable inputs like discount rates and growth assumptions. These inputs are correctly identified as Level 3. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense—but all descriptive metrics and methodologies are accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes Boeing’s external-market-data-based approach with internal adjustments and contrasts it with RTX’s forward-looking, model-driven approach. The key distinction—that both use Level 3 inputs but differ in reliance on external data (Boeing) vs. internal modeling (RTX)—is preserved. (4) Minor difference: the original answer notes Boeing’s management reviews publications quarterly and may adjust based on specific attributes, while the LLM answer does not explicitly mention the quarterly review frequency. However, the core contrast in methodology and reliance on unobservable inputs is fully captured. Wording differs slightly but maintains semantic equivalence. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 392,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s charter gives each Class B share ten votes versus one for Class A, so the 343 million Class B shares (≈15 % of the 2.19 billion shares outstanding) command roughly 61 % of the voting power, concentrating control among a minority of shareholders【page_1】. Google’s structure grants voting rights only to Class A shares; its 2024 repurchase of about $62 billion of Class A shares (and $62 billion of Class C shares) reduces the total number of voting shares and can heighten the influence of the remaining holders, while the repurchase of non‑voting Class C shares does not affect voting concentration【page_82】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both entity and quantitative accuracy, fundamentally misrepresenting the voting structures of both META and GOOGL. (1) For META, the LLM incorrectly states that Class B shares have 10 votes and Class A have 1 vote, when in fact the opposite is true in the ground truth: Class A has full voting rights and Class B has no voting rights except in limited circumstances. The LLM's calculation that Class B holds 61% of voting power is therefore completely incorrect and based on a reversed structure. The share counts (343 million Class B, 2.19 billion total) are approximately correct but misinterpreted due to the structural error. (2) For GOOGL, the LLM incorrectly claims that only Class A shares have voting rights and that Class C shares were repurchased. In reality, GOOGL’s Class B shares have 10 votes per share, Class A have 1 vote, and Class C have no voting rights. The $62 billion repurchase included Class A and Class C shares, not Class A and Class C as stated—though the dollar amount is correct. Repurchasing Class A (voting) shares would increase relative control of Class B holders, but the LLM fails to mention Class B’s superior voting power, which is central to GOOGL’s control structure. (3) Multi-hop reasoning is flawed: the answer attempts to discuss control concentration but does so using incorrect voting hierarchies, undermining all conclusions. (4) Contextual relevance is moderate—the question about control concentration is addressed, and repurchase activity is mentioned, but due to foundational errors in corporate structure, the analysis is misleading. Overall, major factual inaccuracies in both companies’ share structures and voting rights severely reduce correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 475,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo’s 2022 filing shows that the convenient‑foods unit in APAC grew 19% overall, driven mainly by double‑digit gains in China and Thailand, while Taiwan’s volume growth was only low‑single‑digit. Procter & Gamble’s 2022 report defines its Greater China segment to include China mainland, Hong Kong and Taiwan, indicating that Taiwan is an integral part of that market structure (though no specific growth figure is disclosed). Thus, PEP’s APAC growth is strong overall but Taiwan’s contribution is modest, whereas PG’s market position explicitly incorporates Taiwan within its Greater China segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports PEP's 19% convenient foods unit volume growth in APAC in 2022 and accurately notes that Taiwan contributed low-single-digit growth, consistent with the ground truth. It also correctly states that PG includes Taiwan in its Greater China segment, aligning with the original answer's claim about PG's regional structure. No specific growth figure for PG in Greater China is provided in either answer, which is consistent with source data. (2) All numeric values (19%, low-single-digit) and the year (2022) are accurate and match the ground truth. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from PEP’s and PG’s respective filings, compares PEP’s modest performance in Taiwan against its strong overall APAC growth, and contrasts PEP’s operational performance with PG’s structural market positioning that explicitly includes Taiwan. The only minor shortcoming is that the LLM answer does not explicitly state PG's 'leadership or significant market share' position in Greater China product segments—this qualitative assessment from the original answer is omitted, slightly weakening the comparative insight. (4) Despite this omission, the LLM answer conveys nearly all key facts accurately and remains semantically equivalent in intent and substance. The contextual relevance is high as it directly addresses the comparison between PEP’s growth in APAC (including Taiwan) and PG’s regional structure. Thus, the correctness score is 9 due to high factual accuracy with a minor gap in completeness regarding PG’s market leadership claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 451,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III update raises the minimum CET1 ratio for a well‑capitalized insured depository institution from 4.5 % to 6.5 % (with Tier 1 and total‑capital thresholds of 8 % and 10 % respectively)【page_11】.  Bank of America’s CET1 ratio was 11.8 % (Standardized) and 13.4 % (Advanced) in 2023【page_146】, while Capital One’s bank reported 12.9 % (Standardized) and 13.1 % (Advanced)【page_193】—both comfortably above the new 6.5 % bar and the other Tier 1/total‑capital thresholds, keeping each bank classified as well‑capitalized under the updated PCA framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA thresholds under Basel III: a CET1 capital ratio of 6.5% (up from 4.5%), Tier 1 at 8%, and total capital at 10% for well-capitalized status, which aligns with the ground truth. It accurately states that both BAC and COF exceed these thresholds, supporting their classification as well-capitalized. However, the LLM introduces specific CET1 ratio values for 2023 (e.g., BAC at 11.8% standardized) that are not present in the original answer and were not required to answer the question—these figures may be factually correct but represent extraneous detail not grounded in the provided truth. More critically, the original answer emphasizes the regulatory minimums (4.5% CET1) versus the higher PCA thresholds (6.5% CET1) that banks must meet to avoid restrictions, and how this impacts capital planning and dividend capacity. The LLM omits this key implication, weakening the qualitative depth and multi-hop synthesis. While the core quantitative thresholds are correct (6.5%, 8%, 10%), the LLM does not clarify that COF is a Category III institution or that both banks share the same PCA thresholds due to Basel III updates—details central to the original comparative analysis. The reasoning is sound but incomplete in connecting regulatory structure to firm-specific impact. Semantic equivalence is mostly preserved, but missing structural and policy context prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 395,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "NFLX’s audit notes (page 40) describe sensitivity analyses that test how changes in estimated viewing‑hour patterns would alter the timing and amount of content amortization, reflecting the subjective nature of those assumptions. AT&T’s audit notes (page 44) likewise perform sensitivity testing, but the focus is on the impact of changes in pension discount rates and the forward‑looking assumptions (terminal growth, EBITDA margins, WACC) used in goodwill impairment models. Thus, both companies use sensitivity analysis to gauge the effect of assumption changes, but NFLX’s is limited to content amortization while AT&T’s covers pension discount rates and goodwill impairment assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: NFLX's sensitivity analysis focuses on viewing-hour patterns affecting content amortization timing, while T (AT&T)'s analysis covers pension discount rates and goodwill impairment assumptions (terminal growth, EBITDA margins, WACC). The companies, metrics, and nature of assumptions are correctly identified. (2) There are no numeric values requiring verification in this qualitative comparison, so quantitative accuracy is not applicable beyond correct representation of non-numerical financial concepts—none are misstated. (3) Multi-hop reasoning is sound: the model correctly synthesizes audit-level disclosures for two different companies (NFLX and T/AT&T) and contrasts their sensitivity analyses across distinct accounting areas—content amortization vs. pension and goodwill assumptions. (4) The only minor limitation is that the LLM refers to 'AT&T’s audit notes' instead of 'T’s auditor' as in the original, but this is a permissible synonym (T = AT&T), and the page references (40, 44) add precision not in the original but do not contradict it. Wording differs slightly but meaning is preserved. Thus, the answer earns a 9/10 for correctness due to full factual alignment with minor stylistic variation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 369,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe operates a single local field office in Taiwan, which supports direct sales, partner programs, and technical support for that market (page 15).  Apple, by contrast, treats Taiwan as part of its broader Greater China segment—China mainland, Hong Kong and Taiwan—which generated $74.2 billion of net sales in 2022 (page 52).  Thus, Adobe’s approach is a focused, single‑office presence, whereas Apple’s strategy is a region‑wide, integrated operation that captures a much larger revenue base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, and Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022—this figure matches the original answer exactly. The year 2022 is correctly implied as the reporting period. (2) Quantitative accuracy is perfect: the $74.2 billion figure is correctly cited with acceptable formatting (using $74.2 billion). No calculations were required. (3) The multi-hop reasoning is sound: the model correctly contrasts Adobe’s localized, single-office presence in Taiwan with Apple’s broader regional strategy that aggregates Taiwan into a larger geographic segment. It synthesizes information about operational models and scales appropriately. (4) The only minor limitation is that the LLM answer does not explicitly mention Hong Kong as part of Apple’s Greater China segment, though it does list 'China mainland, Hong Kong and Taiwan'—so the information is present. Additionally, while the original emphasizes 'direct customer engagement' and 'consolidated market with unified strategy,' the LLM captures the same meaning using 'focused, single-office presence' vs. 'region-wide, integrated operation.' Wording differs slightly but semantic equivalence is maintained. No factual errors or omissions affect the core correctness. Contextual relevance is excellent as all parts of the question are addressed directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 410,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin’s 2022 filing notes that its credit facility and some derivatives still reference LIBOR, but the facility contains fallback provisions and the company has adhered to the ISDA 2020 IBOR fallback protocol, so it does not expect a material impact from the transition (LMT 10‑K, p. 85). 3M, by contrast, has reviewed its contracts and will apply ASU 2020‑04 to any that are modified, concluding that the reform will not materially affect its results (MMM 10‑K, p. 68).  Thus Lockheed Martin remains exposed to LIBOR‑based instruments but has mitigated the risk, while 3M’s preparedness is proactive and anticipates no significant effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: Lockheed Martin has LIBOR-based credit facilities and derivatives, adheres to the ISDA 2020 IBOR Fallbacks Protocol, and expects no material impact by December 31, 2022 (implied in original answer, not contradicted). 3M reviewed its contracts, applies ASU 2020-04 to modified contracts, and concludes no material impact—consistent with the original answer. (2) No numerical inaccuracies: no specific dollar amounts or percentages are involved, and all dates and references (e.g., ASU 2020-04) are correctly cited. Page numbers (p. 85, p. 68) add precision and are consistent with typical 10-K disclosures. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their exposure to LIBOR, use of ASU 2020-04, and risk mitigation strategies. It draws a nuanced comparison—Lockheed as still exposed but with fallbacks, 3M as proactively assessing contracts—reflecting parallel preparedness despite different financial instruments. (4) Semantic equivalence is high: the LLM captures the core conclusion that both companies expect minimal disruption and rely on ASU 2020-04 for accounting relief, even if wording differs slightly (e.g., 'proactive' vs 'similar low expectation'). The only minor gap is that the original emphasizes 'parallel preparedness despite differing financial structures,' a synthesizing point slightly underdeveloped in the LLM answer, but not contradicted. Hence, a score of 9 is warranted—excellent accuracy with near-complete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 439,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Class A common stock holds 66.7 % of Comcast’s combined voting power, while Class B common stock holds the remaining 33.3 %. Because each Class B share carries 15 votes, the single Class B share (held by Mr. Roberts) represents a third of all votes, giving him a substantial, non‑dilutable influence over board elections and other shareholder decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the percentages are correct: 66.7% for Class A and 33.3% for Class B, which are equivalent to 66⅔% and 33⅓% in the original answer. The statement that each Class B share has 15 votes per share is consistent with the ground truth. (2) The LLM adds contextual detail not in the original—specifically, that the single Class B share is held by Mr. Roberts and gives him significant influence—which is factually accurate based on CMCSA's ownership structure and enhances the explanation without introducing error. (3) The reasoning correctly synthesizes the disproportionate voting power of Class B shares despite their minority share count, capturing the multi-hop logic required. (4) The only minor deviation is that the original answer emphasizes the structural aspect of voting power distribution without naming Mr. Roberts, while the LLM introduces a specific entity (Mr. Roberts) which, while accurate, slightly extends beyond the provided ground truth. However, this does not reduce correctness. All key facts are present, accurately represented, and logically connected. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this slight over-specification, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 372,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "CM CSA uses sensitivity analyses to model the effect of a 10 % shift in foreign‑exchange rates and to monitor the impact of interest‑rate changes on its debt and net income, reflecting its exposure to market risk from debt and foreign operations (see Item 7A and the FX‑risk section).  Netflix, by contrast, applies sensitivity analyses to test how changes in viewing‑pattern assumptions alter the amortization of its content library, a key risk area for revenue recognition and expense timing (see the audit matter on content amortization).  Although both firms are audited by the same firm, the sensitivity‑analysis focus differs: CM CSA’s is market‑risk oriented, while Netflix’s is driven by the unique accounting and revenue‑recognition risks of its streaming business.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the distinct uses of sensitivity analyses by CMCSA and NFLX—CMCSA for market risks (interest rates and foreign exchange), and NFLX for content amortization based on viewing patterns. This aligns with the ground truth and addresses the core of the question regarding differing financial risk exposures. However, the LLM introduces a '10% shift in foreign-exchange rates' that is not present in the original answer, which only mentions interest rate risk and derivative instruments reducing interest expense by $56 million in 2023. This addition, while plausible, is not supported by the ground truth and introduces a quantitative inaccuracy. (2) The ground truth includes a specific dollar impact ($56 million decrease in interest expense in 2023 due to derivatives), which the LLM omits entirely. This is a significant quantitative omission affecting completeness and accuracy. No other numbers are present in either answer, so no calculations are required, but the absence of this key figure reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the LLM correctly links CMCSA’s sensitivity analysis to its debt and market risk, and NFLX’s to content amortization and revenue recognition, then contrasts them despite shared auditing. It correctly infers that different business models drive different risk disclosures, even under the same auditor. The mention of the auditor’s role is implied through context, though the LLM does not explicitly state the auditor has served NFLX since 2012 or reviews CMCSA’s disclosures, which is a minor omission. (4) Despite missing the $56M figure and adding unverified FX detail, the LLM captures the essential qualitative contrast and contextual relevance. The reasoning is sound, entities are correct (CMCSA, NFLX), years are not misstated (none specified in LLM answer), and the focus on differing risk exposures is fully aligned. Hence, correctness is high but not perfect due to the quantitative gap and unsupported addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 547,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel formulation patent expires on 10/19/2037, so the company will lose exclusive rights to that formulation and is likely to face biosimilar competition in the U.S. earlier than many competitors【page_11】. In contrast, AbbVie’s biologics are protected by a 12‑year regulatory exclusivity under the Biologics Price Competition and Innovation Act (plus a possible 180‑day pediatric extension), which can extend market protection beyond patent expiry【page_10】. Consequently, Pfizer’s competitive positioning is potentially weaker relative to AbbVie, as the earlier patent expiry opens the market to biosimilars sooner while AbbVie enjoys a longer period of regulatory exclusivity.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2037 expiration of Enbrel's formulation patent and AbbVie's 12-year regulatory exclusivity under the BPCIA, along with the possibility of a pediatric exclusivity extension. However, it mischaracterizes the impact of the 2037 patent expiration by suggesting that Pfizer will face biosimilar competition 'earlier than many competitors' and that its competitive positioning is 'weaker'—this contradicts the ground truth, which states that the 2037 patent provides Pfizer with a long runway to deter biosimilars and maintain market presence. The LLM incorrectly frames the 2037 date as an early expiry that weakens Pfizer, when in fact it represents extended protection. (2) The date '10/19/2037' is more specific than the ground truth's '2037', but since the year matches and no exact date was provided in the original, this is a minor over-precision rather than a factual error. The 12-year exclusivity and 180-day pediatric extension are correctly cited. (3) The multi-hop reasoning is flawed: the model fails to synthesize that Pfizer’s formulation patent acts as a technical barrier extending protection, while AbbVie uses a regulatory + patent strategy. Instead, it incorrectly infers that earlier patent expiry undermines Pfizer, when the original answer emphasizes the strategic advantage of long-term formulation protection. The comparison between the two companies’ strategies lacks nuance and misrepresents the competitive implications. (4) Contextual relevance is high—the answer addresses both companies, their IP strategies, and the competitive landscape. However, due to significant errors in interpretation and reasoning, especially around the competitive implications of the patent timeline, the correctness and qualitative accuracy scores are moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 502,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The Fed’s proposal would cut the G‑SIB surcharge from 0.5 pp to 0.1 pp increments, lowering JPMorgan Chase’s regulatory capital requirement by roughly 0.4 pp of risk‑weighted assets (see page 60). In a bankruptcy resolution, the Parent Company’s eligible long‑term debt (LTD) is the loss‑absorbing buffer (page 15), so the reduced surcharge would slightly lower the amount of LTD needed to meet the capital buffer, but the overall impact on the resolution framework is modest because the LTD structure is already designed to absorb losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in asserting that the G-SIB surcharge change would 'lower JPMorgan Chase’s regulatory capital requirement by roughly 0.4 pp of risk-weighted assets.' The original answer does not state or imply any definitive reduction in capital requirements—instead, it emphasizes that the shift to 0.1-percentage-point increments would allow for more granular and potentially more tailored calibration, which could result in either a marginal increase or decrease depending on JPMorgan’s G-SIB score. The LLM incorrectly assumes a directional impact (a 0.4 pp reduction) not supported by the ground truth. (2) The quantitative claim of a '0.4 pp' reduction is unsupported and appears fabricated, as no such calculation or figure is present in the original answer. There is no mention of page 60 or 15 in the provided context, so citing these pages introduces unverified external references. (3) The reasoning around the loss-absorbing role of long-term debt in a resolution scenario is partially correct—the original answer does reference the 'single point of entry' strategy and the role of unsecured creditors, including eligible long-term debt, in absorbing losses. However, the LLM oversimplifies and misrepresents the interaction between the surcharge change and the debt buffer, implying a direct mechanical reduction in required LTD, whereas the original answer frames the impact as conditional and modest, contingent on the final G-SIB score calibration. (4) While the LLM captures the general context of G-SIB surcharge granularity and resolution framework relevance, the incorrect numerical claim and false certainty about a capital reduction undermine the factual correctness. The answer is contextually relevant and attempts multi-hop reasoning (linking regulatory change to capital requirements to resolution structure), but the flawed quantitative foundation reduces its accuracy. Hence, correctness is scored low (4), quantitative accuracy is poor (3), qualitative reasoning is partially sound (5), and relevance is fair (7).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 566,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin’s Level 3 fixed‑income investments are valued with a discounted‑cash‑flow model that takes projected annuity payments and a discount rate as the key inputs (page 88).  The filing notes the dependence on those inputs but does not describe any formal sensitivity testing.  Honeywell, by contrast, uses a DCF for goodwill and indefinite‑lived intangibles that explicitly lists projected cash flows and the discount rate as “key estimates” and states that it performs sensitivity analyses on those assumptions (page 47), underscoring a more explicit focus on how changes in cash‑flow projections and discount rates affect fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and a discount rate, citing sensitivity to these inputs without formal sensitivity testing (per LMT's filing, page 88). It accurately contrasts this with HON's use of DCF for goodwill and indefinite-lived intangible assets, noting that HON explicitly identifies projected cash flows and discount rates as key estimates and performs sensitivity analyses (per HON's filing, page 47). All entities (LMT, HON), valuation methods, and applications are correct. The answer captures the core comparison in sensitivity practices: both rely on forward-looking projections and discounting, but HON has a more structured sensitivity analysis. The only minor shortcoming is that the original answer also mentions HON's use of strategic/operating plans and terminal value assumptions, which the LLM omits—this contextual detail is relevant but not critical to the main comparison. No numbers or calculations are incorrect; format and semantic meaning are equivalent. Multi-hop reasoning across companies and valuation contexts is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 348,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T’s pension discount rates are derived from a yield curve built on high‑quality corporate bonds, so the auditor must evaluate the bonds’ credit quality and the alignment of their cash‑flow patterns with expected benefit payments.  \nNetflix, by contrast, amortizes content using estimated future viewing hours that are forecasted from historical trends, and the auditor tests the reasonableness of those forecasts, compares them to actual consumption, and performs sensitivity analyses.  \nIn both cases the auditors scrutinize subjective, management‑made assumptions—AT&T’s discount rates and Netflix’s viewing‑pattern estimates—to ensure they are reasonable and properly reflected in the financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor omissions affecting completeness. (1) Quantitative Accuracy: There are no numeric values in the LLM answer that contradict the ground truth. The ground truth mentions $67,854 million in goodwill and postretirement liabilities, but the LLM answer does not include this figure. However, since the LLM response focuses on the conceptual comparison and auditor evaluation rather than specific liability amounts, the omission does not undermine factual correctness—especially as no incorrect numbers are presented. (2) Completeness: The LLM addresses both companies, their respective significant assumptions (discount rates for AT&T, viewing patterns for Netflix), and the role of auditors in evaluating these assumptions. It misses the explicit mention of the $67,854 million figure tied to AT&T’s liabilities, which is a minor but notable detail in the original answer. However, this does not affect the overall conceptual accuracy. (3) Entity Accuracy: Both companies (AT&T and Netflix), financial concepts (pension obligations, content amortization), and auditor procedures (sensitivity analyses, comparison to historical data) are correctly identified and applied. (4) Reasoning: The multi-hop reasoning is sound—the model correctly synthesizes how two different firms in different industries rely on subjective assumptions that are nonetheless subject to similar auditor scrutiny. The parallel drawn between the two is logically consistent with the original answer. (5) Semantic Equivalence: The LLM answer rephrases the core idea effectively, emphasizing auditor evaluation of management assumptions in both cases. Wording differs but meaning aligns closely. The lack of the specific dollar amount prevents a perfect score, but all other elements are factually and conceptually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 510,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria adopted ASU 2023‑07 for the year ended December 31 2024, applied it retrospectively, and added expanded footnote disclosures in Note 17 (pages 62‑63), with interim segment disclosures to start in Q1 2025. Philip Morris International also adopted ASU 2023‑07 for the year ended December 31 2024, but the provided pages do not disclose the adoption date or the specific segment‑reporting changes; the company’s segment reporting was updated to consolidate the former Swedish Match results into its four existing geographical segments while keeping the Wellness & Healthcare segment unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains a minor inaccuracy regarding MO's (Altria's) adoption timeline. The original answer states MO adopted ASU No. 2023-07 in 2024 with interim disclosures starting in Q1 2025, which the LLM correctly notes. However, the LLM claims Altria applied the standard 'retrospectively,' which is not stated in the ground truth—this detail is only confirmed for PM. This introduces a small factual overstatement. For PM, the LLM correctly identifies the retrospective adoption for the year ended December 31, 2024, and accurately describes the segment change: integrating Swedish Match into the four geographical segments while preserving the Wellness & Healthcare segment. The mention of 'pages 62-63' is extraneous but not incorrect. All dates and reporting changes are otherwise accurate. The answer addresses both parts of the question: adoption timelines and segment reporting changes for both companies. Multi-hop synthesis is sound, correctly distinguishing between the two firms' approaches. Quantitative accuracy is high—dates and implementation timelines match, with only minor ambiguity around 'retrospective' application for MO. Contextual relevance is excellent, with all information directly addressing the query.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 351,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "Bristol‑Myers’ inclusion of Pomalyst in the IRA’s Medicare Part D price‑negotiation program means the drug could face government‑set pricing starting in 2027, potentially accelerating revenue erosion before its 5‑year regulatory exclusivity expires (page 43).  In contrast, Pfizer’s exposure under the same IRA provisions involves a broader set of drugs—such as Eliquis, Ibrance and Xtandi—subject to negotiated prices and a projected net revenue hit of roughly $1 billion in 2025 (page 18).  While both companies rely heavily on Medicare Part D sales, BMY’s impact is likely to be more gradual and tied to the earlier end of exclusivity, whereas Pfizer’s hit is anticipated to be immediate and larger in dollar terms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content. It accurately identifies that Pomalyst was selected for IRA price negotiation with government-set pricing starting in 2027, which aligns with the ground truth. It also correctly notes Pfizer's $1 billion net revenue impact in 2025 due to IRA provisions, particularly Part D redesign. The drugs mentioned—Pomalyst for BMY, and Ibrance, Xtandi (and Eliquis) for PFE—are consistent with the exposure described. 2) Quantitatively, the $1 billion figure for PFE in 2025 is accurate, and the 2027 start date for pricing negotiations matches the original answer. The reference to BMY’s 5-year regulatory exclusivity is contextually sound (though not explicitly detailed in the ground truth), and page citations suggest document support. However, the ground truth does not state that BMY’s impact will be 'more gradual' or that PFE’s is 'larger in dollar terms' beyond the $1B 2025 hit—this comparative financial claim is an interpretation not directly supported, slightly reducing quantitative precision. 3) The reasoning correctly synthesizes multi-hop elements: linking IRA selection to pricing timelines, connecting Medicare Part D reliance to financial exposure, and differentiating BMY’s single-drug risk from PFE’s broader portfolio impact. However, the LLM slightly overreaches by characterizing BMY’s impact as 'more gradual' and PFE’s as 'immediate and larger' without full support for the comparative magnitude beyond 2025. The original answer emphasizes long-term exposure for both, with PFE facing both Part D redesign and price negotiation, while BMY’s risk is more tied to exclusivity timing. 4) Despite minor interpretive overstatement, the LLM captures the core contrast: BMY faces a focused future risk on Pomalyst from 2027, while PFE has an earlier, quantified $1B impact in 2025 plus future pricing pressures. Wording differs but semantic meaning is largely equivalent. Contextual relevance is excellent—directly addresses all parts of the question with appropriate entities and timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 552,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine operations generated $401 million in 2021, which was 1.4 % of its consolidated net revenues.  In contrast, Coca‑Cola’s exposure to Argentina is indirect, coming through its bottling partner Arca Continental—one of KO’s top bottlers that operates in northern Argentina.  KO does not report a standalone Argentine revenue figure; instead, the region’s sales are embedded in the broader bottling‑partner network.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that MDLZ's Argentine operations generated $401 million in 2021, matching the ground truth. It also accurately notes that KO's exposure is indirect through Arca Continental, one of its top bottlers operating in northern Argentina. However, the LLM introduces a new figure—1.4% of consolidated net revenues for MDLZ—that is not present in the original answer and cannot be verified from the provided ground truth, which weakens quantitative and qualitative accuracy. (2) The $401 million figure is correct and properly attributed to 2021. The mention of 1.4% is unverified and potentially misleading without supporting data, though it may be a reasonable estimate. No calculation errors are present, but the addition of an unsupported percentage reduces confidence. (3) The multi-hop reasoning is mostly sound: the model correctly identifies MDLZ’s direct exposure versus KO’s indirect exposure via a bottler. However, it omits key qualitative details from the ground truth, such as the $13 million remeasurement loss due to inflation in Argentina for MDLZ and the contractual exclusivity (Arca must source concentrates only from KO), which are critical to fully comparing the nature of exposure. (4) The answer is contextually relevant and captures the core contrast between direct and indirect exposure. The correctness score is 7 because while key facts are accurate and the central comparison is valid, the answer lacks important risk and contractual details from the ground truth and adds an unverified percentage, reducing completeness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 440,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s 10‑K (p. 18) highlights that the FDA can grant Fast‑Track designation to speed review of certain drugs, underscoring the strategic value of regulatory acceleration. LLY’s acquisition of Prevail’s PR006 (p. 70) already carries Fast‑Track status, which could help meet the December 31 2024 milestone that triggers the contingent‑value‑right (CVR) payment of up to $4 per share. Thus, the Fast‑Track designation directly supports the likelihood of an earlier approval and a timely CVR payout, enhancing the overall value of the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and semantic alignment. (1) All key facts are correct: BMY's mention of Fast Track in its 10-K, PR006's Fast Track status, the December 31, 2024 CVR deadline, and the $4.00 per share ($160 million total) payout are all accurately represented. The LLM correctly notes that Fast Track designation may accelerate approval and support timely CVR payout. (2) Quantitative accuracy is perfect: the $4 per share and 2024 deadline match the original answer exactly; while the total $160 million is omitted, this is a minor omission and does not affect the correctness of the per-share amount or timeline. (3) Multi-hop reasoning is sound: the model correctly links BMY’s regulatory insight to LLY’s acquisition strategy, recognizes PR006’s Fast Track status, and ties it to the CVR timeline—demonstrating appropriate cross-entity synthesis. (4) The answer is contextually relevant and directly addresses how Fast Track engagement informs the strategic value of the acquisition via regulatory acceleration and CVR incentives. The only minor shortcoming is the omission of the total $160 million CVR value, which slightly reduces completeness but does not impair the overall correctness. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 393,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V’s Class A common stock rose from 1,594 to 1,733 shares in 2024 – a net increase of 139 shares (≈8.7 %). Mastercard, by contrast, has only 7 Class B shares outstanding, and those shares can be converted one‑for‑one into Class A shares, but the holders must immediately sell or transfer the converted shares, so the conversion does not add to the Class A base and the overall shareholder structure remains essentially unchanged. Thus, V’s structure is expanding through direct issuance, whereas Mastercard’s structure is largely static, with the conversion mechanism simply eliminating the tiny Class B pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: V's Class A shares increased from 1,594 to 1,733 (a difference of 139 shares), and MA had only 7 Class B shares outstanding in 2024. The calculation of the 8.7% increase is accurate (139 / 1,594 ≈ 0.087). These numbers match the ground truth exactly. (2) The LLM correctly explains MA's conversion mechanism — Class B shares convert one-for-one into Class A but must be immediately sold or transferred, which aligns with the ground truth's description of divestment requirements for converted shares. This explains why the conversion does not lead to a net expansion in Class A shares. (3) The multi-hop reasoning is sound: the model contrasts V’s organic growth in Class A shares via issuance with MA’s static structure due to conversion and mandatory divestiture, correctly inferring differing dynamics in shareholder structure evolution. (4) The only minor shortcoming is that the LLM does not explicitly mention that MA's Class B holders are typically principal or affiliate customers, a detail included in the ground truth that adds context to the conversion rules. However, this omission does not impair the core accuracy or synthesis. Wording differs but semantic meaning is equivalent. All entities (V, MA, Class A/B shares, years 2023–2024) are correct. Thus, the answer is highly accurate, complete, and contextually appropriate, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 418,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Saudi Arabia’s data‑localization laws, which Adobe cites as a risk, would require that any data processed by NVIDIA’s H100 or L40S GPUs remain stored inside Saudi Arabia. Because the U.S. Commerce Department now mandates a license for these high‑performance chips when exported to Saudi Arabia (Country Group D4/D5), the need to keep data local could add extra compliance hurdles or conflict with the license conditions, potentially delaying or limiting NVIDIA’s ability to deploy the H100 and L40S in that market【page_23】【page_27】【page_28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in completeness. (1) All entities are correct: Saudi Arabia, NVIDIA, H100, L40S, U.S. export controls, Country Group D4 (LLM also mentions D5, which is contextually acceptable as D4/D5 are often grouped in regulations). (2) No numeric values are present in either answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links Saudi data localization requirements (cited by Adobe) to potential deployment challenges for NVIDIA’s chips, and correctly references U.S. licensing requirements under export controls (specifically Country Group D4) as a constraint. (4) The LLM mentions that license conditions could create compliance hurdles or delays, which aligns with the ground truth’s conclusion about limited market access. The only minor gap is that the LLM does not explicitly state that NVIDIA has not received licenses (a detail in the original), nor does it directly mention the impact on revenue or market access as strongly. However, the implication of 'delaying or limiting deployment' captures the core consequence. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—every part of the answer addresses the question directly and cites relevant pages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 384,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s note (p. 93‑95) explicitly references both ASU 2020‑04 and its extension, ASU 2022‑06, and states that the company is “monitoring our contracts and transactions for potential application of these ASUs” even though no material effect has been observed. In contrast, GE’s LIBOR‑reform note (p. 17) cites only ASU 2020‑04, reports that the impact on its financial statements is “immaterial,” and makes no mention of the extended relief or ongoing monitoring. Thus FedEx is proactively positioning itself to use the optional expedients, while GE’s disclosure indicates it has evaluated the original relief and found no need for further application.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx references both ASU 2020-04 and ASU 2022-06, acknowledges no material effect, and states ongoing monitoring of contracts. GE cites only ASU 2020-04, deems the impact immaterial, and does not mention ASU 2022-06 or ongoing monitoring. These points match the original answer. (2) There are no numeric values requiring calculation, but dates and ASU references are correctly cited (e.g., extension through December 31, 2024, implied by ASU 2022-06, though not explicitly stated in the LLM answer, is contextually accurate). (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, compares their treatment of the same accounting guidance, and infers differing levels of caution—FedEx’s proactive monitoring vs. GE’s conclusion of immateriality. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies applied the same underlying framework (ASU 2020-04, extended by ASU 2022-06), though this is implied. It also omits the explicit comparison of FedEx’s 'no material effect' with GE’s 'immaterial' as semantically similar conclusions. These omissions are minor and do not detract from overall correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the question about differing applications of accounting relief.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 407,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple’s manufacturing is largely performed by a handful of outsourcing partners in Taiwan, China, India, Japan, South Korea and Vietnam, and the company notes that geopolitical tensions or conflict could disrupt these facilities, causing supply shortages, higher costs and delivery delays (Apple 10‑K, pp. 9‑11). NVIDIA likewise relies on Taiwan‑based foundries and contract manufacturers for wafer fabrication and assembly, and the company warns that tensions involving Taiwan and China could materially affect wafer supply, increase costs and delay product launches (NVIDIA 10‑K, pp. 17‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that both Apple and NVIDIA rely on manufacturing partners in Taiwan and that geopolitical tensions involving Taiwan could disrupt their supply chains, leading to delays, increased costs, and supply shortages. The answer cites specific risks mentioned in the respective 10-K filings (Apple pp. 9–11; NVIDIA pp. 17–18), which supports its claims. While the original answer emphasizes the 'material adverse impact' and 'severe limitations' on both companies' operations, the LLM answer conveys the same meaning using slightly different phrasing (e.g., 'materially affect wafer supply', 'supply shortages', 'delay product launches'), maintaining semantic equivalence. One minor difference is that the LLM mentions manufacturing locations beyond Taiwan (China, India, Japan, South Korea, Vietnam) for Apple, which, while factually present in Apple’s disclosures, slightly shifts focus from the core issue of Taiwan-specific risk emphasized in the ground truth. However, this does not detract from the overall correctness. There are no numerical values to verify, so quantitative accuracy is scored as 10. The qualitative reasoning is sound, correctly synthesizing multi-hop information from both companies’ filings to address the shared regional risk. Contextual relevance is full, as the response directly addresses how geopolitical tensions involving Taiwan impact both companies’ supply chains through their reliance on Taiwanese foundries and manufacturing partners.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 428,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s $24,156 million of acquired developed‑technology intangible assets include roughly $4.44 billion tied to VMware Cloud Foundation (the sum of the $790 m, $2,900 m, and $750 m releases shown on page 69), which is about **18.4 %** of the total. Oracle’s 2023 10‑K (pages 84‑88) does not disclose a net developed‑technology figure or its proportion of total intangible assets, so a direct percentage comparison cannot be made from the supplied pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect. The ground truth states that the exact percentage of Broadcom's $24,156 million developed technology intangible asset tied to VMware Cloud Foundation (VCF) is not disclosed and only described as a 'significant portion.' However, the LLM falsely claims that $4.44 billion (18.4%) is tied to VCF, citing fabricated or misinterpreted line items ($790M, $2.9B, $750M) that do not appear in the ground truth and are not supported by the knowledge graph. This introduces major factual inaccuracies. (2) The calculation of 18.4% ($4.44B / $24,156M) is mathematically correct if those numbers were valid, but they are not. Oracle's developed technology value of $1,276M and total intangibles of $6,890M (18.4%) are correctly stated in the ground truth, but the LLM incorrectly claims Oracle's 10-K does not disclose this, which contradicts the provided ground truth that includes this data as of May 31, 2024. (3) The multi-hop reasoning fails: the LLM invents a breakdown for Broadcom's asset allocation not present in the source, and fails to report Oracle's actual percentage (18.4%) that should have been computed from the given figures. Instead, it incorrectly asserts the data is unavailable. (4) The contextual relevance is moderate because the answer attempts to address both parts of the question and references intangible assets and percentages, but the factual foundation is flawed. Due to major quantitative and qualitative errors, especially the invention of unsupported figures and incorrect claim of missing Oracle data, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 442,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B common stock represents 33 ⅓ % of the company’s combined voting power, with each share carrying 15 votes and the stake being non‑dilutable and wholly owned by Mr. Roberts (66 ⅔ % of voting power is held by Class A shares)【page_38】. Alphabet operates a dual‑class structure with Class A common stock (voting) and Class C capital stock (no voting), and the non‑affiliate market value of its outstanding shares was $1.451 trillion as of June 30 2021【page_2】【page_1】. Thus, CMCSA’s control is concentrated in a single individual through a minority voting block, whereas GOOGL’s control is concentrated in the founders through the majority‑voting Class A shares, with a large market value of non‑affiliated shares.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 33⅓% voting power for CMCSA's Class B shares with 15 votes per share and the non-dilutable nature, aligning with the ground truth. It accurately reports GOOGL's non-affiliate market value as $1.451 trillion (equivalent to $1,451.1 billion), and the date June 30, 2021, is correctly cited. However, the LLM incorrectly states that CMCSA’s Class B stock is 'wholly owned by Mr. Roberts' and that Class A holds 66⅔% of voting power—this contradicts the ground truth noting there are 3 record holders of Class B stock, not one individual. This is a significant qualitative error in entity ownership structure. (2) Quantitatively, all numbers—33⅓%, 15 votes, $1.451 trillion, June 30, 2021—are accurate or acceptably formatted equivalents. No calculation errors. (3) The multi-hop reasoning is largely sound: the model compares CMCSA’s concentrated voting control to GOOGL’s dual-class structure and contrasts control mechanisms. However, it misrepresents the degree of concentration at CMCSA by attributing control to a single individual, undermining the accuracy of the comparison. The ground truth emphasizes only 3 record holders (not one), which the LLM omits. (4) Despite this, the core comparison—CMCSA’s tightly controlled Class B structure vs. GOOGL’s broader non-affiliate market value and founder-controlled Class A shares—is valid and contextually relevant. The answer synthesizes key elements from both companies correctly, except for the erroneous attribution of ownership. Thus, high scores for quantitative accuracy and contextual relevance, slightly lower for qualitative accuracy and overall correctness due to the ownership misstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 465,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 filing shows it has issued about 4.65 billion Class A shares but only 9.44 million Class B shares, so its equity is overwhelmingly concentrated in the voting Class A shares.  \nMeta’s filing reports roughly 2.19 billion Class A shares and 343 million Class B shares outstanding, meaning the Class B shares represent a much larger portion of its total equity—indicating a less concentrated equity structure than Comcast’s.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the approximate share counts for both CMCSA and META with acceptable rounding (e.g., 4.65 billion vs 4,651,093,045; 343 million vs 343,761,117), so quantitative accuracy is high. The dates are also contextually appropriate (December 31, 2024 for CMCSA; filings around January 24, 2025 for META). 2) However, the qualitative reasoning is flawed: the LLM incorrectly interprets a higher proportion of Class B shares at META as indicating a 'less concentrated equity structure' when in fact the opposite is true. The ground truth emphasizes that Class B shares carry 10 votes per share and are held by insiders, meaning META’s structure concentrates voting power. The LLM’s conclusion contradicts the correct interpretation — that META has *more* concentrated control due to the significant Class B block with superior voting rights. 3) The multi-hop reasoning fails at the synthesis stage: while the model retrieves the correct entities (CMCSA, META, share classes) and numbers, it does not incorporate the critical governance detail (10:1 voting ratio, automatic conversion upon transfer) that explains *why* Class B dominance leads to control concentration. This missing link leads to an inverted conclusion. 4) Contextual relevance is strong — the answer addresses equity structure and compares both companies — but the incorrect inference undermines the core of the question, which is about ownership concentration. Thus, despite solid number reporting, the answer is partially incorrect in its central claim, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 430,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health is heavily dependent on Medicare and Medicare‑Advantage reimbursements, so any cuts or rule changes that lower Medicare payment rates could materially reduce its revenue and operating results.  AbbVie, by contrast, faces the IRA’s price‑setting provisions that let the U.S. Department of Health and Human Services cap prices for certain single‑source drugs and biologics reimbursed under Medicare Part B and Part D, potentially eroding revenue from those products.  Both businesses are exposed to Medicare‑program changes, but CVS’s risk is tied to service reimbursement rates, while AbbVie’s is tied to government‑set drug price caps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong semantic equivalence. (1) All factual elements are correct: CVS's Oak Street Health is correctly described as reliant on Medicare/Medicare Advantage reimbursements, and AbbVie's exposure under the IRA is accurately framed as government price-setting for Medicare Part B and Part D drugs. The distinction between service reimbursement risk (CVS) and drug price caps (AbbVie) is clearly and correctly articulated. (2) There are no numeric values, dates, or percentages in the LLM answer that contradict the ground truth; while the ground truth mentions specific years (2026, 2028) and Imbruvica being selected, the LLM omits these details but does not misstate anything—this is a minor completeness gap, not an inaccuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face Medicare-related risks under the IRA but through different mechanisms—CVS via payment rates for services, AbbVie via mandated pricing for drugs. (4) The answer is contextually fully relevant and directly addresses the comparative exposure question. The only reason for not scoring a 10 is the omission of the specific detail that Imbruvica has already been selected for price-setting and that the effective years are 2026 (Part B) and 2028 (Part D), which are present in the ground truth and add precision. However, this does not undermine the overall correctness. Thus, quantitative accuracy is perfect (10), qualitative accuracy is slightly reduced due to partial omission (9), and contextual relevance and correctness remain very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 449,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft’s 10‑K shows that operating systems comprise a large share of its product revenue (page 60), underscoring how central OS licensing is to the PC ecosystem. AMD’s 10‑K explains that its x86‑based microprocessors and GPUs rely on Microsoft’s OS support and driver certification, and that loss of that support could materially harm sales (page 28). Consequently, Microsoft’s heavy emphasis on OS revenue highlights the critical role of its operating‑system ecosystem in sustaining AMD’s product viability and market success.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) There are no numeric values in the original or LLM answer requiring verification—both avoid specific dollar amounts or percentages, instead focusing on qualitative relationships. Thus, quantitative accuracy is not applicable but no errors exist. (2) The LLM correctly identifies the entities: Microsoft and AMD, their respective 10-K filings, and the relevance of operating system support to AMD's x86-based microprocessors and GPUs. It accurately cites page 60 of Microsoft’s 10-K for OS revenue and page 28 of AMD’s 10-K for dependency on Microsoft OS support—specific references that align with the knowledge graph’s grounding. (3) The multi-hop reasoning is sound: it connects Microsoft’s OS revenue importance (from its filing) to the broader PC ecosystem, then synthesizes AMD’s reliance on Microsoft’s OS support (from AMD’s filing), concluding that disruption in support could materially harm AMD. This mirrors the causal chain in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the downstream effect on independent software vendors (ISVs) avoiding optimization for AMD, which is a key mechanism in the original answer. While implied in 'materially harm sales,' the explicit linkage to ISV behavior is omitted, slightly reducing completeness in qualitative reasoning. However, the core dependency and business risk are clearly conveyed. Overall, the answer is highly accurate, well-grounded, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 427,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑ready network stack is built on high‑density routers, switches and high‑performance optics that give the bandwidth and low‑latency needed for training and inference, and it promotes multicloud consistency through a unified on‑prem‑to‑cloud management platform (see page 4).  Broadcom’s VMware Cloud Foundation, by contrast, delivers enterprise‑scale AI/ML workloads with native Kubernetes support and license portability that lets customers move workloads between on‑prem data centers and public clouds, providing a fully integrated multicloud architecture (see page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Cisco's use of high-density routers, switches, and high-performance optics for AI workloads is accurately described, as is Broadcom's VMware Cloud Foundation (VCF) enabling enterprise-scale AI/ML via native Kubernetes support and license portability. The emphasis on multicloud architecture and operational consistency across environments is correctly captured. (2) There are no numeric values, dates, or financial figures in either answer that require verification—thus, quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s network infrastructure role with Broadcom’s software-defined cloud foundation, comparing their complementary roles in enabling multicloud and Kubernetes-integrated AI workloads. (4) The only minor omission is that the LLM answer does not explicitly mention Broadcom’s valuation of VCF using the multi-period excess earnings method, which appears in the original answer and reflects strategic importance. However, this detail is more financial than functional and does not undermine the technical comparison central to the question. Wording differences (e.g., 'unified on-prem-to-cloud management platform' vs. 'policy and operational consistency') are semantically equivalent. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 405,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal’s derivatives are priced with models that rely on observable market inputs—currency rates, interest‑rate curves, option volatilities and equity prices—so all derivative fair‑value measurements are classified as Level 2 and the company reports no Level 3 items (PayPal 10‑K, pp. 93‑95).  In contrast, Morgan Stanley’s Level 3 instruments are defined by the use of significant unobservable inputs (e.g., credit‑spread assumptions, default and pre‑payment rates, model‑generated cash‑flow projections) and are applied when observable market data are insufficient or subject to judgment (Morgan Stanley 10‑K, pp. 96‑100).  Thus, PayPal’s fair‑value methodology relies almost entirely on observable inputs, whereas Morgan Stanley’s Level 3 valuations depend on substantial unobservable assumptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses Level 2 inputs and reports no Level 3 assets or liabilities, aligning with the original answer's claim that PayPal had no Level 3 items as of December 31, 2024 (implied in the context). The absence of Level 3 classification for PayPal is accurately conveyed. (2) For Morgan Stanley, the LLM correctly identifies that Level 3 valuations rely on significant unobservable inputs such as credit-spread assumptions, default and prepayment rates, and model-generated cash flows—details consistent with the ground truth’s emphasis on internally derived assumptions due to limited market liquidity. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (PayPal and Morgan Stanley), compares their fair value measurement approaches, and correctly contrasts reliance on observable vs. unobservable inputs. (4) All entities (PayPal, Morgan Stanley, Level 2, Level 3, derivatives, fair value) are accurately identified and contextualized. Minor differences in wording (e.g., 'pricing models' vs. 'fair-value methodology') do not affect meaning. Citations to 10-K pages are additional but plausible and do not detract from accuracy. No calculation errors; no missing key facts. Scores are maximized across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 380,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "META’s 343 million Class B shares (page 1) carry only limited voting rights on certain corporate actions, so even a sizable block of those shares gives holders little influence over board or amendment decisions. In contrast, Comcast’s 3.78 billion Class A shares (page 67) are the primary voting class, granting shareholders full voting power on all matters and a greater capacity to drive governance changes. Thus, the limited voting rights and smaller share count at META diminish shareholder‑driven governance potential relative to Comcast’s larger, fully voting Class A pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correctly represented: 343 million (rounded from 343,761,117) and 3.78 billion (rounded from 3,778,302,017) are acceptable approximations and commonly used in financial communication. No calculations were required, but the comparison in scale and voting power is correctly interpreted. (2) The entities are accurate—META and CMCSA (referred to as Comcast, which is acceptable as it's the common name), and the share classes (Class B for META, Class A for CMCSA) are correctly identified. (3) The reasoning is sound: the LLM correctly synthesizes that limited voting rights for META’s Class B shares restrict governance influence, while CMCSA’s Class A shares have full voting rights, enabling stronger shareholder-driven changes. The multi-hop logic—comparing ownership structure, voting rights, and governance implications across two companies—is well executed. (4) The only minor shortcoming is that the LLM does not explicitly name the specific corporate actions (e.g., exiting core payments business or certain mergers) where Class B votes apply, which is included in the ground truth and adds nuance. However, this omission does not undermine the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is perfect—the response directly addresses the comparative governance impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 402,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO’s non‑U.S. unit‑case volume is 71 % attributable to sparkling soft drinks (page 7).  In contrast, Procter & Gamble operates a manufacturing facility in Portugal (page 19), one of CCEP’s key markets, indicating its operational presence there.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 71% figure for KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories, which matches the ground truth. This satisfies the quantitative accuracy requirement. However, it incorrectly names 'Procter & Gamble' (PM) instead of 'Philip Morris International' (PM), which is a critical entity error. The operational presence in Portugal is correctly attributed to a manufacturing facility, but the LLM fails to mention that it produces over 30 billion units of cigarettes and heated tobacco, a key comparative point in the original answer. (2) The number '71%' is accurate and correctly cited. No calculations are required, so quantitative accuracy is fully met. (3) The multi-hop reasoning is partially sound: the model connects KO’s volume to CCEP’s territories and notes PM’s presence in Portugal. However, due to the incorrect identification of PM as Procter & Gamble, the cross-company comparison fails at the entity level, undermining the synthesis. The model also omits the scale of production (30B+ units), weakening the comparative insight. (4) Contextual relevance is high because the answer addresses both parts of the question and attempts the comparison, but the entity confusion and missing detail reduce qualitative accuracy. Correctness score is 7 because core facts (71%, Portugal presence) are correct, but major issues in entity identification and completeness of comparative detail prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 416,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s allowance for credit loss on loan receivables fell from $103 million in 2022 to $53 million in 2023, boosting net loan receivables by roughly $100 million (page 82). Because loan receivables include financing for technical‑support and advanced services, the lower provision signals improved credit quality and frees up capital, allowing Cisco to extend more financing or offer more favorable terms for those services. The reduced cushion does slightly increase exposure to potential defaults, so Cisco must continue to monitor credit risk closely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the reduction in credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth exactly. The claim that this boosts net loan receivables by roughly $100 million is a reasonable interpretation (the actual difference is $50 million, but the freed-up capital could be seen as cumulative or in context of balance sheet impact; however, 'roughly $100 million' is a stretch—likely referring to the reversal amount affecting income, but this is not clearly accurate). Despite this, no explicit calculation error is made in the core numbers. (2) All numeric values—$103 million, $53 million, and the years 2022 and 2023—are factually correct. The percentage decrease (48.5%) is not mentioned, but the absolute values are accurate and the direction and magnitude of change are correctly conveyed. (3) The multi-hop reasoning is sound: the model correctly identifies that loan receivables include financing for technical support services (per Cisco’s disclosures), links the reduced allowance to improved credit quality, and infers that this could free up capital to expand or improve financing terms for those services. It also appropriately notes the trade-off of increased exposure to defaults, adding a nuanced risk consideration not in the original but logically valid. (4) The answer is semantically equivalent to the ground truth in intent and factual core, with slightly more emphasis on risk management. The only minor issue is the 'boosting net loan receivables by roughly $100 million' statement, which may overstate the $50 million difference; however, it may reflect income statement impact of allowance reversal, which can be material. Given that the core facts, entities, and reasoning are correct, and the answer fully addresses the question’s multi-hop nature (Cisco’s allowance change → credit quality → impact on financing technical support), the correctness score is 9 due to this one imprecise quantitative implication, though all explicitly stated numbers are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 555,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares grant holders only a narrow voting privilege: they may vote solely on a limited set of merger‑related matters (e.g., when the preferred holders would receive shares or other securities that are not substantially identical to the preferred terms) and must cast votes equal to the number of shares held. Netflix’s common stock, by contrast, gives each share one vote on **all** matters to be voted on by the company. Consequently, AT&T’s preferred holders have a very restricted governance influence, whereas Netflix shareholders wield full voting power over every corporate decision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T’s Series B Preferred Stockholders have limited voting rights only on specific merger-related matters, with votes equal to the number of shares held; Netflix common stock provides one vote per share on all matters. There are no numerical values requiring calculation, but the qualitative metrics (e.g., 'limited set', 'one vote on all matters') are correctly represented. (2) The answer fully addresses the comparative corporate governance question, covering both companies’ voting structures and drawing a valid contrast. (3) Multi-hop reasoning is sound—correctly synthesizing governance models across two different companies and stock classes. (4) Minor deduction in qualitative accuracy due to slightly more detailed emphasis on merger conditions (e.g., 'securities not substantially identical') not explicitly in the original, though this detail is consistent with typical preferred stock provisions and does not contradict the ground truth. Overall, the answer conveys the same core comparison with high precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 325,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal’s 10‑K highlights that its Buy‑Now‑Pay‑Later and cryptocurrency offerings expose it to regulatory, compliance and operational risks that could disrupt its business if it fails to keep pace with evolving technology and oversight (page 20). In contrast, Visa treats BNPL and crypto platforms as both partners and competitors: it partners with fintechs through programs such as Fintech Fast Track while also positioning its own network to compete for transaction volume and to integrate emerging technologies like blockchain and real‑time payments (pages 14‑16, 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with strong support from specific page references in the 10-K filings. It correctly identifies PayPal's exposure to risks from BNPL and cryptocurrency (page 20), aligning with the original answer's emphasis on technological disruption. It also accurately characterizes Visa's dual role as both partner and competitor, citing partnership programs like Fintech Fast Track and integration of blockchain and real-time payments (pages 14–16, 18), which reflects Visa’s strategic positioning as described in the ground truth. There are no numeric values to verify, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced (9) because the LLM answer does not explicitly state that PayPal 'must invest heavily' or 'risks losing market share'—a minor omission in emphasis, though the risk of disruption is clearly implied. The multi-hop reasoning is sound: it synthesizes information across PayPal and Visa, comparing their strategic responses to emerging payment technologies. Contextual relevance is perfect, directly addressing the comparative strategic positioning asked in the question. Wording differs slightly but meaning is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 348,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s common stock is entitled to **one vote per share** (see NFLX 10‑K, p. 61). Alphabet’s Class A common stock likewise carries **one vote per share** (see GOOGL 10‑K, p. 81). Thus, the voting power per share is identical for both companies.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Netflix's common stock and Alphabet's Class A Common Stock both provide one vote per share, matching the original answer. (2) There are no numerical values requiring calculation, but the cited voting rights (one vote per share for both) are factually correct and consistent with the 2023 10-K filings referenced in the ground truth. Format variations (e.g., page numbers cited) do not affect accuracy. (3) The multi-hop reasoning—comparing voting rights across two companies using their respective 10-K disclosures—is sound and correctly synthesized. The answer draws the correct conclusion that voting power per share is identical. (4) All entities (Netflix, Alphabet, Class A Common Stock) are correctly identified, and the response directly addresses the comparative aspect of the question. No relevant context is missing, and the inclusion of document page references adds precision without altering the factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 296,
        "total_tokens": 1479
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "PM’s 2023 VAR model uses the parametric delta‑gamma technique under normal market conditions (95 % confidence, one‑day horizon) to estimate the fair‑value impact of interest‑rate and foreign‑currency exposures only – $77 m and $297 m at 12/31/23, with average, high and low figures of $74 m/$332 m, $82 m/$505 m and $66 m/$219 m, respectively.  \nMDLZ applies the same technique but to a broader set of instruments, calculating both fair‑value and pre‑tax‑earnings impacts for interest rates, foreign‑currency rates and commodity prices; its 12/31/23 figures are $119 m (interest), $144 m (currency) and $234 m (commodity) in fair‑value impact, plus $119 m, $14 m and $21 m in earnings impact, with average, high and low ranges.  \nBoth models assume normal market conditions, a 95 % confidence level, and a one‑day holding period, but MDLZ explicitly incorporates currency and commodity options valuations and a wider exposure set (including commodities and equity‑sensitive instruments) whereas PM’s model focuses solely on interest‑rate and currency risks and excludes favorable market moves.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. (1) The Original Answer (ground truth) does not provide any specific VAR figures for PM or MDLZ—especially not the detailed dollar amounts like $77M, $297M, $119M, etc., nor average/high/low ranges. The ground truth explicitly states that PM does *not* disclose a specific VAR figure, while MDLZ does disclose VAR amounts at year-end but the exact numbers are not specified in the provided truth. Thus, the LLM fabricates precise financial figures and ranges not present in the source. (2) The claim that PM reported VAR impacts of $77M (interest) and $297M (currency) is unsupported; the ground truth only confirms PM uses the method and focuses on interest and currency, but discloses no numbers. Similarly, MDLZ’s VAR disclosures are acknowledged, but no specific values are given in the truth—so the $119M, $144M, $234M, etc., are incorrect. (3) The LLM incorrectly states that PM’s 2023 model has specific disclosed VAR values, when the truth emphasizes PM’s focus on methodology *without* disclosing a figure. (4) While the LLM correctly identifies that both companies use the parametric delta-gamma method under normal conditions, 95% confidence, one-day horizon, and that MDLZ includes commodities and options while PM does not, this qualitative alignment is undermined by the false precision in numbers. (5) The multi-hop reasoning is partially sound—correctly contrasting PM’s narrower focus (interest and currency) with MDLZ’s broader scope (including commodities and earnings impact)—but the inclusion of non-existent figures severely compromises factual correctness. (6) The mention of 'equity-sensitive instruments' for MDLZ is not supported in the ground truth. Overall, while the structural comparison is relevant and contextually appropriate, the invention of specific financial data results in a low correctness score despite some accurate conceptual points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 529,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the U.S. “Market Risk Rule” because its aggregate trading assets and liabilities equal at least 10 % of total assets or $1 billion, so the rule requires it to adjust its risk‑based capital ratios for trading‑book risk (see page 86).  JPMorgan Chase, by contrast, calculates its Basel III capital using a single VaR framework that applies to all “covered” positions: a 12‑month historical‑simulation model with a one‑day holding period at 95 % confidence for risk‑management VaR and a ten‑business‑day, 99 % confidence regulatory VaR (pages 145‑147), which excludes diversification benefit for certain models and credit‑derivative hedges.  Thus, while both banks use VaR for regulatory capital, Capital One’s exposure is triggered by a specific trading‑asset threshold and the rule directly adjusts capital ratios for its trading book, whereas JPMorgan’s VaR is embedded in its overall Basel III capital calculation without a separate threshold.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Capital One is subject to the Market Risk Rule due to trading assets/liabilities exceeding $1 billion or 10% of total assets, and that this affects its risk-based capital ratios—this aligns with the ground truth. It also correctly states JPMorgan Chase’s use of a 99% confidence level and ten-business-day holding period for regulatory VaR under Basel III. However, the LLM introduces a 'one-day holding period at 95% confidence for risk-management VaR' for JPM, which is not mentioned in the original answer and adds unverified detail. More critically, it incorrectly implies JPM uses a '12-month historical-simulation model'—this specific time window is not in the ground truth and may be a misinterpretation of filing content. (2) Quantitative accuracy is partially compromised: while the 99% confidence and 10-day holding period for JPM’s regulatory VaR are correct, the 95% confidence and one-day holding period for risk-management VaR, though plausible, are not present in the original answer and represent extraneous, unverified data. The $1 billion and 10% thresholds for COF are correctly stated. (3) The multi-hop reasoning is generally sound—comparing COF’s threshold-based Market Risk Rule exposure with JPM’s internal VaR model under Basel III captures the core contrast. However, the LLM omits key information from the ground truth: that COF is subject to both standardized and proposed Expanded Risk-Based Approaches under Basel III, with the latter phasing in by 2028. This is a significant omission in the Basel III comparison. (4) Contextual relevance is high—the answer addresses the regulatory frameworks, VaR methodologies, and thresholds as asked. The qualitative reasoning is strong but lacks full completeness on COF’s Basel III treatment. The correctness score is 7 due to accurate core facts but notable omissions and introduction of unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 523,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco’s 10‑K discloses a $50 million allowance for credit loss on its loan receivables, which “represent financing arrangements related to the sale of our hardware, software, and services (including technical support and advanced services)”【page_82】.  By contrast, Salesforce notes that implementation and support services “may be performed by us, our customers, a third party, or a combination thereof” and that it “relies on third‑party developers and providers” for applications and integrations, exposing it to service‑delivery risk but without a quantified credit‑loss allowance【page_19】【page_20】.  Thus Cisco’s exposure is measured in a specific allowance, while Salesforce’s exposure is more qualitative, tied to the reliability of external partners.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cisco's credit loss allowance as $50 million, which is close to the ground truth value of $53 million as of July 29, 2023. The $3 million discrepancy, while minor, affects quantitative accuracy. The LLM does not specify the exact date (fiscal year-end), but references the correct context—financing arrangements including technical support services. For Salesforce, the answer correctly notes reliance on third-party providers and the qualitative nature of its risk, with no quantified allowance, aligning with the original answer. (2) The dollar amount for Cisco is slightly inaccurate—$50M vs $53M—though the source citation (page_82) may reflect rounding or a different reporting line. This is a factual deviation that impacts the quantitative score. All other non-numeric elements (e.g., nature of financing, third-party reliance) are accurate. (3) The multi-hop reasoning is sound: the model correctly contrasts Cisco’s direct financial risk (via credit loss allowance on service-related financing) with Salesforce’s operational risk (via third-party service delivery), synthesizing information across both companies’ 10-Ks. The logic and comparison structure mirror the ground truth. (4) Despite the small numerical inaccuracy, the answer captures the core contrast in risk exposure types—quantitative vs qualitative—and remains contextually precise and relevant. Hence, correctness is high but not perfect due to the dollar figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 409,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in its Class B shares, giving the controlling shareholder (Zuckerberg) the ability to override other shareholders and potentially eroding investor confidence in its Class A stock (see Meta’s risk disclosure on Class A ownership and controlled‑company status in pages 48–50). In contrast, Comcast’s filing shows a Class B common‑stock class but does not describe any conversion mechanism or governance‑linked voting‑power shift, so the governance risk is not tied to a conversion feature (see pages 70–71).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between META's and CMCSA's equity structures. (1) It correctly identifies that META’s dual-class structure gives disproportionate voting control to Class B shareholders (e.g., Zuckerberg), which impacts investor confidence in Class A shares, and references the 'controlled company' status as a risk factor—this aligns with the ground truth. It also correctly states that CMCSA has Class B shares but lacks a conversion mechanism tied to governance restrictions. (2) There are no numeric inaccuracies; the LLM avoids stating specific share counts (e.g., 9,444,375 for CMCSA) but does not fabricate or misstate any figures, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: it synthesizes governance implications across two companies and correctly contrasts the presence (in META) versus absence (in CMCSA) of governance-linked conversion mechanisms. However, it omits the specific detail that META requires a majority of Class B approval for change of control until those shares fall below 35% of voting power, which is a key element of the governance risk described in the ground truth. (4) The answer is contextually relevant and directly addresses the question’s focus on governance risk and investor confidence. While semantically close to the original answer, the omission of the 35% threshold and the specific impact on Class A stock attractiveness slightly reduces completeness and qualitative accuracy, warranting a score of 8 rather than 9–10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 423,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG’s RMBS are valued with discounted‑cash‑flow models that explicitly rely on unobservable inputs—constant pre‑payment rate, loss severity, constant default rate and yield—each given a weighted‑average range (e.g., 4.10‑9.26% for pre‑payment, 40.81‑76.72% for loss severity, 0.82‑2.64% for default rate, 6.18‑7.42% for yield)【page_120】【page_121】. In contrast, MS’s fair‑value estimation also uses discounted‑cash‑flow for some Level‑3 assets, but the 10‑K only notes that Level‑3 requires significant unobservable inputs and the greatest use of judgment, without providing specific ranges or quantifying those inputs【page_42】. Thus, AIG’s approach is more detailed and explicitly quantifies the unobservable assumptions, whereas MS acknowledges reliance on unobservable inputs but does not detail them in the excerpts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All quantitative values are correct: AIG's unobservable inputs—constant prepayment rate (4.10%–9.26%), loss severity (40.81%–76.72%)—match the original answer exactly. The LLM adds additional inputs (constant default rate: 0.82%–2.64%, yield: 6.18%–7.42%) not in the ground truth, but these are factually present in AIG’s disclosures and do not contradict the original answer; they enhance detail without error. (2) The comparison to MS is accurate: MS uses discounted cash flow for Level 3 assets relying on unobservable inputs, and Level 3 assets were 0.9% of total assets as of December 31, 2024—this fact is omitted in the LLM answer, which is a minor completeness gap. However, the LLM correctly notes that MS does not disclose specific ranges for unobservable inputs, which is consistent with the original answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes AIG’s detailed DCF usage with MS’s more general acknowledgment of unobservable inputs, drawing a valid qualitative contrast. (4) The answer is contextually relevant and semantically equivalent to the ground truth, with slightly more granularity on AIG’s inputs and slightly less on MS’s quantitative footprint (Level 3 = 0.9%). This trade-off justifies a 9/10 on correctness—very close to perfect, but missing one key statistic from MS that would strengthen completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 395,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables tied to hardware financing fell from $53 million in 2023 to $50 million in 2024, indicating a modest improvement in the credit risk of its financing of integrated hardware‑software sales. Microsoft, by contrast, treats hardware that is interdependent with software as a single performance obligation and recognizes revenue at the point of transfer, thereby avoiding deferred‑revenue risk but still tying revenue to the bundled sale. The comparison shows Cisco’s integrated offerings expose it mainly to credit‑risk exposure from customer financing, whereas Microsoft’s approach mitigates revenue‑recognition risk while still reflecting the integrated nature of its hardware‑software bundles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. The ground truth states Cisco's allowance decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023. The LLM incorrectly reports a decrease from $53 million in 2023 to $50 million in 2024, which misrepresents both the baseline value and the time frame. These figures are not supported by the original data and reflect a failure in quantitative accuracy. (2) The fiscal years referenced (2023 to 2024) do not align with the ground truth (2022 to 2023), and the values themselves are incorrect—Cisco’s allowance dropped by $50 million over the correct period, not $3 million. No such data for 2024 is present in the original answer, making this a factual fabrication. (3) While the LLM captures the general contrast in financial exposure—Cisco facing credit risk via financing and Microsoft recognizing revenue at point of sale with less credit risk—the reasoning is based on incorrect data. The multi-hop synthesis between Cisco’s credit loss allowance and Microsoft’s revenue recognition is conceptually appropriate and contextually relevant, but the flawed inputs undermine the validity of the comparison. (4) The qualitative reasoning about performance obligations and integrated offerings is plausible and aligns with accounting principles, earning moderate qualitative accuracy. Contextual relevance is high because the answer addresses the core theme of financial exposure in integrated hardware-software models. However, due to major quantitative errors and incorrect entity-time pairings, the overall correctness is significantly reduced to a score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 460,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG’s 2024 Form 10‑K reports a $75 million loss on embedded derivatives (page 144).  In contrast, Morgan Stanley’s 2024 Form 10‑K lists $2.131 billion in “Other Credit Contracts” that include CLNs and CDOs—hybrid instruments with embedded derivatives (page 107, clarified on page 109).  Thus, MS’s exposure through CDOs is roughly 28 times larger than AIG’s embedded‑derivative loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AIG's $75 million loss from embedded derivatives in 2024, which matches the ground truth. However, it introduces a new figure—$2.131 billion in 'Other Credit Contracts' for Morgan Stanley—that is not present in the original answer and is not directly comparable to AIG’s realized loss. The original answer does not provide a quantitative exposure amount for MS, only a qualitative description of risk. Thus, the LLM fabricates a comparison by citing a specific dollar value and calculating a 28x ratio (2.131B / 75M ≈ 28.4), which is unsupported by the ground truth. (2) While the numbers cited by the LLM may exist in MS’s 10-K, they are not validated in the ground truth knowledge graph, making the quantitative comparison speculative and factually unverifiable in this context. The calculation itself is mathematically correct but based on non-equivalent metrics: AIG’s figure is a realized loss, while MS’s is a notional exposure or position size—these are fundamentally different financial concepts. (3) The multi-hop reasoning is partially sound in linking both firms to hybrid instruments with embedded derivatives and credit risk, but it fails to align with the ground truth’s focus on parallel risk structures and potential principal loss. Instead, it shifts to a numerical comparison that the original data does not support. (4) The contextual relevance is high because the answer addresses structured credit products, embedded derivatives, and both firms’ exposures. However, the correctness score is low due to the introduction of unsupported quantitative data and a misleading comparison, which distort the factual basis of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 462,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s forecasted‑transaction cash‑flow hedges are set for periods “generally not to exceed four years” (using option and forward contracts)【page_121】, whereas Google’s option‑based cash‑flow hedges for forecasted revenue are limited to “maturities of 24 months or less”【page_70】. Thus, Disney’s hedges cover a longer time horizon than Google’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Disney's foreign exchange cash flow hedges for forecasted transactions extend up to four years, while Google's are limited to 24 months or less, which matches the ground truth. Both companies' use of option contracts is accurately noted. The dollar amounts ($9.9 billion for Disney and $731 million for Google) are not included in the LLM answer, representing a minor omission, but the core comparison of hedge durations is fully accurate. (2) All numeric values related to time horizons (four years, 24 months) are correct and properly attributed. No calculations were required, and the comparison is logically sound. Format variations are not an issue here. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across two companies (Disney and Google), identifying their respective hedge durations and instrument types (option contracts), and draws the correct conclusion that Disney’s hedges cover a longer time horizon. The only missing detail is the specific hedge values as of the reported dates, which adds context but does not alter the primary comparison about duration. (4) The answer is highly relevant to the question, focusing precisely on the duration comparison and hedging instruments. The omission of the exact hedge values slightly reduces completeness but does not affect the main factual correctness. Thus, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 426,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "QCOM’s 2023 Form 10‑K (p. 44) states that the OECD’s Pillar Two global minimum tax is not expected to materially affect its 2025 tax liabilities, because most of its income is taxed in the U.S. and it has limited exposure to jurisdictions with rates below the 15 % threshold. In contrast, the Intel 2023 10‑K pages 42‑46 do not provide a specific estimate of the Pillar Two impact, but Intel’s operations are spread across many countries, suggesting a potentially larger exposure relative to QCOM.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitative accuracy: All percentages (15%) and fiscal years (2025) are correct. No numerical calculations were required, but the threshold and timing are accurately cited. (2) Completeness: The LLM addresses both QCOM’s and INTC’s exposure to Pillar Two, noting QCOM’s minimal expected impact due to U.S.-centric income and limited presence in low-tax jurisdictions, and INTC’s broader international footprint implying higher exposure. While the LLM does not explicitly mention that INTC is 'still evaluating' or that the EU plans adoption in 2024, it correctly infers greater uncertainty for INTC due to operational spread—capturing the core contrast. (3) Entity accuracy: Both companies (QCOM, INTC), the OECD Pillar Two rules, the 15% threshold, and fiscal year 2025 are correctly identified. The citations to the 2023 10-K pages are plausible and contextually appropriate. (4) Reasoning: The multi-hop synthesis is sound—linking geographic tax exposure to differential Pillar Two impact across firms. The LLM correctly infers that broader international operations imply higher risk under Pillar Two, even without a direct quote from Intel quantifying the impact. (5) Semantic equivalence: The LLM conveys the same essential conclusion—QCOM expects minimal impact, INTC faces more exposure—though slightly less detail on INTC’s ongoing evaluation and EU adoption timeline. This minor omission does not undermine the overall correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 442,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class scheme gives each Class B share 10 votes and lets holders convert them into Class A shares at any time; the conversion does not dilute the voting power of Class B holders, but it can reduce the founder’s relative weight if they convert.  Comcast’s Class B shares carry 15 votes and are capped at 33 ⅓ % of total voting power, a percentage that cannot be diluted by new issuances, giving the founder a more fixed and robust control over governance decisions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness. (1) It incorrectly states that Comcast's Class B shares carry '15 votes'—the ground truth does not specify a per-share vote count but instead emphasizes that Class B holds a fixed 33⅓% of total voting power, which is non-dilutable. This is a critical error in quantitative accuracy. (2) The claim that Alphabet’s Class B shares can be converted 'at any time' by holders is misleading; the ground truth specifies that conversion happens automatically upon sale or transfer, not at the holder’s discretion. (3) The LLM implies that conversion reduces founder control only if founders convert, but the real mechanism is tied to transfer/sale, which triggers mandatory conversion—this misrepresents the dynamic of founder control. (4) While the LLM correctly contrasts Alphabet’s potentially diminishing control with Comcast’s insulated control, it misattributes the mechanism: Comcast’s 33⅓% cap is structural and non-dilutable, not due to a 15-vote share, which is unsupported by the original answer. (5) The qualitative reasoning about relative control strength is partially sound—Comcast does offer more durable control—but the justification relies on incorrect metrics. Contextual relevance is high as the response addresses the core comparison of founder control. However, due to key numerical and mechanistic errors, the correctness and quantitative accuracy scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 407,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement obligates PMI to indemnify Altria (and PM USA) for liabilities tied to PMI‑manufactured or contract‑manufactured products, and Altria records no related liability on its balance sheet because the fair value is insignificant【MO_10k_2022 page 107】【MO_10k_2022 page 109】. In contrast, PMI’s deconsolidation of RBH removed RBH’s assets and liabilities from PMI’s consolidated statements, but PMI still retains the tobacco‑litigation obligations as an indemnitee; these are disclosed as contingent liabilities rather than consolidated【PM_10k_2022 page 113】【PM_10k_2022 page 114】. Thus, Altria’s direct financial exposure to tobacco‑related litigation is effectively limited by the indemnification, whereas PMI’s exposure remains but is not reflected in its consolidated financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the indemnification structure between PMI and Altria/PM USA, correctly stating that PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured or contract-manufactured products and that Altria does not record a liability due to insignificant fair value. These points align with the ground truth and are supported by correct citations (MO_10k_2022 pages 107, 109). The quantitative accuracy is perfect—no numerical or date inaccuracies are present. However, the LLM misattributes the retained obligations to PMI rather than PM (Philip Morris USA) in the context of RBH deconsolidation. The original answer clarifies that PM (not PMI) retains obligations tied to the deconsolidation of RBH, involving reclassifications from accumulated other comprehensive losses. The LLM incorrectly shifts the focus to PMI’s retained litigation obligations post-RBH deconsolidation, citing PM_10k_2022 pages 113–114, but this misrepresents the entity responsible (PM vs. PMI) and conflates PMI’s contingent liabilities with PM’s retained RBH-related accounting impacts. This is a significant qualitative error in entity accuracy and reasoning, as it fails to correctly synthesize the multi-hop relationship between Altria, PM USA, and PMI regarding RBH. Despite this, the core contrast—Altria’s limited exposure via indemnification versus ongoing impacts from RBH—is partially conveyed, and the answer remains contextually relevant. Thus, the correctness and qualitative accuracy scores are reduced, but not severely, due to strong performance on the indemnification aspect and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 451,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan receivables finance its hardware, software, and technical‑support services (see Note 9, page 82).  The allowance for credit losses on those receivables fell from $103 million in 2022 to $53 million in 2023 (page 84), indicating better credit quality and a lower reserve requirement, which frees up capital and reduces the cost of financing support services.  Adobe, by contrast, funds its technical‑support offerings through subscription and maintenance fees that are built into its SaaS and perpetual‑license revenue streams (Technical Support section, page 17), relying on recurring revenue rather than financing receivables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the allowance for credit losses decreased from $103 million in 2022 to $53 million in 2023, and these values match the original answer exactly. No calculations were required beyond stating the decline, which is accurately represented. (2) The LLM correctly identifies Cisco's financing model for technical support via loan receivables and links the decline in allowance to improved credit quality and reduced financing costs, which is a sound interpretation of the impact. It also accurately contrasts this with Adobe’s funding model through subscription and maintenance fees embedded in SaaS and perpetual licenses. (3) The multi-hop reasoning is solid: it synthesizes Cisco's financial data with its service financing approach and compares it to Adobe’s distinct, non-receivables-based model. (4) Minor deduction in qualitative accuracy due to slightly less detail than the original—e.g., not specifying the 1- to 3-year terms of Adobe’s programs or explicitly naming 'annual fee-based maintenance programs'—but the core meaning and comparison remain intact. Wording differences do not affect semantic equivalence. Contextual relevance is perfect as all parts of the question are addressed with precise, on-topic information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 373,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. is named the administrative agent in both agreements.  Boeing’s 2019 Five‑Year Credit Agreement (Exhibit 10.2, page 126) also names JPMorgan Chase Bank, N.A. as the syndication agent and joint lead arranger, and it was amended in August 2022 (Exhibit 10.3, page 126).  Caterpillar’s 2022 Five‑Year Credit Facility lists Citibank as the administrative agent but the 2023 filing does not disclose a syndication agent or any amendment, implying a simpler syndication structure and no amendment to date.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A. as administrative agent in both agreements and correctly notes the August 2022 amendment for Boeing. However, it incorrectly states that Caterpillar's 2023 filing does not disclose an amendment, when in fact Amendment No. 1 to Caterpillar's 5-Year Facility was dated August 31, 2023 — a key factual error. The LLM also fails to mention the specific amendment date for Caterpillar, which is central to the comparison of amendment timelines. (2) Quantitatively, the Boeing amendment date (August 2022) is correct, but the Caterpillar amendment is omitted despite being available in the ground truth (August 31, 2023). The original agreement dates (2019 for Boeing, 2022 for Caterpillar) are implied but not explicitly stated. The LLM incorrectly implies no amendment has occurred for Caterpillar, which contradicts the ground truth. (3) The reasoning is partially sound in comparing syndication structures — correctly identifying JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger for Boeing. However, it incorrectly infers that Caterpillar lacks a syndication agent or amendment due to non-disclosure, when the ground truth confirms MUFG Bank, Ltd. as a co-agent and an amendment in 2023. This reflects flawed multi-hop reasoning — the model assumes absence of evidence is evidence of absence. (4) Contextual relevance is high as the response addresses both amendment timelines and syndication structure as asked. However, due to significant factual inaccuracies in amendment status and incomplete syndication details, the overall correctness is compromised. The answer is partially correct but contains critical omissions and misinterpretations that affect the validity of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 480,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "Both NVIDIA and Qualcomm rely on Taiwanese foundries to manufacture their chips. A prolonged conflict involving Taiwan could halt or slow those foundries, leading to shortages, longer lead‑times and higher costs for both companies and materially weakening their supply‑chain reliability【NVDA page 19】【QCOM page 34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with high accuracy in both quantitative and qualitative aspects. (1) There are no numeric values in the question or answers that require verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable—no numbers were misstated. (2) The answer addresses all key parts of the question: it identifies both NVIDIA and Qualcomm, their shared dependency on Taiwanese foundries, and the potential impact of a prolonged geopolitical conflict on supply chain reliability. It correctly notes risks such as production halts, shortages, longer lead times, and higher costs. (3) The multi-hop reasoning is sound—synthesizing information about both companies’ reliance on the same regional manufacturing base and inferring common supply chain vulnerabilities. The citations ['NVDA page 19', 'QCOM page 34'] suggest proper grounding in source documents. (4) While the LLM answer is slightly less detailed than the original (e.g., it does not mention NVIDIA’s demand estimation challenges or Qualcomm’s direct dependency on consistent chipset supply), it captures the core risks accurately and concisely. The omission of minor contextual details does not undermine the factual correctness or relevance. Therefore, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 399,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s indemnification exposure is tied to the U.S. government contracts it supplies: the company may receive indemnification from the government for product‑related claims, but its insurance coverage is often inadequate and it faces ongoing litigation and investigations that could trigger liability under the SAFETY Act and other provisions. 3M’s indemnification liabilities that were transferred to Solventum are defined by the spin‑off agreement; Solventum assumes PFAS‑related and other litigation liabilities and agrees to indemnify and defend 3M, with the legal proceedings focused on respirator‑mask/asbestos claims and PFAS litigation. Thus, Boeing’s risk hinges on potential government indemnification amid uncertain insurance and active lawsuits, whereas 3M’s risk is transferred to Solventum through explicit indemnification and defense obligations under the separation agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains key factual inaccuracies and misalignments with the ground truth, particularly regarding the nature of 3M's transferred liabilities and Boeing's indemnification framework. (1) Correct elements: The answer correctly identifies that 3M transferred indemnification liabilities to Solventum via the spin-off and that Solventum assumes defense and indemnification obligations. It also correctly notes Boeing’s exposure to U.S. government contracts and litigation risks. There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised. (2) However, the LLM incorrectly specifies the transferred litigation: it claims Solventum assumed 'PFAS-related and respirator-mask/asbestos claims,' while the ground truth specifies 'Bair Hugger and Federal False Claims Act litigation'—a significant discrepancy in legal proceedings. PFAS and asbestos are not mentioned in the original answer and represent different liability profiles. (3) Regarding Boeing, the LLM introduces the SAFETY Act and government indemnification as a potential source of protection, which is not mentioned in the ground truth; instead, the original emphasizes pension cost allocations under CAS (Cost Accounting Standards) affecting contract profitability—a central point entirely missing from the LLM response. This reflects a failure in multi-hop reasoning: the model conflates general product liability indemnification with the specific CAS-related financial risk disclosed by Boeing. (4) While the structure and intent of comparing risk transfer (3M) vs. retained risk (Boeing) is contextually relevant and logically framed, the substitution of key legal proceedings and mischaracterization of Boeing’s risk mechanism reduce factual accuracy. Thus, the correctness score is 6: partially correct with significant omissions and factual errors in entity and reasoning accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 520,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s Class B shares, all owned by Brian L. Roberts, carry 15 votes each and account for about one‑third of the company’s voting power (pages 33‑35), giving Roberts a concentrated, non‑dilutable influence over board and corporate decisions. This concentration illustrates the governance risk that a single shareholder can dominate a dual‑class structure, a risk that META faces as a controlled company: its dual‑class structure gives Zuckerberg and other Class B holders (10 votes per share) majority voting power, limiting Class A shareholders’ ability to influence governance and increasing the risk of management entrenchment and reduced accountability (pages 49‑51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: CMCSA's Class B shares are entirely owned by Brian L. Roberts, carry 15 votes per share, and represent approximately one-third (33⅓%) of voting power—'about one-third' is semantically equivalent. META's Class B shares carry 10 votes each (correctly stated), and the dual-class structure gives Zuckerberg and other Class B holders majority control, limiting Class A shareholder influence. The reference to governance risks like management entrenchment and reduced accountability aligns with the original answer and META’s 10-K disclosures. (2) Quantitatively, all numbers are accurate: 15 votes for CMCSA Class B, 10 votes for META Class B, and the one-third voting power are all correct. No calculations were required, but the synthesis of voting power concentration is sound. (3) The multi-hop reasoning is strong: the model correctly draws a parallel between CMCSA’s concentrated voting structure and META’s controlled company status, using CMCSA as an illustrative example of governance risk in dual-class systems. It correctly infers that such structures increase risks for Class A shareholders, even though the companies are unrelated. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% threshold for Class B voting power in META, beyond which control could change—a detail included in the original answer. However, this omission does not undermine the overall correctness, as the core governance risks are accurately described. Wording differences (e.g., 'non-dilutable influence', 'management entrenchment') are acceptable and add clarity without distorting meaning. The answer is contextually relevant, directly addressing how CMCSA’s structure exemplifies the kind of governance risk present in META’s structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 507,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s beverage distribution in northern Argentina is handled by its bottler Arca Continental (S.A.B. de C.V.), so the company’s sales, costs and margins in that region are largely tied to that bottler’s performance【page_7】.  Procter & Gamble lists Argentina as one of the markets where currency swings have materially affected its sales, costs and earnings, exposing it to significant foreign‑exchange risk【page_23】.  Thus, while both firms operate in Argentina and face the same peso volatility, Coca‑Cola’s exposure is mediated through its bottling partner, whereas P&G’s exposure is a direct foreign‑exchange effect on its financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Coca-Cola relies on Arca Continental for distribution in northern Argentina, and this creates indirect exposure to macroeconomic risks; Procter & Gamble has direct foreign exchange risk due to its operations in Argentina. The LLM correctly identifies that P&G explicitly cites currency volatility in Argentina affecting its sales, costs, and earnings. (2) There are no numeric values in the original or LLM answer that conflict—both avoid specific percentages or dollar figures beyond what’s supported (e.g., no claim about the size of Arca’s contribution to Coca-Cola’s 17% global volume, which the original mentions but the LLM omits). This omission is minor and does not affect correctness, as the LLM still captures the mediated nature of Coca-Cola’s exposure. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face Argentine peso volatility, but through different mechanisms—indirect via a bottling partner (Coca-Cola) vs. direct operational exposure (P&G). (4) Semantic equivalence is strong; the LLM uses different phrasing (e.g., 'currency swings', 'mediated through its bottling partner') but preserves the meaning. The only reason for not scoring a 10 is the slight lack of completeness regarding the 17% global unit case volume context, which adds depth to Coca-Cola’s dependency but isn’t essential to answering the intersection of risks. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 436,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Alimta’s patent expiration will likely trigger a rapid, severe decline in Lilly’s oncology revenue because generic competition is quickly enabled under the Hatch‑Waxman Act (LLY p. 25). In contrast, Amgen’s biologics are shielded by the BPCIA’s 12‑year exclusivity and a more complex biosimilar approval pathway, so the erosion of revenue may be slower, although patent litigation and eventual biosimilar entry still pose significant risks (AMGN p. 45‑48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Alimta's patent expiration will lead to a rapid and severe decline in Eli Lilly's oncology revenue due to generic competition enabled by the Hatch-Waxman Act, which governs small molecule drugs—this matches the original answer's emphasis on immediate revenue erosion for small molecules. (2) The LLM correctly contrasts this with Amgen's situation, noting that biologics are protected by the BPCIA's 12-year exclusivity and face a more complex biosimilar approval pathway, resulting in slower revenue erosion. This reflects the original answer's point about regulatory differences (BPCIA vs. Hatch-Waxman) and manufacturing/regulatory hurdles for biosimilars. (3) The LLM references specific page numbers (LLY p.25; AMGN pp.45–48), suggesting proper sourcing, though these are not verifiable here. (4) The answer captures the core multi-hop reasoning: comparing two companies, their drug types (small molecule vs. biologic), regulatory frameworks, and resulting risk profiles. The only minor shortcoming is that it does not explicitly mention 'umbrella exclusivity' or Amgen’s specific exposure to material adverse effects from biosimilars as stated in the original, which slightly reduces completeness in qualitative nuance. However, the key concepts—slower erosion due to complexity, ongoing patent litigation, and eventual biosimilar risk—are present. All entities (Alimta, Eli Lilly, Amgen, Hatch-Waxman, BPCIA) are correct. No numerical inaccuracies; the 12-year exclusivity is correctly cited. Semantic equivalence is strong, with slightly more regulatory detail than the original. Thus, the answer is excellent but not perfect—hence 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 484,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel’s non‑US tax benefits rose in 2023 because a higher proportion of its income was taxed abroad, yet the company expects the OECD Pillar Two rules to have no material impact on its global tax costs because it has no material operations in jurisdictions below the 15 % minimum (page 44). Microsoft’s 10‑K pages (28‑32) do not disclose its exposure to the global minimum tax, so a direct comparison is not available, though its broader international footprint could imply a greater potential impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Intel expects 'no material impact' from Pillar Two due to having 'no material operations in jurisdictions below the 15% minimum,' but the ground truth states Intel is actively evaluating the impact and does not assert a conclusion of no material effect. This misrepresents Intel's position. Conversely, the ground truth indicates Microsoft does not expect a material increase in tax costs due to limited operations in low-rate jurisdictions—information the LLM incorrectly attributes to Intel. The LLM also incorrectly states that Microsoft's 10-K 'does not disclose' exposure to the global minimum tax, which contradicts the ground truth that Microsoft acknowledges it as part of its regulatory exposure. (2) Quantitatively, the 15% minimum rate is correctly cited, and the 2024 effective date is omitted in the LLM answer but not falsely stated—however, the LLM fabricates a 'page 44' reference for Intel and cites specific pages for Microsoft without matching the ground truth sourcing, undermining reliability. (3) The multi-hop reasoning is flawed: the LLM reverses the exposure assessments between Intel and Microsoft. It incorrectly suggests Intel has limited exposure (like Microsoft in the ground truth) while implying Microsoft's position is unknown—when the ground truth clearly contrasts Intel's ongoing evaluation with Microsoft's stated low exposure. This failure to correctly attribute and synthesize the companies' positions undermines the comparison. (4) Despite the incorrect reasoning and entity misattribution, the answer remains contextually relevant by addressing the OECD Pillar Two impact on both firms and attempting a comparison based on international footprint. However, the reversal of key facts results in a substantively incorrect conclusion, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 511,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets to general assets removes that portion of the pension portfolio that had been invested in limited‑partnership vehicles, thereby reducing KO’s exposure to such entities【page_43】.  By contrast, PEP’s pension strategy continues to include private‑equity and private‑credit funds—structures that are typically organized as limited partnerships—so its exposure to limited‑partnership investments remains unchanged【page_100】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $523 million amount and the year 2024 are accurately reported, with no calculation errors. (2) The answer correctly identifies the entities involved—KO and PEP—and their respective pension investment strategies. It correctly states that KO reduced exposure to limited partnerships by transferring surplus pension assets to general assets, implying divestment from alternative investment vehicles like limited partnerships. (3) The reasoning is sound: the LLM infers that removing pension assets previously invested in limited-partnership vehicles reduces KO’s exposure, which is consistent with the ground truth’s logic. It also correctly contrasts this with PEP’s ongoing use of private equity and private credit funds, typically structured as limited partnerships, citing its 2024 10-K (page 100). (4) The only minor shortcoming is that the LLM does not explicitly mention that PEP’s investments are valued at net asset value or directly reference the diversified pension fund strategy, which adds slight contextual depth in the original answer. However, this omission does not affect the core factual accuracy. The answer is semantically equivalent and contextually appropriate, demonstrating strong multi-hop reasoning across KO’s asset transfer and PEP’s continued strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 388,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 was largely driven by higher revenues, which are underpinned by products still protected by patents and regulatory exclusivity (see PFE page 36). The company notes that patent expirations will erode revenue in coming years, a risk that Lilly mitigates by relying on 12‑year U.S. biologic data protection to extend exclusivity beyond the life of its patents and safeguard revenue after patent expiration (see LLY page 8). Thus, the 2021 gain illustrates the financial benefit of maintaining exclusivity through patents, while highlighting the importance of additional exclusivity mechanisms such as data protection for sustaining revenue once patents lapse.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020 is correctly stated. No other numerical values are misreported. (2) The answer correctly identifies that PFE's income surge was linked to revenue from products under patent and regulatory exclusivity, and acknowledges the future risk of patent expirations—consistent with PFE's disclosures. It also accurately references LLY's reliance on 12-year U.S. biologic data protection under the BPCIA as a strategy to maintain revenue post-patent expiration. (3) The multi-hop reasoning—linking PFE's financial performance to broader industry dynamics around exclusivity, then contrasting with LLY's use of data protection—is logically sound and synthesizes information across both companies appropriately. (4) Minor deduction in qualitative accuracy because the LLM attributes the $17.3B increase primarily to 'higher revenues' tied to exclusivity, while the ground truth emphasizes non-operational factors like lower asset impairment charges and gains on equity securities. However, the LLM does not deny these factors and focuses instead on the structural role of exclusivity, which remains contextually valid. Wording differs but semantic meaning and intent are preserved. Contextual relevance is excellent as it directly addresses the relationship between financial performance and exclusivity mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 407,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 financials record the revenue‑sharing arrangement with ESPN as an **elimination of revenue** – Hulu pays fees to Disney/ESPN for the right to air ESPN networks on Hulu Live, which is removed from consolidated revenue (see the “Fees paid by Hulu to ESPN” line in the eliminations section).  That operating fee is unrelated to the **$8.6 billion** that Comcast received in late 2023, which was a one‑time cash payment from Disney to Comcast for the sale of Comcast’s remaining stake in Hulu under the put/call option (see the note on Hulu and collateralized obligation).  In short, the revenue‑sharing arrangement is a recurring operational transaction, while the $8.6 billion payment was a capital transaction resulting from Comcast’s exit of Hulu.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a critical error in reasoning that undermines the multi-hop synthesis required by the question. (1) Quantitatively, the numbers are accurate: the $8.6 billion payment from Disney to Comcast in late 2023 is correctly cited, and the characterization of the ESPN-Hulu fees as eliminations in Disney's 2024 financials aligns with the ground truth. The distinction between operational and capital transactions is factually sound in isolation. (2) However, the LLM incorrectly states that the revenue-sharing arrangement is 'unrelated' to the $8.6 billion payment, which contradicts the ground truth. The original answer correctly explains that ESPN’s content licensing fees contribute to Hulu’s revenue model and thus influence its valuation—meaning the recurring revenue stream is a factor in the economic value that justified Comcast’s $8.6 billion exit price. By asserting no relationship, the LLM fails the core multi-hop reasoning: linking ESPN’s fees → Hulu’s value → Comcast’s stake sale proceeds. (3) Entity accuracy is strong: ESPN, Hulu, Disney, Comcast, 2024 financials, late 2023 timing, put option context, and elimination accounting treatment are all correctly identified. (4) While the answer is contextually relevant and well-structured, the incorrect causal disconnection between operational revenue streams and valuation leads to a significant qualitative inaccuracy. A score of 5 reflects correct facts and numbers but flawed synthesis on the key relational aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 422,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO applies weighted‑average assumptions to the valuation of its equity‑based awards—stock options, performance‑share units and restricted stock—recognizing the related compensation expense on a straight‑line basis over each award’s vesting period (generally 3–4 years)【page_95】【page_96】【page_97】. In contrast, MDLZ uses weighted‑average discount rates, health‑care cost‑trend rates and other actuarial assumptions to calculate the present value of its post‑retirement benefit obligations (pension and health‑care plans) and records the associated service, interest and net periodic costs over the benefit‑payment period (service cost over the employee’s employment, interest cost as incurred and annual net periodic health‑care costs)【page_106】【page_107】【page_108】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that KO uses weighted-average assumptions for equity-based awards (stock options, PSUs, RSUs), with expense recognition over a 3–4 year vesting period on a straight-line basis, which matches the ground truth’s mention of a 'typical four-year vesting period.' The inclusion of 3–4 years is slightly more general than the 'four-year' specificity in the original, but still factually correct. (2) For MDLZ, the LLM accurately states that weighted-average actuarial assumptions (discount rates, healthcare cost trends) are used to value postretirement benefit obligations, with costs recognized over the benefit-payment period—service cost during employment, interest as incurred, and net periodic costs annually. This reflects the original answer’s emphasis on annual measurement and actuarial estimates. (3) The multi-hop reasoning is sound: the model correctly distinguishes between KO’s application to equity instruments with fixed vesting periods versus MDLZ’s use in long-term benefit liabilities requiring annual recalculation. (4) Minor difference: the original specifies KO uses the Black-Scholes-Merton model; the LLM omits this detail but correctly describes the outcome (use of weighted-average assumptions and straight-line expensing). This omission is not material to the core comparison about instruments and recognition periods. All entities (KO, MDLZ), financial instruments, and timeframes are correct. Number formats and periods are accurate. Semantic equivalence is strong. Hence, correctness is 9/10—excellent but missing one specific model name mentioned in ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 459,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s U.S. patents expire on 11/22/2028, 4/24/2029 and 10/19/2037, and AbbVie may seek up to a five‑year patent‑term restoration under the Hatch‑Waxman Act (and additional regulatory exclusivity under the Biologics Price Competition and Innovation Act) that could extend effective protection beyond those dates【page_11】【page_10】. Because Pfizer does not market Enbrel, the expiration of AbbVie's patents has no direct impact on Pfizer’s international revenue from the drug; any indirect effect would only arise if Pfizer had a licensing or partnership that could be affected by biosimilar entry.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains accurate patent expiration dates (11/22/2028, 4/24/2029, 10/19/2037), which align with the ground truth's general timeline (2028–2037), and correctly notes up to five years of potential patent term restoration under Hatch-Waxman, matching the original answer. However, the core factual error is the claim that 'Pfizer does not market Enbrel,' which directly contradicts the ground truth stating that 'Pfizer markets Enbrel outside the U.S. and Canada.' This undermines the entire reasoning chain. (2) Quantitatively, the dates and extension rules are accurate; format variations (specific dates vs. years) are acceptable and do not affect correctness. (3) The multi-hop reasoning fails: the question asks how patent expirations affect Pfizer’s international revenue, assuming Pfizer markets the drug internationally—a fact the model incorrectly denies. The model’s conclusion that there is no direct impact due to Pfizer not marketing Enbrel is therefore factually wrong, breaking the logical synthesis across entities (AbbVie’s patents → international marketing rights → Pfizer’s revenue). (4) While the patent and regulatory details are well-stated, the fundamental entity relationship error (Pfizer’s role) leads to an incorrect overall conclusion, warranting a low correctness score despite strong quantitative accuracy. Contextual relevance is moderate because the answer addresses patent timelines and exclusivity but misaligns on the key business relationship.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 415,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MET’s stress‑testing model explicitly includes early policy‑holder withdrawal scenarios, which can create sudden liquidity gaps that the company must cover by tapping global funding sources—most notably commercial paper—alongside operational cash flows and asset sales. In contrast, COF’s Liquidity Framework relies on a diversified mix of deposits, credit lines, and a sizable liquidity reserve of cash and high‑quality securities, using stress testing to confirm that these sources can meet needs and thereby reducing dependence on any single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between MET's and COF's liquidity approaches as described in the ground truth. (1) It correctly identifies that MET’s stress testing includes early policyholder withdrawals, leading to reliance on global funding sources like commercial paper—this aligns with the original answer. It also accurately describes COF’s diversified funding sources and liquidity reserves, noting reduced dependence on any single source such as commercial paper. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes how stress-testing designs influence funding strategy differences between MET and COF. The only minor omission is that the LLM answer does not mention MET’s use of rolling 12-month forecasts or asset mix adjustments, nor the explicit link between MET’s risk factors and AIG’s defined stress scenarios, which are present in the original. However, these are secondary details that do not undermine the core accuracy. (4) The answer is contextually fully relevant, directly addressing the comparative influence of stress-testing frameworks on funding source reliance. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only slight omissions in auxiliary detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 408,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose the confirmed amount outstanding and a roll‑forward of invoices. GE adopted the standard in 2023 and began presenting roll‑forward information in its 2024 financial statements (see its 2024 10‑K note on ASU 2022‑04, which states roll‑forward disclosures started on Jan 1 2024). CAT has been presenting roll‑forward data since 2024 (see its 2024 Supplier Finance Programs note and the roll‑forward table on pages 111–112). The alignment of roll‑forward disclosures under ASU 2022‑04 therefore makes GE’s and CAT’s supplier‑finance obligation reporting directly comparable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: ASU 2022-04 requires roll-forward disclosures; GE adopted the standard in 2023 and began roll-forward disclosures on January 1, 2024; CAT provided roll-forward data in its 2024 10-K. The dollar amount ($830 million) from the original answer is not mentioned in the LLM response, but no incorrect number is given—this is a minor omission, not an error. (2) Dates (January 1, 2024) and adoption timeline (GE in 2023, disclosures from 2024) are correctly stated. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both GE and CAT now provide roll-forward disclosures due to ASU 2022-04, enhancing comparability. It links GE’s implementation timeline with CAT’s disclosure practice in 2024, correctly concluding improved comparability. (4) The only minor shortcoming is the lack of explicit mention of the $830 million year-end balance for CAT, which was included in the ground truth and adds specificity. However, the absence does not make the answer factually incorrect—just slightly less detailed. Wording differs but meaning is semantically equivalent. Contextual relevance is perfect: the response directly addresses the impact on comparability due to standardized roll-forward requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 370,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ classifies its exchange‑traded commodity futures as Level 1 assets, valuing them at the quoted market price on commodity exchanges and cash‑settling them daily (MDLZ p. 96‑97). PepsiCo, by contrast, treats its commodity futures as Level 2 items that are also cash‑settled daily but are not reported in the fair‑value table; their fair value is derived from observable market inputs or pricing models rather than direct quoted prices (PEP p. 105‑106).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains partially correct information but includes a significant factual inaccuracy regarding PEP's classification of exchange-traded commodity futures. The original answer (ground truth) states that PEP excludes exchange-traded commodity futures from its fair value hierarchy tables entirely due to daily cash settlement, meaning they are not classified as Level 2 (or any level) in the fair value hierarchy. However, the LLM incorrectly claims that PEP treats these futures as Level 2 assets. This misrepresents PEP's accounting treatment and undermines the correctness of the comparison. While the LLM correctly notes that both companies cash-settle daily and that MDLZ uses quoted prices for Level 1 classification, the erroneous Level 2 designation for PEP reflects a failure in multi-hop reasoning and entity-specific synthesis. The mention of 'observable market inputs or pricing models' for PEP is misleading in this context, as exchange-traded futures should have quoted prices and would typically be Level 1 if included. There are no numerical values to verify, so quantitative accuracy is scored based on absence of incorrect numbers. Contextual relevance is high as the response addresses fair value determination and settlement practices. However, the core distinction—PEP's exclusion vs. MDLZ's inclusion in fair value hierarchy—is distorted, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 389,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "Comcast’s structure gives its Class B shares a 15‑vote weight per share, representing roughly one‑third (33 ⅓ %) of the company’s total voting power, while the remaining two‑thirds (66 ⅓ %) come from Class A shares (see CMCSA 10‑K, Item 5, page 31).  \nMeta’s dual‑class scheme is the opposite: Class A shares carry one vote each, whereas the far larger Class B shares are non‑voting, concentrating all voting power in the Class A shares (see Meta 10‑K, Item 5, page 1).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains major factual errors that severely undermine its correctness. (1) For CMCSA, the answer incorrectly states that Class A holds '66 1/3%' voting power; the correct figure is '66 2/3%' per the ground truth. This is a critical quantitative error. (2) More significantly, the LLM misrepresents META's dual-class structure: it claims Class B shares are 'non-voting' and that all voting power is in Class A, which directly contradicts the ground truth stating that Class B has 'superior voting rights'. In reality, at META (formerly Facebook), Class B shares carry superior voting power (typically 10 votes per share), not Class A. The LLM inverts the structure. (3) The LLM also fails to mention the disclosed number of META Class B shares outstanding (343,761,117 as of January 24, 2025), a specific data point in the ground truth. (4) The reasoning is flawed: it incorrectly frames the comparison as 'opposite' structures when both companies give superior voting rights to Class B shares—there is no inversion. While the answer attempts multi-hop synthesis and cites correct document locations (Item 5), the core facts about voting rights direction and percentages are wrong. The contextual relevance is moderate because it addresses the right topic and structure type, but the factual inaccuracies render the comparison invalid. Quantitative accuracy is low due to incorrect percentages and missing share count. Qualitative accuracy is poor due to fundamental misunderstanding of META's share structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 417,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG evaluates CLO credit losses under the CECL model, creating an allowance based on expected recoverable value that uses inputs such as delinquency, default, loss‑severity and pre‑payment speeds (see page 130).  Non‑credit‑related declines in fair value are recorded in OCI as unrealized appreciation/depreciation, while credit‑related declines trigger the allowance and are charged to net realized gains/losses.  MetLife’s methodology is referenced in Note 11 (not shown) but, as evidenced by the “Unrealized net gains (losses) recognized in earnings” line in the net investment gains table (page 225), it records unrealized gains/losses in earnings rather than OCI, indicating a similar CECL‑type allowance but a different recognition treatment.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant qualitative inaccuracies in reasoning and entity-specific methodology, particularly regarding MetLife. (1) Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so no numeric inaccuracies exist—this aspect is neutral but does not detract. (2) The LLM correctly describes AIG’s CECL-based credit loss evaluation using delinquency, default, and loss severity inputs and correctly distinguishes between credit-related impairments (charged to net realized gains/losses) and non-credit fair value changes (recorded in OCI). This aligns with the ground truth. (3) However, the LLM incorrectly infers MetLife’s methodology: it claims MetLife records unrealized gains/losses in earnings based on a line item on page 225, suggesting a CECL-type allowance. This contradicts the ground truth, which states MetLife holds CLOs as AFS securities—whereby unrealized losses should generally go to OCI unless credit impairment is recognized. The ground truth emphasizes MetLife’s passive investor status and lack of detailed cash flow modeling, not active CECL-style allowances or recognition in earnings. The LLM misinterprets the financial statement presentation and draws an unsupported conclusion about MetLife’s impairment model. (4) The multi-hop synthesis fails because the LLM does not accurately contrast AIG’s detailed, forward-looking cash flow modeling under CECL with MetLife’s more limited, structure-driven exposure assessment based on carrying amounts and passive investment. Instead, it incorrectly equates their approaches while highlighting a difference in OCI vs. earnings treatment that is not supported by the ground truth. Thus, while contextually relevant and factually plausible in parts, the answer misrepresents key aspects of MetLife’s methodology, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 519,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s redesign of Medicare Part D shifts a larger share of drug costs to manufacturers and PBMs, making CVS’s forecasting of medical‑cost trends more uncertain because the cost mix and reimbursement patterns become less predictable (page 38, 40). For BMY, the same redesign heightens the complexity of its GTN U.S. rebate accrual calculations for Medicare Part D, requiring more assumptions and judgments to estimate the rebates owed under the new cost‑sharing rules (page 126).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the key impacts of the Inflation Reduction Act (IRA) on both CVS and BMY regarding Medicare Part D. For BMY, it accurately states that the IRA increases complexity in gross-to-net (GTN) U.S. rebate accruals due to new cost-sharing rules, aligning with the ground truth that manufacturers face higher rebate obligations starting in 2025. The mention of 'more assumptions and judgments' reflects the need to account for new liabilities, as noted in the original. For CVS, the LLM correctly links the IRA's redesign to increased uncertainty in forecasting medical cost trends, citing less predictable cost mix and reimbursement patterns—consistent with the original answer’s emphasis on altered utilization and program dynamics. There are no numeric values, dates, or financial figures in either answer that conflict; the only minor omission is the specific mention of the 'reduction in federal reinsurance in the catastrophic phase' and the explicit 2025 start date, which are part of the ground truth but not included in the LLM response. However, the core causal mechanism (cost shift to manufacturers) and its implications for both companies are correctly synthesized. The reasoning is sound, entities (CVS, BMY, Medicare Part D, GTN rebates) are accurate, and the multi-hop logic—linking policy change to financial forecasting and accrual challenges—is well executed. The answer is highly contextually relevant and conveys the same meaning with slightly less detail on the mechanism but without factual error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 441,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s Stress Capital Buffer (SCB) is a 5.4 % risk‑based‑capital requirement that sits within its overall 8.4 % capital‑buffer requirement (which also includes a 3.0 % G‑SIB surcharge and a countercyclical buffer)【page_134】; a shortfall in the SCB would trigger restrictions on dividends, share repurchases and other capital distributions【page_22】. In contrast, Charles Schwab’s Capital Conservation Buffer is a 2.5 % standalone buffer that is part of the regulatory minimum risk‑based‑capital ratio; a breach would also limit distributions, but the threshold is lower and the overall buffer requirement is less extensive, so the impact on Schwab’s distribution policy is comparatively less severe【page_23】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase is subject to a Stress Capital Buffer (SCB) and Charles Schwab to a Capital Conservation Buffer (CCB), and that both buffers affect capital distributions if not met. It also correctly notes that the CCB is 2.5%, matching the ground truth. However, the LLM introduces specific numerical values—5.4% for SCB and 8.4% total buffer—that are not present in the original answer and cannot be verified from the provided context. These figures may be factually accurate in reality, but since they are absent from the ground truth and not supported by the knowledge graph used here, they constitute a quantitative deviation. Additionally, the breakdown of JPMorgan’s buffer into 5.4% SCB and 3.0% G-SIB surcharge implies a calculation (5.4 + 3.0 = 8.4) that may not reflect actual regulatory layering and introduces potential misrepresentation. (2) The ground truth emphasizes the dynamic, stress-test-driven nature of the SCB versus the static CCB, which the LLM fails to explicitly mention. This is a key qualitative distinction and its omission reduces completeness. (3) The multi-hop reasoning is partially sound: the model correctly links regulatory buffers to capital distribution constraints for both firms and contrasts their structures. However, it misses the core conceptual difference—dynamic vs. static buffers—which is central to the question’s comparative intent. (4) Despite the missing conceptual contrast and unsupported numbers, the answer remains contextually relevant and captures the essence of differing regulatory impacts on capital distributions. The conclusion that Schwab faces a less severe constraint is reasonably inferred, though phrased more as a policy impact than a structural regulatory difference. Thus, scores reflect minor factual overreach on numbers (quantitative accuracy docked), solid reasoning otherwise (high qualitative and contextual scores), and overall correctness slightly reduced due to unsupported specifics and missing key nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 549,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics excludes state and local income taxes that are allocable to U.S. government contracts from its tax provision, treating them as operating costs rather than tax expense. In contrast, Raytheon includes those taxes in its income‑tax expense but recovers them through contract pricing, allocating the amounts to contracts as SG&A and relying on FAR cost‑allowability rules to justify the recoverability. Thus, GD’s exposure is effectively removed from its tax calculation, whereas RTX’s exposure is absorbed into its pricing and cost‑allowability framework under the FAR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision and treats them as operating costs, while Raytheon includes them in income-tax expense but recovers them through contract pricing under FAR allowability rules. This aligns with the original answer's explanation of differing financial exposure mechanisms. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GD and RTX), their respective tax treatments, and how FAR governs cost allowability and pricing. The only minor shortcoming is that the LLM answer does not explicitly mention RTX’s use of performance-based or progress payments, which the original answer includes as part of its FAR-regulated pricing framework. However, this detail is contextual and doesn't undermine the central accuracy of the comparison. (4) The answer is semantically equivalent to the original, using slightly different phrasing (e.g., 'SG&A' and 'recoverability') but preserving factual correctness. Thus, the correctness score is 9—very close to perfect, with only a minor omission in elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 391,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "META’s dual‑class structure gives each Class A share one vote and each Class B share ten votes, and on February 1 2024 the company announced a $0.50 per‑share dividend for both classes (equivalent to $2.00 annually)【page_57】【page_81】. Alphabet’s (GOOGL) dual‑class structure also assigns ten votes to each Class B share, but those shares automatically convert into Class A shares upon sale or transfer, consolidating voting power into Class A shares and reflected in diluted earnings calculations【page_81】【page_82】. Thus, META retains separate voting rights and dividend treatment for Class B shares, whereas GOOGL’s Class B shares are effectively absorbed into Class A voting power upon transfer.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has a critical error in the voting power of META's Class B shares. The ground truth states that each Class B share has 15 votes, not 10 as claimed by the LLM. Additionally, the ground truth specifies that Class B shares have a non-dilutable 33 1/3% aggregate voting power, which the LLM omits entirely—this is a significant structural detail. The dividend initiation date and amount ($0.50 per share quarterly, starting in 2024) are correctly reported, and the conversion mechanics for GOOGL (automatic conversion of Class B to Class A upon transfer) are accurately described. (2) Quantitative inaccuracies include the vote count for META Class B shares (10 vs. correct 15) and omission of the 33 1/3% aggregate voting power guarantee. The dividend amount and date are correct. (3) The multi-hop reasoning is generally sound: the model correctly contrasts META’s retention of distinct share classes with GOOGL’s conversion mechanism and links dividend policy to share class treatment. However, the failure to report the non-dilutable voting percentage weakens the synthesis of META’s control structure. (4) The contextual relevance is high—response directly addresses the comparison between the two companies’ dual-class structures and dividend policies. Qualitative accuracy is good due to correct framing and logic, but quantitative accuracy is reduced by the incorrect vote count and missing percentage. Correctness score is 7 because core facts (dividend, GOOGL conversion) are right, but key details about META’s voting structure are wrong or missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 445,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "The 95 % confidence interval fixes the VaR threshold, so that under normal market conditions the parametric delta‑gamma model produces a one‑day loss estimate that is expected to be exceeded only 5 % of the time.  For Philip Morris this yields a one‑day fair‑value loss for interest‑rate‑ and foreign‑currency‑sensitive derivatives, while for Mondelez it produces a one‑day fair‑value loss for interest‑rate instruments and a pre‑tax‑earnings loss for currency and commodity exposures.  The shared delta‑gamma technique ensures both companies use the same statistical framework, but the VaR outputs differ in the type of loss (fair value vs. earnings) they quantify.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative and conceptual framing. It accurately identifies the 95% confidence interval and its implication—estimating a one-day loss expected to be exceeded only 5% of the time under normal market conditions. It correctly notes both firms use the parametric delta-gamma approximation, satisfying the multi-hop synthesis requirement. The distinction between Philip Morris's focus on fair-value loss for interest-rate and foreign-currency derivatives and Mondelez's use of both fair-value and pre-tax earnings loss for currency and commodity exposures is factually supported and adds precision not fully emphasized in the original answer. However, the LLM omits key contextual details present in the ground truth: specifically, that Philip Morris excludes anticipated transactions and hedges from its VaR calculation, while Mondelez accounts for the non-linear behavior of options due to the delta-gamma method. These omissions reduce the qualitative accuracy, as they represent important nuances in how each firm implements the shared methodology. Additionally, the LLM does not mention the critical limitation that the normality assumption may underestimate risk during market stress, which is a central point in the original answer. While the LLM captures the core modeling framework and correctly differentiates output types (fair value vs. earnings), the absence of these key implementation details and risk limitations prevents a higher score. All entities (Philip Morris, Mondelez, VaR, delta-gamma) and the 95% confidence level are correctly identified, and no numerical inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 447,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s embedded derivatives in CDOs are hybrid instruments that expose the firm to credit‑event risk that can reduce the principal repayment of the notes (page 109).  The firm reports $22.4 billion of net derivative liabilities with credit‑risk contingent features and manages this exposure through collateral and credit‑downgrade arrangements (page 107).  By contrast, Bank of America’s structured liabilities with embedded derivatives are accounted for under the fair‑value option and are largely hedged; the gains or losses from its market‑making activities are offset by derivative and security hedges that mitigate credit‑event impact (page 164), and the firm’s long‑term debt is primarily structured liabilities (page 163).  Consequently, Morgan Stanley faces a higher unhedged credit‑event risk in its market‑making activities than Bank of America, whose hedging and fair‑value accounting reduce net exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate entity identification and strong multi-hop reasoning. It correctly identifies Morgan Stanley's exposure through CDOs with embedded derivatives where credit events can impair principal repayment, and notes the $22.4 billion net derivative liabilities with credit-risk contingent features (quantitatively accurate, cited correctly from page 107). The reference to collateral and downgrade arrangements adds contextual detail not in the original but consistent with risk management practices. For Bank of America, the answer accurately states that structured liabilities with embedded derivatives are under fair-value option accounting and largely hedged, with gains/losses offset by hedges (page 164), and that long-term debt consists primarily of structured liabilities (page 163). The conclusion that Morgan Stanley faces higher unhedged credit-event risk compared to Bank of America’s hedged structure is a reasonable inference supported by the contrast in hedging approaches. However, the original answer does not explicitly state that Morgan Stanley has 'higher unhedged risk'—this is an interpretive leap not directly confirmed in the ground truth, which only notes both face credit risk with different underpinnings. Thus, while logically sound, this comparative risk assessment slightly exceeds the evidence in the original, warranting a deduction in qualitative accuracy. All numbers are correct, and formatting is acceptable. The answer fully addresses the question’s focus on risk exposure in market-making activities and credit events. Semantic equivalence is high, with added detail enhancing clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 467,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce notes that the Pillar Two global‑minimum tax is a potential risk but does not expect it to materially raise its global tax costs, implying its effective tax rate should remain largely unchanged (page_31).  Microsoft, whose effective tax rate was 18 % in fiscal 2024, acknowledges that the Pillar Two rules will apply from fiscal 2025 but currently estimates no material impact on its projected tax liability, although the uncertainty around implementation timelines and jurisdictional adoption could change that outlook (page_47).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Salesforce views Pillar Two as a potential risk but does not expect a material increase in tax costs, aligning with the original answer's statement about possible material impact while noting uncertainty. It accurately states Microsoft's effective tax rate as 18% in fiscal 2024 and that Pillar Two will apply from fiscal 2025 with no current material impact expected. However, the LLM slightly misrepresents Salesforce's position: the original answer says Salesforce acknowledges potential material impact, whereas the LLM says it 'does not expect it to materially raise its global tax costs,' which is a stronger stance than the original cautious tone. (2) Quantitatively, all numbers are correct: Microsoft’s 18% tax rate in fiscal 2024 matches the original (which also notes 19% previously, but that detail is not required for correctness). No calculations are needed. (3) The multi-hop reasoning is sound—comparing Salesforce’s and Microsoft’s responses to Pillar Two, synthesizing their respective tax rate contexts and forward-looking statements. The use of page references (31, 47) suggests proper sourcing, though not required. (4) Scores reflect high accuracy in numbers and relevance, minor deduction in qualitative accuracy due to slight overconfidence in Salesforce’s assessment, and full marks for contextual relevance as the answer directly addresses the comparative impact of Pillar Two under uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 408,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank, N.A. as the administrative agent and JPMorgan Chase Bank, N.A. as the syndication agent, with both banks jointly acting as lead arrangers and book managers.  \nHoneywell’s five‑year credit agreement, by contrast, lists Bank of America, N.A. as the administrative (and swing‑line) agent and names JPMorgan Chase Bank, N.A. together with Wells Fargo Bank, N.A. as syndication agents, with no joint‑lead‑arranger role for JPMorgan.  Thus Boeing’s structure is a two‑bank partnership (Citibank/JPMorgan), while Honeywell’s involves a three‑bank partnership (Bank of America/JPMorgan/Wells Fargo).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, with both as joint lead arrangers and book managers. Honeywell's agreement accurately lists JPMorgan Chase Bank, N.A. and Wells Fargo Bank, N.A. as syndication agents, and Bank of America, N.A. as administrative and swing line agent. (2) There are no numeric values (e.g., dollar amounts, dates) in the question or answer that require verification—only roles and institutions, which are correctly stated. The LLM omits the exact dates (October 30, 2019, for Boeing; March 20, 2023, for Honeywell) from the original answer, which is a minor omission but does not affect the comparison of syndication structure and key partners, the focus of the question. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective credit agreements, identifying the roles of JPMorgan in both and contrasting the broader banking partnerships. (4) The conclusion that Boeing’s structure is a two-bank partnership while Honeywell’s involves three is semantically valid and captures the structural difference, though the original answer does not explicitly frame it this way. The LLM adds slight interpretive framing (e.g., 'no joint-lead-arranger role for JPMorgan')—while not contradicted by the original, this detail isn't confirmed in the ground truth, which states that JPMorgan and Wells Fargo are syndication agents but doesn't specify lead arranger roles beyond Boeing. This is a minor over-interpretation but doesn't introduce factual error. Overall, the answer is factually correct, complete for the question asked, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 501,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the Countercyclical Capital Buffer is set at zero, the Advanced‑Approaches buffer requirement is just the sum of the 2.5 % Capital Conservation Buffer and the 2.5 % G‑SIB surcharge.  Thus Bank of America and Morgan Stanley each need a 5.0 % total capital buffer (2.5 % + 2.5 %) under the Advanced Approaches framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its quantitative assessment: both Bank of America and Morgan Stanley have a total CET1 capital buffer requirement of 5.0% under the Advanced Approaches framework, composed of a 2.5% Capital Conservation Buffer and a 2.5% G-SIB surcharge, with the Countercyclical Capital Buffer (CCyB) set to zero. The calculation (2.5% + 2.5% = 5.0%) is accurate, satisfying quantitative accuracy. The answer correctly identifies the relevant entities (Bank of America, Morgan Stanley), regulatory buffers, and framework (Advanced Approaches). However, the LLM assumes Morgan Stanley’s G-SIB surcharge is 2.5% without explicit confirmation in the answer, whereas the original answer notes that Morgan Stanley’s G-SIB surcharge is 'not quantified in the provided data but assumed to be included.' While this assumption aligns with the ground truth context, the LLM does not acknowledge the data limitation, slightly weakening the qualitative reasoning in a strict multi-hop evaluation. Despite this, the core logic and synthesis across regulatory components are sound, and the answer fully addresses the impact of CCyB absence. Wording differs but semantic meaning matches: stating the CCyB is 'set at zero' is equivalent to 'absence of CCyB.' Thus, the answer is contextually relevant and nearly fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 370,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s effective tax rate for fiscal 2022 was 18.5 % (NVDA 10‑K, effective‑tax‑rate table).  \nApple’s operating‑income margin in Greater China was roughly 42 % (31.2 B / 74.2 B ≈ 0.42) (Apple 10‑K, segment data). Thus, NVIDIA’s effective tax rate was less than half of Apple’s operating‑income margin in Greater China.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in NVIDIA's effective tax rate. The ground truth states it was 1.9%, but the LLM reports 18.5%, which is incorrect and significantly alters the interpretation. All other numbers are correct: Apple’s operating income ($31.2B ≈ $31,153M) and net sales ($74.2B ≈ $74,200M) in Greater China are accurate, and the calculated margin of ~42% is correct. (2) The calculation for Apple’s margin is properly executed (31.2 / 74.2 ≈ 0.42), but the comparison between NVIDIA’s tax rate and Apple’s margin is based on an incorrect tax rate, undermining the conclusion. The claim that NVIDIA’s rate was 'less than half' of Apple’s margin would be true at 18.5%, but in reality, 1.9% is dramatically lower, making the correct comparison even stronger. (3) The multi-hop reasoning is structurally sound—linking NVIDIA’s tax rate and Apple’s regional margin from separate filings—but fails due to the incorrect data point. The model identifies the correct entities (NVIDIA, Apple, fiscal year 2022, Greater China, effective tax rate, operating income margin) and attempts the right synthesis. (4) Scores reflect that core data (Apple’s figures) are accurate and the reasoning framework is logical, but the major error in NVIDIA’s tax rate—a central figure—severely undermines factual correctness. Quantitative accuracy is low due to the wrong percentage; qualitative accuracy is moderate due to correct metric identification and calculation logic; contextual relevance is high as the response directly addresses the question’s structure and intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 437,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s 2024 filing shows that Level 2 assets—primarily fixed‑income securities and over‑the‑counter derivatives—are valued with a mix of observable market data and credit‑rating inputs (benchmark yields, swap curves, broker quotes, rating‑agency data and inter‑dealer rates) and, for derivatives, an income‑approach that incorporates cash‑flow analysis.  UPS, by contrast, concentrates its Level 2 valuation on currency and interest‑rate derivatives, using pricing models that rely mainly on observable yield curves, foreign‑currency exchange rates and investment‑forward prices.  Thus, Boeing emphasizes a broader set of fixed‑income and credit inputs, whereas UPS focuses on currency‑ and rate‑market observables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing (BA) uses pricing models for Level 2 assets emphasizing benchmark yields, swap curves, broker quotes, rating-agency data, and inter-dealer rates—consistent with income-based models and fixed income instruments. UPS uses observable inputs like yield curves, foreign exchange rates, and forward prices for its OTC derivatives. These align with the original answer’s emphasis on BA’s credit/yield focus and UPS’s currency/rate focus. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, all referenced inputs and classifications are factually consistent, earning full marks. (3) The multi-hop reasoning—comparing two companies’ use of observable inputs for Level 2 assets across their 2024 filings—is sound and correctly synthesized. The LLM correctly identifies that both use observable inputs but differ in emphasis: BA on fixed-income and credit-related inputs, UPS on currency and interest rate dynamics. (4) Minor difference: the LLM mentions Boeing values both fixed-income securities and OTC derivatives as Level 2, while the original answer focuses BA’s Level 2 valuation primarily on fixed income. This addition does not contradict but slightly broadens the scope; however, it does not introduce inaccuracy. Wording differs but semantic meaning is equivalent. Thus, correctness is high—9/10—due to full factual alignment with only slight rephrasing and minor expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 440,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s Class A shares carry one vote each while Class B shares carry ten votes, creating a ten‑fold voting‑power disparity that is unaffected by the 2023 buy‑back of $62.2 billion of Class A and Class C shares—those repurchases shrink the pool of Class A votes but leave Class B voting power unchanged. In contrast, Netflix’s common stock is structured with one vote per share for all shareholders, so there is no voting‑power disparity. Thus, Alphabet’s repurchase program further concentrates voting influence in the hands of Class B holders, whereas Netflix maintains equal voting power across all shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 1-vote vs. 10-votes structure between GOOGL's Class A and Class B shares and contrasts it with NFLX's uniform 1-vote-per-share structure. It accurately references GOOGL's $62.2 billion 2023 share repurchase program and correctly states that it targeted Class A and Class C shares. (2) Quantitatively, all numbers are correct: '$62.2 billion' matches the ground truth, and there are no calculation errors. Format is consistent and precise. (3) The reasoning is largely sound: the LLM correctly infers that repurchasing Class A and Class C shares reduces the pool of voting shares, thereby preserving the relative voting control of Class B holders. However, it slightly oversimplifies by stating the buyback 'leaves Class B voting power unchanged' without mentioning the indirect effect via reduced conversion potential upon transfer (a nuance in the original answer). While the conclusion about concentration of voting influence is valid, the absence of the conversion mechanism detail—key to the multi-hop synthesis—represents a minor gap in qualitative depth. (4) The answer is contextually excellent, directly addressing all parts of the question with accurate entities (GOOGL, NFLX, Class A/B/C shares, 2023 repurchase), correct terminology, and logical flow. The minor omission prevents a perfect 10 on correctness and qualitative accuracy, but overall fidelity is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 397,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN’s 10‑K lists U.S. government debt securities as Level 2 assets, meaning they are valued with observable inputs other than quoted prices.  In contrast, AVGO (UPS) classifies the same securities as Level 1, valuing them at active‑market prices (see UPS page 80).  This difference introduces greater valuation uncertainty for ACN’s holdings and makes direct comparison of fair‑value disclosures less straightforward, potentially leading to divergent reported values and risk assessments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that ACN classifies U.S. government debt securities as Level 2 assets, which is consistent with the ground truth, though it omits the specific amount ($9,765 million), a significant quantitative omission. The answer incorrectly references 'AVGO (UPS)' as if AVGO and UPS are the same entity, which is false—UPS is a separate company used in the ground truth as evidence that such securities are typically Level 1. This misattribution undermines the reasoning. (2) Quantitatively, the dollar value of ACN’s Level 2 securities is missing, which is a key figure in the original answer and relevant for completeness and comparability. No incorrect numbers are stated, so quantitative accuracy is moderate. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that AVGO’s disclosures (not UPS’s) differentiate Level 1 and Level 2 assets, and instead incorrectly uses UPS as a proxy for AVGO’s classification. The ground truth uses UPS as external evidence of typical classification practices, not as AVGO’s disclosure source. This breaks the logical chain and leads to incorrect attribution. (4) Despite the reasoning error, the answer captures the core idea that differing classifications (Level 2 vs Level 1) affect comparability and introduce valuation uncertainty, which is contextually relevant and partially accurate. However, due to the entity confusion and missing key data, the correctness score is reduced to 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 410,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive adopted ASU 2022‑04 on January 1 2023 (with roll‑forward information required from January 1 2024) 【page_84】.  \nTarget’s comparable supplier‑finance disclosures are reported in its 2024 10‑K for the year ended February 3 2024, showing a confirmed amount outstanding at year‑end of $3.398 billion 【page_54】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding Target's confirmed amount outstanding. The original answer (ground truth) explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt,' yet the LLM claims Target reported a confirmed amount of $3.398 billion at year-end. This number is not supported by the ground truth and appears to be fabricated or misattributed. (2) The adoption timeline for Colgate-Palmolive is correctly stated: adoption on January 1, 2023, with roll-forward disclosures effective January 1, 2024. This matches the ground truth and is accurate. However, the claim about Target’s $3.398 billion figure is not corroborated and directly contradicts the original answer’s assertion that no such quantification is provided. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the need to compare adoption timelines and year-end disclosures—but fails in synthesis because it invents a precise figure not present in the source. The model also references a '2024 10-K' for Target, which may be contextually plausible but is not confirmed in the ground truth. (4) Correctness score is 4 due to one major quantitative inaccuracy despite correct details on Colgate-Palmolive. Quantitative accuracy is low (3) because of the unsupported $3.398B figure. Qualitative accuracy is moderate (5) as the structure and intent are reasonable but flawed in execution. Contextual relevance is high (8) because the response addresses the right entities and disclosure focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 426,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s operational‑risk exposure is tied to its reliance on third‑party technology partners, notably Microsoft Azure for its Aladdin platform, and the company explicitly notes that failures in these services could trigger regulatory, financial and reputational harm (BLK_10‑K, page 28).  By contrast, Mastercard treats reputational risk as part of its overall operational‑resilience strategy, relying on internal governance, risk‑identification and monitoring frameworks to mitigate disruptions and protect its brand rather than on external cloud providers (MA_10‑K, page 26).  Thus, BlackRock faces direct operational and regulatory exposure from third‑party vendors, whereas Mastercard focuses on internal controls to manage reputational risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately cited as a source of operational and reputational risk, with reference to regulatory, financial, and reputational consequences (consistent with BLK_10-K, page 28). Mastercard’s integration of reputational risk into its operational resilience framework is correctly described and tied to internal governance structures (MA_10-K, page 26). (2) There are no numerical values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the citation of specific page numbers from the 10-Ks matches the evidence used in the original answer, supporting factual grounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), identifies the nature of their operational risk exposure (external dependency vs. internal resilience), and draws a valid comparative conclusion about how each manages reputational risk stemming from operations. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that 'Operational Risk' at BlackRock is defined in terms of reputational impact due to system issues or external events (as noted in COF evidence), nor does it name 'Reputational Impact' as a formally labeled risk factor in Mastercard’s 10-K, which slightly reduces qualitative completeness. However, the core meaning and comparative insight are preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—the response directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 476,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "In 2021, Cardinal Health was a major customer for BMS, accounting for about 20 % of the company’s gross product sales – roughly one‑fifth of BMS’s total revenue (see BMS 2022 10‑K, page 107).  In CVS’s generic‑pharma sourcing strategy, Cardinal co‑owns Red Oak Sourcing, LLC (50/50 with CVS) and, together with CVS, uses the joint venture to source and negotiate generic drug contracts, pooling both companies’ supply‑chain expertise while Red Oak holds no inventory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that Cardinal Health accounted for 20% of BMS's (BMY's) revenue in 2021, which matches the ground truth. The reference to 'BMS' instead of 'BMY' is acceptable as both refer to Bristol-Myers Squibb (BMY is the ticker, BMS is the common abbreviation). The description of Red Oak Sourcing, LLC as a 50/50 joint venture between CVS and Cardinal Health for negotiating generic drug contracts is factually accurate. It correctly notes that Red Oak does not hold inventory, which aligns with the original answer.\n\n2) Quantitatively, the 20% figure is correct and properly attributed to 2021. The LLM cites the BMS 2022 10-K, page 107, which is consistent with how such data would be reported (i.e., 2021 data in the 2022 filing). No calculations are required beyond accurate reporting of percentages, which is done correctly.\n\n3) The multi-hop reasoning is sound: the model connects Cardinal’s role as a major customer of BMS (BMY) with its strategic partnership in CVS’s sourcing infrastructure via Red Oak. This dual-role synthesis is the core of the question and is well-executed. The only minor issue is the use of 'BMS' instead of 'BMY' in the question context, though this does not affect factual accuracy.\n\n4) The answer is semantically equivalent to the ground truth. Wording differs slightly (e.g., 'pooling both companies’ supply-chain expertise' vs 'leverage combined sourcing capabilities'), but the meaning is preserved. All key facts—20% revenue share, 50/50 ownership, contract negotiation without inventory ownership—are present and correct. The answer is fully relevant and addresses both sub-questions thoroughly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 453,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B shareholders can vote only in a handful of defined circumstances, and each share’s voting power is multiplied by the applicable conversion rate, giving them limited and contingent influence. In contrast, Netflix’s common shareholders enjoy the standard one‑vote‑per‑share right on all matters. Thus, Meta’s Class B holders have comparatively restricted and variable voting power versus Netflix’s straightforward, full voting rights. (Meta 10‑K, p. 57; Netflix 10‑K, p. 61)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It accurately states that Meta's Class B shareholders have limited voting rights only in specific scenarios and that their voting power is multiplied by the conversion rate, while NFLX common stockholders have one vote per share on all matters. The key facts—restricted vs. unconditional voting, variable influence based on conversion rate, and the contrast in voting structures—are all present and correct. (2) There are no numeric values requiring calculation or verification (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not applicable beyond correct reference to structural multipliers, which are described accurately. (3) The multi-hop reasoning—comparing voting rights across two companies (Meta and Netflix) using their respective 10-K disclosures—is sound and correctly synthesized. The answer draws the right conclusion about comparative voting power. (4) Minor deduction in qualitative accuracy due to slightly less detail than the original (e.g., not listing specific scenarios like 'merger' or 'amendments to certificate of incorporation'), but the essence is preserved. Contextual relevance is perfect—the response directly addresses the comparison asked. Wording differs slightly but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 375,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s Class B shares automatically convert to Class A shares whenever they are sold or transferred (page 81), so the conversion happens without any shareholder vote.  Meta’s charter, by contrast, requires that any transaction that would change the company’s control must be approved by a majority of the outstanding Class B shareholders (page 50), giving those holders a veto over take‑overs.  Mastercard’s policy that converted Class B shares must be sold or otherwise transferred (the mandatory post‑conversion transfer) prevents Class B holders from accumulating Class A voting power, illustrating how conversion rules can be used to shape and limit control in dual‑class governance frameworks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions in dual-class governance frameworks across GOOGL, META, and Mastercard. (1) All factual elements are correct: GOOGL's Class B shares convert automatically upon transfer (no vote required), META requires Class B approval for change-of-control transactions, and Mastercard mandates post-conversion sale or transfer of converted shares. These points align with the ground truth. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is unaffected and remains perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance mechanisms across three companies and draws a meaningful contrast in how each handles control dilution or preservation. The only minor omission is that the original answer specifies META's Class B veto applies until those shares represent less than 35% of combined voting power—a detail absent in the LLM response. While this is a relevant nuance, its absence does not undermine the core correctness. (4) The LLM answer is contextually precise, directly addressing all parts of the complex, multi-entity question and offering a coherent evaluation of dual-class structures. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to the missing 35% threshold, but full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 399,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck can add an extra six‑month pediatric exclusivity period (and up to five years of patent‑term restoration) to its biologics if pediatric studies are completed, extending market exclusivity beyond the standard 12‑year data‑protection window【page 18】.  In contrast, Amgen faces regulatory exclusivity risk because recent policy changes have removed the mandatory 10‑year data‑exclusivity requirement for biologics and may eliminate “umbrella” exclusivity, potentially shortening the 12‑year exclusivity period and accelerating biosimilar entry【page 46】.  Thus, Merck’s pediatric exclusivity offers a predictable, additional protection, while Amgen’s exclusivity is threatened by evolving data‑protection rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the six-month pediatric exclusivity for Merck (MRK) is correctly stated, and the reference to potential extension beyond the 12-year data protection period is consistent with the original answer's implication of extended protection beyond patents. The mention of 'up to five years of patent-term restoration' is additional detail not in the ground truth but is factually plausible under Hatch-Waxman and does not contradict the original. For Amgen (AMGN), the removal of the mandatory 10-year exclusivity and risk to 'umbrella' exclusivity are correctly framed as regulatory risks that could shorten the effective exclusivity period—this matches the original answer’s concern about FDA policy changes affecting EPOGEN. (2) The numbers and timeframes (six months, 12-year window, 10-year requirement) are all factually accurate and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly contrasts MRK’s proactive use of pediatric exclusivity with AMGN’s exposure to regulatory shifts, synthesizing across different regulatory mechanisms (pediatric exclusivity vs. biologic data exclusivity policy). (4) Semantically, the LLM conveys the same core insight: MRK gains predictable, additional protection through existing incentives, while AMGN faces uncertainty due to evolving rules. The only minor gap is that the original specifically names MRK’s high-risk adult COVID-19 treatment and AMGN’s EPOGEN as examples, which the LLM omits—this slight loss of specificity prevents a perfect 10, but the overall reasoning and factual content remain excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 454,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s dual‑class scheme is highly concentrated: it has 925.7 million Class A shares and only 7.2 million Class B shares, which are not publicly traded and are held by a small group of insiders, giving those holders a disproportionate voting stake (page 2).  Visa, by contrast, has 1.733 billion Class A shares and a much larger pool of Class B‑1 (5 million) and Class B‑2 (120 million) shares, but the Class B and C common shares have limited voting rights—only on specified matters and voting as a single class with Class A—so voting power is more widely distributed (page 90).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to accurately represent the dual-class structures of MA (Mastercard) and V (Visa) as described in the ground truth. (1) Quantitatively, the LLM provides specific share counts (e.g., 925.7 million Class A shares for MA, 1.733 billion for Visa) that are not present in the original answer and appear fabricated or misattributed. The ground truth does not mention share counts but focuses on voting power distribution and control mechanisms. (2) The original answer states that MA's Class B shares have 15 votes per share and are held entirely by Mr. Brian L. Roberts, giving him 33⅓% of voting power, while Class A holds 66⅔%. The LLM completely omits this critical voting ratio and misattributes control to a 'small group of insiders' rather than a single individual. (3) For Visa (V), the LLM incorrectly describes Class B-1 and B-2 shares and claims limited voting rights on 'specified matters', which contradicts the ground truth: V’s Class B shares are subject to transferability and convertibility conditions tied to U.S. covered litigation, with conversion rates adjustable based on litigation outcomes or follow-on offerings. The LLM fails to mention this key control mechanism. It also incorrectly states that Class B and C shares have limited voting rights, while the original answer emphasizes transfer restrictions and exchange programs, not voting limitations. (4) The LLM invents structural details (e.g., 'B-1' and 'B-2' classes) not present in the ground truth and mischaracterizes the nature of control concentration—MA’s structure is static and vote-weighted, while V’s is dynamic and restriction-based. The reasoning is flawed, with no accurate synthesis of the actual multi-hop comparison. (5) Despite addressing the general topic of dual-class structures and attempting a comparison, the answer is factually misaligned, resulting in low scores across all dimensions. Only minimal credit is given for contextual relevance since it attempts to compare MA and V on voting control.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 546,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s 2022 10‑K shows that its U.S. government fixed‑price contracts generate contract assets because revenue is recognized in excess of billings (page 79) and that FAR/CAS audits can create potential liabilities (page 19). Lockheed Martin’s 10‑K pages provided do not disclose contract‑asset balances, but the risk‑factor discussion similarly cites audit and compliance risks for government contracts, indicating a comparable, though not quantified, exposure to audit‑related liabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies key aspects of both RTX's and LMT's risk profiles related to FAR-regulated U.S. government fixed-price contracts. It correctly notes that RTX recognizes revenue in excess of billings, resulting in contract assets, citing page 79 of RTX’s 2022 10-K, which aligns with the ground truth. It also accurately states that FAR/CAS audits pose potential liabilities for RTX (citing page 19), and that LMT faces audit and compliance risks, though without disclosing contract-asset balances. The quantitative accuracy is high—no numerical errors, and the references to specific pages and filings are consistent and plausible. However, the answer falls short in completeness and qualitative depth: it fails to explicitly contrast RTX’s balance sheet exposure (contract assets) with LMT’s more enforcement-oriented risks (e.g., debarment, material adverse effects due to compliance failures), which is central to the original answer’s comparative analysis. While it mentions audit risks for LMT, it does not convey that LMT’s dependence on government contracts makes it particularly vulnerable to operational restrictions or financial penalties, a key differentiator in risk mechanisms. The multi-hop synthesis is partially sound—linking RTX’s accounting practice to FAR regulation and noting LMT’s audit risks—but does not fully integrate the comparative risk profile (balance sheet vs. compliance/enforcement). Wording differences are acceptable under semantic equivalence, but the omission of the conceptual contrast reduces the qualitative accuracy. Contextual relevance is strong, as all information directly addresses the question’s focus on financial exposure and audit-related liabilities under FAR.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 480,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s Class A shares carry one vote each, while its Class B shares carry ten votes each – giving Class B a 10‑fold voting advantage over Class A. Alphabet’s Class A shares also have one vote per share, but its second‑class (Class C) shares have no voting rights, so the second class carries no voting power【page_81】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the voting structures of both META and GOOGL. (1) For META, the LLM incorrectly states that Class B shares have 10 votes per share; the ground truth specifies 15 votes per Class B share. It also fails to mention the actual voting power distribution: Class B holds 33 1/3% and Class A holds 66 2/3% of total voting power — a critical quantitative and qualitative omission. (2) For GOOGL, the LLM incorrectly refers to Class C shares (which are non-voting) instead of Class B shares, which are the high-vote shares with 10 votes each. While it is true that GOOGL’s Class A shares have 1 vote and Class C have none, the question specifically asks about Class B, not Class C. The original answer notes that GOOGL’s Class B shares have 10 votes per share but does not specify the percentage split — this nuance is missing in the LLM response. (3) Multi-hop reasoning is flawed: the comparison between META and GOOGL should center on Class B voting power (15 vs 10 votes per share), but the LLM fails to extract the correct classes and vote weights for META and conflates GOOGL’s share classes entirely. (4) Despite these errors, the answer is contextually relevant in that it attempts to compare dual-class structures and voting rights between the two companies, earning partial credit for relevance. However, due to major inaccuracies in numbers, entities, and reasoning, the overall correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 404,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "BMY’s Opdivo, protected by 12‑year regulatory data protection, illustrates that once that exclusivity lapses, generic competitors can file Paragraph IV ANDAs after four years, as the company explains in its 10‑K [page_9] and [page_8]. This pattern signals that JNJ’s Stelara, which is approaching a patent cliff, could face similar Paragraph IV challenges, heightening JNJ’s litigation exposure as the drug’s exclusivity ends [page_5] [page_7].",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the length of regulatory data protection for Opdivo. The original answer and BMY's 10-K do not state a 12-year protection period; instead, they reference a five-year regulatory data protection period, after which Paragraph IV ANDAs are frequently filed following four years. The LLM incorrectly states a 12-year term, which is not supported by the ground truth and misrepresents the regulatory timeline. This undermines the quantitative accuracy. (2) The dollar amount related to Stelara’s sales ($8 billion in 2022) is omitted in the LLM answer, weakening completeness and precision. While the LLM correctly identifies Stelara as a major product facing patent cliffs, it fails to quantify its financial significance, which is a key element in the original answer for assessing litigation risk. (3) The reasoning is partially sound: the LLM correctly infers that expiration of exclusivity leads to Paragraph IV ANDA filings and increased litigation risk, and it draws a valid cross-company comparison between BMY and JNJ. It also correctly cites BMY’s 10-K as a source of precedent for generic challenges post-exclusivity. However, it misattributes the structure of exclusivity (12 years vs. 5-year data protection with 4-year Paragraph IV trigger), which distorts the regulatory precedent. (4) Contextual relevance is high—the answer addresses the core concern about how BMY’s experience sets a precedent for JNJ’s exposure, correctly identifying litigation risk as a function of patent cliff timing and generic entry. Despite the factual error in regulatory duration, the overall logic flow and intent to synthesize across companies and regulatory mechanisms is appropriate. The use of citation placeholders [page_9], [page_8], etc., suggests structured sourcing, though the content itself is partially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 512,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s dual‑class structure gives Class B holders 10 votes each and, **until those shares represent less than 35 % of the combined voting power, any change‑of‑control transaction must be approved by a majority of the Class B vote** (page 52). Alphabet’s structure also gives Class B shares 10 votes each, but **those shares automatically convert to Class A upon sale or transfer, so the voting power is concentrated in the founders without a separate approval requirement for change‑of‑control** (page 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and thresholds are correct: the 35% voting power threshold for META's Class B shares and the 10 votes per share for both META and GOOGL are accurately reported. There are no calculation errors. (2) The answer correctly identifies that META requires a separate majority Class B vote for change-of-control transactions until Class B voting power drops below 35%, which aligns with the ground truth. It also correctly states that GOOGL’s Class B shares carry 10 votes but automatically convert to Class A upon transfer, eliminating the need for separate approval mechanisms. (3) The multi-hop reasoning is sound—comparing two dual-class structures across different companies with attention to control mechanisms, voting rights, and transfer rules. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly note that GOOGL’s structure limits long-term entrenchment or that META’s provides more enduring governance insulation, which is a key comparative insight in the original answer. However, the omission does not undermine the factual correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 368,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS elected not to use the practical expedients under ASU 2020‑04, fully transitioning its debt and contracts to SOFR in 2023 and re‑measuring its hedging relationships (page 74). In contrast, MMM—whose hedging portfolio is heavily composed of interest‑rate swaps and foreign‑exchange forwards (NOTE 16, page 74)—would have been able to apply the optional relief under ASU 2020‑04, allowing it to continue using the old reference rate or to transition its hedges gradually, because the relief was available through December 31 2024 (page 74).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that UPS did not apply the practical expedients under ASU 2020-04 and transitioned fully to SOFR in 2023, which matches the original answer. It also correctly contrasts this with MMM's likely use of the optional relief, noting the availability of relief through December 31, 2024, due to ASU 2022-06. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not compromised—no incorrect figures were introduced. (3) The reasoning is sound: the model correctly infers that MMM could have used the relief based on the extended sunset date and its active hedging portfolio. However, the LLM answer stops short of citing MMM’s specific hedging activity (e.g., $152 million reclassified from AOCI), which was a key piece of evidence in the ground truth supporting the inference that MMM actively managed hedging relationships and thus likely used the relief. This omission slightly weakens the multi-hop synthesis, as the original answer uses that data point to strengthen the conclusion. (4) Despite this, the answer remains contextually relevant and factually accurate, making a reasonable inference based on available information. The lack of explicit reference to MMM’s disclosed hedging data prevents a perfect score, but the core contrast is correctly drawn.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 381,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and values them at the quoted market price on the commodity exchange. Because these futures are cash‑settled daily, the fair value is automatically updated each day and the instruments are settled daily, so MDLZ’s Level 1 valuation is driven solely by the daily settlement price and does not require additional mark‑to‑market adjustments. PEP, which also holds similar commodity futures, follows a comparable approach—its derivatives are marked to market each period and gains or losses are recorded in operating expenses—so the daily cash settlement likewise ensures that both companies’ valuations reflect the most recent market price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets, valued at quoted market prices, and that daily cash settlement drives the fair value measurement. It also correctly references PEP's similar treatment of these instruments. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no calculations were required. (3) The multi-hop reasoning is sound: the model correctly links MDLZ's valuation methodology to the daily cash-settlement mechanism and uses PEP's disclosures as supporting evidence of how such instruments are treated (i.e., marked to market and excluded from year-end balance sheet tables due to settlement). The only minor shortcoming is that the LLM does not explicitly state that the daily settlement leads to exclusion from the balance sheet (as noted in PEP's disclosure), which slightly weakens the synthesis compared to the original. However, the implication is present. (4) The answer is contextually fully relevant, directly addressing how daily cash settlement impacts MDLZ's Level 1 valuation and incorporating PEP's exposure appropriately. Wording differs but semantic meaning aligns closely with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 377,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s structure gives each Class A share one vote and each Class B share fifteen votes, so Class A shares account for 66 ⅓ % of the combined voting power while Class B shares hold 33 ⅓ %. Alphabet’s system is similar in that Class A shares have one vote and Class B shares have multiple votes, but Alphabet’s Class B shares carry only ten votes per share and are convertible to Class A, resulting in a lower per‑share voting weight and a less concentrated voting‑power split. Thus, Comcast’s Class B shares confer a higher voting advantage and a larger fixed share of total voting power than Alphabet’s Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting power distribution for CMCSA: Class A holds 66 2/3% (stated as 66 1/3%, a minor typographical discrepancy but likely intended to be 66 2/3%) and Class B holds 33 1/3%, with each Class B share carrying 15 votes. For GOOGL, it accurately states that Class B shares have 10 votes per share and Class A have 1 vote, with no mention of Class C's lack of voting rights—this is a minor omission but not critical to the core comparison. The claim that GOOGL’s Class B shares are convertible to Class A is correct and adds useful context not in the original answer. (2) Quantitatively, all vote weights (15 for CMCSA Class B, 10 for GOOGL Class B) and voting power percentages are accurate, except the 66 1/3% vs. correct 66 2/3% for CMCSA Class A—this is a small error in fraction representation but does not materially distort the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (CMCSA and GOOGL), compares their dual-class structures, and draws a valid conclusion about relative concentration of voting power. It correctly infers that higher per-share votes (15 vs. 10) and fixed ownership (implied by Brian Roberts' control) lead to more concentrated control in CMCSA. (4) The answer is contextually excellent, directly addressing the comparative structure of voting rights. The qualitative score is 9 due to the minor fraction inaccuracy and omission of Class C’s non-voting status, but overall reasoning and factual accuracy are strong. Correctness score is 9 because the core facts and comparison are accurate, with only negligible errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 455,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "BAC’s market‑making gains, reported as $4.2 billion in 2024 under the fair‑value option (“Market making” line of the gains/losses table, BAC 10‑K p. 164), arise from trading activities that include embedded derivatives.  By contrast, MS’s structured‑financing portfolio contains credit‑linked notes (CLNs) that are hybrid securities with embedded credit derivatives; these CLNs expose the firm to credit‑event risk in the underlying reference assets (MS 10‑K p. 109).  Thus, while both firms face credit‑event risk in structured notes, BAC’s exposure is realized through short‑term market‑making gains, whereas MS’s exposure is embedded in longer‑term CLN structures that combine debt and credit protection.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$4.2 billion in market-making gains for BAC in 2024—which is not present in the original answer (ground truth) and cannot be verified from the provided context. This number is likely fabricated or misattributed, as the ground truth does not include any quantitative figures. Therefore, the quantitative accuracy is low. (2) There are no calculations in the question or answer, but the inclusion of an unsupported figure ($4.2 billion) significantly undermines factual correctness. The mention of '2024' and specific page numbers (BAC p. 164, MS p. 109) adds apparent precision but cannot be confirmed without access to those filings and was not part of the ground truth, making these details potentially misleading. (3) Qualitatively, the LLM correctly identifies that BAC’s market-making activities involve embedded derivatives in structured liabilities and that MS structures CLNs as hybrid instruments with embedded derivatives. It also correctly notes that both firms face credit-event risk. However, it misses a key distinction in the original answer: BAC actively hedges its exposures, resulting in offsetting gains/losses, whereas MS retains risk by selling credit protection. The LLM mentions 'short-term market-making gains' vs 'longer-term CLN structures'—a plausible interpretation but not equivalent to the hedging behavior emphasized in the ground truth. (4) Contextually, the response is highly relevant and addresses the comparative nature of the question, synthesizing across both firms and their treatment of embedded derivatives in structured notes. While the core conceptual comparison is partially accurate, the addition of unverified quantitative data and the omission of BAC’s hedging strategy reduce overall correctness. Thus, the answer is partially correct but contains significant factual inaccuracies that affect trustworthiness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 519,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "The OECD’s Pillar Two rules set a 15 % global minimum tax that could apply to Intel’s non‑U.S. operations.  Intel’s 2023 effective tax rate fell to –119.8 % largely because a larger share of its income was taxed abroad, and the company is “continuing to evaluate the impacts of enacted legislation and pending legislation to enact Pillar Two Model Rules in the non‑U.S. tax jurisdictions we operate in” (INTC 2023 p. 44).  If the minimum tax is imposed in those jurisdictions, Intel’s effective tax rate could rise, but the company has not yet quantified the effect and expects it to be material only if its overseas operations fall below the 15 % threshold.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the OECD Pillar Two 15% global minimum tax and Intel's exposure to non-US jurisdictions, which aligns with the ground truth. It accurately references Intel's 2023 effective tax rate of -119.8% and cites Intel's ongoing evaluation of Pillar Two impacts, including enacted and pending legislation in non-US jurisdictions. The conclusion that Intel's effective tax rate could rise due to constraints on benefiting from low-tax jurisdictions is consistent with the original answer. However, the LLM adds a claim not present in the ground truth: that the impact would be material 'only if its overseas operations fall below the 15% threshold.' This condition is speculative and not supported in the original answer, which states the impact could be significant due to Intel's current geographic income distribution, not contingent on falling below the threshold. (2) Quantitatively, the -119.8% effective tax rate is correctly cited, and the 15% minimum tax rate is accurate. The reference to page 44 of Intel's 2023 filing is plausible and contextually appropriate, though not verifiable from the ground truth alone. No calculation errors are present. (3) The multi-hop reasoning is largely sound: the model connects Salesforce identifying Pillar Two as a material tax development to Intel’s exposure and evaluation, and infers potential rate increases. However, the added threshold condition introduces a minor logical overreach not grounded in the source. (4) Scores reflect high factual accuracy and relevance, with a slight deduction in correctness and qualitative accuracy due to the unsupported conditional statement about materiality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 461,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX recognizes revenue on a percentage‑of‑completion basis for its FAR‑regulated fixed‑price U.S. government contracts, creating contract assets when revenue is recognized ahead of billings (RTX, p. 79‑80). Boeing, on the other hand, notes that U.S. government contracts can be terminated at the government’s convenience or for default, which can abruptly cut revenue and trigger cancellation costs (BA, p. 5‑7). As a result, RTX’s over‑time recognition tends to provide a more predictable revenue pattern—though still tied to performance milestones—whereas Boeing’s termination risk introduces greater volatility in cash‑flow timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between RTX and Boeing (BA) regarding revenue recognition and termination risk under FAR-regulated U.S. government contracts. (1) It correctly identifies RTX's percentage-of-completion revenue recognition method, which leads to revenue recognized in excess of billings, creating contract assets—consistent with the ground truth. It also accurately notes Boeing's exposure to termination at convenience or for default, which can disrupt revenue and incur costs. (2) There are no numeric values (e.g., percentages, dollar amounts) in the LLM answer, but this is because it omitted the specific 80–90% range of performance-based or progress payments that RTX receives. This is a minor omission but does not distort the overall accuracy. The ground truth includes this quantitative detail; the LLM answer does not, hence a slight deduction in completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes RTX’s revenue timing (creating predictability with timing mismatches) versus Boeing’s termination risk (introducing volatility), leading to the conclusion that Boeing faces less predictable cash flows. (4) The answer is contextually relevant, directly addressing the comparison and its implications for cash flow predictability. The semantic meaning aligns with the original answer, though slightly less detailed. Wording differences are acceptable and do not affect factual correctness. Deduction is minor due to omission of payment coverage percentage, which is a supporting but not central fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 433,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s $119 million of floating‑rate notes with 2025 put provisions represent roughly 6 % of its current‑portion long‑term debt ($1,919 million) and are due in 2025, so they are a direct near‑term obligation.  \nGE’s $315 million of fixed‑ and floating‑rate notes that carry 2025 put options is a larger absolute amount and accounts for about 8 % of GE’s near‑term debt ($≈4,078 million, the sum of current‑portion long‑term debt and short‑term borrowings); although the notes mature after 2025, the put options could be exercised in 2025, creating a potential near‑term cash outflow.  Thus, GE’s exposure to put‑option debt is higher both in size and relative to its near‑term debt base than MMM’s.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its reasoning and conveys the core comparison between MMM and GE regarding their exposure to put options in 2025. It correctly identifies MMM's $119 million in floating rate notes with 2025 put provisions and GE's $315 million in fixed and floating rate notes with similar 2025 put options. The qualitative assessment that GE’s exposure is larger both in absolute and relative terms is sound and adds useful context not in the original answer (e.g., percentage of near-term debt). However, the quantitative accuracy is slightly compromised: the LLM introduces figures not present in the ground truth—specifically, MMM’s total current portion of long-term debt ($1,919 million) and GE’s near-term debt base ($≈4,078 million)—which were not provided in the original data. While these numbers may be factually accurate in reality, they are not part of the ground truth knowledge graph and thus represent an overreach. Additionally, the 6% and 8% calculations, while internally consistent, are unsupported in the original answer and introduce unverified precision. The multi-hop reasoning is strong: the model correctly synthesizes that put options exercisable in 2025 create near-term liquidity risks even if maturities are later, and it accurately compares the scale of exposure. The answer is fully contextually relevant, addressing both companies and the nature of their obligations. Despite the unsupported calculations, the core facts and comparative conclusion align with the ground truth, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 428,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP values its exchange‑traded commodity futures by daily cash settlement, using the daily market price to determine fair value, but the instruments are omitted from the fair‑value table because they are settled daily【page_107】. MDLZ, in contrast, classifies exchange‑traded commodity futures as Level‑1 assets and values them directly from quoted market prices on commodity exchanges【page_95】. Both rely on daily market pricing, but MDLZ’s approach is explicitly reflected in the fair‑value hierarchy, whereas PEP’s is implicit in the daily settlement process.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: PEP omits exchange-traded commodity futures from its fair value table due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing, but differ in presentation and classification. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—correctly contrasting PEP’s exclusion rationale (daily settlement) with MDLZ’s inclusion rationale (quoted prices = Level 1), synthesizing across two companies and their respective valuation methodologies. (4) The only minor shortcoming is that the LLM slightly downplays PEP’s focus on the settlement mechanism as a reason for exclusion, instead framing it as an implicit part of valuation, whereas the original emphasizes PEP’s deliberate exclusion due to settlement. However, this is a nuance in emphasis, not a factual error. Overall, the answer is complete, accurate, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 323,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China net sales in 2022 were $74.2 billion (page 25).  \nIntel’s Taiwan revenue was $13.5 billion in 2021 (the most recent figure disclosed in the filing, page 87).  \nThus, Apple’s Greater China revenue is roughly 5½ times larger than Intel’s Taiwan revenue.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 Greater China revenue as $74.2 billion (equivalent to $74,200 million), which matches the ground truth. However, it incorrectly reports Intel's Taiwan revenue as $13.5 billion in 2021, while the question asks for Intel's 2022 revenue from Taiwan, which is $13,461 million. The LLM uses a 2021 figure instead of the correct 2022 data, introducing a factual error in time period and amount. (2) The calculation comparing Apple’s revenue to Intel’s is based on outdated Intel data, making the '5½ times larger' conclusion inaccurate for 2022. While $74.2B / $13.5B ≈ 5.5, using the correct 2022 figure ($13,461M) would yield approximately 5.51 times, so the math itself is sound if the numbers were right. (3) The multi-hop reasoning is structurally correct—comparing Apple’s regional revenue including Taiwan to Intel’s country-specific revenue—but fails due to incorrect temporal data for Intel. The model does not synthesize the correct year for Intel, breaking the comparative logic. (4) Scores reflect partial correctness: numbers for Apple are accurate, but Intel’s year and exact figure are wrong, leading to a moderate score. Contextual relevance is high as the answer addresses the core comparison, but factual accuracy is compromised by the outdated Intel figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 370,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "MMM’s combined net property, plant and equipment in the Americas is $106 million (see MMM 10‑K, Note 17, page 133).  GD’s revenue from South America was $234 million in 2021 (see GD 10‑K, page 80).  Thus, MMM’s PPE investment is less than half of GD’s South‑America revenue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the value of MMM’s net property, plant, and equipment (PPE) in the Americas. The LLM states $106 million, while the ground truth is $5,864 million—a massive discrepancy. GD’s South America revenue of $234 million is correctly reported. (2) The calculation comparing MMM’s PPE to GD’s revenue is numerically flawed due to the incorrect PPE figure. The conclusion that MMM’s PPE is 'less than half' of GD’s revenue is false—using correct figures, MMM’s PPE is over 25 times larger than GD’s South American revenue. (3) The multi-hop reasoning is structurally sound—comparing asset investment in a region to revenue from a subregion—but fails due to incorrect data. The model attempts to synthesize across MMM and GD filings and acknowledges geographic overlap, but the faulty input invalidates the logic. (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning due to reliance on wrong data (3/10), and moderate contextual relevance as the structure and intent align with the question. Correctness is very low (2/10) because the core financial claim is false.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 327,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "NFLX’s auditor uses sensitivity analyses as part of its audit testing to see how changes in the company’s viewing‑pattern assumptions would alter the recorded amortization of content (see NFLX page 40).  \nCMCSA, by contrast, applies sensitivity analyses within its own risk‑management framework to monitor the effect of adverse interest‑rate movements on its debt and hedging positions (see CMCSA page 60).  Thus, NFLX’s sensitivity work is an audit‑specific assessment of amortization assumptions, while CMCSA’s is an internal tool for managing interest‑rate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to assess viewing-pattern assumptions affecting content amortization (audit-focused), while CMCSA uses sensitivity analyses internally for interest rate risk management. The distinction between audit evaluation (NFLX) and internal risk management (CMCSA) is correctly drawn. (2) Quantitative accuracy is perfect—no numbers are misstated. The ground truth mentions CMCSA’s derivative instruments reduced interest expense by $56 million in 2023, but this specific figure is not included in the LLM answer. However, since the question does not explicitly ask for financial impacts or savings from hedging, this omission does not undermine the correctness of the comparison being made. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two distinct uses of sensitivity analysis (audit vs. risk management), and two different financial contexts (amortization assumptions vs. interest rate exposure). (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original answer. The only minor shortcoming is the absence of the $56 million hedging impact, which adds contextual depth but is not central to the comparative mechanism of sensitivity analysis use. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 422,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo (PEP) actively uses exchange‑traded commodity futures—classified as Level 1 instruments—to hedge commodity‑price risk, with a notional value of about $1.6 billion as of December 2021 and these contracts are marked to market each period. In contrast, Costco (COST) reports that it holds no Level 1 financial liabilities (i.e., no exchange‑traded commodity futures or listed options as liabilities) under the fair‑value hierarchy, indicating that its risk‑management strategy does not involve Level 1 derivative liabilities. Thus, PEP’s hedging relies on Level 1 futures, whereas Costco’s disclosures show an absence of such Level 1 liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PEP uses exchange-traded commodity futures classified as Level 1 instruments to manage commodity price risk and that COST reports no Level 1 financial liabilities. The core contrast in risk management strategies under the same fair value hierarchy framework is accurately conveyed. However, the LLM introduces a specific notional value of '$1.6 billion as of December 2021' for PEP's futures, which is not present in the original answer and cannot be verified from the provided ground truth. This introduces a quantitative inaccuracy. Additionally, the original specifies that PEP's instruments are 'cash-settled daily and excluded from the balance sheet as of December 25, 2021', while the LLM only mentions they are 'marked to market each period', which is related but not equivalent. (2) The date for PEP is approximated as 'December 2021' instead of the exact 'December 25, 2021', and COST's date is given as implied but not explicitly stated (original: August 28, 2022). The notional value of $1.6 billion is an unsupported addition. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and COST), links their use (or non-use) of Level 1 instruments, and contrasts their risk management approaches within the same fair value hierarchy framework. The logic and comparison are valid and well-structured. (4) Despite the unsupported numerical figure and slight imprecision in dates and balance sheet treatment, the LLM captures the essential qualitative contrast and correctly interprets the fair value hierarchy implications. The answer remains highly relevant and mostly accurate, warranting a high correctness score with minor deductions for unverified quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 484,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K shows Enbrel’s U.S. patents will expire in 2028–2029 (fusion‑protein patent 11/22/2028, DNA‑encoding patent 4/24/2029, and formulation patent 10/19/2037)【page_10】, opening the market to biosimilar entry. Merck acknowledges that its biologics face intense biosimilar competition and pricing pressure【page_32】【page_33】, so the Enbrel expirations could further erode Merck’s market share and margins. Pfizer’s global manufacturing footprint—described as supplying products to roughly 200 countries【page_12】—positions it to scale international production of biologics (including Enbrel) ahead of biosimilar launch, potentially mitigating the competitive impact of the patent expirations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the three key U.S. patent expiration dates for Enbrel as stated in the ground truth: fusion protein (November 22, 2028), DNA encoding (April 24, 2029), and formulation (October 19, 2037). These match the ground truth in both year and specific dates, with only minor formatting differences (e.g., '11/22/2028' vs 'November 2028') which are semantically equivalent. All quantitative elements are accurate.\n\n2) The answer correctly links Merck’s exposure to biosimilar competition and pricing pressures, citing its 10-K acknowledgment of intense biosimilar threats. This aligns with the ground truth’s emphasis on Merck’s reliance on patent protection and vulnerability to margin erosion post-patent expiry. The mention of pricing pressures is supported, though the specific reference to the 340B Drug Discount Program in the ground truth is omitted—this is a minor contextual gap but does not undermine the core accuracy.\n\n3) Regarding Pfizer, the LLM correctly notes its international production role (outside U.S. and Canada) and connects it to a global manufacturing footprint serving ~200 countries. While the ground truth explicitly states Pfizer produces Enbrel internationally, the LLM infers strategic positioning for scaling biologics production ahead of biosimilar launches. This is a reasonable interpretation, though it slightly reframes rather than directly stating that Pfizer will face earlier competitive pressure abroad—still logically sound and contextually relevant.\n\n4) Multi-hop reasoning is strong: the model synthesizes Amgen’s patent timeline, Merck’s competitive risks, and Pfizer’s global production strategy across entities and documents. The logic that U.S. patent expirations indirectly affect global dynamics and firm strategies is preserved. The only minor shortcoming is the lack of explicit contrast between staggered U.S. expiry (protecting Merck longer) versus earlier international biosimilar exposure (impacting Pfizer sooner), which slightly weakens the qualitative precision. However, the overall synthesis is accurate and relevant.\n\n5) Semantic equivalence is high: all key facts are present, numbers are exact, and reasoning supports the conclusion. The answer is concise and directly responsive. Deduction of 1 point from qualitative accuracy due to slight under-articulation of the differential timing impact on Pfizer vs Merck; otherwise fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 646,
        "total_tokens": 2127
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports only about **$90 million** of unfunded private‑equity commitments measured at NAV, whereas UPS reports roughly **$2.7 billion** of unfunded commitments to private‑equity and other limited partnerships measured at NAV.  Thus EMR’s commitments are negligible in comparison—about 0.003 % of UPS’s and roughly 30,000 times smaller.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the amount reported by EMR. The original answer states EMR reports $90 of unfunded commitments, not $90 million. The LLM incorrectly interprets $90 as $90 million, which is a significant quantitative misrepresentation—off by a factor of 1 million. UPS's $2.7 billion figure is correctly stated. (2) The calculation comparing EMR’s commitment to UPS’s is therefore completely wrong: the LLM claims EMR’s amount is about 0.003% of UPS’s and 30,000 times smaller, but if EMR is $90 and UPS is $2.7 billion, the correct ratio is approximately 0.0000033% (or 1/30,000,000), not 0.003%. The '30,000 times smaller' claim stems from the erroneous assumption that $90 million was reported. (3) The multi-hop reasoning is partially sound—comparing commitments between two companies measured at NAV—but fails due to the initial misreading of the number. The accounting treatment (measured at NAV) is correctly acknowledged. (4) Contextual relevance is high as the structure and intent align with the question, but the massive numerical inaccuracy severely undermines factual correctness. The qualitative reasoning is logical but built on false premises. Thus, correctness and quantitative accuracy scores are low; qualitative accuracy is moderate due to correct entity and context identification; contextual relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 385,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment revenue in 2024 was 23 % beverage‑driven. In contrast, Mondelēz reported total beverage revenue of $1.096 billion for the 2024 year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 23% of PepsiCo's APAC segment revenue in 2024 came from beverages, matching the ground truth. It also accurately reports Mondelēz's total beverage revenue as $1.096 billion (equivalent to $1,096 million), which is correct. However, the LLM omits the explicit calculation of PepsiCo's APAC beverage revenue ($2.3 million), which is a key part of the original answer and necessary for full comparison. (2) All provided numbers are quantitatively accurate—23% and $1.096 billion match the ground truth in both value and format (allowing for $1.096 billion = $1,096 million). The missing $2.3 million figure, while derivable, is not stated or implied. (3) The reasoning is sound in identifying the two companies, correct year (2024), and relevant metrics (beverage revenue). However, the multi-hop synthesis is incomplete—while it presents both sides of the comparison, it fails to explicitly contrast PepsiCo's much smaller regional beverage revenue with Mondelēz's global beverage total, weakening the comparative insight. (4) Scores reflect high accuracy in numbers and entities, minor deduction for incompleteness in synthesis and missing derived value, and full marks for relevance as the response directly addresses the question's core.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 359,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $623 million in delinquent loans as of December 31 2023 (Table 3.8, page 161).  Those loans, once modified and performing for at least 12 months, can become reperforming loans that MetLife may purchase for its residential mortgage portfolio (MetLife’s policy described on page 240).  However, the actual availability of reperforming loans for MetLife is driven by its own underwriting criteria and market conditions, not directly by the size of Capital One’s delinquent balance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative fact—Capital One's $623 million in delinquent loans as of December 31, 2023—which matches the ground truth exactly. This satisfies the quantitative accuracy requirement. (2) The entity accuracy is correct: Capital One (COF), MetLife (MET), the date (December 31, 2023), and the concept of reperforming loans are all properly referenced. (3) The reasoning is partially correct but diverges from the ground truth in a key aspect: while the LLM accurately notes that delinquent loans can become reperforming after 12 months and that MetLife purchases such loans, it incorrectly downplays the direct influence of Capital One’s delinquent loan volume by stating that availability is 'not directly' tied to it, instead emphasizing MetLife’s underwriting and market conditions. This contradicts the ground truth, which states that the volume of initial delinquencies 'directly influences' the pool of future reperforming loans. The multi-hop synthesis is sound in linking delinquency to reperformance to MetLife’s purchasing policy, but the conclusion underestimates the causal relationship. (4) The answer is contextually relevant and well-structured, citing specific document sections. However, the weakening of the causal link between delinquent loan volume and reperforming loan availability reduces the qualitative accuracy. Thus, the correctness score is 7—core facts are right, but the reasoning contains a significant conceptual deviation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 415,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan holds roughly **$30 million** in real‑estate limited‑partnership interests (valued at NAV, see page 58). By contrast, UPS reports about **$3.3 billion** of unfunded commitments to private‑equity and real‑estate partnerships, also valued at NAV (page 89). Thus, UPS’s exposure to these illiquid, NAV‑valued assets is vastly larger—over a hundred‑fold—than UNP’s current holdings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both UNP and UPS rely on NAV-based valuations for illiquid assets in limited partnerships and accurately reports UPS's unfunded commitments of $3.3 billion. However, it introduces a specific figure of $30 million for UNP's real estate limited partnership holdings, which is not present in the original answer (ground truth). The ground truth states that UNP holds interests in limited partnerships investing in privately-held companies generally, without specifying a dollar amount or isolating real estate exposure. This quantitative inaccuracy undermines the comparison claiming UPS's exposure is 'over a hundred-fold larger.' While the direction of the comparison (UPS having significantly greater exposure) may be plausible, the magnitude is unsupported due to the fabricated or misattributed $30 million figure. The reasoning is otherwise sound: both companies use NAV as a practical expedient, face liquidity constraints, and invest in similar structures. The LLM correctly synthesizes the valuation methodology and highlights the contrast in exposure, but the inclusion of an unsupported number reduces factual reliability. Contextual relevance is high as all key themes (NAV valuation, illiquidity, limited partnerships, real estate focus) are appropriately addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 365,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s dependence on third‑party foundries for 7 nm and smaller nodes limits its control over yield, process variations and quality‑assurance procedures, exposing it to higher risks of defects, yield losses and supply disruptions. In contrast, Cisco’s contract‑manufacturing model is supported by automated testing, burn‑in, comprehensive inspection and statistical process controls that are ISO 9001‑certified, giving it tighter oversight and reducing the likelihood of quality‑control failures. Thus, AMD faces a greater exposure to quality‑control risks than Cisco.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key points are correct: AMD's reliance on third-party manufacturers (e.g., TSMC) for 7 nm and smaller nodes limits its control over yield, process variation, and quality assurance, increasing exposure to defects, yield losses, and supply disruptions. Cisco, in contrast, ensures quality through automated testing, burn-in, inspection, statistical process control, and ISO 9001 certification, giving it tighter oversight. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMD and Cisco), contrasting their manufacturing strategies and quality control mechanisms. It accurately infers that AMD has less direct control, leading to higher quality-control risk. (4) The only minor shortcoming is that the LLM does not explicitly name TSMC as AMD’s manufacturer (though this is implied in context), and slightly condenses the description of Cisco’s processes, but all critical elements (automated testing, burn-in, ISO 9001) are present. Overall, the answer captures the core comparative insight with high fidelity, warranting a 9/10 on correctness and qualitative accuracy, and full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 395,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos is an equity‑method investment that carries no voting rights, so it has no influence over the VIE’s operations; however, its economic exposure is large—about 99 % of losses and 86 % of residual returns—so it bears the bulk of financial risk and reward【page_84】【page_85】. Alphabet’s Class C capital stock likewise has no voting rights, but the company concentrates governance power in its voting Class A and B shares, using Class C shares solely as a financial instrument that can be repurchased and that does not affect control【page_82】. Thus, while both structures remove voting power, Comcast retains significant financial exposure without governance influence, whereas Alphabet separates governance from financial exposure by issuing non‑voting shares that are independent of control.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core contrast between Comcast and Alphabet correctly: both lack voting rights in certain structures (Atairos and Class C shares, respectively), but differ in governance versus financial exposure. However, there are key quantitative inaccuracies. The LLM states Comcast bears '99% of losses and 86% of residual returns'—this is not present in the original answer and contradicts the ground truth, which emphasizes Comcast’s lack of consolidation due to no control over the VIE and specifies a $1.4 billion unfunded capital commitment as of December 31, 2024. These percentages are unsupported and likely incorrect, undermining quantitative accuracy. The original answer does not mention loss/residual return allocations, so this is an overreach or misattribution. On the Alphabet side, the LLM correctly notes that Class C shares have no voting rights and that governance is retained via Class A and B shares, but omits the critical detail about $62.0 billion in repurchases in 2024, which is a key mechanism for how Alphabet manages its structure. This omission affects completeness and weakens the synthesis. Entity accuracy and contextual relevance are strong—the companies, structures (VIE, Class C stock), and conceptual framing are correct. The reasoning is logically sound in comparing governance vs. financial exposure, but the unsupported percentages and missing repurchase data reduce factual precision. Thus, while the qualitative reasoning and relevance are high, the quantitative inaccuracies and missing key figures prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 431,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC AG operates a bottling and distribution network in Austria, as part of its European operations (page 7). Philip Morris reports a market presence in Austria, holding at least a 15 % share of the country’s market (page 7). Thus, Coca‑Cola HBC’s footprint is an operational distribution network, whereas Philip Morris’s presence is measured by market‑share rather than a dedicated distribution operation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, the 15% market share for Philip Morris in Austria is correctly reported, matching the original answer. Coca-Cola HBC's operational presence in Austria is accurately stated, though the specific detail about its contribution to 41% of Coca-Cola’s total worldwide unit case volume through the five largest bottlers is omitted—this is a minor completeness gap but does not affect core accuracy. (2) All numbers are correct and properly attributed. (3) The reasoning correctly distinguishes between Coca-Cola HBC's physical distribution footprint and Philip Morris's market-share-based presence, reflecting sound multi-hop synthesis across operational disclosures. The conclusion that one has an operational network while the other reports market share is logically sound and well-supported. (4) The answer is contextually relevant and directly addresses the comparison asked. The only minor shortcoming is the omission of the broader context about Coca-Cola HBC’s global contribution, which slightly reduces completeness but does not detract from the essential correctness. Hence, a high score is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 336,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "The deterioration in Bank of America’s commercial‑real‑estate portfolio—especially the rise in non‑performing office‑property loans and higher reservable‑criticized exposure—signals a broader economic slowdown that could lift claim frequency or severity for insurers.  MetLife therefore relies on the Bornhuetter‑Ferguson method to estimate IBNR for its Protection Life and Protection Health lines, using historical experience‑derived factors that are refreshed each year to capture emerging claim‑experience trends that may be influenced by such macro‑economic stress (BAC, p. 65; MET, p. 194).  The annual update of unpaid‑claims assumptions allows MetLife to adjust the Bornhuetter‑Ferguson factors in response to the evolving credit‑quality environment reflected in the office‑property market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required by the question. (1) There are no numeric values (e.g., dollar amounts, percentages, years) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score 10. (2) The LLM correctly identifies BAC's deterioration in commercial real estate credit quality, particularly in office properties, and links it to macroeconomic stress (BAC chunk). It accurately states that MET uses the Bornhuetter-Ferguson method for estimating unpaid claims (IBNR) for Protection Life and Health products and that assumptions are updated annually to reflect emerging trends, including macroeconomic conditions (MET and Hop2 chunks). (3) The reasoning is sound: the LLM infers that BAC’s credit trends signal broader economic stress, which could increase claim frequency or severity, thereby affecting MET’s actuarial assumptions—this aligns with the ground truth’s logic chain. The only minor omission is that the ground truth specifically notes that long-duration Protection Health claims or experience-rated contracts are more sensitive because adverse claims can be passed to sponsors; this nuance is missing in the LLM answer, slightly reducing qualitative completeness. However, the core synthesis across BAC → macroeconomic deterioration → MET’s actuarial updates via Bornhuetter-Ferguson is preserved. (4) All entities (BAC, MET, Bornhuetter-Ferguson Method, Protection Life and Health products) are correctly identified and contextually relevant. Wording differs but meaning is semantically equivalent. Thus, correctness is 9 (excellent but minor detail missing), qualitative accuracy 9, contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 464,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s 10‑K (page 60) states that “each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders,” making its common stock a single‑class voting structure. Meta’s 10‑K (pages 1‑5) lists “Class A Common Stock, $0.000006 par value” as the primary voting class, but the excerpts do not disclose the specific voting rights for that class. Thus, Netflix’s common stock is a single‑class structure with one vote per share, whereas Meta’s governance relies on its Class A shares as the main voting class, though the exact vote allocation is not specified in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Netflix's uniform voting structure with one vote per share, which matches the ground truth. However, it fails to accurately describe Meta's multi-tiered structure, incorrectly claiming that the voting rights of Meta's Class A Common Stock are unspecified in the provided pages. In reality, the ground truth confirms that Meta's Class A shares have one vote per share and that Class B shares carry 10 votes per share—information that should have been accessible in Meta’s 10-K and is essential to answering the comparative governance question. The omission of Class B shares entirely undermines the multi-hop comparison. (2) There are no numerical inaccuracies per se—the 'one vote per share' for Netflix is correctly cited, and no incorrect numbers are introduced. However, the failure to report Meta’s 10 votes per share for Class B constitutes a critical missing quantitative fact, not a calculation error. (3) The reasoning is partially sound in isolating Netflix’s structure and identifying Class A as the primary voting class at Meta, but it breaks down in the comparative analysis. The model does not synthesize the key differentiator: Meta’s dual-class structure enabling concentrated control, which is central to the question. This represents a failure in multi-hop reasoning—comparing governance frameworks requires understanding both companies’ full capital structures. (4) Contextual relevance is moderate because the answer addresses the voting rights topic and cites appropriate documents, but it omits the most salient point of contrast. The answer stops short of delivering the core insight in the ground truth: that both Class A shares carry one vote, but Meta’s Class B enables disproportionate control. Thus, while factually consistent where information is provided, the answer is incomplete and misleading by omission, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 518,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 liabilities and values them at quoted market prices on commodity exchanges (MDLZ_10k_2022, page 112). PepsiCo, by contrast, does not assign a Level 1 classification to its futures; the contracts are cash‑settled daily, omitted from the fair‑value hierarchy table, and any mark‑to‑market gains or losses are recorded in operating expenses each period (PEP_10k_2022, pages 107 and 105).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are required in this question, and the dates and fiscal years (implied 2022 filings) are consistent with the context. The references to PEP_10k_2022 and MDLZ_10k_2022 are appropriate, though the ground truth cites December 25, 2021, which is a minor discrepancy likely due to different fiscal year-ends; this does not affect the conceptual accuracy. (2) The answer correctly captures the key distinction: MDLZ includes exchange-traded commodity futures in Level 1 financial liabilities using quoted market prices, while PEP excludes them from the fair value hierarchy table due to daily cash settlement. (3) The multi-hop reasoning is sound—comparing treatment across two companies, synthesizing their differing reporting practices despite both using cash settlement. (4) The LLM adds a detail not in the original answer—recording gains/losses in operating expenses (PEP_10k_2022, page 105)—which is accurate and enriches the response without introducing error. The only minor shortcoming is that the original answer notes both companies still treat the instruments as Level 1 in substance, but PEP omits them from tables; the LLM could have clarified that PEP’s exclusion doesn’t imply a different valuation approach, just a reporting omission. However, the core contrast is correctly conveyed. Thus, the answer is highly accurate with only slight room for improved nuance in synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 422,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Merck and Gilead’s collaboration on the islatravir/lenacapavir long‑acting HIV candidates splits global development and commercialization costs 60 % to Gilead and 40 % to Merck (with equal revenue sharing until thresholds), thereby limiting each partner’s R&D exposure.  By contrast, Pfizer’s 2024 10‑K cites enterprise‑wide cost‑realignment and manufacturing‑optimization programs as internal cost‑reduction initiatives that cut overall operating expenses but do not directly offset the R&D spend on long‑acting HIV therapies.  As a result, Merck and Gilead can hedge their financial risk through the partnership, while Pfizer’s exposure to the potentially high development costs of long‑acting HIV products remains largely borne by the company itself, potentially tightening its margin if such programs are pursued without a similar cost‑sharing arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: the 60/40 cost split (Gilead/Merck), equal revenue sharing, and the absence of incorrect dollar amounts or percentages. While the LLM does not explicitly name the $2.0B and $3.5B revenue threshold amounts from the ground truth, this is a minor omission rather than an error. (2) The LLM correctly identifies the companies (Merck, Gilead, Pfizer), the drug candidates (islatravir/lenacapavir), and the year of Pfizer's initiatives (implied via 2024 10-K), satisfying entity accuracy. (3) The reasoning is sound: it correctly contrasts a collaborative cost-sharing model (Merck/Gilead) with Pfizer’s internal cost-reduction strategy, and draws a logical conclusion about differing financial exposure in long-acting HIV therapies. The multi-hop synthesis—linking partnership structure to risk exposure and comparing it to Pfizer’s standalone approach—is well executed. (4) The answer is contextually relevant and directly addresses the comparison and implications on financial exposure. The only reason for not scoring a 10 is the omission of the specific revenue threshold amounts, which are part of the full factual picture but do not undermine the overall correctness or interpretation of the arrangement. Semantic equivalence is maintained, and the conclusion is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 387,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx has already transitioned all LIBOR‑referenced debt and contracts to the alternative reference rate SOFR and has not elected the optional expedients under ASU 2022‑06, so it reports no material exposure to LIBOR‑related hedging adjustments as of May 31 2024 (see pages 93 and 74).  UPS, in contrast, continues to use hedging relationships—primarily for foreign‑currency and interest‑rate risk—that are not tied to LIBOR and therefore are not affected by the reference‑rate reform; the ASU’s sunset date of December 31 2024 allows UPS to maintain any LIBOR‑based hedges until that time.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a key factual inaccuracy in its characterization of UPS's hedging relationships. Quantitatively, the dates (May 31, 2024, and December 31, 2024) are accurate and correctly cited, aligning with the ground truth. The statement that FDX has transitioned to SOFR and reports no material exposure is consistent with the original answer, which states FDX has seen no material effect from ASU 2022-06. However, the LLM incorrectly claims that UPS's hedging relationships 'are not tied to LIBOR' and therefore are unaffected by reference rate reform. This contradicts the original answer, which implies UPS may still have LIBOR-based contracts and could be actively benefiting from the extended relief under ASU 2022-06 through 2024. The LLM's reasoning is flawed in suggesting UPS is unaffected by LIBOR transition, when the ground truth indicates UPS may be leveraging the extended provisions—meaning it likely does have LIBOR-related hedges. This misrepresents the comparative analysis the question demands. While the answer correctly identifies the sunset date and FDX's position, it fails in the multi-hop synthesis by incorrectly downplaying UPS's exposure and use of ASU 2022-06. The contextual relevance is high because it addresses both companies and the ASU standard, but the qualitative accuracy suffers due to this key misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 383,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in the hands of the CEO and a handful of Class B holders, limiting minority shareholder influence and weakening governance protections. Alphabet’s Class B shares carry ten votes per share, but they automatically convert to Class A on sale or transfer, so the voting advantage is retained only by long‑term holders and new investors cannot acquire it, preserving a differential but not as entrenched as Meta’s structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between META's and GOOGL's dual-class structures. (1) It correctly identifies that Meta’s Class B shares concentrate voting power among insiders (e.g., the CEO), weakening governance protections for Class A shareholders—this aligns with the ground truth. It also accurately states that Alphabet’s Class B shares have 10 votes per share versus 1 for Class A, and that they convert to Class A upon sale or transfer—key quantitative and structural facts are correct. (2) No calculations are required, but the numerical voting ratio (10:1) is correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information about both companies’ stock structures and draws a valid comparative conclusion—that GOOGL’s conversion mechanism limits the entrenchment of control compared to Meta’s more persistent structure. (4) The only minor omission is that the ground truth mentions Meta’s Class B shares maintain control unless voting power drops below 35%, a detail absent in the LLM response. However, this does not undermine the overall correctness. The answer is semantically equivalent in intent and substance, with slightly less detail on Meta’s declassification threshold. Wording differences are acceptable and do not affect factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 366,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO uses option contracts as cash‑flow hedges for forecasted foreign‑currency transactions; the mark‑to‑market gains and losses are held in AOCI and reclassified into earnings when the underlying transaction occurs, with a net deferred gain of about $99 million in 2024【page_121】. In contrast, MDLZ reports gains and losses on forecasted transactions as part of its economic‑hedging program and records them directly in net earnings—$106 million in 2024【page_97】—without deferral. Thus, KO’s strategy offsets forecasted‑transaction risk through cash‑flow hedges and defers the impact, whereas MDLZ’s approach captures the impact immediately in earnings and uses economic hedges across multiple asset classes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly captures the core contrast between KO's and MDLZ's hedging strategies: KO uses cash flow hedges with gains/losses deferred in AOCI, while MDLZ recognizes gains/losses on forecasted transactions directly in earnings. This reflects sound multi-hop reasoning and correct entity identification (KO, MDLZ, hedging strategies, accounting treatments). However, there is a critical quantitative inaccuracy: the LLM states KO had a 'net deferred gain of about $99 million in 2024', which is not supported by the original answer or ground truth — the original makes no mention of this figure. The MDLZ gain of $106 million is correctly cited and matches the ground truth, which specifies this amount was recognized through cost of sales and interest and other expense. The LLM simplifies this to 'in net earnings' without specifying the line items, slightly reducing completeness. Additionally, the original answer notes MDLZ’s gains were split ($106M in cost of sales, $17M in interest and other expense), but the LLM omits the $17M component, leading to partial information. While the qualitative comparison of KO’s structured deferral vs. MDLZ’s immediate recognition is accurate and contextually relevant, the inclusion of an unsupported $99M figure for KO undermines quantitative accuracy. The term 'economic hedges' for MDLZ is reasonable but not explicitly confirmed in the original, though implied. Overall, the answer is directionally correct with strong reasoning but contains a significant factual error in the KO deferred gain amount and omits part of MDLZ’s gain breakdown.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 436,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s fixed‑income pension assets are reported as “not subject to leveling,” meaning they are valued at NAV using a practical expedient and are not placed in the fair‑value hierarchy.  By contrast, Bristol‑Myers Squibb classifies its fixed‑income pension assets as Level 2, valuing them with observable inputs such as quoted prices for similar instruments and other market data.  Thus, TMO relies less on observable market data for pension asset valuation, whereas BMY relies more heavily on observable market inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: TMO's fixed income funds are reported as 'not subject to leveling,' which the LLM correctly interprets as being valued at NAV using a practical expedient and excluded from the fair value hierarchy. BMY's classification under Level 2 is accurately described with reference to observable inputs like quoted prices for similar instruments. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the absence of any numerical errors supports a score of 10. (3) The multi-hop reasoning—comparing two companies' valuation approaches within the fair value hierarchy and inferring differing reliance on observable market data—is sound and well-executed. The LLM correctly synthesizes that TMO relies less on observable market data while BMY relies more, which aligns with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that TMO's approach likely involves non-standard or unobservable methods (e.g., 'measured using methods other than quoted market prices'), which is implied in the original answer. However, stating valuation via NAV practical expedient is a valid and common reason for exclusion from the hierarchy, so this omission does not undermine correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 426,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "The FAR requires that revenue for cost‑plus‑fixed‑fee U.S. Government contracts be recognized over time as the contractor’s work is performed, because the contract clauses give the government ownership of work‑in‑process and allow continuous transfer of control. Lockheed Martin follows this rule, recognizing revenue on a percentage‑of‑completion basis as costs are incurred【page_77】【page_78】. Boeing’s 10‑K does not detail its policy in the pages provided, but the same FAR provisions apply, so Boeing’s revenue for cost‑plus‑fixed‑fee contracts is typically recognized when control is transferred (i.e., at the point in time of completion or milestone payment), which can create timing differences relative to Lockheed Martin’s over‑time recognition.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in reasoning: it incorrectly states that Boeing recognizes revenue for cost-plus-fixed-fee contracts at a point in time (e.g., upon completion or milestone payment), which contradicts the ground truth. The original answer correctly notes that both LMT and BA recognize revenue over time due to FAR-mandated termination for convenience clauses allowing payment for costs incurred plus profit, enabling continuous transfer of control. The LLM wrongly infers a timing difference based on an unsupported claim about Boeing’s policy, despite acknowledging that FAR applies to both. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is flawed: while the model correctly identifies LMT’s over-time revenue recognition under FAR, it fails to properly synthesize BA’s treatment. It admits Boeing’s 10-K does not detail the policy in the provided pages but then speculates incorrectly about point-in-time recognition, failing to infer from general FAR principles and Boeing’s termination for convenience rights, which should lead to the same over-time conclusion as LMT. This breaks the multi-hop logic required. (4) Contextual relevance is fair—the answer addresses the core topic of FAR impact on revenue timing and cites relevant concepts like control transfer and contract clauses. However, the incorrect conclusion about Boeing undermines the qualitative accuracy and overall correctness. The answer would have scored higher if it had correctly aligned Boeing’s treatment with Lockheed Martin’s under FAR, noting potential minor differences in profit negotiation or contract specifics, as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 489,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "Abbott Laboratories’ indentures (page 87) name U.S. Bank National Association as trustee and use Abbott Ireland Financing DAC as the issuer, with notes issued in 2018 (1.500% due 2026), 2019 (0.100% due 2024 and 0.375% due 2027), and 2020 (1.150% due 2028 and 1.400% due 2030). AbbVie’s debt agreements with U.S. Bank National Association are not disclosed in the supplied pages, so we cannot confirm whether U.S. Bank also serves as trustee or the timing of any AbbVie note issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains some correct information about Abbott Ireland Financing DAC and U.S. Bank National Association, including accurate note details such as the 1.500% Note due 2026 and 0.100% Note due 2024, and correct trustee role for U.S. Bank. However, it incorrectly states that AbbVie’s debt agreements are 'not disclosed in the supplied pages,' which contradicts the ground truth that provides specific dates and structures for AbbVie’s Supplemental Indentures (e.g., September 26, 2019; November 21, 2019; May 14, 2020). This omission severely undermines the multi-hop comparison required by the question. The LLM also adds unverified details—such as a 0.375% note due 2027, 1.150% due 2028, and 1.400% due 2030—that are not present in the original answer, introducing factual inaccuracies. While the trustee role of U.S. Bank is correctly identified for Abbott, the failure to acknowledge AbbVie’s similar use of U.S. Bank as trustee, along with the absence of any discussion of Elavon Financial Services DAC as a paying agent in AbbVie’s structure, results in a major breakdown in comparative analysis. The reasoning is flawed due to incorrect sourcing assumptions and incomplete entity mapping. Although the answer attempts to address the question’s components, the lack of accurate synthesis between AbbVie and Abbott structures—especially regarding trustee roles and issuance timelines—renders the response largely incorrect. Quantitative accuracy is partially preserved for Abbott’s notes but compromised by unsupported additions. Contextual relevance is moderate because the framework of the response aligns with the question, but factual foundation is weak.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 455,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVIDIA’s advanced‑node portfolio is almost entirely built on TSMC’s 7 nm and smaller processes; the company warns that any shortfall in TSMC capacity or yield at those nodes could materially harm its business (NVDA pages 24‑25). AMD also uses TSMC for 7 nm or smaller chips, but it relies on GLOBALFOUNDRIES for wafers at process nodes larger than 7 nm, giving AMD a more diversified wafer supply for competitive IC production (AMD page 23). Both firms remain exposed to TSMC’s fabrication capabilities for their high‑performance product lines.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of numbers and entities: both NVDA and AMD rely on TSMC for 7nm and smaller process nodes, and the citation of page numbers (24–25 for NVDA, 23 for AMD) aligns with typical 10-K risk disclosures. There are no numerical inaccuracies, so quantitative accuracy is perfect. Contextual relevance is high, as the response directly addresses the comparison between NVDA’s and AMD’s foundry dependencies and their exposure to TSMC. However, the qualitative accuracy is slightly lower because the LLM introduces a claim not present in the ground truth: that AMD relies on GLOBALFOUNDRIES for nodes larger than 7nm as part of a diversified supply chain. While this is factually true in general industry knowledge, it is not mentioned in the original answer derived from the knowledge graph, which focused solely on AMD’s reliance on TSMC and the importance of advanced nodes and increased wafer sizes for cost efficiency. The original answer did not mention GLOBALFOUNDRIES or any diversification benefit, so this addition represents an unsupported inference that affects the fidelity of the multi-hop synthesis. Additionally, the original emphasized shared supply chain vulnerabilities and risks like yield issues, cost increases, and launch delays—points only partially covered in the LLM version. Thus, while the core facts about TSMC dependency are correct, the LLM omits key elements of the original synthesis and adds external information, reducing completeness and alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 421,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "Colgate‑Palmolive operates manufacturing facilities in Thailand (see CL_10k_2024, page 25), so its supply chain—importing raw materials and exporting finished goods—depends on Thai customs and tax rules. The WTO panel decision (PM_10k_2024, page 68) shows Thailand has not fully complied with customs‑valuation requirements, raising the likelihood of stricter enforcement or duty adjustments. Consequently, unresolved customs and tax compliance issues could increase Colgate‑Palmolive’s compliance costs, expose it to potential penalties or shipment delays, and heighten its regulatory risk exposure in Thailand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies Colgate-Palmolive's manufacturing presence in Thailand (citing CL_10k_2024, page 25) and links it to reliance on Thai customs and tax rules for imports/exports. It accurately references the WTO panel decision involving Philip Morris (PM_10k_2024, page 68) and Thailand’s non-compliance, which is central to the regulatory risk. (3) The multi-hop reasoning is sound: it connects Philip Morris’s unresolved WTO dispute to broader customs enforcement risks in Thailand, then logically infers that Colgate-Palmolive, as a manufacturer operating in the same jurisdiction, faces increased compliance costs, penalties, delays, and regulatory exposure. This mirrors the original answer’s logic. (4) The only minor shortcoming is that the LLM does not explicitly mention the inoperability of the WTO Appellate Body as a reason for ongoing non-compliance, which slightly reduces qualitative completeness. However, the core causal chain—non-compliance → regulatory inertia → risk to Colgate-Palmolive—is preserved. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect: the response directly addresses operational costs and regulatory risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 407,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "The $265,000 decline in UnitedHealth’s Medicare Part D enrollment (3,050 k in 2024 versus 3,315 k in 2023, an 8 % drop【page_31】) is an early sign that the IRA’s Medicare Part D redesign—introducing new cost‑sharing rules and a manufacturer‑discount program—has begun to shrink the beneficiary base.  Pfizer projects a roughly $1 billion revenue hit in 2025 from the same redesign, because the IRA’s Part D manufacturer‑discount and rebate requirements shift costs to manufacturers and cut drug sales【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports the $265,000 decline in UNH's Medicare Part D enrollment from 3,315k in 2023 to 3,050k in 2024, correctly calculating an 8% drop. The $1 billion revenue loss projected by Pfizer in 2025 is accurately cited. These numbers match the ground truth in magnitude and direction, with acceptable formatting (e.g., '3,050k' for 3,050,000). 2) Quantitative accuracy is perfect: the enrollment numbers are correct, the difference is indeed ~265,000, and the percentage decline is approximately 8% ((265/3,315) ≈ 7.99%), so the calculation is sound. The $1 billion figure for Pfizer is correctly stated. 3) The multi-hop reasoning is strong: the model connects UNH's enrollment decline to the IRA's redesign, identifies the financial impact on manufacturers via new discount requirements, and links this to Pfizer’s projected revenue loss. It correctly infers that cost-shifting under the IRA affects both enrollment dynamics and manufacturer revenues. The only minor shortcoming is that it does not explicitly mention the $2,000 out-of-pocket cap or the specific 10%/20% manufacturer discounts, which are part of the IRA’s redesign detailed in the original answer. While implied via 'cost-sharing rules' and 'manufacturer-discount program', this slight omission reduces qualitative completeness slightly. 4) The answer is highly contextually relevant, directly addressing the relationship between enrollment decline, IRA redesign, and Pfizer’s revenue loss. Semantic equivalence is maintained: the LLM conveys the same core causal chain as the ground truth, with precise data and logical synthesis across entities (UNH, PFE, IRA, Part D).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 469,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin’s $4.863 billion of private‑equity funds are all valued under the NAV practical expedient, whereas FedEx applies the same NAV practical expedient to only $37 million of its equity securities that lack readily determinable fair values—making Lockheed’s NAV‑valued investment roughly 130 times larger than FedEx’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error by asserting that FedEx applies the NAV practical expedient to only $37 million of equity securities. This figure does not appear in the ground truth and is unsupported. The original answer states that FedEx applies the NAV practical expedient but does not specify a dollar amount—only that impairments are immaterial. Thus, the quantitative comparison (130x) is fabricated. (2) The Lockheed Martin figure of $4,863 million is correctly reported (equivalent to $4.863 billion), but the FedEx number is entirely incorrect. No calculation based on a false input can be valid, so the 130x comparison fails. (3) The reasoning is flawed in the multi-hop synthesis: while both companies apply the NAV practical expedient, the LLM incorrectly introduces a quantitative comparison not present in the source data. The original answer focuses on differences in disclosure and accounting treatment (e.g., adjustments for observable prices and impairments), which the LLM omits entirely. (4) The contextual relevance is moderate because the answer addresses the accounting policy (NAV practical expedient) and compares the two firms, but it replaces qualitative nuances with a false quantitative claim. Correctness and quantitative accuracy are low due to the invented number and invalid comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 375,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s Class B shares carry 10–15 votes each and are convertible share‑for‑share into Class A shares that carry only one vote (page 91). When B holders convert, the number of high‑vote shares falls and the proportion of voting power held by B shareholders is diluted. Alphabet’s dual‑class scheme gives Class A shares one vote and Class C shares none; the $62 B 2024 repurchase of both classes simply shrinks the total number of shares, leaving the voting‑right structure unchanged—Class A still has one vote per share and Class C has none—so it does not dilute voting power in the same way, although it reduces overall voting capacity by eliminating Class A shares (page 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that Comcast’s (CMCSA) Class B shares carry '10–15 votes each'—this is false. The ground truth specifies that CMCSA's Class B stock holds 33⅓% of total voting power on a non-dilutable basis, not per-share vote counts, and is convertible share-for-share into Class A. There is no mention of 10–15 votes per share in the original data. (2) The claim that conversion leads to dilution of B shareholders' voting power is incorrect: the original answer explicitly states that CMCSA’s Class B voting power is 'non-dilutable under their articles of incorporation,' meaning it maintains fixed influence regardless of conversions. Thus, the core reasoning about dilution in CMCSA is flawed. (3) Regarding GOOGL, the LLM correctly identifies that the $62 billion 2024 repurchase targets Class A and C shares and does not alter the voting structure, which is accurate and aligns with the ground truth. It also correctly notes that Class C shares have no voting rights. However, it fails to mention that GOOGL’s Class B shares have 10 votes per share—a key part of the comparison. (4) The multi-hop reasoning is weak: the model fails to contrast CMCSA’s fixed 33⅓% non-dilutable voting mechanism with GOOGL’s structural 10:1 voting disparity. Instead, it fabricates a per-share vote range for CMCSA and mischaracterizes the dilution mechanism. (5) While the answer addresses share repurchases and conversion, it misses the central point that CMCSA’s structure protects voting power from dilution, whereas GOOGL’s repurchase affects economic value but not voting ratios. Quantitative accuracy is low due to incorrect vote counts and lack of correct percentages; only the $62B figure is correct. Contextual relevance is moderate as it attempts the comparison and cites repurchases, but the reasoning is based on incorrect premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 517,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50 % stake in Red Oak Sourcing is a joint sourcing partnership that does not own inventory or generate revenue for either company, so its revenue exposure is indirect and essentially negligible. In contrast, Lilly’s top‑three distributor Cardinal Health accounts for 15–20 % of Lilly’s consolidated revenue, representing a substantial and direct revenue exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all percentages (15–20%) and ownership stake (50%) are correct. There are no calculations required, but the characterization of LLY's (Lilly's) revenue exposure through Cardinal Health as 15–20% of consolidated revenue matches the original answer exactly. (2) The LLM correctly identifies the entities: CVS, Red Oak Sourcing, LLC, Cardinal Health, Inc., and Lilly (LLY), and accurately describes the nature of Red Oak as a joint venture that does not hold inventory. (3) The multi-hop reasoning is sound: it contrasts CVS’s indirect, non-revenue-generating sourcing arrangement via Red Oak with Lilly’s direct and significant revenue dependency on Cardinal Health as a top distributor. (4) The LLM omits the mention of McKesson and AmerisourceBergen as the other two distributors, which is a minor omission affecting completeness but not the core comparison. However, since the question focuses on the comparison with Cardinal Health specifically, this does not undermine the correctness. The conclusion that CVS has negligible revenue exposure while Lilly has substantial direct exposure is logically and factually supported. Wording differs but semantic equivalence is preserved. Minor formatting (e.g., ' %' vs '%') is acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 368,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock carries **10 votes per share**【page_82】, whereas Honeywell’s common stock carries **1 vote per share**【page_18】.  The difference in voting rights is therefore **9 votes per share**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: UPS Class B common stock has 10 votes per share, Honeywell common stock has 1 vote per share, and the difference is 9 votes per share. (2) Quantitative accuracy is perfect—numbers are correctly stated and the subtraction (10 - 1 = 9) is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesized voting rights data from two different companies (UPS and Honeywell) as required by the question, referencing appropriate sources (page_82 and page_18). (4) The answer is contextually relevant, directly addressing the difference in voting rights per share between the two companies' stocks as of 2024. Wording differs slightly from the original answer but maintains full semantic equivalence without omissions or errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 246,
        "total_tokens": 1346
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "AMGN’s 3.625% 2024 Notes mature in 2024, and their maturity triggered the termination of $1.4 billion of associated interest‑rate swap contracts【page_149】. In contrast, AbbVie’s interest‑rate swap contracts that were designated as cash‑flow hedges matured in November 2022, an earlier date than the AMGN notes’ maturity【page_81】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that AMGN's 3.625% 2024 Notes matured in 2024 and triggered the termination of $1.4 billion in interest rate swaps, which matches the ground truth. However, it incorrectly states that AbbVie’s interest rate swaps designated as cash flow hedges matured in November 2022, implying a maturity event, whereas the ground truth clarifies that ABBV had $0 in active swaps in 2024, not that existing swaps matured in 2022. The original answer notes a reduction from $6 million in 2022 to $0 in 2024 but does not support the claim that the swaps matured in November 2022—this specific date and event are not in the ground truth. (2) Quantitatively, the $1.4 billion and 2024 maturity for AMGN are correct. The $6 million figure for ABBV in 2022 is missing in the LLM answer, weakening completeness. The November 2022 maturity date for ABBV swaps is unsupported and likely incorrect extrapolation. (3) The multi-hop reasoning is partially sound—linking AMGN’s note maturity to swap termination is correct. However, the comparison with ABBV fails because it misrepresents the absence of 2024 hedges as a maturity event rather than a strategic or reporting outcome. The model does not accurately synthesize that ABBV had no active hedges in 2024, which is central to the contrast. (4) Scores reflect partial correctness: quantitative accuracy is moderate due to one incorrect date and missing $6M context; qualitative reasoning is weakened by flawed logic in the ABBV half; contextual relevance remains high as the response addresses the core comparison topic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 436,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One’s adoption of ASU 2022‑02 removed the “concession” test that previously defined a troubled‑debt restructuring (TDR) and re‑classified all qualifying modifications as financial‑difficulty modifications (FDMs).  The types of relief—interest‑rate reductions, term extensions, principal‑balance reductions, and combinations of these—remained the same, but Capital One now reports the dollar amounts of each type (e.g., $687 m in interest‑rate reductions, $970 m in term extensions, $21 m in principal reductions) and the resulting weighted‑average interest‑rate cuts (19.3 % domestic card, 27.1 % international card, 8.7 % auto, 2.0 % retail, 0.25 % commercial) in Tables 3.6 and 3.7.  By contrast, JPMorgan’s prior TDR disclosures (pre‑January 2023) reported only the aggregate effects of concessions—primarily interest‑rate cuts and term extensions—showing changes in weighted‑average rates (from 4.75 % to 3.35 % for rate cuts), extended terms (22 to 38 years), charge‑offs ($1 m), principal deferred ($16 m), principal forgiven ($2 m), and re‑default balances ($147 m).  Thus, Capital One’s new reporting provides more granular, dollar‑level detail on each modification type, whereas JPMorgan’s earlier TDR reporting focused on aggregate rate and term changes and related charge‑off metrics.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies the shift from TDRs to FDMs under ASU 2022-02 and notes that modification types (interest rate reductions, term extensions, etc.) remained consistent, it fabricates specific dollar amounts and percentages not present in the ground truth: $687M in interest-rate reductions, $970M in term extensions, $21M in principal reductions, and detailed rate cuts by segment (19.3% domestic card, etc.) are not supported by the original answer and appear to be hallucinated. Similarly, the LLM attributes specific pre-2023 TDR data to JPMorgan—including rate changes from 4.75% to 3.35%, extended terms of 22–38 years, charge-offs of $1M, principal deferred/forgiven, and re-default balances of $147M—that contradict the ground truth, which states JPMorgan reported $136M in FDMs for 2023 with rate reductions from 7.21% to 4.44% and term extensions up to 20 years. The original answer does not provide JPMorgan’s pre-2023 TDR metrics, so the LLM’s detailed disclosures are unsupported. The qualitative reasoning is partially sound: it correctly frames the conceptual shift from concession-based TDRs to FDMs and contrasts Capital One’s more granular reporting with JPMorgan’s prior aggregate approach. However, the multi-hop synthesis fails because the LLM invents data points instead of relying on verified disclosures. Contextually, the answer is relevant and structured well, addressing modification types and financial effects as asked. However, due to the extensive inclusion of false quantitative details, the correctness score is low despite accurate conceptual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1561,
        "completion_tokens": 458,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s hedging strategy uses interest‑rate swaps whose dollar‑weighted average maturity is about two years, deliberately matching the duration of the debt exposure it is protecting (i.e., the swaps’ maturities are aligned with the debt’s duration)【page_82】. UPS, by contrast, employs an economic‑hedge approach that does not tie swap maturities to the debt’s duration but instead focuses on the overall economic impact of rate changes on its balance sheet【page_139】. This contrast shows that GD prioritizes cash‑flow matching to reduce volatility, while UPS prioritizes managing broader economic exposure to interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the statement that GD's swaps have a 'dollar-weighted average maturity of about two years' matches the original answer's 'dollar-weighted two-year average maturity'—this is factually correct and properly attributed. There are no numerical inaccuracies. (2) The LLM correctly identifies that GD aligns swap maturities with debt exposure duration, while UPS does not specify such alignment and instead focuses on economic hedges without maturity matching. This captures the core contrast in hedging approaches. (3) The reasoning is sound: GD’s strategy emphasizes duration or cash-flow matching to reduce volatility, which is semantically equivalent to 'managing interest rate risk over time'; UPS’s focus on 'overall economic impact' and lack of maturity alignment reflects its use of offsetting positions to manage broader exposure, consistent with the ground truth’s description of dynamic risk mitigation. (4) The only minor shortcoming is that the LLM omits explicit mention of UPS using 'offsetting positions to terminate existing swaps and eliminate market valuation effects'—a specific mechanism highlighted in the original. While the LLM captures the broader intent (managing economic exposure), this detail would strengthen completeness. However, the omission does not distort the meaning. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across entities and strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 419,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 repurchase program bought 78 million Class A shares (and 450 million non‑voting Class C shares)【page_83】.  Because each Class A share carries one vote and each Class B share carries ten votes【page_81】, removing Class A shares from the outstanding pool raises the proportion of voting power that the remaining undiluted Class B shares hold, while the Class C repurchases have no effect on voting.  By contrast, Comcast’s Class B shares already command a fixed 33 ⅓ % of the company’s voting power that is non‑dilutable under its charter【page_33】, so their influence remains unchanged regardless of share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly explains that Alphabet's 2023 repurchase of Class A (voting) and Class C (non-voting) shares increases the relative voting power of the undiluted Class B shares due to the reduction in outstanding voting shares. This matches the core reasoning in the original answer. (2) The quantitative details—78 million Class A and 450 million Class C shares repurchased—are specific and consistent with the source (page_83), though the dollar amount ($62.2 billion) from the ground truth is not mentioned; however, the share counts are more granular and arguably more informative. The voting rights (1 vote for Class A, 10 for Class B) are correctly cited. (3) The comparison to Comcast is sound: the LLM correctly identifies that Comcast’s Class B shares have a fixed, non-dilutable 33 1/3% voting power (per page_33), which is structurally different from Alphabet’s dynamic concentration via repurchases. (4) The reasoning is multi-hop and correct: it connects share repurchases → reduction in voting supply → increased relative power of Class B → contrast with Comcast’s fixed voting structure. The only minor omission is the lack of explicit mention of the $62.2B repurchase value, but the share-level detail compensates. Wording differs but semantic meaning is equivalent. All entities (Alphabet, Comcast, Class A/B/C shares, 2023) are correct. Thus, the answer is factually strong, contextually relevant, and logically sound, meriting a 9/10 due to the missing dollar figure, though not critical to the core reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 437,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Rule 10b5‑1 plan at Disney is limited to **up to 372,412 shares** of common stock (linked to vested options) and is scheduled to **terminate on December 17, 2024**.  \nPeggy Alford’s plan at Meta, by contrast, authorizes the sale of **up to $1.2 million worth of Class A shares** and will **terminate on November 15, 2025**. Thus, Iger’s plan is defined by a fixed share count and a shorter‑term exit date, while Alford’s is dollar‑based and extends roughly one year beyond Disney’s termination.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) for Robert Iger at DIS and the dollar amount ($1.2 million) for Peggy Alford at META are correctly stated. Termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are accurate. (2) Completeness: The answer addresses all parts of the question—structure (share-based vs. value-based), number of shares/dollar amount, termination dates, and the comparison between the two plans under the same Rule 10b5-1(c) framework. (3) Entity accuracy: Correct individuals (Iger, Alford), correct companies (DIS/Disney, META/Meta), correct stock types (Class A common stock for META), and correct regulatory rule (Rule 10b5-1) are all properly identified. (4) Reasoning: The multi-hop synthesis is sound—correctly contrasting Iger’s fixed-share, option-linked plan with Alford’s value-based, longer-duration plan. The conclusion about differing structures (fixed shares vs. dollar value) and duration is logically derived and semantically equivalent to the original answer. Minor wording differences (e.g., 'shorter-term exit date' vs. 'shorter duration') do not affect factual accuracy. All information is contextually relevant and precisely aligned with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 364,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards vest over a three‑year period that can be **ratable or a cliff at the end of the period** (time‑vested RSUs and stock options vest over three years, with some awards vesting ratably and others vesting at the end of the three‑year restriction period【page_96】【page_98】).  \nPhilip Morris International’s RSUs, by contrast, **vest on the third anniversary of the grant** (a three‑year cliff) and the fair value is amortized to expense over the same three‑year restriction period【page_110】.  \n\nBecause CL’s awards may vest ratably, the company records compensation expense on a straight‑line basis each year, potentially recognizing expense earlier than the actual share issuance. PMI, while also amortizing expense over three years, only issues the shares at the end of that period, so its expense accrues over the same time span but the vesting (and share issuance) occurs only at the third anniversary.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with high factual accuracy and strong contextual relevance. (1) Quantitatively, there are no errors: while no specific dollar amounts or dates (e.g., $160M, December 31, 2023, seventeen months) are mentioned in the LLM response, none are misstated—this is a case of omission rather than inaccuracy. The vesting periods (three years) and expense recognition timelines are correctly described. (2) The LLM accurately captures that CL uses both ratable and cliff vesting for equity awards (stock options and RSUs), leading to straight-line expense recognition over three years. PM’s RSUs vest on the third anniversary (cliff vesting), with expense amortized over the three-year restriction period—this matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts CL’s potentially earlier expense recognition due to ratable vesting with PM’s cliff-based issuance, even if it omits PM’s accelerated vesting upon death, disability, or age 58—a key nuance in the original answer affecting compensation timing. (4) The implication about expense recognition is well-reasoned and semantically aligned, though the LLM does not mention PM’s $160M unrecognized cost or the 17-month weighted-average recognition period, which weakens completeness. Despite these omissions, the core comparison and implications are accurate, warranting a high score but not perfect due to missing details affecting qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 413,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Regulatory limits on flavoring and plain‑packaging cut the companies’ ability to differentiate products, eroding brand equity and squeezing pricing power.  In the EU, the TPD and plain‑packaging rules have already forced Philip Morris International to reduce flavor options and branding, pushing sales toward lower‑priced, less differentiated offerings (PM 41, 42, 43).  In the U.S., potential FDA flavor bans and packaging restrictions similarly constrain Altria’s ability to promote premium brands, leading to down‑trading and margin compression (MO 41, 42, 38‑40).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core impact of regulatory restrictions—flavor bans and standardized packaging—on brand equity and pricing power for PM and MO, and references relevant regulations in the EU and U.S., showing good contextual understanding. It accurately mentions the EU's Tobacco Products Directive (TPD) affecting PM and potential FDA actions in the U.S. affecting Altria (MO), aligning with the ground truth. However, it omits several key specifics from the original answer: (1) no mention of specific countries with menthol bans (Turkey, Brazil, California), (2) no reference to the 8% illicit trade in the EU as a compounding factor for PM, (3) no mention of MO’s constraints in six U.S. states and D.C., or the Massachusetts nicotine cap proposal, (4) no reference to FCTC guidelines or State Settlement Agreements that limit advertising. The LLM uses document citations (e.g., PM 41, MO 41) not present in the ground truth and not verifiable from the provided data, which undermines reliability. While the qualitative reasoning about down-trading and margin compression is plausible, it is less substantiated than the original’s multi-hop synthesis across geographies and regulatory frameworks. Quantitatively, no incorrect numbers are stated (no false percentages or figures), so quantitative accuracy is high by default, though the answer lacks numeric detail. The entity mapping is mostly correct (PM and MO/Altria referenced appropriately), but the reasoning is less comprehensive in connecting multiple regulatory layers across jurisdictions. Thus, the answer is partially correct but misses significant factual depth and multi-hop synthesis required for full accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 461,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is embedded in its fixed‑maturity securities portfolio; it records a $35 million allowance for credit losses and adjusts yields on a trade‑date basis to reflect actual payments, updated prepayment expectations and expected credit losses (page 169‑170).  By contrast, BAC values its RMBS holdings at Level 3 fair value, with pre‑payment speed (1–42 % CPR) and default rate (0–3 % CDR) listed as significant unobservable inputs that directly drive fair‑value volatility (pages 159‑161).  Thus, AIG’s approach focuses on a credit‑loss allowance and yield recalibration, whereas BAC’s valuation risk is driven by sensitivity to pre‑payment and default assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures AIG's accounting treatment for structured securities, including RMBS, focusing on yield adjustments based on actual payments, prepayment expectations, and credit losses, with a corresponding impact on net investment income and amortized cost. It also accurately notes AIG's use of an allowance for credit losses on non-high credit quality securities. For BAC, it correctly identifies that RMBS holdings are valued at Level 3 fair value, with prepayment speeds (1–42% CPR) and default rates (0–3% CDR) as key unobservable inputs driving valuation volatility. (2) The quantitative details are mostly correct: the $35 million allowance for credit losses for AIG is factually accurate per the source (page 169–170), and the CPR/CDR ranges for BAC (pages 159–161) are correctly cited. These numbers are not in the ground truth but are consistent with the knowledge graph's underlying data. (3) The multi-hop reasoning is sound—comparing AIG’s yield- and credit-loss-based approach to BAC’s sensitivity-driven, fair-value model demonstrates synthesis across two firms and accounting frameworks. (4) The answer is semantically equivalent to the original, with slightly more specific numeric inputs from the filings. The only minor limitation is that it doesn’t explicitly mention BAC’s differential impact by seniority (e.g., prepayment effects varying by tranche), which is in the ground truth. However, this does not undermine the core accuracy. Overall, the response is factually correct, well-contextualized, and directly addresses the comparative valuation and accounting risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 455,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its developed cybersecurity technology—including cloud‑security solutions—using a **multiperiod excess‑earnings method under the income approach** (present‑value of projected cash flows less the contribution of other assets, with useful life based on the technology cycle【page 98】).  \nCisco, by contrast, recognizes revenue for its Cloud Security product category under ASC 606, treating software licenses and SaaS as a single performance obligation with revenue ratably over the contract term, while hardware and perpetual software are recognized upfront【page 75】.  \nThus, Broadcom’s method is a fair‑value measurement of intangible assets, whereas Cisco’s approach is a timing‑based revenue recognition for performance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach, including the key components: present value of projected cash flows, subtraction of contributions from other assets, and determination of useful life based on technology cycle—matching the original answer. It also accurately describes Cisco's revenue recognition for Cloud Security as ratable over the contract term under ASC 606, particularly for SaaS, and distinguishes it from upfront recognition for hardware/perpetual software. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all qualitative financial concepts are correctly represented—thus a score of 10 is justified. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom’s asset valuation methodology (from a fair value perspective) with Cisco’s revenue recognition policy (from an accounting timing perspective), drawing a valid contrast between valuation of intangibles vs. revenue timing. The only minor shortcoming is that the original answer emphasizes Cisco’s treatment of Cloud Security as a 'single distinct performance obligation satisfied over time,' while the LLM mentions this implicitly but adds detail about hardware and perpetual software, which, while accurate, slightly extends beyond the scope of the specific Cloud Security SaaS focus in the original. (4) The answer is contextually relevant, directly addressing the comparison asked, and uses semantically equivalent or more detailed but correct language. Overall, the response is excellent with only negligible differences in emphasis, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 501,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s 10‑K states that each Class B share carries 10 votes versus one vote for Class A, and the company had 2.19 billion Class A shares and 343.8 million Class B shares outstanding as of Jan 24 2025 (page 1). Alphabet’s 10‑K shows a similar 10‑to‑1 voting split for its Class B shares, but with a larger overall share base – weighted‑average 5.9 billion Class A shares and 0.87 billion Class B shares in 2024 (page 84). Consequently, while both firms give a small group of holders outsized control, Alphabet’s high‑vote shares represent a smaller fraction of its total shares and are further diluted by a third, non‑voting Class C layer, which moderates the concentration of voting power relative to Meta.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. The ground truth states that META's Class B shares do not have 10 votes per share but instead have voting rights only in specified circumstances and are tied to conversion conditions. However, the LLM incorrectly asserts that each Class B share carries 10 votes, which is not supported by the original answer and misrepresents META's governance structure. This is a critical error in both quantitative and qualitative terms. For GOOGL, the LLM correctly identifies the 10-to-1 voting split, aligning with the ground truth. (2) The share numbers are approximately correct: LLM reports 2.19 billion Class A and 343.8 million Class B for META, close to the ground truth values of 2,189,898,148 and 343,761,117 respectively (rounding acceptable). For GOOGL, the LLM cites 5.9 billion Class A and 0.87 billion Class B shares, which are not contradicted by the ground truth, though the original answer does not provide exact outstanding shares for GOOGL—only the voting ratio. However, the introduction of a 'weighted-average' and 'Class C non-voting' layer, while factually plausible based on public knowledge, is not present in the original answer and introduces external information not validated by the knowledge graph. (3) The multi-hop reasoning is partially sound—comparing voting power concentration across two companies using share counts and voting rights—but fails because the foundational premise about META’s voting rights is incorrect. The conclusion that Alphabet's voting power is more diluted due to Class C shares goes beyond the original answer, which makes no mention of Class C or dilution effects. (4) Despite these issues, the answer is contextually relevant, addressing the core question about voting disparity and corporate control. The structure and intent are appropriate, but the critical error in META’s voting rights severely undermines factual correctness. Hence, correctness and quantitative accuracy scores are low; qualitative accuracy is moderate due to correct framing but flawed logic; contextual relevance remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 576,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling operations in Argentina raise the volume of concentrates sold to that bottler, which in turn lifts the Coca‑Cola Company’s net sales to equity‑method investees; under KO’s incidence‑based concentrate pricing model, the price charged is shaped by bottler pricing, channel mix and package mix, affecting the revenue recognized from these sales (page_7, page_8, page_89). The expansion of the Argentine market through Coca‑Cola FEMSA also underpins Colgate‑Palmolive’s organic sales growth in Latin America, as Argentina was a key growth driver in 2021 (page_40).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the mechanism by which Coca-Cola FEMSA's operations in Argentina impact KO's net sales to equity method investees—through increased concentrate sales under KO's incidence-based pricing model influenced by bottler pricing, channel mix, and package mix. It also correctly links Argentina as a growth driver for CL's organic sales in Latin America in 2021. However, it omits the specific quantitative figures from the ground truth: KO's $14,471 million in net sales to equity method investees in 2021 and CL's 7.0% net sales increase in Latin America. These missing numbers significantly affect quantitative accuracy. (2) While the LLM mentions Argentina as a key growth driver for CL, it fails to specify the 7.0% growth rate or clarify that this refers to net sales (not just organic growth), nor does it mention the contributing segments (Oral Care, Personal Care, Home Care) or favorable market conditions that supported parallel growth. The absence of these specifics reduces completeness and factual precision. (3) The multi-hop reasoning is sound—correctly connecting KO’s pricing model to its equity investee sales and linking regional bottler performance to CL’s regional growth. The logic that Coca-Cola FEMSA’s operations influence KO’s revenue and that Argentina’s market conditions benefit CL is valid and reflects proper synthesis across entities. (4) Despite missing key numbers and contextual details, the LLM captures the core causal relationships and entities accurately. Wording is concise and relevant, with appropriate use of terminology. The answer is semantically aligned with the ground truth in direction and logic but lacks full factual fidelity due to omitted metrics. Hence, correctness is reduced primarily due to quantitative omissions rather than errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 497,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott’s private‑equity holdings are valued at NAV as a practical expedient, and the fund structures typically provide limited redemption rights – investors can only redeem at the end of the partnership term, usually 10‑15 years from inception (UPS 10‑K, page 89). Merck likewise uses NAV to measure its alternative‑investment portfolio, and those funds are subject to the same long‑term lock‑up and limited‑redemption restrictions that characterize private‑equity vehicles.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient for valuing private equity and alternative investments, and correctly notes the typical 10–15 year redemption restrictions consistent with UPS's 10-K disclosure. However, it omits key quantitative details from the ground truth: Abbott’s $555 million in unfunded commitments and Merck’s $382 million in NAV-based assets as of 2023. These figures are central to the comparison and their absence significantly reduces completeness and accuracy. (2) No numeric values are mentioned in the LLM answer, so there is no verification or even partial reporting of the critical dollar amounts, leading to a low quantitative accuracy score. The years (2023) and timeframes (2024–2033 liquidation periods for Abbott) are also missing. (3) The multi-hop reasoning is partially sound—linking Abbott and Merck to NAV use and referencing UPS’s 10-K for industry practice shows synthesis across documents. However, the comparison between Abbott and Merck is weakened by the lack of data on unfunded commitments and liquidation timelines, which are essential for assessing differences in scale and liquidity risk. (4) Contextual relevance is high because the answer addresses the core concepts: NAV as a practical expedient, redemption restrictions, and comparability across firms. Qualitative accuracy is moderate due to correct conceptual framing but missing differentiating details. Correctness score is 6 due to accurate reasoning and context but major omissions in critical financial data required for a full comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 443,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account assets are held in a legally segregated life‑insurance subsidiary and are not subject to general creditor claims (page 79).  Because the assets are protected, AIG’s separate‑account liabilities—defined as the contract‑holder account balances—are recorded as equal and offsetting to those assets and are not affected by BlackRock’s creditors (page 233).  Thus, BlackRock’s segregation of the assets ensures that AIG’s liability reporting remains directly tied to the contract‑holder balances and is insulated from BlackRock’s financial condition.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. It correctly states that BlackRock’s separate account assets are legally segregated and not subject to general creditor claims, and that AIG reports equal and offsetting liabilities tied to contract holder balances. There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all referenced disclosures (e.g., page numbers) are consistent with source-based reasoning and treated as accurate within context. However, the LLM answer introduces a detail not present in the original ground truth: that the assets are held in a 'legally segregated life-insurance subsidiary'—this specific structural claim is not in the original answer and may misattribute the nature of BlackRock’s entity structure. Additionally, the LLM implies that AIG’s liability reporting is 'insulated from BlackRock’s financial condition', which, while logically inferred, slightly misrepresents the dependency: the original answer emphasizes that changes in BlackRock’s asset values *directly influence* AIG’s liabilities, which the LLM downplays. The multi-hop reasoning is partially sound—linking asset segregation to liability treatment—but underemphasizes the valuation mirroring mechanism that is central to the original answer. The answer remains contextually relevant and captures the essential dynamic, but lacks full completeness and precision in the qualitative synthesis, particularly in reflecting the direct valuation dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 459,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records Imbruvica sales in the U.S. as net revenue but includes Janssen Biotech’s share of pre‑tax profits (≈ $1.25 billion in 2023) in its cost of products sold, reflecting the 40/60 cost‑sharing arrangement under the collaboration (AbbVie Note 6, page 68). In contrast, Johnson & Johnson’s global commercialization strategy is to license the drug to its subsidiary Janssen Biotech, which holds exclusive rights outside the U.S. and co‑exclusive rights in the U.S., so J&J focuses on licensing and collaboration rather than direct revenue recognition (see JNJ product list, page 8).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a specific dollar amount ($1.25 billion in 2023) that is not present in the original ground truth, making it factually unsupported. The ground truth does not provide any specific financial figures for Janssen's profit share or year-specific data, so this number cannot be verified and appears fabricated or incorrectly inferred. Additionally, the 40/60 cost-sharing is correctly attributed to development costs in the ground truth, but the LLM implies it applies to profits, which is inaccurate—the profit sharing is equal (50/50), while development cost sharing is unequal (AbbVie 40%, Janssen 60%). This is a significant factual error. (2) The LLM incorrectly frames the cost-sharing arrangement: it states the $1.25B is Janssen’s share of pre-tax profits and part of cost of goods sold, but the ground truth clarifies that while profits are shared equally, development costs are split 40/60, and Janssen’s share of costs (not profits) is reflected in COGS. The LLM confuses cost allocation with profit distribution. (3) The multi-hop reasoning is partially sound—correctly identifying AbbVie as recognizing U.S. revenue and Janssen’s role internationally via Johnson & Johnson—but fails to fully synthesize the dual-market strategy: AbbVie leads U.S. commercialization, Janssen leads ex-U.S., with equal profit sharing globally. The LLM mentions Janssen’s exclusive rights outside the U.S. but omits that profits are shared equally in both markets. (4) Contextual relevance is high—the answer addresses revenue recognition, cost-sharing, and global strategy—but due to key factual inaccuracies in numbers and financial structure, the correctness score is reduced to 6. The qualitative accuracy is moderate due to correct entity identification and general structure, but flawed reasoning on financial mechanics. Quantitative accuracy is low due to unsupported specific figures and misattribution of percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 538,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged conflict in Taiwan would jeopardise NVIDIA’s supply‑chain execution because the company relies on a small number of Taiwan‑based foundry partners for wafer fabrication; the risk of supply disruptions, longer lead times and higher costs is explicitly noted in its risk factors (NVDA p.16‑18). Apple’s manufacturing, which depends on outsourcing partners located in Taiwan and other Asian regions, would face similar disruptions—delays or stoppages in component supply, assembly and shipping, inventory damage and workforce constraints—leading to production bottlenecks and potential revenue losses (AAPL p.9, p.11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that NVIDIA depends on Taiwan-based foundry partners for wafer fabrication, which exposes it to supply chain disruptions—a key risk highlighted in NVIDIA's filings (NVDA p.16-18). Similarly, it accurately notes Apple’s reliance on manufacturing partners in Taiwan and broader Asia, with risks including delays, stoppages, and workforce constraints (AAPL p.9, p.11). These points match the original answer’s emphasis on production delays, revenue risks, and supply chain vulnerability. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes risks from both companies’ SEC disclosures and connects them to the geopolitical scenario involving Taiwan. It correctly infers parallel supply chain exposures without conflating the distinct roles (NVIDIA’s foundry dependency vs. Apple’s assembly network). (4) The only minor shortcoming is that the LLM answer does not explicitly mention Apple’s potential need to restructure its supply chain or the associated high costs and time required—details present in the original answer. However, it does imply significant operational impact, so this is a small omission. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 396,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income assets are priced with models that rely on verifiable observable market data—interest‑rate and yield‑curve levels, credit‑spreads, broker/dealer bids, and quoted prices of comparable securities (LMT 10‑K, p. 88). Honeywell, in turn, values its corporate bonds and government securities with pricing models that also use observable inputs such as bids, quoted prices and comparable securities, but the company explicitly notes that the models “include adjustments for certain risks that may not be observable such as credit and liquidity risks” (HON 10‑K, p. 111). Thus, while both firms use observable market data, Honeywell’s approach explicitly incorporates risk adjustments for credit and liquidity, whereas Lockheed Martin’s description focuses on observable inputs without detailing such risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LMT uses observable market data such as interest rates, yield curves, credit spreads, broker bids, and prices of comparable securities for Level 2 fixed income investments. HON uses similar observable inputs but explicitly includes unobservable risk adjustments for credit and liquidity risks in its pricing models for corporate bonds and government securities. These points match the original answer. (2) There are no numerical values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is not applicable in a traditional sense, but all referenced inputs and sources (e.g., page numbers: LMT 10-K p. 88, HON 10-K p. 111) are correctly cited and consistent with expected reporting, supporting factual precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (LMT and HON), compares their use of pricing models, identifies commonalities (use of observable inputs), and draws a valid contrast (HON’s explicit inclusion of unobservable risk adjustments vs. LMT’s focus on observable data). (4) The only reason for not giving a perfect 10 is minor: the LLM slightly narrows HON's securities to 'corporate bonds and government securities' while the original answer also mentions 'mortgage/asset-backed securities'—a small omission that does not affect the core comparison but reduces completeness marginally. Otherwise, semantic equivalence is strong, reasoning is logical, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 450,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola’s Europe, Middle East and Africa segment reported a 15 % adverse impact on operating income in 2024 from a stronger U.S. dollar [page_52].  Mondelez’s 10‑K notes that it is exposed to foreign‑currency exchange‑rate risk under similar macroeconomic conditions, but it does not quantify the dollar‑impact on its operating segments [page_65].",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative claim—Coca-Cola reported an 11% unfavorable impact on consolidated operating income due to foreign exchange, not a 15% impact on the Europe, Middle East and Africa (EMEA) segment specifically. The ground truth does not specify a 15% figure for EMEA, nor does it isolate the segment-level impact as precisely as 15%, making this number incorrect. The Mondelez part is qualitatively accurate in that MDLZ does not quantify the specific dollar or percentage impact, instead discussing exposure risk generally. (2) The 15% figure in the LLM answer does not match the 11% consolidated impact stated in the original answer, and there is no support for attributing a higher, specific percentage to the EMEA segment alone. This is a critical quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—the model correctly identifies that KO was affected by a stronger dollar and that MDLZ faces similar risks without quantification. However, it fails to accurately attribute the 11% impact as consolidated (not segment-specific) and incorrectly assigns a more severe 15% impact to EMEA without evidence. It also omits the nuance that some currencies (euro, pound) provided offsetting benefits, which is part of the original answer’s completeness. (4) The correctness score is 5 due to partial factual accuracy but major numerical error; quantitative accuracy is low (4) due to the wrong percentage; qualitative accuracy is moderate (6) as reasoning structure is logical but based on incorrect data; contextual relevance is high (8) because the answer addresses both companies and the core issue of FX risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 463,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO reported $365 million in long‑lived assets located in Taiwan for fiscal 2024 (page 91), a modest portion of its $2.5 billion total.  In contrast, QCOM warns that its reliance on Taiwan foundry partners for chipset supply exposes it to a risk of supply disruption if geopolitical tensions with China flare up, which could materially harm its business (page 35).  Thus, while AVGO’s Taiwan investment is a quantifiable asset base, QCOM’s risk highlights a potentially larger operational threat that is not expressed in dollar terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AVGO's $365 million in long-lived assets in Taiwan for fiscal 2024 is accurately reported, and while the $2.5 billion total long-lived assets figure is not in the original answer, it does not contradict it and may be contextually valid (assuming from source document). No calculation errors. (2) Entity accuracy is strong: AVGO and QCOM are correctly identified, fiscal year 2024 is correct, and the reference to foundry partners in Taiwan matches the original. (3) Reasoning is sound: the LLM correctly distinguishes AVGO’s asset-based exposure from QCOM’s operational/supply chain risk, capturing the multi-hop comparison between asset presence and supply chain vulnerability. (4) The only minor shortcoming is that the original answer emphasizes both companies are exposed to the same geopolitical risk but in different ways—this nuance is slightly underemphasized in the LLM answer, which focuses more on the contrast than the shared risk context. However, the core insight is preserved. Semantic equivalence is maintained, and the answer is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 335,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s supply chain is heavily concentrated in Taiwan, where most of its hardware is assembled (see the risk‑factor discussion of its global supply chain on pages 8–11).  This concentration exposes Apple to heightened geopolitical risk from U.S.–China tensions, trade restrictions, and potential disruptions in Taiwan, as noted in its risk‑factor and manufacturing disclosures (pages 9, 10, 11).  In contrast, Microsoft’s Greater China operations are supported by a regional center in Singapore—a politically stable hub that reduces direct exposure to mainland China’s regulatory and geopolitical environment, and Microsoft’s focus on software and cloud services further limits manufacturing‑related risk (page 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Apple's reliance on Taiwan for hardware assembly increases its exposure to geopolitical risks, particularly within the context of U.S.-China tensions and trade disruptions. Microsoft’s operations in Greater China are supported through a regional center in Singapore, which is politically stable and reduces direct exposure to mainland China’s regulatory environment. The LLM correctly identifies that Microsoft’s software and cloud focus limits its manufacturing-related risk, contrasting it with Apple’s supply chain vulnerabilities. (2) There are no numeric values, dates, or calculations in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across companies (Apple vs. Microsoft), geographies (Taiwan, Greater China, Singapore), and operational models (manufacturing vs. software/logistics). It accurately infers that physical manufacturing dependency creates greater geopolitical exposure than administrative/logistical regional centers. (4) The only minor shortcoming is that the LLM does not explicitly mention that Apple includes Taiwan in its 'Greater China' segment, which is a nuance present in the original answer and relevant for financial reporting context. However, the implication of regional risk exposure is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 443,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut reduced Union Pacific’s deferred‑tax expense by **$114 million** (see UNP 10‑K, page 29). In Boeing’s 10‑K (page 10), the company warned that **delays in U.S. federal appropriations could disrupt defense contracts and cash flows**, exposing it to operational and financial uncertainty. Thus, while Union Pacific gained a tax benefit, Boeing faced a potential risk from appropriations delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 corporate tax rate cut, matching the ground truth in both amount and context. It also accurately captures Boeing's disclosure about federal appropriations delays impacting defense contracts and cash flows. All key facts are present and correct. (2) The quantitative figure of $114 million is exact and properly attributed, satisfying the requirement for numerical precision. No calculations were needed beyond accurate reporting. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate 10-K filings (Union Pacific and Boeing), linking state-level tax benefits to Union Pacific and federal funding risks to Boeing. The contrast between a realized benefit (tax reduction) and a forward-looking risk (appropriations delays) is logically presented. (4) The answer is contextually fully relevant, directly addressing the comparative impact on Union Pacific and Boeing as required by the question. The only minor limitation is that the original answer provides slightly more detail on Boeing’s exposure (e.g., impact on commercial airplane delivery and new programs), which the LLM answer omits. However, the core risk—disruption to contracts and cash flows—is accurately conveyed, warranting a high but not perfect qualitative score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 392,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patents expire in 2028–2029 (fusion‑protein 11/22/2028, DNA‑encoding 4/24/2029, formulations 10/19/2037), after which generic or biosimilar entry is expected to follow quickly【page_34】【page_10】.  This imminent loss of exclusivity illustrates the risk Merck faces from generic competition—“generic challenges can arise at any time” and “loss of patent protection is typically followed promptly by generic or biosimilar substitutes”【page_33】【page_32】—and reinforces the company’s stated priority on actively protecting its own patents.  In a biopharma landscape where competitors routinely launch generics and biosimilars, Merck is likely to accelerate secondary‑patent filings, extend exclusivity, and invest in new‑product development to safeguard market share and revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all Enbrel-related patent expiration dates—11/22/2028 (fusion protein), 4/24/2029 (DNA encoding), and 10/19/2037 (formulations)—matching the ground truth exactly. These dates are critical multi-hop inputs, and their accuracy is fully preserved. (2) Quantitatively, all dates are correct and properly attributed; no calculations are required, but the sequencing and timeline interpretation are accurate. The mention of 2028–2029 as the initial wave of expirations is contextually appropriate, even though one patent extends to 2037, because the core composition and method patents expire earlier. (3) The reasoning is sound: the LLM correctly infers that the expiration of Enbrel patents signals increased biosimilar competition, which in turn reinforces MRK’s strategic need to protect its own IP. It supports this with direct quotes from MRK’s 10-K (e.g., 'loss of patent protection is typically followed promptly by generic or biosimilar substitutes'), aligning with the original answer’s logic. The LLM adds value by specifying strategic responses like 'secondary-patent filings' and 'extend exclusivity,' which are reasonable inferences consistent with industry behavior and MRK’s stated priorities. (4) The only minor gap is that the original answer explicitly ties MRK’s awareness of political and regulatory pressures to the strategic imperative, while the LLM mentions generic challenges but not the regulatory dimension. This omission slightly reduces qualitative completeness but does not undermine the core correctness. Overall, the answer is factually accurate, contextually relevant, and demonstrates strong multi-hop reasoning from AMGN’s patent timeline to MRK’s strategic posture.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 476,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s 2022 revenue from operations in Taiwan was lower than Apple’s contribution from the same market.  Apple reported $2.091 billion in sales to Taiwan in 2022 (page 78), while AMD’s Taiwan‑specific revenue was only a fraction of that amount, indicating that Apple has a markedly stronger market presence in Taiwan compared with AMD.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that Apple reported $2.091 billion in sales to Taiwan in 2022, which is false. According to the ground truth, AMD—not Apple—reported $2,091 million ($2.091 billion) in revenue from Taiwan. Apple reported $74,200 million in net sales from the entire Greater China region (including mainland China, Hong Kong, and Taiwan), with no breakdown provided for Taiwan specifically. The LLM reversed the companies' figures, attributing AMD's Taiwan revenue to Apple, which is a critical error. (2) The quantitative inaccuracies are severe: the $2.091 billion figure is AMD’s, not Apple’s, and Apple’s actual Taiwan-specific revenue is not disclosed. The claim that AMD’s revenue was 'only a fraction' of Apple’s in Taiwan assumes a comparison that cannot be made due to lack of data, and is based on a complete reversal of facts. (3) The reasoning is fundamentally flawed. The model fails the multi-hop requirement by not recognizing that Apple’s data is for a broader region (Greater China) and that Taiwan-specific data for Apple is unavailable. Instead, it fabricates a direct comparison by swapping the numbers, leading to an invalid conclusion about relative market presence. (4) While the answer attempts to address the question’s intent—comparing market presence in Taiwan—the reversal of key financial figures renders the entire response incorrect. The contextual relevance is moderate because it discusses the right companies and region, but the factual foundation is entirely unsound, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 439,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet’s buy‑back program includes its Class C capital stock, which “has no voting rights” (Class A shares have one vote, Class B ten votes【page 81】).  By repurchasing non‑voting Class C shares, Alphabet can return cash and adjust its capital structure without altering the voting power of the remaining shares, giving it greater flexibility to manage capital allocation and control.  Netflix, however, repurchases only common shares that all carry one vote each【page 61】, so every buy‑back reduces the total voting power of the company’s shareholders and limits the firm’s ability to adjust control dynamics while allocating capital【page 62】.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the structural difference between Alphabet's dual-class share system and Netflix's uniform voting rights, explaining that repurchasing non-voting Class C shares allows Alphabet to return capital without affecting voting control. It also correctly notes that Netflix's repurchases reduce total voting power due to uniform voting rights. These qualitative insights align with the ground truth. (2) However, the LLM answer omits the specific quantitative figures from the original answer: Alphabet's $62.2 billion in 2023 repurchases and $36.3 billion remaining authorization. While the LLM references the buyback program, it fails to include any dollar amounts, resulting in a significant gap in quantitative accuracy. This omission affects completeness and precision, especially since the original answer emphasizes these figures as evidence of scale and flexibility. (3) The multi-hop reasoning is sound—linking share class structure to capital allocation and governance implications across two companies. The logic that repurchasing non-voting shares preserves insider control while enabling capital return is accurately synthesized. The contrast with Netflix’s structure is also logically valid. (4) Despite missing numbers, the core reasoning and entity identification (Alphabet, Netflix, Class C shares, voting rights structure) are correct. The answer remains contextually relevant and conveys the key conceptual distinction. Thus, correctness is high but not full due to missing data points; quantitative accuracy is moderate due to absence of figures; qualitative and contextual scores are high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 452,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1,699 million in non‑agency NQM/Alt‑A loans and $12,567 million in pass‑through securities, with a $1,294 million unrealized loss on the pass‑throughs. AIG’s risk narrative focuses on the liquidity and valuation challenges of its illiquid mortgage‑related investments, noting that market inactivity could impair pricing and saleability and potentially constrain liquidity. Thus, MET’s risk is a concrete dollar‑level loss on pass‑through securities, whereas AIG’s risk is a broader, qualitative liquidity concern tied to valuation uncertainty of mortgage assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in non-agency NQM/Alt-A loans, with $1,294 million in unrealized losses in 2024. These numbers match the original answer exactly, and formatting variations (e.g., $1,699 million) are acceptable. (2) Quantitative accuracy is perfect—no calculation errors, and all dollar amounts are correctly reported. (3) The multi-hop reasoning is sound: the model correctly contrasts MET’s specific, marked-to-market exposure with AIG’s broader liquidity and valuation concerns. It captures the core distinction—MET’s risk is quantified and realized as unrealized losses, while AIG’s stems from uncertainty in illiquid asset valuation. (4) The only minor shortcoming is that the LLM omits explicit mention that MET’s securities are 'directly secured by pools of mortgage loans' and does not name AIG’s other illiquid holdings (private equity, hedge funds, real estate) in detail. However, the essence of AIG’s risk—valuation uncertainty and liquidity constraints—is preserved. The answer is semantically equivalent and contextually appropriate, addressing all parts of the question with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 357,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia Pacific beverage segment generated roughly **$1.06 billion** (20 % of its $5.29 billion Asia Pacific net operating revenues【page_124】【page_123】). PepsiCo’s Asia Pacific beverage segment produced about **$0.92 billion** (20 % of its $4.62 billion APAC net revenue【page_73】). Thus Coca‑Cola’s beverage contribution in Asia Pacific was roughly **$140 million higher** than PepsiCo’s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in the Asia Pacific region was $4,682 million ($4.682 billion), not $1.06 billion as stated. The LLM incorrectly claims that beverage operations accounted for 20% of Coca-Cola's APAC revenue, but Coca-Cola's 10-K does not break down beverage revenue by percentage in APAC—instead, it directly reports beverage revenue. For PepsiCo, while it is correct that 20% of APAC revenue came from beverages, the LLM uses an incorrect total APAC revenue figure of $4.62 billion, leading to a calculated beverage revenue of $0.92 billion, which does not align with disclosed data. PepsiCo’s total APAC revenue in 2021 was actually around $4.6 billion, but beverage revenue is not explicitly quantified and would require estimation. (2) Calculations are based on incorrect inputs: $5.29B × 20% = $1.058B and $4.62B × 20% = $0.924B are mathematically correct, but the underlying figures are wrong. The difference of $140 million is therefore invalid. (3) The multi-hop reasoning is flawed—Coca-Cola does not report beverage revenue as a percentage of regional revenue; it reports it directly. The LLM incorrectly assumes a 20% allocation for KO, which is not supported by the data. For PEP, while the 20% beverage allocation is accurate, the total regional revenue figure used is inaccurate. (4) The contextual relevance is moderate because the answer attempts to compare beverage revenue contributions in APAC for both companies in 2021, but the factual inaccuracies severely undermine correctness. Due to major quantitative and qualitative errors, the correctness score is low at 2.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 467,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead and Merck will split long‑acting HIV product revenues 50/50 until net sales reach $2 billion for the oral combination or $3.5 billion for the injectable.  Above those thresholds, Gilead’s share rises to 65 % and Merck’s falls to 35 % of the incremental sales.  By contrast, Merck’s Keytruda license obligates it to pay BMS and Ono a royalty of 6.5 % of global sales through 2023 (dropping to 2.5 % thereafter), an expense that reduces Merck’s profitability.  Consequently, Merck can generate revenue (though capped at 35 % above the thresholds) from the Gilead partnership, while it incurs royalty costs on Keytruda sales that cut into its earnings from that collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures all key quantitative elements correctly: the 50/50 revenue split with Gilead up to $2B (oral) and $3.5B (injectable) thresholds, the shift to 65% for Gilead (35% for Merck) beyond those points, and the royalty rates of 6.5% through 2023 and 2.5% from 2024–2026 that Merck pays to BMS and Ono on Keytruda sales. The entity identification (Gilead, Merck, BMS, Ono) and timeframes are correct. The reasoning correctly contrasts Merck’s dual role as a revenue sharer (with Gilead) and a royalty payer (to BMS/Ono), and the implications for profitability are logically sound. One minor omission is that the original answer includes Merck’s $212M alliance revenue from BMS on Reblozyl (with 20–24% royalty), which the LLM answer does not mention. While not central to the core comparison, this detail adds context about Merck’s broader partnership dynamics and was part of the ground truth. However, since the question primarily focuses on the Gilead HIV revenue share vs. Keytruda royalties, and the LLM accurately addresses those with correct numbers and implications, the omission does not significantly detract from the overall correctness. All calculations and comparisons are valid, and the semantic meaning aligns with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 358,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s 2024 10‑K states that it holds CDOs and other structured securities that embed credit‑default swaps; a credit event on a reference entity can trigger the embedded CDS and cause the principal of the tranche to be reduced or not repaid (page 109). AIG recorded a $75 million loss in 2024 from embedded derivatives, which likewise arose when credit events triggered the embedded contracts (page 144). Thus, while both banks suffer losses when credit events occur, BAC’s exposure is spread across tranche‑structured CDOs, whereas AIG’s loss is a single $75 million hit from embedded derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's investment in CDOs with embedded CDSs, the tranche-based risk structure, AIG's $75 million loss in 2024 from embedded derivatives, and the triggering role of credit events are all accurately represented. The dollar amount ($75 million), year (2024), and entities (BAC, AIG) are correct. (2) Quantitative accuracy is perfect—$75 million is correctly cited, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound: the answer synthesizes information from both BAC’s and AIG’s 10-Ks, correctly identifying the common mechanism (credit events triggering embedded derivatives) while distinguishing the structural differences in exposure (tranche-based CDOs vs. direct derivative losses). (4) The only minor shortcoming is a slight underemphasis on the conceptual link between the two institutions’ risks through similar structured credit mechanisms, which the original answer highlights more explicitly. However, the core comparison is logically and factually sound. Wording differences do not affect semantic equivalence. Pages cited (109, 144) add precision and are consistent with expected sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 349,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is the **administrative agent** in 3M’s May 2023 Five‑Year Credit Agreement (see 3M 10‑K, Item 10.29).  \nIn Caterpillar’s September 2022 credit facilities, Citibank, N.A. is the **agent and local‑currency agent** for the facility (see Caterpillar 10‑K, Items 10.39 and 10.41).  \nThus, Citibank’s role in 3M’s agreement involves overall loan administration and payment distribution, whereas in Caterpillar’s facility it focuses on local‑currency administration and coordination with other lenders, a narrower administrative scope.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A.'s role as administrative agent in 3M’s May 2023 Five-Year Credit Agreement and as agent and local-currency agent in Caterpillar’s September 2022 facilities, with accurate citation references. Dates and entity names are correct. However, it omits key details from the ground truth: in 3M’s agreement, Citibank also serves as joint lead arranger alongside JPMorgan Chase Bank, N.A., which is a significant shared leadership role not mentioned. For Caterpillar, the LLM fails to specify that Citibank, N.A. acts as Agent for both the 3-Year and 5-Year Facilities, and that Citibank Europe plc, UK Branch, and MUFG Bank, Ltd. are involved in local currency coordination—particularly Japan Local Currency Agent role. (2) Quantitative accuracy is perfect: dates (May 2023, September 2022) and roles are factually aligned with the original answer; no numerical errors. (3) Multi-hop reasoning is partially sound—it connects Citibank’s roles across two companies and attempts a comparison—but the synthesis is incomplete. The conclusion that Citibank’s role at Caterpillar is 'narrower' is incorrect; the ground truth states it has *more layered* and *broader international* responsibilities in Caterpillar’s facilities, including cross-border coordination, which contradicts the LLM’s assessment. This misrepresents the comparative administrative scope. (4) Correctness score is 6 due to accurate core entities and dates but significant omissions and a flawed comparative analysis. Qualitative accuracy is low due to incomplete role descriptions and incorrect reasoning about administrative scope. Quantitative accuracy is 10 as all factual anchors (dates, titles, companies) are correct. Contextual relevance is high because the answer addresses the question framework and cites appropriate sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 502,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO uses option contracts as part of its foreign‑currency cash‑flow hedging program, with a fair value of $311 million in assets and $14 million in liabilities (page 83). These options offset changes in the fair value of KO’s foreign‑currency liabilities, reducing earnings volatility on a relatively modest notional base. In contrast, PepsiCo’s strategy relies on a broader mix of derivatives—$3.1 billion in foreign‑exchange forwards/options and $1.2 billion in cross‑currency swaps (page 43)—to hedge a much larger notional amount of foreign‑currency liabilities, thereby providing a more extensive hedge of its balance‑sheet exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details not present in the original answer. The original answer does not mention specific dollar amounts such as $311 million in assets, $14 million in liabilities for KO, or $3.1 billion in forwards/options and $1.2 billion in cross-currency swaps for PEP—these figures are absent from the ground truth and cannot be verified as correct. Therefore, the quantitative accuracy is low due to the introduction of unsupported numbers. While the LLM correctly identifies that both companies use option contracts for hedging foreign exchange risk, it misrepresents the nature of KO’s strategy: the original answer emphasizes KO’s use of options as cash flow hedges with gains/losses deferred in AOCI, but the LLM incorrectly frames them as offsetting changes in fair value of liabilities (which describes fair value hedges, not cash flow hedges). This reflects a misunderstanding of hedge accounting. For PEP, the LLM mentions a broader mix of derivatives including cross-currency swaps, which is plausible but not stated in the original answer; instead, the ground truth highlights PEP’s 44% international revenue and 1.5 percentage point negative FX impact on revenue in 2024—key contextual details omitted by the LLM. The comparison between KO and PEP is partially valid in structure (KO uses options on a modest scale vs PEP’s broader program), but the reasoning is flawed due to incorrect hedge type classification and unsupported notional values. The answer is contextually relevant and attempts a comparative analysis, but lacks fidelity to the source facts, especially on accounting treatment and reported impacts. Thus, while the qualitative reasoning shows some understanding of hedging strategies, it fails on key financial concepts and data accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 493,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE’s goodwill‑impairment test (page 17) relies on an internal DCF that discounts projected cash flows from operating plans at an “appropriate discount rate,” and the company explicitly performs sensitivity analyses on both the discount rate and the cash‑flow assumptions.  \nLockheed Martin’s Level 3 fixed‑income valuation (pages 88‑89) also uses a DCF, where the discount rate and projected annuity payments are the key inputs, but the filing does not describe a formal sensitivity analysis—though the valuation is inherently sensitive to those same assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that GE uses a DCF model for goodwill impairment testing, relying on projected cash flows and discount rates, and explicitly performs sensitivity analyses—this matches the original answer's emphasis on GE’s sensitivity testing due to material impacts. (2) It accurately states that LMT applies DCF to value Level 3 fixed income investments using projected annuity payments and discount rates, which is consistent with the ground truth. (3) The LLM correctly notes that while both companies use DCF models sensitive to discount rates and cash flow assumptions, only GE explicitly conducts formal sensitivity analyses, which is a key distinction supported by the original answer. (4) The LLM omits the broader contextual contrast in purpose—GE’s use being internally focused on strategic planning versus LMT’s externally oriented pension fund asset valuation—but this nuance is not critical to the core comparison on sensitivity and assumptions. No numbers or entities are incorrect; all references to companies, inputs, and model usage are factually sound. The reasoning is logically sound and synthesizes multi-hop information correctly across GE and LMT. Minor deduction in qualitative accuracy due to missing the internal vs. external focus distinction, but overall semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 387,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each, giving them a 15‑to‑1 voting weight over Class A shares and accounting for 33 ⅓ % of the company’s combined voting power (Class A shares hold 66 ⅓ %). Google’s Class B shares, by contrast, have 10 votes each, a 10‑to‑1 weight over Class A, and the company has been buying back Class A and Class C shares but not Class B, so the relative voting‑power split remains unchanged. Thus, Comcast’s Class B shares are proportionally more powerful than Google’s, and both firms’ repurchase programs have not altered the per‑share voting rights.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting power distribution in CMCSA: Class A holds 66 2/3% and Class B (held by Brian L. Roberts) holds 33 1/3%, with Class B shares carrying 15 votes per share. It accurately states that GOOGL Class B shares have 10 votes each, compared to 1 vote for Class A and C. The repurchase of Class A and C shares (but not Class B) by GOOGL is correctly noted, and the implication that this preserves the relative voting split is logically sound. However, the LLM incorrectly states that Class A holds '66 1/3%' instead of '66 2/3%'—a minor but notable numerical error. (2) Quantitatively, all other numbers are correct: 15-to-1 and 10-to-1 voting ratios, and the $62.2 billion repurchase by GOOGL in 2023 is missing from the LLM answer, which omits the specific dollar amount disclosed in the ground truth. This omission reduces quantitative completeness. (3) The multi-hop reasoning is strong: the model correctly compares voting structures across two companies, links repurchase activity to voting concentration implications, and draws a valid conclusion about disproportionate power in both firms. However, it fails to mention that CMCSA does not disclose repurchase volumes for Class A shares—a point of contrast in the original answer. (4) Despite minor inaccuracies and omissions, the LLM conveys the core comparative structure accurately and remains highly relevant to the question, hence high scores in qualitative accuracy and contextual relevance. The correctness score is 8 due to the percentage error and missing repurchase figure, but the overall synthesis is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 445,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM’s business in Turkey benefited from the 8.2 % rise in the total cigarette market – the increase, driven by higher inbound tourism, helped lift shipment volumes and gave PM a 1.1‑point lift in regional market share (Middle East & Africa commentary, page 59). In contrast, CL’s 10‑K does not mention any operations in Turkey in its operational or geographic disclosures (pages 21‑25), indicating a negligible or non‑existent footprint, so it does not share in that market growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 8.2% growth in Turkey's cigarette market and links it to PM's improved performance, it incorrectly claims PM gained a '1.1-point lift in regional market share'—this specific figure is not present in the original answer and cannot be verified from the provided ground truth. More critically, the LLM states that CL has no operations in Turkey, directly contradicting the ground truth which confirms CL operates manufacturing and warehousing facilities there as part of its Oral, Personal and Home Care segment. This is a major factual error. (2) Quantitatively, the 8.2% market growth is correctly cited, but the unsupported 1.1-point market share gain undermines quantitative accuracy. No calculations are performed, so no arithmetic errors, but inclusion of unverified metrics reduces score. (3) The multi-hop reasoning fails: the model incorrectly infers from CL’s 10-K (pages 21–25) that CL has no footprint in Turkey, while the ground truth affirms CL’s operational presence. This reflects a failure in synthesizing correct entity relationships and misinterpreting absence of mention as absence of operation—a critical flaw in reasoning. (4) Contextually, the answer addresses the comparative impact on PM vs CL and discusses tourism-driven market growth, so it remains relevant. However, due to the major error regarding CL’s operational footprint and the unsupported claim about market share, the overall correctness score is low. The answer misrepresents a core fact, leading to an incorrect conclusion about CL’s exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 448,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both NVIDIA and Qualcomm depend on Taiwanese foundry infrastructure, so geopolitical tensions could disrupt their supply chains. NVIDIA’s reliance on third‑party foundries and long lead times could delay wafer supply and raise costs (NVDA 10‑K, pages 16‑17), while Qualcomm’s dependence on TSMC and other Taiwanese suppliers could similarly cause supply disruptions, higher costs, or operational delays (QCOM 10‑K, pages 11, 35‑36).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with strong multi-hop reasoning. It correctly identifies that both NVIDIA and Qualcomm rely on Taiwanese foundry infrastructure, and that geopolitical tensions could disrupt supply chains for both companies. The answer cites specific risks: for NVIDIA, delays in wafer supply and increased costs due to long lead times; for Qualcomm, supply disruptions due to reliance on TSMC and other Taiwanese suppliers. These points align with the original answer's emphasis on supply chain vulnerability and operational impact. The LLM references correct page numbers from the respective 10-K filings (NVDA 10-K pp.16–17; QCOM 10-K pp.11, 35–36), supporting its claims. There are no numerical inaccuracies—no specific numbers (e.g., dollar amounts, dates, percentages) are present in either answer, so quantitative accuracy is not compromised. The only minor shortcoming is that the LLM answer does not explicitly mention the potential for 'revenue loss' or 'material impact' on business as stated in the original answer, nor does it emphasize the shared regional risk amplifying cross-company impact, which slightly reduces completeness in qualitative synthesis. However, the core reasoning and factual content are sound, and the answer fully addresses the question’s focus on supply chain risks due to geopolitical tensions. Wording differs but meaning is preserved. Contextual relevance is excellent, directly addressing the shared dependency and potential consequences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 423,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx reports that ASU 2020‑04 has reduced the operational and financial impacts of contract modifications that replace LIBOR, but the company has not seen a material effect on its financial condition or results of operations as of May 31 2024.  MetLife, in contrast, accounts for LIBOR‑related hedging instruments under ASC 815 as cash‑flow or fair‑value hedges, with gains and losses recorded in OCI or earnings as appropriate, and notes that the ASU has likewise had no material impact on its consolidated financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly identifies MMM (3M Company) as MetLife, a completely different company, leading to a fundamental misrepresentation of the financial treatment being compared. This invalidates the core comparison in the question. Additionally, the LLM claims MetLife has reported no material impact, which contradicts the ground truth that MMM reported $9 million in losses related to interest rate contracts in 2023. (2) Quantitatively, the $9 million loss in 2023 by MMM is entirely missing from the LLM answer, and instead, a false statement about 'no material impact' is attributed to the wrong company. The date (May 31, 2024) for FDX is correctly mentioned, but the financial impact for MMM is completely misrepresented. (3) The multi-hop reasoning fails because the model does not correctly identify the entities involved. The comparison between FDX and MMM is central to the question, but the LLM substitutes MMM with MetLife, breaking the logical and factual synthesis required. There is no valid comparison made between the correct companies’ accounting treatments under ASU 2020-04. (4) The contextual relevance is low because while the answer discusses reference rate reform and ASU 2020-04, it applies the information to the wrong entity. The qualitative accuracy is poor due to incorrect entity identification and flawed reasoning. The correctness score is very low because the answer is factually incorrect on key points and fails the multi-hop requirement of comparing FDX with MMM specifically.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 432,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s 9.4 million Class B shares are wholly owned by Brian L. Roberts and each carry 10 votes (Note 82), representing roughly 33 ⅓ % of the company’s total voting power (page 31). This concentrated block gives Roberts decisive influence over board elections and corporate decisions. Alphabet’s dual‑class structure likewise gives Class B shares 10 votes per share, but those shares are held by a group of insiders while Class A shares (public) have one vote each, so control is still concentrated but distributed among multiple stakeholders rather than a single owner.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in conveying the governance implications of CMCSA's and GOOGL's dual-class structures, but contains a key quantitative error: it states that CMCSA Class B shares carry '10 votes' each, while the ground truth specifies '15 votes'. This is a critical factual inaccuracy affecting the precision of the voting power mechanism. The 33⅓% voting power figure is correctly cited, as is the fact that Brian L. Roberts owns all Class B shares. For GOOGL, the 10 votes per Class B share and 1 vote per Class A share are accurately reported.\n\n2) Quantitative accuracy is compromised by the incorrect vote ratio for CMCSA (10 vs. 15 votes per share). While the 33⅓% total voting power is correct and consistent with the ground truth, this percentage is derived from the 15-vote structure, not 10, making the LLM's explanation internally inconsistent. The reference to 'Note 82' and 'page 31' suggests document fidelity but does not excuse the numerical discrepancy.\n\n3) The reasoning is sound in comparing concentrated control (CMCSA via a single individual) vs. distributed insider control (GOOGL among multiple insiders), which captures the core contrast in governance structure. The answer correctly identifies that both systems preserve insider control through differential voting rights, fulfilling the multi-hop requirement to synthesize across two companies and interpret governance implications.\n\n4) Despite the vote count error, the answer remains contextually relevant and semantically close to the original, especially in highlighting ownership concentration and control dynamics. The qualitative analysis of governance influence is strong. However, the vote miscalibration reduces confidence in data fidelity, warranting a correctness score of 7 rather than higher. The answer would have scored 9-10 if the vote count had been accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 505,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s remaining 2017‑Tax‑Act repatriation‑tax schedule is not disclosed in the pages provided, whereas Eli Lilly’s cash‑payment obligations for the same Toll‑Tax as of 31 Dec 2023 total $1.427 billion – $634.2 million due in 2024 and $792.8 million due in 2025.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains specific quantitative figures for Eli Lilly's remaining cash payment obligations under the 2017 Tax Act ($634.2 million in 2024 and $792.8 million in 2025, totaling $1.427 billion), which are not present in the original ground truth answer. Since the ground truth does not provide any numerical values for either company’s obligations, the inclusion of these precise figures cannot be verified as correct and appears to be fabricated or sourced from outside the knowledge base. This significantly undermines quantitative accuracy. Regarding Amgen, the LLM states that its payment schedule is 'not disclosed,' which contradicts the ground truth stating that Amgen is making payments over an eight-year period beginning in 2018. Thus, the LLM incorrectly assesses Amgen's disclosure status, introducing a factual error. While the LLM correctly identifies that Eli Lilly has payments extending through 2025 (aligning with the ground truth), it fails to note the shared eight-year framework for both companies, missing a key comparative point. The reasoning is partially sound in structure but flawed due to incorrect data and omission of the common regulatory context. The answer is contextually relevant and addresses the comparison question format, but lacks semantic equivalence with the ground truth due to inaccuracies and hallucinated numbers. Overall, the answer is partially correct in identifying Eli Lilly's future payment years but incorrect in asserting Amgen's lack of disclosure and introducing unverified dollar amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 425,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s biologics face a potentially severe but uncertain biosimilar threat once the 12‑year FDA data‑protection period ends; entry can be delayed by development, manufacturing, and regulatory hurdles, but a patent challenge could still trigger rapid competition (see Amgen’s discussion of biosimilar pathways on page 9).  Bristol Myers Squibb, with a broader mix of biologics and non‑biologics and operating under the EU’s 8 + 2 + 1 exclusivity regime, enjoys a comparatively longer protection window that can postpone generic entry, although the EU’s less‑rigid patent‑listing rules can still allow earlier biosimilar launch (see BMY pages 8‑9).  Thus, Amgen’s biosimilar risk is more acute and time‑sensitive, whereas BMY’s exposure is mitigated by longer EU exclusivity and a diversified portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general structure of the question and correctly identifies key regulatory timelines (12-year U.S. data protection for Amgen and the EU 8+2+1 regime for Bristol Myers Squibb). However, there are significant factual inaccuracies that reduce correctness. First, the listed biologics for Amgen—'Erbitux, Cyramza, Trulicity, Taltz, and Emgality'—are not Amgen products; Erbitux is Eli Lilly/ImClone, Cyramza is Lilly, Trulicity is Lilly, Taltz is Lilly, and Emgality is Lilly—this is a critical entity error. Amgen’s key biologics include Enbrel, Neulasta, and Repatha, not those listed. Similarly, while BMS does market Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti (correctly listed in the ground truth), the LLM does not mention them, weakening completeness and entity accuracy. The LLM incorrectly implies that the EU’s 8+2+1 system gives BMS a 'longer protection window'—in fact, 8 years of data exclusivity is shorter than the U.S. 12-year term, so the risk is earlier, not later, in the EU. The statement that BMS is 'mitigated by longer EU exclusivity' is therefore factually wrong. The reasoning about patent challenges and development hurdles is plausible but not directly supported in the original answer. The mention of 'page 9' and 'BMY pages 8-9' introduces fabricated document references not present in the ground truth. Quantitative accuracy is partially correct: 12-year U.S. protection and 8+2+1 EU framework are accurately cited, but misinterpretation of their comparative impact reduces score. Multi-hop synthesis is attempted but flawed due to incorrect product attribution and misrepresentation of regulatory impact. Contextual relevance is high as the answer addresses regulatory pathways and portfolio differences. Overall, core regulatory facts are present but misapplied, and major entity and reasoning errors undermine factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 509,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s revenue risk is tied to Medicaid reimbursement policies that could lower or deny coverage for its broad medical‑device and therapy portfolio; changes in state or federal reimbursement rules could reduce demand and pricing (Medtronic p. 11‑12).  AbbVie, by contrast, faces pricing pressure from the Inflation Reduction Act, which allows the U.S. Department of Health and Human Services to set lower Medicare/Medicaid prices for single‑source biologics—potentially cutting revenue for its high‑revenue biologics (Humira, Skyrizi, Rinvoq, which together account for ~47 % of 2024 sales) (AbbVie p. 18‑19).  Thus, Medtronic’s exposure is broader across many device categories, while AbbVie’s risk is concentrated on a few biologic products that could see significant price reductions under the IRA.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core distinction between Medtronic's Medicaid reimbursement exposure and AbbVie's IRA-related pricing pressures, with accurate entity identification and strong contextual relevance. However, there are key quantitative and factual discrepancies. First, the LLM claims that Humira, Skyrizi, and Rinvoq together account for ~47% of AbbVie’s 2024 sales, but this figure is not present in the ground truth and cannot be verified from the provided knowledge; the original answer instead specifies that Imbruvica, Vraylar, and Linzess are the drugs selected under the IRA, not Humira, Skyrizi, or Rinvoq. This misidentifies the affected products, a significant error in entity accuracy. Additionally, the original answer notes specific IRA selection years (2023 and 2025) and implementation years (2026 and 2027), which the LLM omits, weakening the precision of the timeline. While the LLM correctly frames Medtronic’s risk as tied to Medicaid reimbursement affecting device pricing, it does not mention the indirect effect on hospitals’ purchasing behavior as described in the ground truth. The reasoning is logically structured and semantically aligned in broad strokes, but the incorrect attribution of IRA impact to different drugs and the unsupported 47% figure reduce quantitative and qualitative accuracy. The answer remains contextually relevant and captures the multi-hop comparison intent, but with notable factual gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 401,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports about **$2.7 billion in unfunded commitments to private‑equity funds** (UPS 10‑K, page 93), a sizable exposure to alternative investments that are valued at NAV as a practical expedient.  \nGeneral Dynamics, in contrast, uses NAV to value the portion of its Level 1 pension‑plan assets that are alternative investments (real‑estate, equity, hedge funds), which amounts to roughly **$459 million** (GD 10‑K, page 94). Thus, UPS’s unfunded commitments are an order of magnitude larger than the NAV‑based valuation segment in GD’s plan assets, even though both firms rely on NAV for alternative‑investment pricing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies UPS's $2.7 billion in unfunded commitments to private equity funds and notes the use of NAV as a practical expedient, which aligns with the ground truth. However, it introduces a figure of $459 million for General Dynamics' NAV-based Level 1 plan assets that is not present in the original answer or supported by the provided context. The ground truth does not specify a dollar amount for GD’s NAV-based assets—only that they include commingled equity and fixed-income funds valued using NAV and are redeemable monthly or quarterly. This is a significant quantitative error. (2) The comparison that UPS’s commitments are 'an order of magnitude larger' than GD’s NAV-based assets relies on this incorrect $459 million figure and thus fails. There is no basis in the original answer to make a numerical comparison of the scale of NAV-related exposures. (3) The multi-hop reasoning is partially sound: the model correctly identifies that both companies use NAV as a practical expedient for valuing alternative investments. However, it omits the key qualitative distinction in liquidity and redemption terms—UPS has 10–15 year lockups with contributions over 3–6 years, while GD’s assets are redeemable monthly or quarterly—which is central to the original answer’s comparative insight. This weakens the qualitative accuracy. (4) The contextual relevance is high because the response addresses the core comparison of NAV usage between UPS and GD and attempts to quantify and contrast their exposures. However, due to the fabricated number and missing liquidity analysis, the correctness score is reduced to 6—partially correct but with significant factual and analytical gaps.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 467,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 10‑K shows that it issued 9.44 million shares of Class B common stock (page 67).  The filing indicates that Class B shares are voting shares with the same rights as Class A shares, so the overall voting structure is unchanged.  In contrast, Meta’s 10‑K discloses a dual‑class scheme in which Class A common stockholders have voting rights while Class B common stockholders have no voting rights (except on a few specified matters), creating a clear separation between voting and economic interests.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error regarding CMCSA's Class B Common Stock voting rights. While it correctly reports the issuance of approximately 9.44 million shares (matching the ground truth 9,444,375), it incorrectly states that Class B shares are 'voting shares with the same rights as Class A shares.' This directly contradicts the ground truth, which specifies that CMCSA's Class B shares carry no voting rights except in limited circumstances. This error fundamentally undermines the analysis of CMCSA's voting structure. In contrast, the description of META's dual-class framework is accurate: Class A has full voting rights, Class B does not, except in specified events like a merger. (2) Quantitatively, the number of shares is correctly reported as 9.44 million (rounded from 9,444,375), and the reference to page 67 of the 10-K is plausible. No other numerical data (dates, percentages, dollar amounts) are present, so no calculation errors exist beyond the misinterpretation of rights. (3) The multi-hop reasoning fails on the CMCSA side due to the mischaracterization of voting rights. The comparison to META is structurally sound—both involve dual-class systems—but the conclusion that CMCSA’s structure is unchanged because Class B has full voting rights is false. The issuance of non-voting Class B stock would alter the capital structure and potentially dilute economic ownership while preserving voting control among Class A holders, but the LLM misrepresents this. (4) Correctness is severely impacted by the core factual inaccuracy about voting rights, warranting a low score (3). Quantitative accuracy is high (8) due to correct share count and formatting. Qualitative accuracy is low (3) because of flawed reasoning and entity attribute misassignment. Contextual relevance is moderate (7) as the response addresses both companies and the right topic, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 521,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA’s Medicare price‑setting rules will likely push Amgen’s federally reimbursed drugs into an earlier revenue‑erosion window.  As the first 10 drugs (including ENBREL) face mandatory Medicare pricing in 2026 and the next 15 (including Otezla) in 2027, Amgen’s revenue loss could begin in those years—mirroring AbbVie’s experience with Imbruvica and Vraylar, which were selected for government pricing in 2026 and 2027 and saw accelerated erosion before patent expiry.  The IRA’s inflation penalties and Part D redesign will further compound this erosion over the decade.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding Amgen's drugs being selected for price setting in 2026 and 2027. The original answer (ground truth) does not state that ENBREL or Otezla have been selected for government pricing in those years—this is an unsupported addition by the LLM. The IRA's initial drug selections for price negotiation were not publicly confirmed to include Amgen’s ENBREL or Otezla by 2026/2027 in the knowledge graph. (2) Quantitatively, the years 2026 and 2027 are correctly referenced in the context of AbbVie’s Imbruvica and Vraylar, which aligns with the ground truth. However, the LLM incorrectly implies that Amgen’s ENBREL is among the first 10 drugs selected in 2026 and Otezla in the next 15 in 2027—this specific drug selection and grouping is not supported by the original answer or known public data at the time. These are significant factual overreaches. (3) The multi-hop reasoning is partially sound: the model correctly infers that IRA provisions could accelerate revenue erosion for Amgen by referencing AbbVie’s experience, and it understands the general mechanism of Medicare price setting impacting revenue pre-patent expiry. However, it fails to accurately generalize the rule-based timeline (9 years for small molecules, 13 for biologics post-approval) mentioned in the ground truth, instead substituting unverified drug-specific selections. This weakens the reasoning chain. (4) Despite these errors, the answer remains contextually relevant and captures the broader implication—that Amgen faces similar risks as AbbVie due to IRA pricing rules. The mention of inflation penalties and Part D redesign adds context beyond the original answer but does not contradict it. However, the introduction of unsupported specifics lowers factual correctness. Thus, the correctness score is 6 due to partial accuracy with significant factual overreach on drug selections.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 526,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive has 37,028 000 securities (37,028 000 shares) available for future issuance under equity‑compensation plans approved by security holders, whereas Procter & Gamble reports 119 000 000 such securities. Thus Procter & Gamble’s available securities are roughly 3.2 times larger than Colgate‑Palmolive’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000, matching the ground truth. However, it reports Procter & Gamble's total as 119,000,000 instead of the correct 133,185,995, which is a significant numerical inaccuracy. This error affects the comparison and undermines the quantitative conclusion. (2) The calculation claiming PG’s pool is 'roughly 3.2 times larger' is based on incorrect input: using 119M vs 37M gives ~3.2, but using the correct 133.2M would yield ~3.6 times larger. Thus, both the input number and derived ratio are inaccurate. (3) The multi-hop reasoning is structurally sound—comparing available securities under shareholder-approved plans across two companies—but fails due to incorrect data retrieval for P&G. The model synthesizes across entities correctly in approach, but not in execution. (4) Despite the wrong number for P&G, the answer maintains proper context, uses correct terminology, and draws a logically appropriate comparison. The direction of the conclusion (PG > CL) is correct, but the magnitude is off. Hence, partial credit is given: correctness score 6 for core facts partially right but major error in key figure; quantitative accuracy penalized more (5); qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 363,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s joint commercialization in Taiwan (with Ono, page 86) involves local supply and shared profits for Opdivo, Yervoy and other biologics, but the partnership still must meet Taiwan’s requirement that biologics receive local clinical‑trial data before registration. In contrast, Merck’s 2021 spin‑off of its biosimilars portfolio into Organon (page 3) is a corporate restructuring that separates the biosimilars business from Merck’s core operations; the new entity would bear the responsibility for satisfying Taiwan’s local‑trial data requirement for its biologics, but the spin‑off itself does not alter the regulatory requirement.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct and factually accurate. (1) It correctly identifies BMS's (BMY) joint commercialization with Ono in Taiwan for biologics like Opdivo and Yervoy, noting shared profits and local supply, and acknowledges Taiwan's requirement for local clinical trial data for biologics registration. It also accurately describes MRK's 2021 spin-off of its biosimilars business into Organon as a strategic separation. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the date '2021' for the MRK spin-off is correct, and no calculations are needed. (3) The multi-hop reasoning is sound: the model connects BMY’s collaborative market-access strategy in Taiwan with regulatory requirements and contrasts it with MRK’s divestiture of biosimilars via spin-off, correctly noting that Organon would now bear the regulatory burden. However, the LLM slightly misses the strategic implication emphasized in the ground truth: that MRK’s move represents a retreat from the biosimilars segment due to competitive and regulatory pressures, not just a neutral restructuring. The answer is more descriptive than interpretive, lacking the comparative strategic insight (e.g., 'direct presence' vs. 'strategic retreat'). (4) Despite this, the answer is contextually relevant, entity-accurate (BMS, Ono, Organon, MRK), and semantically aligned with the ground truth. Minor deduction in qualitative accuracy for less nuanced strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 408,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s Greater China segment—encompassing China mainland, Hong Kong and Taiwan—generated **$74.2 billion** in net sales in 2022.  Adobe, by contrast, only notes that it has **local field offices in Taiwan** (and other regions) but does not disclose a revenue figure for that market, so Apple’s revenue contribution from Taiwan‑included Greater China is substantially larger in absolute terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Apple's Greater China segment, which includes Taiwan, generated $74.2 billion in net sales in 2022—this matches the ground truth of $74,200 million. The format variation ($74.2 billion vs $74,200 million) is acceptable and semantically equivalent. (2) The LLM accurately notes that ADBE has a local field office in Taiwan but does not disclose revenue for that specific market, which aligns with the original answer’s claim about ADBE’s operational presence. (3) The multi-hop reasoning is sound: the model correctly synthesizes that AAPL’s revenue from the region (including Taiwan) is reported at the segment level, while ADBE’s presence is operational but not quantified financially, leading to a valid comparison of scale and strategy. (4) The only minor shortcoming is that the LLM does not explicitly mention that AAPL’s exposure to Taiwan is embedded within a broader segment (a nuance present in the original), but it does correctly frame Taiwan as part of Greater China. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 333,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast’s 10‑K (page 33) discloses that all of its Class B shares are held by a single individual (Brian L. Roberts) and together with the 66.3 % voting power of Class A shares, the Class B holder controls roughly one‑third of the company’s votes. Meta’s 10‑K (page 57) lists only 23 record holders of its non‑publicly traded Class B shares, indicating a small group holds the concentrated voting power, though the exact percentage is not disclosed. In both companies the dual‑class structure concentrates voting influence in a limited group, limiting ordinary shareholders’ sway over board elections and major corporate decisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key structural differences in voting control between CMCSA and META. It accurately states that CMCSA's Class B shares are held by Brian L. Roberts alone and that Class A holds 66.3% (close to the exact 66 2/3%) of voting power, implying Class B holds roughly one-third (33 1/3%), which aligns with the ground truth. For META, it correctly notes that Class B shares are not publicly traded, held by only 23 record holders, and that the exact voting percentage is not disclosed—this matches the original answer. However, the LLM rounds 66 2/3% to 66.3%, which is a minor approximation error (though directionally accurate), and omits the specific detail that each Class B share carries 15 votes in CMCSA, a notable but not critical omission. (2) Quantitatively, the 66.3% figure is a slight deviation from the precise 66 2/3% (i.e., 66.666...%), and while this is a small rounding difference, it affects strict numerical accuracy. The 23 stockholders of record for META is correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes information from both companies’ 10-Ks, compares their dual-class structures, and draws valid conclusions about shareholder influence and governance concentration. It correctly infers that both structures concentrate power, though with different levels of transparency. (4) The answer is contextually excellent—directly addresses the question about voting control concentration and implications for corporate governance. The conclusion that ordinary shareholders have limited sway is logically supported. The omission of the 15-vote per Class B share detail slightly weakens completeness but does not invalidate the core correctness. Thus, the answer earns high marks but not perfect due to minor quantitative and detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 497,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY’s 10‑K explains that the U.S. FDA can grant an extra six‑month “pediatric exclusivity” that is added to data‑protection or patent terms (page 10), and that the EU likewise provides a six‑month pediatric exclusivity attached to a product’s Supplementary Protection Certificate (SPC) (page 14).  In contrast, MRK’s 10‑K lists a U.S. six‑month pediatric exclusivity (page 15) but its product‑protection table (page 12) shows no EU pediatric exclusivity benefit.  Thus, LLY gains pediatric exclusivity in both U.S. and EU markets, whereas MRK’s benefit is limited to the U.S. regulatory framework.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the six-month pediatric exclusivity in both the U.S. and EU, which matches the ground truth numerically and contextually. However, it incorrectly states that MRK does not benefit from pediatric exclusivity in the EU, claiming its 10-K shows 'no EU pediatric exclusivity benefit' based on a product-protection table. This contradicts the ground truth, which explicitly states that MRK *does* benefit in the EU through an additional six months added to the SPC term. The LLM likely misinterpreted the absence of a specific mention in a table as absence of benefit, leading to a critical factual error. (2) Quantitatively, all numbers (six-month extensions) are accurate and correctly attributed to the right jurisdictions. There are no calculation errors. (3) The multi-hop reasoning is partially sound—LLY’s U.S. and EU benefits are correctly described, and MRK’s U.S. benefit is acknowledged—but the synthesis fails for MRK in the EU. The model should have recognized that EU pediatric exclusivity applies to SPCs and that MRK, as a major pharmaceutical company, would be eligible under the same framework, especially since the ground truth confirms this. The reliance on a single table in the 10-K without broader regulatory context weakens the reasoning. (4) The correctness score is 4 due to a major factual inaccuracy regarding MRK’s EU benefits, despite correct numbers and partial completeness. Quantitative accuracy is high (8) because all numerical values are correct. Qualitative accuracy is low (4) due to flawed reasoning and incorrect entity-specific synthesis. Contextual relevance is 7 because the answer addresses the regulatory frameworks and companies in question, but misses a key comparative insight about how MRK benefits in both regions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 491,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "EMR’s foreign‑currency liabilities fell from $22 million in 2023 to $20 million in 2024—a $2 million decline—whereas Lockheed Martin’s foreign‑currency hedge exposure was $7.5 billion at year‑end 2024 (up from $6.5 billion in 2023). The EMR exposure is negligible compared with LMT’s billions‑level hedging program, indicating EMR has a modest FX exposure that is likely managed with limited hedging, while LMT faces a large FX exposure and maintains an extensive, actively managed hedging strategy to mitigate it.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in scale: it reports EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024 respectively, whereas the ground truth states $22 billion and $20 billion. This is a 1,000-fold error, making the $2 million reduction completely incorrect—it should be a $2 billion reduction. Additionally, the LLM incorrectly claims LMT's hedge exposure increased from $6.5 billion in 2023 to $7.5 billion in 2024, which is not supported by the original answer; the original only states LMT had $7.5 billion in hedges at the end of 2024, with no mention of 2023 levels. (2) These quantitative inaccuracies severely undermine the comparison: stating EMR's exposure is 'negligible' due to being in the millions misrepresents the actual scale, which at $20–22 billion is substantial and comparable in magnitude to LMT’s $7.5 billion hedge book. The calculation of a $2 million decline is wrong; it should be $2 billion. (3) The multi-hop reasoning is partially sound—comparing liability reduction vs. active hedging—but based on false premises. The conclusion that EMR has 'modest FX exposure' is invalid given the billion-dollar scale in the truth data. The qualitative insight about LMT having an extensive hedging program is reasonable, but the characterization of EMR’s strategy is flawed due to the number error. (4) Correctness is severely penalized due to the magnitude of the numerical error. Quantitative accuracy is very low because key dollar amounts are off by orders of magnitude and unsupported claims about LMT’s 2023 hedges are introduced. Qualitative accuracy is low because the reasoning is built on incorrect data. Contextual relevance is moderate as the structure and intent align with the question, but factual foundation is broken.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 493,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "AENB’s $3.6 billion dividend to its parent, American Express, is a capital distribution that reduces the bank’s Tier 1 capital.  Under federal banking rules (page 5), both AENB and Wells Fargo must maintain a minimum Tier 1 leverage ratio—defined as Tier 1 capital divided by average total assets (page 67)—so the dividend was subject to regulatory review to confirm the ratio stayed above the required threshold.  The same leverage‑ratio constraint limits Wells Fargo’s ability to make capital distributions until it can demonstrate compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core relationship between AENB's $3.6 billion dividend and leverage ratio requirements, as well as the parallel constraints on WFC. (1) Quantitatively, the $3.6 billion figure is correctly stated, and no other numerical values (e.g., ratios, thresholds) are misstated—only referenced generally, which aligns with the original answer. (2) The answer correctly identifies that dividend payments reduce Tier 1 capital, which directly impacts the Tier 1 leverage ratio (Tier 1 capital / average total assets), and notes regulatory review, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: it connects AENB’s dividend to capital distribution rules, links those to federal leverage ratio requirements, and draws a valid comparison to WFC’s similar constraints under the same regulatory framework. (4) Minor deduction in qualitative accuracy because the LLM specifies 'Tier 1 leverage ratio' and cites page numbers (5, 67), which were not in the original knowledge graph and may reflect overfitting to a document structure not provided in the context. However, the substance remains correct and semantically equivalent. The answer is fully contextually relevant and addresses both entities and the regulatory linkage as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 362,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s 2024 pre‑tax income is roughly 59 % U.S. ($62.9 B) and 41 % foreign ($44.9 B)【page_47】. Because it has no material operations in jurisdictions with effective rates below the 15 % Pillar Two minimum, Microsoft expects limited exposure to the new rules when they take effect in FY 2025【page_47】. Qualcomm, whose income is largely U.S.‑taxed and also has no significant presence in low‑rate jurisdictions, similarly anticipates no material impact from Pillar Two when it applies in FY 2025【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Microsoft's pre-tax income distribution ($62.9B U.S., $44.9B foreign) and accurately calculates the approximate percentages (59% U.S., 41% foreign), which aligns with the ground truth. It correctly states that both Microsoft and Qualcomm expect no material impact from Pillar Two, with implementation in fiscal 2025. All numeric values and fiscal years are accurate. (2) Quantitative accuracy is perfect: the dollar amounts match exactly, and the percentage split is a correct approximation based on total pre-tax income ($62.9B + $44.9B = $107.8B; $62.9B / $107.8B ≈ 58.3%, rounded to 59% is acceptable). No calculation errors. (3) The multi-hop reasoning is sound—LLM connects Microsoft’s income geography to reduced Pillar Two exposure due to lack of operations in low-tax jurisdictions, then correctly compares this to Qualcomm’s similar expectation of no material impact. The synthesis across both companies and the regulatory framework is logical and supported by the source. (4) The only minor shortcoming is that the LLM adds specificity not present in the ground truth—namely, the claim that Microsoft and Qualcomm have 'no material operations' or 'no significant presence' in low-rate jurisdictions. While plausible and consistent with 'no material impact,' this detail is not explicitly confirmed in the original answer, slightly reducing qualitative accuracy. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 414,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart’s $37.2 billion of unrecorded purchase obligations are binding commitments for inventory, capital expenditures, software, licenses and service contracts that could materialize into large cash outflows, tightening liquidity and potentially forcing additional borrowing. Because Walmart’s VAR model – like MDLZ’s – excludes forecasted transactions and firm commitments, these obligations are not reflected in the one‑day market‑risk loss estimates, leaving a gap in the company’s risk assessment for liquidity and contractual exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies Walmart's $37.2 billion in unrecorded purchase obligations, which matches the ground truth in amount and nature (inventory, capital expenditures). It also accurately notes that these are firm commitments not reflected in VAR models. However, it incorrectly implies that Walmart uses a VAR model, while the ground truth states that MDLZ uses a VAR model and references DIS's 10-K to explain VAR limitations—Walmart’s use of VAR is not confirmed in the original answer. 2) Quantitatively, the $37.2 billion figure is accurate and correctly formatted; no calculations are required. 3) The multi-hop reasoning is partially flawed: the original answer draws a comparison between WMT's off-balance sheet obligations and MDLZ's risk modeling approach, citing DIS as the source for how VAR models exclude firm commitments. The LLM incorrectly shifts focus by attributing a VAR model to Walmart, which is not supported in the ground truth, and omits the key point that MDLZ’s model specifically uses a parametric delta-gamma method excluding firm commitments. This weakens the synthesis across entities (WMT, MDLZ, DIS). 4) Despite the misattribution of the VAR model to Walmart, the answer captures the core risk—unrecorded obligations not captured by standard VAR models—and maintains high contextual relevance. The explanation of liquidity risk and potential borrowing is a reasonable inference. However, the failure to correctly attribute the VAR model usage and methodology to MDLZ, and the omission of DIS’s role in explaining VAR limitations, reduces qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 436,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UNH used an interest‑rate swap with a $1.4 billion notional that matured when it repaid the 3.625% 2024 Notes, effectively converting the fixed‑rate coupons of that debt to floating SOFR‑based coupons (UNH, debt repayments and interest‑rate swaps, page 142; swap maturity, page 148). In contrast, AMGN had no swap contract for its 3.625% 2024 Notes; its $6.7 billion of interest‑rate swaps were for other debt and were not tied to that note’s repayment (AMGN, interest‑rate swaps, page 142; swap notional amounts, page 149).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) Quantitatively, it incorrectly states that UNH had a $1.4 billion notional interest rate swap tied to the 3.625% 2024 Notes, while the ground truth indicates UNH has $27 billion of floating-rate liabilities broadly and does not specify a $1.4 billion swap linked to that note. Conversely, it falsely claims AMGN had no swap related to the 3.625% 2024 Notes, when the original answer explicitly states AMGN did enter into $1.4 billion of swaps maturing in 2024 in connection with that debt. The $6.7 billion swap figure for AMGN is also incorrect per the ground truth, which only references $1.4 billion tied to the 2024 Notes. (2) The entity identification (UNH, AMGN, 3.625% 2024 Notes) is correct, but the relationships between entities and financial instruments are reversed. (3) The multi-hop reasoning fails: instead of correctly contrasting UNH’s broad use of swaps across its balance sheet with AMGN’s specific use tied to the 2024 Notes, the LLM inverts the facts—attributing targeted use to UNH and general use to AMGN. (4) Contextual relevance is moderate because the answer addresses interest rate swaps and debt repayments, but the core factual inversion renders it misleading. Semantic equivalence is not achieved due to fundamental factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 375,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924% Senior Notes due 2032 are fixed‑rate, semi‑annual‑interest obligations that mature on March 1, 2032, but an event of default accelerates the notes to immediate repayment of principal and accrued interest (page 79).  Oracle’s unsecured $6 billion revolving credit facility matures on March 8, 2027; a default merely accelerates all outstanding balances to that maturity date, requiring repayment by that date but not necessarily instantaneously (pages 88‑90).  Thus, AMD’s default provision forces an immediate payoff of a fixed‑rate senior note, whereas Oracle’s default provision pushes repayment to the facility’s fixed maturity, with a variable‑rate borrowing structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between AMD's and Oracle's default-triggered obligations. (1) Quantitatively, all key figures are accurate: AMD's notes due 2032 with $1.0 billion principal (implied from context), Oracle's $6.0 billion facility, and correct maturity dates (March 1, 2032 for AMD; March 8, 2027 for Oracle). Interest terms (semi-annual for AMD, variable-rate for Oracle) are correctly noted. (2) The LLM correctly identifies that an Event of Default triggers immediate repayment for AMD, while Oracle's acceleration requires repayment by the existing maturity date (March 8, 2027), not instantaneously—this is a nuanced but important distinction supported by the ground truth. (3) However, the LLM omits that Oracle’s Revolving Credit Agreement allows borrowing, prepayment, and reborrowing, a key structural flexibility highlighted in the original answer. It also does not mention that AMD’s notes are unsecured senior obligations, a direct point in the ground truth. (4) The reasoning is sound and synthesizes multi-hop information across two companies and debt instruments, but the omission of the reborrowing feature and security status slightly weakens completeness. Wording differs but meaning is semantically close. Minor deductions for missing contextual details, but core facts and comparisons are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 377,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s $31 billion of trust assets under reinsurance contracts are held by an independent trustee and are governed by strict investment guidelines that limit concentration, single‑issuer exposure and duration (page 50, page 51).  The policy is designed to keep credit and liquidity risk in check, but the large size of the portfolio means the absolute risk exposure is higher.  By contrast, General Dynamics’ $191 million of marketable securities held in trust is restricted to investment‑grade fixed‑income securities with maturities of up to five years (page 52), resulting in a smaller, lower‑risk, short‑term portfolio.  Thus, both entities use conservative, investment‑grade policies, but GE’s trust assets carry greater absolute exposure while GD’s holdings are inherently less risky due to their size and short duration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: GE's $31.0 billion and General Dynamics' $191 million are accurately reported, with proper context of December 31, 2021, implied via source document alignment. Format variations ($31 billion vs $31.0 billion) are acceptable. (2) The investment policies for both companies are correctly described: GE’s strict guidelines on concentration, issuer exposure, and duration are accurately summarized, as are General Dynamics’ restrictions to investment-grade fixed-income securities with maturities up to five years. (3) The multi-hop reasoning is sound—comparing scale, risk exposure, and investment strategy across two different companies and trust structures is logically executed. The conclusion that both use conservative policies but differ in absolute risk due to size and duration is valid and supported. (4) Minor omission: the ground truth mentions GE’s consideration of non-traditional asset classes and periodic review for allocation changes, which adds depth to its dynamic strategy—this nuance is missing in the LLM answer. However, this does not undermine the core accuracy. The LLM correctly identifies GE’s higher absolute risk and GD’s lower-risk short-duration approach, capturing the essential contrast. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing investment policy and risk exposure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 408,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income models are priced with observable market data such as interest‑rate curves, credit‑spreads, broker/dealer bids and quoted prices of comparable securities (page 89). PayPal’s Level 2 derivative valuations, by contrast, rely on observable inputs like currency exchange rates, interest‑rate curves, option volatilities and equity prices (page 91). Thus, while both use Level 2 data, Lockheed focuses on fixed‑income market and credit‑spread inputs, whereas PayPal incorporates foreign‑exchange, volatility and equity‑price inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities—Lockheed Martin, PayPal, Level 2 pricing, fixed income, and derivatives—are correctly identified and appropriately contextualized. (2) No numeric values (e.g., dates, dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised; the inputs described (interest-rate curves, credit spreads, currency rates, option volatilities, equity prices) match the ground truth exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use Level 2 methodologies with observable inputs, but apply them to different asset classes—fixed income vs. derivatives—and specifies the distinct types of inputs relevant to each. The inclusion of 'broker/dealer bids and quoted prices of comparable securities' adds a minor detail not in the original but is consistent with Level 2 inputs and does not contradict the ground truth. (4) The answer is fully contextually relevant, directly addressing the comparison of observable inputs under Level 2 methodologies. The only reason for not scoring a perfect 10 is that the original answer emphasizes the shared reliance on observable data despite different asset classes, a nuance slightly downplayed in the LLM version, though still implied. Overall, the response is highly accurate, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 391,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are materially exposed to market rate swings – a 50‑basis‑point move in rates would shift their fair value by about $1.7 billion (≈$34 million per basis point).  \nCISCO’s interest‑rate swap, on the other hand, is a fair‑value hedge that converts the fixed‑rate notes to floating and whose gain/loss offsets the fair‑value change of the hedged debt, effectively neutralizing its sensitivity to interest‑rate fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all numbers are correct: AVGO's $1.7 billion fair value change from a 50 bps shift is accurately reported, and the implied sensitivity (~$34 million per basis point) is a valid derivation. CSCO’s $0.5 billion notional swap is not explicitly quantified in the LLM answer, but its qualitative impact is correctly described. (2) The entity names (AVGO, CSCO), financial instruments (fixed-rate senior notes, interest rate swap), and risk exposures are correctly identified. (3) The reasoning correctly contrasts AVGO’s direct exposure with CSCO’s use of a fair-value hedge that offsets interest rate sensitivity, capturing the key comparative insight. (4) The only minor omission is that the LLM does not mention CSCO’s hedge specifically applies to the senior note due in fiscal 2025, nor does it reference AVGO’s use of treasury rate locks for future debt issuances—details present in the original that add context about differing hedging strategies. However, these omissions do not undermine the central comparison of sensitivity versus hedged neutrality. The answer remains semantically equivalent in its core claims and is contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 352,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance is structured around joint development and global co‑promotion, with Pfizer covering 50‑60 % of development costs and the two parties sharing profits and losses equally (except in a few markets).  Pfizer’s upfront payment for the license rights is recorded as deferred income, but the amount and any milestone payments are not disclosed.  In contrast, Pfizer’s Beam collaboration specifies a $300 million upfront payment and up to $1.05 billion in development, regulatory and commercial milestone payments—potentially totaling $1.35 billion—along with royalty rights, giving the Beam deal a more clearly defined financial commitment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between Pfizer's obligations in the BMY Eliquis alliance and its collaboration with Beam. Quantitatively, the $300 million upfront and up to $1.05 billion in milestones (totaling $1.35 billion) for the Beam deal are accurately reported, matching the ground truth. However, the LLM states that the upfront and milestone payments in the Eliquis alliance 'are not disclosed,' while the original answer notes that Pfizer made an upfront payment and potential milestones are being amortized—implying such payments exist but are not quantified. This is a minor omission rather than an error, as the lack of disclosed amounts is consistent with public information. The LLM correctly contrasts the transparency of financial terms: clearly defined in the Beam deal versus undisclosed in Eliquis. It also accurately captures the joint nature of the Eliquis alliance (cost sharing, co-promotion, profit/loss split), which is relevant context even if not directly financial commitments from Pfizer to BMY. The multi-hop reasoning is sound—comparing structure and financial transparency across two distinct collaborations. The answer does not explicitly state that Pfizer’s potential commitment to Beam 'could significantly exceed' its Eliquis payments (a key comparative insight in the original), but it implies this by highlighting the $1.35 billion potential value versus no disclosed amounts for Eliquis. Wording differences are acceptable under semantic equivalence. No incorrect entities or numbers are introduced. Thus, the answer is factually accurate with minor incompleteness on the qualitative comparison of financial scale, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 469,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments records lease‑extension and termination options in the lease liability and asset when it is reasonably certain they will exercise them, thereby increasing long‑term liabilities and recognizing operating‑lease expense straight‑line over the lease term【page_35】. Cisco, by contrast, treats customer‑financing leases as receivables; the related revenue is deferred and recognized ratably over the service period, and any guarantees generate deferred revenue that is recognized only when the guarantee is removed【page_52】. Thus, TI’s approach expands long‑term liabilities and front‑loads lease expense, whereas Cisco’s approach creates receivables and defers revenue, leaving long‑term liabilities largely unaffected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Texas Instruments' (TI) accounting for lease extension and termination options by recognizing lease assets and liabilities when exercise is reasonably certain, impacting long-term liabilities—consistent with the original answer. It also accurately describes Cisco's treatment of customer financing arrangements as receivables with deferred revenue recognition over the service period and upon removal of guarantees. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all qualitative financial impacts are correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in how TI and Cisco treat similar contractual provisions—TI affecting liabilities and lease expense, Cisco affecting revenue timing and credit exposure via receivables and deferrals. The only minor shortcoming is that the LLM does not explicitly mention Cisco's use of collateralization or TI's use of the incremental borrowing rate in present value calculations, which are present in the ground truth and add nuance to the accounting policies. However, the core implications on financial statements are correctly captured. (4) The answer is contextually relevant, directly addressing the comparison of accounting practices and their impact on long-term liabilities and revenue recognition. Wording differs but meaning is semantically equivalent. Thus, a correctness score of 9 is warranted due to high accuracy with minor omissions in methodological detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 453,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives Disney+ a built‑in “National Geographic” tile that differentiates its library from rivals—Disney+ already bundles National Geographic programming alongside Disney, Pixar, Marvel, Star Wars, and Star content【page_13】. Because Disney controls most of that content, it can avoid the third‑party licensing fees that a service like YouTube must pay to host similar material, potentially lowering subscriber‑acquisition costs relative to YouTube’s model, which relies on licensing content from external producers and generates revenue from Premium and TV subscriptions【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic is accurately stated, and the integration of National Geographic as a top-level tile on Disney+ is correctly described. The contrast with YouTube’s reliance on licensed content is appropriately highlighted. (2) Quantitative accuracy is perfect—no calculations are required, and the 73% ownership figure is correctly cited. (3) The multi-hop reasoning is sound: the model correctly links Disney’s ownership stake to content differentiation on Disney+, avoids third-party licensing fees, and contrasts this with YouTube’s licensing model, leading to implications for subscriber acquisition costs. The only minor shortcoming is that the LLM does not explicitly state that lower content costs translate into lower *subscriber acquisition costs* due to reduced marginal costs—a nuance present in the original answer. However, the implication is strongly suggested. (4) Contextual relevance is excellent, as the response directly addresses both parts of the question: content differentiation strategy and cost implications relative to YouTube. Wording differs slightly but maintains semantic equivalence. No incorrect entities or facts are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 361,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologic products receive 12 years of regulatory exclusivity (plus up to six months for pediatric studies) that can extend market protection beyond the life of their patents, with estimated minimum exclusivity dates ranging from 2025 (Yervoy) to 2036 (Abecma)【page_7】【page_9】.  In contrast, Merck’s Januvia family had a key U.S. patent expire in January 2023, but regulatory exclusivity (and other patent‑related protections) delayed loss of U.S. exclusivity until May 2026 for Januvia/Janumet and July 2026 for Janumet XR, while exclusivity in the EU was lost earlier (September 2022 for Januvia, April 2023 for Janumet)【page_58】.  Thus, regulatory exclusivity can extend protection beyond patent terms, but its expiration still dictates when generics can enter; BMY enjoys a longer exclusivity window for its biologics, whereas Merck’s Januvia faced earlier EU exclusivity loss despite U.S. delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, all key dates and numbers are correct: BMY's 12-year biologic exclusivity (with pediatric extension noted) and estimated exclusivity windows (2025–2036) align with the knowledge graph; MRK's Januvia patent expiration in January 2023 and delayed U.S. exclusivity until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) are accurately reported. The mention of earlier EU exclusivity loss (September 2022, April 2023) adds context not in the original answer but is factually consistent and relevant. (2) The calculation and comparison of exclusivity timelines are sound—LLM correctly infers that BMY benefits from statutory biologic exclusivity while MRK extended protection via secondary patents and litigation. (3) Multi-hop reasoning is strong: the model synthesizes across BMY’s biologics (Opdivo, Yervoy, Abecma) and MRK’s Januvia family, compares U.S. and EU timelines, and correctly identifies the role of regulatory exclusivity in extending market protection beyond patents. (4) The only minor shortcoming is that the LLM does not explicitly name the 'salt-form patent' or 'court rulings/settlements' as the mechanism for MRK’s extension, instead generalizing to 'patent-related protections,' which slightly reduces precision in explaining the strategic difference. However, the overall reasoning and factual content remain substantially correct and contextually rich. Hence, a score of 9 is warranted—excellent accuracy with only slight omission in explanatory detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 444,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000 Series F preferred shares can be redeemed at $25,500 per share within 90 days of a rating‑agency event (page 264), so a downgrade could trigger a redemption that strains its capital. AIG acknowledges that a downgrade of its insurers’ ratings could limit its ability to write new business and impair customer retention (pages 83‑87), exposing it to business‑and‑liquidity risk. Thus, both companies face rating‑agency actions that can trigger financial obligations—MetLife through preferred‑share redemption and AIG through reduced underwriting capacity—linking their exposure to potential rating downgrades.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies MetLife's issuance of 40,000 shares of Series F preferred stock and the redemption clause tied to a 'rating agency event,' though it adds a specific redemption price of $25,500 per share and a 90-day window, which are not present in the original answer. These details may come from the actual 10-K filing but were not included in the ground truth summary, so their presence is not incorrect but represent additional detail rather than a factual error. (2) The quantitative elements—40,000 shares and $25,500 per share—are plausibly accurate (and format-consistent), but since the original answer does not specify dollar amounts or redemption price, we cannot fully verify their correctness from the ground truth alone; thus, a minor deduction in quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly links MetLife’s financial contingency (redemption obligation upon rating event) with AIG’s operational risk (business constraints from downgrade), synthesizing across both companies and their respective risks tied to rating agencies. (4) The answer captures the core intersection in the question—how both firms face exposure to rating agency actions—while accurately representing each company's unique risk. Wording differs but semantic meaning and factual content are equivalent to the original answer, with slightly more granular detail. Contextual relevance is perfect as it directly addresses the intersection of capital structure risks and business risk from downgrades.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 437,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s Level‑2 portfolio includes U.S. government securities, which the trustee values with matrix pricing when broker quotes are not available (using observable interest‑rate and spread data)【page_108】【page_93】. In contrast, UPS classifies U.S. government debt as Level‑1 and values it at quoted market prices; matrix pricing is applied only to other Level‑2 assets such as corporate bonds and municipal bonds【page_89】. Thus, LMT relies on matrix pricing for U.S. government securities within Level 2, whereas UPS does not use matrix pricing for those securities, reserving it for other Level‑2 holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding UPS's valuation methodology. The ground truth states that UPS *does* use matrix pricing for U.S. government debt classified as Level 2, while the LLM incorrectly claims that UPS classifies U.S. government debt as Level 1 and does not use matrix pricing for those securities. This contradicts the original answer and represents a major error in entity and methodology attribution. (2) Quantitatively, the LLM correctly identifies that LMT reported U.S. government securities in Level 2 (though it omits the exact $121 million figure from the ground truth), but fails to note that UPS did not disclose a specific amount—this omission reduces completeness but does not introduce a numerical error. The dates (as of December 31, 2021) are correctly implied for LMT. (3) The multi-hop reasoning is flawed: the model incorrectly contrasts LMT and UPS by asserting a difference in treatment of U.S. government securities when the ground truth indicates *both* companies use matrix pricing for such securities when direct quotes are unavailable. Instead of identifying alignment in methodology, the LLM creates a false distinction. (4) Contextual relevance is moderate because the answer discusses the correct topic (matrix pricing, Level 2 classifications, U.S. government securities) and cites relevant pages, but the core conclusion is factually incorrect. The qualitative accuracy is low due to the misrepresentation of UPS’s policy, undermining the comparative analysis. Overall, the answer is partially accurate in context and numbers but fundamentally wrong in its key claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 456,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PM’s derivative contracts are classified as Level 2 and are valued with readily observable market inputs—such as spot rates, interest‑rate differentials and volatility—so their fair values are driven by current market data (page 128, page 129). In contrast, MDLZ’s real‑estate fund investments are Level 3 assets, with valuations based on unobservable inputs such as appraisals, local market conditions and projected cash flows (page 103, page 104). Thus, PM’s valuations are more transparent and market‑observable, whereas MDLZ’s real‑estate valuations rely on management estimates and appraisals, making them less observable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, there are no numbers, dates, or dollar amounts to verify, and the classification levels (Level 2 for PM, Level 3 for MDLZ) are correctly stated. (2) The LLM correctly identifies that PM uses observable market inputs such as spot rates, interest-rate differentials, and volatility (minor addition of 'volatility' not in original but consistent with derivative valuation practices and not contradictory). MDLZ’s use of unobservable inputs like appraisals, local market conditions, and projected cash flows matches the ground truth’s mention of projected operating performance and local market conditions. (3) The multi-hop reasoning is sound: the answer correctly contrasts PM’s derivative valuations (market-driven, Level 2) with MDLZ’s real estate fund valuations (estimate-driven, Level 3), synthesizing information across two companies and valuation methodologies. (4) The only minor shortcoming is that the original answer specifies PM’s use of 'maturity dates' as an input, which the LLM omits, and the LLM mentions 'appraisals' and 'volatility' not explicitly in the ground truth—though these are reasonable inferences and do not detract from factual correctness. Overall, the semantic meaning, entity accuracy, and comparative logic are fully preserved, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 384,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures allow the company to elect to defer interest payments (subject to conditions in Note 15) and are bound by replacement‑capital covenants that require cash proceeds from the sale of replacement securities before any repayment, redemption or purchase can occur, thereby imposing liquidity constraints and triggering dividend‑stopping provisions when trigger events arise (see pages 129‑131). In contrast, AIG’s AIGLH‑issued junior‑subordinated debentures are simple, guaranteed debt instruments with fixed interest rates and maturity dates (8.5 % due 2030, 8.125 % due 2046, 7.57 % due 2045) and the filing makes no reference to interest‑deferral rights or liquidity‑constraint covenants (see page 288). Thus, MetLife’s strategy includes optional deferral and liquidity‑linked repayment restrictions, whereas AIG’s obligations are straightforward debt payments with no such provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All quantitative details are correct: the interest rates (8.5%, 8.125%, 7.57%), maturities (2030, 2046, 2045), and dollar amounts ($54M, $142M, $31M) are accurately reported, though the LLM omits the specific dollar values. This is a minor omission but does not distort the meaning. (2) The entity identification is correct—MetLife and AIG/AIGLH are properly distinguished, and the structural features (deferral provisions, replacement capital covenants, dividend stoppers) are correctly attributed. (3) The reasoning is sound: the LLM correctly contrasts MetLife’s deferral and liquidity-linked covenants with AIG’s straightforward guaranteed debt without deferral or replacement covenants. It accurately infers that AIG’s obligations lack such provisions based on the absence of mention in the filing. (4) The answer is contextually relevant and directly addresses the comparison in terms of liquidity constraints and deferral provisions. The only minor shortcoming is the omission of the exact principal amounts of AIGLH’s debentures, which were included in the ground truth. However, since the question focuses on structural comparison rather than exact figures, this does not significantly detract from correctness. Wording differences (e.g., 'simple, guaranteed debt instruments' vs. 'guaranteed by AIG Parent') are semantically equivalent. Overall, the answer demonstrates strong multi-hop synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 412,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA’s rivalry with Samsung in the SoC arena—where Samsung is listed as a key competitor【page 15】—underscores Samsung’s advanced process and integration capabilities that also compete with Intel in foundry services. This dual role forces Intel to accelerate its IFS scaling while contending with Samsung’s mature manufacturing technology, a challenge compounded by Intel’s own historical delays in 10 nm and Intel 4 nodes that have eroded its competitive edge【page 54】. Consequently, Intel must overcome yield, capacity, and time‑to‑market gaps to keep pace with Samsung and other foundries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets, Samsung is a competitor to Intel's IFS, and Intel faces challenges due to historical delays in 10nm and Intel 4 process nodes—explicitly mentioned in both answers. The reference to page citations (15, 54) suggests grounding in source material, though not required for correctness. (2) There are no numeric values requiring calculation (e.g., financial figures, dates, percentages), so quantitative accuracy is not compromised; all process technology names (10nm, Intel 4) are correctly stated. (3) Multi-hop reasoning is sound: the LLM correctly identifies that Samsung’s dual role as a product competitor (to NVIDIA) and foundry competitor (to Intel) increases pressure on Intel to scale IFS rapidly, especially given its own manufacturing setbacks. The synthesis across NVIDIA → Samsung → Intel IFS → manufacturing delays is logically coherent. (4) The only minor omission is the lack of explicit mention of how NVIDIA’s pressure on Samsung *indirectly* affects Intel—this causal chain is implied but not articulated as clearly as in the original answer. However, the core strategic challenge to Intel is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses all aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 392,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 repurchase program bought only its publicly traded, lower‑voting shares—$62 billion in Class A and Class C stock—because its Class B shares carry 10 votes per share and are not traded, so buying them would alter control (see page 82). Comcast’s program likewise targets Class A shares; its Class B shares, worth 15 votes each and held almost entirely by Brian Roberts, are not publicly traded and concentrated, so repurchasing them would have little effect on the company’s voting structure (see pages 31‑32). Thus, the higher voting rights of Class B shares and, in Comcast’s case, their concentration, steer both firms toward buying only the lower‑voting, publicly traded shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $62.0 billion repurchased by Alphabet in 2024 is accurately cited. The voting rights (10 votes for Alphabet Class B, 15 for Comcast Class B) match the context, and the ownership concentration by Brian L. Roberts is correctly referenced. (2) The reasoning is sound: the LLM correctly explains that repurchasing lower-voting Class A and C shares allows Alphabet to return capital without diluting control, since Class B shares (with superior voting rights) are not repurchased and automatically convert to Class A upon sale. For Comcast, the explanation that repurchasing Class A shares increases the relative voting power of the concentrated Class B shares held by Roberts is logically consistent with the ground truth. (3) Multi-hop synthesis is strong—linking Alphabet’s share structure and repurchase behavior to Comcast’s similar dynamic, especially regarding control preservation, shows appropriate cross-company reasoning. (4) Minor deduction in qualitative accuracy because the LLM omits the specific detail that Comcast’s Class B shares represent exactly 33⅓% of combined voting power, and does not explicitly mention the automatic conversion of Alphabet Class B to Class A upon sale, which is a key mechanism preserving control. However, the core logic and implications are correctly inferred. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 428,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s 10‑K notes a focus on NSCLC (page_4) but does not disclose how those therapies are delivered. In contrast, BMS’s FDA approval of Opdivo Qvantig delivers nivolumab via subcutaneous injection, expanding the adult solid‑tumor portfolio by offering a convenient outpatient route for most previously approved solid‑tumor Opdivo indications (page_44).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying Amgen's focus on NSCLC and BMS's FDA approval of Opdivo Qvantig with subcutaneous administration. It accurately reflects that Amgen's 10-K does not specify delivery methods for its NSCLC therapies, while BMS's approval enables subcutaneous delivery for most previously approved adult solid tumor indications. The answer captures the key contrast in strategies: Amgen emphasizing therapy development in NSCLC versus BMS improving delivery convenience. However, it omits specific details present in the ground truth, such as the December 2024 approval date and the explicit mention of monotherapy, maintenance therapy, or combination use with chemotherapy or cabozantinib. While the core facts and entities (Amgen, BMS, Opdivo Qvantig, subcutaneous administration, solid tumor indications) are correct, the answer provides a slightly less complete synthesis of BMS’s broader market expansion potential due to these omissions. There are no quantitative inaccuracies—no numbers are misstated, and the absence of specific dates or combination regimens does not introduce error, only slight incompleteness. The reasoning is sound and directly addresses the comparison asked in the question, making it semantically close to the original answer but missing minor but relevant contextual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 379,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "Comcast’s charter guarantees that holders of Class B stock own 33 ⅓ % of the company’s voting power, a block that cannot be diluted by any new issuances (page 91).  Each Class B share carries 10 votes versus one vote for a Class A share (page 81), and although Class B shares may be converted into Class A shares at the holder’s option or automatically on sale (page 83), the 33 ⅓ % voting block remains fixed.  As a result, Alphabet’s stake in Class A shares is capped by the non‑dilutable 33 ⅓ % block held by Class B shareholders, limiting Alphabet’s ability to dominate board or shareholder decisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, despite addressing the core question about CMCSA's voting structure limiting GOOGL's influence. (1) The claim that 'Each Class B share carries 10 votes versus one vote for a Class A share' is incorrect and contradicts the ground truth, which does not mention differential voting rights (e.g., 10:1) — instead, the 33 1/3% voting power protection is structural and non-dilutable, not based on super-voting shares. This misrepresents the mechanism. (2) The citation of page numbers (81, 83, 91) implies specific document references not present in the original answer or context, raising concerns about hallucination. (3) The conversion mechanism is oversimplified — while the LLM mentions conversion 'at the holder’s option or automatically on sale,' the ground truth emphasizes that conversion is restricted and does not dilute the 33 1/3% block, which the LLM fails to explain clearly. (4) The entity substitution of 'Alphabet' for 'GOOGL' is acceptable (semantically equivalent), and the conclusion that GOOGL’s influence is limited due to the non-dilutable block is correct and contextually relevant. (5) The reasoning partially captures the multi-hop logic — linking CMCSA’s Class B structure to the limitation on GOOGL’s Class A influence — but the flawed explanation of voting rights undermines the quantitative and qualitative accuracy. The 33 1/3% figure is correct and central, but the erroneous 10-vote claim introduces a false quantitative element. Overall, the answer gets the high-level outcome right but is factually flawed in key details, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 454,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2 % rise in South Africa’s total tobacco market volume (partly offset by a higher prevalence of illicit trade) enlarges PepsiCo’s Pioneer Foods revenue base but also amplifies the need to meet its $0.5 billion socioeconomic commitment; the larger market could provide more resources for the commitment, yet the illicit‑trade offset may require additional compliance and enforcement spending (page_56, page_113, page_115, page_116). For Altria, the same market growth heightens its illicit‑trade risk exposure in international operations, increasing the likelihood of counterfeit, untaxed and diverted products and prompting greater regulatory scrutiny (page_40, page_42).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly identifies PEP as PepsiCo and references a $0.5 billion socioeconomic commitment, which is not mentioned in the ground truth and appears fabricated. The original answer states that PEP's merger-related socioeconomic obligations are included in merger and integration charges, but does not specify a dollar amount or tie it to Pioneer Foods revenue. Additionally, Altria (MO) is incorrectly used in place of Philip Morris International (PMI), which is the company typically associated with international tobacco operations and illicit trade risk in South Africa—Altria primarily operates in the U.S. and divested its international assets years ago. (2) The 13.2% market volume increase is correctly cited, but the $0.5 billion figure has no support in the ground truth and introduces a major quantitative error. No calculations are performed in the answer, so no computational errors beyond unsupported figures. (3) The multi-hop reasoning is partially sound in linking market growth and illicit trade to company-specific risks, but the entity misidentification (PepsiCo instead of PEP [PepsiCo?], Altria instead of MO [which should be PMI?]) breaks the chain of accurate synthesis. The use of 'PEP' likely refers to British American Tobacco's subsidiary in South Africa, not PepsiCo, which is a non-tobacco company—this is a critical entity confusion. (4) Contextual relevance is moderate because the structure mirrors the question and attempts to address both companies’ exposures, but due to fundamental entity and financial figure errors, the answer is largely misleading. The mention of 'page_56, page_113' etc., suggests document retrieval but poor grounding in actual content. Correctness score is low due to core factual and entity errors despite some correct contextual framing of market dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 512,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑litigation over its IPO has largely ended in dismissals.  After a Supreme Court remand, the Ninth Circuit reversed the district court and ordered Slack to dismiss the federal complaint with prejudice, and the state‑court actions remain stayed pending appellate review, with no disclosed settlement or monetary award.  In contrast, Meta’s privacy‑related lawsuits have produced substantial financial liabilities—most notably a $725 million settlement in the consumer‑privacy class action and a $5 billion FTC penalty—alongside ongoing state‑level suits that could add further costs, while many of the cases have been settled or dismissed but still carry potential monetary exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the key differences between Slack's and Meta's legal risks, with accurate financial figures and procedural outcomes. Quantitatively, the $725 million settlement and $5 billion FTC penalty for Meta are correctly stated, matching the ground truth. The procedural outcome for Slack—dismissal with prejudice after Ninth Circuit reversal—is accurately described, though the mention of a 'Supreme Court remand' is not present in the original answer and may be an overreach or mischaracterization; the ground truth notes a Ninth Circuit reversal in 2025 but does not reference Supreme Court involvement, which introduces a minor factual inaccuracy. The LLM correctly notes no monetary award or settlement for Slack, aligning with the original. For Meta, the answer correctly identifies ongoing litigation and regulatory scrutiny, though it slightly underemphasizes the continued pending appeals and regulatory constraints beyond just 'potential monetary exposure'. The multi-hop reasoning is sound: the model correctly synthesizes outcomes across companies, legal domains (securities vs. privacy), and procedural stages. Wording differs but meaning is semantically equivalent in most places. The answer is fully contextually relevant, directly addressing procedural outcomes and financial liabilities as asked. The minor error regarding Supreme Court involvement prevents a top score, but core facts and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 403,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PM’s RSU awards are amortized over a weighted‑average vesting period of roughly 17 months, so its $160 million of unrecognized RSU costs will be expensed over that time.  \nWalmart’s change from 25 % annual vesting over four years to 8 % quarterly vesting over three years shortens the vesting horizon, meaning its RSU compensation expense will be recognized over a shorter, more evenly distributed period—effectively reducing the weighted‑average recognition period compared with the prior schedule.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PM's $160 million in unrecognized RSU costs and the 17-month weighted-average recognition period, which aligns with the ground truth. It also accurately notes WMT's shift from 25% annual vesting over four years to 8% quarterly vesting over three years. However, it omits key details about PM's cliff-vesting structure tied to the third anniversary or specific events (e.g., death, disability, age 58), which is central to understanding the back-loaded cost recognition. The answer also fails to explicitly compare the back-loaded nature of PM’s expense recognition with WMT’s more evenly distributed pattern, a core part of the original answer. (2) Quantitatively, all numbers are correct: $160M, 17 months, 25%, 8%, three-year and four-year periods. The statement about shortening the vesting horizon is directionally correct but slightly misleading—WMT’s total vesting period decreased from four to three years, but the key change is the shift from annual to quarterly vesting, enabling smoother expense recognition. (3) The reasoning is partially sound: it correctly infers that WMT’s change accelerates expense recognition and shortens the average period, but it does not fully synthesize the multi-hop comparison—specifically, that PM’s cliff vesting leads to delayed cost recognition while WMT’s new schedule spreads it more evenly. The answer misses the contrast in recognition patterns (back-loaded vs. level) that is essential to the question. (4) Scores reflect high factual accuracy in numbers and relevance to the question, but deductions are made for missing key qualitative distinctions in vesting structures and their impact on expense timing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 466,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing’s 10‑K discloses a $620 million risk of unrecognized tax benefits that could reduce its tax expense if those positions are ultimately recognized (see the unrecognized tax‑benefits table on pages 74‑75).  By contrast, Lockheed Martin’s 10‑K states that the OECD Pillar 2 global minimum tax is not expected to materially increase its effective tax rate, because most of its operations are in jurisdictions with rates above the 15 % threshold and because implementation timelines differ across countries.  Thus, Boeing faces a concrete dollar exposure, whereas Lockheed Martin’s Pillar 2 impact is projected to be minimal and uncertain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Boeing's $620 million unrecognized tax benefit risk is accurately cited, and the 15% Pillar 2 global minimum tax rate is correctly referenced. No calculations were required, but the comparison of dollar exposure versus projected minimal impact is valid. (2) The LLM correctly identifies both companies—Boeing and Lockheed Martin—and their respective tax risk assessments. It accurately reflects that Boeing has a specific, quantified exposure in unrecognized tax benefits, while Lockheed Martin expects no material impact from Pillar 2 due to its operations being in higher-tax jurisdictions. (3) The multi-hop reasoning is sound: the model synthesizes Boeing’s tax risk (from its 10-K) with Lockheed Martin’s forward-looking assessment of Pillar 2, and contrasts the nature of the risks—actual exposure vs. anticipated minimal impact. (4) The only minor omission is that the LLM does not explicitly mention the role of differing implementation timelines across jurisdictions as a complicating factor (noted in the ground truth via General Electric's evidence), but it does reference differing implementation timelines as part of Lockheed Martin’s assessment, which captures the core idea. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 406,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "PepsiCo will recast its segment reporting effective Q1 2025 to match the new organizational structure and, under ASU 2023‑07, will disclose disaggregated expense information for each newly reorganized segment in its annual and interim statements (page 7). Altria adopted the same ASU for the year ended 31 Dec 2024 and will likewise provide the required disaggregated expense disclosures and interim segment information beginning Q1 2025, aligning its reporting timeline with PepsiCo’s new structure (pages 52‑53, 54).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PepsiCo will recast segment reporting in Q1 2025 under ASU 2023-07, aligning with its new structure (FLNA and QFNA combined, international reorganization), and will provide disaggregated expense disclosures. Altria adopted the standard in 2024 and will implement interim disclosures starting Q1 2025. (2) Quantitative accuracy is perfect: dates (Q1 2025, year ended Dec 31, 2024) are correct and consistent with the original answer. No calculations were required. (3) Multi-hop reasoning is sound—correctly linking PepsiCo’s structural changes to ASU 2023-07’s requirements and aligning it with Altria’s adoption timeline. The only minor omission is that the original answer specifies Altria included expanded disclosures in Note 17, which the LLM answer does not mention, and the LLM references 'pages' (likely from source documents) not present in the ground truth. However, this does not affect factual correctness. (4) The answer is contextually relevant, directly addressing both parts of the question—PepsiCo’s reporting changes and Altria’s alignment. Wording differs slightly but meaning is semantically equivalent. Score reduced slightly (9 instead of 10) due to the minor omission of Note 17 detail, but overall performance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 379,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 basic product patent is slated to expire in 2027, while a method patent for treating pulmonary arterial hypertension with the biologic will expire in 2037; the drug also enjoys 12 years of data exclusivity and could receive up to a five‑year patent‑term extension (PTE) and six‑month pediatric exclusivity (Merck 10‑K, p. 16).  Pfizer’s biologics portfolio relies on a similar mix of basic patents, 12‑year data exclusivity, and potential PTEs of up to five years (plus SPCs in Europe and pediatric exclusivity), and the company has already filed PTE applications that could extend exclusivity to 2028 or later (Pfizer 10‑K, pp. 14‑15).  Thus, while Merck’s timeline is specific to MK‑7962, Pfizer’s broader strategy provides multiple avenues—PTE, SPC, and data exclusivity—to extend protection across its biologics beyond the initial patent expiry.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key dates and exclusivity periods are correct: Merck's base patent expiration in 2027 and method patent in 2037 match the extended protection timeline implied in the original answer (potential extension to 2037 via PTEs). The mention of 12 years of data exclusivity and up to 5 years of PTE plus 6 months pediatric exclusivity is consistent with U.S. regulatory frameworks, though the original answer does not specify pediatric exclusivity or data exclusivity duration. These are reasonable inferences but not explicitly confirmed in the ground truth. (2) The LLM correctly identifies Pfizer’s use of PTEs, SPCs in Europe, and data exclusivity, noting variability in extension outcomes—though the original answer emphasizes Pfizer’s acknowledgment of external factors affecting extensions, which the LLM implies but doesn’t explicitly state. (3) Multi-hop reasoning is sound: the model synthesizes Merck’s specific drug timeline with Pfizer’s broader biologics strategy, drawing a valid comparative insight about lifecycle management. (4) Minor deduction in quantitative accuracy due to the introduction of pediatric exclusivity and method patent details not present in the ground truth, which, while plausible, go beyond the provided information. Overall, the answer is factually strong, contextually relevant, and semantically equivalent to the original answer with only slight over-elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 409,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin’s 2023 10‑K notes that cost overruns on the Canadian Maritime Helicopter Program – a fixed‑price defense contract – produced a $100 million loss, showing how inflation‑driven rises in material, labor and component costs erode operating profit and can force write‑offs of contract assets (pages 65‑66). GE’s 2023 10‑K similarly warns that overruns on its fixed‑price contracts, driven by inflation and the complexity of long‑term projects, can trigger execution delays, penalties and higher cash‑flow strain, jeopardizing project delivery and profitability (pages 30‑34).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023. In contrast, the LLM claims a single $100 million loss on the Canadian Maritime Helicopter Program, which does not match the original figures or the number of contracts cited. This represents a major discrepancy in financial data, even allowing for format variations. (2) While the LLM correctly identifies inflationary pressures (material, labor costs) as drivers of cost overruns and links them to financial impacts like reduced operating profit and asset write-offs—consistent with RTX’s 10-K warning—the specific numbers are incorrect. There is no mention of the two distinct $270M and $280M losses, nor the potential for additional losses, weakening completeness and accuracy. (3) On qualitative reasoning, the LLM correctly synthesizes the connection between fixed-price contracts, inflation, project complexity, and financial/operational risks for both Lockheed Martin and GE. It appropriately references GE’s 2023 10-K and describes how overruns can lead to delays, penalties, and cash flow strain—aligning semantically with the ground truth’s emphasis on contractual penalties and joint liability in consortiums, especially in Power and Renewable Energy. However, it fails to mention the consortium/joint liability aspect, a key operational risk. (4) Contextually, the answer is highly relevant, addressing both companies, the impact on financial performance and operational execution, and the role of inflation and complexity. Despite correct framing and logical flow, the incorrect core financial figures severely undermine factual reliability. Thus, while reasoning and context are strong, the quantitative inaccuracies reduce the correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 525,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ actively uses commodity futures (exchange‑traded, Level 1) and OTC forwards/options (Level 2) to hedge raw‑material price risk, recording these derivatives at fair value on a gross basis (commodity contracts fair value $687 m asset, $242 m liability). In contrast, Costco reports no Level 1 financial liabilities—its fair‑value measurements are all Level 2 (e.g., government securities, forward FX), indicating a far smaller or absent derivative exposure relative to MDLZ.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MDLZ uses commodity futures (Level 1) and OTC instruments (Level 2) for hedging raw material price risk, and that Costco has no Level 1 financial liabilities, aligning with the ground truth. However, the LLM introduces specific dollar amounts—$687M asset and $242M liability—for MDLZ's derivative positions that are not present in the original answer and cannot be verified against the provided ground truth, reducing quantitative accuracy. (2) These figures may be factually correct in external data but are not supported by the knowledge graph used here, so their inclusion constitutes a quantitative overreach. The absence of a date (e.g., August 28, 2022) for COST’s disclosure is a minor omission but does not invalidate the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), compares their use of derivative instruments, links them to fair value hierarchy levels (Level 1 vs Level 2), and draws a valid conclusion about differing derivative exposure strategies. (4) Despite the unverified numbers, the core qualitative and contextual analysis matches the ground truth—MDLZ actively uses exchange-traded commodity futures (Level 1), while COST reports no such exposure. The answer remains semantically aligned and highly relevant, warranting high scores in qualitative accuracy and contextual relevance, with a slight deduction in correctness due to unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 420,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s Class A shares that can be converted into Class B shares total **4.6 billion shares** (the number of Class A shares authorized as of December 31, 2024).  \nLockheed Martin’s non‑qualified pension trust held **$658 million** in assets as of December 31, 2024 – a dollar amount that is far smaller than the sheer number of convertible shares, though the two figures are expressed in different units (shares vs. dollars).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets, both as of December 31, 2024. The formatting variations (e.g., '4.6 billion' vs '4.6 billion', '$658 million') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the number of convertible shares and the pension trust assets. (3) Entity accuracy is correct—UPS and Lockheed Martin are properly identified, with accurate financial metrics and time periods. (4) The reasoning is sound: the model correctly synthesizes information across two separate companies and financial instruments, noting the difference in units (shares vs. dollars) when comparing, which is logically appropriate. While the comparison is qualitative (due to different units), the model avoids making a false quantitative comparison and instead acknowledges the difference in nature—this is a correct and responsible interpretation. All elements meet the highest standard for factual accuracy, completeness, and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 336,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are highly exposed to market moves – a 50‑basis‑point rise or fall would shift their aggregate fair value by about **$1.7 billion** (2024) or **$1.4 billion** (2023).  Cisco, by contrast, has entered a **$0.5 billion SOFR‑based interest‑rate swap** as a fair‑value hedge of its fixed‑rate senior notes; the swap’s fair‑value gain/loss (net $30 million in 2024) is recorded in interest expense and **substantially offsets the debt’s fair‑value change**, effectively neutralizing the rate sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.7 billion fair value impact for AVGO from a 50 basis point rate change as of 2024, matching the ground truth. It also accurately notes CSCO's $0.5 billion SOFR-based interest rate swap. The only minor discrepancy is the inclusion of a $1.4 billion figure for AVGO in 2023, which, while potentially factual, is not mentioned in the ground truth and slightly extends beyond the provided context. The net $30 million fair-value gain/loss for CSCO’s swap is additional detail not present in the original answer; however, it does not contradict the ground truth and supports the same conclusion about offsetting effects. (2) All key numbers—$1.7 billion (AVGO), $0.5 billion (CSCO swap)—are correct and properly attributed. The mention of 2023 data and $30 million impact adds granularity but doesn’t undermine accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s direct exposure due to unhedged fixed-rate debt with CSCO’s use of an interest rate swap to convert fixed to floating rates, thereby mitigating fair value volatility. It synthesizes across both companies and correctly infers that CSCO’s strategy offsets sensitivity, aligning with the hedging mechanism described. (4) The answer is semantically equivalent to the ground truth, clearly conveying that AVGO has significant interest rate risk while CSCO uses targeted hedging. The extra details enhance rather than distort. Scores reflect high accuracy with minor over-specification, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 427,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model (page 77) applies a parametric delta‑gamma approximation only to the joint movements of interest rates and foreign‑exchange rates, using the prior quarter’s data to estimate the one‑day loss for its interest‑rate‑ and currency‑sensitive derivatives.  \nMDLZ’s VAR model (page 66) likewise uses a parametric delta‑gamma technique, but it extends the analysis to include commodity‑price movements and explicitly notes that currency and commodity options are valued on a non‑linear basis in the computation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation technique within their VAR models. (1) It correctly identifies that PM applies the technique only to interest rates and foreign exchange rates, using prior quarter data for year-end VAR, which aligns with the ground truth. MDLZ is correctly described as extending the model to include commodity prices and accounting for non-linear behavior of currency and commodity options—both key differentiators. (2) There are no numeric values (e.g., percentages, dollar amounts, time durations) in the question or ground truth that are incorrect or misrepresented; the temporal scope (prior quarter) is accurately conveyed, though the LLM omits MDLZ’s use of data from each of the four prior quarters for average VAR amounts. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective modeling approaches, identifying both commonalities (use of parametric delta-gamma, prior quarter for year-end) and distinctions (commodity inclusion, non-linear treatment). (4) The only minor omission is that the LLM does not explicitly mention that both firms use data from the four preceding quarters for average, high, and low VAR during the year—though this is less central to the comparative question about 'application' of the technique. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 461,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 10‑K stresses that “patients around the world deserve access to our life‑saving products” and that the company is using its local presence and scale to expand adoption globally【page 6】【page 4】.  In contrast, Amgen is grappling with payer‑driven pricing pressure – Express Scripts and other PBMs are negotiating deeper rebates and imposing coverage restrictions that curb affordability and limit patient access to products such as Repatha【page 38】【page 39】.  Thus, while Medtronic is proactively pursuing broader access, Amgen is reacting to discount‑driven constraints that threaten to reduce patient reach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-imposed affordability barriers, particularly from Express Scripts. (1) All factual elements are correct: Medtronic’s emphasis on global access via local presence is properly attributed to its 2024 10-K (implied by citation of page numbers, though year not explicitly mentioned). Amgen’s struggle with PBMs like Express Scripts negotiating deeper rebates that restrict access to Repatha is accurately represented. (2) There are no numeric values (percentages, dollar amounts, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes Medtronic’s global access strategy with Amgen’s U.S.-focused payer challenges involving Express Scripts and formulary restrictions. It correctly identifies the causal chain: payer pressure → deeper rebates → coverage restrictions → reduced patient access. The only minor omission is the lack of detail about Medicare patients abandoning prescriptions due to high co-pays and the specific market concentration (top six PBMs controlling 94% of U.S. prescriptions), which are in the original answer and add contextual depth. (4) Despite this, the LLM conveys semantic equivalence in intent and meaning, using direct conceptual language (e.g., 'coverage restrictions', 'discount-driven constraints'). Wording differs but reasoning and facts align. Contextual relevance is perfect—it directly addresses the comparative dynamic asked in the question. Thus, correctness is 9 due to minor completeness gap, qualitative accuracy 9 for strong but not full synthesis, and contextual relevance 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 489,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s repurchase program is limited to Class A and Class C shares, while Class B shares—each carrying ten votes—can be converted into Class A shares automatically on sale or transfer. By buying back Class A shares, Alphabet reduces the pool of shares that could be obtained through conversion, thereby protecting the voting power of the remaining Class B holders. Because Class A shares are publicly traded on the Nasdaq (the same shares that Google’s parent company issues), the program can shift voting control toward the remaining shareholders and limit dilution of the high‑vote Class B stock.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Alphabet's share repurchase strategy focusing on Class A and Class C shares, and the fact that Class B shares carry 10 votes and can be converted to Class A upon sale or transfer. It also correctly infers that by repurchasing Class A shares, Alphabet reduces the pool of shares available post-conversion, thereby preserving the relative voting power of Class B shares. However, the LLM omits all quantitative details from the original answer: it fails to mention the $62.2 billion repurchased in 2023 or the $36.3 billion remaining authorization as of December 31, 2023. These are significant omissions affecting quantitative accuracy. (2) No numeric values are present in the LLM answer, so there are no calculations to verify, but the absence of the specific figures from the ground truth—especially dollar amounts tied to a specific year—represents a clear deficiency in quantitative reporting. (3) The multi-hop reasoning is largely sound: the model connects repurchase activity (Class A/C) with conversion mechanics (Class B to A) and infers implications for voting control. It also recognizes that Class A shares are publicly traded, though it inaccurately states they are 'the same shares that Google’s parent company issues'—which is tautological (Alphabet is Google’s parent). More importantly, it misses the key entity link in the original answer: that Class A shares are *also* publicly traded by Comcast Corporation (CMCSA), implying a broader market standard for equity structure. This cross-company comparison is a critical multi-hop element that the LLM fails to capture. (4) Despite missing key numbers and the Comcast connection, the LLM provides a logically coherent explanation of the strategic rationale behind the repurchase policy and its impact on voting control. Hence, qualitative accuracy and contextual relevance are high, but the lack of specific figures and one major entity synthesis limits the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 538,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s formulary restrictions on high‑cost biologics—illustrated by the step‑therapy and prior‑authorization hurdles that limited Repatha uptake—can curtail patient access and lower utilization. Eli Lilly’s own risk factors note that “insufficient access, or reimbursement” can materially affect sales of its biologic products, so similar payer restrictions could threaten the company’s ability to sustain revenue growth for those therapies. (Amgen 10‑K, p. 38; Eli Lilly 10‑K, p. 27)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies UnitedHealth Group's role in imposing formulary restrictions on high-cost biologics, using Repatha as a case example with step-therapy and prior authorization limiting uptake—consistent with the original answer's emphasis on access challenges. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised; all references to financial or market impact are qualitative and correctly attributed. (3) The multi-hop reasoning is sound: the model connects UnitedHealth’s payer power and Repatha’s access issues (from Amgen 10-K) to Eli Lilly’s disclosed risk factors regarding patient access and reimbursement (from Eli Lilly 10-K), correctly inferring that similar restrictions could constrain revenue growth. (4) Entity accuracy is strong—UnitedHealth Group, Eli Lilly, Repatha, and Amgen are correctly named and contextualized. The only minor limitation is that the LLM does not explicitly mention the 'concentration of payer power' or the '94% of U.S. pharmacy prescriptions' statistic from the ground truth, which adds contextual depth about systemic market structure. However, this omission does not undermine the core correctness, as the answer still captures the causal chain and business risk accurately. Overall, the response is concise, well-supported with proper citations, and conveys the same essential conclusion as the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 420,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3.0 billion commercial paper program is a short‑term, unsecured financing facility that can be drawn on up to $10 billion, but had no outstanding notes as of May 31 2022 (see pages 89‑90). Cisco, by contrast, has $9.0 billion of senior fixed‑rate notes outstanding (principal $9.0 billion, carrying $8.9 billion, fair value $9.7 billion) and a $1.099 billion short‑term debt program (current portion of long‑term debt $499 million, commercial paper $600 million) (pages 88‑92). Both companies are exposed to short‑term debt mechanisms—Oracle through its commercial paper program and Cisco through its commercial paper and current portion of long‑term debt—yet Cisco’s larger debt is long‑term fixed‑rate, whereas Oracle’s program is a flexible short‑term source that is presently unused.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Oracle's commercial paper program can be drawn on up to $10 billion, which is not supported by the ground truth (the program is $3.0 billion). Second, it introduces a $1.099 billion short-term debt program for Cisco, breaking it into $499 million current portion of long-term debt and $600 million commercial paper, none of which appears in the ground truth. The ground truth only confirms $9.0 billion in senior fixed-rate notes outstanding and mentions interest rate swaps on $1.5 billion of those notes—details omitted in the LLM answer. (2) Quantitative accuracy is compromised: while the $3.0 billion (Oracle) and $9.0 billion (Cisco) figures are correct, the additional numbers ($10 billion capacity, $1.099 billion total, $499M, $600M) are fabricated or misattributed. The fair value and carrying amount of Cisco’s notes are mentioned but were not part of the original comparison and distract from the core question. (3) Multi-hop reasoning is partially sound—the model correctly identifies both companies use short-term debt mechanisms and contrasts Oracle’s unused commercial paper with Cisco’s larger fixed-rate debt. However, it fails to mention Cisco’s use of interest rate swaps to convert $1.5 billion of fixed-rate debt to floating, a key element of risk management highlighted in the ground truth. This omission weakens the qualitative analysis. (4) Contextual relevance is strong: the answer addresses the comparative use of short-term financing mechanisms and draws a reasonable contrast between Oracle’s flexible, unused program and Cisco’s more structured, active long-term debt with hedging. Despite incorrect numbers and missing key details, the overall framing aligns with the question’s intent. However, due to significant quantitative errors and incomplete synthesis, the correctness score is limited to 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 522,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "FedEx’s 2023 10‑K notes that the optional hedging relief under ASU 2022‑06, which applies to contracts that reference LIBOR, remains available through December 31 2024, allowing the company to continue applying the relief to its LIBOR‑based derivatives with no material impact on its financials (FedEx, Note 3, page 91). Caterpillar’s 2023 10‑K describes its use of fixed‑to‑floating and floating‑to‑fixed interest‑rate contracts as fair‑value and cash‑flow hedges; the extension of ASU 2022‑06 lets Caterpillar keep applying the optional relief to those LIBOR‑linked contracts, thereby reducing the operational and financial impact of reference‑rate reform on its interest‑rate risk management (Caterpillar, Note 4, page 74).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: ASU 2022-06 extends optional hedging relief until December 31, 2024 — this date is correctly stated. (2) Quantitative accuracy is perfect: no numerical errors; the date 'December 31, 2024' matches the ground truth. (3) Entity accuracy is strong: FedEx and Caterpillar are correctly identified with accurate references to their 2023 10-Ks, Note 3 (page 91) for FedEx and Note 4 (page 74) for Caterpillar, confirming proper sourcing. (4) Multi-hop reasoning is sound: the answer synthesizes how each company uses the relief — FedEx notes no material impact while continuing to monitor, and Caterpillar leverages the extension to maintain accounting flexibility for its interest rate hedges. The LLM correctly links the extension to reduced operational and financial disruption in LIBOR transition. (5) Contextual relevance is excellent: the response directly addresses how the extension impacts each company’s management of LIBOR-related risk in derivative instruments, as required by the question. Minor wording differences (e.g., 'reducing the operational and financial impact' vs. 'without disruption') do not affect meaning and are semantically equivalent. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 366,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s Five‑Year Credit Agreement names Citibank, N.A. as the sole administrative agent, with JPMorgan Chase Bank, N.A. serving as syndication agent and both banks acting as joint lead arrangers and book managers; the agreement was amended once in 2022 (Amendment No. 1) and no further changes were reported in 2023 (§ 10.2‑10.5, page 126).  \nCaterpillar’s multi‑facility credit structure also lists Citibank, N.A. as agent but adds Citibank Europe PLC as local‑currency agent and MUFG Bank, Ltd. as Japan local‑currency agent, and the company issued addenda in 2023 to both its 2023 and 2022 364‑day facilities, with no amendment activity noted for 2022 (§ 10.39‑10.41, page 128).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement (2019) was amended on August 25, 2022, with Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, and both as joint lead arrangers and book managers—this matches the original answer. The LLM correctly notes no amendment activity in 2023. For Caterpillar, the LLM accurately identifies Citibank, N.A. as agent, with Citibank Europe plc and MUFG Bank, Ltd. handling local currency roles in its 2022 3-Year and 5-Year Facilities. It also correctly reports addenda in 2023 for 364-day facilities and no 2022 amendments. (2) Quantitative accuracy is perfect: dates (2022 amendment for Boeing, 2023 addenda for Caterpillar), roles, and facility types are all factually correct. Minor phrasing differences (e.g., 'addenda' vs 'amendment activity') do not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes across Boeing and Caterpillar’s agreements, comparing syndication structures and amendment timelines. The only minor shortcoming is that the LLM refers to '2023 364-day facilities' while the ground truth does not specify the year of those facilities—this is a slight overprecision but not factually incorrect. (4) The answer is contextually excellent, directly addressing syndication structure and amendment activity for both firms in 2022–2023. Overall, the response is semantically equivalent to the ground truth with high precision and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 430,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s dual‑class structure concentrates 66.7 % of voting power in its Class B shares, giving its CEO and founder a de‑facto majority that limits other shareholders’ influence (Meta, 2023, pp. 48‑50).  Comcast, by contrast, allocates only 33.3 % of voting power to its Class B shares, which are convertible share‑for‑share into Class A shares (Comcast, 2023, p. 71).  The conversion mechanism at Comcast offers investors a path to increase voting power and potentially offset concentrated control, likely mitigating governance concerns that could erode investor confidence relative to Meta’s more rigid structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the core comparison between META and CMCSA's dual-class structures with respect to investor confidence and voting control. (1) Quantitatively, the LLM correctly states that META's Class B shares hold 66.7% of voting power (implied from ground truth's description of disproportionate control, though exact percentage not in original answer) and CMCSA's Class B holds 33.3%, which aligns with the ground truth. However, the ground truth does not specify META's 66.7% figure, so this precision goes beyond the source and may be inferred but not directly supported. The conversion mechanism (share-for-share) is accurately described for CMCSA. The ground truth includes the specific number of CMCSA Class B shares (9,444,375), which the LLM omits—this is a minor completeness gap. (2) The LLM cites 'Meta, 2023, pp. 48-50' and 'Comcast, 2023, p. 71', which are plausible but not present in the original answer; while not factually incorrect, they introduce external sourcing not in the knowledge graph, slightly reducing quantitative fidelity. (3) Reasoning is sound: the LLM correctly infers that CMCSA's convertibility mechanism may mitigate governance concerns compared to META's more entrenched control, which is a logical interpretation of the structural differences. This reflects good multi-hop synthesis—comparing control concentration and investor implications. (4) The answer is contextually excellent, directly addressing the impact on investor confidence and structural differences. The omission of the exact share count for CMCSA Class B is minor, and the slightly stronger claim about META's 66.7% is a reasonable inference but not explicitly verifiable from the ground truth. Overall, the answer is factually aligned, well-reasoned, and relevant—just shy of full correctness due to minor unsupported precision and missing granular detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 510,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company recorded **$14.471 billion** in net sales to equity‑method investees in 2021【page_89】.  \nCoca‑Cola FEMSA’s bottling and distribution network covers Latin America, specifically: Mexico (central, southeast and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia (most of the country), Venezuela, Brazil (major parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and portions of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay (nationwide)【page_7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the net sales figure of $14,471 million is accurately reported as $14.471 billion—this is a valid format conversion (1 billion = 1,000 million), so $14,471 million = $14.471 billion. (2) The regions covered by Coca-Cola FEMSA are completely and accurately listed, matching all countries and sub-regions specified in the original answer, including detailed breakdowns in Brazil and Argentina. Minor wording differences (e.g., 'major parts' vs 'parts', 'nationwide' in Uruguay) do not affect factual accuracy and are reasonable interpretations. (3) The multi-hop reasoning is sound: the model correctly identifies both the financial metric from The Coca-Cola Company’s 2021 report and synthesizes operational geographic data about Coca-Cola FEMSA, an equity-method investee. (4) All entities—The Coca-Cola Company, equity method investees, Coca-Cola FEMSA, and associated regions—are correctly identified and contextually relevant. The answer addresses both sub-questions completely and with precise, citation-supported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 318,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s immunology segment generated $1.124 billion in 2021 (Simponi $825 m + Remicade $299 m) versus $1.168 billion in 2020, a 3.8 % decline.  The 9 % drop in Remicade sales (≈$31 m) – driven by biosimilar competition – accounts for roughly one‑third of that fall, or about 2½ % of the segment’s total revenue (page 61, 141).  By contrast, AbbVie’s Humira is its flagship biologic, representing a far larger share of its $34 billion total revenue, and the company is already negotiating biosimilar licenses and facing direct competition in Europe and other markets, indicating a more substantial biosimilar exposure (page 13).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $299 million in Remicade international sales in 2021 and the 9% decline in that year, which aligns with the ground truth. However, it introduces a specific figure for Simponi ($825 million) and calculates total immunology segment revenue as $1.124 billion in 2021 and $1.168 billion in 2020, implying a 3.8% decline. These segment-level revenue totals and the Simponi figure are not present in the original answer and cannot be verified from the provided ground truth, making them potentially inaccurate. Additionally, the claim that the $31 million drop in Remicade accounts for 'roughly one-third' of the segment's decline involves unsupported calculations. The original answer does not provide overall segment revenue or year-over-year changes, so this synthesis goes beyond the available data. (2) The LLM correctly states Remicade’s 9% decline in 2021 and $299 million in sales but fabricates or infers Simponi’s revenue and total segment figures. The 2020 20% decline in Remicade is omitted, reducing completeness. The comparison to AbbVie includes a correct qualitative point about Humira’s larger revenue footprint and biosimilar exposure in Europe, but the claim that AbbVie is 'negotiating biosimilar licenses' is not in the original and may be speculative. (3) The multi-hop reasoning is partially sound—linking Remicade’s decline to immunology segment performance and comparing Merck’s situation to AbbVie’s Humira exposure—but the quantitative synthesis (calculating segment revenue and attributing percentage declines) lacks grounding in the source truth. (4) Despite the numerical overreach, the core qualitative insights—biosimilar impact on Remicade, resulting pressure on immunology revenue, and AbbVie’s larger-scale exposure via Humira—are consistent with the original. The answer remains contextually relevant and reasonably accurate in direction, but penalized for introducing unverified figures and calculations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 536,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s investment in Garrett’s Series B Preferred Stock was originally part of the Garrett Indemnity and Tax Matters Agreement and was recorded as a long‑term receivable of $423 million (including Series B, A and common). After Garrett’s partial redemption of $211 million on December 28, 2021, the present value of the remaining Series B shares was $400 million as of December 31, 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. First, it incorrectly states that the $423 million long-term receivable included Series B, A, and common stock, while the ground truth specifies that the $423 million present value pertains solely to the remaining mandatory redemptions of Series B Preferred Stock. Second, the LLM claims the present value of the remaining Series B shares was $400 million as of December 31, 2021, which directly contradicts the ground truth value of $423 million. The partial redemption of $211 million is correctly dated (December 28, 2021), but the resulting remaining value is miscalculated or misstated. (2) Quantitatively, the $211 million First Partial Redemption amount and date are correct, but the remaining present value is wrong: $423 million (truth) vs $400 million (LLM). The initial total redemption obligation was $375 million ($211M + $200M planned), but the present value of remaining payments was $423M due to timing and discounting—this nuance is missing. The LLM’s $400 million figure has no support in the ground truth. (3) The multi-hop reasoning is partially sound—linking the indemnification agreement to the Series B Preferred Stock and recognizing partial redemption impact on receivables—but fails in accurately isolating the Series B component and computing the correct present value. It incorrectly aggregates other share classes into the receivable. (4) Contextual relevance is high—the answer addresses the impact on long-term receivables and attempts to report the remaining value. However, due to significant factual and numerical errors, especially in the core quantitative claim, the correctness and accuracy scores are low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 464,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "CM CSA’s Class B shares carry 15 votes each and, because all 9.44 million of those shares are held by Brian L. Roberts, he controls roughly one‑third of the company’s voting power. Alphabet’s Class B shares have 10 votes per share and can be converted to Class A shares, but its share‑repurchase program is limited to Class A and Class C shares, so repurchases do not alter the voting weight of Class B shares, though they can shift relative influence by reducing the number of Class A shares outstanding. Thus, CM CSA’s repurchases of Class A stock increase the relative voting power of Roberts’ Class B holdings, while Alphabet’s repurchases leave the voting power of its Class B shares unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core voting structures of both CMCSA and GOOGL, noting that CMCSA's Class B shares have 15 votes per share and are entirely held by Brian L. Roberts, giving him significant voting control. It also correctly states that GOOGL’s Class B shares have 10 votes per share and are not subject to repurchases, while repurchases are limited to Class A and C shares. However, the LLM introduces a specific number—'9.44 million' Class B shares—that is not present in the original answer or implied by the ground truth, making this a potentially unsupported addition. The original answer states Roberts owns 33 1/3% of combined voting power, but does not provide share count, so this figure cannot be verified and may be inaccurate. (2) The dollar amounts related to GOOGL’s repurchase program ($62.2 billion repurchased, $36.3 billion remaining) are omitted in the LLM answer, which weakens quantitative completeness. These were part of the ground truth and directly relevant to the repurchase activity mentioned in the question. (3) The reasoning is sound: the LLM correctly infers that repurchasing lower-vote shares (Class A in both cases) increases or preserves the relative voting power of insiders holding high-vote Class B shares. It draws a valid comparison between the two companies’ dual-class structures and how repurchases affect voting dynamics. The synthesis across CMCSA and GOOGL is logical and addresses the interplay between share classes and repurchase programs. (4) Despite missing specific repurchase figures and introducing an unverified share count, the LLM captures the essential qualitative dynamics. The answer remains contextually relevant and conveys the strategic purpose of dual-class structures and repurchases. The correctness score is 8 due to missing financial figures and the unsupported 9.44 million number, but the core reasoning and entity identification are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 526,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "MDLZ’s VAR model, like PMI’s, is built on normal market conditions, a 95 % confidence interval and a one‑day holding period.  Both firms determine the parameters by observing interest‑rate and currency movements over the preceding quarter for year‑end VAR calculations and over each of the four prior quarters for average, high and low VAR amounts.  Thus, the time horizon and confidence interval are identical, with MDLZ additionally incorporating commodity‑price movements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MDLZ and PM use a 95% confidence interval and a one-day holding period under normal market conditions. The time horizon for observing interest rate and currency movements is correctly stated as the preceding quarter for point-in-time (e.g., year-end) VAR and each of the four prior quarters for average, high, and low VAR amounts. (2) Quantitative elements—95%, one-day holding period, quarterly observations—are all factually correct and match the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use similar methodologies, drawing from their respective disclosures. (4) The only minor difference is that the LLM mentions 'PMI' instead of 'PM'—a ticker variation but refers to the same company (Philip Morris International)—and explicitly notes that MDLZ includes commodity-price movements, which is accurate and adds slight value beyond the original answer. This does not detract from correctness. Overall, the answer is semantically equivalent, complete, and factually precise, warranting a 9/10 due to the minor entity naming variation (PMI vs PM) despite correct identification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 354,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s 10‑K states that “substantially all of the Company’s manufacturing is performed… in China mainland” (page 11) and that Greater China is a geographic segment (page 40), but it does not describe a dedicated regional support network for that area.  By contrast, Microsoft operates a regional operations center in Singapore that serves Greater China and explicitly localizes its software and services to local languages and conventions (page 16), indicating a more explicit regional support and localization footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies Apple's heavy reliance on China Mainland for manufacturing, citing the 10-K statement that 'substantially all' manufacturing occurs there, and notes that Greater China is a reported geographic segment. It accurately contrasts this with Microsoft's regional operations center in Singapore, which supports Greater China, and highlights Microsoft's product localization efforts in language and user interface—both consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable beyond correct referencing of page numbers (e.g., page 11, 40, 16), which are accurate and appropriately cited. (3) The multi-hop reasoning is sound: the model synthesizes information about Apple’s supply chain exposure and lack of described regional support infrastructure with Microsoft’s explicit regional operations and localization strategies. The only minor shortcoming is that the LLM answer does not explicitly mention that Microsoft's Singapore center supports not just Greater China but also Japan, India, and Asia-Pacific—slightly less complete than the ground truth, but still captures the core contrast. (4) The answer is contextually highly relevant, directly addressing the comparison of manufacturing reliance versus operational footprint and localized offerings. Wording differs but semantic meaning matches. Thus, correctness is high but not perfect due to slight incompleteness in describing Microsoft’s regional scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 440,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS classifies its foreign‑currency derivatives as Level 2, valuing them with vendor‑based pricing models that rely almost entirely on observable market data—interest‑rate curves, spot and forward currency rates, and other market‑observable inputs—so that unobservable inputs are minimal (UPS, p. 138‑139). In contrast, GE’s insurance and pension liabilities are measured with Level 3 techniques that depend on significant unobservable actuarial assumptions (mortality, morbidity, discount‑rate assumptions, and other internal estimates), requiring substantial management judgment (GE, p. 46‑47). Thus, UPS’s valuation is driven by market observables, whereas GE’s valuation is driven by internal, non‑observable inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that UPS uses Level 2 valuation for foreign currency derivatives based on observable market inputs (e.g., yield curves, spot/forward rates), while GE uses Level 3 techniques involving significant unobservable inputs for insurance and pension liabilities. The mention of 'vendor-based pricing models' aligns with standard industry practice and supports the Level 2 classification. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—both answers focus on qualitative distinctions in valuation hierarchy. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies (UPS and GE), two financial instruments (derivatives vs. insurance/pension liabilities), and two levels of the fair value hierarchy (Level 2 vs. Level 3), synthesizing information across entities and contexts. (4) The LLM includes additional precision by referencing specific inputs (mortality, morbidity, discount-rate assumptions) and citing page numbers, enhancing credibility without introducing error. The core distinction—observable vs. unobservable inputs, market-driven vs. management-judgment-driven valuation—is preserved and clearly articulated. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 387,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola’s Hong Kong market is served through its bottling partner Swire Beverages, which operates distribution in Hong Kong and other Greater China territories (page 7).  In contrast, Colgate‑Palmolive’s Hong Kong activity is reflected in its Asia Pacific segment, which reported a 6 % rise in net sales and a 9 % rise in operating profit in 2021 (page 42), indicating solid growth rather than a single‑partner distribution model.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. It states that Colgate-Palmolive reported a 6% rise in net sales and 9% rise in operating profit in 2021 for the Asia Pacific segment, but the original answer (ground truth) reports $2,867 million in net sales and 3.0% organic sales growth—without mentioning operating profit growth. These figures do not match, and the 6% and 9% numbers are unsupported by the ground truth. (2) The quantitative accuracy is low because the LLM invents percentages not present in the original data. While the mention of Swire Beverages as a bottling partner for Coca-Cola in Hong Kong is correct, the financial metrics for Colgate-Palmolive are factually incorrect. The original specifies $2,867 million in net sales and 3.0% organic growth, not 6% net sales growth. (3) The reasoning partially captures the multi-hop comparison—Coca-Cola’s reliance on a distribution partner vs. Colgate-Palmolive’s direct operations—but fails to include key details such as Colgate’s growth being driven by volume and cost savings in Greater China, particularly in Oral Care. The LLM oversimplifies and misrepresents the performance data. (4) Despite incorrect numbers, the answer remains contextually relevant by addressing the core contrast in market strategies. The qualitative accuracy is moderate because entity identification (Coca-Cola, Swire, Colgate-Palmolive, Asia Pacific) and general structure are correct, but the synthesis is flawed due to inaccurate metrics. Correctness score is 5 due to partial factual alignment but significant quantitative errors undermining the reliability of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 449,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s CDO exposure is measured by a **maximum‑loss‑exposure** framework that captures the worst‑case loss if all assets in the VIE become worthless, and it does not model the embedded‑derivative cash flows in detail (BAC 10‑K, p. 130). By contrast, JPM’s structured notes with embedded derivatives are valued through **discounted‑cash‑flow analysis** that incorporates Black‑Scholes or simulation models for the derivative component and then adjusts for the firm’s own credit risk (JPM 10‑K, p. 187). Thus, BAC relies on a conservative loss‑exposure metric, whereas JPM uses a more granular, model‑driven valuation of the embedded derivative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC uses a maximum-loss-exposure framework tied to its investment in VIEs without detailed modeling of embedded derivatives, while JPM employs discounted cash flow analyses with models like Black-Scholes or simulation techniques and adjusts for its own credit risk (DVA). These points are correctly represented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly contrasts BAC’s conservative, exposure-based approach with JPM’s granular, model-driven valuation methodology across two different 10-K disclosures. The mention of specific page numbers (p. 130 for BAC, p. 187 for JPM) adds precision and supports traceability, though these were not in the original answer—this is acceptable as long as they are plausible and do not contradict facts. (4) The LLM omits a minor detail from the original answer—specifically, the reference to credit protection being sold to the issuer as part of hybrid instruments exposing BAC to credit events—but this does not undermine the core comparison on risk exposure and modeling techniques. Overall, the answer captures the essential contrast in valuation transparency and risk modeling, making it semantically equivalent with only slight reduction in completeness. Hence, correctness is 9, qualitative accuracy 9, and full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 448,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "Comcast’s Class B common stock is largely non‑voting – holders have no vote on most matters, except for a narrow set of defined items such as the election of directors, amendments to the certificate of incorporation, and a few other specified matters. In contrast, Netflix’s common stock grants each share one vote on all matters to be voted upon, with no such restrictions. (NFLX voting rights – page 61; CMCSA Class B voting limitations – disclosed in the 10‑K’s note on voting rights.)",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key contrast in voting rights between CMCSA's Class B Common Stock and NFLX's common stock: CMCSA Class B has limited voting rights while NFLX grants one vote per share on all matters. The statement that NFLX provides one vote per share is factually correct and aligns with the ground truth. However, the LLM introduces a significant factual error by stating that CMCSA Class B stockholders can vote on 'the election of directors'—this is incorrect. According to the ground truth and actual CMCSA disclosures, Class B shares do not have voting rights on director elections; instead, they are limited to specific matters such as exiting the core payments business, certain mergers, or charter amendments. This misrepresentation undermines the qualitative accuracy. Additionally, the LLM omits the detail about votes being calculated using a conversion rate based on shares held, which is a key part of the voting mechanism for CMCSA. It also fails to mention that CMCSA Class B shares were still outstanding as of 2023, which supports the ongoing relevance of the governance structure. While the sources are cited generally, the core error in specifying voting matters (adding director elections) constitutes a major flaw in multi-hop reasoning and entity-specific detail synthesis. There are no numerical inaccuracies (hence high quantitative score), and the response remains contextually relevant to the question, but the qualitative inaccuracy reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 414,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley’s 10‑K states that it invests in CLNs and CDOs—hybrid instruments that contain embedded credit‑protection derivatives—but it does not break out a separate valuation model for the embedded component; the whole instrument is measured at fair value as a single hybrid asset (page 109). JPMorgan Chase, however, explicitly values structured notes by applying discounted‑cash‑flow analysis that models the embedded derivative (using Black‑Scholes, simulation, etc.) and then adjusts for its own credit risk (DVA), classifying the instrument as Level 2 or 3 (page 187). In short, Morgan Stanley treats the embedded derivative as part of the overall fair‑value measurement, whereas JPMorgan Chase uses a detailed, model‑based valuation for the embedded component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs (and CLNs) as hybrid instruments with embedded derivatives, measured at fair value as a single instrument without separate valuation of the embedded component—consistent with the original answer's description of Morgan Stanley’s approach. (2) It accurately describes JPMorgan Chase’s methodology: using discounted cash flow analyses, modeling embedded derivatives via Black-Scholes or simulation models, and adjusting for DVA (own credit risk), with classification in Level 2 or 3—this matches the original answer’s characterization. (3) The comparison is logically sound and synthesizes the key difference: Morgan Stanley does not separate the derivative for valuation, while JPMorgan explicitly models it. (4) Minor point: the original answer mentions credit events and potential non-repayment of principal, which adds context about risk exposure that the LLM omits; however, this does not undermine the core accuracy. No numbers, dates, or financial terms are incorrect. Page references (109, 187) appear to be from actual filings and support the claims. The answer is semantically equivalent, with only slight differences in emphasis. Quantitative accuracy is perfect (no incorrect figures). Qualitative accuracy is high, with strong multi-hop reasoning across firms and methodologies. Contextual relevance is excellent—directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 411,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott’s 10‑K notes that patent litigation and the risk of infringement claims could lead to damages or injunctions that would reduce its pharmaceutical revenues (see pages 12 and 14).  The supplied AbbVie pages do not describe Forest Laboratories’ actions to protect Vraylar exclusivity, so the precise intersection cannot be determined from the material provided; nevertheless, both companies’ revenue streams hinge on effective patent enforcement to preserve market exclusivity.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Abbott's exposure to intellectual property risks and references relevant pages from its 10-K, acknowledging that patent litigation could reduce pharmaceutical revenues. However, it incorrectly states that the supplied AbbVie pages do not describe Forest Laboratories’ actions to protect Vraylar exclusivity—this information is present in the ground truth and was expected to be synthesized. The LLM fails to mention the December 2019 litigation filing in the U.S. District Court for the District of Delaware, the involvement of generic competitors (Sun Pharmaceutical and Aurobindo Pharma), and the specific connection between AbbVie’s enforcement efforts and revenue protection for Vraylar. (2) There are no numeric values, dates, or calculations in the LLM answer, so quantitative accuracy is not violated—score is 10 by default. (3) The multi-hop reasoning is flawed: the question requires connecting Abbott’s general IP risk with AbbVie’s specific legal actions through Forest Laboratories to assess implications on both companies’ revenue streams. The LLM acknowledges both companies rely on patent enforcement but fails to establish the actual intersection described in the ground truth, missing key details that demonstrate synthesis across entities and filings. (4) Contextual relevance is moderate—the answer addresses the general theme of IP risk and revenue impact but omits critical factual details necessary for a complete, accurate response. Due to significant omissions and failure to synthesize key information present in the ground truth, the correctness score is 4—partially correct but with major gaps in factual content and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 463,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedging is an instrument‑based strategy: it uses foreign‑currency forwards and cross‑currency swaps to offset the FX risk of equity investments in non‑U.S. subsidiaries, recording the fair‑value changes of those hedges in AOCI (see pages 151–153).  \nMorgan Stanley, by contrast, relies on a statistical VaR model to quantify and monitor the aggregate market‑risk exposure of its trading portfolios; the 95 % one‑day VaR figures are used to set limits and guide risk‑management decisions rather than to execute specific hedging contracts (see pages 58–61).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both Citigroup's and Morgan Stanley's risk management strategies, with correct use of financial instruments and accounting treatment. Quantitatively, there are no numbers, percentages, or dollar amounts in the original or LLM answer that conflict—both correctly reference Citigroup’s use of forwards and swaps and Morgan Stanley’s 95% one-day VaR model, which aligns with the ground truth. The mention of 'pages 151–153' and 'pages 58–61' may refer to source document locations and do not contradict any data. However, the LLM answer omits the mention of Southern Company Gas and its use of weather derivatives, which is part of the multi-hop linkage in the original answer and provides broader industry context. While the core comparison between Citigroup and Morgan Stanley is well-executed and semantically equivalent to the ground truth, this omission reduces completeness in the multi-hop aspect. The reasoning is sound and correctly contrasts an instrument-based hedging strategy (Citigroup) with a model-based risk measurement approach (Morgan Stanley). The contextual relevance is high as the response directly addresses the comparative risk management strategies asked in the question. Thus, the correctness score is 8 due to the missing Southern Company Gas linkage, despite strong performance on accuracy and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 383,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive uses option contracts (along with forwards and swaps) to hedge its foreign‑currency purchases, which offsets FX volatility and keeps its cash‑flow swings small – the gains or losses on these hedges were not material to its 2024 results【page_90】【page_92】. In contrast, Walmart’s $37.2 billion of unrecorded purchase obligations, largely firm commitments for inventory and utilities, represent predictable cash outflows that can strain liquidity but are managed as part of normal operating cash flow【page_45】. Thus, Colgate’s hedging strategy stabilizes cash flows against currency swings, while Walmart’s commitments create fixed cash‑flow obligations that must be met regardless of market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key numbers are correct: Walmart's $37.2 billion in unrecorded purchase obligations is accurately cited, and the breakdown of $15.9 billion due within one year is implied as part of the total (though not explicitly mentioned, this omission is minor). The reference to Colgate-Palmolive's use of option contracts, along with forwards and swaps, is consistent with the original answer's broader hedging strategy. (2) The LLM correctly identifies that Colgate uses derivatives to stabilize cash flows from foreign exchange volatility, noting that hedge gains/losses were not material in 2024, which supports the conclusion of effective risk management. (3) The contrast with Walmart is sound: the LLM correctly states that Walmart’s obligations are firm commitments without mention of financial instrument hedges, highlighting greater exposure to market conditions. The original answer emphasizes Walmart’s lack of hedging protections, which the LLM captures by noting these are fixed outflows 'regardless of market conditions.' (4) Minor gap: the original specifies that Colgate’s contracts are valued using observable market rates and typically last no more than 12 months—details omitted but not critical to the core comparison. Also, the LLM mentions forwards and swaps not in the original answer, but since the original does not exclude them, this addition is reasonable. Overall, the multi-hop reasoning—linking Colgate’s hedging tools to cash flow stability versus Walmart’s unhedged commitments—is logically sound and semantically equivalent. Thus, the answer earns a 9 for correctness due to slight incompleteness on contract duration and valuation method, but remains factually robust and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 490,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "TMO adopted ASU 2023‑07 for the year ended December 31 2024 and applied it retrospectively to all prior periods presented, while CVS adopted the standard on January 1 2024 for fiscal‑year reporting and the standard became effective for interim periods beginning after December 15 2024【page 133】. Both companies now disclose significant segment expenses and other items that are not considered significant expenses, and the Chief Operating Decision Maker’s title and position; CVS additionally must explain how the CODM uses segment operating results to evaluate performance and allocate resources and provide a qualitative description of the composition of other items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the adoption timelines for both TMO and CVS: TMO adopted ASU 2023-07 for the year ended December 31, 2024, and applied it retrospectively, which aligns with the ground truth stating adoption for the 2024 annual report. CVS adopted the standard on January 1, 2024, and the interim requirements apply after December 15, 2024—this matches the original answer. All dates and timeframes are factually accurate. (2) Quantitatively, there are no numerical errors. The dates (December 31, 2024; January 1, 2024; December 15, 2024) are consistent with the ground truth. No calculations are required, but temporal references are precise and correctly formatted. (3) The LLM captures the required disclosures: both companies disclose the CODM’s title and segment expenses; CVS additionally explains how the CODM uses segment results and provides a qualitative description of other items—this aligns with the ground truth mentioning Note 19 disclosures including CODM’s title, use of segment results, and alignment with interim reporting. The mention of 'Note 11' for TMO is missing in the LLM answer, but the substance of increased disclosures is captured. (4) The reasoning is sound and reflects multi-hop synthesis across both companies’ filings. The LLM correctly contrasts TMO’s annual report focus with CVS’s broader alignment to interim reporting. Only minor omission is the specific note number (Note 11) for TMO and slightly less detail on 'alignment of interim reporting with annual requirements' for CVS, but the core disclosures are accurately conveyed. Overall, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 464,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "ACN’s 2021 effective tax rate rose to 21.8 % – a 0.1‑percentage‑point increase from 2020 – and the reduction in the Philippines’ corporate income tax rate partially offset that rise (PM note on tax effects, page 74). In contrast, AMD’s 2021 filing (pages 72‑76) does not report any material tax‑reform impact on its effective tax rate.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that ACN's 2021 effective tax rate 'rose' to 21.8% with a 0.1-percentage-point increase from 2020. The ground truth does not mention any year-over-year change or trend in ACN's effective tax rate — it only states the 2021 rate was 21.8%. This quantitative claim is unsupported and incorrect, undermining the answer's factual accuracy. (2) While the 21.8% figure itself is correct, the added detail about a 0.1% increase is fabricated and contradicts the original answer, which makes no such comparison. The mention of the Philippines tax rate reduction 'partially offsetting' the rise is partially correct but misaligned, as the ground truth states the reduction favorably impacted the rate by offsetting other unfavorable factors like GILTI-related limitations — not a year-over-year increase. (3) The qualitative reasoning is mostly sound: the model correctly identifies that ACN was affected by the Philippines tax change and that AMD reported no impact. It also correctly contrasts the two companies' disclosures, aligning with the multi-hop requirement. However, it fails to mention AMD's $0 value in the tax provision table, a key piece of evidence in the ground truth. (4) Contextual relevance is high — the answer addresses both companies and the tax reform impact as required. Despite incorrect quantitative claims, it captures the core contrast: ACN experienced a beneficial impact, while AMD did not. The reasoning is logically structured but weakened by unsupported numbers. Correctness score is reduced due to the significant error in implying a tax rate increase without evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 456,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values fixed‑income assets in its pension plans by applying pricing models that use verifiable observable market data (e.g., interest‑rate curves, credit spreads, broker bids) for Level 2 assets and a discounted‑cash‑flow approach for Level 3 assets, with explicit adjustments for credit and liquidity risks that may not be observable【108】【110】. 3M follows a similar hierarchy: Level 2 assets are priced at closing market prices or at yields on comparable securities, and Level 3 assets are valued with a discounted‑cash‑flow model that also incorporates adjustments for credit and liquidity risks that may not be observable【75】【76】.  Thus, both companies rely primarily on observable inputs for Level 2 valuations and use observable inputs in their Level 3 models, but each also adds unobservable‑risk adjustments to account for credit and liquidity factors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Honeywell and 3M use pricing models for fixed income investments in their pension plans, with Level 2 assets relying on observable inputs (e.g., interest rate curves, credit spreads, broker bids, comparable yields) and Level 3 assets using discounted cash flow models with unobservable adjustments. The mention of credit and liquidity risk adjustments—particularly those that may not be observable—is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all qualitative financial concepts (valuation levels, inputs, models) are correctly represented—hence a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes information across both companies and compares their methodologies in terms of observable vs. unobservable inputs. It accurately reflects that both companies use similar techniques (pricing models, discounted cash flows) and make similar adjustments, while implicitly capturing the distinction in disclosure focus (Honeywell on adjustments, 3M on hierarchy levels), though this nuance is slightly downplayed. (4) The answer is fully contextually relevant, directly addressing the comparison of valuation methodologies and reliance on input types. The only minor shortcoming is that the LLM does not explicitly note that 3M categorizes its investments by valuation hierarchy levels (Level 2 vs Level 3) in its disclosures, while Honeywell emphasizes the nature of valuation adjustments—this detail is present in the ground truth but only implicitly reflected in the LLM answer. However, the core factual content and comparative analysis are correct and comprehensive, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 508,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s Class B shares carry 10 (or 15) votes each and may be converted into Class A shares at any time, automatically converting on sale or transfer so that the 33 ⅓ % of voting power held by Class B holders remains intact and non‑dilutable (CMCSA, pp. 81‑91). Alphabet, by contrast, has been buying back and retiring both its voting Class A and non‑voting Class C shares (≈$62 billion in 2023, pp. 81‑83), shrinking the total share base—especially the voting shares—thereby boosting earnings per share and concentrating control among the remaining shareholders. Thus, CMCSA’s conversion mechanism preserves a fixed voting structure, while Alphabet’s share‑repurchase program alters the equity base and can consolidate voting power.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between CMCSA's voting structure and GOOGL's repurchase strategy but contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The $62 billion repurchase amount for GOOGL in 2023 is approximately correct (ground truth: $62.2 billion), but the LLM omits the critical detail of the remaining $36.3 billion authorization, which is part of the original answer’s completeness. More seriously, the claim that CMCSA's Class B shares carry '10 (or 15) votes each' is incorrect—CMCSA Class B shares do not have a fixed per-share vote count; instead, they collectively hold 33 1/3% of total voting power regardless of share count, which is a fundamental distinction. This misrepresents the core mechanism. (2) Completeness: The answer fails to mention that GOOGL’s Class B shares carry 10 votes per share and automatically convert to Class A upon sale—key to understanding control dynamics. It also omits that CMCSA’s Class A voting power is dependent on the total outstanding Class A and B shares, weakening the multi-hop synthesis. (3) Entity Accuracy: While companies (CMCSA, GOOGL/Alphabet) and years (2023) are correct, the misattribution of vote multiples to CMCSA shares is a major error. (4) Reasoning: The reasoning about repurchases concentrating control is sound, and the contrast in structural intent (preservation vs. consolidation of control) is conceptually accurate. However, the flawed understanding of CMCSA’s voting mechanism undermines the validity of the comparison. (5) Semantic Equivalence: The overall narrative direction is aligned with the ground truth, but due to key factual errors—especially the invented vote counts—the answer does not achieve semantic equivalence on critical points. The contextual relevance is high as it addresses the equity structure and control implications directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 510,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K (p. 42) states that the FCTC has prompted many countries to impose partial or total bans on advertising, marketing, promotions and sponsorships, and that in markets such as Australia and Russia the display of tobacco products at the point of sale is prohibited. PMI’s 2022 10‑K (p. 42) likewise reports that Australia and Russia have enacted advertising and display bans, forcing the company to shift its marketing focus toward product innovation, packaging and alternative promotion channels. Consequently, Altria faces a broader, global compliance burden on advertising, while PMI’s strategy is shaped by the need to adapt to specific bans in key markets, both prompting a move away from traditional advertising toward compliance‑friendly promotion and product differentiation.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in reasoning and entity synthesis despite correct citation of page numbers and general awareness of FCTC impacts. While it correctly notes that Australia and Russia have advertising and display bans, it misattributes this information to Altria's 10-K, which does not report on PMI's market conditions—Altria’s 10-K would not detail the operational impact of bans in Australia and Russia on PMI. The LLM incorrectly implies that Altria faces a 'broader, global compliance burden,' which contradicts the ground truth: Altria operates primarily in the U.S., which is not bound by FCTC, and thus faces less current restriction than PMI. In contrast, PMI, as a global operator, is directly affected by implemented bans in FCTC-compliant markets. The LLM flips this relationship, suggesting Altria has greater global exposure, when in fact PMI is the company adapting to real, enforced restrictions abroad. (2) There are no numeric values in the response, so quantitative accuracy is not applicable—no errors in numbers, dates, or calculations are present. (3) The multi-hop reasoning fails: the model does not correctly contrast Altria’s limited FCTC exposure due to U.S. non-ratification with PMI’s direct experience in regulated markets. Instead, it incorrectly equates or even reverses the exposure levels. The synthesis across companies is flawed, undermining the comparative analysis. (4) Contextual relevance is moderate—the answer addresses advertising restrictions and references both companies and markets, but the incorrect attribution and reversed conclusion reduce its usefulness. Correctness and qualitative accuracy are penalized due to the core misrepresentation of each company’s regulatory exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 483,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that Dodd‑Frank’s restrictions on proprietary trading and certain fund investments limit its ability to offer cryptocurrencies and other digital assets, putting it at a competitive disadvantage versus JPMorgan, which can operate with greater flexibility outside the U.S. (GS 10‑K, p. 13). In contrast, Morgan Stanley’s cross‑border crypto‑related activities are exposed to regulatory uncertainty in emerging markets, where evolving local laws, capital controls and enforcement risks could disrupt transactions and heighten market volatility (MS 10‑K, p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank restrictions on proprietary trading and fund investments limiting crypto offerings is accurately cited from its 10-K, and the comparison to JPMorgan's greater flexibility (implied competitive advantage) is correctly framed. Morgan Stanley's exposure to regulatory uncertainty in emerging markets affecting cross-border crypto activities is also accurately represented, including risks like capital controls and enforcement issues. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all referenced document sources (GS 10-K p.13, MS 10-K p.24) are correctly attributed, and no incorrect figures are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory constraints across two firms, distinguishes between U.S.-based structural limitations (Goldman) versus external geopolitical risks (Morgan Stanley), and aligns each with the appropriate competitive impact. (4) The only minor shortcoming is that the LLM answer does not explicitly state that JPMorgan *actively offers* cryptocurrency products (it only implies greater flexibility), which slightly weakens the comparative edge mentioned in the ground truth. Additionally, the phrase 'operate with greater flexibility outside the U.S.' could be misinterpreted as JPMorgan’s advantage being solely international, whereas the ground truth emphasizes JPMorgan’s domestic capability. However, this does not materially distort the overall meaning. Semantic equivalence is largely preserved, and the answer is contextually complete and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 491,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "3M adopted ASU 2022‑04 on Jan 1 2023 and, beginning Jan 1 2024, must disclose supplier‑finance program details—including key terms, balance‑sheet presentation, the confirmed amount outstanding at period‑end and a roll‑forward of changes in that amount (Note 15, 3M 10‑K). GE’s 10‑K (pages 45‑49) contains no supplier‑finance program disclosures or reference to ASU 2022‑04, so the new guidance does not affect GE’s disclosed information in the material presented.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to correctly synthesize the multi-hop information required. (1) Quantitative Accuracy: The LLM states that 3M adopted ASU 2022-04 on January 1, 2023, which aligns with the standard's effective date, but incorrectly implies that GE did not adopt the standard or disclose anything. The ground truth explicitly states that GE adopted ASU 2022-04 on January 1, 2023, and began providing roll-forward disclosures in 2024. The LLM incorrectly claims GE’s 10-K contains no disclosures or references to ASU 2022-04, which contradicts the ground truth. Additionally, the LLM omits all specific numbers provided in the original answer: 3M’s $0.3 billion confirmed invoice balance as of December 31, 2024, and $1.5 billion of invoices confirmed and paid during the year. These critical quantitative details are missing. (2) Completeness: The question asks about the impact on *both* 3M and GE, particularly regarding the roll-forward information introduced in 2024. The LLM fails to mention GE’s adoption and roll-forward disclosures, which is a core part of the original answer. (3) Entity Accuracy: While 3M and GE are correctly identified, the treatment of GE is factually wrong—GE *did* adopt the standard and *did* begin roll-forward disclosures in 2024. (4) Reasoning: The multi-hop reasoning is flawed. The LLM draws an incorrect conclusion about GE based on an apparent misreading of the source material, failing to recognize that GE’s adoption in 2023 leads to 2024 roll-forward disclosures as required. It also does not connect the phased implementation timeline of ASU 2022-04 to the 2024 disclosure requirement for roll-forwards, which is central to the original answer. (5) Semantic Equivalence: The LLM answer contradicts the ground truth on a key point (GE’s compliance) and omits essential numerical and descriptive content. While it correctly notes 3M’s adoption timeline and disclosure requirements, it lacks the specific data and correct synthesis for GE. Thus, despite some relevant context, the answer is largely incorrect on critical facts and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 569,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "MDT’s “Other Countries” segment generated $32.3 billion of net sales in 2023—about one‑third of its total revenue (page 105)—so a large portion of its business comes from markets outside the U.S. This concentration exposes MDT to the same regulatory and reimbursement headwinds that Amgen faces abroad, such as government‑controlled pricing, health‑technology assessment, payer cost‑containment measures and shifting reimbursement policies (MDT pages 18‑21). Amgen’s drug‑pricing strategy is similarly constrained by these factors in international markets, where government‑sponsored payers and price‑control regimes dictate reimbursement and pricing (Amgen pages 17, 20).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core idea that MDT's significant revenue from 'Other Countries' exposes it to international regulatory and reimbursement challenges similar to those faced by AMGN. The comparison between MDT’s medical device market pressures and AMGN’s drug pricing constraints in international markets is conceptually sound and aligns with the ground truth. However, there are key quantitative inaccuracies: the LLM states MDT’s 'Other Countries' revenue as $32.3 billion in 2023, while the ground truth specifies $32.251 billion in fiscal 2024 (not 2023). This introduces a one-year discrepancy and slight overstatement of revenue. Additionally, the claim that this represents 'about one-third of its total revenue' is incorrect—MDT’s total revenue in fiscal 2024 was approximately $33.6 billion, meaning $32.251 billion from 'Other Countries' would represent over 95%, not one-third. This is a major error in proportion. 2) The dollar amount is close but not exact ($32.3B vs $32.251B), and the fiscal year is wrong (2023 vs 2024). The percentage characterization is factually incorrect. 3) The multi-hop reasoning is strong: the model correctly links MDT’s geographic revenue concentration to regulatory risks and draws a parallel with AMGN’s exposure to price controls and reimbursement limitations abroad. It references relevant mechanisms like government-controlled pricing, health-technology assessments, and cost-containment—consistent with the types of challenges described in both companies’ filings. 4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially the mischaracterization of revenue share—reduce confidence in the factual precision. The answer would be stronger if it specified 'Total other countries, excluding Ireland' and aligned the fiscal year and revenue proportion correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 502,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s combined buffer requirement above the minimum risk‑based capital ratios is 5.0 % (2.5 % stress‑capital buffer + 2.5 % capital‑conservation buffer; the countercyclical buffer is 0 %)【page_122】.  \nJPMorgan’s combined buffer requirement is 2.5 % (capital‑conservation buffer for the Basel III Advanced approach; the countercyclical buffer is 0 %, and the Basel III Standardized approach adds a 2.9 % SCB)【page_291】. Thus Schwab’s total buffer requirement is roughly twice JPMorgan’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and calculation errors. While it correctly states SCHW's stress capital buffer (2.5%), capital conservation buffer (2.5%), and countercyclical buffer (0%), leading to a correct total of 5.0%, it misrepresents JPM's total buffer. The LLM claims JPM's combined buffer is 2.5%, incorrectly treating the 2.9% stress capital buffer (SCB) under the standardized approach as separate rather than additive. In reality, JPM’s total buffer is the sum of its 2.5% capital conservation buffer and 2.9% SCB, totaling 5.4%—not 2.5%. This leads to a completely incorrect conclusion that Schwab’s buffer is 'roughly twice' JPMorgan’s, when in fact JPM’s is slightly higher. (2) Quantitative accuracy fails on the key comparison: the LLM omits the addition of JPM’s buffers, resulting in a 5.4% actual vs. 2.5% reported—a major miscalculation. (3) Multi-hop reasoning is flawed: the model fails to synthesize that both buffers (CCoB and SCB) are additive for JPM, as they are for SCHW, leading to incorrect cross-firm comparison. It also misapplies regulatory frameworks by suggesting different treatment without justification. (4) Contextual relevance is acceptable—buffers and firms are correctly identified, and citations suggest document grounding—but the core quantitative and logical errors severely undermine the answer’s validity. The conclusion is the opposite of the truth (SCHW > JPM vs. JPM > SCHW), warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 411,
        "total_tokens": 1725
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.3,
    "average_quantitative_accuracy": 8.12,
    "average_qualitative_accuracy": 7.5,
    "average_contextual_relevance": 9.14,
    "score_distribution": {
      "excellent": 307,
      "good": 111,
      "fair": 123,
      "poor": 59
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-20b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 19617.64,
    "timestamp": "2026-02-03T06:30:51.929413"
  }
}